PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eggeling, C; Ringemann, C; Medda, R; Schwarzmann, G; Sandhoff, K; Polyakova, S; Belov, VN; Hein, B; von Middendorff, C; Schonle, A; Hell, SW				Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Schwarzmann, Guenter; Sandhoff, Konrad; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.			Direct observation of the nanoscale dynamics of membrane lipids in a living cell	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CULTURED-CELLS; RAFTS; MICROSCOPY; DIFFUSION; ORGANIZATION; RESOLUTION; GLUCOSYLCERAMIDE; MICRODOMAINS; DEPLETION	Cholesterol-mediated lipid interactions are thought to have a functional role in many membrane-associated processes such as signalling events(1-5). Although several experiments indicate their existence, lipid nanodomains ('rafts') remain controversial owing to the lack of suitable detection techniques in living cells(4,6-9). The controversy is reflected in their putative size of 5-200 nm, spanning the range between the extent of a protein complex and the resolution limit of optical microscopy. Here we demonstrate the ability of stimulated emission depletion (STED) far-field fluorescence nanoscopy(10) to detect single diffusing (lipid) molecules in nanosized areas in the plasma membrane of living cells. Tuning of the probed area to spot sizes similar to 70-fold below the diffraction barrier reveals that unlike phosphoglycerolipids, sphingolipids and glycosylphosphatidylinositol-anchored proteins are transiently (similar to 10-20 ms) trapped in cholesterol-mediated molecular complexes dwelling within <20-nm diameter areas. The non-invasive optical recording of molecular time traces and fluctuation data in tunable nanoscale domains is a powerful new approach to study the dynamics of biomolecules in living cells.	[Eggeling, Christian; Ringemann, Christian; Medda, Rebecca; Polyakova, Svetlana; Belov, Vladimir N.; Hein, Birka; von Middendorff, Claas; Schoenle, Andreas; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Schwarzmann, Guenter; Sandhoff, Konrad] Univ Bonn, LIMES Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Eggeling, C (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, Fassberg 11, D-37077 Gottingen, Germany.	ceggeli@gwdg.de; shell@gwdg.de	Polyakova, Svetlana M./U-4325-2018	Polyakova, Svetlana M./0000-0002-2971-5267; Belov, Vladimir N/0000-0002-7741-4653				BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; FAHEY PF, 1977, SCIENCE, V195, P305, DOI 10.1126/science.831279; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Fielding C. J, 2006, LIPID RAFTS CAVEOLAE; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Lommerse PHM, 2004, BBA-BIOMEMBRANES, V1664, P119, DOI 10.1016/j.bbamem.2004.05.005; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; OSBORN M, 1977, P NATL ACAD SCI USA, V74, P2490, DOI 10.1073/pnas.74.6.2490; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; SCHWARZMANN G, 1995, J BIOL CHEM, V270, P21271, DOI 10.1074/jbc.270.36.21271; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wenger J, 2007, BIOPHYS J, V92, P913, DOI 10.1529/biophysj.106.096586; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	32	1103	1118	16	746	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1159	U121		10.1038/nature07596	http://dx.doi.org/10.1038/nature07596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19098897	Green Published			2022-12-28	WOS:000263680100047
J	Ma, DK; Jang, MH; Guo, JU; Kitabatake, Y; Chang, ML; Pow-Anpongkul, N; Flavell, RA; Lu, B; Ming, GL; Song, H				Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Flavell, Richard A.; Lu, Binfeng; Ming, Guo-li; Song, Hongjun			Neuronal Activity-Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis	SCIENCE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MOUSE; TRANSCRIPTION; METHYLATION; MECHANISMS; PLASTICITY; SIGNALS; PROTEIN; CORTEX	The mammalian brain exhibits diverse types of neural plasticity, including activity- dependent neurogenesis in the adult hippocampus. How transient activation of mature neurons leads to long-lasting modulation of adult neurogenesis is unknown. Here we identify Gadd45b as a neural activity- induced immediate early gene in mature hippocampal neurons. Mice with Gadd45b deletion exhibit specific deficits in neural activity- induced proliferation of neural progenitors and dendritic growth of newborn neurons in the adult hippocampus. Mechanistically, Gadd45b is required for activity- induced DNA demethylation of specific promoters and expression of corresponding genes critical for adult neurogenesis, including brain- derived neurotrophic factor and fibroblast growth factor. Thus, Gadd45b links neuronal circuit activity to epigenetic DNA modification and expression of secreted factors in mature neurons for extrinsic modulation of neurogenesis in the adult brain.	[Ma, Dengke K.; Jang, Mi-Hyeon; Guo, Junjie U.; Kitabatake, Yasuji; Chang, Min-lin; Pow-Anpongkul, Nattapol; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Jang, Mi-Hyeon; Kitabatake, Yasuji; Chang, Min-lin; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ma, DK (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	dma2@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075	NIH; McKnight; NARSAD; March of Dimes; Johns Hopkins Brain Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight; NARSAD(NARSAD); March of Dimes(March of Dimes); Johns Hopkins Brain Science Institute(Johns Hopkins University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty, S. Synder, and members of Ming and Song laboratories for help and critical comments and L. Liu and Y. Cai for technical support. This work was supported by NIH, McKnight, and NARSAD (to H.S.) and by NIH, March of Dimes, and Johns Hopkins Brain Science Institute (to G-L.M.). R.A.F. is an investigator with the Howard Hughes Medical Institute.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Alam KY, 1996, J BIOL CHEM, V271, P30263, DOI 10.1074/jbc.271.47.30263; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kempermann G, 2000, Prog Brain Res, V127, P35; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MING GL, 2005, BIOL PSYCHIAT, V47, P223; Ploski JE, 2006, J NEUROCHEM, V99, P1122, DOI 10.1111/j.1471-4159.2006.04156.x; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang YX, 2001, BBA-GENE STRUCT EXPR, V1521, P45, DOI 10.1016/S0167-4781(01)00282-2	28	699	722	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1074	1077		10.1126/science.1166859	http://dx.doi.org/10.1126/science.1166859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119186	Green Accepted			2022-12-28	WOS:000263478400046
J	Wilczek, AM; Roe, JL; Knapp, MC; Cooper, MD; Lopez-Gallego, C; Martin, LJ; Muir, CD; Sim, S; Walker, A; Anderson, J; Egan, JF; Moyers, BT; Petipas, R; Giakountis, A; Charbit, E; Coupland, G; Welch, SM; Schmitt, J				Wilczek, Amity M.; Roe, Judith L.; Knapp, Mary C.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Sim, Sheina; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Giakountis, Antonis; Charbit, Erika; Coupland, George; Welch, Stephen M.; Schmitt, Johanna			Effects of Genetic Perturbation on Seasonal Life History Plasticity	SCIENCE			English	Article							FLOWERING TIME CONTROL; LOCUS-C ACTIVITY; ARABIDOPSIS-THALIANA; VERNALIZATION; PHOTOPERIOD; PHENOTYPE; PLANTS; TEMPERATURE; CONSTANS; GIGANTEA	Like many species, the model plant Arabidopsis thaliana exhibits multiple different life histories in natural environments. We grew mutants impaired in different signaling pathways in field experiments across the species' native European range in order to dissect the mechanisms underlying this variation. Unexpectedly, mutational loss at loci implicated in the cold requirement for flowering had little effect on life history except in late- summer cohorts. A genetically informed photothermal model of progression toward flowering explained most of the observed variation and predicted an abrupt transition from autumn flowering to spring flowering in late- summer germinants. Environmental signals control the timing of this transition, creating a critical window of acute sensitivity to genetic and climatic change that may be common for seasonally regulated life history traits.	[Wilczek, Amity M.; Cooper, Martha D.; Lopez-Gallego, Cristina; Martin, Laura J.; Muir, Christopher D.; Walker, Alexis; Anderson, Jillian; Egan, J. Franklin; Moyers, Brook T.; Petipas, Renee; Schmitt, Johanna] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Roe, Judith L.; Knapp, Mary C.; Sim, Sheina; Charbit, Erika; Welch, Stephen M.] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Giakountis, Antonis; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Brown University; Kansas State University; Max Planck Society	Schmitt, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	johanna_schmitt@brown.edu	Coupland, George/AAP-8609-2020; Lopez-Gallego, Cristina/F-5034-2015; Muir, Christopher/V-4461-2017; Moyers, Brook T./E-1516-2012	Coupland, George/0000-0001-6988-4172; Muir, Christopher/0000-0003-2555-3878; Moyers, Brook T./0000-0003-0340-9488; Petipas, Renee/0000-0002-8712-8183; Lopez-Gallego, Cristina/0000-0002-5872-6053; Giakountis, Antonis/0000-0001-8648-9908	NSF Frontiers in Integrative Biological Research [EF- 0425759]; Alexander von Humboldt Research Award	NSF Frontiers in Integrative Biological Research(National Science Foundation (NSF)); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation)	We thank M. Blazquez, C. Dean, M. Hoffmann, M. Koornneef, H. Kuittinen, and O. Savolainen for hosting these experiments at the European field sites; L. Albertson, L. Burghardt, C. Cooper, M.F. Cooper, Josephs, A. Lockwood, S. Myllyla, C. Oakley, R. Palmer, S. Rudder, and E. vonWettberg for assistance with planting and censusing; B. Robertson, M. Gosling, C. Lister, F. Eikelmann, G. Leuffen, W. Schuchert, T. Kauppila, and H. Eissner for technical and field assistance; R. Griffin, J. Kreikemeier, and G. Ragusa for assistance with the chamber experiment; A. Heim for contributions to the processing of temperature data; R. Amasino and J. Martinez- Zapater for sharing lines; S. Ruzsa of the Purugganan lab, who bulked lines for the experiments; and R. Amasino and C. Dean for manuscript comments. Supported by NSF Frontiers in Integrative Biological Research program grant EF- 0425759 and an Alexander von Humboldt Research Award.	Ausin I, 2005, INT J DEV BIOL, V49, P689, DOI 10.1387/ijdb.052022ia; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; BURGHARDT LT, 2008, 19 INT C AR RES MONT; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; De Melo-Abreu JP, 2004, AGR FOREST METEOROL, V125, P117, DOI 10.1016/j.agrformet.2004.02.009; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LAIBACH F, 1965, ARABIDOPSIS INFORMAT; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; McMaster GS, 2008, ANN BOT-LONDON, V102, P561, DOI 10.1093/aob/mcn115; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Schmitz RJ, 2007, BBA-GENE STRUCT EXPR, V1769, P269, DOI 10.1016/j.bbaexp.2007.02.003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403	28	288	293	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					930	934		10.1126/science.1165826	http://dx.doi.org/10.1126/science.1165826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19150810				2022-12-28	WOS:000263295400041
J	Holick, MF; Lim, R; Dighe, AS; Carroll, BC; Rosenberg, ES; Sherry, NA				Holick, Michael F.; Lim, Ruth; Dighe, Anand S.; Carroll, Bronwen C.; Rosenberg, Eric S.; Sherry, Nicole A.			A 9-Month-Old Boy with Seizures Rickets due to vitamin D deficiency. Iron-deficiency anemia. Severe protein-calorie malnutrition.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITIONAL RICKETS; INFANTS; CHILDREN; SUPPLEMENTATION; RISK		[Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA; [Holick, Michael F.] Boston Univ, Med Ctr, Dept Endocrinol, Boston, MA USA; [Holick, Michael F.] Boston Univ, Med Ctr, Dept Diabet, Boston, MA USA; [Lim, Ruth] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Holick, MF (corresponding author), Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758; Holick, Michael/0000-0001-6023-9062	Novartis; Bayer; Merck; Procter Gamble; Quest Diagnostics; National Dairy Council; UV Foundation	Novartis(Novartis); Bayer(Bayer AG); Merck(Merck & Company); Procter Gamble(Procter & Gamble); Quest Diagnostics; National Dairy Council; UV Foundation	Dr. Holick reports receiving consulting fees or serving on the paid advisory boards of Novartis, Bayer, Merck, Procter & Gamble, and Quest Diagnostics; lecture fees from Merck, Procter & Gamble, and Novartis; and grant support from the National Dairy Council and the UV Foundation. No other potential conflict of interest relevant to this article was reported. We thank Dr. Ian Michelow, the infectious-disease consultant on the case, and Dr. Nicole Sherry for their contributions to the development of this case study.	Camargo CA, 2006, J ALLERGY CLIN IMMUN, V117, P721, DOI 10.1016/j.jaci.2006.01.024; Chantry CJ, 2007, BREASTFEED MED, V2, P63, DOI 10.1089/bfm.2007.0002; David L, 1991, NESTLE NUTR WORKSHOP, P107; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; HESS AF, 1936, COLLECTED WRITINGS; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kiesler J, 2003, AM FAM PHYSICIAN, V67, P2547; Kottamasu S. R., 2004, CAFFEYS PEDIAT DIAGN, P2242; Kreiter SR, 2000, J PEDIATR-US, V137, P153, DOI 10.1067/mpd.2000.109009; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Weisberg P, 2004, AM J CLIN NUTR, V80, p1697S, DOI 10.1093/ajcn/80.6.1697S; Yorifuji J, 2008, J CLIN ENDOCR METAB, V93, P1784, DOI 10.1210/jc.2007-2254	17	21	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					398	407		10.1056/NEJMcpc0807821	http://dx.doi.org/10.1056/NEJMcpc0807821			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19164191				2022-12-28	WOS:000262519900012
J	Steinbrook, R				Steinbrook, Robert			Online Disclosure of Physician-Industry Relationships.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						ABELSON R, 2008, NY TIMES         DEC, V3, pB1; LOPES MJ, 2008, PHARM MED DEVICE MAN, pCH111; Steinbrook R, 2008, NEW ENGL J MED, V359, P559, DOI 10.1056/NEJMp0805309; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128	4	26	27	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					325	327		10.1056/NEJMp0810197	http://dx.doi.org/10.1056/NEJMp0810197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164185				2022-12-28	WOS:000262519900003
J	White, DB; Katz, MH; Luce, JM; Lo, B				White, Douglas B.; Katz, Mitchell H.; Luce, John M.; Lo, Bernard			Who Should Receive Life Support During a Public Health Emergency? Using Ethical Principles to Improve Allocation Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							FAIR PROCESS; PANDEMIC INFLUENZA; CRITICALLY-ILL; CRITICAL-CARE; TRIAGE	A public health emergency, such as an influenza pandemic, will lead to shortages of mechanical ventilators, critical care beds, and other potentially life-saving treatments. Difficult decisions about who will and will not receive these scarce resources will have to be made. Existing recommendations reflect a narrow utilitarian perspective, in which allocation decisions are based primarily on patients' chances of survival to hospital discharge. Certain patient groups, such as the elderly and those with functional impairment, are denied access to potentially life-saving treatments on the basis of additional allocation criteria. We analyze the ethical principles that could guide allocation and propose an allocation strategy that incorporates and balances multiple morally relevant considerations, including saving the most lives, maximizing the number of "life-years" saved, and prioritizing patients who have had the least chance to live through life's stages. We also argue that these principles are relevant to all patients and therefore should be applied to all patients, rather than selectively to the elderly, those with functional impairment, and those with certain chronic conditions. We discuss strategies to engage the public in setting the priorities that will guide allocation of scarce life-sustaining treatments during a public health emergency.	[White, Douglas B.] Univ Calif San Francisco, Program Med Eth, Sch Med, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco General Hospital Medical Center	White, DB (corresponding author), Univ Calif San Francisco, Program Med Eth, Sch Med, 521 Parnassus Ave,Suite C-126,Box 0903, San Francisco, CA 94143 USA.	dwhite@medicine.ucsf.edu			National Center for Research Resources [KL2 RR024130]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032875] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grant KL2 RR024130 from the National Center for Research Resources, a component of the NIH and NIH Roadmap for Medical Research and by the Greenwall Foundation.	Agency for Healthc.Res.Quality (AHRQ), 2005, AHRQ PUBL, V05-P022; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Burkle FM, 2002, EMERG MED CLIN N AM, V20, P409, DOI 10.1016/S0733-8627(01)00008-6; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; Childress JF, 2003, TRIAGE RESPONSE BIOT; Childress JF., 1970, SOUNDINGS, V53, P339; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 2005, LANCET, V366, P169, DOI 10.1016/S0140-6736(05)66518-X; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Danis M, 1997, CRIT CARE MED, V25, P887; *DEP HLTH HUM SERV, 2007, DRAFT GUID IN PRESS; Devereaux AV, 2008, CHEST, V133, p51S, DOI 10.1378/chest.07-2693; Egan TM, 2005, CHEST, V128, P407, DOI 10.1378/chest.128.1.407; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gostin L, 2006, JAMA-J AM MED ASSOC, V295, P1700, DOI 10.1001/jama.295.14.1700; Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Harris J., 1985, VALUE LIFE; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; LEVINSKY NG, 1984, NEW ENGL J MED, V311, P1573, DOI 10.1056/NEJM198412133112412; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pesik N, 2001, ANN EMERG MED, V37, P642, DOI 10.1067/mem.2001.114316; PHILLIPS SJ, 2006, AHRQ PUBLICATION; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; *PUBL ENG PIL PROJ, 2005, CIT VOIC PAND FLU CH; Ramsey Paul, 1970, PATIENT PERSON; Repine TB, 2005, MIL MED, V170, P505, DOI 10.7205/MILMED.170.6.505; RESCHER N, 1969, ETHICS, V79, P173, DOI 10.1086/291723; Rubinson L, 2005, CRIT CARE MED, V33, P2393, DOI 10.1097/01.CCM.0000173411.06574.D5; SANDERS D, 1968, UCLA LAW REV, V15, P357; Shortt SED, 1999, CAN MED ASSOC J, V161, P823; TANNER L, 2008, WASHINGTON POST 0505; Toner E, 2006, BIOSECUR BIOTERROR, V4, P207, DOI 10.1089/bsp.2006.4.207; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P1034, DOI 10.1037/0022-3514.72.5.1034; Veatch RM, 1997, KENNEDY INST ETHIC J, V7, P391, DOI 10.1353/ken.1997.0041; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	41	183	196	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					132	U94		10.7326/0003-4819-150-2-200901200-00011	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397ID	19153413	Green Accepted			2022-12-28	WOS:000262655200008
J	Carr, R; Brocklehurst, P; Dore, CJ; Modi, N				Carr, Robert; Brocklehurst, Peter; Dore, Caroline J.; Modi, Neeno			Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial	LANCET			English	Article							NEUTROPHIL KINETICS; GM-CSF; INFECTIONS; CHILDREN; INFANTS; NEWBORN; PLACEBO; CANCER	Background Systemic sepsis is a major cause of death in preterm neonates. There are compelling theoretical reasons why treatment with haemopoietic colony-stimulating factors might reduce sepsis and improve outcomes, and as a consequence these agents have entered into use in neonatal medicine without adequate evidence. We assessed whether granulocyte-macrophage colony stimulating factor (GM-CSF) administered as prophylaxis to preterm, neonates at high risk of neutropenia would reduce sepsis, mortality, and morbidity. Methods We undertook a single-blind, multicentre, randomised controlled trial in 26 centres between June, 2000, and June, 2006. 280 neonates of below or equal to 31 weeks' gestation and below the 10th centile for birthweight were randomised within 72 h of birth to receive GM-CSF 10 pg/kg per day subcutaneously for 5 days or standard management. From recruitment to day 28 a detailed daily clinical record form was completed by the treating clinicians. Primary outcome was sepsis-free survival to 14 days from trial entry. Analysis was by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN42553489. Findings Neutrophil counts after trial entry rose significantly more rapidly in infants treated with GM-CSF than in control infants during the first 11 days (difference between neutrophil count slopes 0.34x10(9)/L/day; 95% CI 0 . 12-0.56). There was no significant difference in sepsis-firee survival for all infants (93 of 139 treated infants, 105 of 141 control infants; difference -8%, 95% Cl -18 to 3). A meta-analysis of this trial and previous published prophylactic trials showed no survival benefit. Interpretation Early postnatal prophylactic GM-CSF corrects neutropenia but does not reduce sepsis or improve survival and short-term outcomes in extremely preterm neonates. Funding Action Medical Research.	[Carr, Robert] Kings Coll London, Guys & St Thomas Hosp, Dept Haematol, London WC2R 2LS, England; [Brocklehurst, Peter] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England; [Dore, Caroline J.] MRC, Clin Trials Unit, London, England; [Modi, Neeno] Univ London Imperial Coll Sci Technol & Med, Div Med, Sect Neonatal Med, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Medical Research Council Clinical Trials Unit; Imperial College London	Carr, R (corresponding author), Guys Hosp, Dept Haematol, London SE1 9RT, England.	robert.carr@gstt.nhs.uk	Brocklehurst, Peter/B-5804-2011; Dore, Caroline J/J-4716-2012	Dore, Caroline J/0000-0001-9796-4970	Action Medical Research	Action Medical Research	We acknowledge gratefully the contribution of the PROGRAMS administrative team (Anne Smith, PROGRAMS coordinator, Sarah Ayers, Ursula Bowler and staff of the National Perinatal Epidemiology Unit), Frances Cowan for defining the cranial ultrasound categories, Action Medical Research for funding the primary trial, BLISS, the premature newborn charity for assistance with trial materials and an parent and infant participants. The trial was funded by Action Medical Research.	Ahmad A, 2002, PEDIATR INFECT DIS J, V21, P1061, DOI 10.1097/00006454-200211000-00017; Bilgin K, 2001, PEDIATRICS, V107, P36, DOI 10.1542/peds.107.1.36; BURGESS AW, 1987, BLOOD, V69, P43; CADNAPAPHORNCHAI M, 1992, J PEDIATR-US, V121, P956, DOI 10.1016/S0022-3476(05)80351-8; Cairo MS, 1999, J PEDIATR-US, V134, P64, DOI 10.1016/S0022-3476(99)70373-2; CAIRO MS, 1990, PEDIATR RES, V27, P612, DOI 10.1203/00006450-199006000-00016; CAIRO MS, 1995, BLOOD, V86, P2509, DOI 10.1182/blood.V86.7.2509.bloodjournal8672509; Carr R, 2000, ARCH DIS CHILD-FETAL, V83, pF160, DOI 10.1136/fn.83.2.F160; Carr R, 2000, BRIT J HAEMATOL, V110, P18, DOI 10.1046/j.1365-2141.2000.01992.x; Carr R, 1997, ARCH DIS CHILD-FETAL, V76, pF128, DOI 10.1136/fn.76.2.F128; Carr R, 1999, PEDIATRICS, V103, P796, DOI 10.1542/peds.103.4.796; Carr R, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003066; CHRISTENSEN RD, 1989, AM J PEDIAT HEMATOL, V11, P215; CHRISTENSEN RD, 1980, J PEDIATR-US, V96, P316, DOI 10.1016/S0022-3476(80)80837-7; Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X; Fossati G, 1998, INT J MOL MED, V1, P943; FRENCK RW, 1990, J INFECT DIS, V162, P109, DOI 10.1093/infdis/162.1.109; GESSLER P, 1995, AM J PERINAT, V12, P34, DOI 10.1055/s-2007-994396; Gray PH, 1999, EUR J PEDIATR, V158, P71, DOI 10.1007/s004310051013; HAMILTON K, 2003, EARLY HUM DEV, V73, P116; HILL HR, 1987, PEDIATR RES, V22, P375, DOI 10.1203/00006450-198710000-00001; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; Kocherlakota P, 1998, PEDIATRICS, V102, P1107, DOI 10.1542/peds.102.5.1107; KOENIG JM, 1989, NEW ENGL J MED, V321, P557, DOI 10.1056/NEJM198908313210901; Lejeune M, 1999, BRIT J HAEMATOL, V106, P756, DOI 10.1046/j.1365-2141.1999.01589.x; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; MAYER P, 1987, BLOOD, V70, P206; Molloy EJ, 2005, PEDIATR RES, V57, P806, DOI 10.1203/01.PDR.0000156500.13600.B5; MOUZINHO A, 1994, PEDIATRICS, V94, P76; Ohlsson A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000361.pub3; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Sung L, 2004, J CLIN ONCOL, V22, P3350, DOI 10.1200/JCO.2004.09.106	34	83	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					226	233		10.1016/S0140-6736(09)60071-4	http://dx.doi.org/10.1016/S0140-6736(09)60071-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19150703				2022-12-28	WOS:000262537500025
J	van Zanten, SV				van Zanten, Sander Veldhuyzen			Dyspepsia and reflux in primary care: rough DIAMOND of a trial	LANCET			English	Editorial Material							UNINVESTIGATED DYSPEPSIA; FUNCTIONAL DYSPEPSIA; MANAGEMENT; HEARTBURN; DISEASE		[van Zanten, Sander Veldhuyzen] Univ Alberta, Div Gastroenterol, Edmonton, AB T6G 2X8, Canada	University of Alberta	van Zanten, SV (corresponding author), Univ Alberta, Div Gastroenterol, Edmonton, AB T6G 2X8, Canada.	vanzanten@ualberta.ca						Armstrong D, 2005, ALIMENT PHARM THER, V21, P1189, DOI 10.1111/j.1365-2036.2005.02466.x; Delaney B, 2005, COCHRANE DB SYST REV, V4; Irvine EJ, 2006, GASTROENTEROLOGY, V130, P1538, DOI 10.1053/j.gastro.2005.11.058; Junghard O, 2003, SCAND J GASTROENTERO, V38, P1197, DOI 10.1080/00365520310004920; Nyren O, 2002, GUT, V51, P464, DOI 10.1136/gut.51.4.464; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; van Marrewijk CJ, 2009, LANCET, V373, P215, DOI 10.1016/S0140-6736(09)60070-2; van Zanten SV, 2008, GUT, V57, P723, DOI 10.1136/gut.2007.139923; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					187	188		10.1016/S0140-6736(09)60051-9	http://dx.doi.org/10.1016/S0140-6736(09)60051-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19150689				2022-12-28	WOS:000262537500004
J	Bengtson, S; Rasmussen, B				Bengtson, Stefan; Rasmussen, Birger			PALEONTOLOGY New and Ancient Trace Makers	SCIENCE			English	Editorial Material							ANIMALS; INDIA		[Bengtson, Stefan] Swedish Museum Nat Hist, Nord Ctr Earth Evolut, SE-10405 Stockholm, Sweden; [Bengtson, Stefan] Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden; [Rasmussen, Birger] Curtin Univ Technol, Dept Appl Geol, Perth, WA 6845, Australia	Swedish Museum of Natural History; Swedish Museum of Natural History; Curtin University	Bengtson, S (corresponding author), Swedish Museum Nat Hist, Nord Ctr Earth Evolut, Box 50007, SE-10405 Stockholm, Sweden.	stefan.bengtson@nrm.se		Bengtson, Stefan/0000-0003-0206-5791; Rasmussen, Birger/0000-0002-2745-0904				Azmi RJ, 1998, SCIENCE, V282, P627; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Crimes T. Peter, 1994, P105; Matz MV, 2008, CURR BIOL, V18, P1849, DOI 10.1016/j.cub.2008.10.028; Morris SC, 2002, SCIENCE, V298, P57; Rasmussen B, 2002, SCIENCE, V296, P1112, DOI 10.1126/science.1070166; Seilacher A, 1998, SCIENCE, V282, P80, DOI 10.1126/science.282.5386.80; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43	9	10	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					346	347		10.1126/science.1168794	http://dx.doi.org/10.1126/science.1168794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150833	Green Submitted			2022-12-28	WOS:000262481400025
J	Geuking, MB; Weber, J; Dewannieux, M; Gorelik, E; Heidmann, T; Hengartner, H; Zinkernagel, RM; Hangartner, L				Geuking, Markus B.; Weber, Jacqueline; Dewannieux, Marie; Gorelik, Elieser; Heidmann, Thierry; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars			Recombination of Retrotransposon and Exogenous RNA Virus Results in Nonretroviral cDNA Integration	SCIENCE			English	Article							GENE-EXPRESSION; GERM-LINE; CELLS; ACTIVATION; GENOME; IDENTIFICATION; SEQUENCES; ONCOGENE; LEUKEMIA; ELEMENTS	Retroviruses have the potential to acquire host cell-derived genetic material during reverse transcription and can integrate into the genomes of larger, more complex DNA viruses. In contrast, RNA viruses were believed not to integrate into the host's genome under any circumstances. We found that illegitimate recombination between an exogenous nonretroviral RNA virus, lymphocytic choriomeningitis virus, and the endogenous intracisternal A-type particle (IAP) retrotransposon occurred and led to reverse transcription of exogenous viral RNA. The resulting complementary DNA was integrated into the host's genome with an IAP element. Thus, RNA viruses should be closely scrutinized for any capacity to interact with endogenous retroviral elements before their approval for therapeutic use in humans.	[Geuking, Markus B.; Weber, Jacqueline; Hengartner, Hans; Zinkernagel, Rolf M.; Hangartner, Lars] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Dewannieux, Marie; Heidmann, Thierry] Inst Gustave Roussy, CNRS, Unite Mixte Rech 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; [Dewannieux, Marie; Heidmann, Thierry] Univ Paris 11, F-91405 Orsay, France; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15232 USA	University of Zurich; University Zurich Hospital; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geuking, MB (corresponding author), McMaster Univ, Dept Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	geuking@mcmaster.ca; rolf.zinkernagel@usz.ch; hangartner.lars@virology.uzh.ch	Hangartner, Lars/AAS-1320-2021; Hangartner, Lars/H-3503-2011	Hangartner, Lars/0000-0002-3165-2058; Dewannieux, Marie/0000-0003-3918-2414	Swiss National Science Foundation; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	We are very grateful to K. K. Lueders for providing plasmids and critically reading the manuscript. We thank A. Macpherson, K. McCoy, and D. Burton for their support. We would also like to thank K. McCoy for critically reading the manuscript and for helpful comments. This study was supported by the Swiss National Science Foundation and the Canton of Zurich. M. B. G. planned and performed the experiments and wrote the paper together with L. H.; J. W. performed experiments; M. D., E. G., and T. H. provided reagents, cell lines, or plasmids; H. H. and R. M. Z. were involved in the planning and discussions of experiments, helped to write the paper, and provided the infrastructure used for this study; and L. H. initiated and supervised the study, planned and conducted experiments, and wrote the paper together with M. B. G. Sequences depicted in Fig. 1 are available from GenBank under accession numbers FJ460582 (MC57.18) and FJ460583 (MC57.23).	Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Braun E, 2000, VIROLOGY, V277, P136, DOI 10.1006/viro.2000.0568; CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Ishihara H, 2004, J RADIAT RES, V45, P25, DOI 10.1269/jrr.45.25; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; KUFF EL, 1983, NATURE, V302, P547, DOI 10.1038/302547a0; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; Lehmann- Grube F, 1971, VIROLOGY MONOGRAPHS; LESLIE KB, 1991, MOL CELL BIOL, V11, P5562, DOI 10.1128/MCB.11.11.5562; Li MF, 1996, J GEN VIROL, V77, P2757, DOI 10.1099/0022-1317-77-11-2757; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; ONO M, 1983, NUCLEIC ACIDS RES, V11, P7169, DOI 10.1093/nar/11.20.7169; Recher M, 2007, NAT MED, V13, P1316, DOI 10.1038/nm1670; Wang XY, 1997, CYTOKINES CELL MOL T, V3, P3	19	106	113	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					393	396		10.1126/science.1167375	http://dx.doi.org/10.1126/science.1167375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150848				2022-12-28	WOS:000262481400042
J	Rodriguez-Torres, M; Jeffers, LJ; Sheikh, MY; Rossaro, L; Ankoma-Sey, V; Hamzeh, FM; Martin, P				Rodriguez-Torres, Maribel; Jeffers, Lennox J.; Sheikh, Muhammad Y.; Rossaro, Lorenzo; Ankoma-Sey, Victor; Hamzeh, Fayez M.; Martin, Paul		Latino Study Grp	Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; VIRUS-INFECTION; COMBINATION THERAPY; UNITED-STATES; RACIAL-DIFFERENCES; ANTIVIRAL THERAPY; AMERICAN PATIENTS; PREVALENCE; TOLL-LIKE-RECEPTOR-7	Background Race has been shown to be a factor in the response to therapy for hepatitis C virus ( HCV) infection, and limited data suggest that ethnic group may be as well; however, Latinos and other ethnic subpopulations have been underrepresented in clinical trials. We evaluated the effect of Latino ethnic background on the response to treatment with peginterferon alfa- 2a and ribavirin in patients infected with HCV genotype 1 who had not been treated previously. Methods In a multicenter, open- label, nonrandomized, prospective study, 269 Latino and 300 non- Latino whites with HCV infection received peginterferon alfa- 2a, at a dose of 180 mu per week, and ribavirin, at a dose of 1000 or 1200 mg per day, for 48 weeks, and were followed through 72 weeks. The primary end point was a sustained virologic response. We enrolled Latinos whose parents and grandparents spoke Spanish as their primary language; nonwhite Latinos were excluded. Results Baseline characteristics were similar in the Latino and non- Latino groups, although higher proportions of Latino patients were 40 years of age or younger, had a body-mass index ( BMI, the weight in kilograms divided by the square of the height in meters) of more than 27 or more than 30, and had cirrhosis. The rate of sustained virologic response was higher among non- Latino whites than among Latinos ( 49% vs. 34%, P< 0.001). The absence of HCV RNA in serum was more frequent in non-Latino whites at week 4 ( P = 0.045) and throughout the treatment period ( P< 0.001 for all other comparisons). Latino or non- Latino background was an independent predictor of the rate of sustained virologic response in an analysis adjusted for baseline differences in BMI, cirrhosis, and other characteristics. Adherence to treatment did not differ significantly between the two groups. The numbers of patients with adverse events and dose modifications were similar in the two groups, but fewer Latino patients discontinued therapy because of adverse events. Conclusions Treatment with peginterferon alfa- 2a and ribavirin for 48 weeks resulted in rates of sustained virologic response among patients infected with HCV genotype 1 that were lower among Latino whites than among non- Latino whites. Strategies to improve the sustained virologic response in Latinos are needed. (ClinicalTrials. gov number, NCT00107653.).	[Rodriguez-Torres, Maribel] Fdn Invest Diego, San Juan, PR 00909 USA; [Rodriguez-Torres, Maribel] Ponce Sch Med, Ponce, PR USA; [Jeffers, Lennox J.; Martin, Paul] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Sheikh, Muhammad Y.] Univ Calif San Francisco, Fresno Med Educ Program, Community Reg Med Ctr, Fresno, CA USA; [Rossaro, Lorenzo] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Ankoma-Sey, Victor] Univ Texas Houston, Sch Med, Houston, TX USA; [Ankoma-Sey, Victor] St Lukes Episcopal Hosp, Ctr Liver Dis, Houston, TX 77030 USA; [Hamzeh, Fayez M.; Martin, Paul] Roche, Nutley, NJ USA	University of Miami; University of California System; University of California San Francisco; University of California San Francisco at Fresno; University of California System; University of California Davis; University of Texas System; University of Texas Health Science Center Houston; Saint Lukes Episcopal Hospital; Roche Holding	Rodriguez-Torres, M (corresponding author), Fdn Invest Diego, Ave de Diego 359,Suite 302, San Juan, PR 00909 USA.	rodztorres@coqui.net	Schildgen, Oliver/D-5327-2014; Vargas, Hugo E./K-1562-2019	Schildgen, Oliver/0000-0003-4297-9627; Vargas, Hugo E./0000-0002-7802-688X	Roche; Abbott Laboratories; Anadys; Pharmasset; Vertex; GlaxoSmithKline; Bristol-Myers Squibb; Merck; Valeant; Novartis; Wyeth; Virochem Pharma; Idera; Intarcia; Sanofi-Aventis; Human Genome Sciences; Idenix; Pfizer; Gilead; Tibotec; Gilead Sciences; Health and Environmental Science Institute; Schering; Three Rivers; Salix; Axcan Pharma	Roche(Roche Holding); Abbott Laboratories(Abbott Laboratories); Anadys; Pharmasset; Vertex(Vertex Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Valeant; Novartis(Novartis); Wyeth(Wyeth); Virochem Pharma; Idera; Intarcia; Sanofi-Aventis(Sanofi-Aventis); Human Genome Sciences(GlaxoSmithKline); Idenix; Pfizer(Pfizer); Gilead(Gilead Sciences); Tibotec; Gilead Sciences(Gilead Sciences); Health and Environmental Science Institute; Schering; Three Rivers; Salix; Axcan Pharma	Supported by Roche.; Dr. Rodriguez- Torres reports receiving consulting fees from Roche, Abbott Laboratories, Anadys, Pharmasset, Vertex, GlaxoSmithKline, Bristol-Myers Squibb, and Merck, lecture fees from Roche, and grant support from Vertex, Anadys, Roche, Valeant, GlaxoSmithKline, Novartis, Wyeth, Bristol-Myers Squibb, Virochem Pharma, Idera, Intarcia, Pharmasset, Sanofi-Aventis, Human Genome Sciences, Idenix, Pfizer, Gilead, Tibotec, and Merck; Dr. Jeffers, consulting and lecture fees from Roche and Bristol-Myers Squibb and grant support from Roche, Gilead Sciences, Bristol-Myers Squibb, and the Health and Environmental Science Institute; Dr. Sheikh, lecture fees and grant support from Roche; Dr. Rossaro, lecture fees from Roche, Schering, and Three Rivers, consulting fees from Roche and Schering, and grant support from Roche, Schering-Plough, Salix, Novartis, and Bristol-Myers Squibb; and Dr. Ankoma-Sey, consulting fees from Roche, Schering, Three Rivers, and Gilead, lecture fees from Axcan Pharma, Bristol-Myers Squibb, Roche, Gilead Sciences, Schering- Plough, Three Rivers, and Valeant, and grant support from Roche; Dr. Hamzeh, being an employee of Roche and owning equity in the company; and Dr. Martin, receiving consulting fees from Roche, Gilead, Bristol-Myers Squibb, and Vertex, lecture fees from Gilead, Bristol-Myers Squibb, Novartis, and Roche, and grant support from Gilead, Bristol-Myers Squibb, Vertex, and Roche. No other potential conflict of interest relevant to this article was reported.; We thank Ellen Lentz, Ph. D., of Roche, and Ambrose Kwok, Ph. D., of Everest Clinical Services, for statistical support and Susan Sutch, Pharm. D., of Envision Pharma for editorial assistance, which was funded by Roche.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Bonacini M, 2001, AM J GASTROENTEROL, V96, P2438, DOI 10.1111/j.1572-0241.2001.04050.x; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Cheung RC, 2005, AM J GASTROENTEROL, V100, P2186, DOI 10.1111/j.1572-0241.2005.00240.x; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Foster GR, 2007, SCAND J GASTROENTERO, V42, P247, DOI 10.1080/00365520600955526; Freilich B, 2006, HEPATOLOGY, V44, p320A; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gaglio PJ, 2004, J CLIN GASTROENTEROL, V38, P599, DOI 10.1097/00004836-200408000-00012; Gheorghe L, 2007, J GASTROINTEST LIVER, V16, P23; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hepburn MJ, 2004, AM J MED, V117, P163, DOI 10.1016/j.amjmed.2004.02.043; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lepe R, 2006, J VIRAL HEPATITIS, V13, P116, DOI 10.1111/j.1365-2893.2005.00672.x; McHutchison JG, 2000, GASTROENTEROLOGY, V119, P1317, DOI 10.1053/gast.2000.19289; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; Munoz Humberto, 2004, P R Health Sci J, V23, P61; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Persico M, 2008, GUT, V57, P507, DOI 10.1136/gut.2007.129478; Reddy KR, 1999, HEPATOLOGY, V30, P787, DOI 10.1002/hep.510300319; Rodriguez-Torres M, 2006, J CLIN GASTROENTEROL, V40, P358, DOI 10.1097/01.mcg.0000210105.66994.dc; Rodriguez-Torres M, 2008, CLIN GASTROENTEROL H, V6, P484, DOI 10.1016/j.cgh.2008.02.036; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Rosen HR, 2007, HEPATOLOGY, V46, P350, DOI 10.1002/hep.21714; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Strader DB, 2004, HEPATOLOGY, V40, P269, DOI 10.1002/hep.20316; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; United States Census Bureau, 2004, US INT PROJ AG SEX R; Verma S, 2006, AM J GASTROENTEROL, V101, P1817, DOI 10.1111/j.1572-0241.2006.00682.x; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165	36	128	131	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					257	267		10.1056/NEJMoa0805062	http://dx.doi.org/10.1056/NEJMoa0805062			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144941				2022-12-28	WOS:000262434500008
J	Schwartz, RS				Schwartz, Robert S.			Management of Prostate Cancer - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Schroder FH, 2008, NEW ENGL J MED, V359, P2605, DOI 10.1056/NEJMclde0805491	1	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					E4	U101		10.1056/NEJMclde0810802	http://dx.doi.org/10.1056/NEJMclde0810802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144933				2022-12-28	WOS:000262434500015
J	Boulton, AJM; Jeffcoate, WJ; Jones, TLZ; Ulbrecht, JS				Boulton, Andrew J. M.; Jeffcoate, William J.; Jones, Teresa L. Z.; Ulbrecht, Jon S.			International collaborative research on Charcot's disease	LANCET			English	Editorial Material									[Jeffcoate, William J.] Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, Nottingham NG5 1PB, England; [Boulton, Andrew J. M.] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England; [Jones, Teresa L. Z.] NIDDK, DEM, NIH, Bethesda, MD USA; [Ulbrecht, Jon S.] Penn State Univ, Penn State Inst Diabet & Obes, University Pk, PA 16802 USA	Nottingham University Hospital NHS Trust; University of Nottingham; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park	Jeffcoate, WJ (corresponding author), Nottingham Univ Hosp Trust, Foot Ulcer Trials Unit, Dept Diabet & Endocrinol, City Hosp Campus, Nottingham NG5 1PB, England.	william.jeffcoate@tiscali.co.uk						Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8	1	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					105	106		10.1016/S0140-6736(09)60019-2	http://dx.doi.org/10.1016/S0140-6736(09)60019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135599				2022-12-28	WOS:000262340900009
J	Davis, JM; Ramakrishnan, L				Davis, J. Muse; Ramakrishnan, Lalita			The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection	CELL			English	Article							MYCOBACTERIUM-MARINUM INFECTION; HUMAN MACROPHAGES; CELL-DEATH; CALMETTE-GUERIN; IN-VIVO; APOPTOSIS; IMMUNITY; ZEBRAFISH; PATHOGENESIS; VIRULENCE	Granulomas, organized aggregates of immune cells, form in response to persistent stimuli and are hallmarks of tuberculosis. Tuberculous granulomas have long been considered host-protective structures formed to contain infection. However, work in zebrafish infected with Mycobacterium marinum suggests that granulomas contribute to early bacterial growth. Here we use quantitative intravital microscopy to reveal distinct steps of granuloma formation and assess their consequence for infection. Intracellular mycobacteria use the ESX-1/RD1 virulence locus to induce recruitment of new macrophages to, and their rapid movement within, nascent granulomas. This motility enables multiple arriving macrophages to efficiently find and phagocytose infected macrophages undergoing apoptosis, leading to rapid, iterative expansion of infected macrophages and thereby bacterial numbers. The primary granuloma then seeds secondary granulomas via egress of infected macrophages. Our direct observations provide insight into how pathogenic mycobacteria exploit the granuloma during the innate immune phase for local expansion and systemic dissemination.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Davis, J. Muse/0000-0001-9959-6921; Ramakrishnan, Lalita/0000-0003-0692-5533	NIH [RO1 AI54503, RO1 AI36396]; Burroughs Wellcome Foundation; American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396, R01AI054503, R37AI054503] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); American Society for Engineering Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Troll for mathematical modelling, K. Winglee for data analysis, G. MacDonald, G. Davis, and F. Peri for technical advice, O. Humbert for initial observations, and B. Cormack, P. Edelstein, K. Urdahl, J. Egen, E. Brown, D. Tobin, H. Clay, H. Volkman, R. Lesley, and C. Cosma for discussion and critical comments. J. M. D. is grateful to R. Ahmed and to the late H. K. Ziegler for guidance. This work was supported by NIH RO1 grants AI54503 and AI36396 and the Burroughs Wellcome Foundation (L.R.) and an American Society for Engineering Education predoctoral fellowship (J.M.D.).	ADAMS DO, 1976, AM J PATHOL, V84, P164; ADAMS DO, 1975, AM J PATHOL, V80, P101; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; CREE IA, 1987, J CLIN PATHOL, V40, P1314, DOI 10.1136/jcp.40.11.1314; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Miller EA, 2008, IMMUNITY, V29, P175, DOI 10.1016/j.immuni.2008.07.003; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Oddo M, 1998, J IMMUNOL, V160, P5448; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters W, 2003, MICROBES INFECT, V5, P151, DOI 10.1016/S1286-4579(02)00082-5; Rich AR, 1946, PATHOGENESIS TUBERCU; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STANLEY SA, 2003, SCIENCE, V296, P1873; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Webb SE, 1996, J CELL SCI, V109, P793; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	62	584	608	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					37	49		10.1016/j.cell.2008.11.014	http://dx.doi.org/10.1016/j.cell.2008.11.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135887	Green Accepted, Bronze			2022-12-28	WOS:000262318400013
J	Weitz, DA				Weitz, David A.			MATERIALS SCIENCE Unjamming a Polymer Glass	SCIENCE			English	Editorial Material							DYNAMICS		[Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	weitz@seas.harvard.edu						ANGELL CA, 1924, SCIENCE, V267, P1995; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Eyring H, 1936, J CHEM PHYS, V4, P283, DOI 10.1063/1.1749836; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Lee HN, 2009, SCIENCE, V323, P231, DOI 10.1126/science.1165995; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Meijer HEH, 2005, PROG POLYM SCI, V30, P915, DOI 10.1016/j.progpolymsci.2005.06.009; Menon N, 1997, PHYS REV LETT, V79, P3407, DOI 10.1103/PhysRevLett.79.3407; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	10	17	18	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					214	215		10.1126/science.1168304	http://dx.doi.org/10.1126/science.1168304			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131616				2022-12-28	WOS:000262290600022
J	Greenfield, PM				Greenfield, Patricia M.			Technology and Informal Education: What Is Taught, What Is Learned	SCIENCE			English	Editorial Material							ACTION VIDEO GAMES; COMPUTER GAMES; SPATIAL SKILLS; MENTAL EFFORT; TELEVISION; IMPULSIVITY; EXPERIENCE; IMPACT; GAINS; IQ		[Greenfield, Patricia M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Greenfield, PM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.							Anderson CA, 2004, ADV EXP SOC PSYCHOL, V36, P199, DOI 10.1016/S0065-2601(04)36004-1; BEENTJES JWJ, 1993, COMMUN EDUC, V42, P191, DOI 10.1080/03634529309378927; Bergen L, 2005, HUM COMMUN RES, V31, P311, DOI 10.1093/hcr/31.3.311; BRUNER JS, 1965, AM PSYCHOL, V20, P1007, DOI 10.1037/h0023276; Carnagey NL, 2007, J EXP SOC PSYCHOL, V43, P489, DOI 10.1016/j.jesp.2006.05.003; Daley TC, 2003, PSYCHOL SCI, V14, P215, DOI 10.1111/1467-9280.02434; De Lisi R, 2002, J GENET PSYCHOL, V163, P272, DOI 10.1080/00221320209598683; Dede C, 2009, SCIENCE, V323, P66, DOI 10.1126/science.1167311; DeLisi R, 1996, COMPUT HUM BEHAV, V12, P351, DOI 10.1016/0747-5632(96)00013-1; DORVAL M, 1986, PERCEPT MOTOR SKILL, V62, P159, DOI 10.2466/pms.1986.62.1.159; Dye MW., 2004, J VISION, V4, P40, DOI [DOI 10.1167/4.11.40, 10.1167/4.11.40]; Flynn J. R., 1998, RISING CURVE LONG TE, P25; Flynn J. R., 1994, ENCY HUMAN INTELLIGE, P617; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Foehr U.G., 2006, MEDIA MULTITASKING A; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; GADBERRY S, 1980, Journal of Applied Developmental Psychology, V1, P45, DOI 10.1016/0193-3973(80)90061-1; GAGNON D, 1985, ECTJ-EDUC COMMUN TEC, V33, P263; Gardner H, 1983, FRAMES MIND THEORY M; GLENN ND, 1994, SOCIOL EDUC, V67, P216, DOI 10.2307/2112792; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; GREENFIELD P, 1988, J COMMUN, V38, P71, DOI 10.1111/j.1460-2466.1988.tb02048.x; Greenfield Patricia M., 1984, MIND MEDIA EFFECTS T; GREENFIELD PM, 1993, DEVELOPMENT AND MEANING OF PSYCHOLOGICAL DISTANCE, P161; GREENFIELD PM, DEV PSYCHOL IN PRESS; Greenfield PM, 1994, J APPL DEV PSYCHOL, V15, P105, DOI [10.1016/0193-3973(94)90008-6, DOI 10.1016/0193-3973(94)90008-6]; GREENFIELD PM, 1994, J APPL DEV PSYCHOL, V15, P87, DOI DOI 10.1016/0193-3973(94)90007-8; Greenfield PM., 1998, RISING CURVE LONG TE, P81, DOI 10.1037/10270-003; Gross EF, 2004, J APPL DEV PSYCHOL, V25, P633, DOI 10.1016/j.appdev.2004.09.005; Healy Jane., 1990, ENDANGERED MINDS WHY; Hembrooke H., 2003, Journal of Computing in Higher Education, V15, P46, DOI 10.1007/BF02940852; KAGAN J, 1966, CHILD DEV, V37, P583, DOI 10.1111/j.1467-8624.1966.tb04308.x; KAGAN J, 1965, CHILD DEV, V36, P609; KEARNEY P, 2005, P DIGRA WORLD C; Klineberg Otto, 1935, RACE DIFFERENCES; Lenhart A., 2008, VIDEO GAMES CIVICS; LIU X, 2001, CHIN J CLIN PSYCHOL, V9, P268; Mayo MJ, 2009, SCIENCE, V323, P79, DOI 10.1126/science.1166900; MCCLELLAN S, 2001, BROADCASTING CABLE, V131, P16; MCCLURG PA, 1987, J EDUC COMPUT RES, V3, P95, DOI 10.2190/9N5U-P3E9-R1X8-0RQM; Okagaki Lynn, 1994, J APPL DEV PSYCHOL, V15, P33, DOI DOI 10.1016/0193-3973(94)90005-1; Perucchini P., 1994, J APPL DEV PSYCHOL, V15, P59, DOI [10.1016/0193-3973(94)90006-X, DOI 10.1016/0193-3973(94)90006-X]; RICE ML, 1990, DEV PSYCHOL, V26, P421, DOI 10.1037/0012-1649.26.3.421; Rideout V. J., 2005, GENERATION M MEDIA L; Rosser JC, 2007, ARCH SURG-CHICAGO, V142, P181, DOI 10.1001/archsurg.142.2.181; SALOMON G, 1984, J EDUC PSYCHOL, V76, P647, DOI 10.1037/0022-0663.76.4.647; Salomon G., 1979, INTERACTION MEDIA CO, DOI DOI 10.4324/9780203052945; Schooler C., 1998, RISING CURVE LONG TE, P67, DOI DOI 10.1037/10270-002; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; TERENZINI PT, 1995, RES HIGH EDUC, V36, P23, DOI 10.1007/BF02207765; Valkenburg PM, 2000, HDB CHILDREN MEDIA, P121; Wheeler L. R., 1970, CROSS CULTURAL STUDI, P120	55	180	191	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					69	71		10.1126/science.1167190	http://dx.doi.org/10.1126/science.1167190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119220				2022-12-28	WOS:000262104100040
J	Hall, NJ; Pacilli, M; Eaton, S; Reblock, K; Gaines, BA; Pastor, A; Langer, JC; Koivusalo, AI; Pakarinen, MP; Stroedter, L; Beyerlein, S; Haddad, M; Clarke, S; Ford, H; Pierro, A				Hall, Nigel J.; Pacilli, Maurizio; Eaton, Simon; Reblock, Kim; Gaines, Barbara A.; Pastor, Aimee; Langer, Jacob C.; Koivusalo, Antti I.; Pakarinen, Mikko P.; Stroedter, Lutz; Beyerlein, Stefan; Haddad, Munther; Clarke, Simon; Ford, Henri; Pierro, Agostino			Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial	LANCET			English	Article							CLINICAL-TRIAL; EXPERIENCE; INCISION	Background A laparoscopic approach to pyloromyotomy for infantile pyloric stenosis has gained popularity but its effectiveness remains unproven. We aimed to compare outcomes after open or laparoscopic pyloromyotomy for the treatment of pyloric stenosis. Methods We did a multicentre international, double-blind, randomised, controlled trial between June, 2004, and May, 2007, across six tertiary paediatric surgical centres. 180 infants were randomly assigned to open (n=93) or laparoscopic pyloromyotomy (n=87) with minimisation for age, weight, gestational age at birth, bicarbonate at initial presentation, feeding type, preoperative duration of symptoms, and trial Centre. Infants with a diagnosis of pyloric stenosis were eligible. Primary outcomes were time to achieve full enteral feed and duration of postoperative recovery. We aimed to recruit 200 infants (100 per group); however, the data monitoring and ethics committee recommended halting the trial before full recruitment because of significant treatment benefit in one group at interim analysis. Participants, parents, and nursing staff were unaware of treatment. Data were analysed on an intention-to-treat basis with regression analysis. The trial is registered with ClinicalTrials.gov, number NCT00144924. Findings Time to achieve full enteral feeding in the open pyloromyotomy group was (median [IQR]) 23.9 h (16.0-41.0) versus 18.5 h (12.3-24. 0; p=0 . 002) in the laparoscopic group; postoperative length of stay was 43.8 h (25.3-55. 6) versus 33.6 h (22.9-48.1; p=0.027). Postoperative vomiting, and intra-operative and postoperative complications were similar between the two groups. Interpretation Both open and laparoscopic pyloromyotomy are safe procedures for the management of pyloric stenosis. However, laparoscopy has advantages over open pyloromyotomy, and we recommend its use in centres with suitable laparoscopic experience. Funding Sir Arthur Halley Stewart Trust.	[Hall, Nigel J.; Pacilli, Maurizio; Eaton, Simon; Pierro, Agostino] UCL, Inst Child Hlth, Dept Paediat Surg, London WC1N 1EH, England; [Hall, Nigel J.; Pacilli, Maurizio; Eaton, Simon; Pierro, Agostino] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Reblock, Kim; Gaines, Barbara A.] Childrens Hosp, Pittsburgh, PA 15213 USA; [Pastor, Aimee; Langer, Jacob C.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Koivusalo, Antti I.; Pakarinen, Mikko P.] Univ Helsinki Hosp, Helsinki, Finland; [Stroedter, Lutz; Beyerlein, Stefan] Med Univ Graz, Graz, Austria; [Haddad, Munther; Clarke, Simon] Chelsea & Westminster Hosp, London, England; [Ford, Henri] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Helsinki; Helsinki University Central Hospital; Medical University of Graz; Imperial College London; Children's Hospital Los Angeles	Hall, NJ (corresponding author), UCL, Inst Child Hlth, Dept Paediat Surg, 30 Guilford St, London WC1N 1EH, England.	n.hall@ich.ucl.ac.uk	Pacilli, Maurizio/O-3714-2017; Pakarinen, Mikko/AAD-8834-2019; Eaton, Simon/C-4942-2008	Pacilli, Maurizio/0000-0003-1259-4304; Eaton, Simon/0000-0003-0892-9204				Adibe OO, 2006, J PEDIATR SURG, V41, P1676, DOI 10.1016/j.jpedsurg.2006.05.051; ALAIN JL, 1991, J PEDIATR SURG, V26, P1191, DOI 10.1016/0022-3468(91)90331-M; Aldridge RD, 2007, J LAPAROENDOSC ADV S, V17, P131, DOI 10.1089/lap.2006.0525; Ali A, 2008, SURG ENDOSC, V22, P151, DOI 10.1007/s00464-007-9392-8; Bufo AJ, 1998, PEDIATR SURG INT, V13, P240, DOI 10.1007/s003830050307; Caceres Manuel, 2003, JSLS, V7, P123; Campbell BT, 2007, J PEDIATR SURG, V42, P2026, DOI 10.1016/j.jpedsurg.2007.08.021; Campbell BT, 2002, J PEDIATR SURG, V37, P1068, DOI 10.1053/jpsu.2002.33846; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Downey E C Jr, 1998, Semin Pediatr Surg, V7, P220; Ford Henri R, 2005, Surg Infect (Larchmt), V6, P313, DOI 10.1089/sur.2005.6.313; Ford WDA, 1997, J PEDIATR SURG, V32, P552, DOI 10.1016/S0022-3468(97)90705-3; Fujimoto T, 1999, J PEDIATR SURG, V34, P370, DOI 10.1016/S0022-3468(99)90212-9; GREASON KL, 1995, J PEDIATR SURG, V30, P1571, DOI 10.1016/0022-3468(95)90159-0; Greason KL., 1997, PEDIATR ENDOSURG INN, V1, P175; Hall NJ, 2004, ANN SURG, V240, P774, DOI 10.1097/01.sla.0000143250.48265.d6; Hall NJ, 2004, BRIT J SURG, V91, P1325, DOI 10.1002/bjs.4523; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; Kim SS, 2005, J AM COLL SURGEONS, V201, P66, DOI 10.1016/j.jamcollsurg.2005.03.020; Langer JC, 2004, PEDIATRICS, V113, P1342, DOI 10.1542/peds.113.5.1342; Leclair MD, 2007, J PEDIATR SURG, V42, P692, DOI 10.1016/j.jpedsurg.2006.12.016; Merkel S I, 1997, Pediatr Nurs, V23, P293; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; NAJMALDIN A, 1995, J PEDIATR SURG, V30, P37, DOI 10.1016/0022-3468(95)90604-5; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; Ramstedt C, 1912, MED KLIN, V26, P1191; SCORPIO RJ, 1995, J LAPAROENDOSC SURG, V5, P81, DOI 10.1089/lps.1995.5.81; Sitsen E, 1998, SURG ENDOSC-ULTRAS, V12, P813, DOI 10.1007/s004649900719; St Peter SD, 2006, ANN SURG, V244, P363, DOI 10.1097/01.sla.0000234647.03466.27; TAN KC, 1986, BRIT J SURG, V73, P399, DOI 10.1002/bjs.1800730529; Taqi E, 2007, J PEDIATR SURG, V42, P865, DOI 10.1016/j.jpedsurg.2006.12.051; Treasure T, 1998, BRIT MED J, V317, P362; van der Bilt JDW, 2004, SURG ENDOSC, V18, P907, DOI 10.1007/s00464-003-9075-z; Wade Angie, 2006, BMC Med Res Methodol, V6, P11, DOI 10.1186/1471-2288-6-11; Yagmurlu A, 2004, J PEDIATR SURG, V39, P292, DOI 10.1016/j.jpedsurg.2003.11.047	35	120	130	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					390	398		10.1016/S0140-6736(09)60006-4	http://dx.doi.org/10.1016/S0140-6736(09)60006-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19155060				2022-12-28	WOS:000262912100030
J	Grossman, D				Grossman, Daniel			Should the contraceptive pill be available without prescription? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL-CONTRACEPTIVES; HORMONAL CONTRACEPTION; NATIONAL-SURVEY; UNITED-STATES; WOMENS; ACCESS; MEXICO; GUIDELINES; ATTITUDES; FAILURE		[Grossman, Daniel] Ibis Reprod Hlth, San Francisco, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grossman, D (corresponding author), Ibis Reprod Hlth, San Francisco, CA USA.	DGrossman@ibisreproductivehealth.org	Potter, Joseph E/A-3122-2008					Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Editorial, 2008, LANCET, V371, P275; Foster DG, 2006, OBSTET GYNECOL, V108, P1107, DOI 10.1097/01.AOG.0000239122.98508.39; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; Gianfrancesco F., 2002, DRUG BENEFIT TRENDS, V14, P13; Gianfrancesco F, 2002, DRUG BENEFIT TRENDS, V14, P44; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Grossman D, 2006, AM J PUBLIC HEALTH, V96, P791, DOI 10.2105/AJPH.2004.040774; Grossman D, 2008, OBSTET GYNECOL, V112, P572, DOI 10.1097/AOG.0b013e31818345f0; Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013; Landau SC, 2006, CONTRACEPTION, V74, P463, DOI 10.1016/j.contraception.2006.07.006; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; *NAT I REPR HLTH, EXP MED COV EC STAT; *POP REF BUR, FAM PLANN WORLDW 200; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; Shah MA, 2001, INT J GYNECOL OBSTET, V73, P243, DOI 10.1016/S0020-7292(01)00375-7; Shotorbani S, 2006, CONTRACEPTION, V73, P501, DOI 10.1016/j.contraception.2005.12.001; Smith JD, 2005, J MIDWIFERY WOM HEAL, V50, P380, DOI 10.1016/j.jmwh.2005.01.011; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; Tatum C, 2005, CONTRACEPTION, V71, P208, DOI 10.1016/j.contraception.2004.08.018; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; WHO, 2004, MED EL CRIT CONTR US, V3; Yeatman SE, 2006, STUD FAMILY PLANN, V37, P197, DOI 10.1111/j.1728-4465.2006.00098.x; ZAVALA AS, 1987, STUD FAMILY PLANN, V18, P284, DOI 10.2307/1966857	24	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 23	2008	337								a3044	10.1136/bmj.a3044	http://dx.doi.org/10.1136/bmj.a3044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EL	19106138				2022-12-28	WOS:000262428400003
J	Ehlmann, BL; Mustard, JF; Murchie, SL; Poulet, F; Bishop, JL; Brown, AJ; Calvin, WM; Clark, RN; Des Marais, DJ; Milliken, RE; Roach, LH; Roush, TL; Swayze, GA; Wray, JJ				Ehlmann, Bethany L.; Mustard, John F.; Murchie, Scott L.; Poulet, Francois; Bishop, Janice L.; Brown, Adrian J.; Calvin, Wendy M.; Clark, Roger N.; Des Marais, David J.; Milliken, Ralph E.; Roach, Leah H.; Roush, Ted L.; Swayze, Gregg A.; Wray, James J.			Orbital Identification of Carbonate-Bearing Rocks on Mars	SCIENCE			English	Article							MINERALS; CLIMATE; TEMPERATURE; PRODUCTS; SULFATES; OLIVINE; SYSTEM; MODEL	Geochemical models for Mars predict carbonate formation during aqueous alteration. Carbonate- bearing rocks had not previously been detected on Mars' surface, but Mars Reconnaissance Orbiter mapping reveals a regional rock layer with near- infrared spectral characteristics that are consistent with the presence of magnesium carbonate in the Nili Fossae region. The carbonate is closely associated with both phyllosilicate- bearing and olivine- rich rock units and probably formed during the Noachian or early Hesperian era from the alteration of olivine by either hydrothermal fluids or near- surface water. The presence of carbonate as well as accompanying clays suggests that waters were neutral to alkaline at the time of its formation and that acidic weathering, proposed to be characteristic of Hesperian Mars, did not destroy these carbonates and thus did not dominate all aqueous environments.	[Ehlmann, Bethany L.; Mustard, John F.; Roach, Leah H.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Poulet, Francois] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bishop, Janice L.; Brown, Adrian J.] SETI Inst, Mountain View, CA 94043 USA; [Bishop, Janice L.; Brown, Adrian J.; Des Marais, David J.; Roush, Ted L.] NASA, Ames Res Ctr, Mountain View, CA 94043 USA; [Calvin, Wendy M.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA; [Clark, Roger N.; Swayze, Gregg A.] US Geol Survey, Lakewood, CO 80225 USA; [Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Wray, James J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Brown University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University	Ehlmann, BL (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Brown, Adrian Jon/AAC-5047-2022; Murchie, Scott L/E-8030-2015; Wray, James J/B-8457-2008	Murchie, Scott L/0000-0002-1616-8751; Wray, James J/0000-0001-5559-2179; Calvin, Wendy/0000-0002-6097-9586; Bishop, Janice/0000-0002-6681-9954	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database	NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database(National Aeronautics & Space Administration (NASA))	We thank R. Arvidson, R. Morris, N. Mangold, A. Baldridge, J.-P. Bibring, D. Jouglet, A. Fraeman, S. Wiseman, A. McEwen, G. Marzo, P. McGuire, and M. Wyatt for thoughtful discussions during manuscript preparation and E. Cloutis and others who have made quality spectral libraries available and contributed to the building of the NASA/Keck Reflectance Experiment Laboratory (RELAB) spectral database. We are grateful for the ongoing efforts of the MRO science and engineering teams, in particular the CRISM team, which enable these discoveries.	Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Bullock MA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030688; Burns R. G, 1993, MINERALOGICAL APPL C; CALVIN WM, 1994, J GEOPHYS RES-PLANET, V99, P14659, DOI 10.1029/94JE01090; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chevrier V, 2007, NATURE, V448, P60, DOI 10.1038/nature05961; CHRISTENSEN PR, 2003, 6 INT C MARS LUN PLA; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; CLOUTIS EA, 2000, LUNAR PLANET SCI C, V31; Ehlmann BL, 2008, NAT GEOSCI, V1, P355, DOI 10.1038/ngeo207; EHLMANN BL, 2007, 7 INT C MARS LUN PLA; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; GAFFEY SJ, 1987, J GEOPHYS RES-SOLID, V92, P1429, DOI 10.1029/JB092iB02p01429; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; Greeley R., 1987, GEOLOGICAL MAP E EQU; Hanchen M, 2008, CHEM ENG SCI, V63, P1012, DOI 10.1016/j.ces.2007.09.052; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Hamilton VE, 2005, GEOLOGY, V33, P433, DOI 10.1130/G21258.1; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Hunt G. R., 1971, Modern Geology, V2, P23; Hurowitz JA, 2007, EARTH PLANET SC LETT, V260, P432, DOI 10.1016/j.epsl.2007.05.043; JOUGLET D, 2007, 7 INT C MARS LUN PLA; JULL AJT, 1988, SCIENCE, V242, P417, DOI 10.1126/science.242.4877.417; Koeppen WC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002984; Konigsberger E, 1999, GEOCHIM COSMOCHIM AC, V63, P3105, DOI 10.1016/S0016-7037(99)00238-0; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Mangold N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002835; Melezhik VA, 2001, SEDIMENTOLOGY, V48, P379, DOI 10.1046/j.1365-3091.2001.00369.x; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002834; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Parente M., 2008, LUNAR PLANET SCI C, VXXXIX; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Poulet F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002840; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Poulet F., 2007, 7 INT C MARS LUN PLA; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Tornabene LL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002988; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; Wagner C, 1996, ICARUS, V123, P256, DOI 10.1006/icar.1996.0156	45	477	484	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1828	1832		10.1126/science.1164759	http://dx.doi.org/10.1126/science.1164759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095939				2022-12-28	WOS:000261799400050
J	Luan, B; Zhao, J; Wu, HY; Duan, BY; Shu, GW; Wang, XY; Li, DS; Jia, WP; Kang, JH; Pei, G				Luan, Bing; Zhao, Jian; Wu, Haiya; Duan, Baoyu; Shu, Guangwen; Wang, Xiaoying; Li, Dangsheng; Jia, Weiping; Kang, Jiuhong; Pei, Gang			Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATION; PROTEIN; KINASE; AKT; SRC; OBESITY; PHOSPHORYLATION; TRANSDUCTION; PATHWAYS	Insulin resistance, a hallmark of type 2 diabetes, is a defect of insulin in stimulating insulin receptor signalling(1,2), which has become one of the most serious public health threats. Upon stimulation by insulin, insulin receptor recruits and phosphorylates insulin receptor substrate proteins(3), leading to activation of the phosphatidylinositol-3-OH kinase (PI(3) K)-Akt pathway. Activated Akt phosphorylates downstream kinases and transcription factors, thus mediating most of the metabolic actions of insulin(4-6). beta-arrestins mediate biological functions of G-protein-coupled receptors by linking activated receptors with distinct sets of accessory and effecter proteins, thereby determining the specificity, efficiency and capacity of signals(7-11). Here we show that in diabetic mouse models, beta-arrestin-2 is severely downregulated. Knockdown of beta-arrestin-2 exacerbates insulin resistance, whereas administration of beta-arrestin-2 restores insulin sensitivity in mice. Further investigation reveals that insulin stimulates the formation of a new beta-arrestin-2 signal complex, in which beta-arrestin-2 scaffolds Akt and Src to insulin receptor. Loss or dysfunction of beta-arrestin-2 results in deficiency of this signal complex and disturbance of insulin signalling in vivo, thereby contributing to the development of insulin resistance and progression of type 2 diabetes. Our findings provide new insight into the molecular pathogenesis of insulin resistance, and implicate new preventive and therapeutic strategies against insulin resistance and type 2 diabetes.	[Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Luan, Bing; Zhao, Jian; Duan, Baoyu; Shu, Guangwen; Kang, Jiuhong; Pei, Gang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Diabet Inst, Shanghai, Peoples R China; [Wu, Haiya; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Wang, Xiaoying] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai 200032, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Shanghai Jiao Tong University; Fudan University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Luan, Bing/B-5521-2014; Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Luan, Bing/0000-0002-0409-2964; Kang, Jiuhong/0000-0001-7538-1889	Ministry of Science and Technology [2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000, 2009CB941100]; National Natural Science Foundation of China [30621091, 30625014, 30623003, 30871285, 90713047]; Shanghai Municipal Commission for Science and Technology [07PJ14099, 06DZ22032]; Chinese Academy of Sciences [KSCX2-YW-R-56, 2007KIP204]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences)	We are grateful to R. J. Lefkowitz for providing us with beta-arr2-KO mice. We thank J.-L. Guan for discussions and comments on the manuscripts. We thank all members of the laboratory for sharing reagents and advice. This research was supported by the Ministry of Science and Technology (2005CB522406, 2006CB943900, 2007CB947904, 2007CB947100, 2007CB948000 and 2009CB941100), National Natural Science Foundation of China (30621091, 30625014, 30623003, 30871285 and 90713047), Shanghai Municipal Commission for Science and Technology (07PJ14099 and 06DZ22032), Chinese Academy of Sciences (KSCX2-YW-R-56 and 2007KIP204).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Craxton A, 1999, J BIOL CHEM, V274, P30644, DOI 10.1074/jbc.274.43.30644; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Shen HQ, 1999, METABOLISM, V48, P965, DOI 10.1016/S0026-0495(99)90191-9; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	26	181	202	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1146	U105		10.1038/nature07617	http://dx.doi.org/10.1038/nature07617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122674				2022-12-28	WOS:000263680100044
J	Sun, JC; Beilke, JN; Lanier, LL				Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.			Adaptive immune features of natural killer cells	NATURE			English	Article							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS; ACTIVATION RECEPTOR; VIRAL-INFECTION; NK CELLS; IN-VIVO; MEMORY; EFFECTOR; RECOGNITION; ANTIGEN	In an adaptive immune response, naive T cells proliferate during infection and generate long- lived memory cells that undergo secondary expansion after a repeat encounter with the same pathogen. Although natural killer (NK) cells have traditionally been classified as cells of the innate immune system, they share many similarities with cytotoxic T lymphocytes. We use a mouse model of cytomegalovirus infection to show that, like T cells, NK cells bearing the virus-specific Ly49H receptor proliferate 100-fold in the spleen and 1,000- fold in the liver after infection. After a contraction phase, Ly49H- positive NK cells reside in lymphoid and non- lymphoid organs for several months. These self- renewing 'memory' NK cells rapidly degranulate and produce cytokines on reactivation. Adoptive transfer of these NK cells into naive animals followed by viral challenge results in a robust secondary expansion and protective immunity. These findings reveal properties of NK cells that were previously attributed only to cells of the adaptive immune system.	[Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sun, Joseph C.; Beilke, Joshua N.; Lanier, Lewis L.] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	National Institutes of Health [AI068129]; Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute for Immunological Research; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Lanier laboratory for comments and discussions, and R. Locksley and W. Seaman for critical reading of this manuscript. The work was supported by National Institutes of Health grant AI068129. J.C.S. is supported by the Irvington Institute for Immunological Research. J.N.B. is supported by the Juvenile Diabetes Research Foundation. L.L.L. is an American Cancer Society Research Professor.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lanier LL, 2007, EUR J IMMUNOL, V37, P1424, DOI 10.1002/eji.200737418; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Vidal SM, 2006, CURR TOP MICROBIOL, V298, P183; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	36	1061	1113	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2009	457	7229					557	561		10.1038/nature07665	http://dx.doi.org/10.1038/nature07665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400FA	19136945	Green Accepted			2022-12-28	WOS:000262852200035
J	Mega, JL; Close, SL; Wiviott, SD; Shen, L; Hockett, RD; Brandt, JT; Walker, JR; Antman, EM; Macias, W; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Close, Sandra L.; Wiviott, Stephen D.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Walker, Joseph R.; Antman, Elliott M.; Macias, William; Braunwald, Eugene; Sabatine, Marc S.			Cytochrome P-450 Polymorphisms and Response to Clopidogrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PLATELET INHIBITION; INDIVIDUAL RESPONSIVENESS; ATHEROTHROMBOTIC EVENTS; STENT THROMBOSIS; INCREASED RISK; PRASUGREL; PHARMACOKINETICS; PHARMACODYNAMICS; VARIABILITY	Background: Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet effect. The genes encoding CYP enzymes are polymorphic, with common alleles conferring reduced function. Methods: We tested the association between functional genetic variants in CYP genes, plasma concentrations of active drug metabolite, and platelet inhibition in response to clopidogrel in 162 healthy subjects. We then examined the association between these genetic variants and cardiovascular outcomes in a separate cohort of 1477 subjects with acute coronary syndromes who were treated with clopidogrel in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI) 38. Results: In healthy subjects who were treated with clopidogrel, carriers of at least one CYP2C19 reduced-function allele (approximately 30% of the study population) had a relative reduction of 32.4% in plasma exposure to the active metabolite of clopidogrel, as compared with noncarriers (P<0.001). Carriers also had an absolute reduction in maximal platelet aggregation in response to clopidogrel that was 9 percentage points less than that seen in noncarriers (P<0.001). Among clopidogrel-treated subjects in TRITON-TIMI 38, carriers had a relative increase of 53% in the composite primary efficacy outcome of the risk of death from cardiovascular causes, myocardial infarction, or stroke, as compared with noncarriers (12.1% vs. 8.0%; hazard ratio for carriers, 1.53; 95% confidence interval [CI], 1.07 to 2.19; P=0.01) and an increase by a factor of 3 in the risk of stent thrombosis (2.6% vs. 0.8%; hazard ratio, 3.09; 95% CI, 1.19 to 8.00; P=0.02). Conclusions: Among persons treated with clopidogrel, carriers of a reduced-function CYP2C19 allele had significantly lower levels of the active metabolite of clopidogrel, diminished platelet inhibition, and a higher rate of major adverse cardiovascular events, including stent thrombosis, than did noncarriers. N Engl J Med 2009;360:354-62.	[Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, Boston, MA 02115 USA; [Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Close, Sandra L.; Shen, Lei; Hockett, Richard D.; Brandt, John T.; Macias, William] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Walker, Joseph R.] Daiichi Sankyo Pharma Dev, Edison, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eli Lilly; Daiichi Sankyo Company Limited	Mega, JL (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Thrombolysis Myocardial Infarct Study Grp, Dept Med, 350 Longwood Ave, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Wiviott, Stephen/HIK-2534-2022; Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359	Daiichi Sankyo; Eli Lilly; Sanofi-Aventis; Schering-Plough; AstraZeneca; Bristol-Myers Squibb	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb)	Supported by research grants from Daiichi Sankyo and Eli Lilly.; The TIMI Study Group reports receiving grant support from Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, and Schering-Plough. In addition, Dr. Mega reports receiving grant support from Schering-Plough; Dr. Wiviott, grant support from Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis, consulting fees from AstraZeneca and Sanofi-Aventis, and lecture fees from Daiichi-Sankyo, Eli Lilly, and AstraZeneca; Dr. Antman, grant support from Daiichi Sankyo and Eli Lilly, consulting fees from Sanofi- Aventis, and lecture fees from Eli Lilly and Sanofi-Aventis; Dr. Braunwald, grant support from Daiichi Sankyo, Eli Lilly, SanofiAventis, and Schering- Plough, consulting fees from Daiichi Sankyo, Eli Lilly, and Schering- Plough, and lecture fees from Eli Lilly and Schering-Plough; and Dr. Sabatine, grant support from Sanofi- Aventis and Schering-Plough, consulting fees from AstraZeneca, Bristol-Myers Squibb, and Sanofi- Aventis, and lecture fees from Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis. Dr. Walker reports being an employee of Daiichi Sankyo and having an equity interest or stock options in the company; and Drs. Close, Shen, Hockett, Brandt, and Macias, being employees of Eli Lilly and having an equity interest or stock options in the company. No other potential conflict of interest relevant to this article was reported.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; *BLUE CROSS BLUE S, 2004, SPEC REP GEN CYT P45; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Daly TM, 2007, CLIN CHEM, V53, P1222, DOI 10.1373/clinchem.2007.086348; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Farid NA, 2007, RAPID COMMUN MASS SP, V21, P169, DOI 10.1002/rcm.2813; Farid NA, 2008, PHARMACOTHERAPY, V28, P1483, DOI 10.1592/phco.28.12.1483; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; *KAR I, HUM CYT P450 CYP ALL; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kurihara A., 2005, DRUG METAB REV S2, V37, P99; LI YG, 2008, AM J CARDIOL S, V102, P76; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Payne CD, 2008, PLATELETS, V19, P275, DOI 10.1080/09537100801891640; Payne CD, 2007, J CARDIOVASC PHARM, V50, P555, DOI 10.1097/FJC.0b013e3181492209; Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Small DS, 2008, CURR MED RES OPIN, V24, P2251, DOI 10.1185/03007990802205985; SMALL DS, 2008, CLIN PHARM THER S1, V83, pS56; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	38	1817	1958	6	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					354	362		10.1056/NEJMoa0809171	http://dx.doi.org/10.1056/NEJMoa0809171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106084				2022-12-28	WOS:000262519900007
J	Min, BK; Ostby, E; Sorger, V; Ulin-Avila, E; Yang, L; Zhang, X; Vahala, K				Min, Bumki; Ostby, Eric; Sorger, Volker; Ulin-Avila, Erick; Yang, Lan; Zhang, Xiang; Vahala, Kerry			High-Q surface-plasmon-polariton whispering-gallery microcavity	NATURE			English	Article							NANOCAVITIES; RESONATORS; OPTICS; MODES; LIMIT; CHIP	Surface plasmon polaritons (SPPs) are electron density waves excited at the interfaces between metals and dielectric materials(1). Owing to their highly localized electromagnetic fields, they may be used for the transport and manipulation of photons on subwavelength scales(2-9). In particular, plasmonic resonant cavities represent an application that could exploit this field compression to create ultra-smal-lmode- volume devices. Akey figure of merit in this regard is the ratio of cavity quality factor, Q ( related to the dissipation rate of photons confined to the cavity), to cavity mode volume, V ( refs 10, 11). However, plasmonic cavity Q factors have so far been limited to values less than 100 both for visible and near- infrared wave-lengths(12) (-16). Significantly, such values are far below the theoretically achievable Q factors for plasmonic resonant structures. Here we demonstrate a high- Q SPP whispering- gallery microcavity that is made by coating the surface of a high- Q silica microresonator with a thin layer of a noble metal. Using this structure, Q factors of 1,376+/-65 can be achieved in the near infrared for surface- plasmonic whispering- gallery modes at room temperature. This nearly ideal value, which is close to the theoretical metal- loss- limited Q factor, is attributed to the suppression and minimization of radiation and scattering losses that are made possible by the geometrical structure and the fabrication method. The SPP eigenmodes, as well as the dielectric eigenmodes, are confined within the whispering- gallery microcavity and accessed evanescently using a single strand of low-loss, tapered optical waveguide(17,18). This coupling scheme provides a convenient way of selectively exciting and probing confined SPP eigenmodes. Up to 49.7 per cent of input power is coupled by phase- matching control between the microcavity SPP and the tapered fibre eigenmodes.	[Min, Bumki; Sorger, Volker; Ulin-Avila, Erick; Zhang, Xiang] Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Min, Bumki; Ostby, Eric; Yang, Lan; Vahala, Kerry] CALTECH, Thomas J Watson Lab Appl Phys, Pasadena, CA 91125 USA; [Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; California Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, 5130 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu; vahala@caltech.edu	Yang, Lan/AAC-5397-2019; ulin-avila, erick/M-3278-2014; Zhang, Xiang/F-6905-2011; Yang, Lan/AAC-5390-2019; Min, Bumki/A-1294-2007; Yang, Lan/B-5407-2018	Yang, Lan/0000-0002-9052-0450; Yang, Lan/0000-0002-9052-0450; Zhang, Xiang/0000-0002-3272-894X; Ulin-Avila, Erick/0000-0003-4098-529X	US Air Force Office of Scientific Research MURI [FA9550-04-1-0434]; NSF Nanoscale Science and Engineering Center [DMI-0327077]	US Air Force Office of Scientific Research MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); NSF Nanoscale Science and Engineering Center(National Science Foundation (NSF))	We thank R. F. Oulton and G. Bartal for discussions and S. Zhang for a critical reading of the manuscript. This work was supported by the US Air Force Office of Scientific Research MURI program (grant no. FA9550-04-1-0434) and by the NSF Nanoscale Science and Engineering Center under award no. DMI-0327077.	Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Borselli M, 2005, OPT EXPRESS, V13, P1515, DOI 10.1364/OPEX.13.001515; Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Brongersma ML, 2007, SPRINGER SER OPT SCI, V131, P1, DOI 10.1007/978-1-4020-4333-8; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Cubukcu E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2339286; Ditlbacher H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257403; Gong YY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2431450; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kippenberg TJ, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.051802; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Lopez-Tejeira F, 2007, NAT PHYS, V3, P324, DOI 10.1038/nphys584; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Miyazaki HT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097401; Noda S, 2007, NAT PHOTONICS, V1, P449, DOI 10.1038/nphoton.2007.141; Oxborrow M, 2007, IEEE T MICROW THEORY, V55, P1209, DOI 10.1109/TMTT.2007.897850; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Palik E D, 1985, HDB OPTICAL CONSTANT; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; ROWLAND DR, 1993, IEE PROC-J, V140, P177, DOI 10.1049/ip-j.1993.0028; Spillane SM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.013817; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; Vesseur EJR, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885344; Weeber JC, 2007, NANO LETT, V7, P1352, DOI 10.1021/nl070403y	30	396	407	8	494	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					455	U3		10.1038/nature07627	http://dx.doi.org/10.1038/nature07627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158793				2022-12-28	WOS:000262519200041
J	Allison, DB; Mattes, RD				Allison, David B.; Mattes, Richard D.			Nutritively Sweetened Beverage Consumption and Obesity The Need for Solid Evidence on a Fluid Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTING CHILDHOOD OBESITY; WEIGHT; CHILDREN; YOUNG; FOOD		[Allison, David B.] Univ Alabama, Sect Stat Genet, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Birmingham, AL 35294 USA; [Mattes, Richard D.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Allison, DB (corresponding author), Univ Alabama, Sect Stat Genet, Dept Biostat, Ryals Publ Hlth Bldg,Ste 414,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079913, P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK079913, P30 DK056336, P30DK056336, R01 DK079913-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala C, 2008, AM J CLIN NUTR, V88, P605, DOI 10.1093/ajcn/88.3.605; Almiron-Roig E, 2004, PHYSIOL BEHAV, V82, P671, DOI 10.1016/j.physbeh.2004.06.003; [Anonymous], 1931, BIOMETRIKA, V23, P398; Belpoggi F, 2006, ANN NY ACAD SCI, V1076, P736, DOI 10.1196/annals.1371.078; BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2007, BMJ-BRIT MED J, V335, P762, DOI 10.1136/bmj.39342.571806.55; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; NAGOURNEY E, 2006, NY TIMES        0307; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	14	48	49	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					318	320		10.1001/jama.2008.974	http://dx.doi.org/10.1001/jama.2008.974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155459	Green Accepted			2022-12-28	WOS:000262518700023
J	Shamliyan, TA; MacDonald, R; Shaukat, A; Taylor, BC; Yuan, JM; Johnson, JR; Tacklind, J; Rutks, I; Kane, RL; Wilt, TJ				Shamliyan, Tatyana A.; MacDonald, Roderick; Shaukat, Aasma; Taylor, Brent C.; Yuan, Jian-Min; Johnson, James R.; Tacklind, James; Rutks, Indulis; Kane, Robert L.; Wilt, Timothy J.			Antiviral Therapy for Adults With Chronic Hepatitis B: A Systematic Review for a National Institutes of Health Consensus Development Conference	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE CHRONIC HEPATITIS; LAMIVUDINE/INTERFERON COMBINATION THERAPY; LONG-TERM THERAPY; E-ANTIGEN; ADEFOVIR DIPIVOXIL; CONTROLLED-TRIAL; ALPHA-INTERFERON; DOUBLE-BLIND; PREDNISONE WITHDRAWAL; LAMIVUDINE THERAPY	Background: Chronic hepatitis B infection can lead to liver failure, hepatocellular carcinoma, and death. Purpose: To evaluate the effectiveness of antiviral therapy for adults with chronic hepatitis B infection. Data Sources: Randomized, controlled trials (RCTs) of interferon (alpha 2b and pegylated alpha 2a), lamivudine, adefovir, entecavir, and telbivudine published from 1990 to 2008. Study Selection: Randomized, controlled clinical trials of adults with chronic hepatitis B published in English after 1989 that reported death; incidence of hepatocellular carcinoma or liver failure; prevalence and incidence of cirrhosis; presence or seroconversion of hepatitis B e antigen (HBeAg) or surface antigen (HBsAg), viral load of hepatitis B virus DNA; aspartate aminotransferase and alanine aminotransferase (ALT) levels; or fibrosis scores after therapy with interferon-alpha 2b, pegylated interferon-alpha 2a, lamivudine, adefovir, entecavir, and telbivudine. Data Extraction: Data extracted with standard protocols to calculate risk difference for clinical outcomes, viral load, HBeAg and HBsAg, ALT, histologic scores, and adverse events. Data Synthesis: In 16 RCTs (4431 patients), drug treatment did not improve clinical outcomes of chronic hepatitis B infection, but the trials were underpowered. In 60 RCTs that examined intermediate outcomes, no single treatment improved all intermediate outcomes. Low-quality evidence suggested HBsAg clearance after interferon-alpha 2b (2 RCTs; 211 patients). Moderate-quality evidence suggested ALT normalization at follow-up after treatment with adefovir (2 RCTs; 600 patients) and HBeAg loss with lamivudine (2 RCTs; 318 patients). With interferon-alpha 2b, moderate-quality evidence suggested HBeAg loss (3 RCTs; 351 patients), seroconversion (2 RCTs; 304 patients), and ALT normalization (2 RCTs; 131 patients). Pegylated interferon-alpha 2a versus lamivudine improved HBeAg seroconversion (1 RCT; 814 patients) and ALT normalization (2 RCTs; 905 patients) off treatment. Pegylated interferon-alpha 2a combined with lamivudine versus lamivudine improved HBeAg loss (1 RCT; 543 patients) and ALT normalization (2 RCTs; 905 patients). Adverse events during antiretroviral therapy occurred in more than 50% of patients but were not associated with increased treatment discontinuation. However, most studies excluded patients with hepatic or renal insufficiency or other serious comorbid conditions. Limitation: Marked heterogeneity in study samples, interventions, and measured outcomes preclude definitive conclusions. Conclusion: Evidence was insufficient to assess treatment effect on clinical outcomes or determine whether inconsistent improvements in selected intermediate measures are reliable surrogates. Future research is needed to provide evidence-based recommendations about optimal antiviral therapy in adults with chronic hepatitis B infection.	[Shamliyan, Tatyana A.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Shamliyan, TA (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis Vet Affairs Ctr Chron Dis Outcomes Re, D351 Mayo MMC 197,420 Delaware St SE, Minneapolis, MN 55455 USA.	shaml005@umn.edu	Taylor, Brent C/A-8069-2009; Shamliyan, Tatyana/AAU-8323-2020	Taylor, Brent C/0000-0002-2140-8377; Shamliyan, Tatyana/0000-0003-3584-2008; Yuan, Jian-Min/0000-0002-4620-3108				Akarca US, 2004, ANTIVIR THER, V9, P325; Akyildiz M, 2007, DIGEST DIS SCI, V52, P3444, DOI 10.1007/s10620-006-9718-8; Akyuz F, 2007, ACTA GASTRO-ENT BELG, V70, P20; Al-Marzouki S, 2005, BMJ-BRIT MED J, V331, P267, DOI 10.1136/bmj.331.7511.267; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Atkins D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-25; Barbaro G, 2001, J HEPATOL, V35, P406, DOI 10.1016/S0168-8278(01)00145-3; BIRNKRANT D, 2008, 21356S025 NDA CTR DR; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Buster EHCJ, 2007, HEPATOLOGY, V46, P388, DOI 10.1002/hep.21723; Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Chan HLY, 2006, ALIMENT PHARM THER, V23, P1703, DOI 10.1111/j.1365-2036.2006.02948.x; Chan HLY, 2007, ANN INTERN MED, V147, P745, DOI 10.7326/0003-4819-147-11-200712040-00183; Chan HLY, 2007, ANTIVIR THER, V12, P345; Chan HLY, 2005, HEPATOLOGY, V41, P1357, DOI 10.1002/hep.20695; Chan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006; Chang TT, 2005, GASTROENTEROLOGY, V129, P1198, DOI 10.1053/j.gastro.2005.06.055; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Chung YH, 2003, EUR J GASTROEN HEPAT, V15, P489, DOI [10.1097/00042737-200305000-00006, 10.1097/01.meg.0000059120.41030.52]; Cindoruk M, 2007, J CLIN GASTROENTEROL, V41, P513, DOI 10.1097/01.mcg.0000225586.78330.60; *CLINICALTRIALS GO, 2002, INF FED PRIV SUPP CL; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; DAWSON B, 2004, BASIC  CLIN BIOSTATI; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIBISCEGLIE AM, 1993, AM J GASTROENTEROL, V88, P1887; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dore GJ, 2004, J INFECT DIS, V189, P1185, DOI 10.1086/380398; Economou M, 2005, WORLD J GASTROENTERO, V11, P5882, DOI 10.3748/wjg.v11.i37.5882; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 2001, SYSTEMATIC REV HLTH; *EUR AG EV MED PRO, 1995, EUR PUBL ASS REP EPA; Flink HJ, 2006, AM J GASTROENTEROL, V101, P297, DOI 10.1111/j.1572-0241.2006.00418.x; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Gish RG, 2005, J HEPATOL, V43, P60, DOI 10.1016/j.jhep.2005.02.017; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; *GREAT BRIT COMM S, CURR PROBL PHARM; HADZIYANNIS S, 1990, J HEPATOL, V11, pS133, DOI 10.1016/0168-8278(90)90180-Y; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Honkoop P, 1998, J VIRAL HEPATITIS, V5, P307, DOI 10.1046/j.1365-2893.1998.00121.x; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hui CK, 2008, J CLIN GASTROENTEROL, V42, P533, DOI 10.1097/MCG.0b013e31804bbdff; Jang JW, 2006, HEPATOLOGY, V43, P233, DOI 10.1002/hep.21024; Jang MK, 2004, J GASTROEN HEPATOL, V19, P1363, DOI 10.1111/j.1440-1746.2004.03464.x; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Janssen HLA, 1999, HEPATOLOGY, V30, P238, DOI 10.1002/hep.510300113; Kahn HA, 1989, STAT METHODS EPIDEMI; Ke CZ, 2006, WORLD J GASTROENTERO, V12, P4061, DOI 10.3748/wjg.v12.i25.4061; Kim YJ, 2006, J GASTROENTEROL, V41, P240, DOI 10.1007/s00535-005-1750-5; Knapp G, 2006, BIOMETRICAL J, V48, P271, DOI 10.1002/bimj.200510175; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lampertico P, 1997, HEPATOLOGY, V26, P1621, DOI 10.1002/hep.510260634; Lee HS, 2006, HEPATOLOGY, V43, P982, DOI 10.1002/hep.21166; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lim SG, 2006, ANTIMICROB AGENTS CH, V50, P1642, DOI 10.1128/AAC.50.5.1642-1648.2006; Lim SG, 2006, ARCH INTERN MED, V166, P49, DOI 10.1001/archinte.166.1.49; Liu Guozhen, 1998, Hunan Yike Daxue Xuebao, V23, P400; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; LOK ASF, 1992, GASTROENTEROLOGY, V102, P2091, DOI 10.1016/0016-5085(92)90337-X; LopezAlcorocho JM, 1997, J VIRAL HEPATITIS, V4, P27, DOI 10.1111/j.1365-2893.1997.tb00157.x; Lu HY, 2007, WORLD J GASTROENTERO, V13, P2878, DOI 10.3748/wjg.v13.i20.2878; Ma H, 2001, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V15, P147; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MULLER R, 1993, GUT, V34, pS97, DOI 10.1136/gut.34.2_Suppl.S97; MULLER R, 1990, J HEPATOL, V11, pS137, DOI 10.1016/0168-8278(90)90181-P; Mutimer D, 1998, J HEPATOL, V28, P923, DOI 10.1016/S0168-8278(98)80338-3; National Center for Health Statistics, 2006, DHHS PUBL; Nevens F, 1997, GASTROENTEROLOGY, V113, P1258, DOI 10.1053/gast.1997.v113.pm9322520; Niederau C, 1992, Eur J Med, V1, P396; *PEG ALF 2A HBEAG, 2005, NEW ENGL J MED, V352, P2682; *PEG ALF 2A HBEAG, 2004, NEW ENGL J MED, V351, P1206; PEREZ V, 1993, GUT, V34, pS91, DOI 10.1136/gut.34.2_Suppl.S91; PEREZ V, 1990, J HEPATOL, V11, pS113, DOI 10.1016/0168-8278(90)90175-Q; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; Peters MG, 2006, HEPATOLOGY, V44, P1110, DOI 10.1002/hep.21388; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Poynard T, 2005, AM J GASTROENTEROL, V100, P1970, DOI 10.1111/j.1572-0241.2005.41957.x; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; REICHEN J, 1994, J HEPATOL, V20, P168, DOI 10.1016/S0168-8278(05)80054-6; ROBSON SC, 1992, S AFR MED J, V82, P317; Santantonio T, 2002, J HEPATOL, V36, P799, DOI 10.1016/S0168-8278(02)00056-9; Sarin SK, 2005, AM J GASTROENTEROL, V100, P2463, DOI 10.1111/j.1572-0241.2005.00247.x; Schalm SW, 2000, GUT, V46, P562, DOI 10.1136/gut.46.4.562; Schiff ER, 2003, J HEPATOL, V38, P818, DOI 10.1016/S0168-8278(03)00076-X; Scotto Gaetano, 2006, Infez Med, V14, P145; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Shi M, 2006, J ANTIMICROB CHEMOTH, V58, P1031, DOI 10.1093/jac/dkl385; Song Jia-wu, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P593; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; *US FDA, 2002, 3500 US FDA; Viechtbauer W, 2007, STAT MED, V26, P37, DOI 10.1002/sim.2514; Wai CT, 2002, HEPATOLOGY, V36, P1425, DOI 10.1053/jhep.2002.37139; WAKED I, 1990, J CHEMOTHERAPY, V2, P310, DOI 10.1080/1120009X.1990.11739035; West S, 2002, Evid Rep Technol Assess (Summ), P1; Westland CE, 2003, HEPATOLOGY, V38, P96, DOI 10.1053/jhep.2003.50288; Whitehead A., 2002, METAANALYSIS CONTROL; WILT TJ, 2008, AHRQ PUBLICATION; WONG JB, 1995, ANN INTERN MED, V122, P664, DOI 10.7326/0003-4819-122-9-199505010-00004; Yalcin K, 2003, CLIN INFECT DIS, V36, P1516, DOI 10.1086/375085; Yao G, 1999, Zhonghua Gan Zang Bing Za Zhi, V7, P80; Yao GB, 2000, J MED VIROL, V61, P392, DOI 10.1002/1096-9071(200007)61:3&lt;392::AID-JMV19&gt;3.0.CO;2-V; Yao GB, 1999, CHINESE MED J-PEKING, V112, P387; Yao Guang-bi, 2003, Zhonghua Nei Ke Za Zhi, V42, P382; Yao Guang-bi, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P484; Yao Guang-bi, 2006, Zhonghua Nei Ke Za Zhi, V45, P891; Yoo BC, 2007, HEPATOLOGY, V46, P1041, DOI 10.1002/hep.21800; Yoo BC, 2007, HEPATOLOGY, V45, P1172, DOI 10.1002/hep.21629; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; ZARSKI JP, 1994, J HEPATOL, V20, P735, DOI 10.1016/S0168-8278(05)80143-6; Zeng MD, 2006, HEPATOLOGY, V44, P108, DOI 10.1002/hep.21225; Zhao H, 2007, CLIN INFECT DIS, V44, P541, DOI 10.1086/511042; Zhao Hong, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P323; Zhao Hong, 2007, Zhonghua Nei Ke Za Zhi, V46, P294; Zhu Mei, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P534	127	83	99	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					111	U78		10.7326/0003-4819-150-2-200901200-00101	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00101			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19124812				2022-12-28	WOS:000262655200006
J	Knigge, C; Leigh, N; Sills, A				Knigge, Christian; Leigh, Nathan; Sills, Alison			A binary origin for 'blue stragglers' in globular clusters	NATURE			English	Article							STELLAR COLLISION PRODUCTS; RADIAL-DISTRIBUTION; MAIN-SEQUENCE; 47 TUCANAE; MILKY-WAY; EVOLUTION; STARS; CORE; PROGENITORS; PARAMETERS	Blue stragglers in globular clusters are abnormally massive stars that should have evolved off the stellar main sequence long ago. There are two known processes that can create these objects: direct stellar collisions(1) and binary evolution(2). However, the relative importance of these processes has remained unclear. In particular, the total number of blue stragglers found in a given cluster does not seem to correlate with the predicted collision rate(3,4), providing indirect support for the binary- evolution model. Yet the radial distributions of blue stragglers in many clusters are bimodal, with a dominant central peak(5-7): this has been interpreted as an indication that collisions do dominate blue straggler production, at least in the high- density cluster cores(7,8). Here we report that there is a clear, but sublinear, correlation between the number of blue stragglers found in a cluster core and the total stellar mass contained within it. From this we conclude that most blue stragglers, even those found in cluster cores, come from binary systems. The parent binaries, however, may themselves have been affected by dynamical encounters. This may be the key to reconciling all of the seemingly conflicting results found to date.	[Knigge, Christian] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Leigh, Nathan; Sills, Alison] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	University of Southampton; McMaster University	Knigge, C (corresponding author), Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England.	christian@astro.soton.ac.uk		Sills, Alison/0000-0003-3551-5090; Knigge, Christian/0000-0002-1116-2553	Natural Sciences and Engineering Research Council of Canada; STFC [PP/D001013/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D001013/1] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Research support for C.K. was provided by the UK Science and Technology Facilities Council. A.S. and N.L. are supported by the Natural Sciences and Engineering Research Council of Canada. C.K. would like to thank T. Maccarone for discussions.	BENZ W, 1987, ASTROPHYS J, V323, P614, DOI 10.1086/165857; Davies MB, 2004, MON NOT R ASTRON SOC, V349, P129, DOI 10.1111/j.1365-2966.2004.07474.x; Ferraro FR, 2006, ASTROPHYS J, V647, pL53, DOI 10.1086/507327; FERRARO FR, 1993, ASTRON J, V106, P2324, DOI 10.1086/116804; Ferraro FR, 2004, ASTROPHYS J, V603, P127, DOI 10.1086/381229; GEHRELS N, 1986, ASTROPHYS J, V303, P336, DOI 10.1086/164079; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; HILLS JG, 1976, ASTROPHYS LETT COMM, V17, P87; Knigge C, 2006, ASTROPHYS J, V641, P281, DOI 10.1086/500311; Knigge C, 2008, ASTROPHYS J, V683, P1006, DOI 10.1086/589987; Leigh N, 2008, ASTROPHYS J, V678, P564, DOI 10.1086/529584; Leigh N, 2007, ASTROPHYS J, V661, P210, DOI 10.1086/514330; LEONARD PJT, 1989, ASTRON J, V98, P217, DOI 10.1086/115138; LEONARD PJT, 1995, ASTROPHYS J, V447, pL121, DOI 10.1086/309581; Mapelli M, 2006, MON NOT R ASTRON SOC, V373, P361, DOI 10.1111/j.1365-2966.2006.11038.x; Mapelli M, 2004, ASTROPHYS J, V605, pL29, DOI 10.1086/386370; MCCREA WH, 1964, MON NOT R ASTRON SOC, V128, P147, DOI 10.1093/mnras/128.2.147; McLaughlin DE, 2005, ASTROPHYS J SUPPL S, V161, P304, DOI 10.1086/497429; MILONE AP, 2008, 21 CENTURY CHALLENGE, P623; Piotto G, 2004, ASTROPHYS J, V604, pL109, DOI 10.1086/383617; Piotto G, 2002, ASTRON ASTROPHYS, V391, P945, DOI 10.1051/0004-6361:20020820; PRYOR C, 1993, ASTR SOC P, V50, P357; Sandquist EL, 1997, ASTROPHYS J, V477, P335, DOI 10.1086/303709; Sills A, 1997, ASTROPHYS J, V487, P290, DOI 10.1086/304588; Sills A, 1999, ASTROPHYS J, V513, P428, DOI 10.1086/306840; Sills A, 2001, ASTROPHYS J, V548, P323, DOI 10.1086/318689; SILLS AP, 1995, ASTROPHYS J, V455, pL163; Sollima A, 2008, ASTRON ASTROPHYS, V481, P701, DOI 10.1051/0004-6361:20079082; Sollima A, 2007, MON NOT R ASTRON SOC, V380, P781, DOI 10.1111/j.1365-2966.2007.12116.x; VERBUNT FWM, 2007, HIGHLIGHTS ASTRON, V14, P440; WEBBINK RF, 1985, DYNAMICS STAR CLUSTE, P541	31	114	114	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					288	290		10.1038/nature07635	http://dx.doi.org/10.1038/nature07635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148094	Green Submitted			2022-12-28	WOS:000262440900033
J	Malizia, BA; Hacker, MR; Penzias, AS				Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.			Cumulative Live-Birth Rates after In Vitro Fertilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ONGOING PREGNANCY; SPERM INJECTION; AGE; IVF; PROBABILITY; CONCEPTION; CYCLES; NUMBER; DIAGNOSIS	BACKGROUND Outcomes of in vitro fertilization ( IVF) treatment are traditionally reported as pregnancies per IVF cycle. However, a couple's primary concern is the chance of a live birth over an entire treatment course. METHODS We estimated cumulative live- birth rates among patients undergoing their first fresh-embryo, nondonor IVF cycle between 2000 and 2005 at one large center. Couples were followed until either discontinuation of treatment or delivery of a live- born infant. Analyses were stratified according to maternal age and performed with the use of both optimistic and conservative methods. Optimistic methods assumed that patients who did not return for subsequent IVF cycles would have the same chance of a pregnancy resulting in a live birth as patients who continued treatment; conservative methods assumed no live births among patients who did not return. RESULTS Among 6164 patients undergoing 14,248 cycles, the cumulative live- birth rate after 6 cycles was 72% ( 95% confidence interval [ CI], 70 to 74) with the optimistic analysis and 51% ( 95% CI, 49 to 52) with the conservative analysis. Among patients who were younger than 35 years of age, the corresponding rates after six cycles were 86% ( 95% CI, 83 to 88) and 65% ( 95% CI, 64 to 67). Among patients who were 40 years of age or older, the corresponding rates were 42% ( 95% CI, 37 to 47) and 23% ( 95% CI, 21 to 25). The cumulative live- birth rate decreased with increasing age, and the age-stratified curves (< 35 vs. = 40 years) were significantly different from one another ( P< 0.001). CONCLUSIONS Our results indicate that IVF may largely overcome infertility in younger women, but it does not reverse the age- dependent decline in fertility.	[Malizia, Beth A.; Penzias, Alan S.] Boston IVF, Waltham, MA 02451 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA; [Malizia, Beth A.; Hacker, Michele R.; Penzias, Alan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Penzias, AS (corresponding author), Boston IVF, 130 2nd Ave, Waltham, MA 02451 USA.	apenzias@bidmc.harvard.edu	Hacker, Michele/ABC-5031-2021	Penzias, Alan/0000-0002-7160-494X; Hacker, Michele/0000-0003-0217-9991	Ferring Pharmaceuticals; EMD Serono; Organon; Repromedix	Ferring Pharmaceuticals(Ferring Pharmaceuticals); EMD Serono; Organon; Repromedix	Dr. Malizia reports receiving an educational grant from Ferring Pharmaceuticals for work unrelated to this study, and Dr. Penzias, receiving consulting and lecture fees and grant support (to Boston IVF) from Ferring Pharmaceuticals and grant support (to Boston IVF) from EMD Serono, Organon, and Repromedix. No other potential conflict of interest relevant to this article was reported. We thank Benjamin B. Taylor, M.D., M.P.H., for his assistance with revisions of an earlier version of the manuscript, Emily B. Levitan, Sc.D., for her statistical review, and the many nurses, assistants, scientists, and physicians at Boston IVF for their care of the patients in this study.	*AM SOC REPR MED S, 2007, 2005 ASS REPR TECHN; Andersen AN, 2008, HUM REPROD, V23, P756, DOI 10.1093/humrep/den014; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Dickey RP, 2002, FERTIL STERIL, V78, P1088, DOI 10.1016/S0015-0282(02)04212-7; EATON JL, 2008, FERTIL STERIL   0426; Elizur SE, 2006, GYNECOL ENDOCRINOL, V22, P25, DOI 10.1080/09513590500453916; Engmann L, 1999, BRIT J OBSTET GYNAEC, V106, P165, DOI 10.1111/j.1471-0528.1999.tb08217.x; Fukuda J, 2001, ACTA OBSTET GYN SCAN, V80, P71, DOI 10.1080/791201838; Gnoth C, 2003, HUM REPROD, V18, P1959, DOI 10.1093/humrep/deg366; GUTTMACHER AF, 1956, JAMA-J AM MED ASSOC, V161, P855, DOI 10.1001/jama.1956.02970090081016; GUZICK DS, 1986, FERTIL STERIL, V46, P663; HULL MGR, 1992, BRIT MED J, V304, P1465, DOI 10.1136/bmj.304.6840.1465; Jain T, 2005, FERTIL STERIL, V84, P221, DOI 10.1016/j.fertnstert.2005.01.118; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Klipstein S, 2005, FERTIL STERIL, V84, P435, DOI 10.1016/j.fertnstert.2005.02.020; Land JA, 1997, FERTIL STERIL, V68, P278, DOI 10.1016/S0015-0282(97)81515-4; Lintsen AME, 2007, HUM REPROD, V22, P2455, DOI 10.1093/humrep/dem183; Olivius K, 2002, FERTIL STERIL, V77, P505, DOI 10.1016/S0015-0282(01)03217-4; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Seif MM, 2006, COCHRANE DB SYST REV, V1; Stem JE, 2007, FERTIL STERIL, V88, P275, DOI 10.1016/j.fertnstert.2006.09.016; Stolwijk AM, 2000, HUM REPROD, V15, P203, DOI 10.1093/humrep/15.1.203; TAN SL, 1992, LANCET, V339, P1390, DOI 10.1016/0140-6736(92)91205-M; TAN SL, 1994, AM J OBSTET GYNECOL, V171, P513, DOI 10.1016/0002-9378(94)90291-7; TIETZE C, 1957, FERTIL STERIL, V8, P89; van Disseldorp J, 2007, REPROD BIOMED ONLINE, V14, P455, DOI 10.1016/S1472-6483(10)60893-0; Witsenburg C, 2005, FERTIL STERIL, V84, P99, DOI 10.1016/j.fertnstert.2005.02.013; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8; 2006, FERTIL STERIL S, V86, pS51	29	286	303	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					236	243		10.1056/NEJMoa0803072	http://dx.doi.org/10.1056/NEJMoa0803072			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144939				2022-12-28	WOS:000262434500006
J	Raftery, J				Raftery, James			NICE and the challenge of cancer drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-EXCELLENCE; NATIONAL-INSTITUTE		[Raftery, James] Univ Southampton, Southampton SO16 7PX, Hants, England	University of Southampton	Raftery, J (corresponding author), Univ Southampton, Southampton SO16 7PX, Hants, England.	j.p.raftery@soton.ac.uk						Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; NICE, 2008, APPR LIF EXT END LIF; ODOWD A, 2008, BRIT MED J, V336, pA444; Raftery JP, 2008, MED J AUSTRALIA, V188, P26, DOI 10.5694/j.1326-5377.2008.tb01500.x; Richards M, 2008, IMPROVING ACCESS MED; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Thompson Coon J, 2008, BEVACIZUMAB SORAFENI	7	34	34	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2009	338								b67	10.1136/bmj.b67	http://dx.doi.org/10.1136/bmj.b67			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404ZY	19141502				2022-12-28	WOS:000263192900001
J	Acosta, IF; Laparra, H; Romero, SP; Schmelz, E; Hamberg, M; Mottinger, JP; Moreno, MA; Dellaporta, SL				Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Schmelz, Eric; Hamberg, Mats; Mottinger, John P.; Moreno, Maria A.; Dellaporta, Stephen L.			tasselseed1 Is a Lipoxygenase Affecting Jasmonic Acid Signaling in Sex Determination of Maize	SCIENCE			English	Article							ZEA-MAYS; ANTHER DEHISCENCE; ARCHITECTURE; ARABIDOPSIS; PLANTS; GENE; INFLORESCENCES; BIOSYNTHESIS; GRASSES; ENCODES	Sex determination in maize is controlled by a developmental cascade leading to the formation of unisexual florets derived from an initially bisexual floral meristem. Abortion of pistil primordia in staminate florets is controlled by a tasselseed- mediated cell death process. We positionally cloned and characterized the function of the sex determination gene tasselseed1 ( ts1). The TS1 protein encodes a plastid- targeted lipoxygenase with predicted 13- lipoxygenase specificity, which suggests that TS1 may be involved in the biosynthesis of the plant hormone jasmonic acid. In the absence of a functional ts1 gene, lipoxygenase activity was missing and endogenous jasmonic acid concentrations were reduced in developing inflorescences. Application of jasmonic acid to developing inflorescences rescued stamen development in mutant ts1 and ts2 inflorescences, revealing a role for jasmonic acid in male flower development in maize.	[Acosta, Ivan F.; Laparra, Helene; Romero, Sandra P.; Moreno, Maria A.; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Schmelz, Eric] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden; [Mottinger, John P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	Yale University; United States Department of Agriculture (USDA); Karolinska Institutet; University of Rhode Island	Dellaporta, SL (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	stephen.dellaporta@yale.edu	Acosta, Ivan/Q-2274-2018	Acosta, Ivan/0000-0001-7080-3384; Schmelz, Eric/0000-0002-2837-734X; Hamberg, Mats/0000-0002-8910-7810	NIH [R01 GM38148]; USDA [99-35301-8048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hake, P. Chomet, and B. Lowe for providing ts1 mutant alleles; A. Signorovitch and R. Rosengarten for help with phylogenetic analyses; E. Bortiri, C. Whipple, P. Bommet, and D. Jackson for advice on in situ hybridizations; I. Hwang for the pRbcSnt: GFP construct; and R. Tsien for the mCherry gene. Supported by NIH grant R01 GM38148 (S.L.D.) and USDA grant 99-35301-8048 (J.P.M.). Sequences obtained in this study were deposited in GenBank (accession numbers FJ360855 and FJ360856).	Ainsworth C, 1998, CURR TOP DEV BIOL, V38, P167; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bonnett OT, 1940, J AGRIC RES, V60, P0025; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emerson RA, 1920, J HERED, V11, P65, DOI 10.1093/oxfordjournals.jhered.a101971; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gaut BS, 2001, GENOME RES, V11, P55, DOI 10.1101/gr.160601; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; Irish EE, 1996, BIOESSAYS, V18, P363, DOI 10.1002/bies.950180506; IRISH EE, 1993, AM J BOT, V80, P292, DOI 10.2307/2445352; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kiesselbach T.A., 1949, STRUCTURE REPROD COR; Kim JC, 2007, GENETICS, V177, P2547, DOI 10.1534/genetics.107.082446; Lee KH, 2002, MOL CELLS, V14, P388; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sanders PM, 2005, SEX PLANT REPROD, V17, P219, DOI 10.1007/s00497-004-0231-y; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; SHIBATA D, 1995, J LIPID MEDIAT CELL, V12, P213, DOI 10.1016/0929-7855(95)00020-Q; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; WEILER EW, 1993, PHYTOCHEMISTRY, V32, P591, DOI 10.1016/S0031-9422(00)95142-2; Wu XQ, 2007, FEBS J, V274, P1172, DOI 10.1111/j.1742-4658.2007.05642.x; Yamasaki S, 2005, VITAM HORM, V72, P79, DOI 10.1016/S0083-6729(05)72003-3	34	195	224	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					262	265		10.1126/science.1164645	http://dx.doi.org/10.1126/science.1164645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131630				2022-12-28	WOS:000262290600041
J	Smith, E; Shilatifard, A				Smith, Edwin; Shilatifard, Ali			DEVELOPMENTAL BIOLOGY Histone Cross-Talk in Stem Cells	SCIENCE			English	Editorial Material							H3 METHYLATION; H2B; UBIQUITINATION; CHROMATIN; TRANSCRIPTION; CANCER; UBIQUITYLATION; COMPASS; ROLES		[Smith, Edwin; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Smith, E (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers-institute.org						Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2007, GENE DEV, V21, P835, DOI 10.1101/gad.1516207; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	19	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					221	222		10.1126/science.1168660	http://dx.doi.org/10.1126/science.1168660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131622				2022-12-28	WOS:000262290600028
J	Fletcher, JD				Fletcher, J. D.			Education and Training Technology in the Military	SCIENCE			English	Editorial Material							CAI		[Fletcher, J. D.] Inst Def Anal, Alexandria, VA 22311 USA		Fletcher, JD (corresponding author), Inst Def Anal, 4850 Mark Ctr Dr, Alexandria, VA 22311 USA.	fletcher@ida.org						ALLUISI EA, 1991, HUM FACTORS, V33, P343, DOI 10.1177/001872089103300308; Anderson L. W., 2001, TAXONOMY LEARNING TE; ANDREWS DH, 1996, ALHRTR19950195 AIRCR; ATKINSON RC, 1969, COMPUTER ASSISTED IN; Bennett W., 2006, PERFORMANCE MEASUREM; BIDDLE CJ, 1968, FIGHTING AIRMAN WAY; BITZER D, 1961, IRE T EDUC, VE  4, P157, DOI 10.1109/TE.1961.4322215; CANNONBOWERS JA, 1992, TEAMS THEIR TRAINING, P355; CARBONEL.JR, 1970, IEEE T MAN MACHINE, VMM11, P190, DOI 10.1109/TMMS.1970.299942; COHN JV, PERFORMANCE IN PRESS; COULSON JE, 1962, PROGRAMMED LEARNING; Dodds P., 2004, J ED MULTIMEDIA HYPE, V13, P391; Fletcher J.D., 1986, MILITARY CONTRIBUTIO, P171; FLETCHER JD, 2001, INT J COGN ERGON, V5, P317; FORD JD, 1972, 7313 SRR NAV PERS RE; GALANTER E, 1959, AUTOMATIC TEACHING S; Gibbons A., 2000, TRAINING RETRAINING, P410; Gorman P. F., 1991, Proceedings of the 1991 Summer Computer Simulation Conference. Twenty-Third Annual Summer Computer Simulation Conference, P1181; Huey B, 1993, WORKLOAD TRANSITION; Jones MB, 1996, HUM FACTORS, V38, P167, DOI 10.1518/001872096778940787; KISZELY J, 2007, 5 DEF AC UK; Klein G, 2000, HUM FAC TRANSP, P165; Lesgold A., 1988, SHERLOCK COACHED PRA; Luckin R., 2007, ARTIFICIAL INTELLIGE; Morrison J. E., 1999, 42 USA RES I BEH SOC; ONEIL HF, 2000, AIRCREW TRAINING ASS; Psotka J., 1988, INTELLIGENT TUTORING; Roscoe S. N., 1980, AVIATION PSYCHOL, P182; Scriven M., 1975, SYSTEMS INDIVIDUALIZ, P199; THORPE JA, 1987, P 9 INT TRAIN SYST C, P492; TOBIAS S, 2008, CONSTRUCTIVIST THEOR; *US C, 1988, OTACIT396 US C, P158; Uttal WR, 1962, PROGRAMMED LEARNING, P171; VINSONHALER JF, 1972, EDUC TECHNOL, V12, P29; Williams Jr A. C., 1980, AVIATION PSYCHOL, P11; Wulfeck W. H., 2007, ASSESSMENT PROBLEM S, P223	36	44	44	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					72	75		10.1126/science.1167778	http://dx.doi.org/10.1126/science.1167778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119221				2022-12-28	WOS:000262104100041
J	Klein, J				Klein, Jacob			CHEMISTRY Repair or Replacement-A Joint Perspective	SCIENCE			English	Editorial Material							MATERIALS SCIENCE; LUBRICATION; CARTILAGE; BIOMATERIALS; POLYMER		[Klein, Jacob] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klein, J (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	jacob.klein@weizmann.ac.il						Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Chen FH, 2008, CURR RHEUMATOL REV, V4, P161, DOI 10.2174/157339708785133550; Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; 2008, ROYAL SOC CHEM C CHE	18	167	175	9	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					47	48		10.1126/science.1166753	http://dx.doi.org/10.1126/science.1166753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119205				2022-12-28	WOS:000262104100029
J	Nersesyan, H; Kattah, JC				Nersesyan, Hrachya; Kattah, Jorge C.			Monocular Paralysis of Vertical Ductions after Facial Trauma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nersesyan, Hrachya; Kattah, Jorge C.] OSF St Francis Med Ctr, Peoria, IL 61637 USA		Nersesyan, H (corresponding author), OSF St Francis Med Ctr, Peoria, IL 61637 USA.	nerses@uic.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					E1	E1		10.1056/NEJMicm073050	http://dx.doi.org/10.1056/NEJMicm073050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118298				2022-12-28	WOS:000262096800010
J	Ingelfinger, JR				Ingelfinger, Julie R.			Melamine and the Global Implications of Food Contamination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chen K., 2007, PUBLIC HLTH SECURITY, P169; *FOOD DRUG ADM, 2008, MEL CONT CHIN; HAUGE MD, 1992, INVEST NEW DRUG, V10, P299, DOI 10.1007/BF00944184; TURNIPSEED S, 2008, LAB INFORMATION B, V4421	5	251	256	3	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2745	2748		10.1056/NEJMp0808410	http://dx.doi.org/10.1056/NEJMp0808410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109571				2022-12-28	WOS:000261950800001
J	Breitbart, W; Alici, Y				Breitbart, William; Alici, Yesne			Agitation and Delirium at the End of Life "We Couldn't Manage Him"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MULTICOMPONENT GERIATRIC INTERVENTION; ILL CANCER-PATIENTS; DOUBLE-BLIND TRIAL; HYPOACTIVE DELIRIUM; PALLIATIVE SEDATION; ELDERLY INPATIENTS; MEDICAL INPATIENTS; COGNITIVE FAILURE; CLINICAL-PRACTICE; TERMINAL CANCER	Delirium is the most common neuropsychiatric complication experienced by patients with advanced illness, occurring in up to 85% of patients in the last weeks of life. Using the case of Mr L, a 59- year- old man with metastatic lung cancer who developed an agitated delirium in the last week of life, were view the evaluation and management of delirium near the end of life. Although some studies have identified agitation as a central feature of delirium in 13% to 46% of patients, other studies have found up to 80% of patients near the end of life develop a hypoactive, nonagitated delirium. Both the agitated ( hyperactive) and nonagitated ( hypoactive) forms of delirium are harbingers of impending death and are associated with increased morbidity in patients who are terminally ill, causing distress for patients, family members, and staff. Delirium is a sign of significant physiological disturbance, usually involving multiple causes, including infection, organ failure, and medication adverse effects. Often these causes of delirium are not reversible in the dying patient, and this influences the outcomes of its management. Delirium can also significantly interfere with the recognition and control of other physical and psychological symptoms, such as pain. Unfortunately, delirium is often misdiagnosed or unrecognized and thus inappropriately treated or untreated in terminally ill patients. To manage delirium in terminally ill patients, clinicians must be able to diagnose it accurately, undertake appropriate assessment of underlying causes, and understand the benefits and risks of the available pharmacological and non-pharmacological interventions.	[Breitbart, William] Cornell Univ, Dept Psychiat & Behav Sci, Mem Sloan Kettering Canc Ctr, Weill Med Coll,Psychiat Serv,Pain & Palliat Care, New York, NY 10022 USA; [Alici, Yesne] Cent Reg Hosp, Geriatr Serv Unit, Butner, NC USA	Cornell University; Memorial Sloan Kettering Cancer Center	Breitbart, W (corresponding author), Cornell Univ, Dept Psychiat & Behav Sci, Mem Sloan Kettering Canc Ctr, Weill Med Coll,Psychiat Serv,Pain & Palliat Care, 641 Lexington Ave,7th Floor, New York, NY 10022 USA.	breitbaw@mskcc.org			California HealthCare Foundation; Fetzer Institute; US National Cancer Institute [RO1CA128187, 1R21 CA101767, RO1 CA10194, RO1CA102201]; NATIONAL CANCER INSTITUTE [R01CA128187, R21CA101767, R01CA102201] Funding Source: NIH RePORTER	California HealthCare Foundation; Fetzer Institute; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Perspectives on Care at the Close of Life series is made possible by funding from the California HealthCare Foundation. Dr Breitbart's work is currently supported by grants from the Fetzer Institute and by grants RO1CA128187, 1R21 CA101767, RO1 CA10194, and RO1CA102201 from the US National Cancer Institute.	Adamis D, 2005, J GERIATR PSYCH NEUR, V18, P129, DOI 10.1177/0891988705277535; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1999, Am J Psychiatry, V156, P1; Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Boettger Soenke, 2005, Palliat Support Care, V3, P227; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Breitbart W, 2002, PSYCHOSOMATICS, V43, P175, DOI 10.1176/appi.psy.43.3.175; BREITBART W, 2006, PALLIATIVE MED, P688; BRUERA E, 1989, PAIN, V39, P13, DOI 10.1016/0304-3959(89)90169-3; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P192, DOI 10.1016/0885-3924(92)90074-R; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P267, DOI 10.1016/0885-3924(92)90060-U; Buss MK, 2007, J PALLIAT MED, V10, P1083, DOI 10.1089/jpm.2006.0253; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; COLE MG, 1994, CAN MED ASSOC J, V151, P965; Cole MG, 2002, CAN MED ASSOC J, V167, P753; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; COYLE N, 1994, J PAIN SYMPTOM MANAG, V9, P44, DOI 10.1016/0885-3924(94)90146-5; de Rooij SE, 2005, INT J GERIATR PSYCH, V20, P609, DOI 10.1002/gps.1343; DEROGATIS LR, 1979, CANCER, V44, P1919, DOI 10.1002/1097-0142(197911)44:5<1919::AID-CNCR2820440555>3.0.CO;2-T; DiMartini A, 2007, PSYCHOSOMATICS, V48, P436, DOI 10.1176/appi.psy.48.5.436; FAINSINGER R, 1992, J PAIN SYMPTOM MANAG, V7, P54, DOI 10.1016/0885-3924(92)90108-T; Fainsinger R, 1991, J PALLIAT CARE, V7, P5, DOI DOI 10.1177/082585979100700102; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; FERNANDEZ F, 1988, J CLIN PSYCHIAT, V49, P239; Gagnon B, 2005, J PSYCHIATR NEUROSCI, V30, P100; Gagnon B, 2001, J PAIN SYMPTOM MANAG, V22, P826, DOI 10.1016/S0885-3924(01)00339-6; Gagnon P, 2000, J PAIN SYMPTOM MANAG, V19, P412, DOI 10.1016/S0885-3924(00)00143-3; Gaudreau JD, 2005, J CLIN ONCOL, V23, P6712, DOI 10.1200/JCO.2005.05.140; GOLDBLOOM R, 1988, CAN MED ASSOC J, V138, P618; Han CS, 2004, PSYCHOSOMATICS, V45, P297, DOI 10.1016/S0033-3182(04)70170-X; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Horikawa N, 2003, GEN HOSP PSYCHIAT, V25, P289, DOI 10.1016/S0163-8343(03)00024-0; Hu H, 2004, CHONGGING MED J, P1234; Inouye SK, 2007, ARCH INTERN MED, V167, P1406, DOI 10.1001/archinte.167.13.1406; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jackson KC, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004770; Kalisvaart C J, 2004, Ned Tijdschr Geneeskd, V148, P1501; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Keen J C, 2004, Palliat Support Care, V2, P199; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; Kim KS, 2001, PSYCHIAT CLIN NEUROS, V55, P515, DOI 10.1046/j.1440-1819.2001.00898.x; Kim KY, 2003, J GERIATR PSYCH NEUR, V16, P29, DOI 10.1177/0891988702250533; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Lawlor PG, 2000, JAMA-J AM MED ASSOC, V284, P2427, DOI 10.1001/jama.284.19.2427; Lawlor PG, 2000, CANCER, V88, P2859, DOI 10.1002/1097-0142(20000615)88:12<2859::AID-CNCR29>3.3.CO;2-K; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Leonard M, 2008, PALLIATIVE MED, V22, P848, DOI 10.1177/0269216308094520; Leso L, 2002, PSYCHOSOMATICS, V43, P61, DOI 10.1176/appi.psy.43.1.61; Liptzin B, 2005, AM J GERIAT PSYCHIAT, V13, P1100, DOI 10.1176/appi.ajgp.13.12.1100; Liu S, 2004, IEEE AERO EL SYS MAG, V19, P3, DOI 10.1109/MAES.2004.1365659; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Lonergan E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005594.pub2; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Marchandin H, 2001, PATHOL BIOL, V49, P522, DOI 10.1016/S0369-8114(01)00212-7; MASSIE MJ, 1983, AM J PSYCHIAT, V140, P1048; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Meagher DJ, 2000, J NEUROPSYCH CLIN N, V12, P51, DOI 10.1176/jnp.12.1.51; MENZA MA, 1988, HEART LUNG, V17, P238; Mercadante S, 1995, J PAIN SYMPTOM MANAG, V10, P639, DOI 10.1016/0885-3924(95)00131-X; Michaud L, 2007, J PSYCHOSOM RES, V62, P371, DOI 10.1016/j.jpsychores.2006.10.004; Milisen K, 2005, J ADV NURS, V52, P79, DOI 10.1111/j.1365-2648.2005.03557.x; Mittal D, 2004, J CLIN PSYCHIAT, V65, P662; Morita T, 2005, J PAIN SYMPTOM MANAG, V30, P320, DOI 10.1016/j.jpainsymman.2005.03.017; Morita T, 2004, PSYCHOSOMATICS, V45, P107, DOI 10.1176/appi.psy.45.2.107; Morita T, 2003, J PAIN SYMPTOM MANAG, V26, P827, DOI 10.1016/S0885-3924(03)00287-2; Morita T, 2000, SUPPORT CARE CANCER, V8, P134, DOI 10.1007/s005200050028; Morita T, 2001, J PAIN SYMPTOM MANAG, V22, P997, DOI 10.1016/S0885-3924(01)00360-8; Morita T, 1999, JPN J CLIN ONCOL, V29, P156, DOI 10.1093/jjco/29.3.156; Morrison RS, 2006, ARCH INTERN MED, V166, P1033, DOI 10.1001/archinte.166.9.1033; Mukadam N, 2008, INT PSYCHOGERIATR, V20, P209, DOI 10.1017/S1041610207006205; NICHOLAS LM, 1995, PSYCHOSOMATICS, V36, P471, DOI 10.1016/S0033-3182(95)71628-0; *NOV, 2004, CLOZ PRESCR INF; Overshott R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005317.pub2; Parellada E, 2004, J CLIN PSYCHIAT, V65, P348; Pereira J, 1997, CANCER-AM CANCER SOC, V79, P835; Pitkala KH, 2008, J GERONTOL A-BIOL, V63, P56, DOI 10.1093/gerona/63.1.56; Pitkala KH, 2006, J GERONTOL A-BIOL, V61, P176, DOI 10.1093/gerona/61.2.176; Rietjens JAC, 2008, J PAIN SYMPTOM MANAG, V36, P228, DOI 10.1016/j.jpainsymman.2007.10.014; Ross C A, 1991, Int Psychogeriatr, V3, P135, DOI 10.1017/S1041610291000613; SADOCK BJ, 2003, KAPLAN SADOCKS SYNOP, P1351; Sampson EL, 2007, INT J GERIATR PSYCH, V22, P343, DOI 10.1002/gps.1679; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schwartz Thomas L., 2000, Prim Care Companion J Clin Psychiatry, V2, P10; Seitz DP, 2007, J CLIN PSYCHIAT, V68, P11, DOI 10.4088/JCP.v68n0102; Siddiqi N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub2; Sipahimalani A, 1998, PSYCHOSOMATICS, V39, P422, DOI 10.1016/S0033-3182(98)71301-5; Skrobik YK, 2004, INTENS CARE MED, V30, P444, DOI 10.1007/s00134-003-2117-0; SMITH MJ, 1995, J PAIN SYMPTOM MANAG, V10, P35, DOI 10.1016/0885-3924(94)00066-T; Spiller JA, 2006, PALLIATIVE MED, V20, P17, DOI 10.1191/0269216306pm1097oa; Stagno Daniele, 2004, Palliat Support Care, V2, P171; STIEFEL FC, 1989, CANCER INVEST, V7, P479, DOI 10.3109/07357908909041378; Straker DA, 2006, PSYCHOSOMATICS, V47, P385, DOI 10.1176/appi.psy.47.5.385; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; Trzepacz PT, 1999, PSYCHOSOMATICS, V40, P193, DOI 10.1016/S0033-3182(99)71235-1; U.S. Food and Drug Administration, INF HEALTHC PROF ANT; *US FDA, INF HEALTHC PROF HAL; Ventafridda V, 1990, J Palliat Care, V6, P7; Vitetta Luis, 2005, Am J Hosp Palliat Care, V22, P465; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Young CC, 2004, ANESTHESIOLOGY, V101, P794, DOI 10.1097/00000542-200409000-00031	104	128	129	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2898	2910						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386ZG	19109118				2022-12-28	WOS:000261920900023
J	Barkun, J; Ergina, PL; Meakins, J				Barkun, Jeffrey; Ergina, Patrick L.; Meakins, Jonathan			Call for papers: surgical research-Act 2, answers?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; SURGERY; QUALITY; CARE		[Barkun, Jeffrey; Ergina, Patrick L.] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Meakins, Jonathan] Univ Oxford, Oxford, England	McGill University; University of Oxford	Barkun, J (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada.	jeffrey.barkun@muhc.mcgill.ca						Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; BUNKER JP, 1977, COSTS RISKS BENEFITS; Chang DC, 2006, J AM COLL SURGEONS, V203, P827, DOI 10.1016/j.jamcollsurg.2006.08.013; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Meakins JL, 2002, AM J SURG, V183, P399, DOI 10.1016/S0002-9610(02)00825-5; Piggott M, 2004, PALLIATIVE MED, V18, P32, DOI 10.1191/0269216304pm857oa; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Wente MN, 2003, DIGEST SURG, V20, P263, DOI 10.1159/000071183	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2097	2098		10.1016/S0140-6736(08)61906-6	http://dx.doi.org/10.1016/S0140-6736(08)61906-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101370				2022-12-28	WOS:000261894000010
J	Murayama, M; Perez-Garci, E; Nevian, T; Bock, T; Senn, W; Larkum, ME				Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.			Dendritic encoding of sensory stimuli controlled by deep cortical interneurons	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PRIMARY SOMATOSENSORY CORTEX; DISTAL APICAL DENDRITES; MOUSE SMI CORTEX; ACTION-POTENTIALS; IN-VIVO; LAYER-I; PROJECTION NEURONS; CELLS; RAT	The computational power of single neurons is greatly enhanced by active dendritic conductances(1) that have a large influence on their spike activity(2-4). In cortical output neurons such as the large pyramidal cells of layer 5 (L5), activation of apical dendritic calcium channels leads to plateau potentials that increase the gain of the input/output function(5) and switch the cell to burst-firing mode(6-9). The apical dendrites are innervated by local excitatory and inhibitory inputs as well as thalamic(10-13) and corticocortical projections(14-16), which makes it a formidable task to predict how these inputs influence active dendritic properties in vivo. Here we investigate activity in populations of L5 pyramidal dendrites of the somatosensory cortex in awake and anaesthetized rats following sensory stimulation using a new fibre-optic method(17) for recording dendritic calcium changes. We show that the strength of sensory stimulation is encoded in the combined dendritic calcium response of a local population of L5 pyramidal cells in a graded manner. The slope of the stimulus-response function was under the control of a particular subset of inhibitory neurons activated by synaptic inputs predominantly in L5. Recordings from single apical tuft dendrites in vitro showed that activity in L5 pyramidal neurons disynaptically coupled via interneurons directly blocks the initiation of dendritic calcium spikes in neighbouring pyramidal neurons. The results constitute a functional description of a cortical microcircuit in awake animals that relies on the active properties of L5 pyramidal dendrites and their very high sensitivity to inhibition. The microcircuit is organized so that local populations of apical dendrites can adaptively encode bottom-up sensory stimuli linearly across their full dynamic range.	[Murayama, Masanori; Perez-Garci, Enrique; Nevian, Thomas; Bock, Tobias; Senn, Walter; Larkum, Matthew E.] Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland	University of Bern	Larkum, ME (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	larkum@pyl.unibe.ch	Senn, Walter/D-6308-2014; Murayama, Masanori/B-4319-2009; Murayama, Masanori/G-5457-2015; Murayama, Masanori/AHA-9840-2022	Senn, Walter/0000-0003-3622-0497; Murayama, Masanori/0000-0001-7623-010X; Nevian, Thomas/0000-0001-9804-608X; Bock, Tobias/0000-0002-7734-1183; Larkum, Matthew/0000-0001-9799-2656	Swiss National Science Foundation [PP00A-102721/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Martin, H.-R. Luscher and Y. Kudo for their comments on the manuscript, O. Gschwend for support in the laboratory, D. Morris for software development, D. Limoges and J. Burkhalter for their expert technical support and K. Fischer for Neurolucida reconstructions of the biocytin-filled neurons. We also thank Sumitomo Electric Industries for their generous donation of the optical fibre. This work was supported by the Swiss National Science Foundation (grant no. PP00A-102721/1).	Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HERSCH SM, 1981, NEUROSCI LETT, V24, P207, DOI 10.1016/0304-3940(81)90157-9; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Tan ZJ, 2008, P NATL ACAD SCI USA, V105, P2187, DOI 10.1073/pnas.0710628105; WHITE EL, 1982, J NEUROCYTOL, V11, P137, DOI 10.1007/BF01258009; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004	26	259	263	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1137	U95		10.1038/nature07663	http://dx.doi.org/10.1038/nature07663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151696				2022-12-28	WOS:000263680100042
J	Grande, C; Patel, NH				Grande, Cristina; Patel, Nipam H.			Nodal signalling is involved in left-right asymmetry in snails	NATURE			English	Article							SEA-URCHIN EMBRYO; CONSERVED ROLE; EXPRESSION; DEUTEROSTOMES; ESTABLISHMENT; INHERITANCE; EVOLUTION; INVERSUS; LIMNAEA; AXES	Many animals display specific internal or external features with left right asymmetry. In vertebrates, the molecular pathway that leads to this asymmetry uses the signalling molecule Nodal, a member of the transforming growth factor-beta superfamily(1), which is expressed in the left lateral plate mesoderm(2), and loss of nodal function produces a randomization of the left - right asymmetry of visceral organs(3,4). Orthologues of nodal have also been described in other deuterostomes, including ascidians and sea urchins(5,6), but no nodal orthologue has been reported in the other two main clades of Bilateria: Ecdysozoa ( including flies and nematodes) and Lophotrochozoa ( including snails and annelids). Here we report the first evidence for a nodal orthologue in a non- deuterostome group. We isolated nodal and Pitx ( one of the targets of Nodal signalling) in two species of snails and found that the side of the embryo that expresses nodal and Pitx is related to body chirality: both genes are expressed on the right side of the embryo in the dextral ( right- handed) species Lottia gigantea and on the left side in the sinistral ( left- handed) species Biomphalaria glabrata. We pharmacologically inhibited the Nodal pathway and found that nodal acts upstream of Pitx, and that some treated animals developed with a loss of shell chirality. These results indicate that the involvement of the Nodal pathway in left - right asymmetry might have been an ancestral feature of the Bilateria.	[Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Grande, Cristina; Patel, Nipam H.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Patel, NH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nipam@uclink.berkeley.edu	; Grande Pardo, Maria Cristina/N-8956-2015	Patel, Nipam/0000-0003-4328-654X; Grande Pardo, Maria Cristina/0000-0002-5659-8967	Ministerio de Educacion y Ciencia (Spain); Center for Integrative Genomics	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Center for Integrative Genomics	We thank E. Begovic, E.E. Gonzales and I. Martinez-Solano for help collecting and fertilizing L. gigantea. A. Almeida helped with the drug experiments. D. R. Lindberg provided the Busycon pulleyi specimen. The NIAID Schistosomiasis Resource Center provided adults of B. glabrata. We thank M. Levine, D. R. Lindberg, P. Liu, M. Modrell, S. Nichols, M. Protas and J.Rehm for comments on the manuscript, and I. Hariharan for suggesting the experiments with rapamycin. C.G. was sponsored by a postdoctoral fellowship of the Ministerio de Educacion y Ciencia (Spain) and the Center for Integrative Genomics. N.H.P. is an Investigator of the Howard Hughes Medical Institute.	Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; CAMEY T, 1970, Netherlands Journal of Zoology, V20, P93; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gould MC, 2001, J EXP ZOOL, V290, P411, DOI 10.1002/jez.1082; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hibino T, 2006, DEV GROWTH DIFFER, V48, P587, DOI 10.1111/j.1440-169x.2006.00892.x; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Morokuma J, 2002, DEV GENES EVOL, V212, P439, DOI 10.1007/s00427-002-0242-3; Nederbragt AJ, 2002, NATURE, V417, P811, DOI 10.1038/417811b; Nogi T, 2005, LATERALITY, V10, P193, DOI 10.1080/1357650054200001440; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oviedo NJ, 2007, CELL, V129, P645, DOI 10.1016/j.cell.2007.05.005; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Price AL, 2008, J EXP ZOOL PART B, V310B, P24, DOI 10.1002/jez.b.21135; Schilthuizen M, 2005, NATURWISSENSCHAFTEN, V92, P504, DOI 10.1007/s00114-05-0045-2; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; VandenBiggelaar J, 1996, NETH J ZOOL, V46, P8	28	192	194	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1007	1011		10.1038/nature07603	http://dx.doi.org/10.1038/nature07603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098895	Green Accepted, Green Submitted			2022-12-28	WOS:000263425400041
J	Simon, T; Verstuyft, C; Mary-Krause, M; Quteineh, L; Drouet, E; Meneveau, N; Steg, PG; Ferrieres, J; Danchin, N; Becquemont, L				Simon, Tabassome; Verstuyft, Celine; Mary-Krause, Murielle; Quteineh, Lina; Drouet, Elodie; Meneveau, Nicolas; Steg, P. Gabriel; Ferrieres, Jean; Danchin, Nicolas; Becquemont, Laurent		French Registry Acute ST-Elevation	Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; OF-FUNCTION POLYMORPHISM; SEQUENCE VARIATIONS; P-GLYCOPROTEIN; DUODENAL ENTEROCYTES; DRUG RESPONSE; ST-ELEVATION; MDR1 GENE; ASPIRIN	Background: Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic antiplatelet activity of the drug. The effect of these determinants on clinical outcomes after an acute myocardial infarction is unknown. Methods: We consecutively enrolled 2208 patients presenting with an acute myocardial infarction in a nationwide French registry and receiving clopidogrel therapy. We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up. Results: Death occurred in 225 patients, and nonfatal myocardial infarction or stroke in 94 patients, during the follow-up period. None of the selected single-nucleotide polymorphisms (SNPs) in CYP3A5, P2RY12, or ITGB3 were associated with a risk of an adverse outcome. Patients with two variant alleles of ABCB1 (TT at nucleotide 3435) had a higher rate of cardiovascular events at 1 year than those with the ABCB1 wild-type genotype (CC at nucleotide 3435) (15.5% vs. 10.7%; adjusted hazard ratio, 1.72; 95% confidence interval [CI], 1.20 to 2.47). Patients carrying any two CYP2C19 loss-of-function alleles (*2, *3, *4, or *5), had a higher event rate than patients with none (21.5% vs. 13.3%; adjusted hazard ratio, 1.98; 95% CI, 1.10 to 3.58). Among the 1535 patients who underwent percutaneous coronary intervention during hospitalization, the rate of cardiovascular events among patients with two CYP2C19 loss-of-function alleles was 3.58 times the rate among those with none (95% CI, 1.71 to 7.51). Conclusions: Among patients with an acute myocardial infarction who were receiving clopidogrel, those carrying CYP2C19 loss-of-function alleles had a higher rate of subsequent cardiovascular events than those who were not. This effect was particularly marked among the patients undergoing percutaneous coronary intervention. (ClinicalTrials.gov number, NCT00673036.) N Engl J Med 2009;360:363-75.	[Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Univ Paris 06, Dept Pharmacol, F-75012 Paris, France; [Simon, Tabassome; Quteineh, Lina; Drouet, Elodie] Hop St Antoine, AP HP, F-75571 Paris, France; [Verstuyft, Celine; Becquemont, Laurent] Univ Paris 11, AP HP, Hop Bicetre, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, P. Gabriel] INSERM, Unite 698, Paris, France; [Steg, P. Gabriel] Univ Paris 07, Paris, France; [Danchin, Nicolas] Univ Paris 05, AP HP, Hop Europeen Georges Pompidou, Paris, France; [Meneveau, Nicolas] Ctr Hosp Univ Besancon, F-25030 Besancon, France; [Ferrieres, Jean] Fac Med Toulouse, INSERM, Unite 558, F-31073 Toulouse, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Simon, T (corresponding author), Univ Paris 06, Dept Pharmacol, 27 Rue Chaligny, F-75012 Paris, France.	tabassome.simon@sat.aphp.fr	Danchin, Nicolas/AAN-8291-2020; verstuyft, celine/AAU-3343-2021; STEG, Philippe Gabriel/Z-1567-2019; Ferrieres, Jean/S-7993-2016	verstuyft, celine/0000-0002-8534-224X; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450; STEG, Philippe Gabriel/0000-0001-6896-2941	Pfizer; Servier; French Caisse Nationale d'Assurance Maladie; Bayer Schering; Pfizer and Eli Lilly; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Endotis; GlaxoSmithKline; MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis; Medicines Company	Pfizer(Pfizer); Servier(Servier); French Caisse Nationale d'Assurance Maladie; Bayer Schering(Bayer AG); Pfizer and Eli Lilly; Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Endotis; GlaxoSmithKline(GlaxoSmithKline); MedtronicMerck Sharp Dohme; Nycomed; Sanofi-Aventis(Sanofi-Aventis); Medicines Company	Supported by unrestricted grants from Pfizer and Servier for FAST-MI, a registry of the French Society of Cardiology, and a research grant from the French Caisse Nationale d'Assurance Maladie.; Dr. Simon reports receiving consulting fees from Bayer Schering, Pfizer and Eli Lilly, lecture fees from Bayer-Schering, and grant support from Pfizer and Servier; Dr. Steg, consulting fees from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Endotis, GlaxoSmithKline, Medtronic, Merck Sharp & Dohme, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Nycomed, Sanofi-Aventis, Servier, and the Medicines Company, and grant support from Sanofi-Aventis; Dr. Danchin, consulting fees from Servier, Sanofi- Aventis, Eli Lilly, and AstraZeneca, lecture fees from Servier, Sanofi- Aventis, and Bristol-Myers Squibb, and grant support from Pfizer and Servier; and Dr. Becquemont, consulting fees from Sanofi- Aventis, Pfizer, and Servier and lecture fees from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.; We thank the physicians who cared for the patients at the participating institutions, E. Martin and F. Rousseau (IntegraGene, Paris), the International Clinical Trials Association Contract Research Organization (Fontaine-les-Dijon, France), Liliane Dubert (Department of Pharmacology, Universit, Pierre et Marie Curie [UPMC] Paris 06), the Clinical Research Assistant team of Unit, de Recherche Clinique de l'Est Parisien (Assistance Publique-Hopitaux de Paris and UPMC Paris 06), and Benoit Pace and Genevieve Mulak (French Society of Cardiology) for their assistance in designing the electronic case-record form and data management during the follow-up period.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson SD, 2008, CIRCULATION, V117, pE174, DOI 10.1161/CIRCULATIONAHA.107.737551; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/00001721-200401000-00014; Angiolillo DJ, 2007, THROMB HAEMOSTASIS, V98, P707, DOI 10.1160/TH07-08-0518; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Antman EM, 2008, J AM COLL CARDIOL, V51, P977, DOI 10.1016/j.jacc.2008.01.007; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cuisset T, 2007, THROMB RES, V120, P893, DOI 10.1016/j.thromres.2007.01.012; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Fontana P, 2008, THROMB RES, V121, P463, DOI 10.1016/j.thromres.2007.06.012; Gerloff T, 2002, BRIT J CLIN PHARMACO, V54, P610, DOI 10.1046/j.1365-2125.2002.01691.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Moriya Y, 2002, BIOL PHARM BULL, V25, P1356, DOI 10.1248/bpb.25.1356; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Philippi A, 2005, MOL PSYCHIATR, V10, P950, DOI 10.1038/sj.mp.4001704; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Smith SMG, 2006, PLATELETS, V17, P250, DOI 10.1080/09537100500475844; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Suh JW, 2006, CAN MED ASSOC J, V175, P64, DOI 10.1503/cmaj.060701; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wang TH, 2006, EUR HEART J, V27, P647, DOI 10.1093/eurheartj/ehi684; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	42	1334	1454	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					363	375		10.1056/NEJMoa0808227	http://dx.doi.org/10.1056/NEJMoa0808227			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19106083				2022-12-28	WOS:000262519900008
J	Kunz, W; Kellermeier, M				Kunz, Werner; Kellermeier, Matthias			MATERIALS SCIENCE Beyond Biomineralization	SCIENCE			English	Editorial Material									[Kunz, Werner; Kellermeier, Matthias] Univ Regensburg, Inst Phys & Theoret Chem, D-90340 Regensburg, Germany	University of Regensburg	Kunz, W (corresponding author), Univ Regensburg, Inst Phys & Theoret Chem, D-90340 Regensburg, Germany.	werner.kunz@chemie.uni-regensburg.de	Kunz, Werner/D-2847-2009	Kunz, Werner/0000-0002-9463-632X				Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Liesegang RE, 1914, Z PHYS CHEM-STOCH VE, V88, P1; Lowenstam HA, 1989, BIOMINERALIZATION; Terada T, 2003, J CRYST GROWTH, V253, P435, DOI 10.1016/S0022-0248(03)01008-X; Voinescu AE, 2008, CRYST GROWTH DES, V8, P1515, DOI 10.1021/cg700692t; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0	9	44	44	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					344	345		10.1126/science.1168653	http://dx.doi.org/10.1126/science.1168653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150832				2022-12-28	WOS:000262481400024
J	Fuchs, VR				Fuchs, Victor R.			Health Care Reform - Why So Much Talk and So Little Action?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							HIRSHFIELD DS, 1970, LOST REFORM CAMPAIGN	1	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					208	209		10.1056/NEJMp0809733	http://dx.doi.org/10.1056/NEJMp0809733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144935				2022-12-28	WOS:000262434500002
J	Kondo, T; Khasanov, R; Takeuchi, T; Schmalian, J; Kaminski, A				Kondo, Takeshi; Khasanov, Rustem; Takeuchi, Tsunehiro; Schmalian, Joerg; Kaminski, Adam			Competition between the pseudogap and superconductivity in the high-T-c copper oxides	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; CUPRATE SUPERCONDUCTORS; SUPERFLUID DENSITY; UNDERDOPED BI2212; NORMAL-STATE; BI2SR2CACU2O8+DELTA; GAPS	In a classical Bardeen - Cooper - Schrieffer superconductor, pairing and coherence of electrons are established simultaneously below the critical transition temperature ( T-c), giving rise to a gap in the electronic energy spectrum. In the high- T-c copper oxide superconductors, however, a pseudogap(1-8) extends above T-c. The relationship between the pseudogap and superconductivity is one of the central issues in this field(9-17). Spectral gaps arising from pairing precursors are qualitatively similar to those caused by competing electronic states, rendering a standard approach to their analysis inconclusive(10-16). The issue can be settled, however, by studying the correlation between the weights associated with the pseudogap and superconductivity spectral features. Here we report a study of two spectral weights using angle- resolved photo-emission spectroscopy. The weight of the superconducting coherent peak increases away from the node following the trend of the superconducting gap, but starts to decrease in the antinodal region. This striking non- monotonicity reveals the presence of a competing state. We emonstrate a direct correlation, for different values of momenta and doping, between the loss in the low- energy spectral weight arising from the opening of the pseudogap and a decrease in the spectral weight associated with superconductivity. We therefore conclude that the pseudogap competes with the superconductivity by depleting the spectral weight available for pairing.	[Kondo, Takeshi; Schmalian, Joerg; Kaminski, Adam] Iowa State Univ, Ames Lab, Ames, IA 50011 USA; [Kondo, Takeshi; Schmalian, Joerg; Kaminski, Adam] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Khasanov, Rustem] Paul Scherrer Inst, Lab Muon Spin Spect, CH-5232 Villigen, Switzerland; [Takeuchi, Tsunehiro] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan; [Takeuchi, Tsunehiro] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Nagoya University; Nagoya University	Kaminski, A (corresponding author), Iowa State Univ, Ames Lab, Ames, IA 50011 USA.	kondo@ameslab.gov; kaminski@ameslab.gov	Schmalian, Joerg/H-2313-2011; Kondo, Takeshi/H-2680-2016	Schmalian, Joerg/0000-0003-4142-2448; Khasanov, Rustem/0000-0002-4768-5524	Basic Energy Sciences; US Department of Energy	Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	We thank A.J. Millis, C. Varma and H.M. Fretwell for discussions. This work was supported by Basic Energy Sciences, US Department of Energy. The Ames Laboratory is operated for the US Department of Energy, Basic Energy Sciences, by Iowa State University under contract no. DE-AC02-07CH11358.	Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Balents L, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.144509; Boyer MC, 2007, NAT PHYS, V3, P802, DOI 10.1038/nphys725; Campuzano JC, 2004, PHYSICS OF SUPERCONDUCTORS, VOL II, P167; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Ding H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.227001; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; Feng DL, 2000, SCIENCE, V289, P277, DOI 10.1126/science.289.5477.277; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Kanigel A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.137002; Khasanov R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.227002; Kondo T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.267004; Le Tacon M, 2006, NAT PHYS, V2, P537, DOI 10.1038/nphys362; Lee WS, 2007, NATURE, V450, P81, DOI 10.1038/nature06219; Loeser AG, 1997, PHYS REV B, V56, P14185, DOI 10.1103/PhysRevB.56.14185; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Russo PL, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054511; Schmalian J, 1998, PHYS REV LETT, V80, P3839, DOI 10.1103/PhysRevLett.80.3839; Shi M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047002; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Wei J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.097005; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Yang HB, 2008, NATURE, V456, P77, DOI 10.1038/nature07400	30	215	215	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					296	300		10.1038/nature07644	http://dx.doi.org/10.1038/nature07644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148096	Green Submitted			2022-12-28	WOS:000262440900035
J	Ray, WA; Chung, CP; Murray, KT; Hall, K; Stein, CM				Ray, Wayne A.; Chung, Cecilia P.; Murray, Katherine T.; Hall, Kathi; Stein, C. Michael			Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADE-DE-POINTES; INTERVAL ABNORMALITIES; QT INTERVAL; MECHANISM; THERAPY; PROLONGATION; PATIENT	Background Users of typical antipsychotic drugs have an increased risk of serious ventricular arrhythmias and sudden cardiac death. However, less is known regarding the cardiac safety of the atypical antipsychotic drugs, which have largely replaced the older agents in clinical practice. Methods We calculated the adjusted incidence of sudden cardiac death among current users of antipsychotic drugs in a retrospective cohort study of Medicaid enrollees in Tennessee. The primary analysis included 44,218 and 46,089 baseline users of single typical and atypical drugs, respectively, and 186,600 matched nonusers of antipsychotic drugs. To assess residual confounding related to factors associated with the use of antipsychotic drugs, we performed a secondary analysis of users of antipsychotic drugs who had no baseline diagnosis of schizophrenia or related psychoses and with whom nonusers were matched according to propensity score ( i. e., the predicted probability that they would be users of antipsychotic drugs). Results Current users of typical and of atypical antipsychotic drugs had higher rates of sudden cardiac death than did nonusers of antipsychotic drugs, with adjusted incidence-rate ratios of 1.99 ( 95% confidence interval [ CI], 1.68 to 2.34) and 2.26 ( 95% CI, 1.88 to 2.72), respectively. The incidence- rate ratio for users of atypical antipsychotic drugs as compared with users of typical antipsychotic drugs was 1.14 ( 95% CI, 0.93 to 1.39). Former users of antipsychotic drugs had no significantly increased risk ( incidence-rate ratio, 1.13; 95% CI, 0.98 to 1.30). For both classes of drugs, the risk for current users increased significantly with an increasing dose. Among users of typical antipsychotic drugs, the incidence- rate ratios increased from 1.31 ( 95% CI, 0.97 to 1.77) for those taking low doses to 2.42 ( 95% CI, 1.91 to 3.06) for those taking high doses ( P< 0.001). Among users of atypical agents, the incidence- rate ratios increased from 1.59 ( 95% CI, 1.03 to 2.46) for those taking low doses to 2.86 ( 95% CI, 2.25 to 3.65) for those taking high doses ( P = 0.01). The findings were similar in the cohort that was matched for propensity score. Conclusions Current users of typical and of atypical antipsychotic drugs had a similar, dose- related increased risk of sudden cardiac death.	[Ray, Wayne A.; Hall, Kathi] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; [Chung, Cecilia P.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37212 USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ray, Wayne A.] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Village Vanderbilt,Suite 2600,1501 21st Ave S, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	National Heart, Lung, and Blood Institute [HL081707]; Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics [HS1-0384]; Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081707] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics; Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (HL081707) and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics (cooperative agreement, HS1-0384).; Dr. Ray reports receiving research support from Pfizer and consulting fees from plaintiffs' attorneys in litigation involving rofecoxib and zoledronic acid and from insurance companies regarding rofecoxib and hormone- replacement therapy; and Dr. Stein, consulting fees from insurance companies regarding antipsychotic drugs. No other potential conflict of interest relevant to this article was reported.; We thank the staff of the Tennessee Bureau of TennCare and the Department of Health, who gave us access to the study data.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; *AM MED ASS, 1995, DRUG EV ANN 1995; Aparasu Rajender R, 2005, Ann Clin Psychiatry, V17, P147, DOI 10.1080/10401230591002084; Arbogast PG, 2008, EPIDEMIOLOGY, V19, P30, DOI 10.1097/EDE.0b013e31815be000; Buckley NA, 2000, DRUG SAFETY, V23, P215, DOI 10.2165/00002018-200023030-00004; Darpo B, 2001, EUR HEART J SUPPL, V3, pK70, DOI 10.1016/S1520-765X(01)90009-4; Flockhart DA, 2000, J CLIN PSYCHOPHARM, V20, P317, DOI 10.1097/00004714-200006000-00005; Glassman AH, 2005, J CLIN PSYCHIAT, V66, P5; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Haddad PM, 2002, DRUGS, V62, P1649, DOI 10.2165/00003495-200262110-00006; Harrigan EP, 2004, J CLIN PSYCHOPHARM, V24, P62, DOI 10.1097/01.jcp.0000104913.75206.62; Heinrich TW, 2006, PSYCHOSOMATICS, V47, P264, DOI 10.1176/appi.psy.47.3.264; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kongsamut S, 2002, EUR J PHARMACOL, V450, P37, DOI 10.1016/S0014-2999(02)02074-5; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Reilly JG, 2002, BRIT J PSYCHIAT, V180, P515, DOI 10.1192/bjp.180.6.515; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; STRAUS SM, 2004, ARCH INTERN MED, V164, P1839; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Tei Y, 2004, PSYCHOSOMATICS, V45, P450, DOI 10.1176/appi.psy.45.5.450; THOMAS SHL, 1994, ADVERSE DRUG REACT T, V13, P77; Vieweg WVR, 2005, ACTA PSYCHIAT SCAND, V112, P318, DOI 10.1111/j.1600-0447.2005.00592.x; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zarate CA, 2001, ARCH GEN PSYCHIAT, V58, P1168, DOI 10.1001/archpsyc.58.12.1168	39	799	828	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					225	235		10.1056/NEJMoa0806994	http://dx.doi.org/10.1056/NEJMoa0806994			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144938	Green Accepted			2022-12-28	WOS:000262434500005
J	Wharam, JF; Sulmasy, D				Wharam, J. Frank; Sulmasy, Daniel			Improving the Quality of Health Care Who Is Responsible for What?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; PAY		[Wharam, J. Frank] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; [Wharam, J. Frank] Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; [Sulmasy, Daniel] St Vincents Hosp, New York, NY USA; [Sulmasy, Daniel] New York Med Coll, New York, NY USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Saint Vincents Hospital Manhattan; New York Medical College	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@partners.org		Wharam, James/0000-0003-2053-0757				Apostle Hippocrates G., 1979, ARISTOTLES METAPHYSI, P13; Casalino LP, 2007, HEALTH AFFAIR, V26, P492, DOI 10.1377/hlthaff.26.2.492; *COMM QUAL HLTH CA, CROSS QUAL CHASM NEW; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Gutmann A., 1996, DEMOCRACY DISAGREEME; Hayward RA, 2007, AM J MANAG CARE, V13, P126; LOHR KN, 1990, MED STRATEGY QUALITY, V1; PELLEGRINO ED, 1981, PHILOS BASIS MED PRA, P192; Rao M, 2006, BMJ-BRIT MED J, V333, P19, DOI 10.1136/bmj.38874.499167.7C; Rosenthal MB, 2008, AM J MANAG CARE, V14, P670; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Sabin JE., 2008, SETTING LIMITS FAIRL; WHARAM JF, HIGH QUALITY CARE ET	14	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					215	217		10.1001/jama.2008.964	http://dx.doi.org/10.1001/jama.2008.964			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141771				2022-12-28	WOS:000262405500025
J	Lipworth, BJ; Williamson, PA				Lipworth, Brian J.; Williamson, Peter A.			beta blockers for asthma: a double-edged sword	LANCET			English	Editorial Material							INHALED CORTICOSTEROIDS; METAANALYSIS; BLOCKADE; MODEL		[Lipworth, Brian J.; Williamson, Peter A.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	b.j.lipworth@googlemail.com						Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Currie GP, 2003, QJM-INT J MED, V96, P435, DOI 10.1093/qjmed/hcg071; Currie GP, 2003, ANN ALLERG ASTHMA IM, V90, P194, DOI 10.1016/S1081-1206(10)62140-0; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; IND PW, 1989, AM REV RESPIR DIS, V139, P1390, DOI 10.1164/ajrccm/139.6.1390; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P467, DOI 10.1007/BF00315224; Lipworth BJ, 2007, TRENDS PHARMACOL SCI, V28, P257, DOI 10.1016/j.tips.2007.04.003; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Salpeter SR, 2002, ANN INTERN MED, V137, P715, DOI 10.7326/0003-4819-137-9-200211050-00035; WHEELDON NM, 1994, BRIT J CLIN PHARMACO, V38, P103, DOI 10.1111/j.1365-2125.1994.tb04332.x	12	18	22	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					104	105		10.1016/S0140-6736(09)60018-0	http://dx.doi.org/10.1016/S0140-6736(09)60018-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135598				2022-12-28	WOS:000262340900008
J	Smith, ER; Mackie, DM				Smith, Eliot R.; Mackie, Diane M.			BEHAVIOR Surprising Emotions	SCIENCE			English	Editorial Material									[Smith, Eliot R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Mackie, Diane M.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA	Indiana University System; Indiana University Bloomington; University of California System; University of California Santa Barbara	Smith, ER (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	esmith4@indiana.edu; mackie@psych.ucsb.edu	Smith, Eliot R./J-7818-2019					BREWER MB, 1994, J PERS SOC PSYCHOL, V66, P268, DOI 10.1037/0022-3514.66.2.268; Dunn EW, 2003, PERS SOC PSYCHOL B, V29, P1421, DOI 10.1177/0146167203256867; Gilbert DT, 1998, J PERS SOC PSYCHOL, V75, P617, DOI 10.1037/0022-3514.75.3.617; Kawakami K, 2009, SCIENCE, V323, P276, DOI 10.1126/science.1164951; Leach CW, 2006, PERS SOC PSYCHOL B, V32, P1232, DOI 10.1177/0146167206289729; Mackie DM, 2008, SOC PERSONAL PSYCHOL, V2, P1866, DOI 10.1111/j.1751-9004.2008.00130.x; MILGRAM S, 1963, J ABNORM PSYCHOL, V67, P371, DOI 10.1037/h0040525; Smith ER, 2007, J PERS SOC PSYCHOL, V93, P431, DOI 10.1037/0022-3514.93.3.431; Subasic E, 2008, PERS SOC PSYCHOL REV, V12, P330, DOI 10.1177/1088868308323223; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2	10	6	7	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					215	216		10.1126/science.1168650	http://dx.doi.org/10.1126/science.1168650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131617				2022-12-28	WOS:000262290600023
J	Yang, Q; She, H; Gearing, M; Colla, E; Lee, M; Shacka, JJ; Mao, ZX				Yang, Qian; She, Hua; Gearing, Marla; Colla, Emanuela; Lee, Michael; Shacka, John J.; Mao, Zixu			Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy	SCIENCE			English	Article							MYOCYTE ENHANCER FACTOR-2; TRANSCRIPTION FACTOR MEF2; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; PROTEIN-DEGRADATION; CELL-DEATH; NEURODEGENERATION	Chaperone- mediated autophagy controls the degradation of selective cytosolic proteins and may protect neurons against degeneration. In a neuronal cell line, we found that chaperone- mediated autophagy regulated the activity of myocyte enhancer factor 2D ( MEF2D), a transcription factor required for neuronal survival. MEF2D was observed to continuously shuttle to the cytoplasm, interact with the chaperone Hsc70, and undergo degradation. Inhibition of chaperone- mediated autophagy caused accumulation of inactive MEF2D in the cytoplasm. MEF2D levels were increased in the brains of alpha-synuclein transgenic mice and patients with Parkinson's disease. Wild-type alpha-synuclein and a Parkinson's disease- associated mutant disrupted the MEF2D-Hsc70 binding and led to neuronal death. Thus, chaperone- mediated autophagy modulates the neuronal survival machinery, and dysregulation of this pathway is associated with Parkinson's disease.	[Yang, Qian; She, Hua; Mao, Zixu] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Gearing, Marla; Mao, Zixu] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Colla, Emanuela; Lee, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Shacka, John J.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA	Emory University; Emory University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Mao, ZX (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	zmao@pharm.emory.edu	Lee, Michael K/D-9491-2013; Colla, Emanuela/H-2483-2013	Lee, Michael K/0000-0001-5865-9682; Colla, Emanuela/0000-0002-4755-7450	NIH [NS048254, AG023695, NS038065]; Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038065, R01NS038065, P30NS057098, P30NS055077, R01NS048254, P30NS047466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023695, P50AG025688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory; UAB Alzheimer's Disease Research Center; Robert Woodruff Health Sciences Center Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Rees and D. Cooper at Emory Neuroscience NINDS Core Facility (NS055077) and UAB Neuroscience Core Facility (NS47466 and NS57098) for assistance in imaging and immunohistochemistry analysis, and J. Blum and A. M. Cuervo for Hsc70 and Lamp2a constructs. Supported by NIH grants NS048254 (Z.M.), AG023695 (Z.M.), and NS038065 (M.L.) and by Emory and UAB Alzheimer's Disease Research Center pilot grants (Z.M. and J.J.S.) and the Robert Woodruff Health Sciences Center Fund (Z.M.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gonzalez P, 2007, NEUROSCI LETT, V411, P47, DOI 10.1016/j.neulet.2006.09.055; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200	25	245	256	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					124	127		10.1126/science.1166088	http://dx.doi.org/10.1126/science.1166088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119233	Green Accepted			2022-12-28	WOS:000262104100056
J	Webber, M				Webber, Matthew			Electroconvulsive therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Webber, M (corresponding author), Care of Thompson C, Harplands Hosp, Hilton Rd, Stoke On Trent ST4 6TH, Staffs, England.	cathmjthompson@hotmail.com							0	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2008	337								a2998	10.1136/bmj.a2998	http://dx.doi.org/10.1136/bmj.a2998			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MX	19116213				2022-12-28	WOS:000262946100002
J	Cohen, SP; Argoff, CE; Carragee, EJ				Cohen, Steven P.; Argoff, Charles E.; Carragee, Eugene J.			Management of low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-PRACTICE GUIDELINE; PRIMARY-CARE; FACET JOINT; DIAGNOSIS; PHYSICIANS; IDENTIFY; THERAPY; COLLEGE; NECK		[Cohen, Steven P.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Pain Management Div, Baltimore, MD 21205 USA; [Cohen, Steven P.] Walter Reed Army Med Ctr, Dept Surg, Washington, DC 20307 USA; [Argoff, Charles E.] Albany Med Coll, Dept Neurol, Comprehens Pain Program, Albany, NY 12208 USA; [Carragee, Eugene J.] Stanford Univ, Sch Med, Dept Orthoped Surg, Div Spine Surg, Stanford, CA 94305 USA	Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Albany Medical College; Stanford University	Cohen, SP (corresponding author), 550 N Broadway,Suite 301, Baltimore, MD 21205 USA.	scohen40@jhmi.edu						Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andersson GBJ, 1998, ACTA ORTHOP SCAND, V69, P28, DOI 10.1080/17453674.1998.11744790; Assendelft W, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000447.PUB2; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cohen SP, 2005, ANESTH ANALG, V101, P1440, DOI 10.1213/01.ANE.0000180831.60169.EA; Cohen SP, 2007, ANESTHESIOLOGY, V106, P591, DOI 10.1097/00000542-200703000-00024; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Hagen KB, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001254.PUB2; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; Hayden JA, 2005, ANN INTERN MED, V142, P765, DOI 10.7326/0003-4819-142-9-200505030-00013; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Riew KD, 2006, J BONE JOINT SURG AM, V88A, P1722, DOI 10.2106/JBJS.E.00278; Rubinstein SM, 2008, BEST PRACT RES CL RH, V22, P471, DOI 10.1016/j.berh.2007.12.003; Seffinger MA, 2004, SPINE, V29, pE413, DOI 10.1097/01.brs.0000141178.98157.8e; Stochkendahl MJ, 2006, J MANIP PHYSIOL THER, V29, P475, DOI 10.1016/j.jmpt.2006.06.011; van Tulder MW, 2003, SPINE, V28, P1978, DOI 10.1097/01.BRS.0000090503.38830.AD; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136	22	77	78	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2008	337								a2718	10.1136/bmj.a2718	http://dx.doi.org/10.1136/bmj.a2718			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394EI	19103627				2022-12-28	WOS:000262428100001
J	Varricchio, DJ; Moore, JR; Erickson, GM; Norell, MA; Jackson, FD; Borkowski, JJ				Varricchio, David J.; Moore, Jason R.; Erickson, Gregory M.; Norell, Mark A.; Jackson, Frankie D.; Borkowski, John J.			Avian Paternal Care Had Dinosaur Origin	SCIENCE			English	Article							PARENTAL-CARE; SEXUAL-MATURITY; EVOLUTION; BIRDS; CLUTCHES; EGGS	The repeated discovery of adult dinosaurs in close association with egg clutches leads to speculation over the type and extent of care exhibited by these extinct animals for their eggs and young. To assess parental care in Cretaceous troodontid and oviraptorid dinosaurs, we examined clutch volume and the bone histology of brooding adults. In comparison to four archosaur care regressions, the relatively large clutch volumes of Troodon, Oviraptor, and Citipati scale most closely with a bird- paternal care model. Clutch- associated adults lack the maternal and reproductively associated histologic features common to extant archosaurs. Large clutch volumes and a suite of reproductive features shared only with birds favor paternal care, possibly within a polygamous mating system. Paternal care in both troodontids and oviraptorids indicates that this care system evolved before the emergence of birds and represents birds' ancestral condition. In extant birds and over most adult sizes, paternal and biparental care correspond to the largest and smallest relative clutch volumes, respectively.	[Varricchio, David J.; Jackson, Frankie D.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Moore, Jason R.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA; [Erickson, Gregory M.] Florida State Univ, Dept Sci Biol, Tallahassee, FL 32306 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Borkowski, John J.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Texas A&M University System; Texas A&M University College Station; State University System of Florida; Florida State University; American Museum of Natural History (AMNH); Montana State University System; Montana State University Bozeman	Varricchio, DJ (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	djv@montana.edu			NSF [EAR-0418649, DBI-446224]	NSF(National Science Foundation (NSF))	We thank J. Horner, A. Chinsamy-Turan, L. Hall, H. Akashi, J. Rotella, and P.T. Varricchio Sr. Supported by NSF grants EAR-0418649 and DBI-446224 (G.M.E.).	BRANCH W R, 1975, Journal of Herpetology, V9, P243, DOI 10.2307/1563048; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Davies S.J.J.F., 2002, RATITES TINAMOUS; Elzanowski A., 1985, ACT 18 C INT ORN, V1, P178; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lourdais O, 2007, J COMP PHYSIOL B, V177, P569, DOI 10.1007/s00360-007-0155-6; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Pahl R, 1997, P ROY SOC B-BIOL SCI, V264, P239, DOI 10.1098/rspb.1997.0034; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Shine R, 1988, BIOL REPTILIA, V16, P276; Simkiss K., 1967, CALCIUM REPROD PHYSL; SOMMA LA, 1990, SMITHSONIAN HERPETOL; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; van Mierop L.H.S., 1976, Journal Herpet, V10, P333; VANRHIJN J, 1984, NETH J ZOOL, V34, P103, DOI 10.1163/002829684X00092; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; WINK CS, 1986, J MORPHOL, V189, P183, DOI 10.1002/jmor.1051890208; [No title captured]	28	94	97	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1826	1828		10.1126/science.1163245	http://dx.doi.org/10.1126/science.1163245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095938				2022-12-28	WOS:000261799400049
J	Lam, HS; Ng, PC; Chu, WCW; Wong, W; Chan, DFY; Ho, SS; Wong, KT; Ahuja, AT; Li, CK				Lam, Hugh S.; Ng, Pak C.; Chu, Winnie C. W.; Wong, William; Chan, Dorothy F. Y.; Ho, Stella S.; Wong, Ka T.; Ahuja, Anil T.; Li, Chi K.			Renal screening in children after exposure to low dose melamine in Hong Kong: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							PROTEINURIA; BLOOD; CATS	Objective To investigate the renal outcomes of children after exposure to low dose melamine in Hong Kong. Design Cross sectional study. Setting Special assessment centres, Hong Kong. Participants 3170 children ( 1422 girls and 1748 boys) aged 12 years or less referred from territory- wide primary care clinics after daily consumption for one month or more of milk products tainted with melamine. Main outcome measures Presence of renal stones and haematuria. Results One child had a confirmed renal stone, seven were suspected of having melamine related renal deposits, and 208 ( 6.6%) were positive for blood in urine by reagent strip. A proportion of these children were followed up at the special assessment centre, but only 7.4% of those positive for blood on reagent strip were confirmed by microscopy, suggesting an overall estimated prevalence of less than 1% for microscopic haematuria. Conclusions No severe adverse renal outcomes, such as acute renal failure or urinary tract obstruction, were detected in children after exposure to low dose melamine. Our results were similar to territory- wide findings in Hong Kong. Even including the seven children with suspected renal deposits, the prevalence of suspected melamine related abnormalities on ultrasonography was only 0.2%. None of these children required specific treatment. The prevalence of microscopic haematuria was probably overestimated by the reagent strip. These data suggest that large scale and urgent screening programmes may not be informative or cost effective for populations who have been exposed to low dose melamine.	[Lam, Hugh S.; Ng, Pak C.; Wong, William; Chan, Dorothy F. Y.; Li, Chi K.] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Peoples R China; [Chu, Winnie C. W.; Ho, Stella S.; Wong, Ka T.; Ahuja, Anil T.] Chinese Univ Hong Kong, Dept Diagnost Radiol & Organ Imaging, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lam, HS (corresponding author), Prince Wales Hosp, Dept Paediat, 6-F Clin Sci Bldg, Hong Kong, Peoples R China.	hshslam@cuhk.edu.hk	Li, Chi-kong/J-8456-2013; Ahuja, Anil T/H-4031-2017; Lam, Hugh Simon/G-8373-2015; Chu, Winnie CW/F-8449-2014	Li, Chi-kong/0000-0002-2810-5758; Ahuja, Anil T/0000-0002-0726-5402; Lam, Hugh Simon/0000-0001-9912-0544; Chu, Winnie CW/0000-0003-4962-4132				Centre for Food Safety, 2008, FREQ ASK QUEST; Chan EYY, 2008, LANCET, V372, P1444, DOI 10.1016/S0140-6736(08)61604-9; Cianciolo RE, 2008, JAVMA-J AM VET MED A, V233, P729, DOI 10.2460/javma.233.5.729; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; GOOD LI, 1979, GASTROENTEROLOGY, V77, P258; La Manna A, 1998, PEDIATR NEPHROL, V12, P214, DOI 10.1007/s004670050440; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; Parry Jane, 2008, BMJ, V337, pa1738, DOI 10.1136/bmj.a1738; Parry Jane, 2008, BMJ, V337, pa1890, DOI 10.1136/bmj.a1890; Pugia MJ, 1999, CLIN CHEM LAB MED, V37, P149, DOI 10.1515/CCLM.1999.027; Pugia MJ, 2000, CLIN CHEM LAB MED, V38, P975, DOI 10.1515/CCLM.2000.145; Robbiani JH, 2006, J NEPHROL, V19, P605; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; World Health Organization, 2008, MEL CYAN AC TOX PREL	14	50	57	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 18	2008	337								a2991	10.1136/bmj.a2991	http://dx.doi.org/10.1136/bmj.a2991			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SY	19097976	Green Published, hybrid			2022-12-28	WOS:000262185200001
J	Cullen, BR				Cullen, Bryan R.			Viral and cellular messenger RNA targets of viral microRNAs	NATURE			English	Review							GENE-EXPRESSION; IDENTIFICATION; NEUROVIRULENCE; TRANSLATION; INFECTION; ORTHOLOG; ENCODES; PROTEIN	Given the propensity of viruses to co- opt cellular pathways and activities for their benefit, it is perhaps not surprising that several viruses have now been shown to reshape the cellular environment by reprogramming the host's RNA- interference machinery. In particular, microRNAs are produced by the various members of the herpesvirus family during both the latent stage of the viral life cycle and the lytic ( or productive) stage. Emerging data suggest that viral microRNAs are particularly important for regulating the transition from latent to lytic replication and for attenuating antiviral immune responses.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA	Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA.	culle002@mc.duke.edu			National Institutes of Health [GM071408, AI067968]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968, R56AI067968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in my laboratory was supported by the National Institutes of Health (grant numbers GM071408 and AI067968). I thank M. Luftig, E. Gottwein and J.L. Umbach for critical comments on the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buck AH, 2007, J VIROL, V81, P13761, DOI 10.1128/JVI.01290-07; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cui C, 2006, J VIROL, V80, P5499, DOI 10.1128/JVI.00200-06; Dolken L, 2007, J VIROL, V81, P13771, DOI 10.1128/JVI.01313-07; Gottwein E, 2006, COLD SPRING HARB SYM, V71, P357, DOI 10.1101/sqb.2006.71.004; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hussain M, 2008, J VIROL, V82, P9164, DOI 10.1128/JVI.01109-08; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schafer A, 2007, VIROLOGY, V364, P21, DOI 10.1016/j.virol.2007.03.029; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; Yao YX, 2007, J VIROL, V81, P7164, DOI 10.1128/JVI.00112-07; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	40	223	236	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					421	425		10.1038/nature07757	http://dx.doi.org/10.1038/nature07757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158788	Green Accepted			2022-12-28	WOS:000262519200035
J	Yudofsky, SC				Yudofsky, Stuart C.			Contracting Schizophrenia Lessons From the Influenza Epidemic of 1918-1919	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yudofsky, Stuart C.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Yudofsky, SC (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, 1 Baylor Plaza,Room 115-D, Houston, TX 77030 USA.	stuarty@bcm.tmc.edu						Andreasen NC, 2007, SCHIZOPHRENIA BULL, V33, P108, DOI 10.1093/schbul/sbl054; Bagalkote H, 2000, INT J MENT HEALTH, V29, P3, DOI 10.1080/00207411.2000.11449500; Battle YL, 1999, J PSYCHIAT RES, V33, P501, DOI 10.1016/S0022-3956(99)00022-9; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Cuesta MJ, 2008, SCHIZOPHRENIA BULL, V34, P587, DOI 10.1093/schbul/sbn041; First M.B., 2004, DSM 4 TR GUIDEBOOK; Fromm-Reichmann F, 1948, PSYCHIATR, V11, P263; KRAEPELIN E, 1990, TXB STUDENTS PHYS, V2, P110; MAMELUND SE, 2003, 292003 U OSL DEP EC; Menninger KA, 1919, J AMER MED ASSOC, V72, P235, DOI 10.1001/jama.1919.02610040001001; Menninger KA, 1926, AM J PSYCHIAT, V5, P469; SABSHIN M, 1990, AM J PSYCHIAT, V147, P1267; TAMMINGA CA, 2008, AM PSYCHIAT PUBLISHI, P969; van den Berg B J, 1979, World Health Stat Q, V32, P269	15	18	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					324	326		10.1001/jama.2008.980	http://dx.doi.org/10.1001/jama.2008.980			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155461	Bronze			2022-12-28	WOS:000262518700025
J	Chalmers, I				Chalmers, Iain			Gaza-a symptom of an insufficiently acknowledged cause	LANCET			English	Editorial Material									[Chalmers, Iain] James Lind Lib, James Lind Initiat, Oxford OX2 7LG, England		Chalmers, I (corresponding author), James Lind Lib, James Lind Initiat, Oxford OX2 7LG, England.	ichalmers@jameslindlibrary.org						BLACK I, 2007, GUARDIAN        0628; CHOMSKY N, 2000, FATEFUL TRIANGLE US; Evans M., 2009, TIMES           0108, P6; Hass Amira, 2000, DRINKING SEA GAZA DA; Shavit Ari, 2007, HAARETZ         0607; Steele Jonathan, 2008, GUARDIAN        0526; Stein Leonard, 1961, BALFOUR DECLARATION	7	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					197	198		10.1016/S0140-6736(09)60055-6	http://dx.doi.org/10.1016/S0140-6736(09)60055-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150693				2022-12-28	WOS:000262537500010
J	Seibel, BA; Dierssen, HM				Seibel, Brad A.; Dierssen, Heidi M.			OCEAN SCIENCE Animal Function at the Heart (and Gut) of Oceanography	SCIENCE			English	Editorial Material							DEEP-SEA		[Seibel, Brad A.] Univ Rhode Isl, Kingston, RI 02891 USA; [Dierssen, Heidi M.] Univ Connecticut, Groton, CT 06340 USA	University of Rhode Island; University of Connecticut	Seibel, BA (corresponding author), Univ Rhode Isl, Kingston, RI 02891 USA.	seibel@uri.edu; heidi.dierssen@uconn.edu						Balch WM, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002560; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; DAM HG, 1995, DEEP SEA RES 2, V42, P732; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; HORNE RA, 1969, STRUCTURE WATER CHEM; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; Kintisch E, 2008, SCIENCE, V319, P886, DOI 10.1126/science.319.5865.886b; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2008, ECOLOGY, V89, P3449, DOI 10.1890/08-0638.1; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; SABINE CL, 2003, CO2 STABILIZATION IS, P7; WALSH PJ, 1991, LIMNOL OCEANOGR, V36, P1227, DOI 10.4319/lo.1991.36.6.1227; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972	16	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					343	344		10.1126/science.1161618	http://dx.doi.org/10.1126/science.1161618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150831				2022-12-28	WOS:000262481400023
J	Semple, CAM; Taylor, MS				Semple, Colin A. M.; Taylor, Martin S.			MOLECULAR BIOLOGY The Structure of Change	SCIENCE			English	Editorial Material									[Semple, Colin A. M.] MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Taylor, Martin S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England	University of Edinburgh; European Molecular Biology Laboratory (EMBL)	Semple, CAM (corresponding author), MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	colins@hgu.mrc.ac.uk; mst@ebi.ac.uk	Taylor, Martin S/C-3825-2009; Semple, Colin A M/A-5613-2009	Taylor, Martin S/0000-0001-7656-330X; Semple, Colin A M/0000-0003-1765-4118	Medical Research Council Funding Source: Medline; Wellcome Trust [GR078968] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Taylor MS, 2008, NAT GENET, V40, P1262, DOI 10.1038/ng1108-1262; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Warnecke T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000250; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003	11	6	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					347	348		10.1126/science.1169408	http://dx.doi.org/10.1126/science.1169408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150834				2022-12-28	WOS:000262481400026
J	Brazeau, MD				Brazeau, Martin D.			The braincase and jaws of a Devonian 'acanthodian' and modern gnathostome origins	NATURE			English	Article							SOUTHEASTERN AUSTRALIA; PLACODERMI; FISH; FIN	Modern gnathostomes ( jawed vertebrates) emerged in the early Palaeozoic era(1), but this event remains unclear owing to a scant early fossil record. The exclusively Palaeozoic 'acanthodians' are possibly the earliest(2,3) gnathostome group and exhibit amosaic of shark- and bony fish- like characters that has long given them prominence in discussions of early gnathostome evolution(1). Their relationships with modern gnathostomes have remained mysterious, partly because their un- mineralized endoskeletons rarely fossilized. Here I present the first- known braincase of an Early Devonian (approximately 418-412 Myr BP) acanthodian, Ptomacanthus anglicus(4), and re- evaluate the interrelationships of basal gnathostomes. Acanthodian braincases have previously been represented by a single genus, Acanthodes(5), which occurs more than 100 million years later in the fossil record. The braincase of Ptomacanthus differs radically from the osteichthyan- like braincase of Acanthodes(5) in exhibiting several plesiomorphic features shared with placoderms(6,7) and some early chondrichthyans(8,9). Most striking is its extremely short sphenoid region and its jaw suspension, which displays features intermediate between some Palaeozoic chondrichthyans and osteichthyans. Phylogenetic analysis resolves Ptomacanthus as either the most basal chondrichthyan or as the sister group of all living gnathostomes. These new data alter earlier conceptions of basal gnathostome phylogeny and thus help to provide a more detailed picture of the acquisition of early gnathostome characters.	[Brazeau, Martin D.] Uppsala Univ, Evolut Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, SE-75236 Uppsala, Sweden	Uppsala University	Brazeau, MD (corresponding author), Uppsala Univ, Evolut Biol Ctr, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, SE-75236 Uppsala, Sweden.	martin.brazeau@gmail.com	Brazeau, Martin D/AAU-5390-2020; Brazeau, Martin D/B-6971-2009	Brazeau, Martin D/0000-0001-6566-2820; Brazeau, Martin/0000-0002-0650-1282	Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship	Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	I thank M. Richter for loans of specimens and access to collections; S. Davis, M. Friedman, D. Goujet, J. Long, J. Maisey and G. Young for discussions on early gnathostome endocranial anatomy; P. Ahlberg and H. Blom for discussions and support during all phases of this work. Financial support for this work was provided by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship (NSERC PGS-D 331758-2006) awarded to the author. Thanks to J. Maisey, R. Miller and S. Turner for access to unpublished data on Doliodus.	Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Gagnier PY, 1996, PALAEONTOLOGY, V39, P241; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Goujet D, 1984, POISSONS PLACODERMES; Hanke G.F., 2004, RECENT ADV ORIGIN EA, P703; Hanke GF, 2002, CAN J EARTH SCI, V39, P1071, DOI 10.1139/E02-023; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johanson Z, 2002, LETHAIA, V35, P169, DOI 10.1080/002411602320184024; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; MAISEY JG, 1980, AM MUS NOVIT, P1; Miles RS., 1973, B BR MUS NAT HIS G, V24, P111; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Nelson G.J., 1969, B AM MUS NAT HIST, V141, P475; ORVIG T, 1975, PROBLEMES ACTUELS PA, P41; SCHAEFFER B, 1981, Bulletin of the American Museum of Natural History, V169, P1; Schaeffer B, 1975, PROBLEMES ACTUELS PA, P101; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; Smith MM, 1997, PALAEONTOLOGY, V40, P645; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; Wilson Mark V.H., 2007, P122; YOUNG GC, 1982, PALAEONTOLOGY, V25, P817; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; [No title captured]	29	176	183	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					305	308		10.1038/nature07436	http://dx.doi.org/10.1038/nature07436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148098	Green Submitted			2022-12-28	WOS:000262440900037
J	Bold, TD; Ernst, JD				Bold, Tyler D.; Ernst, Joel D.			Who Benefits from Granulomas, Mycobacteria or Host?	CELL			English	Editorial Material							TUBERCULOSIS; MACROPHAGE; INITIATION	By investigating host-pathogen interactions in zebrafish using intravital imaging, Davis and Ramakrishnan (2009) provide evidence that aggregates of immune cells known as granulomas, long thought to constrain mycobacterial infection, may instead facilitate its spread.	[Ernst, Joel D.] NYU, Langone Med Ctr, Dept Med Infect Dis, New York, NY 10016 USA; NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Ernst, JD (corresponding author), NYU, Langone Med Ctr, Dept Med Infect Dis, 550 1St Ave, New York, NY 10016 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084041, R01AI051242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051242, R01 AI084041] Funding Source: Medline; NIGMS NIH HHS [T32 GM007308] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS DO, 1976, AM J PATHOL, V84, P164; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367	7	46	48	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					17	19		10.1016/j.cell.2008.12.032	http://dx.doi.org/10.1016/j.cell.2008.12.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135882	Bronze, Green Accepted			2022-12-28	WOS:000262318400008
J	Xiao, CC; Rajewsky, K				Xiao, Changchun; Rajewsky, Klaus			MicroRNA Control in the Immune System: Basic Principles	CELL			English	Review							INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; T-CELL PROLIFERATION; TUMOR INVASION; INHIBITOR P21; C-MYB; EXPRESSION; GENE; DIFFERENTIATION; TRANSCRIPTION	MicroRNA (miRNA) control has emerged as a critical regulatory principle in the mammalian immune system. Genetic ablation of the miRNA machinery, as well as loss or deregulation of certain individual miRNAs, severely compromises immune development and response and can lead to immune disorders like autoimmunity and cancer. Although individual miRNAs modulate protein output from hundreds of target genes, they may impact physiological processes by regulating the concentrations of just a few key cellular proteins that may be components of a single or of functionally interrelated pathways in a given cellular context.	[Xiao, Changchun; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu		Rajewsky, Klaus/0000-0002-6633-6370	National Institutes of Health; European Union, through MUGEN; Cancer Research Institute; Joint Program in Hematology and Transfusion Medicine at Harvard Medical School	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union, through MUGEN; Cancer Research Institute; Joint Program in Hematology and Transfusion Medicine at Harvard Medical School	We thank H. von Boehmer and N. Rajewsky for critical reading of this manuscript. K. R. is supported by grants from the National Institutes of Health and the European Union, through MUGEN. C. X. was supported by a Cancer Research Institute postdoctoral fellowship and a T32 training grant awarded to the Joint Program in Hematology and Transfusion Medicine at Harvard Medical School.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; de Yebenes VG, 2008, J EXP MED, V205, P2199, DOI 10.1084/jem.20080579; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gardner PP, 2008, TRENDS GENET, V24, P262, DOI 10.1016/j.tig.2008.03.009; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KORALOV SB, 2008, CELL IN PRESS; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Santiago-Raber ML, 2001, J IMMUNOL, V167, P4067, DOI 10.4049/jimmunol.167.7.4067; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smilenov LB, 2006, CANCER LETT, V240, P17, DOI 10.1016/j.canlet.2005.08.015; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tanzola MB, 2006, MOL IMMUNOL, V43, P754, DOI 10.1016/j.molimm.2005.03.006; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JW, 2001, MOL CELL BIOL, V21, P8547, DOI 10.1128/MCB.21.24.8547-8564.2001	115	842	903	1	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					26	36		10.1016/j.cell.2008.12.027	http://dx.doi.org/10.1016/j.cell.2008.12.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135886	Bronze			2022-12-28	WOS:000262318400012
J	Chen, J; Novick, RP				Chen, John; Novick, Richard P.			Phage-Mediated Intergeneric Transfer of Toxin Genes	SCIENCE			English	Article							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; PATHOGENICITY ISLAND; BACTERIOPHAGE THERAPY; BOVINE MASTITIS; SHOCK; EVOLUTION; VIRULENCE	Because bacteriophages generally parasitize only closely related bacteria, it is assumed that phage- mediated genetic exchange occurs primarily within species. Here we report that staphylococcal pathogenenicity islands, containing superantigen genes, and other mobile elements transferred to Listeria monocytogenes at the same high frequencies as they transfer within Staphylococcus aureus. Several staphylococcal phages transduced L. monocytogenes but could not form plaques. In an experiment modeling phage therapy for bovine mastitis, we observed pathogenicity island transfer between S. aureus and L. monocytogenes in raw milk. Thus, phages may participate in a far more expansive network of genetic information exchange among bacteria of different species than originally thought, with important implications for the evolution of human pathogens.	[Chen, John; Novick, Richard P.] NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Novick, RP (corresponding author), NYU, Med Ctr, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	novick@saturn.med.nyu.edu		Novick, richard/0000-0003-4418-7893; Chen, John/0000-0002-2318-1823	Kimmel Center for Biology and Medicine; New York University Medical Center	Kimmel Center for Biology and Medicine; New York University Medical Center	We thank D. Portnoy, R. Calendar, M. Bowden, and M. Wiedmann for gifts of strains and for helpful discussions. The expert technical assistance of A. Subedi is gratefully acknowledged. This work was supported by grants-in-aid from the Kimmel Center for Biology and Medicine, from New York University Medical Center, and by personal funds (R.P.N.).	Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Gill JJ, 2006, ANTIMICROB AGENTS CH, V50, P2912, DOI 10.1128/AAC.01630-05; Jensen NE, 1996, INT J FOOD MICROBIOL, V32, P209, DOI 10.1016/0168-1605(96)01105-1; KENNY K, 1993, J CLIN MICROBIOL, V31, P706, DOI 10.1128/JCM.31.3.706-707.1993; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maiques E, 2007, J BACTERIOL, V189, P5608, DOI 10.1128/JB.00619-07; MAZODIER P, 1991, ANNU REV GENET, V25, P147, DOI 10.1146/annurev.ge.25.120191.001051; MILES H, 1992, J DAIRY SCI, V75, P596, DOI 10.3168/jds.S0022-0302(92)77797-2; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P482, DOI 10.1111/j.1472-765X.2005.01781.x; SHIMADA K, 1972, J MOL BIOL, V63, P483, DOI 10.1016/0022-2836(72)90443-3; Stephenson J, 2007, JAMA-J AM MED ASSOC, V298, P1388, DOI 10.1001/jama.298.12.1388; Stone R, 2002, SCIENCE, V298, P728, DOI 10.1126/science.298.5594.728; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; WATTS JL, 1988, VET MICROBIOL, V16, P41, DOI 10.1016/0378-1135(88)90126-5	24	212	225	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					139	141		10.1126/science.1164783	http://dx.doi.org/10.1126/science.1164783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119236				2022-12-28	WOS:000262104100060
J	Freudiger, CW; Min, W; Saar, BG; Lu, S; Holtom, GR; He, CW; Tsai, JC; Kang, JX; Xie, XS				Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; He, Chengwei; Tsai, Jason C.; Kang, Jing X.; Xie, X. Sunney			Label-Free Biomedical Imaging with High Sensitivity by Stimulated Raman Scattering Microscopy	SCIENCE			English	Article							IN-VIVO; CARS-MICROSCOPY; SPECTROSCOPY	Label- free chemical contrast is highly desirable in biomedical imaging. Spontaneous Raman microscopy provides specific vibrational signatures of chemical bonds, but is often hindered by low sensitivity. Here we report a three- dimensional multiphoton vibrational imaging technique based on stimulated Raman scattering ( SRS). The sensitivity of SRS imaging is significantly greater than that of spontaneous Raman microscopy, which is achieved by implementing high- frequency ( megahertz) phase- sensitive detection. SRS microscopy has a major advantage over previous coherent Raman techniques in that it offers background- free and readily interpretable chemical contrast. We show a variety of biomedical applications, such as differentiating distributions of omega- 3 fatty acids and saturated lipids in living cells, imaging of brain and skin tissues based on intrinsic lipid contrast, and monitoring drug delivery through the epidermis.	[Freudiger, Christian W.; Min, Wei; Saar, Brian G.; Lu, Sijia; Holtom, Gary R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Freudiger, Christian W.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [He, Chengwei; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [He, Chengwei; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tsai, Jason C.] Pfizer Global Med, New York, NY 10017 USA	Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pfizer	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Wei, Min/GSI-8510-2022	He, Chengwei/0000-0003-4701-2984	Boehringer Ingelheim Fonds for a Ph.D. Fellowship; Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH [CA113605]; U. S. Department of Energy's Basic Energy Sciences [DE-FG02-07ER15875]; NSF [DBI-0649892]; NIH Director's Pioneer Award; Melinda Gates Foundation Gates Foundation; Pfizer Global Medical; NATIONAL CANCER INSTITUTE [R01CA113605] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds for a Ph.D. Fellowship(Boehringer Ingelheim); Army Research Office for a National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy's Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melinda Gates Foundation Gates Foundation(Bill & Melinda Gates Foundation); Pfizer Global Medical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Ackermann and S. Zhang for advice on skin imaging; S. Kesari, X. Xu and the MCB Harvard Mouse Facilities for providing mouse tissue; J. Grice and M. Roberts for the loan of a sonicator; and G. Young, X. Xu, M. Ruckel, and P. Sims for helpful discussions. C.W.F. and B.G.S. thank Boehringer Ingelheim Fonds for a Ph.D. Fellowship and the Army Research Office for a National Defense Science and Engineering Graduate Fellowship, respectively. J.X.K. acknowledges support from the NIH (grant CA113605). The Xie Group is grateful to the U. S. Department of Energy's Basic Energy Sciences program (DE-FG02-07ER15875) for supporting high-sensitivity Raman detection. The instrumentation development was supported by NSF (grant DBI-0649892), NIH Director's Pioneer Award (to X.S.X.), the Bill & Melinda Gates Foundation Gates Foundation, and Pfizer Global Medical. Harvard University has filed a patent application based on this work.	BLOEMBERGEN N, 1967, AM J PHYS, V35, P989, DOI 10.1119/1.1973774; Boyd R. W., 2003, NONLINEAR OPTICS; Caspers PJ, 2002, PHARMACEUT RES, V19, P1577, DOI 10.1023/A:1020481305420; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Einstein A, 1917, PHYS Z, V18, P121; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P27; Fu D, 2007, OPT LETT, V32, P2641, DOI 10.1364/OL.32.002641; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Heinrich C, 2008, OPT EXPRESS, V16, P2699, DOI 10.1364/OE.16.002699; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kukura P, 2004, J PHYS CHEM A, V108, P5921, DOI 10.1021/jp0482971; Kukura P, 2007, ANNU REV PHYS CHEM, V58, P461, DOI 10.1146/annurev.physchem.58.032806.104456; Levenson M. D., 1988, INTRO NONLINEAR LASE; LEVINE BF, 1979, IEEE J QUANTUM ELECT, V15, P1418, DOI 10.1109/JQE.1979.1069939; OWYOUNG A, 1977, OPT COMMUN, V22, P323, DOI 10.1016/S0030-4018(97)90020-1; Ploetz E, 2007, APPL PHYS B-LASERS O, V87, P389, DOI 10.1007/s00340-007-2630-x; Potma EO, 2000, J OPT SOC AM B, V17, P1678, DOI 10.1364/JOSAB.17.001678; Raman CV, 1928, NATURE, V121, P711, DOI 10.1038/121711a0; Shen Y. R, 2003, PRINCIPLE NONLINEAR; Turrell G., 1996, RAMAN MICROSCOPY DEV; Van De Kerkhof PCM, 2006, J DERMATOL TREAT, V17, P198, DOI 10.1080/09546630600830596; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WOODBURY EJ, 1962, P IRE, V50, P2367; Ye J, 1998, J OPT SOC AM B, V15, P6, DOI 10.1364/JOSAB.15.000006; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	27	1488	1534	34	705	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1857	1861		10.1126/science.1165758	http://dx.doi.org/10.1126/science.1165758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095943	Green Submitted, Green Accepted			2022-12-28	WOS:000261799400059
J	Belhadj, H; Toure, A				Belhadj, Hedia; Toure, Aminata			Gender equality and the right to health	LANCET			English	Editorial Material									[Belhadj, Hedia; Toure, Aminata] UNFPA, New York, NY 10017 USA	United Nations Population Fund	Toure, A (corresponding author), UNFPA, 220 E 42nd St, New York, NY 10017 USA.	toure@unfpa.org						Gwatkin DR, 2004, LANCET, V363, P5, DOI 10.1016/S0140-6736(03)15231-2; HAUB C, 2002, FAMILY PLANNING WORL; HEISE L, 2003, POPULATION REP L; *IPPF UNFPA YOUNG, 2007, CHANG CHOIC POW YOUN; *UN EC SOC COUNC C, 2008, FLOW FIN RES ASS IMP; *UNAIDS, 2007, 07 AIDS EP UPD; *WHO UNICEF UNFPA, 2007, MAT MORTL 2005 EST D; World Health Organization, 2007, UNS AB GLOB REG EST	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2008	2009		10.1016/S0140-6736(08)61786-9	http://dx.doi.org/10.1016/S0140-6736(08)61786-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19097278				2022-12-28	WOS:000261746900008
J	Gillett, G				Gillett, Grant			The art of medicine - Autonomy and selfishness	LANCET			English	Editorial Material									[Gillett, Grant] Univ Otago, Dept Philosophy, Dunedin 9054, New Zealand	University of Otago	Gillett, G (corresponding author), Univ Otago, Dept Philosophy, POB 56, Dunedin 9054, New Zealand.	grant.gillett@stonebow.otago.ac.nz						BRODY H, 1992, HEALERS POWER; Campbell A, 2005, MED ETHICS; CARSON R, 1997, PHILOS MED BIOETHICS; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; GILLETT G, 2004, BIOETHICS CLIN	5	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 4	2008	372	9645					1214	1215		10.1016/S0140-6736(08)61507-X	http://dx.doi.org/10.1016/S0140-6736(08)61507-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	19105247				2022-12-28	WOS:000259882000013
J	AbouZahr, C; Gollogly, L; Stevens, G				AbouZahr, Carla; Gollogly, Laragh; Stevens, Gretchen			Better data needed: everyone agrees, but no one wants to pay	LANCET			English	Editorial Material							COUNTS; HEALTH; SYSTEMS		[AbouZahr, Carla; Gollogly, Laragh; Stevens, Gretchen] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	AbouZahr, C (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	abouzahrc@who.int						AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; G8 Health Expert Group, 2008, TOYAK FRAM ACT GLOB; *GLOB FUND FIGHT A, 2008, DISB DET; *GOV IND, 2007, MORT STAT IND STAT M; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; MDG Africa Steering Group, 2008, ACH MILL DEV GOALS A; REICH MR, 2009, LANCET; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; Third High Level Forum on Aid Effectiveness, 2008, ACCR AG ACT; United Nations, 2008, HIGH LEV EV MILL DEV	13	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					619	621		10.1016/S0140-6736(09)60004-0	http://dx.doi.org/10.1016/S0140-6736(09)60004-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	19150130				2022-12-28	WOS:000275210900008
J	Klareskog, L; Catrina, AI; Paget, S				Klareskog, Lars; Catrina, Anca Irinel; Paget, Stephen			Rheumatoid arthritis	LANCET			English	Review							CYCLIC CITRULLINATED PEPTIDE; ANTITUMOR NECROSIS FACTOR; COLLEGE-OF-RHEUMATOLOGY; HLA-DRB1 SHARED EPITOPE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; CIGARETTE-SMOKING; RISK-FACTORS; RADIOLOGICAL PROGRESSION; CARDIOVASCULAR-DISEASE	Rheumatoid arthritis is a systemic, inflammatory, autoimmune disorder. Enhanced understanding of molecular pathogenesis has enabled development of innovative biological agents that target specific parts of the immune system. These treatments have changed the course and face of rheumatoid arthritis and outcomes for patients and society New knowledge has emerged of how environmental factors interact with susceptibility genes and the immune system in the pathogenesis of a major subset of rheumatoid arthritis. Research undertaken on the longitudinal disease process and molecular pathology of joint inflammation has led to new therapeutic strategies that promote early use of disease-modifying drugs with tight disease control and distinct and quantifiable treatment goals. Today, such approaches can halt most cases of joint destruction but not all instances of joint inflammation and comorbidity Understanding the cause and pathogenesis of different rheumatoid arthritis subsets will lead not only to individualised treatments during early phases of the illness but also, possibly, to disease prevention.	[Paget, Stephen] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Inst, Rheumatol Unit, Dept Med, Stockholm, Sweden; [Klareskog, Lars; Catrina, Anca Irinel] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Paget, S (corresponding author), Hosp Special Surg, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA.	pagets@hss.edu		Klareskog, Lars/0000-0001-9601-6186	EU FP6 programme Autocure; Rheuminations; James and Linda Gosden Robinson Foundation	EU FP6 programme Autocure(European Commission); Rheuminations; James and Linda Gosden Robinson Foundation	For work that led to this Seminar, we acknowledge funding from the EU FP6 programme Autocure (to LK) and from Rheuminations and the James and Linda Gosden Robinson Foundation (to SP). We thank our colleagues for discussions and advice that led to the ideas described in this Seminar.	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P334, DOI 10.1097/BOR.0b013e3282f7c706; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Boonen A, 2005, RHEUM DIS CLIN N AM, V31, P681, DOI 10.1016/j.rdc.2005.07.004; BRENNAN FM, 1989, LANCET, V2, P244; BRENNAN FM, 1989, J AUTOIMMUN, V2, P177, DOI 10.1016/0896-8411(89)90129-7; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Bukhari M, 2002, ARTHRITIS RHEUM-US, V46, P906, DOI 10.1002/art.10167; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAPLAN A, 1959, P ROY SOC MED, V52, P1111, DOI 10.1177/003591575905201225; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Combe B, 2007, BEST PRACT RES CL RH, V21, P27, DOI 10.1016/j.berh.2006.08.011; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; DING B, ARTHRITIS R IN PRESS; Dougados M, 2005, J RHEUMATOL, V32, P1; Edwards JCW, 1999, IMMUNOLOGY, V97, P188; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Erickson Alan R, 2007, Curr Rheumatol Rep, V9, P416, DOI 10.1007/s11926-007-0066-2; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Freeston JE, 2007, ANN RHEUM DIS, V66, P1538, DOI 10.1136/ard.2007.074708; Furst DE, 2007, ANN RHEUM DIS, V66, P2, DOI 10.1136/ard.2007.081430; Genovese MC, 2008, ANN RHEUM DIS, V67, P547, DOI 10.1136/ard.2007.074773; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jacobsson LTH, 2003, BRIT MED J, V326, P1068, DOI 10.1136/bmj.326.7398.1068; Jarrett SJ, 2006, ARTHRITIS RHEUM-US, V54, P1410, DOI 10.1002/art.21824; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Karlson EW, 1999, ARTHRITIS RHEUM-US, V42, P910, DOI 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.3.CO;2-4; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059; KLARESKOG L, 1982, P NATL ACAD SCI-BIOL, V79, P3632, DOI 10.1073/pnas.79.11.3632; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; KLOCKARS M, 1987, BMJ-BRIT MED J, V294, P997, DOI 10.1136/bmj.294.6578.997; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Kremer JM, 2008, CURR OPIN RHEUMATOL, V20, P123, DOI 10.1097/BOR.0b013e3282f50eb1; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Landewe R, 2006, ARTHRITIS RHEUM-US, V54, P3119, DOI 10.1002/art.22143; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Lee AT, 2005, GENES IMMUN, V6, P129, DOI 10.1038/sj.gene.6364159; Lee HS, 2008, MOL MED, V14, P293, DOI 10.2119/2007-00123.Lee; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; Linn-Rasker SP, 2006, ANN RHEUM DIS, V65, P366, DOI 10.1136/ard.2005.041079; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Michaud K, 2007, BEST PRACT RES CL RH, V21, P885, DOI 10.1016/j.berh.2007.06.002; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; Moreland LW, 2006, ARTHRIT RHEUM-ARTHR, V55, P287, DOI 10.1002/art.21838; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; *NAT I HLTH CLIN E, 2008, AB TREATM RHEUM ARTH, V141; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Oliver JE, 2006, SCAND J RHEUMATOL, V35, P169, DOI 10.1080/03009740600718080; Olsson AR, 2004, OCCUP ENVIRON MED, V61, P233, DOI 10.1136/oem.2003.007971; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; PINCUS T, 1986, J RHEUMATOL, V13, P841; Plant MJ, 1998, J RHEUMATOL, V25, P417; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rengel Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2304; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Roman MJ, 2005, HYPERTENSION, V46, P194, DOI 10.1161/01.HYP.0000168055.89955.db; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schepp PP, 2007, ADV ENG MATER, V9, P1; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Silman AJ, 1996, ARTHRITIS RHEUM, V39, P732, DOI 10.1002/art.1780390504; Smolen JS, 2007, ANN RHEUM DIS, V66, P143, DOI 10.1136/ard.2006.061002; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; SPITZ P W, 1987, Clinical Rheumatology, V6, P105, DOI 10.1007/BF02203393; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Svensson B, 2005, ARTHRITIS RHEUM-US, V52, P3360, DOI 10.1002/art.21298; Sverdrup B, 2005, ARTHRITIS RES THER, V7, pR1296, DOI 10.1186/ar1824; Symmons DPM, 1997, ARTHRITIS RHEUM, V40, P1955, DOI 10.1002/art.1780401106; Szkudlarek M, 2004, ARTHRITIS RHEUM-US, V50, P2103, DOI 10.1002/art.20333; Teng YKO, 2007, ARTHRITIS RHEUM-US, V56, P3909, DOI 10.1002/art.22967; Ulfgren AK, 2000, ANN RHEUM DIS, V59, P439, DOI 10.1136/ard.59.6.439; van der Helm-van Mil AHM, 2005, ARTHRITIS RHEUM-US, V52, P2637, DOI 10.1002/art.21272; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302; VESSEY MP, 1987, CONTRACEPTION, V35, P457, DOI 10.1016/0010-7824(87)90082-5; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Watts RA, 2004, RHEUMATOLOGY, V43, P920, DOI 10.1093/rheumatology/keh210; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Zendman AJW, 2006, RHEUMATOLOGY, V45, P20, DOI 10.1093/rheumatology/kei111; Zhang HG, 2002, J IMMUNOL, V168, P4164, DOI 10.4049/jimmunol.168.8.4164	135	656	712	1	132	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2009	373	9664					659	672		10.1016/S0140-6736(09)60008-8	http://dx.doi.org/10.1016/S0140-6736(09)60008-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19157532				2022-12-28	WOS:000263563500031
J	Grewal, J; McCully, RB; Kane, GC; Lam, C; Pellikka, PA				Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.			Left Ventricular Function and Exercise Capacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIASTOLIC DYSFUNCTION; CARDIAC-FUNCTION; HEART-FAILURE; AGE; MEN; ECHOCARDIOGRAPHY; PERFORMANCE; TOLERANCE; GENDER; WOMEN	Context Limited information exists regarding the role of left ventricular function in predicting exercise capacity and impact on age- and sex- related differences. Objectives To determine the impact of measures of cardiac function assessed by echocardiography on exercise capacity and to determine if these associations are modified by sex or advancing age. Design Cross- sectional study of patients undergoing exercise echocardiography with routine measurements of left ventricular systolic and diastolic function by 2- dimensional and Doppler techniques. Analyses were conducted to determine the strongest correlates of exercise capacity and the age and sex interactions of these variables with exercise capacity. Setting Large tertiary referral center in Rochester, Minnesota, in 2006. Participants Patients undergoing exercise echocardiography using the Bruce protocol ( N= 2867). Patients with echocardiographic evidence of exercise- induced ischemia, ejection fractions lower than 50%, or significant valvular heart disease were excluded. Main Outcome Measure Exercise capacity in metabolic equivalents ( METs). Results Diastolic dysfunction was strongly and inversely associated with exercise capacity. Compared with normal function, after multivariate adjustment, those with moderate/ severe resting diastolic dysfunction (- 1.30 METs; 95% confidence interval [ CI], - 1.52 to - 0.99; P <. 001) and mild resting diastolic dysfunction (- 0.70 METs; 95% CI, - 0.88 to - 0.46; P <. 001) had substantially lower exercise capacity. Variation of left ventricular systolic function within the normal range was not associated with exercise capacity. Left ventricular filling pressures measured by resting E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.70 to - 0.11; P=. 007) or postexercise E/ e' of 15 or greater (- 0.41 METs; 95% CI, - 0.71 to - 0.11; P=. 007) were similarly associated with a reduction in exercise capacity, each in separate multivariate analyses. Individuals with impaired relaxation ( mild dysfunction) or resting E/e' of 15 or greater had a progressive increase in the magnitude of reduction in exercise capacity with advancing age ( P <. 001 and P=. 02, respectively). Other independent correlates of exercise capacity were age ( unstandardized beta coefficient, - 0.85 METs; 95% CI, - 0.92 to - 0.77, per 10- year increment; P <. 001), female sex (- 1.98 METs; 95% CI, - 2.15 to - 1.84; P <. 001), and body mass index greater than 30 (- 1.24 METs; 95% CI, - 1.41 to - 1.10; P <. 001). Conclusion In this large cross- sectional study of those referred for exercise echocardiography and not limited by ischemia, abnormalities of left ventricular diastolic function were independently associated with exercise capacity.	[Grewal, Jasmine; McCully, Robert B.; Kane, Garvan C.; Lam, Carolyn; Pellikka, Patricia A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	pellikka.patricia@mayo.edu	Lam, Carolyn SP/ABD-6810-2021; Pellikka, Patricia A/N-5387-2014	Lam, Carolyn SP/0000-0003-1903-0018; Pellikka, Patricia A/0000-0001-6800-3521	National Center for Research Resources [1 UL1 RR024150]; National Institutes of Health; NIH Roadmap for Medical Research; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by grant No. 1 UL1 RR024150 (for biostatistical analysis) from the National Center for Research Resources, a component of the National Institutes of Health (NIH); the NIH Roadmap for Medical Research; and the Mayo Foundation (data management).	BRANDAO MUP, 1993, J APPL PHYSIOL, V75, P1989, DOI 10.1152/jappl.1993.75.5.1989; Brassard P, 2007, MED SCI SPORT EXER, V39, P1896, DOI 10.1249/mss.0b013e318145b642; Burgess MI, 2006, J AM COLL CARDIOL, V47, P1891, DOI 10.1016/j.jacc.2006.02.042; BUSKIRK ER, 1987, FASEB J, V46, P1824; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; ELLSTAD MH, 1996, STRESS TESTING PRINC, P75; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Gilman G, 2007, J AM SOC ECHOCARDIOG, V20, P199, DOI 10.1016/j.echo.2006.08.005; Ha JW, 2003, AM J CARDIOL, V91, P114, DOI 10.1016/S0002-9149(02)03016-3; HIGGINBOTHAM MB, 1983, AM J CARDIOL, V51, P52, DOI 10.1016/S0002-9149(83)80010-1; HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3; HOSSACK KF, 1982, J APPL PHYSIOL, V53, P799, DOI 10.1152/jappl.1982.53.4.799; JULIUS S, 1967, CIRCULATION, V36, P222, DOI 10.1161/01.CIR.36.2.222; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY WC, 1993, CIRCULATION, V88, P116, DOI 10.1161/01.CIR.88.1.116; Little WC, 2006, AM J CARDIOL, V98, P383, DOI 10.1016/j.amjcard.2006.01.106; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Okura H, 2000, AM HEART J, V139, P716, DOI 10.1016/S0002-8703(00)90054-1; OLDERSHAW PJ, 1983, BRIT HEART J, V49, P568; Ommen SR, 2000, CIRCULATION, V102, P1788; PAINTAL AS, 1969, J PHYSIOL-LONDON, V203, P511, DOI 10.1113/jphysiol.1969.sp008877; Proctor DN, 1998, J APPL PHYSIOL, V84, P599, DOI 10.1152/jappl.1998.84.2.599; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROBERTS AM, 1986, CIRC RES, V58, P512, DOI 10.1161/01.RES.58.4.512; Shubair Mamdouh M, 2004, J Cardiopulm Rehabil, V24, P405, DOI 10.1097/00008483-200411000-00008; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Smart N, 2007, AM HEART J, V153, P530, DOI 10.1016/j.ahj.2007.01.004; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; VANOVERSCHELDE JLJ, 1993, J APPL PHYSIOL, V74, P2225, DOI 10.1152/jappl.1993.74.5.2225; Warner JG, 1999, J AM COLL CARDIOL, V33, P1567, DOI 10.1016/S0735-1097(99)00048-0; Weiss EP, 2006, J APPL PHYSIOL, V101, P938, DOI 10.1152/japplphysiol.01398.2005; Woo JS, 2006, J AM COLL CARDIOL, V47, P1049, DOI 10.1016/j.jacc.2005.09.066	36	174	178	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					286	294		10.1001/jama.2008.1022	http://dx.doi.org/10.1001/jama.2008.1022			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155455	Bronze, Green Accepted			2022-12-28	WOS:000262518700019
J	Tanaka, H; Kato, K; Yamashita, E; Sumizawa, T; Zhou, Y; Yao, M; Iwasaki, K; Yoshimura, M; Tsukihara, T				Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Sumizawa, Tomoyuki; Zhou, Yong; Yao, Min; Iwasaki, Kenji; Yoshimura, Masato; Tsukihara, Tomitake			The Structure of Rat Liver Vault at 3.5 Angstrom Resolution	SCIENCE			English	Article							RIBONUCLEOPROTEIN-PARTICLES; PROTEIN; CELLS; RESISTANCE; DOMAIN; RNA; ASSOCIATION; POLYMERASE; STOMATIN; SYMMETRY	Vaults are among the largest cytoplasmic ribonucleoprotein particles and are found in numerous eukaryotic species. Roles in multidrug resistance and innate immunity have been suggested, but the cellular function remains unclear. We have determined the x-ray structure of rat liver vault at 3.5 angstrom resolution and show that the cage structure consists of a dimer of half-vaults, with each half-vault comprising 39 identical major vault protein (MVP) chains. Each MVP monomer folds into 12 domains: nine structural repeat domains, a shoulder domain, a cap-helix domain, and a cap-ring domain. Interactions between the 42-turn-long cap-helix domains are key to stabilizing the particle. The shoulder domain is structurally similar to a core domain of stomatin, a lipid-raft component in erythrocytes and epithelial cells.	[Tanaka, Hideaki; Kato, Koji; Yamashita, Eiki; Iwasaki, Kenji; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sumizawa, Tomoyuki] Univ Occupat & Environm Hlth, Fukuoka, Japan; [Zhou, Yong; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Iwasaki, Kenji] RIKEN, Harima Inst, Biomultisome Res Team, Struct Physiol Res Grp, Mikazuki, Hyogo 6795148, Japan; [Yoshimura, Masato] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Tsukihara, Tomitake] Univ Hyogo, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Osaka University; University of Occupational & Environmental Health - Japan; Hokkaido University; RIKEN; National Synchrotron Radiation Research Center; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsuki@protein.osaka-u.ac.jp	yao, min/F-5287-2011; Tanaka, Hideaki/AGY-8426-2022; Kato, Koji/H-8502-2017; Yamashita, Eiki/V-6758-2019	yao, min/0000-0003-1687-5904; Kato, Koji/0000-0001-9846-5903; Yamashita, Eiki/0000-0002-4278-0039; Yoshimura, Masato/0000-0002-7466-2192	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10188101, 10179101, A-041, 19770082, 16048216, 20051001]; Japan Space Forum	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	We thank T. Tomizaki for help in the diffraction data collection on X10SA (PX II) at the Swiss Light Source (Villigen, Switzerland). This work was supported in part by a Grant-in-Aid for Scientific Research in a Priority Area ( 10188101 and 10179101) and the Global Center of Excellence (GCOE) program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and by a Ground-Based Research Announcement for Space Utilization provided by the Japan Space Forum (T. T.). This work was also supported in part by a Grant-in-Aid for Young Scientists (B) 19770082 (H. T.) and Grant-in-Aids for Scientific Research in a Priority Area 16048216 ( H. T.) and 20051001 (M. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Coordinates and structure factors have been deposited with the PDB under accession codes 2ZUO, 2ZV4, and 2ZV5. The three entries were made because the number of coordinates exceeded the limits of a PDB file. A PDB formatted file that contains whole coordinates and structure factors is available from www.protein.osaka-u.ac.jp/crystallograpy/mvp/.	Anderson DH, 2007, PLOS BIOL, V5, P2661, DOI 10.1371/journal.pbio.0050318; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUGANI DC, 1993, J CELL SCI, V106, P23; Gopinath SCB, 2005, NUCLEIC ACIDS RES, V33, P4874, DOI 10.1093/nar/gki809; Hamill DR, 1997, DEV BIOL, V190, P117, DOI 10.1006/dbio.1997.8676; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kato K, 2008, ACTA CRYSTALLOGR D, V64, P525, DOI 10.1107/S0907444908004277; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Kickhoefer VA, 2001, J CELL BIOL, V152, P157, DOI 10.1083/jcb.152.1.157; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kong LB, 2000, RNA, V6, P890, DOI 10.1017/S1355838200000157; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kozlov G, 2006, J MOL BIOL, V356, P444, DOI 10.1016/j.jmb.2005.11.064; Mikyas Y, 2004, J MOL BIOL, V344, P91, DOI 10.1016/j.jmb.2004.09.021; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephen AG, 2001, J BIOL CHEM, V276, P23217, DOI 10.1074/jbc.C100226200; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	30	101	110	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					384	388		10.1126/science.1164975	http://dx.doi.org/10.1126/science.1164975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150846				2022-12-28	WOS:000262481400040
J	Hsu, HE; Shutt, KA; Moore, MR; Beall, BW; Bennett, NM; Craig, AS; Farley, MM; Jorgensen, JH; Lexau, CA; Petit, S; Reingold, A; Schaffner, W; Thomas, A; Whitney, CG; Harrison, LH				Hsu, Heather E.; Shutt, Kathleen A.; Moore, Matthew R.; Beall, Bernard W.; Bennett, Nancy M.; Craig, Allen S.; Farley, Monica M.; Jorgensen, James H.; Lexau, Catherine A.; Petit, Susan; Reingold, Arthur; Schaffner, William; Thomas, Ann; Whitney, Cynthia G.; Harrison, Lee H.			Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; UNITED-STATES; DISEASE; ERA; CHILDHOOD; SEROTYPES; CARRIAGE; ADULTS	Background Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine ( PCV7) in 2000, but its effect on pneumococcal meningitis is unclear. Methods We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population- based surveillance data from eight sites in the United States. Isolates were grouped into PCV7 serotypes ( 4, 6B, 9V, 14, 18C, 19F, and 23F), PCV7- related serotypes ( 6A, 9A, 9L, 9N, 18A, 18B, 18F, 19B, 19C, 23A, and 23B), and non- PCV7 serotypes ( all others). Changes in the incidence of pneumococcal meningitis were assessed against baseline values from 1998- 1999. Results We identified 1379 cases of pneumococcal meningitis. The incidence declined from 1.13 cases to 0.79 case per 100,000 persons between 1998- 1999 and 2004- 2005 ( a 30.1% decline, P< 0.001). Among persons younger than 2 years of age and those 65 years of age or older, the incidence decreased during the study period by 64.0% and 54.0%, respectively ( P< 0.001 for both groups). Rates of PCV7- serotype meningitis declined from 0.66 case to 0.18 case ( a 73.3% decline, P< 0.001) among patients of all ages. Although rates of PCV7- related- serotype disease decreased by 32.1% ( P = 0.08), rates of non- PCV7- serotype disease increased from 0.32 to 0.51 ( an increase of 60.5%, P< 0.001). The percentages of cases from non- PCV7 serotypes 19A, 22F, and 35B each increased significantly during the study period. On average, 27.8% of isolates were nonsusceptible to penicillin, but fewer isolates were nonsusceptible to chloramphenicol ( 5.7%), meropenem ( 16.6%), and cefotaxime ( 11.8%). The proportion of penicillin-nonsusceptible isolates decreased between 1998 and 2003 ( from 32.0% to 19.4%, P = 0.01) but increased between 2003 and 2005 ( from 19.4% to 30.1%, P = 0.03). Conclusions Rates of pneumococcal meningitis have decreased among children and adults since PCV7 was introduced. Although the overall effect of the vaccine remains substantial, a recent increase in meningitis caused by non- PCV7 serotypes, including strains nonsusceptible to antibiotics, is a concern.	[Hsu, Heather E.; Shutt, Kathleen A.; Harrison, Lee H.] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA; [Moore, Matthew R.; Beall, Bernard W.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Farley, Monica M.] Emory Univ, Vet Affairs Med Ctr, Atlanta, GA 30322 USA; [Bennett, Nancy M.] Univ Rochester, Rochester, NY USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Jorgensen, James H.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Lexau, Catherine A.] Minnesota Dept Hlth, St Paul, MN USA; [Petit, Susan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Thomas, Ann] Oregon State Publ Hlth Div, Portland, OR USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Rochester; Tennessee Department Health; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; Minnesota Department of Health (MHD); University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, 521 Parran Hall,130 Desoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.pitt.edu		Hsu, Heather/0000-0002-5863-1804; Shutt, Kathleen/0000-0003-3376-6152	National Institute of Allergy and Infectious Diseases [K24 AI052788]; Sanofi-Pasteur; AstraZeneca; Wyeth; BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson; Cubist; Merck; Pfizer; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052788] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sanofi-Pasteur; AstraZeneca(AstraZeneca); Wyeth(Wyeth); BD Diagnostics; bioMerieux; Astellis; Siemens MicroScan; Accelr8 Technology; Arpida; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Cubist; Merck(Merck & Company); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the CDC and a career development award from the National Institute of Allergy and Infectious Diseases (K24 AI052788, to Dr. Harrison). Ms. Shutt reports receiving grant support from Sanofi-Pasteur and AstraZeneca; Dr. Bennett, honoraria and travel expenses from Wyeth for an advisory board meeting on an experimental pneumococcal vaccine and from Merck for participation on an advisory board on herpes zoster vaccine; Dr. Farley, travel expenses for lectures from Wyeth; Dr. Jorgensen, consulting, lecture, or advisory fees from BD Diagnostics, bioMerieux, Astellis, Siemens MicroScan, and Accelr8 Technology and grant support from bioMerieux, Arpida, Johnson & Johnson, Cubist, Merck, and Pfizer; Dr. Schaffner, honoraria from Wyeth for an advisory board meeting about an experimental vaccine and from Merck for participation on a data and safety monitoring board for experimental vaccines and advisory-board meetings on adult immunization and pneumococcal vaccine; and Dr. Harrison, consulting fees and honoraria from Wyeth, Merck, Sanofi-Pasteur, and GlaxoSmithKline and grant support from Sanofi-Pasteur. No other potential conflict of interest relevant to this article was reported.; We thank the personnel in the Active Bacterial Core surveillance sites of the Emerging Infections Program, especially Wendy Baughman and Paul Malpiedi of the Georgia Emerging Infections Program; Rosemary Hollick and Kim Holmes of the Johns Hopkins Bloomberg School of Public Health; Brenda G. Barnes of the Department of Preventive Medicine, Vanderbilt School of Medicine; Lori Triden, Ruth Lynfield, and Richard Danila of the Clinical Microbiology Section, Minnesota Public Health Laboratory; James L. Hadler and Zack Fraser of the Connecticut Department of Public Health; Karen Stefonek of the Oregon Public Health Division; Shelley M. Zansky of the Emerging Infections Program, New York State Department of Health; Glenda L. Smith of the Emerging Infections Program, Rochester, NY; and Susan Brooks and Pamala Daily of the California Emerging Infections Program, Oakland, CA; and also Delois Jackson and her team in the CDC Strep Laboratory for serotyping and data on minimal inhibitory concentrations; M. Leticia McElmeel, Letitia Fulcher, and Christa Trippy for assistance with the antimicrobial susceptibility testing; and Tamara Pilishvili and Elizabeth Zell for assistance with data management and programming.	Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; Bingen E, 2008, EUR J CLIN MICROBIOL, V27, P191, DOI 10.1007/s10096-007-0417-y; Black S, 2007, PEDIATR INFECT DIS J, V26, P771, DOI 10.1097/INF.0b013e318124a494; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; *CDCP, 2007, ACT BACT COR SURV OV; *CDCP, 2007, METH SURV POP ACT BA; *CDCP, 2006, ABCS REP EM INF PROG; *CLIN LAB STAND I, 2007, M100S17 NCCLS, P126; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V355, P638; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; *NAT CTR HLTH STAT, 2007, DAT FIL DOC; *NAT CTR IMM RESP, 2007, IMM COV US COV IND V; Neuman HB, 2001, CLIN PEDIATR, V40, P595, DOI 10.1177/000992280104001102; *NIH, 2007, STUD EV 13 VAL PNEUM; *NIH, 2006, SAF IMM STUD 10 VAL; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Temime L, 2005, EPIDEMIOL INFECT, V133, P493, DOI 10.1017/S0950268804003565; THIGPEN MC, 2005, 43 ANN M INF DIS SOC; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yu XH, 1999, J INFECT DIS, V180, P1569, DOI 10.1086/315096	35	330	356	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					244	256		10.1056/NEJMoa0800836	http://dx.doi.org/10.1056/NEJMoa0800836			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144940	Green Accepted			2022-12-28	WOS:000262434500007
J	Gray, A; Read, S; McGale, P; Darby, S				Gray, Alastair; Read, Simon; McGale, Paul; Darby, Sarah			Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLLABORATIVE ANALYSIS; RESIDENTIAL RADON; INDIVIDUAL DATA; REMEDIATION; HOMES	Objective To determine the number of deaths from lung cancer related to radon in the home and to explore the cost effectiveness of alternative policies to control indoor radon and their potential to reduce lung cancer mortality. Design Cost effectiveness analysis. Setting United Kingdom. Data sources Epidemiological data on risks from indoor radon and from smoking, vital statistics on deaths from lung cancer, survey information on effectiveness and costs of radon prevention and remediation. Main outcome measures Estimated number of deaths from lung cancer related to indoor radon, lifetime risks of death from lung cancer before and after various potential interventions to control radon, the cost per quality adjusted life year ( QALY) gained from different policies for control of radon, and the potential of those policies to reduce lung cancer mortality. Results The mean radon concentration in UK homes is 21 becquerels per cubic metre (Bq/m(3)). Each year around 1100 deaths from lung cancer ( 3.3% of all deaths from lung cancer) are related to radon in the home. Over 85% of these arise from radon concentrations below 100 Bq/m(3) and most are caused jointly by radon and active smoking. Current policy requiring basic measures to prevent radon in new homes in selected areas is highly cost effective, and such measures would remain cost effective if extended to the entire UK, with a cost per QALY gained of 11 400 ((euro) 12 200; $ 16 913). Current policy identifying and remediating existing homes with high radon levels is, however, neither cost effective ( cost per QALY gained 36 800) nor effective in reducing lung cancer mortality. Conclusions Policies requiring basic preventive measures against radon in all new homes throughout the UK would be cost effective and could complement existing policies to reduce smoking. Policies involving remedial work on existing homes with high radon levels cannot prevent most radon related deaths, as these are caused by moderate exposure in many homes. These conclusions are likely to apply to most developed countries, many with higher mean radon concentrations than the UK.	[Gray, Alastair] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Read, Simon; McGale, Paul; Darby, Sarah] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England	University of Oxford; University of Oxford; University of Oxford	Gray, A (corresponding author), Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford OX3 7LF, England.	alastair.gray@dphpc.ox.ac.uk			Cancer Research UK [C500/A10573, A10293]; Medical Research Council [E270/4]; European Commission [516483 (FI6R)]; National Institute for Health Research; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Cancer Research UK [grant Nos C500/A10573, A10293], the Medical Research Council [grant No E270/4], the European Commission sixth framework programme ( project: alpha risk grant No 516483 (FI6R)), and the National Institute for Health Research. The funders had no role in the design of the study, carrying out the analysis, or the decision to submit for publication.	AKERBLOM G, 1999, 9918 SWED RAD PROT I; Bradley EJ, 1996, NRPBM707; Cancer Research UK, 2008, CANC STAT; Chilton S., 2004, VALUATION HLTH BENEF; *COMM BIOL EFF ION, 1999, HLTH EFF EXP IND RAD; Coskeran T, 2005, HEALTH POLICY, V71, P43, DOI 10.1016/j.healthpol.2004.05.003; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; *DEP HLTH, 2004, POL APPR HLTH GUID D; *DEP TRANSP, 2007, 1 DEP TRANSP; Department of the Environment Transport and the Regions, 2000, DETRRAS00004; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ford ES, 1999, AM J PUBLIC HEALTH, V89, P351, DOI 10.2105/AJPH.89.3.351; Gold MR, 1996, COST EFFECTIVENESS H; *HLTH PROT AG, HPA ADV RAD PROT MEA; HUNTER N, 2005, 7 INT S NAT RAD ENV, P438; *IND ADV GROUP ION, 2009, RAD PUBL HL IN PRESS; Kennedy CA, 1999, BRIT J CANCER, V81, P1243, DOI 10.1038/sj.bjc.6690836; LOMAS PR, 1994, RADIAT PROT DOSIM, V56, P323; Naismith SP, 1998, HEALTH PHYS, V75, P410, DOI 10.1097/00004032-199810000-00008; *NAT I HLTH CLIN E, 2005, GUID NICE; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; *OFF NAT STAT, 2006, LIV BRIT 2004 GEN HO; *PARL OFF SCI TECH, RED RAD RISKS HOM; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Stigum H, 2003, HEALTH PHYS, V84, P227, DOI 10.1097/00004032-200302000-00011; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, UNSCEAR 2006 REP GEN, V1; *WHO, WHO IND AIR QUAL GUI; Wrixon AD, 1988, NRPBR190	31	102	102	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2009	338								a3110	10.1136/bmj.a3110	http://dx.doi.org/10.1136/bmj.a3110			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PN	19129153	Green Published, hybrid			2022-12-28	WOS:000263165600003
J	Pryce, R				Pryce, R.			Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; THERAPY; ADOLESCENTS; MANAGEMENT; INFUSION		[Pryce, R.] Mildura Base Hosp, Mildura, Vic 3500, Australia		Pryce, R (corresponding author), Mildura Base Hosp, Ontario Ave, Mildura, Vic 3500, Australia.	bekyp@doctors.org.uk						Ahern Jo Ann H, 2002, Pediatr Diabetes, V3, P10; DeFelippis MR, 2006, DIABETES TECHNOL THE, V8, P358, DOI 10.1089/dia.2006.8.358; *DIAB UK DEP HLTH, 2007, INS PUMP SERV REP IN; DiMeglio LA, 2004, J PEDIATR-US, V145, P380, DOI 10.1016/j.jpeds.2004.06.022; GREGORY R, 1991, DIABETES CARE, V14, P42, DOI 10.2337/diacare.14.1.42; Haynes A, 2004, DIABETOLOGIA, V47, P866, DOI 10.1007/s00125-004-1385-8; Herter CD, 1999, DIABETES SPECTRUM, V12, P198; *INS DEP DIAB TRUS, 2003, STOR INS; Jeitler K, 2008, DIABETOLOGIA, V51, P941, DOI 10.1007/s00125-008-0974-3; Littom J, 2002, J PEDIATR-US, V141, P490, DOI 10.1067/mpd.2002.127500; McMahon SK, 2005, DIABETIC MED, V22, P92, DOI 10.1111/j.1464-5491.2004.01359.x; *MEDTR, 2008, INS PUMP THER EX; *NAT I HLTH CLIN E, 2003, GUID US CONT SUBC IN; Plotnick LP, 2003, DIABETES CARE, V26, P1142, DOI 10.2337/diacare.26.4.1142; Steppel JH, 2003, REV ENDOCR METAB DIS, V4, P355, DOI 10.1023/A:1027302112655; Weinzimer SA, 2004, PEDIATRICS, V114, P1601, DOI 10.1542/peds.2004-0092	16	16	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2009	338								a2218	10.1136/bmj.a2218	http://dx.doi.org/10.1136/bmj.a2218			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PM	19124546				2022-12-28	WOS:000263165500001
J	McMeniman, CJ; Lane, RV; Cass, BN; Fong, AWC; Sidhu, M; Wang, YF; O'Neill, SL				McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.			Stable Introduction of a Life-Shortening Wolbachia Infection into the Mosquito Aedes aegypti	SCIENCE			English	Article							CYTOPLASMIC INCOMPATIBILITY; VIRULENT WOLBACHIA; TRANSMISSION; DROSOPHILA; AGE; TEMPERATURE; STRAIN	Most pathogens require a relatively long period of development in their mosquito vector before they can be transmitted to a new human host; hence, only older insects are of epidemiological importance. The successful transfer of a life- shortening strain of the inherited bacterial symbiont, Wolbachia, into the major mosquito vector of dengue, Aedes aegypti, halved adult life span under laboratory conditions. The association is stable, and the Wolbachia strain is maternally inherited at high frequency. It is capable of inducing complete cytoplasmic incompatibility, which should facilitate its invasion into natural field populations and its persistence over time. Our data suggest that targeting mosquito age with inherited Wolbachia infections may be a viable strategy to reduce the transmission of pathogens such as dengue viruses.	[McMeniman, Conor J.; Lane, Roxanna V.; Cass, Bodil N.; Fong, Amy W. C.; Sidhu, Manpreet; Wang, Yu-Feng; O'Neill, Scott L.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Wang, Yu-Feng] Cent China Normal Univ, Coll Life Sci, Wuhan 430079, Peoples R China	University of Queensland; Central China Normal University	O'Neill, SL (corresponding author), Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	scott.oneill@uq.edu.au	O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019; wang, yufeng/E-5122-2010	O'Neill, Scott L/0000-0002-4131-3615; O'Neill, Scott/0000-0002-4131-3615; McMeniman, Conor/0000-0001-8502-8712	Foundation for the NIH; Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Dobson, Z. Xi, and Y. Fu for their advice on microinjection of mosquito eggs; C. Williams and S. Ritchie for supplying the JCU mosquito strain; and E. McGraw and members of the O'Neill laboratory for helpful comments. This research was supported by a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Reynolds KT, 2003, GENETICS, V164, P1027; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Warrell DA., 2002, ESSENTIAL MALARIOLOG; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	25	642	678	6	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					141	144		10.1126/science.1165326	http://dx.doi.org/10.1126/science.1165326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119237				2022-12-28	WOS:000262104100061
J	Dougan, G				Dougan, Gordon			Does the Trojan Horse Have an Achilles' Heel?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Dougan, G (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge, England.							Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; SMITH H, 1958, ANNU REV MICROBIOL, V12, P77, DOI 10.1146/annurev.mi.12.100158.000453	2	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					83	84		10.1056/NEJMcibr0808335	http://dx.doi.org/10.1056/NEJMcibr0808335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118310				2022-12-28	WOS:000262096800014
J	Roux, A; Antonny, B				Roux, Aurelien; Antonny, Bruno			The long and Short of membrane Fission	CELL			English	Editorial Material							DYNAMIN	During membrane fission, the GTPase dynamin forms helical assemblies at the neck of membrane buds. Although it has been proposed that fission results from the constriction of the dynamin helix, new work by Bashkirov et al. (2008) and Pucadyil and Schmid (2008) unexpectedly shows that helix disassembly is also necessary for membrane fission.	[Roux, Aurelien] Inst Curie, CNRS, Lab Physicochim Curie, F-75248 Paris 05, France; [Antonny, Bruno] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Roux, A (corresponding author), Inst Curie, CNRS, Lab Physicochim Curie, F-75248 Paris 05, France.	aurelien.roux@curie.fr; antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020; Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Antonny, Bruno/0000-0002-9166-8668; Roux, Aurelien R/0000-0002-6088-0711; 				Lenz M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011911; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0	6	19	20	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1163	1165		10.1016/j.cell.2008.12.003	http://dx.doi.org/10.1016/j.cell.2008.12.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109885	Bronze			2022-12-28	WOS:000261989800005
J	Verghese, A				Verghese, Abraham			Culture Shock - Patient as Icon, Icon as Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Verghese, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							[Anonymous], 2007, EVIDENCE BASED PHYS; Garber AM, 2008, ANN INTERN MED, V148, P964, DOI 10.7326/0003-4819-148-12-200806170-00223; MCDERMOTT W, 1978, PERSPECT BIOL MED, V21, P167; Reilly BM, 2003, LANCET, V362, P1100, DOI 10.1016/S0140-6736(03)14464-9	4	201	203	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2748	2751		10.1056/NEJMp0807461	http://dx.doi.org/10.1056/NEJMp0807461			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109572				2022-12-28	WOS:000261950800002
J	King, CR; Knutson, KL; Rathouz, PJ; Sidney, S; Liu, K; Lauderdale, DS				King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Sidney, Steve; Liu, Kiang; Lauderdale, Diane S.			Short Sleep Duration and Incident Coronary Artery Calcification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; COMPUTED-TOMOGRAPHY; APNEA-HYPOPNEA; CALCIUM; ATHEROSCLEROSIS; ASSOCIATION; PROGRESSION; ACTIGRAPHY; ADULTS; HYPERTENSION	Context Coronary artery calcification is a subclinical predictor of coronary heart disease. Recent studies have found that sleep duration is correlated with established risk factors for calcification including glucose regulation, blood pressure, sex, age, education, and body mass index. Objective To determine whether objective and subjective measures of sleep duration and quality are associated with incidence of calcification over 5 years and whether calcification risk factors mediate the association. Design, Setting, and Participants Observational cohort of home monitoring in a healthy middle- aged population of 495 participants from the Coronary Artery Risk Development in Young Adults ( CARDIA) cohort Chicago site ( black and white men and women aged 35- 47 years at year 15 of the study in 2000- 2001 with follow- up data at year 20 in 2005- 2006). Potential confounders ( age, sex, race, education, apnea risk, smoking status) and mediators ( lipids, blood pressure, body mass index, diabetes, inflammatory markers, alcohol consumption, depression, hostility, selfreported medical conditions) were measured at both baseline and follow- up. Sleep metrics ( wrist actigraphy measured duration and fragmentation, daytime sleepiness, overall quality, self- reported duration) were examined for association with incident calcification. Participants had no detectable calcification at baseline. Main Outcome Measure Coronary artery calcification was measured by computed tomography in 2000- 2001 and 2005- 2006 and incidence of new calcification over that time was the primary outcome. Results Five- year calcification incidence was 12.3% ( n= 61). Longer measured sleep duration was significantly associated with reduced calcification incidence ( adjusted odds ratio, 0.67 per hour [ 95% confidence interval, 0.49- 0.91 per hour]; P=. 01). No potential mediators appreciably altered the magnitude or significance of sleep ( adjusted odds ratio estimates ranged from 0.64 to 0.68 per sleep hour; maximum P=. 02). Alternative sleep metrics were not significantly associated with calcification. Conclusion Longer measured sleep is associated with lower calcification incidence independent of examined potential mediators and confounders.	[King, Christopher Ryan; Knutson, Kristen L.; Rathouz, Paul J.; Lauderdale, Diane S.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Sidney, Steve] Kaiser Permanente, Oakland, CA USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA	University of Chicago; Kaiser Permanente; Northwestern University	Lauderdale, DS (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	lauderdale@uchicago.edu		King, Christopher/0000-0002-4574-8616; Knutson, Kristen/0000-0002-2751-6168	National Institute on Aging [AG 11412]; Medical Scientist National Research Service Award [T 32 GM07281]; US Public Health Service [NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050]; National Heart, Lung, and Blood Institute [NO1-HC-95095]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048050, N01HC048047, N01HC095095, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Scientist National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research for this study was supported by grant AG 11412 from the National Institute on Aging and the Medical Scientist National Research Service Award T 32 GM07281. The Coronary Artery Risk Development in Young Adults (CARDIA) study is supported by US Public Health Service contracts NO1-HC-48047, NO1-HC-48048, NO1-HC48049, NO1-HC-48050, and NO1-HC-95095 from the National Heart, Lung, and Blood Institute.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; EVANS PD, 1987, J BEHAV MED, V10, P311, DOI 10.1007/BF00846544; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; Garcia-Diaz E, 2007, CHEST, V131, P725, DOI 10.1378/chest.06-1604; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Hastings PC, 2006, EUR RESPIR J, V27, P748, DOI 10.1183/09031936.06.00063005; Hedner J, 2004, SLEEP, V27, P1560, DOI 10.1093/sleep/27.8.1560; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JeanLouis G, 1997, PERCEPT MOTOR SKILL, V85, P207, DOI 10.2466/pms.1997.85.1.207; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung HH, 2005, AM J KIDNEY DIS, V45, P875, DOI 10.1053/j.ajkd.2005.01.006; Knutson KL, 2007, SLEEP, V30, P793, DOI 10.1093/sleep/30.6.793; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Knutson KL, 2006, SLEEP, V29, P878, DOI 10.1093/sleep/29.7.878; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199; Leproult R, 1997, SLEEP, V20, P865; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Matthews K, 2006, PSYCHOSOM MED, V68, P657, DOI 10.1097/01.psy.0000244071.42939.0e; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; PATEL SR, INT J OBES IN PRESS; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Silva GE, 2007, J CLIN SLEEP MED, V3, P622; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STAESSEN J, 1992, AM J HYPERTENS, V5, P386, DOI 10.1093/ajh/5.6.386; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; van den Berg JF, 2008, INT J OBESITY, V32, P1083, DOI 10.1038/ijo.2008.57; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Yoon HC, 2002, RADIOLOGY, V224, P236, DOI 10.1148/radiol.2241011191; Zisapel N, 2007, CELL MOL LIFE SCI, V64, P1174, DOI 10.1007/s00018-007-6529-9; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	48	236	242	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2859	2866						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109114	Green Accepted			2022-12-28	WOS:000261920900019
J	Sokol, DK				Sokol, Daniel K.			Ethics Man "But you're not a doctor!"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London, England.	daniel.sokol@talk21.com						CUSHING H, 1928, CLIN TEACHER MED CUR, P186; Sokol D, 2006, BMJ-BRIT MED J, V333, P1226, DOI 10.1136/bmj.39055.658762.59; Sokol DK, 2005, BRIT MED J, V330, P741, DOI 10.1136/bmj.330.7494.741	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2008	337								a3077	10.1136/bmj.a3077	http://dx.doi.org/10.1136/bmj.a3077			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EL	19106129				2022-12-28	WOS:000262428400005
J	Quigley, DA; To, MD; Perez-Losada, J; Pelorosso, FG; Mao, JH; Nagase, H; Ginzinger, DG; Balmain, A				Quigley, David A.; To, Minh D.; Perez-Losada, Jesus; Pelorosso, Facundo G.; Mao, Jian-Hua; Nagase, Hiroki; Ginzinger, David G.; Balmain, Allan			Genetic architecture of mouse skin inflammation and tumour susceptibility	NATURE			English	Article							ATOPIC-DERMATITIS; LINKAGE ANALYSIS; INNATE IMMUNITY; STEM-CELLS; DISEASE; CANCER; IDENTIFICATION; EXPRESSION; PSORIASIS; NETWORKS	Germline polymorphisms in model organisms and humans influence susceptibility to complex trait diseases such as inflammation and cancer(1-4). Mice of the Mus spretus species are resistant to tumour development, and crosses between M. spretus and susceptible Mus musculus strains have been used to map locations of genetic variants that contribute to skin cancer susceptibility(4-6). We have integrated germline polymorphisms with gene expression in normal skin from a M. musculus 3 M. spretus backcross to generate a network view of the gene expression architecture of mouse skin. Here we demonstrate how this approach identifies expression motifs that contribute to tissue organization and biological functions related to inflammation, haematopoiesis, cell cycle control and tumour susceptibility. Motifs associated with inflammation, epidermal barrier function and proliferation are differentially regulated in backcross mice susceptible or resistant to tumour development. The intestinal stem cell marker Lgr5 is identified as a candidate master regulator of the hair follicle, and the vitamin D receptor (Vdr) is linked to coordinated control of epidermal barrier function, inflammation and tumour susceptibility.	[Quigley, David A.; To, Minh D.; Pelorosso, Facundo G.; Mao, Jian-Hua; Ginzinger, David G.; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [To, Minh D.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94115 USA; [Perez-Losada, Jesus] Univ Salamanca, Fac Med, Dept Med, Salamanca 37007, Spain; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nagase, Hiroki] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo, Japan; [Nagase, Hiroki] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Nihon University; Roswell Park Cancer Institute	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022; 2009, Secribsal/A-1266-2012; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X	National Cancer Institute; Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'; European Community; Fondo de Investigaciones Sanitarias; Junta de Castilla y Leon; NATIONAL CANCER INSTITUTE [U01CA141455, U01CA084244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR050440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barbara Bass Bakar Chair of Cancer Genetics; Sandler Foundation; Spanish 'Ministerio de Educacion y Ciencia'(Spanish Government); European Community(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to R. Del Rosario for technical assistance with mouse breeding. We thank G. Hirst, R. Akhurst and H. Quigley for their comments. This work was supported by the National Cancer Institute. A. B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. M. D. T. was supported in part by a Sandler Foundation postdoctoral research fellowship. J. P.-L. is an investigator of the 'Programa Ramon y Cajal' from the Spanish 'Ministerio de Educacion y Ciencia' partially supported by the European Community; his research is partially funded by the 'Fondo de Investigaciones Sanitarias' and Junta de Castilla y Leon.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bikle DD, 2002, J INVEST DERMATOL, V119, P1109, DOI 10.1046/j.1523-1747.2002.19508.x; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen L, 2006, GENETICS, V173, P2371, DOI 10.1534/genetics.105.052506; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Giovannucci E, 2008, ADV EXP MED BIOL, V624, P31, DOI 10.1007/978-0-387-77574-6_3; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIAJE A, 1977, CANCER RES, V37, P1530; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	29	100	101	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					505	508		10.1038/nature07683	http://dx.doi.org/10.1038/nature07683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19136944	Green Submitted, Green Accepted			2022-12-28	WOS:000264532400044
J	Bidere, N; Ngo, VN; Lee, J; Collins, C; Zheng, LX; Wan, FY; Davis, RE; Lenz, G; Anderson, DE; Arnoult, D; Vazquez, A; Sakai, K; Zhang, J; Meng, ZJ; Veenstra, TD; Staudt, LM; Lenardo, MJ				Bidere, Nicolas; Ngo, Vu N.; Lee, Jeansun; Collins, Cailin; Zheng, Lixin; Wan, Fengyi; Davis, R. Eric; Lenz, Georg; Anderson, D. Eric; Arnoult, Damien; Vazquez, Aime; Sakai, Keiko; Zhang, Jun; Meng, Zhaojing; Veenstra, Timothy D.; Staudt, Louis M.; Lenardo, Michael J.			Casein kinase 1 alpha governs antigen-receptor-induced NF-kappa B activation and human lymphoma cell survival	NATURE			English	Article							T-CELL; CARMA1; REQUIREMENT; PHOSPHORYLATION; BETA; WNT; UBIQUITINATION; PROLIFERATION; ADDICTION; REGULATOR	The transcription factor NF-kappa B is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types(1,2). Antigen receptor stimulation assembles an NF-kappa B activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-kappa B kinase complex(3-12), but signal transduction is not fully understood(1). We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL)(12). Here we report that both screens identified casein kinase 1 alpha (CK1 alpha) as a bifunctional regulator of NF-kappa B. CK1 alpha dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1 alpha kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1 alpha has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-kappa B. ABCDLBCL cells required CK1 alpha for constitutive NF-kappa B activity, indicating that CK1 alpha functions as a conditionally essential malignancy gene-a member of a new class of potential cancer therapeutic targets.	[Bidere, Nicolas; Lee, Jeansun; Zheng, Lixin; Wan, Fengyi; Sakai, Keiko; Zhang, Jun; Lenardo, Michael J.] NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA; [Ngo, Vu N.; Collins, Cailin; Davis, R. Eric; Lenz, Georg; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Anderson, D. Eric] NIDDK, Proteom & Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Arnoult, Damien; Vazquez, Aime] Univ Paris Sud, Hop Paul Brousse, INSERM, U542, F-94800 Villejuif, France; [Meng, Zhaojing; Veenstra, Timothy D.] NCI, LPAT, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Sect, Immunol Lab, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov; lenardo@nih.gov	sakai, Keiko/F-5807-2013; Arnoult, Damien/R-2032-2018; Staudt, Louis/AAC-5324-2019; Lenz, Georg/I-6844-2012; Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008; Ngo, Vu/0000-0002-9501-6990	Intramural Research Program of the NIH; NIAID; NCI; NIDDK; Agence Nationale de la Recherche (ANR); NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011007, Z01BC011007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000565, Z01AI000565] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIH, NIAID, NCI, NIDDK and by the Agence Nationale de la Recherche (ANR). We thank M.-T. Auffredou for technical assistance; X. Lin and J. Gavard for reagents; R. Germain, R. Schwartz, U. Siebenlist, P. Schwartzberg, J. Bosco de Oliveira, L. Yu, D. Baltimore, P. Sharp, H. Varmus and A. Snow for discussions and comments; and S. Porcella and the DNA sequencing core facility of the Rocky Mountain Laboratories, NIAID.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shambharkar PB, 2007, EMBO J, V26, P1794, DOI 10.1038/sj.emboj.7601622; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027	31	110	124	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					92	U7		10.1038/nature07613	http://dx.doi.org/10.1038/nature07613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19118383	Green Accepted			2022-12-28	WOS:000263836000039
J	Sureshkumar, S; Todesco, M; Schneeberger, K; Harilal, R; Balasubramanian, S; Weigel, D				Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef			A Genetic Defect Caused by a Triplet Repeat Expansion in Arabidopsis thaliana	SCIENCE			English	Article							FRIEDREICH ATAXIA; SOMATIC INSTABILITY; EPIGENETIC CHANGES; IN-VIVO; TRANSCRIPTION; SEQUENCE; MECHANISMS; DELETION; BRAIN	Variation in the length of simple DNA triplet repeats has been linked to phenotypic variability in microbes and to several human disorders. Population- level forces driving triplet repeat contraction and expansion in multicellular organisms are, however, not well understood. We have identified a triplet repeat- associated genetic defect in an Arabidopsis thaliana variety collected from the wild. The Bur- 0 strain carries a dramatically expanded TTC/ GAA repeat in the intron of the ISOPROPYL MALATE ISOMERASE LARGE SUB UNIT1 ( IIL1; At4g13430) gene. The repeat expansion causes an environment-dependent reduction in IIL1 activity and severely impairs growth of this strain, whereas contraction of the expanded repeat can reverse the detrimental phenotype. The Bur- 0 IIL1 defect thus presents a genetically tractable model for triplet repeat expansions and their variability in natural populations.	[Sureshkumar, Sridevi; Todesco, Marco; Schneeberger, Korbinian; Harilal, Ramya; Balasubramanian, Sureshkumar; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Sureshkumar, Sridevi; Balasubramanian, Sureshkumar] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Max Planck Society; University of Queensland	Balasubramanian, S (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	mb.suresh@uq.edu.au; weigel@weigelworld.org	Schneeberger, Korbinian/U-6329-2019; Todesco, Marco/HCH-3494-2022; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Balasubramanian, Sureshkumar/AAS-6919-2020	Schneeberger, Korbinian/0000-0002-5512-0443; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Todesco, Marco/0000-0002-6227-4096	EMBO (European Molecular Biology Organization) Long-Term Fellowship; Marie Curie Research Training Network SY-STEM; European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium; European Union Sixth Framework Programme for Research and Technological Development Integrated Project [EU FP6 IP, LSHG-CT-2006-037704]; Leibniz Award; Max Planck Society	EMBO (European Molecular Biology Organization) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Research Training Network SY-STEM(European Commission); European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium(German Research Foundation (DFG)); European Union Sixth Framework Programme for Research and Technological Development Integrated Project(European Commission); Leibniz Award; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are very grateful to T. Knill and S. Binder for sharing unpublished information. We acknowledge experimental support from our colleagues at the Max Planck Institute and University of Queensland. We also thank them as well as J. Carrington and D. Tautz for critical reading of the manuscript, and the European Arabidopsis Stock Centre and the French National Institute for Agricultural Research (INRA) at Versailles for seeds. Supported by an EMBO (European Molecular Biology Organization) Long-Term Fellowship (S.B.), Marie Curie Research Training Network SY-STEM, European Research Area-Plant Genomics (ERA-PG) Deutsche Forschungsgemeinschaft ARelatives Consortium, European Union Sixth Framework Programme for Research and Technological Development Integrated Project (EU FP6 IP) Agronomics (LSHG-CT-2006-037704), a Leibniz Award (DFG), and the Max Planck Society (D.W.). GenBank accession numbers are FJ665284 to FJ665378.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Baralle M, 2008, AM J HUM GENET, V83, P77, DOI 10.1016/j.ajhg.2008.06.018; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Frisch R, 2001, MOL GENET METAB, V74, P281, DOI 10.1006/mgme.2001.3229; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hashem VI, 2004, NUCLEIC ACIDS RES, V32, P6334, DOI 10.1093/nar/gkh976; Hashem VI, 2002, MUTAT RES-FUND MOL M, V508, P107, DOI 10.1016/S0027-5107(02)00190-2; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; KNILL T, COMMUNICATION; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	26	55	57	7	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1060	1063		10.1126/science.1164014	http://dx.doi.org/10.1126/science.1164014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150812				2022-12-28	WOS:000263478400042
J	Sudhof, TC; Rothman, JE				Sudhof, Thomas C.; Rothman, James E.			Membrane Fusion: Grappling with SNARE and SM Proteins	SCIENCE			English	Review							SYNAPTIC VESICLE FUSION; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; SYNAPTOTAGMIN-I; PHOSPHOLIPID-BINDING; VESICULAR TRANSPORT; GOLGI-COMPLEX; YEAST; EXOCYTOSIS; IDENTIFICATION	The two universally required components of the intracellular membrane fusion machinery, SNARE and SM (Sec1/Munc18- like) proteins, play complementary roles in fusion. Vesicular and target membrane- localized SNARE proteins zipper up into an alpha- helical bundle that pulls the two membranes tightly together to exert the force required for fusion. SM proteins, shaped like clasps, bind to trans- SNARE complexes to direct their fusogenic action. Individual fusion reactions are executed by distinct combinations of SNARE and SM proteins to ensure specificity, and are controlled by regulators that embed the SM- SNARE fusion machinery into a physiological context. This regulation is spectacularly apparent in the exquisite speed and precision of synaptic exocytosis, where synaptotagmin ( the calcium- ion sensor for fusion) cooperates with complexin ( the clamp activator) to control the precisely timed release of neurotransmitters that initiates synaptic transmission and underlies brain function.	[Sudhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Stanford University; Yale University	Sudhof, TC (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA.	tcs1@stanford.edu; james.rothman@yale.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants to T.C.S. and J.E.R. T.C.S. is an HHMI investigator.	BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; BRENNER S, 1974, GENETICS, V77, P71; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; INOUE A, 1992, J BIOL CHEM, V267, P10613; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Parlati F, 2000, NATURE, V407, P194, DOI 10.1038/35025076; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103	68	1374	1407	14	795	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					474	477		10.1126/science.1161748	http://dx.doi.org/10.1126/science.1161748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164740	Green Accepted			2022-12-28	WOS:000262587900033
J	Westall, F				Westall, Frances			GEOCHEMISTRY Life on an Anaerobic Planet	SCIENCE			English	Editorial Material							CARBON ISOTOPES; MICROBIAL MATS		[Westall, Frances] CNRS, Ctr Biophys Mol, F-45071 Orleans 2, France; [Westall, Frances] Univ Orleans, F-45071 Orleans 2, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Westall, F (corresponding author), CNRS, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans 2, France.	Frances.Westall@cnrs-orleans.fr						Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Derenne S, 2008, EARTH PLANET SC LETT, V272, P476, DOI 10.1016/j.epsl.2008.05.014; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Gerdes G., 1987, Lecture Notes in Earth Sciences, V9, P1; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; Mcloughlin N, 2008, GEOBIOLOGY, V6, P95, DOI 10.1111/j.1472-4669.2007.00141.x; Noffke N, 2006, GEOLOGY, V34, P253, DOI 10.1130/G22246.1; NOFFKE N, 2008, EARTH IN PRESS  0910, DOI DOI 10.1016/J.EARSCIREV.2008.08.002; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Schidlowski M, 2001, PRECAMBRIAN RES, V106, P117, DOI 10.1016/S0301-9268(00)00128-5; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; Walsh M.M., 1999, GEOL S AM S, P329; Westall F, 2006, GEOL SOC AM SPEC PAP, P105; Westall F, 2006, GEOPHYS MONOGR SER, V164, P283; Westall F, 2006, PHILOS T R SOC B, V361, P1857, DOI 10.1098/rstb.2006.1896	20	10	10	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					471	472		10.1126/science.1167220	http://dx.doi.org/10.1126/science.1167220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164738				2022-12-28	WOS:000262587900031
J	Isanaka, S; Nombela, N; Djibo, A; Poupard, M; Van Beckhoven, D; Gaboulaud, V; Guerin, PJ; Grais, RF				Isanaka, Sheila; Nombela, Nohelly; Djibo, Ali; Poupard, Marie; Van Beckhoven, Dominique; Gaboulaud, Valerie; Guerin, Philippe J.; Grais, Rebecca F.			Effect of Preventive Supplementation With Ready-to-Use Therapeutic Food on the Nutritional Status, Mortality, and Morbidity of Children Aged 6 to 60 Months in Niger A Cluster Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOME-BASED THERAPY; MALNOURISHED MALAWIAN CHILDREN; ZINC SUPPLEMENTATION; DEVELOPING-COUNTRIES; PRESCHOOL-CHILDREN; MALNUTRITION; APPETITE; IRON; RISK	Context Ready- to- use therapeutic foods ( RUTFs) are an important component of effective outpatient treatment of severe wasting. However, their effectiveness in the population-based prevention of moderate and severe wasting has not been evaluated. Objective To evaluate the effect of a 3- month distribution of RUTF on the nutritional status, mortality, and morbidity of children aged 6 to 60 months in Niger. Design, Setting, and Participants A cluster randomized trial of 12 villages in Maradi, Niger. Six villages were randomized to intervention and 6 to no intervention. All children in the study villages aged 6 to 60 months were eligible for recruitment. Intervention Children with weight- for- height 80% or more of the National Center for Health Statistics reference median in the 6 intervention villages received a monthly distribution of 1 packet per day of RUTF ( 92 g [ 500 kcal/ d]) from August to October 2006. Children in the 6 nonintervention villages received no preventive supplementation. Active surveillance for conditions requiring medical or nutritional treatment was conducted monthly in all 12 study villages from August 2006 to March 2007. Main Outcome Measures Changes in weight- for- height z score ( WHZ) according to the World Health Organization Child Growth Standards and incidence of wasting ( WHZ <- 2) over 8 months of follow- up. Results The number of children with height and weight measurements in August, October, December, and February was 3166, 3110, 2936, and 3026, respectively. The WHZ difference between the intervention and nonintervention groups was - 0.10 z ( 95% confidence interval [ CI], - 0.23 to 0.03) at baseline and 0.12 z ( 95% CI, 0.02 to 0.21) after 8 months of follow- up. The adjusted effect of the intervention on WHZ from baseline to the end of follow- up was thus 0.22 z ( 95% CI, 0.13 to 0.30). The absolute rate of wasting and severe wasting, respectively, was 0.17 events per child- year ( 140 events/ 841 child-years) and 0.03 events per child- year ( 29 events/ 943 child- years) in the intervention villages, compared with 0.26 events per child- year ( 233 events/ 895 child- years) and 0.07 events per child- year ( 71 events/ 1029 child- years) in the nonintervention villages. The intervention thus resulted in a 36% ( 95% CI, 17% to 50%; P <. 001) reduction in the incidence of wasting and a 58% ( 95% CI, 43% to 68%; P <. 001) reduction in the incidence of severe wasting. There was no reduction in mortality, with a mortality rate of 0.007 deaths per child- year ( 7 deaths/ 986 child- years) in the intervention villages and 0.016 deaths per child- year ( 18 deaths/ 1099 child- years) in the nonintervention villages ( adjusted hazard ratio, 0.51; 95% CI, 0.25 to 1.05). Conclusion Short- term supplementation of nonmalnourished children with RUTF reduced the decline in WHZ and the incidence of wasting and severe wasting over 8 months. Trial Registration clinicaltrials.gov Identifier: NCT00682708.	[Isanaka, Sheila] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Isanaka, Sheila] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nombela, Nohelly] WHO, CH-1211 Geneva, Switzerland; [Djibo, Ali] Minist Hlth, Niamey, Niger; [Poupard, Marie] Hosp Delafontaine, Infect & Trop Dis Serv, St Denis, France; [Van Beckhoven, Dominique] Sci Inst Publ Hlth, Epidemiol Sect, Brussels, Belgium; [Gaboulaud, Valerie] Hop Avicenne, Dept Psychiat, F-93009 Bobigny, France; [Guerin, Philippe J.; Grais, Rebecca F.] Epicenter, Paris, France; [Isanaka, Sheila; Guerin, Philippe J.; Grais, Rebecca F.] Harvard Humanitarian Initiat, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Harvard University	Isanaka, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	sisanaka@hsph.harvard.edu	Isanaka, Sheila/AAQ-9056-2020; Guerin, Philippe/AAH-8873-2021	Freeman Grais, Rebecca/0000-0002-5037-8218; Van Beckhoven, Dominique/0000-0003-0821-2756; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres; National Cancer Institute [R25-CA098566]; NATIONAL CANCER INSTITUTE [R25CA098566] Funding Source: NIH RePORTER	Medecins Sans Frontieres; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Medecins Sans Frontieres (MSF). Ms Isanaka was supported in part by National Cancer Institute grant R25-CA098566.	Balding DJ, 2004, APPL LONGITUDINAL AN; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Donner A, 2000, DESIGN ANAL CLUSTER; Dossa RAM, 2002, APPETITE, V39, P111, DOI 10.1006/appe.2002.0501; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; ELDIOP HI, 2003, AM J CLIN NUTR, V78, P302; Garenne M, 2006, J NUTR, V136, P2893, DOI 10.1093/jn/136.11.2893; Grillenberger M, 2003, J NUTR, V133, p3957S, DOI 10.1093/jn/133.11.3957S; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; *NAT I STAT NIG MA, 2007, DEM HLTH SURV MULT I; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; *NIG BUR CENTR REC, 2004, RES DEF REP SEX GROU; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; SCRIMSHAW NS, 1968, INTERACTION NUTR INF; Serfling R. J, 1980, APPROXIMATION THEORE; *UN CHILDR FUND, UNICEF GLOB DAT CHIL; WHO, WHO CHILD GROWTH STA; *WHO J HOPK SCH PU, 1999, STAND VERB AUT METH; World Health Organization, 2007, WORLD HLTH STAT 2007	30	82	83	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					277	285		10.1001/jama.2008.1018	http://dx.doi.org/10.1001/jama.2008.1018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155454	Green Accepted, Bronze			2022-12-28	WOS:000262518700018
J	Morrell, CJ; Slade, P; Warner, R; Paley, G; Dixon, S; Walters, SJ; Brugha, T; Barkham, M; Parry, GJ; Nicholl, J				Morrell, C. Jane; Slade, Pauline; Warner, Rachel; Paley, Graham; Dixon, Simon; Walters, Stephen J.; Brugha, Traolach; Barkham, Michael; Parry, Gareth J.; Nicholl, Jon			Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTPARTUM DEPRESSION	Objective To evaluate benefits for postnatal women of two psychologically informed interventions by health visitors. Design Prospective cluster trial randomised by general practice, with 18 month follow- up. Setting 101 general practices in Trent, England. Participants 2749 women allocated to intervention, 1335 to control. Intervention Health visitors ( n= 89 63 clusters) were trained to identify depressive symptoms at six to eight weeks postnatally using the Edinburgh postnatal depression scale ( EPDS) and clinical assessment and also trained in providing psychologically informed sessions based on cognitive behavioural or person centred principles for an hour a week for eight weeks. Health visitors in the control group ( n= 49 38 clusters) provided usual care. Main outcome measures Score >= 12 on the Edinburgh postnatal depression scale at six months. Secondary outcomes were mean Edinburgh postnatal depression scale, clinical outcomes in routine evaluation- outcome measure ( CORE- OM), state- trait anxiety inventory ( STAI), SF- 12, and parenting stress index short form ( PSI- SF) scores at six, 12, 18 months. Results 4084 eligible women consented and 595 women had a six week EPDS score = 12. Of these, 418 had EPDS scores available at six weeks and six months. At six months, 34% women ( 93/ 271) in the intervention group and 46% ( 67/ 147) in the control group had an EPDS score >= 12. The odds ratio for score = 12 at six months was 0.62 ( 95% confidence interval 0.40 to 0.97, P= 0.036) for women in the intervention group compared with women in the control group. After adjustment for covariates, the odds ratio was 0.60 ( 0.38 to 0.95, P= 0.028). At six months, 12.4% ( 234/ 1880) of all women in the intervention group and 16.7% ( 166/ 995) of all women in the control group had scores >= 12 ( 0.67, 0.51 to 0.87, P= 0.003). Benefit for women in the intervention group with a six week EPDS score = 12 and for all women was maintained at 12 months postnatally. There was no differential benefit for either psychological approach over the other. Conclusion Training health visitors to assess women, identify symptoms of postnatal depression, and deliver psychologically informed sessions was clinically effective at six and 12 months postnatally compared with usual care. Trial registration ISRCTN92195776.	[Morrell, C. Jane; Dixon, Simon; Walters, Stephen J.; Nicholl, Jon] Univ Sheffield, Sch Hlth Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England; [Slade, Pauline] Univ Sheffield, Clin Psychol Unit, Dept Psychol, Sheffield S10 2U4, S Yorkshire, England; [Warner, Rachel] Adult Mental Hlth Serv, Sheffield S11 9AR, S Yorkshire, England; [Paley, Graham] Leeds Mental hlth Trust Specialist Psychotherapy, Leeds LS2 9PJ, W Yorkshire, England; [Brugha, Traolach] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester LE5 4PW, Leics, England; [Barkham, Michael] Univ Sheffield, Ctr Psychol Serv Res, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; [Parry, Gareth J.] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp, Boston, MA 02115 USA	University of Sheffield; University of Sheffield; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Sheffield; Harvard University; Boston Children's Hospital; Harvard Medical School	Morrell, CJ (corresponding author), Univ Huddersfield, Ctr Hlth & Social Care Res Human & Hlth Sci, Huddersfield HD1 3DH, W Yorkshire, England.	j.morrell@hud.ac.uk	Parry, Gareth/CAF-6975-2022; Brugha, Traolach/T-9326-2019; Barkham, Michael/A-2547-2010	Brugha, Traolach/0000-0002-9786-9591; Walters, Stephen/0000-0001-9000-8126; Dixon, Simon/0000-0001-7394-7009; Barkham, Michael/0000-0003-1687-6376	NHS; National Institute for Health Research [99/33/51] Funding Source: researchfish	NHS; National Institute for Health Research(National Institute for Health Research (NIHR))	The trial was commissioned, funded, and sponsored by the NHS research and development health technology assessment programme.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; BALLARD CG, 1994, BRIT J PSYCHIAT, V164, P782, DOI 10.1192/bjp.164.6.782; Barkham M, 2001, J CONSULT CLIN PSYCH, V69, P184, DOI 10.1037//0022-006X.69.2.184; Bower P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001025.pub2; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; BRUGHA TS, 1987, SOC PSYCH PSYCH EPID, V22, P123, DOI 10.1007/BF00584017; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Chilvers C, 2001, BMJ-BRIT MED J, V322, P772, DOI 10.1136/bmj.322.7289.772; Churchill R, 2001, Health Technol Assess, V5, P1; Clark D.M., 1997, SCI PRACTICE COGNITI; Colquitt JA, 2000, J APPL PSYCHOL, V85, P678, DOI 10.1037/0021-9010.85.5.678; Cooper PJ, 2003, BRIT J PSYCHIAT, V182, P412, DOI 10.1192/bjp.182.5.412; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; *DEP HLTH, 2003, MAINSTR IMPL PLAN MA; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; ELLIOTT S, 2005, SCREENING PERINATAL, P171; Friedli K, 1997, LANCET, V350, P1662, DOI 10.1016/S0140-6736(97)05298-7; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; GERRARD J, 1993, J ADV NURS, V18, P1825, DOI 10.1046/j.1365-2648.1993.18111825.x; Henshaw C., 2004, CLIN EFF NURS, V8, P170; HOFFBRAND S, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002018; HOLDEN J, 1994, PERINATAL PSYCHIATRY, P125; HOLDEN JM, 1989, BRIT MED J, V298, P223, DOI 10.1136/bmj.298.6668.223; Lewis G., 2004, WHY MOTHERS DIE 2000; Milgrom J, 2005, BRIT J CLIN PSYCHOL, V44, P529, DOI 10.1348/014466505X34200; Morrell C J, 2000, Health Technol Assess, V4, P1; Morrell CJ, 2006, CLIN EFF NURS, V9, pe135, DOI DOI 10.1016/j.cein.2006.11.006; Murray Lynne, 1997, P111; NEAL D, 2004, INDEX MULTIPLE DEPRI; NICE, 2007, ANT POSTN MENT HLTH; Oates MR, 2004, BRIT J PSYCHIAT, V184, pS10, DOI 10.1192/bjp.184.46.s10; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; SANDERS P, 2000, PERSON CTR PRACTICE, V8, P62; Spielberger C. D., 1983, MIND GARDEN; Stiles WB, 2006, PSYCHOL MED, V36, P555, DOI 10.1017/S0033291706007136; STILES WB, 1986, AM PSYCHOL, V41, P165, DOI 10.1037/0003-066X.41.2.165; TUDOR K, 2006, 7 WORLD C PERS CTR E; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383; Ware JE, 1995, SCORE SF 12 PHYS MEN; Wills T.A., 1985, SOCIAL SUPPORT HLTH, P61	45	138	141	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2009	338								a3045	10.1136/bmj.a3045	http://dx.doi.org/10.1136/bmj.a3045			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405AD	19147636	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-28	WOS:000263193400002
J	Mattson-DiCecca, AA; Farag, NR; Burns, RB				Mattson-DiCecca, Anna A.; Farag, Nadine R.; Burns, Risa B.			Update: A 60-Year-Old Woman With Sexual Difficulties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Potter JE, 2007, JAMA-J AM MED ASSOC, V297, P620, DOI 10.1001/jama.297.6.620	1	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					94	94		10.1001/jama.2008.932	http://dx.doi.org/10.1001/jama.2008.932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126813				2022-12-28	WOS:000262220400024
J	Smith, JC; Snider, DE; Pickering, LK				Smith, Jean C.; Snider, Dixie E.; Pickering, Larry K.			Immunization Policy Development in the United States: The Role of the Advisory Committee on Immunization Practices	ANNALS OF INTERNAL MEDICINE			English	Article								The Advisory Committee on Immunization Practices ( ACIP) consists of 15 experts in immunization and related fields, selected by the Secretary of the U. S. Department of Health and Human Services, to provide advice and guidance on control of vaccine-preventable diseases. In its role as a federal advisory committee, the ACIP develops written recommendations, subject to approval of the Director of the Centers for Disease Control and Prevention, for administration of U. S. Food and Drug Administration-licensed vaccines to children, adolescents, and adults in the U. S. civilian population. On the basis of careful review of available scientific data, including disease morbidity and mortality in the general U. S. population and in specific risk groups, vaccine safety and efficacy, cost-effectiveness, and related factors, the ACIP recommends vaccines and age for vaccine administration, number of doses and dosing interval, and precautions and contraindications. The ACIP works closely with several liaison organizations, including the American College of Physicians, to develop immunization recommendations that are harmonized among key professional medical organizations in the United States. This report includes a description of the member composition of the ACIP, the degree to which Committee members are screened for conflicts of interest, the workgroups that gather information before full Committee consideration, and the process and types of evidence used to formulate recommendations.	[Smith, Jean C.; Pickering, Larry K.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pickering, LK (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop E-05, Atlanta, GA 30333 USA.	LPickering@cdc.gov						*ADV COMM IMM PRAC, ACIP GUID HLTH EC ST; *ADV COMM IMM PRAC, 2008, ACIP CHART; *AM AC PED, STAT LIC REC NEW VAC; DULL HB, 1982, INFECT CONT HOSP EP, V3, P316, DOI 10.1017/S019594170005640X; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Poland GA, 2007, ANN INTERN MED, V147, P735, DOI 10.7326/0003-4819-147-10-200711200-00188	6	61	62	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					45	W9		10.7326/0003-4819-150-1-200901060-00009	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124820				2022-12-28	WOS:000262655100007
J	Mayadas, AF; Bourne, J; Bacsich, P				Mayadas, A. Frank; Bourne, John; Bacsich, Paul			Online Education Today	SCIENCE			English	Review								Online education is established, growing, and here to stay. It is creating new opportunities for students and also for faculty, regulators of education, and the educational institutions themselves. Much of what is being learned by the practitioners will flow into the large numbers of blended courses that will be developed and delivered on most campuses. Some of what is being learned will certainly improve pedagogical approaches and possibly affect other important problems, such as the lengthening time to completion of a degree. Online education is already providing better access to education for many, and many more will benefit from this increased access in the coming years.	[Mayadas, A. Frank] Alfred P Sloan Fdn, New York, NY 10111 USA; [Bourne, John] Babson Coll, Needham, MA 02492 USA; [Bacsich, Paul] ViCa Project, Oxford OX3 0BP, England; [Bacsich, Paul] Assoc Learning Technol, Oxford OX3 0BP, England	Babson College; Oxford Brookes University; Oxford Brookes University	Mayadas, AF (corresponding author), Alfred P Sloan Fdn, 630 5th Ave, New York, NY 10111 USA.	mayadas@sloan.org		Bacsich, Paul/0000-0002-0958-591X				Allen I. E., 2008, STAYING COURSE ONLIN; Bacsich P., 2005, LESSONS LEARNED FAIL; Dziuban C. D., 2001, EDUCAUSE Q, V24, P60; FINDER A, 2007, INT HERALD TRIB 1120; Fjermestad J, 2005, LEARNING TOGETHER ONLINE: RESEARCH ON ASYNCHRONOUS LEARNING NETWORKS, P39; HARTMAN J, 1999, ONL ED P SLOAN SUMM, P155; Kashy E., 2000, J ASYNCHRONOUS LEARN, V4, P231, DOI [10.1002/j.2168-9830.2001.tb00631.x, DOI 10.1002/J.2168-9830.2001.TB00631.X]; MCLEOD D, 2004, GUARDIAN        1130; *NASULGC SLOAN NAT, 2008, BENCHM STUD PREL FIN; National Center for Education Statistics, 2007, DIG ED STAT; NOAM EM, 1995, SCIENCE, V270, P247, DOI 10.1126/science.270.5234.247; PICKETT A, SLOAN C EFFECTIVE PR; RAGAN R, 2008, J ASYNCHRONOUS LEARN, V8, P15; *SCOTT INT U, 2002, MEG E LEARN PROV E L; Shea P., 2007, J ASYNCHRONOUS LEARN, V11, P73	15	65	65	7	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					85	89		10.1126/science.1168874	http://dx.doi.org/10.1126/science.1168874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119225				2022-12-28	WOS:000262104100045
J	Smith, MS				Smith, Marshall S.			Opening Education	SCIENCE			English	Review								Spurred by the publication of Massachusetts Institute of Technology OpenCourseWare in 2002, the open educational resources ( OER) movement, which has rapidly expanded and captured the imagination and energy of millions of creators and users throughout the world, now faces many opportunities and substantial challenges as it moves to become an integral part of the world's educational environment. The confluence of the Web and a spirit of sharing intellectual property have fueled a worldwide movement to make knowledge and education materials open to all for use. OER are content ( courses, books, lesson plans, articles, etc.), tools ( virtual laboratories, simulations, and games), and software that support learning and educational practice. OER are free on the Web, and most have licenses that allow copyright holders to retain ownership while providing specified rights for use in original and modified forms. At the least, OER have helped to level the distribution of knowledge across the world. A second promise of OER is to help transform educational practices. This article explores the history of and promises and challenges for OER.	[Smith, Marshall S.] Carnegie Fdn Adv Teaching, Stanford, CA 94305 USA		Smith, MS (corresponding author), Carnegie Fdn Adv Teaching, Stanford, CA 94305 USA.	mike.marshallsmith@gmail.com						Brown J.S., 2007, CREATIVE COMMON MOUN, P1; Christensen C., 2008, DISRUPTING CLASS DIS; HOWARD J, 2008, CHRON HIGH ED, V55, pA12; Iiyoshi T., 2008, OPENING UP ED; Lessig Lawrence, 2001, FUTURE IDEAS FATE CO; LOVETT M, 2008, J INTERACTIVE MEDIA; National Science Foundation, 2003, BRIEF HIST NSF INT; *ORG EC COOP DEV, 2007, GIV KNOWL FREE EM OP, P9; Smith M., 2008, OPEN ICT4D; Smith MS., 2006, CHANGE MAGAZINE HIGH, V38, P8, DOI [10.3200/CHNG.38.5.8-17, DOI 10.3200/CHNG.38.5.8-17]	10	35	35	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					89	93		10.1126/science.1168018	http://dx.doi.org/10.1126/science.1168018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119226				2022-12-28	WOS:000262104100046
J	Dalcanton, JJ				Dalcanton, Julianne J.			18 years of science with the Hubble Space Telescope	NATURE			English	Review							EARLY-TYPE GALAXIES; DWARF COOLING SEQUENCE; STAR-FORMATION HISTORY; LY-ALPHA FOREST; SUPERMASSIVE BLACK-HOLES; GAMMA-RAY BURSTS; HIGH-REDSHIFT SUPERNOVAE; INITIAL MASS FUNCTION; CLUSTER MS 1054-03; DEEP FIELD	After several decades of planning, the Hubble Space Telescope (HST) was launched in 1990 as the first of NASA's Great Observatories. After a rocky start arising from an error in the fabrication of its main mirror, it went on to change forever many fields of astronomy, and to capture the public's imagination with its images. An ongoing programme of servicing missions has kept the telescope on the cutting edge of astronomical research. Here I review the advances made possible by the HST over the past 18 years.	[Dalcanton, Julianne J.] Univ Washington, Seattle, WA 98195 USA; [Dalcanton, Julianne J.] Max Planck Inst Astron, D-69117 Heidelberg, Germany	University of Washington; University of Washington Seattle; Max Planck Society	Dalcanton, JJ (corresponding author), Univ Washington, Seattle, WA 98195 USA.	jd@astro.washington.edu		Dalcanton, Julianne/0000-0002-1264-2006				Allen PR, 2007, ASTROPHYS J, V668, P492, DOI 10.1086/521207; Bahcall JN, 1997, ASTROPHYS J, V479, P642, DOI 10.1086/303926; BAHCALL JN, 1993, ASTROPHYS J SUPPL S, V87, P1, DOI 10.1086/191797; Balcells M, 2007, ASTROPHYS J, V665, P1084, DOI 10.1086/519752; Balick B, 2002, ANNU REV ASTRON ASTR, V40, P439, DOI 10.1146/annurev.astro.40.060401.093849; Balick B, 1998, ASTRON J, V116, P360, DOI 10.1086/300429; Balogh ML, 2002, ASTROPHYS J, V566, P123, DOI 10.1086/338056; Barker MK, 2007, ASTRON J, V133, P1138, DOI 10.1086/511186; Beckwith SVW, 2006, ASTRON J, V132, P1729, DOI 10.1086/507302; Bedin LR, 2005, ASTROPHYS J, V624, pL45, DOI 10.1086/430310; Bedin LR, 2004, ASTROPHYS J, V605, pL125, DOI 10.1086/420847; Bedin LR, 2008, ASTROPHYS J, V678, P1279, DOI 10.1086/529370; BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Benedict GF, 2007, ASTRON J, V133, P1810, DOI 10.1086/511980; Bloom JS, 2002, ASTRON J, V123, P1111, DOI 10.1086/338893; Bond HE, 2003, NATURE, V422, P405, DOI 10.1038/nature01508; Bouy H, 2004, ASTRON ASTROPHYS, V423, P341, DOI 10.1051/0004-6361:20040551; Brown TM, 2007, ASTROPHYS J, V658, pL95, DOI 10.1086/515395; Brown TM, 2006, ASTROPHYS J, V652, P323, DOI 10.1086/508015; Brown TM, 2003, ASTROPHYS J, V592, pL17, DOI 10.1086/376935; Burgasser AJ, 2003, ASTROPHYS J, V586, P512, DOI 10.1086/346263; BURROWS CJ, 1995, ASTROPHYS J, V452, P680, DOI 10.1086/176339; Calamida A, 2008, ASTROPHYS J LETT, V673, pL29, DOI 10.1086/527436; Chen HW, 1998, ASTROPHYS J, V498, P77, DOI 10.1086/305554; Clowe D, 2006, ASTROPHYS J, V648, pL109, DOI 10.1086/508162; Connolly AJ, 1995, ASTRON J, V110, P2655, DOI 10.1086/117720; Connolly AJ, 1997, ASTROPHYS J, V486, pL11, DOI 10.1086/310829; Cool AM, 1996, ASTROPHYS J, V468, P655, DOI 10.1086/177723; Couch WJ, 1998, ASTROPHYS J, V497, P188, DOI 10.1086/305462; Currie DG, 1996, ASTRON J, V112, P1115, DOI 10.1086/118083; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; Dohm-Palmer RC, 2002, ASTRON J, V123, P813, DOI 10.1086/324635; Dressler A, 1997, ASTROPHYS J, V490, P577, DOI 10.1086/304890; DRESSLER A, 1994, ASTROPHYS J, V430, P107, DOI 10.1086/174386; DRIVER SP, 1995, ASTROPHYS J, V453, P48, DOI 10.1086/176369; Ellis RS, 1997, ASTROPHYS J, V483, P582, DOI 10.1086/304261; Faber SM, 1997, ASTRON J, V114, P1771, DOI 10.1086/118606; FELLI M, 1993, ASTRON ASTROPHYS SUP, V98, P137; Fernandez R, 2004, ASTROPHYS J, V603, P595, DOI 10.1086/381523; Fernandez-Soto A, 1999, ASTROPHYS J, V513, P34, DOI 10.1086/306847; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Ferrarese L., 2006, Astrophysical Journal, Letters, V644, pL21, DOI 10.1086/505388; Ferrarese L, 1996, ASTROPHYS J, V470, P444, DOI 10.1086/177876; Ferrarese L, 2006, ASTROPHYS J SUPPL S, V164, P334, DOI 10.1086/501350; Fruchter AS, 2006, NATURE, V441, P463, DOI 10.1038/nature04787; Fruchter AS, 1999, ASTROPHYS J, V519, pL13, DOI 10.1086/312094; Garnavich PM, 1998, ASTROPHYS J, V509, P74, DOI 10.1086/306495; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gebhardt K, 2002, ASTROPHYS J, V578, pL41, DOI 10.1086/342980; Gebhardt K, 2000, ASTRON J, V119, P1157, DOI 10.1086/301240; Gebhardt K, 2001, ASTRON J, V122, P2469, DOI 10.1086/323481; Gerssen J, 2002, ASTRON J, V124, P3270, DOI 10.1086/344584; Giavalisco M, 2004, ASTROPHYS J, V600, pL93, DOI 10.1086/379232; Giavalisco M, 1996, ASTROPHYS J, V470, P189, DOI 10.1086/177859; GLAZEBROOK K, 1995, MON NOT R ASTRON SOC, V275, pL19, DOI 10.1093/mnras/275.1.L19; Golimowski DA, 2006, ASTRON J, V131, P3109, DOI 10.1086/503801; Golimowski DA, 1998, ASTRON J, V115, P2579, DOI 10.1086/300370; Guzman R, 1997, ASTROPHYS J, V489, P559, DOI 10.1086/304797; Hansen BMS, 2002, ASTROPHYS J, V574, pL155, DOI 10.1086/342528; Hansen BMS, 2004, ASTROPHYS J SUPPL S, V155, P551, DOI 10.1086/424832; Harris GLH, 1999, ASTRON J, V117, P855, DOI 10.1086/300749; Harris WE, 2002, ASTRON J, V123, P3108, DOI 10.1086/340466; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; Henry TJ, 1999, ASTROPHYS J, V512, P864, DOI 10.1086/306793; Hoekstra H, 2000, ASTROPHYS J, V532, P88, DOI 10.1086/308556; Hoekstra H, 1998, ASTROPHYS J, V504, P636, DOI 10.1086/306102; Hogg DW, 1998, ASTRON J, V115, P1418, DOI 10.1086/300277; Holland S, 1996, ASTRON J, V112, P1035, DOI 10.1086/118075; JAKOBSEN P, 1991, ASTROPHYS J, V369, pL63, DOI 10.1086/185959; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Kennicutt RC, 1998, ASTROPHYS J, V498, P181, DOI 10.1086/305538; King IR, 1998, ASTROPHYS J, V492, pL37, DOI 10.1086/311082; Kneib JP, 1996, ASTROPHYS J, V471, P643, DOI 10.1086/177995; Knop RA, 2003, ASTROPHYS J, V598, P102, DOI 10.1086/378560; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; Kormendy J, 1996, ASTROPHYS J, V459, pL57, DOI 10.1086/309950; Krist JE, 2005, ASTRON J, V129, P1008, DOI 10.1086/426755; LANZETTA KM, 1995, ASTROPHYS J, V442, P538, DOI 10.1086/175459; Lauer TR, 2007, ASTROPHYS J, V664, P226, DOI 10.1086/519229; Lauer TR, 1995, ASTRON J, V110, P2622, DOI 10.1086/117719; Le Fevre O, 2000, MON NOT R ASTRON SOC, V311, P565, DOI 10.1046/j.1365-8711.2000.03083.x; LeBrun V, 1997, ASTRON ASTROPHYS, V321, P733; Lehner N, 2007, ASTROPHYS J, V658, P680, DOI 10.1086/511749; Lilly S, 1998, ASTROPHYS J, V500, P75, DOI 10.1086/305713; Lowenthal JD, 1997, ASTROPHYS J, V481, P673, DOI 10.1086/304092; Lowrance PJ, 1999, ASTROPHYS J, V512, pL69, DOI 10.1086/311858; Luhman KL, 2000, ASTROPHYS J, V540, P1016, DOI 10.1086/309365; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388, DOI 10.1093/mnras/283.4.1388; Martin EL, 2000, ASTROPHYS J, V543, P299, DOI 10.1086/317089; Martin EL, 1999, SCIENCE, V283, P1718, DOI 10.1126/science.283.5408.1718; MORRIS SL, 1991, ASTROPHYS J, V377, pL21, DOI 10.1086/186107; Morse JA, 2001, ASTROPHYS J, V548, pL207, DOI 10.1086/319092; Najita JR, 2000, ASTROPHYS J, V541, P977, DOI 10.1086/309477; Nicastro F, 2003, NATURE, V421, P719, DOI 10.1038/nature01369; O'Dell CR, 2003, ASTRON J, V125, P277, DOI 10.1086/345512; O'Dell CR, 2002, ASTRON J, V123, P3329, DOI 10.1086/340726; ODELL CR, 1993, ASTROPHYS J, V410, P696, DOI 10.1086/172786; ODELL CR, 1994, ASTROPHYS J, V436, P194, DOI 10.1086/174892; Odewahn SC, 1996, ASTROPHYS J, V472, pL13, DOI 10.1086/310345; Penton SV, 2004, ASTROPHYS J SUPPL S, V152, P29, DOI 10.1086/382877; Perlmutter S, 1997, ASTROPHYS J, V483, P565, DOI 10.1086/304265; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Piotto G, 2007, ASTROPHYS J, V661, pL53, DOI 10.1086/518503; PLAIT PC, 1995, ASTROPHYS J, V439, P730, DOI 10.1086/175213; Postman M, 1998, ASTRON J, V116, P560, DOI 10.1086/300463; Ravindranath S, 2001, ASTRON J, V122, P653, DOI 10.1086/321175; Reed DS, 1999, ASTRON J, V118, P2430, DOI 10.1086/301091; Rest A, 2001, ASTRON J, V121, P2431, DOI 10.1086/320370; Richer HB, 2008, ASTRON J, V135, P2141, DOI 10.1088/0004-6256/135/6/2141; Richer HB, 1997, ASTROPHYS J, V484, P741, DOI 10.1086/304379; Riess AG, 2001, ASTROPHYS J, V560, P49, DOI 10.1086/322348; Riess AG, 2004, ASTROPHYS J, V607, P665, DOI 10.1086/383612; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Rix HW, 2004, ASTROPHYS J SUPPL S, V152, P163, DOI 10.1086/420885; Sahai R, 1998, ASTRON J, V116, P1357, DOI 10.1086/300504; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; Sawicki MJ, 1997, ASTRON J, V113, P1, DOI 10.1086/118231; Schneider G, 1999, ASTROPHYS J, V513, pL127, DOI 10.1086/311921; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Sembach KR, 2003, ASTROPHYS J SUPPL S, V146, P165, DOI 10.1086/346231; Seth AC, 2006, ASTRON J, V132, P2539, DOI 10.1086/508994; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; Simard L, 1999, ASTROPHYS J, V519, P563, DOI 10.1086/307403; Squires G, 1996, ASTROPHYS J, V461, P572, DOI 10.1086/177085; Stanford SA, 1998, ASTROPHYS J, V492, P461, DOI 10.1086/305050; Steidel CC, 1997, ASTROPHYS J, V480, P568, DOI 10.1086/303994; Steidel CC, 1996, ASTRON J, V112, P352, DOI 10.1086/118019; STOCKE JT, 1995, ASTROPHYS J, V451, P24, DOI 10.1086/176197; Tripp TM, 2000, ASTROPHYS J, V534, pL1, DOI 10.1086/312644; Tripp TM, 1998, ASTROPHYS J, V508, P200, DOI 10.1086/306397; van der Marel RP, 1998, ASTROPHYS J, V493, P613, DOI 10.1086/305147; van Dokkum PG, 1999, ASTROPHYS J, V520, pL95, DOI 10.1086/312154; van Dokkum PG, 1998, ASTROPHYS J, V504, pL17, DOI 10.1086/311567; Walter FM, 2001, ASTROPHYS J, V549, P433, DOI 10.1086/319058; Wehner E. H., 2006, Astrophysical Journal, Letters, V644, pL17, DOI 10.1086/505387; WILLIAMS BF, 2008, ACS NEARBY GALAXY SU; Williams RE, 1996, ASTRON J, V112, P1335, DOI 10.1086/118105; Williams RE, 2000, ASTRON J, V120, P2735, DOI 10.1086/316854; Williger GM, 2006, ASTROPHYS J, V636, P631, DOI 10.1086/498127	143	7	7	4	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					41	50		10.1038/nature07621	http://dx.doi.org/10.1038/nature07621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122634				2022-12-28	WOS:000262104900027
J	de Smet, AMGA; Kluytmans, JAJW; Cooper, BS; Mascini, EM; Benus, RFJ; van der Werf, TS; van der Hoeven, JG; Pickkers, P; Bogaers-Hofman, D; van der Meer, NJM; Bernards, AT; Kuijper, EJ; Joore, JCA; Hall, MALV; Bindels, AJGH; Jansz, AR; Wesselink, RMJ; de Jongh, BM; Dennesen, PJW; van Asselt, GJ; Velde, LFT; Frenay, IHME; Kaasjager, K; Bosch, FH; van Iterson, M; Thijsen, SFT; Kluge, GH; Pauw, W; de Vries, JW; Kaan, JA; Arends, JP; Aarts, LPHJ; Sturm, PDJ; Harinck, HIJ; Voss, A; Uijtendaal, EV; Blok, HEM; Groen, EST; Pouw, ME; Kalkman, CJ; Bonten, MJM				de Smet, A. M. G. A.; Kluytmans, J. A. J. W.; Cooper, B. S.; Mascini, E. M.; Benus, R. F. J.; van der Werf, T. S.; van der Hoeven, J. G.; Pickkers, P.; Bogaers-Hofman, D.; van der Meer, N. J. M.; Bernards, A. T.; Kuijper, E. J.; Joore, J. C. A.; Hall, M. A. Leverstein-van; Bindels, A. J. G. H.; Jansz, A. R.; Wesselink, R. M. J.; de Jongh, B. M.; Dennesen, P. J. W.; van Asselt, G. J.; Velde, L. F. te; Frenay, I. H. M. E.; Kaasjager, K.; Bosch, F. H.; van Iterson, M.; Thijsen, S. F. T.; Kluge, G. H.; Pauw, W.; de Vries, J. W.; Kaan, J. A.; Arends, J. P.; Aarts, L. P. H. J.; Sturm, P. D. J.; Harinck, H. I. J.; Voss, A.; Uijtendaal, E. V.; Blok, H. E. M.; Groen, E. S. Thieme; Pouw, M. E.; Kalkman, C. J.; Bonten, M. J. M.			Decontamination of the Digestive Tract and Oropharynx in ICU Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; CRITICALLY ILL PATIENTS; INTENSIVE-CARE-UNIT; RANDOMIZED CONTROLLED-TRIAL; SELECTIVE DECONTAMINATION; DOUBLE-BLIND; ANTIBIOTIC-PROPHYLAXIS; ORAL DECONTAMINATION; SURGICAL-PATIENTS; CLINICAL-TRIAL	Background Selective digestive tract decontamination ( SDD) and selective oropharyngeal decontamination ( SOD) are infection- prevention measures used in the treatment of some patients in intensive care, but reported effects on patient outcome are conflicting. Methods We evaluated the effectiveness of SDD and SOD in a crossover study using cluster randomization in 13 intensive care units ( ICUs), all in the Netherlands. Patients with an expected duration of intubation of more than 48 hours or an expected ICU stay of more than 72 hours were eligible. In each ICU, three regimens ( SDD, SOD, and standard care) were applied in random order over the course of 6 months. Mortality at day 28 was the primary end point. SDD consisted of 4 days of intravenous cefotaxime and topical application of tobramycin, colistin, and amphotericin B in the oropharynx and stomach. SOD consisted of oropharyngeal application only of the same antibiotics. Monthly point- prevalence studies were performed to analyze antibiotic resistance. Results A total of 5939 patients were enrolled in the study, with 1990 assigned to standard care, 1904 to SOD, and 2045 to SDD; crude mortality in the groups at day 28 was 27.5%, 26.6%, and 26.9%, respectively. In a random- effects logistic- regression model with age, sex, Acute Physiology and Chronic Health Evaluation (APACHE II) score, intubation status, and medical specialty used as covariates, odds ratios for death at day 28 in the SOD and SDD groups, as compared with the standard- care group, were 0.86 ( 95% confidence interval [CI], 0.74 to 0.99) and 0.83 ( 95% CI, 0.72 to 0.97), respectively. Conclusions In an ICU population in which the mortality rate associated with standard care was 27.5% at day 28, the rate was reduced by an estimated 3.5 percentage points with SDD and by 2.9 percentage points with SOD. (Controlled Clinical Trials number, ISRCTN35176830.).	[de Smet, A. M. G. A.; Groen, E. S. Thieme; Pouw, M. E.; Kalkman, C. J.] Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, NL-3508 GA Utrecht, Netherlands; [Joore, J. C. A.] Univ Med Ctr Utrecht, Div Intens Care Med, NL-3508 GA Utrecht, Netherlands; [Hall, M. A. Leverstein-van; Blok, H. E. M.; Bonten, M. J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3508 GA Utrecht, Netherlands; [Uijtendaal, E. V.] Univ Med Ctr Utrecht, Dept Clin Pharm, NL-3508 GA Utrecht, Netherlands; [Bonten, M. J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Kluytmans, J. A. J. W.; Bogaers-Hofman, D.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van der Meer, N. J. M.] Amphia Hosp, Dept Anesthesiol & Intens Care, Breda, Netherlands; [Mascini, E. M.] Rijnstate Hosp, Lab Med Microbiol & Immunol, Arnhem, Netherlands; [van der Werf, T. S.] Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands; [van der Werf, T. S.] Rijnstate Hosp, Dept Pulm Dis & TB, Arnhem, Netherlands; [Aarts, L. P. H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9713 AV Groningen, Netherlands; [van der Hoeven, J. G.; Pickkers, P.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Intens Care, NL-6525 ED Nijmegen, Netherlands; [Sturm, P. D. J.; Voss, A.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Bernards, A. T.; Kuijper, E. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Harinck, H. I. J.] Leiden Univ, Med Ctr, Dept Intens Care, Leiden, Netherlands; [Jansz, A. R.] Catharina Hosp, Labs Pathol & Med Microbiol, Lab Med Microbiol, Eindhoven, Netherlands; [Wesselink, R. M. J.] St Antonius Hosp, Dept Anesthesiol & Intens Care, Nieuwegein, Netherlands; [de Jongh, B. M.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [Dennesen, P. J. W.] Med Ctr Haaglanden, Dept Intens Care, The Hague, Netherlands; [van Asselt, G. J.] Med Ctr Haaglanden, Dept Med Microbiol, The Hague, Netherlands; [Velde, L. F. te] Albert Schweitzer Hosp, Dept Intens Care, Dordrecht, Netherlands; [Frenay, I. H. M. E.] Albert Schweitzer Hosp, Reg Lab Med Microbiol & Infect Dis, Dordrecht, Netherlands; [van Iterson, M.] Diakonessen Hosp, Dept Intens Care, Utrecht, Netherlands; [Thijsen, S. F. T.] Diakonessen Hosp, Dept Med Microbiol, Utrecht, Netherlands; [Kluge, G. H.] Slotervaart Hosp, Dept Intens Care, Amsterdam, Netherlands; [Pauw, W.] Slotervaart Hosp, Dept Clin Microbiol, Amsterdam, Netherlands; [de Vries, J. W.] Mesos Med Ctr, Dept Intens Care, Utrecht, Netherlands; [Kaan, J. A.] Mesos Med Ctr, Dept Med Microbiol & Immunol, Utrecht, Netherlands; [Cooper, B. S.] Ctr Infect Hlth Protect Agcy Stat, Modelling & Bioinformat Dept, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Amphia Hospital; Amphia Hospital; Rijnstate Hospital; Rijnstate Hospital; Rijnstate Hospital; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catharina Hospital; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Haaglanden Medical Center; Haaglanden Medical Center; Albert Schweitzer Ziekenhuis; Albert Schweitzer Ziekenhuis; Diakonessenhuis; Diakonessenhuis; Slotervaart Hospital; Slotervaart Hospital	de Smet, AMGA (corresponding author), Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, Q04-2-313,POB 85500, NL-3508 GA Utrecht, Netherlands.	a.desmet@umcutrecht.nl	Cooper, Ben/HGC-7082-2022; Kuijper, ed/AAB-7853-2022; Pickkers, P./H-8080-2014; Bosch, Frank/AAW-6704-2020; van der Hoeven, J.G./H-8048-2014; Voss, A./H-8111-2014; Kalkman, Cor/O-3215-2019	Kuijper, ed/0000-0001-5726-2405; Pickkers, P./0000-0002-1104-4303; Kalkman, Cor/0000-0002-8372-6960; Kluge, Georg/0000-0002-3312-3141; van der Werf, Tjip/0000-0002-4824-1642; de Smet, Anne Marie G.A./0000-0002-4421-4890; Cooper, Ben/0000-0002-9445-7217				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; BONTEN MJM, 1994, CHEST, V105, P878, DOI 10.1378/chest.105.3.878; Bonten MJM, 2004, CLIN INFECT DIS, V38, P1141, DOI 10.1086/383039; Bonten MJM, 2003, LANCET, V362, P2118, DOI 10.1016/S0140-6736(03)15120-3; BRANSON RD, 1993, CHEST, V104, P1800, DOI 10.1378/chest.104.6.1800; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de La Cal MA, 2005, ANN SURG, V241, P424, DOI 10.1097/01.sla.0000154148.58154.d5; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; HAMMOND JMJ, 1992, LANCET, V340, P5, DOI 10.1016/0140-6736(92)92422-C; HARTENAUER U, 1991, CRIT CARE MED, V19, P463, DOI 10.1097/00003246-199104000-00003; Heininger A, 2006, INTENS CARE MED, V32, P1569, DOI 10.1007/s00134-006-0304-5; KERVER AJH, 1988, CRIT CARE MED, V16, P1087, DOI 10.1097/00003246-198811000-00001; Koeman M, 2006, AM J RESP CRIT CARE, V173, P1348, DOI 10.1164/rccm.200505-820OC; Krueger WA, 2002, AM J RESP CRIT CARE, V166, P1029, DOI 10.1164/rccm.2105141; Lingnau W, 1998, J HOSP INFECT, V39, P195, DOI 10.1016/S0195-6701(98)90258-4; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Smit MJ, 2007, INTENS CARE MED, V33, P2025, DOI 10.1007/s00134-007-0774-0; Stoutenbeek CP, 2007, INTENS CARE MED, V33, P261, DOI 10.1007/s00134-006-0455-4; STOUTENBEEK CP, 1984, INTENS CARE MED, V10, P185, DOI 10.1007/BF00259435; Tablan OC, 2003, GUIDELINES PREVENTIN; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Verwaest C, 1997, CRIT CARE MED, V25, P63, DOI 10.1097/00003246-199701000-00014; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6	31	537	547	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					20	31		10.1056/NEJMoa0800394	http://dx.doi.org/10.1056/NEJMoa0800394			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118302	Green Published			2022-12-28	WOS:000262096800004
J	Shortell, SM; Swartzberg, J				Shortell, Stephen M.; Swartzberg, John			The Physician as Public Health Professional in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBESITY; BURDEN		[Shortell, Stephen M.; Swartzberg, John] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Shortell, Stephen M.; Swartzberg, John] Univ Calif Berkeley, Sch Publ Hlth, Joint Med Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 407 Warren Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu						Association of American Physicians and Surgeons, PHYS OATHS; Bentz CJ, 2006, AM J PREV MED, V30, P31, DOI 10.1016/j.amepre.2005.08.043; BURNET M, 1953, NATURAL HIST INFECT; COFFMAN J, 2001, HOLDING OUR OWN MIGR; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Druss BG, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.6.233; Grumbach KCJ., 2003, STRATEGIES IMPROVING; Hill A, 2001, CAN FAM PHYSICIAN, V47, P15; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Syme SL, 2008, HEALTH AFFAIR, V27, P456, DOI 10.1377/hlthaff.27.2.456; *U CAL BERK SCH PU, UCB UCSF JOINT MED P	14	12	13	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2916	2918						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109121				2022-12-28	WOS:000261920900026
J	Morris, K				Morris, Kelly			Profile George Daley: individualising stem-cell research	LANCET			English	Biographical-Item												vital@dircon.co.uk							0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2107	2107		10.1016/S0140-6736(08)61913-3	http://dx.doi.org/10.1016/S0140-6736(08)61913-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101376				2022-12-28	WOS:000261894000017
J	Summerskill, W				Summerskill, William			Voting opens for paper of the year 2008	LANCET			English	Editorial Material									[Summerskill, William] The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.							Horton R, 2003, LANCET, V362, P2101, DOI 10.1016/S0140-6736(03)15110-0; Summerskill W, 2008, LANCET, V371, P370, DOI 10.1016/S0140-6736(08)60183-X	2	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2096	2097		10.1016/S0140-6736(08)61905-4	http://dx.doi.org/10.1016/S0140-6736(08)61905-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101369				2022-12-28	WOS:000261894000009
J	Krumholz, MR; Klein, RI; Mckee, CF; Offner, SSR; Cunningham, AJ				Krumholz, Mark R.; Klein, Richard I.; McKee, Christopher F.; Offner, Stella S. R.; Cunningham, Andrew J.			The Formation of Massive Star Systems by Accretion	SCIENCE			English	Article							PROTOSTELLAR DISKS; MOLECULAR CLOUDS; CORES; COLLAPSE; LIMIT; FRAGMENTATION; TURBULENT; EVOLUTION; TRANSPORT	Massive stars produce so much light that the radiation pressure they exert on the gas and dust around them is stronger than their gravitational attraction, a condition that has long been expected to prevent them from growing by accretion. We present three- dimensional radiation-hydrodynamic simulations of the collapse of a massive prestellar core and find that radiation pressure does not halt accretion. Instead, gravitational and Rayleigh- Taylor instabilities channel gas onto the star system through nonaxisymmetric disks and filaments that self- shield against radiation while allowing radiation to escape through optically thin bubbles. Gravitational instabilities cause the disk to fragment and form a massive companion to the primary star. Radiation pressure does not limit stellar masses, but the instabilities that allow accretion to continue lead to small multiple systems.	[Krumholz, Mark R.] Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA; [Klein, Richard I.; McKee, Christopher F.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Klein, Richard I.; Cunningham, Andrew J.] Lawrence Livermore Natl Lab, AX Div, Livermore, CA 94550 USA; [McKee, Christopher F.; Offner, Stella S. R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Krumholz, MR (corresponding author), Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA.	krumholz@ucolick.org		Krumholz, Mark/0000-0003-3893-854X	NSF [AST-0807739, AST-0606831]; Spitzer Space Telescope Theoretical Research Program; NASA; Jet Propulsion Laboratory; Astrophysics Theory and Fundamental Physics Program [NAG 05-12042, NNG 06-GH96G]; U.S. Department of Energy at Lawrence Livermore National Laboratory [B-542762]; NSF San Diego Supercomputer Center [UCB267]	NSF(National Science Foundation (NSF)); Spitzer Space Telescope Theoretical Research Program; NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); Astrophysics Theory and Fundamental Physics Program; U.S. Department of Energy at Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NSF San Diego Supercomputer Center(National Science Foundation (NSF))	Supported by NSF grants AST-0807739 (M.R.K.) and AST-0606831 (R.I.K. and C.F.M.); the Spitzer Space Telescope Theoretical Research Program, provided by NASA through a contract issued by the Jet Propulsion Laboratory (M.R.K.); NASA through Astrophysics Theory and Fundamental Physics Program grants NAG 05-12042 and NNG 06-GH96G (R.I.K. and C.F.M.); and the U.S. Department of Energy at Lawrence Livermore National Laboratory under contract B-542762 (R.I.K., S.S.R.O., and A.J.C.). This research used the Datastar system at the NSF San Diego Supercomputer Center (grant UCB267).	Alves J, 2007, ASTRON ASTROPHYS, V462, pL17, DOI 10.1051/0004-6361:20066389; Bate MR, 2000, MON NOT R ASTRON SOC, V314, P33, DOI 10.1046/j.1365-8711.2000.03333.x; Beuther H, 2007, ASTRON ASTROPHYS, V466, P1065, DOI 10.1051/0004-6361:20066742; Figer DF, 2005, NATURE, V434, P192, DOI 10.1038/nature03293; FISHER RT, 2002, THESIS U CALIFORNIA; GOODMAN AA, 1993, ASTROPHYS J, V406, P528, DOI 10.1086/172465; Jijina J, 1996, ASTROPHYS J, V462, P874, DOI 10.1086/177201; KAHN FD, 1974, ASTRON ASTROPHYS, V37, P149; Klein RI, 1999, J COMPUT APPL MATH, V109, P123, DOI 10.1016/S0377-0427(99)00156-9; Kratter KM, 2008, ASTROPHYS J, V681, P375, DOI 10.1086/587543; Krumholz MR, 2007, ASTROPHYS J, V667, P626, DOI 10.1086/520791; Krumholz MR, 2007, ASTROPHYS J, V656, P959, DOI 10.1086/510664; Krumholz MR, 2005, ASTROPHYS J, V618, pL33, DOI 10.1086/427555; Lodato G, 2005, MON NOT R ASTRON SOC, V358, P1489, DOI 10.1111/j.1365-2966.2005.08875.x; MARINAK MM, 1995, PHYS REV LETT, V75, P3677, DOI 10.1103/PhysRevLett.75.3677; Mason BD, 1998, ASTRON J, V115, P821, DOI 10.1086/300234; Matzner CD, 2000, ASTROPHYS J, V545, P364, DOI 10.1086/317785; McKee CF, 2003, ASTROPHYS J, V585, P850, DOI 10.1086/346149; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; NAKANO T, 1995, ASTROPHYS J, V450, P183, DOI 10.1086/176130; Sana H, 2008, MON NOT R ASTRON SOC, V386, P447, DOI 10.1111/j.1365-2966.2008.13037.x; Shestakov AI, 2008, J COMPUT PHYS, V227, P2154, DOI 10.1016/j.jcp.2007.09.019; SHU FH, 1990, ASTROPHYS J, V358, P495, DOI 10.1086/169003; Turner NJ, 2007, ASTROPHYS J, V662, P1052, DOI 10.1086/513179; Weidner C, 2004, MON NOT R ASTRON SOC, V348, P187, DOI 10.1111/j.1365-2966.2004.07340.x; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Yorke HW, 1999, ASTROPHYS J, V525, P330, DOI 10.1086/307867; Yorke HW, 2002, ASTROPHYS J, V569, P846, DOI 10.1086/339264	29	441	445	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 6	2009	323	5915					754	757		10.1126/science.1165857	http://dx.doi.org/10.1126/science.1165857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19150809	Green Submitted			2022-12-28	WOS:000263066800038
J	Oberlander, J				Oberlander, Jonathan			Health Care 2009: Great Expectations -- The Obama Administration and Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Russell Sage Fdn, New York, NY 10021 USA.							Dorn S., 2008, MEDICAID SCHIP EC DO; Oberlander J, 2007, NEW ENGL J MED, V357, P1677, DOI 10.1056/NEJMp078201; ORSZAG P, 2008, PRELIMINARY ANAL PRO; PEAR R, 2008, NY TIMES        1111; STARR P, 1994, AM PROSPECT, V6, P20	5	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					321	323		10.1056/NEJMp0809584	http://dx.doi.org/10.1056/NEJMp0809584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164183				2022-12-28	WOS:000262519900001
J	Shann, F				Shann, Frank			Sepsis in babies: should we stimulate the phagocytes?	LANCET			English	Editorial Material							GRANULOCYTE TRANSFUSIONS; G-CSF; NEUTROPHILS; SAFETY; CARE		[Shann, Frank] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Melbourne, Vic 3052, Australia.	frank.shann@rch.org.au	Shann, Frank/C-9510-2011					Carr R, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003066; Carr R, 2009, LANCET, V373, P226, DOI 10.1016/S0140-6736(09)60071-4; CHRISTENSEN RD, 1980, J PEDIATR-US, V96, P316, DOI 10.1016/S0022-3476(80)80837-7; Cuzzolin L, 2006, EXPERT OPIN DRUG SAF, V5, P703, DOI 10.1517/14740338.5.5.703; Hirschel B, 2002, SWISS MED WKLY, V132, P301; Hubel K, 2002, J INFECT DIS, V185, P1490, DOI 10.1086/340221; La Gamma EF, 2002, ACTA PAEDIATR, V91, P109; Molloy EJ, 2005, PEDIATR RES, V57, P806, DOI 10.1203/01.PDR.0000156500.13600.B5; Napolitano LM, 2005, CHEST, V127, P1882, DOI 10.1378/chest.127.6.1882; Ramachandrappa A, 2008, CLIN PERINATOL, V35, P1, DOI 10.1016/j.clp.2007.11.012; Robinson SP, 2004, BONE MARROW TRANSPL, V34, P839, DOI 10.1038/sj.bmt.1704630; Schibler KR, 1999, PEDIATRICS, V103, P1310; Spiekermann K, 1997, LEUKEMIA, V11, P466, DOI 10.1038/sj.leu.2400607; Vamvakas EC, 1996, J CLIN APHERESIS, V11, P1	14	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					188	190		10.1016/S0140-6736(09)60052-0	http://dx.doi.org/10.1016/S0140-6736(09)60052-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19150690				2022-12-28	WOS:000262537500005
J	Heal, CF; Buettner, PG; Cruickshank, R; Graham, D; Browning, S; Pendergast, J; Drobetz, H; Gluer, R; Lisec, C				Heal, Clare F.; Buettner, Petra G.; Cruickshank, Robert; Graham, David; Browning, Sheldon; Pendergast, Jayne; Drobetz, Herwig; Gluer, Robert; Lisec, Carl			Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-PROPHYLAXIS; OCULAR CHLORAMPHENICOL; DERMATOLOGICAL SURGERY; MUPIROCIN RESISTANCE; CONTACT-DERMATITIS; GENERAL-PRACTICE; APLASTIC-ANEMIA; EPIDEMIOLOGY; OINTMENT	Objective To determine the effectiveness of a single application of topical chloramphenicol ointment in preventing wound infection after minor dermatological surgery. Design Prospective randomised placebo controlled double blind multicentre trial. Setting Primary care in a regional centre in Queensland, Australia. Participants 972 minor surgery patients. Interventions A single topical dose of chloramphenicol ( n= 488) or paraffin ointment ( n= 484; placebo). Main outcome measure Incidence of infection. Results The incidence of infection in the chloramphenicol group ( 6.6%; 95% confidence interval 4.9 to 8.8) was significantly lower than that in the control group ( 11.0%; 7.9 to 15.1) ( P= 0.010). The absolute reduction in infection rate was 4.4%, the relative reduction was 40%, and the relative risk of wound infection in the control group was 1.7 ( 95% confidence interval 1.1 to 2.5) times higher than in the intervention group. The number needed to treat was 22.8. Conclusion Application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produces a moderate absolute reduction in infection rate that is statistically but not clinically significant. Trial registration Current Controlled Trials	[Heal, Clare F.; Drobetz, Herwig; Gluer, Robert] James Cook Univ, Sch Med, Mackay Base Hosp, Mackay, Qld 4740, Australia; [Buettner, Petra G.] James Cook Univ, Townsville, Qld 4811, Australia; [Cruickshank, Robert; Graham, David; Pendergast, Jayne] Walkerston Med Ctr, Mackay, Qld 4740, Australia; [Browning, Sheldon] Molescan Mackay, Mackay, Qld 4740, Australia; [Lisec, Carl] Townsville Gen Hosp, Townsville, Qld 4740, Australia	James Cook University; James Cook University	Heal, CF (corresponding author), James Cook Univ, Sch Med, Mackay Base Hosp, Mackay, Qld 4740, Australia.	clare.heal@jcu.edu.au	Heal, Clare/D-3786-2015	Heal, Clare/0000-0002-5041-2666; Drobetz, Herwig/0000-0003-0837-2696	Chris Silagy scholarship; Royal Australian College of General Practice	Chris Silagy scholarship; Royal Australian College of General Practice	Research was funded by the Chris Silagy scholarship from the Royal Australian College of General Practice. The authors' work is independent of this funding.	ALLEN LV, 2007, SECUNDUM ARTEM, P4; Amici JM, 2005, BRIT J DERMATOL, V153, P967, DOI 10.1111/j.1365-2133.2005.06861.x; *AUSTR GOV BUR MET, 2008, CLIM DAT ONL; Australian Bureau of Statistics, 2006, CENS POP HOUS BAS CO; BLONDEEL A, 1978, CONTACT DERMATITIS, V4, P270, DOI 10.1111/j.1600-0536.1978.tb04557.x; BRADLEY SF, 1995, INFECT CONT HOSP EP, V16, P354; *BRIT MED ASS ROYA, 2006, BRIT NAT FORM, P605; Bruce J, 2001, J HOSP INFECT, V49, P99, DOI 10.1053/jhin.2001.1045; BUCKLEY S, 1999, BRIT MED J, V300, P1497; Cho CY, 1998, DERMATOL CLIN, V16, P25, DOI 10.1016/S0733-8635(05)70485-X; COLEBROOK L, 1948, LANCET, V252, P682, DOI 10.1016/S0140-6736(48)91114-3; CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; Dixon AJ, 2006, DERMATOL SURG, V32, P819, DOI 10.1111/j.1524-4725.2006.32167.x; EDLICH RF, 1992, WOUND HEALING, P581; Edwards PS, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003949.PUB2; Erel E, 1999, BRIT J PLAST SURG, V52, P326; Fukuda M, 2002, CORNEA, V21, pS86, DOI 10.1097/01.ico.0000263125.99262.42; HAAS AF, 1995, J AM ACAD DERMATOL, V32, P155, DOI 10.1016/0190-9622(95)90119-1; Heal C, 2006, BMJ-BRIT MED J, V332, P1053, DOI 10.1136/bmj.38800.628704.AE; Heal Clare, 2006, Aust Fam Physician, V35, P825; Heal C, 2006, MED J AUSTRALIA, V185, P255, DOI 10.5694/j.1326-5377.2006.tb00555.x; Kamath S, 2005, INJURY, V36, P783, DOI 10.1016/j.injury.2005.01.001; Laporte JR, 1998, BRIT J CLIN PHARMACO, V46, P181, DOI 10.1046/j.1365-2125.1998.00773.x; Lathlean S, 1999, Aust Fam Physician, V28 Suppl 1, pS28; LEYDEN JJ, 1979, JAMA-J AM MED ASSOC, V242, P1276, DOI 10.1001/jama.242.12.1276; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Marks JG, 1998, J AM ACAD DERMATOL, V38, P911, DOI 10.1016/S0190-9622(98)70587-0; Messingham MJ, 2005, DERMATOL SURG, V31, P1068; Miller MA, 1996, INFECT CONT HOSP EP, V17, P811; Pasapula C, 2004, J HAND SURG-BRIT EUR, V29B, P634, DOI 10.1016/j.jhsb.2004.07.004; *PFIZ, 2005, PROD INF CHLOR EYE O; Platt R, 1998, NEW HORIZ-SCI PRACT, V6, pS53; Rayner SA, 1996, DRUG SAFETY, V14, P273, DOI 10.2165/00002018-199614050-00001; *THER GUID, 2006, THER GUID ANT VERS 1; THOMAS S, 1990, WOUND MANAGEMENT DRE, P9	36	52	52	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2009	338								a2812	10.1136/bmj.a2812	http://dx.doi.org/10.1136/bmj.a2812			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AD	19147639	Green Published, hybrid			2022-12-28	WOS:000263193400001
J	Wyatt, TD				Wyatt, Tristram D.			Fifty years of pheromones	NATURE			English	Editorial Material									[Wyatt, Tristram D.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Wyatt, TD (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tristram.wyatt@zoo.ox.ac.uk	Wyatt, Tristram D./C-1222-2008	Wyatt, Tristram D./0000-0003-0371-0713				KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0	2	116	119	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					262	263		10.1038/457262a	http://dx.doi.org/10.1038/457262a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	394IR	19148082	Bronze			2022-12-28	WOS:000262440900020
J	Kapp, C				Kapp, Clare			Profile Marian Jacobs: pioneer of child health in South Africa	LANCET			English	Biographical-Item												clarekapp@hotmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					115	115		10.1016/S0140-6736(09)60025-8	http://dx.doi.org/10.1016/S0140-6736(09)60025-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135601				2022-12-28	WOS:000262340900013
J	Bowler, PJ				Bowler, Peter J.			Darwin's Originality	SCIENCE			English	Review							ARTIFICIAL SELECTION		[Bowler, Peter J.] Queens Univ Belfast, Sch Philosophy & Anthropol Studies, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Bowler, PJ (corresponding author), Queens Univ Belfast, Sch Philosophy & Anthropol Studies, University Rd Belfast, Belfast BT7 1NN, Antrim, North Ireland.	p.bowler@qub.ac.uk						Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bowler Peter, 2003, EVOLUTION HIST IDEA, V3rd; BOWLER PJ, 1976, J HIST IDEAS, V37, P631, DOI 10.2307/2709028; Bowler PJ, 1983, ECLIPSE DARWINISM; BROWNE J, 1985, C DARWIN VOYAGING; Corsi P., 1988, AGE LAMARCK EVOLUTIO; DARWIN C, 1838, TRANSMUTATION NOTEBO; Darwin Charles., 2002, POWER PLACE POWER PLACE; DESMOND A, 1991, DARWIN; Desmond AJ, 2009, DARWINS SACRED CAUSE; Desmond AJ, 1989, POLITICS EVOLUTION M; Eiseley Loren, 1958, DARWINS CENTURY EVOL; Francis M., 2007, H SPENCER INVENTION; GAYON J, 1998, DARWINISMS STRUGGLE; Hodge M. J. S., 2003, CAMBRIDGE COMPANION; Hodge M. J. S., 1982, STUDIES HIST BIOL, V6, P1; KOHN D, 1985, DARWINIAN HERITAGE C; MAYR E, 1991, 1 LONG ARGUMENT C DA; NEUMEISTER G, 1876, GANZE TAUBENZUCHT; Rehbock P. F., 1983, PHILOS NATURALISTS T; Richards R. J., 1992, MEANING EVOLUTION MO, DOI 10.7208/chicago/9780226712055.001.0001; Richards RA, 1997, STUD HIST PHILOS SCI, V28, P75, DOI 10.1016/S0039-3681(96)00008-8; RUSE M, 1975, J HIST IDEAS, V36, P339, DOI 10.2307/2708932; Secord James A., 2000, VICTORIAN SENSATION	24	22	24	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					223	226		10.1126/science.1160332	http://dx.doi.org/10.1126/science.1160332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131623				2022-12-28	WOS:000262290600029
J	Venditti, M; Falcone, M; Corrao, S; Licata, G; Serra, P				Venditti, Mario; Falcone, Marco; Corrao, Salvatore; Licata, Giuseppe; Serra, Pietro		Study Grp Italian Soc Internal Med	Outcomes of Patients Hospitalized With Community-Acquired, Health Care-Associated, and Hospital-Acquired Pneumonia	ANNALS OF INTERNAL MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS; MANAGEMENT; RISK; IDENTIFICATION; EPIDEMIOLOGY; INFECTIONS; ADULTS	Background: Traditionally, pneumonia has been classified as either community- or hospital-acquired. Although only limited data are available, health care-associated pneumonia has been recently proposed as a new category of respiratory infection. "Health care associated pneumonia" refers to pneumonia in patients who have recently been hospitalized, had hemodialysis, or received intravenous chemotherapy or reside in a nursing home or long-term care facility. Objective: To ascertain the epidemiology and outcome of community-acquired, health care-associated, and hospital-acquired pneumonia in adults hospitalized in internal medicine wards. Design: Multicenter, prospective observational study. Setting: 55 hospitals in Italy comprising 1941 beds. Patients: 362 patients hospitalized with pneumonia during two 1-week surveillance periods. Measurements: Cases of radiologically and clinically assessed pneumonia were classified as community-acquired, health care associated, or hospital-acquired and rates were compared. Results: Of the 362 patients, 61.6% had community-acquired pneumonia, 24.9% had health care-associated pneumonia, and 13.5% had hospital-acquired pneumonia. Patients with health care associated pneumonia had higher mean Sequential Organ Failure Assessment scores than did those with community-acquired pneumonia (3.0 vs. 2.0), were more frequently malnourished (11.1% vs. 4.5%, and had more frequent bilateral (34.4% vs. 19.7%) and multilobar (27.8% vs. 21.5%) involvement on a chest radiograph. Patients with health care-associated pneumonia also had higher fatality rates (17.8% [CI, 10.6% to 24.9%] vs. 6.7% [CI, 2.9% to 10.5%]) and longer mean hospital stay (18.7 days [CI, 15.9 to 21.5 days] vs. 14.7 days [CI, 13.4 to 15.9 days]). Logistic regression analysis revealed that depression of consciousness (odds ratio [OR], 3.2 [CI, 1.06 to 9.8]), leukopenia (OR, 6.2 [CI, 1.01 to 37.6]), and receipt of empirical antibiotic therapy not recommended by international guidelines (OR, 6.4 [CI, 2.3 to 17.6]) were independently associated with increased intrahospital mortality. Limitations: The number of patients with health care-associated pneumonia was relatively small. Microbiological investigations were not always homogeneous. The study included only patients with pneumonia that required hospitalization; results may not apply to patients treated as outpatients. Conclusion: Health care-associated pneumonia should be considered a distinct subset of pneumonia associated with more severe disease, longer hospital stay, and higher mortality rates. Physicians should differentiate between patients with health care-associated pneumonia and those with community-acquired pneumonia and provide more appropriate initial antibiotic therapy.	[Venditti, Mario; Falcone, Marco; Serra, Pietro] Univ Roma La Sapienza, Policlin Umberto I, Dipartimento Med Clin, I-00161 Rome, Italy; [Corrao, Salvatore; Licata, Giuseppe] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, I-90127 Palermo, Italy	Sapienza University Rome; University Hospital Sapienza Rome; University of Palermo	Venditti, M (corresponding author), Univ Roma La Sapienza, Policlin Umberto I, Dipartimento Med Clin, Viale Univ 37, I-00161 Rome, Italy.	mario.venditti@uniroma1.it	Falcone, Marco/K-7614-2016; Doroldi, Carlo Giovanni/AAY-6977-2021; Catalano, Antonino/H-7109-2016; Corrao, Salvatore SC/K-3504-2018; Carrabba, Maria/AAM-5651-2020; Cosentini, Roberto/L-4232-2013; Corrao, Salvatore/AAQ-5768-2020; Manfredini, Roberto/A-3471-2008; Fanelli, Filippo Rossi/E-9587-2011; Corazza, Gino Roberto/K-8500-2016; Perciaccante, Antonio/R-3796-2017; Manfredini, Roberto/N-3859-2019; Fabio, Giovanna/M-7595-2015; Doroldi, Carlo Giovanni Giovanni/AAW-9313-2021; Manfredini, Roberto/AAJ-5442-2020; CAPPELLINI, MARIA DOMENICA/B-4475-2017; Zoppoli, Gabriele/B-6935-2016	Falcone, Marco/0000-0003-3813-8796; Catalano, Antonino/0000-0003-3890-2299; Corrao, Salvatore SC/0000-0001-5621-1374; Carrabba, Maria/0000-0002-0717-9096; Cosentini, Roberto/0000-0003-3407-3630; Corrao, Salvatore/0000-0001-5621-1374; Manfredini, Roberto/0000-0002-8364-2601; Fanelli, Filippo Rossi/0000-0002-8674-1672; Corazza, Gino Roberto/0000-0001-9532-0573; Manfredini, Roberto/0000-0002-8364-2601; Fabio, Giovanna/0000-0002-8805-2942; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; grieco, antonio/0000-0002-0544-8993; Tuttolomondo, Antonino/0000-0001-6440-7318; Zoppoli, Gabriele/0000-0002-1619-1708; VENDITTI, Mario/0000-0003-2639-0281; Tresoldi, Moreno/0000-0003-1541-6650				Abrahamian FM, 2008, AM J EMERG MED, V26, P1, DOI 10.1016/j.ajem.2008.03.015; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hosmer D., 2002, APPL LOGISTIC REGRES; Kollef MH, 2008, CLIN INFECT DIS, V46, pS296, DOI 10.1086/526355; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2005, CHEST, V127, P1260, DOI 10.1378/chest.127.4.1260; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; Mykietiuk A, 2006, EUR J CLIN MICROBIOL, V25, P457, DOI 10.1007/s10096-006-0161-8; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; WHO. World Health Organization, 1995, TECHNICAL REPORT SER, V854	19	246	250	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					19	W5		10.7326/0003-4819-150-1-200901060-00005	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124816				2022-12-28	WOS:000262655100003
J	Thavarajah, D; Attavar, S; Menon, J				Thavarajah, Dushan; Attavar, Srilekha; Menon, Jay			A case of hepatomegaly	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYDATID-DISEASE; LIVER; CYST		[Thavarajah, Dushan; Attavar, Srilekha; Menon, Jay] Basildon Univ Hosp, Basildon SS16 5NL, England		Thavarajah, D (corresponding author), Basildon Univ Hosp, Basildon SS16 5NL, England.	dushanthavarajah@yahoo.com						Abu-Eshy SA, 1998, J ROY COLL SURG EDIN, V43, P347; Ayles HM, 2002, ANN ROY COLL SURG, V84, P100; DALESSANDRO A, 1979, AM J TROP MED HYG, V28, P303, DOI 10.4269/ajtmh.1979.28.303; DALESSANDRO A, 1995, AM J TROP MED HYG, V15, P29; Greenberg RM, 2007, FUTURE MICROBIOL, V2, P265, DOI 10.2217/17460913.2.3.265; Pelaez V, 2000, ACTA TROP, V75, P197, DOI 10.1016/S0001-706X(00)00058-9; Sayek I, 2001, WORLD J SURG, V25, P21, DOI 10.1007/s002680020004	7	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 29	2008	337								a3090	10.1136/bmj.a3090	http://dx.doi.org/10.1136/bmj.a3090			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MV	19114446				2022-12-28	WOS:000262945900011
J	Rai, K; Huggins, IJ; James, SR; Karpf, AR; Jones, DA; Cairns, BR				Rai, Kunal; Huggins, Ian J.; James, Smitha R.; Karpf, Adam R.; Jones, David A.; Cairns, Bradley R.			DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45	CELL			English	Article							PATERNAL GENOME; METHYLATION; 5-METHYLCYTOSINE; ARABIDOPSIS; MBD4; ACTIVATION; PROMOTER; DEMETER	Evidence for active DNA demethylation in vertebrates is accumulating, but the mechanisms and enzymes remain unclear. Using zebrafish embryos we provide evidence for 5-methylcytosine (5-meC) removal in vivo via the coupling of a 5-meC deaminase (AID, which converts 5-meC to thymine) and a G: T mismatch-specific thymine glycosylase (Mbd4). The injection of methylated DNA into embryos induced a potent DNA demethylation activity, which was attenuated by depletion of AID or the non enzymatic factor Gadd45. Remarkably, overexpression of the deaminase/glycosylase pair AID/Mbd4 in vivo caused demethylation of the bulk genome and injected methylated DNA fragments, likely involving a G: T intermediate. Furthermore, AID or Mbd4 knockdown caused the remethylation of a set of common genes. Finally, Gadd45 promoted demethylation and enhanced functional interactions between deaminase/glycosylase pairs. Our results provide evidence for a coupled mechanism of 5-meC demethylation, whereby AID deaminates 5-meC, followed by thymine base excision by Mbd4, promoted by Gadd45.	[Rai, Kunal; Jones, David A.; Cairns, Bradley R.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rai, Kunal; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Huggins, Ian J.; Jones, David A.; Cairns, Bradley R.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [James, Smitha R.; Karpf, Adam R.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Jones, DA (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu; brad.cairns@hci.utah.edu		Karpf, Adam/0000-0002-0866-0666; Rai, Kunal/0000-0003-2321-6894	Huntsman Cancer Institute; National Cancer Institute [CA24014, CA16056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA116468, P30CA016056, R01CA116674] Funding Source: NIH RePORTER	Huntsman Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jacqui Wittmeyer for generating antibodies for Apobec2a/b, Richard Dorsky for probes, Sung Wan Kim for plasmids, M. Ben Major for Gadd45 morpholino efficacy determinations, Bob Schackmann for oligos and Helaman Escobar for sequencing. We thank Brenda Bass, Don Ayer, and Barbara Graves for comments on the manuscript. Support has been received from: Huntsman Cancer Institute (supplies, genomics and support of K.R., I.H., and D.A.J.), the National Cancer Institute (for D.A.J, S.R.J., and A.R.K.), CA24014 and CA16056 (for core facilities), and the Howard Hughes Medical Institute (supplies, genomics, and support of B.R.C.).	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collas P, 1998, NUCLEIC ACIDS RES, V26, P4454, DOI 10.1093/nar/26.19.4454; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157	33	517	538	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1201	1212		10.1016/j.cell.2008.11.042	http://dx.doi.org/10.1016/j.cell.2008.11.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109892	Green Accepted, Bronze			2022-12-28	WOS:000261989800012
J	Chapman, C				Chapman, Corry			Always on call	LANCET			English	Editorial Material											Chapman, C (corresponding author), 408 E Monroe Ave, Alexandria, VA 22301 USA.	corrychapman@gmail.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2162	2163		10.1016/S0140-6736(08)61931-5	http://dx.doi.org/10.1016/S0140-6736(08)61931-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19101392				2022-12-28	WOS:000261894000039
J	Roberts, TL; Idris, A; Dunn, JA; Kelly, GM; Burnton, CM; Hodgson, S; Hardy, LL; Garceau, V; Sweet, MJ; Ross, IL; Hume, DA; Stacey, KJ				Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.			HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA	SCIENCE			English	Article							CELL-DEATH; INTERFERON; GENE; RECOGNITION; SIGNALS; FAMILY	The mammalian innate immune system is activated by foreign nucleic acids. Detection of double- stranded DNA ( dsDNA) in the cytoplasm triggers characteristic antiviral responses and macrophage cell death. Cytoplasmic dsDNA rapidly activated caspase 3 and caspase 1 in bone marrow- derived macrophages. We identified the HIN- 200 family member and candidate lupus susceptibility factor, p202, as a dsDNA binding protein that bound stably and rapidly to transfected DNA. Knockdown studies showed p202 to be an inhibitor of DNA- induced caspase activation. Conversely, the related pyrin domain- containing HIN- 200 factor, AIM2 ( p210), was required for caspase activation by cytoplasmic dsDNA. This work indicates that HIN- 200 proteins can act as pattern recognition receptors mediating responses to cytoplasmic dsDNA.	[Roberts, Tara L.; Idris, Adi; Dunn, Jasmyn A.; Kelly, Greg M.; Burnton, Carol M.; Hodgson, Samantha; Hardy, Lani L.; Garceau, Valerie; Sweet, Matthew J.; Ross, Ian L.; Hume, David A.; Stacey, Katryn J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Roberts, Tara L.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Sweet, Matthew J.; Stacey, Katryn J.] Univ Queensland, Sch Chem & Biomol Sci, Brisbane, Qld 4072, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland	Stacey, KJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	k.stacey@imb.uq.edu.au	Sweet, Matthew J/F-2229-2011; Ross, Ian/A-8622-2011; Roberts, Tara L/B-7278-2011; Hume, David A/C-7695-2013; Idris, Adi/N-3500-2016	Sweet, Matthew J/0000-0002-0406-8139; Ross, Ian/0000-0002-2389-4292; Roberts, Tara L/0000-0001-9266-0943; Idris, Adi/0000-0002-0562-1549; Stacey, Katryn/0000-0002-3992-7802; Hume, David/0000-0002-2615-1478	National Health and Medical Research Council (NHMRC) of Australia [455920, 455882]; Cooperative Research Centre for Chronic Inflammatory Diseases; NHMRC Peter Doherty Fellowship; Australian Research Council Special Research Centre for Functional and Applied Genomics; Australian Cancer Research Foundation; Medical Research Council [G9900991B] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Special Research Centre for Functional and Applied Genomics(Australian Research Council); Australian Cancer Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (grants 455920 and 455882), and by the Cooperative Research Centre for Chronic Inflammatory Diseases. T. L. R. is the recipient of an NHMRC Peter Doherty Fellowship. Mass spectrometry facilities are supported by the Australian Research Council Special Research Centre for Functional and Applied Genomics. Confocalmicroscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology funded by the Australian Cancer Research Foundation. R. Johnstone and C. Clarke provided materials and valuable advice on the HIN-200 family proteins. S. Akira provided TLR9<SUP>-/-</SUP> mice. The work presented here is related to International Patent Application PCT/AU2007/001330.	Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Choubey D, 2000, FEBS LETT, V474, P38, DOI 10.1016/S0014-5793(00)01571-4; Choubey D, 1996, BIOCHEM BIOPH RES CO, V221, P396, DOI 10.1006/bbrc.1996.0607; Haywood M, 2006, GENES IMMUN, V7, P250, DOI 10.1038/sj.gene.6364294; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; STACEY KJ, 1993, IMMUNOL CELL BIOL, V71, P75, DOI 10.1038/icb.1993.8; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	20	641	680	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1057	1060		10.1126/science.1169841	http://dx.doi.org/10.1126/science.1169841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131592				2022-12-28	WOS:000263478400041
J	Scott, FL; Stec, B; Pop, C; Dobaczewska, MK; Lee, JJ; Monosov, E; Robinson, H; Salvesen, GS; Schwarzenbacher, R; Riedl, SJ				Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Robinson, Howard; Salvesen, Guy S.; Schwarzenbacher, Robert; Riedl, Stefan J.			The Fas-FADD death domain complex structure unravels signalling by receptor clustering	NATURE			English	Article							CELL-DEATH; MUTATIONAL ANALYSIS; APOPTOSIS; CD95; ARCHITECTURE; INFLAMMATION; INTERFACES; SPOTS	The death inducing signalling complex ( DISC) formed by Fas receptor, FADD( Fas- associated death domain protein) and caspase 8 is a pivotal trigger of apoptosis(1-3). The Fas - FADD DISC represents a receptor platform, which once assembled initiates the induction of programmed cell death. A highly oligomeric network of homotypic protein interactions comprised of the death domains of Fas and FADD is at the centre of DISC formation(4,5). Thus, characterizing the mechanistic basis for the Fas - FADD interaction is crucial for understanding DISC signalling but has remained unclear largely because of a lack of structural data. We have successfully formed and isolated the human Fas - FADD death domain complex and report the 2.7 angstrom crystal structure. The complex shows a tetrameric arrangement of four FADD death domains bound to four Fas death domains. We show that an opening of the Fas death domain exposes the FADD binding site and simultaneously generates a Fas - Fas bridge. The result is a regulatory Fas - FADD complex bridge governed by weak protein - protein interactions revealing a model where the complex itself functions as a mechanistic switch. This switch prevents accidental DISC assembly, yet allows for highly processive DISC formation and clustering upon a sufficient stimulus. In addition to depicting a previously unknown mode of death domain interactions, these results further uncover a mechanism for receptor signalling solely by oligomerization and clustering events.	[Scott, Fiona L.; Stec, Boguslaw; Pop, Cristina; Dobaczewska, Malgorzata K.; Lee, JeongEun J.; Monosov, Edward; Salvesen, Guy S.; Riedl, Stefan J.] Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Brookhaven National Laboratory; Salzburg University	Riedl, SJ (corresponding author), Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA.	robert.schwarzenbacher@sbg.ac.at; sriedl@burnham.org		Stec, Boguslaw/0000-0002-8696-0349	cancer center grant [P30 CA030199]; Biological and Environmental Research DOE; National Center for Research Resources NIH; LLS scholarship;  [R01AA017238];  [PO1CA69381];  [MCEXT-033534]; NATIONAL CANCER INSTITUTE [P30CA030199, P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017238] Funding Source: NIH RePORTER	cancer center grant; Biological and Environmental Research DOE(United States Department of Energy (DOE)); National Center for Research Resources NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); LLS scholarship; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Snipas for protein sequencing and technical assistance, J. Reed for providing Fas cDNA and A. Bobkov for the AUC. This work was supported by a P30 CA030199 cancer center grant and R01AA017238 to S.J.R.; PO1CA69381 to G. S. S.; and MCEXT-033534 to R. S. Data measured at beamline X29 of the National Synchrotron Light Source were also supported by Biological and Environmental Research DOE, and National Center for Research Resources NIH. Earlier stages of the work were supported by a LLS scholarship to S.J.R. S.J.R. is currently a V Foundation scholar.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Ferguson BJ, 2007, CELL DEATH DIFFER, V14, P1717, DOI 10.1038/sj.cdd.4402191; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Festjens N, 2006, BIOL CHEM, V387, P1005, DOI 10.1515/BC.2006.124; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Huxford T, 2002, J MOL BIOL, V324, P587, DOI 10.1016/S0022-2836(02)01149-X; ITOH N, 1993, J BIOL CHEM, V268, P10932; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; O'Reilly LA, 2004, CELL DEATH DIFFER, V11, P724, DOI 10.1038/sj.cdd.4401408; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Werner MH, 2006, CELL CYCLE, V5, P2332, DOI 10.4161/cc.5.20.3385	30	261	274	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1019	1022		10.1038/nature07606	http://dx.doi.org/10.1038/nature07606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19118384	Green Accepted			2022-12-28	WOS:000263425400044
J	Primarolo, D; Malloch-Brown, M; Lewis, I				Primarolo, Dawn; Malloch-Brown, Mark; Lewis, Ivan		Interministerial Grp Global Hlth	Health is global: a UK Government strategy for 2008-13	LANCET			English	Editorial Material									[Primarolo, Dawn] Dept Hlth, London SW1A 2NS, England; [Malloch-Brown, Mark] Foreign & Commonwealth Off, London, England; [Lewis, Ivan] Dept Int Dev, London, England		Primarolo, D (corresponding author), Dept Hlth, London SW1A 2NS, England.	dhmail@dh.gsi.gov.uk						Brown G., 2007, COMMUNICATION   1112; Cabinet Office, 2008, NAT SEC STRAT UK SEC; *CHATH HOUS, IND THINK INT AFF; *CHIEF MED ADV UK, 2007, HLTH IS GLOB PROP UK; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; *DEP HLTH, 2007, UK GOV STRAT GLOB HL; *DEP HLTH DEP INT, 2008, GLOB HLTH PARTN UK C; HM Government, 2008, HLTH IS GLOB UK GOV; *IHP, INT HLTH PARTN REL I; Kickbusch I, 2008, LANCET, V371, P1733, DOI 10.1016/S0140-6736(08)60741-2; *WHO, 2003, 2003 WORLD HLTH REP, pCH5	11	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					443	445		10.1016/S0140-6736(08)61820-6	http://dx.doi.org/10.1016/S0140-6736(08)61820-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404EF	19097639	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000263132800009
J	Yan, H; Chen, ZH; Zheng, Y; Newman, C; Quinn, JR; Dotz, F; Kastler, M; Facchetti, A				Yan, He; Chen, Zhihua; Zheng, Yan; Newman, Christopher; Quinn, Jordan R.; Dotz, Florian; Kastler, Marcel; Facchetti, Antonio			A high-mobility electron-transporting polymer for printed transistors	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; ORGANIC TRANSISTORS; CHARGE-TRANSPORT; GATE DIELECTRICS; DESIGN; SEMICONDUCTORS; TRANSITION; DISPLAYS; VOLTAGE	Printed electronics is a revolutionary technology aimed at unconventional electronic device manufacture on plastic foils, and will probably rely on polymeric semiconductors for organic thin- film transistor (OTFT) fabrication. In addition to having excellent charge- transport characteristics in ambient conditions, such materials must meet other key requirements, such as chemical stability, large solubility in common solvents, and inexpensive solution and/or low- temperature processing. Furthermore, compatibility of both p- channel (hole- transporting) and n- channel (electron- transporting) semiconductors with a single combination of gate dielectric and contact materials is highly desirable to enable powerful complementary circuit technologies, where p- and n- channel OTFTs operate in concert. Polymeric complementary circuits operating in ambient conditions are currently difficult to realize: although excellent p- channel polymers are widely available, the achievement of high- performance n- channel polymers is more challenging. Here we report a highly soluble (similar to 60 g l(-1)) and printable n- channel polymer exhibiting unprecedented OTFT characteristics ( electron mobilities up to similar to 0.45 - 0.85 cm(2) V-1 s(-1)) under ambient conditions in combination with Au contacts and various polymeric dielectrics. Several top- gate OTFTs on plastic substrates were fabricated with the semiconductor- dielectric layers deposited by spin- coating as well as by gravure, flexographic and inkjet printing, demonstrating great processing versatility. Finally, all- printed polymeric complementary inverters ( with gain 25-65) have been demonstrated.	[Yan, He; Chen, Zhihua; Zheng, Yan; Newman, Christopher; Quinn, Jordan R.; Facchetti, Antonio] Polyera Corp, Skokie, IL 60077 USA; [Dotz, Florian] BASF Global Res Ctr Singapore, Singapore 112575, Singapore; [Kastler, Marcel] BASF SE, GKS E B001, D-67056 Ludwigshafen, Germany	Polyera; BASF; BASF	Facchetti, A (corresponding author), Polyera Corp, 8045 Lamon Ave, Skokie, IL 60077 USA.	afacchetti@polyera.com	CHEN, Jin-dong/F-3610-2011; Facchetti, Antonio/B-8034-2014; Yan, He/B-3113-2010	Facchetti, Antonio/0000-0002-8175-7958; Yan, He/0000-0003-1780-8308				Ando S, 2005, J AM CHEM SOC, V127, P14996, DOI 10.1021/ja055686f; Anthopoulos TD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387892; Bao ZN, 1999, J MATER CHEM, V9, P1895, DOI 10.1039/a902652e; Briseno AL, 2008, CHEM MATER, V20, P4712, DOI 10.1021/cm8010265; Briseno AL, 2006, NATURE, V444, P913, DOI 10.1038/nature05427; Chang JF, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205204; Chen ZH, 2009, J AM CHEM SOC, V131, P8, DOI 10.1021/ja805407g; Chesterfield RJ, 2004, J PHYS CHEM B, V108, P19281, DOI 10.1021/jp046246y; Cheung CH, 2008, J APPL PHYS, V103, DOI 10.1063/1.2909904; Cho JH, 2008, ADV MATER, V20, P686, DOI 10.1002/adma.200701069; Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; Dholakia GR, 2006, NANO LETT, V6, P2447, DOI 10.1021/nl061566+; Dhoot AS, 2006, P NATL ACAD SCI USA, V103, P11834, DOI 10.1073/pnas.0605033103; Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822; DODABALAPUR A, 1995, SCIENCE, V269, P1560, DOI 10.1126/science.269.5230.1560; Facchetti A, 2005, ADV MATER, V17, P1705, DOI 10.1002/adma.200500517; Gamota D., 2004, PRINTED ORGANIC MOL; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Gundlach DJ, 2008, NAT MATER, V7, P216, DOI 10.1038/nmat2122; Guo XG, 2008, ORG LETT, V10, P5333, DOI 10.1021/ol801918y; Huttner S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2885712; Hulea IN, 2006, NAT MATER, V5, P982, DOI 10.1038/nmat1774; Jones BA, 2007, J AM CHEM SOC, V129, P15259, DOI 10.1021/ja075242e; Kim C, 2007, SCIENCE, V318, P76, DOI 10.1126/science.1146458; Klauk H., 2006, ORGANIC ELECT MAT MA; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Kline RJ, 2005, MACROMOLECULES, V38, P3312, DOI 10.1021/ma047415f; Letizia JA, 2008, J AM CHEM SOC, V130, P9679, DOI 10.1021/ja710815a; Malliaras G, 2005, PHYS TODAY, V58, P53, DOI 10.1063/1.1995748; Mcculloch I, 2006, NAT MATER, V5, P328, DOI 10.1038/nmat1612; Menard E, 2004, ADV MATER, V16, P2097, DOI 10.1002/adma.200401017; Muccini M, 2006, NAT MATER, V5, P605, DOI 10.1038/nmat1699; Newman CR, 2004, CHEM MATER, V16, P4436, DOI 10.1021/cm049391x; Pan HL, 2007, J AM CHEM SOC, V129, P4112, DOI 10.1021/ja067879o; Richards T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2825584; Richards T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2937729; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Salleo A, 2003, J APPL PHYS, V94, P471, DOI 10.1063/1.1581352; See KC, 2007, ADV MATER, V19, P3322, DOI 10.1002/adma.200602924; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Sivaramakrishnan S, 2007, NAT MATER, V6, P149, DOI 10.1038/nmat1806; Stoliar P, 2007, J AM CHEM SOC, V129, P6477, DOI 10.1021/ja069235m; Veres J, 2003, ADV FUNCT MATER, V13, P199, DOI 10.1002/adfm.200390030; VIKRAM CS, 2004, SCIENCE, V303, P1644; Waldauf C, 2003, ADV MATER, V15, P2084, DOI 10.1002/adma.200305623; Westenhoff S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.016102; Zaumseil J, 2006, NAT MATER, V5, P69, DOI 10.1038/nmat1537; Zhan XW, 2007, J AM CHEM SOC, V129, P7246, DOI 10.1021/ja071760d	51	2534	2593	37	1623	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2009	457	7230					679	U1		10.1038/nature07727	http://dx.doi.org/10.1038/nature07727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EA	19158674				2022-12-28	WOS:000263064700032
J	Stewart, CE; Wilson, CM; Fielder, AR				Stewart, Catherine E.; Wilson, Clare M.; Fielder, Alistair R.			A 3(1/2) year old girl presenting with strabismus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOSE-RESPONSE; AMBLYOPIA; OCCLUSION; VISION; RISK; PREVALENCE; EYE		[Stewart, Catherine E.; Wilson, Clare M.; Fielder, Alistair R.] City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England	City University London	Stewart, CE (corresponding author), City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England.	c.e.stewart@city.ac.uk			National Institute for Health Research [N&AHP/C3/04/PD/015] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		ANDERSON SJ, 2002, AMBLYOPIA MULTIDISCI, P43; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; Beck RW, 2003, OPHTHALMOLOGY, V110, P2075, DOI 10.1016/S0161-6420(03)01023-6; BLAKEMORE C, 1978, J PHYSIOL-LONDON, V283, P223, DOI 10.1113/jphysiol.1978.sp012498; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; Cotter SA, 2006, OPHTHALMOLOGY, V113, P895, DOI 10.1016/j.ophtha.2006.01.068; Daw NW, 2003, ADV INFAN R, P43; Hall DMB, 2003, HLTH ALL CHILDREN, P230; Hartmann EE, 2001, OPHTHALMOLOGY, V108, P479, DOI 10.1016/S0161-6420(00)00588-1; HISCOX F, 1992, EYE, V6, P300, DOI 10.1038/eye.1992.59; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kiorpes L, 1999, CURR OPIN NEUROBIOL, V9, P480, DOI 10.1016/S0959-4388(99)80072-5; LEA S J H, 1989, Eye (London), V3, P783; Loudon S E, 2002, Strabismus, V10, P79, DOI 10.1076/stra.10.2.79.8143; MASSIE H, 1965, T OPHTHALMOL SOC AUS, V24, P39; MOSELEY MJ, 2002, OPHTHAL PHYSL OPT, V23, P1; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Stewart CE, 2007, BMJ-BRIT MED J, V335, P707, DOI 10.1136/bmj.39301.460150.55; Stewart CE, 2007, INVEST OPHTH VIS SCI, V48, P2589, DOI 10.1167/iovs.05-1243; Stewart CE, 2004, BRIT J OPHTHALMOL, V88, P1552, DOI 10.1136/bjo.2004.044214; Stewart CE, 2004, INVEST OPHTH VIS SCI, V45, P3048, DOI 10.1167/iovs.04-0250; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Ziakas NG, 2002, EYE, V16, P519, DOI 10.1038/sj.eye.6700138	25	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2009	338								b68	10.1136/bmj.b68	http://dx.doi.org/10.1136/bmj.b68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BR	19158182	Green Submitted			2022-12-28	WOS:000263197600001
J	Wilson, JF				Wilson, Jennifer Fisher			All Health Care Reform Lead Back to Medicaid?	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Bindman Andrew B, 2003, J Ambul Care Manage, V26, P334; Bindman AB, 2008, ANN INTERN MED, V149, P854, DOI 10.7326/0003-4819-149-12-200812160-00004; *CAL MED ASS, 2006, DO PAT GO SEP NEED H; Coughlin TA, 2008, MILBANK Q, V86, P209, DOI 10.1111/j.1468-0009.2008.00520.x; CUNNINGHAM PJ, 2006, 16 CTR STUD HLTH SYS; Hoadley JF, 2004, HEALTH AFFAIR, V23, P143, DOI 10.1377/hlthaff.23.2.143; Smith V, 2008, HEADED CRUNCH UPDATE	7	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					149	151		10.7326/0003-4819-150-2-200901200-00024	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397ID	19153423				2022-12-28	WOS:000262655200020
J	Islam, SM; Shinmyo, Y; Okafuji, T; Su, YH; Bin Naser, I; Ahmed, G; Zhang, SB; Chen, S; Ohta, K; Kiyonari, H; Abe, T; Tanaka, S; Nishinakamura, R; Terashima, T; Kitamura, T; Tanaka, H				Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Kiyonari, Hiroshi; Abe, Takaya; Tanaka, Satomi; Nishinakamura, Ryuichi; Terashima, Toshio; Kitamura, Toshio; Tanaka, Hideaki			Draxin, a Repulsive Guidance Protein for Spinal Cord and Forebrain Commissures	SCIENCE			English	Article							AXON GUIDANCE; CORPUS-CALLOSUM; CHEMOATTRACTANT; NETRIN-1; RYK	Axon guidance proteins are critical for the correct wiring of the nervous system during development. Several axon guidance cues and their family members have been well characterized. More unidentified axon guidance cues are assumed to participate in the formation of the extremely complex nervous system. We identified a secreted protein, draxin, that shares no homology with known guidance cues. Draxin inhibited or repelled neurite outgrowth from dorsal spinal cord and cortical explants in vitro. Ectopically expressed draxin inhibited growth or caused misrouting of chick spinal cord commissural axons in vivo. draxin knockout mice showed defasciculation of spinal cord commissural axons and absence of all forebrain commissures. Thus, draxin is a previously unknown chemorepulsive axon guidance molecule required for the development of spinal cord and forebrain commissures.	[Islam, Shahidul M.; Shinmyo, Yohei; Okafuji, Tatsuya; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Chen, Sandy; Ohta, Kunimasa; Tanaka, Hideaki] Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Islam, Shahidul M.; Shinmyo, Yohei; Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Tanaka, Hideaki] Kumamoto Univ, 21st Century COE Ctr Excellence, Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Su, Yuhong; Bin Naser, Iftekhar; Ahmed, Giasuddin; Zhang, Sanbing; Nishinakamura, Ryuichi; Tanaka, Hideaki] Kumamoto Univ, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8600811, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Kobe, Chuo Ku, Lab Anim Resources & Genet Engn, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Tanaka, Satomi; Nishinakamura, Ryuichi] Kumamoto Univ, Div Integrat Cell Biol, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Terashima, Toshio] Kobe Univ, Grad Sch Med, Div Anat & Neurobiol, Kobe, Hyogo 6500017, Japan; [Kitamura, Toshio] Univ Tokyo, Minato Ku, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan	Kumamoto University; Kumamoto University; Kumamoto University; RIKEN; Kumamoto University; Kobe University; University of Tokyo	Tanaka, H (corresponding author), Kumamoto Univ, Div Dev Neurobiol, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hitanaka@kumamoto-u.ac.jp	Islam, Shahidul/N-5897-2013; Kiyonari, Hiroshi/N-7936-2015; Kitamura, Toshio/AAA-2071-2021; Ohta, Kunimasa/AAW-6993-2020	Ohta, Kunimasa/0000-0002-4564-9757	Ministry of Education, Science, Sports, and Culture of Japan (MEXT); (Cell Fate Regulation Research and Education Unit), MEXT, Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Cell Fate Regulation Research and Education Unit), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. S. Campbell for careful reading of the manuscript, C. Krull for the pMES-internal ribosome entry site (IRES)-EGFP vector, J. G. Flanagan for APTag-2 vector, H. Fujisawa for helpful discussions, and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT), by the 21st Century COE Program and by the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan.	Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shu TZ, 2003, J NEUROSCI, V23, P8176; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	15	116	128	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					388	393		10.1126/science.1165187	http://dx.doi.org/10.1126/science.1165187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150847				2022-12-28	WOS:000262481400041
J	Nagase, T; Katsura, Y; Iwaki, Y; Nemoto, K; Sekine, H; Miwa, K; Oh-i, T; Kou, K; Iwaya, K; Noritake, M; Matsuoka, T				Nagase, Terumasa; Katsura, Yoshiya; Iwaki, Yoshiki; Nemoto, Kenji; Sekine, Hidenori; Miwa, Kazuhiro; Oh-i, Tsunao; Kou, Keni; Iwaya, Keiichi; Noritake, Masayuki; Matsuoka, Takeshi			The insulin ball	LANCET			English	Editorial Material							SITES		[Nagase, Terumasa; Katsura, Yoshiya; Iwaki, Yoshiki; Nemoto, Kenji; Sekine, Hidenori; Miwa, Kazuhiro; Noritake, Masayuki; Matsuoka, Takeshi] Tokyo Med Univ, Dept Internal Med 5, Kasumigaura Hosp, Ibaraki 3000395, Japan; [Oh-i, Tsunao] Tokyo Med Univ, Dept Dermatol, Kasumigaura Hosp, Ibaraki 3000395, Japan; [Kou, Keni; Iwaya, Keiichi] Tokyo Med Univ, Div Diagnost Pathol, Kasumigaura Hosp, Ibaraki 3000395, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Nagase, T (corresponding author), Tokyo Med Univ, Dept Internal Med 5, Kasumigaura Hosp, 3-20-1 Chuou, Ibaraki 3000395, Japan.	tnagase@tokyo-med.ac.jp						Albert SG, 2007, DIABETES RES CLIN PR, V75, P374, DOI 10.1016/j.diabres.2006.07.013; Chowdhury TA, 2003, BRIT MED J, V327, P383, DOI 10.1136/bmj.327.7411.383; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; GOLDFINE AB, 2004, JOSLINS DIABETES MEL, P493; Swift B, 2002, DIABETIC MED, V19, P881, DOI 10.1046/j.1464-5491.2002.07581.x	5	38	40	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					184	184		10.1016/S0140-6736(09)60041-6	http://dx.doi.org/10.1016/S0140-6736(09)60041-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135614				2022-12-28	WOS:000262340900034
J	Landers, SH				Landers, Steven H.			The Other Medical Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Landers, Steven H.] Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, Independence, OH 44131 USA	Cleveland Clinic Foundation	Landers, SH (corresponding author), Ctr Home Hlth Serv, Cleveland Clin Rehabil Inst, 6801 Brecksville Rd, Independence, OH 44131 USA.	landers@ccf.org						Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Goldman DP, 2005, HLTH AFF MILLWOO S2, V24; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Johnson L.B., 1965, REMARKS PRESIDENT TR; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Leff B, 1996, J AM GERIATR SOC, V44, P603, DOI 10.1111/j.1532-5415.1996.tb01452.x; Levine SA, 2003, JAMA-J AM MED ASSOC, V290, P1203, DOI 10.1001/jama.290.9.1203; Medalie J, 1978, FAMILY MED PRINCIPLE; Sands LP, 2006, J AM GERIATR SOC, V54, P339, DOI 10.1111/j.1532-5415.2005.00590.x; 2005, RAND HLTH WORKING PA	11	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					97	99		10.1001/jama.2008.917	http://dx.doi.org/10.1001/jama.2008.917			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391FY	19126815				2022-12-28	WOS:000262220400026
J	Quellmalz, ES; Pellegrino, JW				Quellmalz, Edys S.; Pellegrino, James W.			Technology and Testing	SCIENCE			English	Editorial Material									[Quellmalz, Edys S.] WestEd, Redwood City, CA 94063 USA; [Pellegrino, James W.] Univ Illinois, Learning Sci Res Inst, MC 057, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Quellmalz, ES (corresponding author), WestEd, 400 Seaport Court,Suite 222, Redwood City, CA 94063 USA.	equellm@wested.org						Bennett R, 2007, 2007466 NCES US DEP; Bennett R. E., 2008, RM0810 ETS; BENNETT RE, 2001, ED POLICY ANAL ARCH, V9, P5; Black P, 2004, PHI DELTA KAPPAN, V86, P8, DOI 10.1177/003172170408600105; Black P., 1998, INSIDE BLACK BOX RAI; Brown J., 2008, 21 CENTURY ED, V2, P245; Feng MY, 2006, LECT NOTES COMPUT SC, V4053, P31; Klein S. P, 2008, PROBABILITY STAT ESS, V2, P76, DOI [10.1214/193940307000000392, DOI 10.1214/193940307000000392]; KOOMEN M, 2006, ANN M AM ED RES ASS; Landauer T. K., 2003, ASSESS EDUC, V10, P295, DOI [10.1080/0969594032000148154, DOI 10.1080/0969594032000148154]; MINSTRELL J, 2005, STUDENTS LEARN HIST, pCH11; Mislevy R.J., 2006, ED MEASUREMENT ISSUE, V25, P6, DOI [10.1111/j.1745-3992.2006.00075.x, DOI 10.1111/J.1745-3992.2006.00075.X]; *NAT CTR ED EC, 2006, TOUGH CHOIC TOUGH TI; National Research Council, 2001, KNOWING WHAT STUDENT; Natl. Res. Counc, 2006, RIS GATH STORM EN EM; Perie M, 2007, MOVING COMPREHENSIVE; Quellmalz E. S., 2004, MODELS MULTILEVEL ST; QUELLMALZ ES, 2008, ASSESSING SCI LEARNI, pCH10; SANDENE B, 2005, 2005457 NCES US DEP; Thissen-Roe A, 2004, BEHAV RES METH INS C, V36, P234, DOI 10.3758/BF03195568; VENDLINSKI T, 2002, J TECHNOLOGY LEARNIN, V1, P3; Wiliam D., 2007, 2 HDB RES MATH TEACH, P1051; Wilson MR, 2005, SYSTEMS STATE SCI AS; [No title captured]	24	65	73	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					75	79		10.1126/science.1168046	http://dx.doi.org/10.1126/science.1168046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119222				2022-12-28	WOS:000262104100042
J	Goldston, D				Goldston, David			The new boss in town	NATURE			English	Editorial Material									[Goldston, David] Bipartisan Policy Ctr, Washington, DC USA		Goldston, D (corresponding author), Bipartisan Policy Ctr, Washington, DC USA.	partyofonecolumn@gmail.com							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					17	17		10.1038/457017a	http://dx.doi.org/10.1038/457017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OR	19122616	Bronze			2022-12-28	WOS:000262104900010
J	Kim, S; Takahashi, H; Lin, WW; Descargues, P; Grivennikov, S; Kim, Y; Luo, JL; Karin, M				Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael			Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis	NATURE			English	Article							LEWIS-LUNG-CARCINOMA; CANCER METASTASIS; PROSTATE-CANCER; INNATE IMMUNITY; TUMOR-GROWTH; PROTEOGLYCAN; INFLAMMATION; MACROPHAGES; ANGIOGENESIS; HYALURONAN	Metastatic progression depends on genetic alterations intrinsic to cancer cells as well as the inflammatory microenvironment of advanced tumours(1,2). To understand how cancer cells affect the inflammatory microenvironment, we conducted a biochemical screen for macrophage- activating factors secreted by metastatic carcinomas. Here we show that, among the cell lines screened, Lewis lung carcinoma (LLC)(3) were the most potent macrophage activators leading to production of interleukin-6 (IL-6) and tumour-necrosis factor-alpha (TNF-alpha) through activation of the Toll-like receptor (TLR) family members(4) TLR2 and TLR6. Both TNF-alpha and TLR2 were found to be required for LLC metastasis. Biochemical purification of LLC- conditioned medium ( LCM) led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumours including lung cancer(5,6), as a macrophage activator that acts through TLR2 and its coreceptors TLR6 and CD14. By activating TLR2: TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth. These results explain how advanced cancer cells usurp components of the host innate immune system, including bone- marrow- derived myeloid progenitors(7), to generate an inflammatory microenvironment hospitable for metastatic growth.	[Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Sunhwa; Takahashi, Hiroyuki; Lin, Wan-Wan; Descargues, Pascal; Grivennikov, Sergei; Kim, Youngjun; Luo, Jun-Li; Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Lin, Wan-Wan] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; National Taiwan University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555; Luo, Jun-Li/0000-0002-7625-4766; Lin, Wan Wan/0000-0002-3207-734X	International Human Frontier Science Program Organization; National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award; California Institute of Regenerative Medicine; Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health; Littlefield-AACR; NATIONAL CANCER INSTITUTE [R01CA132586, R01CA118165, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); National Cancer Institute-sponsored Cancer Therapeutic Training Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Japanese Respiratory Society; Life Science Research Foundation; IHFSPO; Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Littlefield-AACR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.K. was supported by the International Human Frontier Science Program Organization (IHFSPO), the National Cancer Institute-sponsored Cancer Therapeutic Training Program and a Ruth L. Kirschstein National Research Service Award. Y.K., H.T., J.-L.L., P.D. and S.G. were supported by the California Institute of Regenerative Medicine, the Japanese Respiratory Society, the Life Science Research Foundation, IHFSPO and the Crohn's and Colitis Foundation of America, respectively. Work in the M. K. laboratory was supported by grants from the National Institutes of Health and a Littlefield-AACR grant in Metastatic Colon Cancer Research. M. K. is an American Cancer Society Research Professor. We thank S. Akira and B. Beutler for TLR and adaptor protein deficient mice, D. Zimmermann for human versican construct, R. Hoffman for DsRed-LLC cells and K. Takenaga for LLC-P29 cells. We also thank R. Gallo and K. Yamasaki for the hyaluronan- inhibiting peptides and advice, J. Varner for analysing cell migration and Santa Cruz Biotechnology for gifts of antibodies.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Eckmann L, 1996, J IMMUNOL, V156, P2894; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Isogai Z, 1996, CANCER RES, V56, P3902; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Urosevic M, 2004, BLOOD, V103, P1796, DOI 10.1182/blood-2003-10-3372; WEISS L, 1987, INT J CANCER, V40, P570, DOI 10.1002/ijc.2910400423; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	27	830	886	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					102	U108		10.1038/nature07623	http://dx.doi.org/10.1038/nature07623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122641	Green Accepted			2022-12-28	WOS:000262104900039
J	Yagmurlu, A				Yagmurlu, Aydin			Laparoscopic versus open pyloromyotomy	LANCET			English	Editorial Material							PYLORIC-STENOSIS		[Yagmurlu, Aydin] Ankara Univ, Fac Med, Dept Paediat Surg, TR-06100 Ankara, Turkey	Ankara University	Yagmurlu, A (corresponding author), Ankara Univ, Fac Med, Dept Paediat Surg, TR-06100 Ankara, Turkey.	eayagmur@medicine.ankara.edu.tr	Sheir, Hesham/AAY-1216-2020; Yagmurlu, Aydin/AAQ-4887-2020	Sheir, Hesham/0000-0003-4606-4328; 				Adibe OO, 2006, J PEDIATR SURG, V41, P1676, DOI 10.1016/j.jpedsurg.2006.05.051; ALAIN JL, 1991, J PEDIATR SURG, V26, P1191, DOI 10.1016/0022-3468(91)90331-M; Bickler SW, 2000, B WORLD HEALTH ORGAN, V78, P1330; Ceccanti S, 2008, J PEDIATR SURG, V43, P1579, DOI 10.1016/j.jpedsurg.2008.03.036; Fischer JD, 2008, J PEDIATR SURG, V43, P1580, DOI 10.1016/j.jpedsurg.2008.03.035; Hall NJ, 2009, LANCET, V373, P390, DOI 10.1016/S0140-6736(09)60006-4; Hall NJ, 2004, BRIT J SURG, V91, P1325, DOI 10.1002/bjs.4523; Haricharan RN, 2008, J PEDIATR SURG, V43, P97, DOI 10.1016/j.jpedsurg.2007.09.028; Haricharan RN, 2008, J PEDIATR SURG, V43, P92, DOI 10.1016/j.jpedsurg.2007.09.026; Leclair MD, 2007, J PEDIATR SURG, V42, P692, DOI 10.1016/j.jpedsurg.2006.12.016; MOWATT G, 1997, HEALTH TECHNOL ASSES, V1, P1; St Peter SD, 2006, ANN SURG, V244, P363, DOI 10.1097/01.sla.0000234647.03466.27; Yagmurlu A, 2004, J PEDIATR SURG, V39, P292, DOI 10.1016/j.jpedsurg.2003.11.047	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					358	360		10.1016/S0140-6736(09)60007-6	http://dx.doi.org/10.1016/S0140-6736(09)60007-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19155061				2022-12-28	WOS:000262912100006
J	Watts, G				Watts, Geoff			Google watches over flu	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						GINSBERG J, 2008, NATURE          1119; *HLTH PROT AG, SOURC UK FLU DAT	2	7	9	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 31	2008	337								a3076	10.1136/bmj.a3076	http://dx.doi.org/10.1136/bmj.a3076			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118085				2022-12-28	WOS:000262946300002
J	Jarvis, S				Jarvis, Sarah			Should the contraceptive pill be available without prescription? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL-CONTRACEPTIVES; PREGNANCY		[Jarvis, Sarah] Royal Coll Gen Practitioners, London SW7 1PU, England		Jarvis, S (corresponding author), Royal Coll Gen Practitioners, London SW7 1PU, England.	Sarah.jarvis@gp-e85016.nhs.uk	Potter, Joseph E/A-3122-2008					BOTTING B, TRENDS FERTILITY CON; Churchill Dick, 2002, Int J Adolesc Med Health, V14, P153; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; *DEP HLTH, NAT SURV LOC HLTH SE; Free C, 2004, J FAM PLAN REPROD H, V30, P91, DOI 10.1783/147118904322995447; Mc Millan H M, 2004, Ir Med J, V97, P276; *NAT I CLIN EXC, 2005, 30 NAT I CLIN EXC; ROSENBERG MJ, 1995, CONTRACEPTION, V51, P283, DOI 10.1016/0010-7824(95)00074-K; Rosenberg MJ, 1998, FAM PLANN PERSPECT, V30, P89, DOI 10.2307/2991665; *SOC EXCL UN, 1999, TEEN PREGN REP; Thurman AR, 2007, J PEDIATR ADOL GYNEC, V20, P61, DOI 10.1016/j.jpag.2006.11.006; Wilkinson P, 2006, LANCET, V368, P1879, DOI 10.1016/S0140-6736(06)69777-8	12	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2008	337								a3056	10.1136/bmj.a3056	http://dx.doi.org/10.1136/bmj.a3056			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EL	19106139				2022-12-28	WOS:000262428400004
J	James, AB; Monreal, JA; Nimmo, GA; Kelly, CL; Herzyk, P; Jenkins, GI; Nimmo, HG				James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Herzyk, Pawel; Jenkins, Gareth I.; Nimmo, Hugh G.			The Circadian Clock in Arabidopsis Roots Is a Simplified Slave Version of the Clock in Shoots	SCIENCE			English	Article							GENE-EXPRESSION; MOLECULAR-BASES; FEEDBACK LOOP; RHYTHMS; PATHWAYS; LIVER; PRR7; CCA1; LHY	The circadian oscillator in eukaryotes consists of several interlocking feedback loops through which the expression of clock genes is controlled. It is generally assumed that all plant cells contain essentially identical and cell- autonomous multiloop clocks. Here, we show that the circadian clock in the roots of mature Arabidopsis plants differs markedly from that in the shoots and that the root clock is synchronized by a photosynthesis- related signal from the shoot. Two of the feedback loops of the plant circadian clock are disengaged in roots, because two key clock components, the transcription factors CCA1 and LHY, are able to inhibit gene expression in shoots but not in roots. Thus, the plant clock is organ- specific but not organ- autonomous.	[James, Allan B.; Monreal, Jose A.; Nimmo, Gillian A.; Kelly, Ciaran L.; Jenkins, Gareth I.; Nimmo, Hugh G.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Div Integrated Biol, Glasgow G12 8QQ, Lanark, Scotland; [Herzyk, Pawel] Univ Glasgow, Fac Biomed & Life Sci, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Nimmo, HG (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland.	h.g.nimmo@bio.gla.ac.uk	Jenkins, Gareth I/B-4785-2010; Kelly, Ciarán/AAR-2404-2021; Monreal, Jose Antonio/K-2210-2014	Kelly, Ciarán/0000-0002-2263-5176; Monreal, Jose Antonio/0000-0002-0186-5634; James, Allan/0000-0003-4472-7095; Nimmo, Hugh/0000-0003-1389-7147	Leverhulme Trust; Spanish Ministry of Education and Science	Leverhulme Trust(Leverhulme Trust); Spanish Ministry of Education and Science(Spanish Government)	We thank A. Millar (Edinburgh), S.A. Kay (San Diego), and C.R. McClung (Dartmouth) for Arabidopsis lines; I. Carr, (Warwick) and E. M. Tobin (Los Angeles) for the LHY- and CCA1-specific antisera, respectively; K. Edwards (Advanced Technologies, Cambridge) for advice on COSOPT; and J. Galbraith (Faculty of Biomedical and Life Sciences, University of Glasgow) for microarray experiments. The work was supported by the Leverhulme Trust. J.A.M. holds a fellowship from the Spanish Ministry of Education and Science.	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Straume M, 2004, METHOD ENZYMOL, V383, P149; Sullivan S, 2004, PLANT PHYSIOL, V135, P2078, DOI 10.1104/pp.104.042762; Thain SC, 2000, CURR BIOL, V10, P951, DOI 10.1016/S0960-9822(00)00630-8; Thain SC, 2002, PLANT PHYSIOL, V130, P102, DOI 10.1104/pp.005405; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101	28	177	193	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1832	1835		10.1126/science.1161403	http://dx.doi.org/10.1126/science.1161403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095940				2022-12-28	WOS:000261799400051
J	Kara, P; Boyd, JD				Kara, Prakash; Boyd, Jamie D.			A micro-architecture for binocular disparity and ocular dominance in visual cortex	NATURE			English	Article							POSTNATAL-DEVELOPMENT; HORIZONTAL DISPARITY; DEPTH DISCRIMINATION; STRIATE CORTEX; PRIMATE V1; SENSITIVITY; NEURONS; ORGANIZATION; MECHANISMS; STEREOPSIS	In invertebrate predators such as the praying mantis and vertebrate predators such as wild cats the ability to detect small differences in inter-ocular retinal disparities is a critical means for accurately determining the depth of moving objects such as prey(1). In mammals, the first neurons along the visual pathway that encode binocular disparities are found in the visual cortex. However, a precise functional architecture for binocular disparity has never been demonstrated in any species, and coarse maps for disparity have been found in only one primate species(2,3). Moreover, the dominant approach for assaying the developmental plasticity of binocular cortical neurons used monocular tests of ocular dominance to infer binocular function(4). The few studies that examined the relationship between ocular dominance and binocular disparity of individual cells used single-unit recordings and have provided conflicting results regarding whether ocular dominance can predict the selectivity or sensitivity to binocular disparity(5-9). We used two-photon calcium imaging to sample the response to monocular and binocular visual stimuli from nearly every adjacent neuron in a small region of the cat visual cortex, area 18. Here we show that local circuits for ocular dominance always have smooth and graded transitions from one apparently monocular functional domain to an adjacent binocular region. Most unexpectedly, we discovered a new map in the cat visual cortex that had a precise functional micro-architecture for binocular disparity selectivity. At the level of single cells, ocular dominance was unrelated to binocular disparity selectivity or sensitivity. When the local maps for ocular dominance and binocular disparity both had measurable gradients at a given cortical site, the two gradient directions were orthogonal to each other. Together, these results indicate that, from the perspective of the spiking activity of individual neurons, ocular dominance cannot predict binocular disparity tuning. However, the precise local arrangement of ocular dominance and binocular disparity maps provide new clues regarding how monocular and binocular depth cues may be combined and decoded.	[Kara, Prakash; Boyd, Jamie D.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kara, P (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	kara@musc.edu			NIH; Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE [R01EY017925] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall; Dana Foundations; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Cumming and N. Swindale for discussions. We thank B. Shi, Z. Shen, Z. Lu and J. Schnellmann for comments on the manuscript. This work was supported by grants from the NIH, Whitehall and Dana Foundations to P. K.	Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Chen G, 2008, NEURON, V58, P442, DOI 10.1016/j.neuron.2008.02.032; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREEMAN RD, 1992, J NEUROSCI, V12, P4721; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MITCHELL DE, 2004, VISUAL NEUROSCIENCES, P189; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker A., 2003, BLINK EYE VISION SPA; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; ROSSEL S, 1983, NATURE, V302, P821, DOI 10.1038/302821a0; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011	30	81	81	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					627	U93		10.1038/nature07721	http://dx.doi.org/10.1038/nature07721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19158677	Green Accepted			2022-12-28	WOS:000264796200040
J	Fernandes-Alnemri, T; Yu, JW; Datta, P; Wu, JH; Alnemri, ES				Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.			AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA	NATURE			English	Article							INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; ASC PYROPTOSOME; CASPASE-1; SILICA; FAMILY; GENES; BETA	Host-and pathogen-associated cytoplasmic double-stranded DNA triggers the activation of a NALP3 (also known as cryopyrin and NLRP3)-independent inflammasome(1), which activates caspase-1 leading to maturation of pro-interleukin-1 beta and inflammation. The nature of the cytoplasmic-DNA-sensing inflammasome is currently unknown. Here we show that AIM2 (absent in melanoma 2), an interferon-inducible HIN-200 family member that contains an amino-terminal pyrin domain and a carboxy-terminal oligonucleotide/oligosaccharide-binding domain(2,3), senses cytoplasmic DNA by means of its oligonucleotide/oligosaccharide-binding domain and interacts with ASC (apoptosis-associated speck-like protein containing a CARD) through its pyrin domain to activate caspase-1. The interaction of AIM2 with ASC also leads to the formation of the ASC pyroptosome(4), which induces pyroptotic cell death in cells containing caspase-1. Knockdown of AIM2 by short interfering RNA reduced inflammasome/pyroptosome activation by cytoplasmic DNA in human and mouse macrophages, whereas stable expression of AIM2 in the non-responsive human embryonic kidney 293T cell line conferred responsiveness to cytoplasmic DNA. Our results show that cytoplasmic DNA triggers formation of the AIM2 inflammasome by inducing AIM2 oligomerization. This study identifies AIM2 as an important inflammasome component that senses potentially dangerous cytoplasmic DNA, leading to activation of the ASC pyroptosome and caspase-1.	[Fernandes-Alnemri, Teresa; Yu, Je-Wook; Datta, Pinaki; Wu, Jianghong; Alnemri, Emad S.] Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	E_Alnemri@lac.jci.tju.edu	Alnemri, Emad S/B-4526-2010	Yu, Je-Wook/0000-0001-5943-4071	NIH [AG14357, AR055398]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG14357 and AR055398 to E. S. A. We thank M. McCormick and D. Wang for technical assistance, X. Jiao for help with the confocal microscopy, J. Sagara for the anti-human ASC antibody, J. Yuan for the anti-mouse caspase-1 antibody, R. Johnstone for the anti-human AIM2 antibody, M.-C. Hung for the anti-human IFIX antibody, T. Ouchi for the IFI16 complementary DNA and E. Latz for the immortalized mouse bone marrow macrophages.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Meier O, 2005, J VIROL, V79, P2604, DOI 10.1128/JVI.79.4.2604-2613.2005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	18	1260	1315	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					509	U5		10.1038/nature07710	http://dx.doi.org/10.1038/nature07710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158676	Green Accepted			2022-12-28	WOS:000264532400045
J	Jinek, M; Doudna, JA				Jinek, Martin; Doudna, Jennifer A.			A three-dimensional view of the molecular machinery of RNA interference	NATURE			English	Review							PIWI-INTERACTING RNAS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HUMAN DICER; MICRORNA MATURATION; ARGONAUTE COMPLEXES; SILENCING COMPLEX; PASSENGER-STRAND; GUIDE-STRAND; PAZ DOMAIN	In eukaryotes, small non- coding RNAs regulate gene expression, helping to control cellular metabolism, growth and differentiation, to maintain genome integrity, and to combat viruses and mobile genetic elements. These pathways involve two specialized ribonucleases that control the production and function of small regulatory RNAs. The enzyme Dicer cleaves double- stranded RNA precursors, generating short interfering RNAs and microRNAs in the cytoplasm. These small RNAs are transferred to Argonaute proteins, which guide the sequence- specific silencing of messenger RNAs that contain complementary sequences by either enzymatically cleaving the mRNA or repressing its translation. The molecular structures of Dicer and the Argonaute proteins, free and bound to small RNAs, have offered exciting insights into the molecular mechanisms that are central to RNA silencing pathways.	[Jinek, Martin; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	doudna@berkeley.edu	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	Howard Hughes Medical Institute; National Institutes of Health; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073794] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Patel for communicating results in advance of publication. We also thank members of the Doudna laboratory for discussions and critical reading of the manuscript. Research in the Doudna laboratory is supported by the Howard Hughes Medical Institute and the National Institutes of Health. M. J. was supported by the European Molecular Biology Organization and is now a postdoctoral fellow of the Human Frontier Science Program.	Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	92	519	571	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					405	412		10.1038/nature07755	http://dx.doi.org/10.1038/nature07755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158786				2022-12-28	WOS:000262519200033
J	Moazed, D				Moazed, Danesh			Small RNAs in transcriptional gene silencing and genome defence	NATURE			English	Review							DOUBLE-STRANDED-RNA; FISSION YEAST; HISTONE H3; C-ELEGANS; DNA METHYLATION; SIRNA PATHWAY; CAENORHABDITIS-ELEGANS; LYSINE-9 METHYLATION; ARABIDOPSIS-THALIANA; CHROMATIN-STRUCTURE	Small RNA molecules of about 20 - 30 nucleotides have emerged as powerful regulators of gene expression and genome stability. Studies in fission yeast and multicellular organisms suggest that effector complexes, directed by small RNAs, target nascent chromatin- bound non- coding RNAs and recruit chromatin modifying complexes. Interactions between small RNAs and nascent non- coding transcripts thus reveal a new mechanism for targeting chromatin- modifying complexes to specific chromosome regions and suggest possibilities for how the resultant chromatin states may be inherited during the process of chromosome duplication.	[Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh_moazed@hms.harvard.edu			National Institutes of Health; Leukemia and Lymphoma Society; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank the members of my laboratory and colleagues in the chromatin and RNA silencing fields for fruitful discussions, and the National Institutes of Health, the Leukemia and Lymphoma Society, and the Howard Hughes Medical Institute for funding.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; DeBeauchamp JL, 2008, MOL CELL BIOL, V28, P2154, DOI 10.1128/MCB.01637-07; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalez S, 2008, CELL CYCLE, V7, P2601, DOI 10.4161/cc.7.16.6541; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Partridge JF, 2000, GENE DEV, V14, P783; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wutz A, 2003, BIOESSAYS, V25, P434, DOI 10.1002/bies.10274; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	100	559	587	3	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					413	420		10.1038/nature07756	http://dx.doi.org/10.1038/nature07756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158787	Green Accepted			2022-12-28	WOS:000262519200034
J	Garcia-Ruiz, JM; Melero-Garcia, E; Hyde, ST				Garcia-Ruiz, Juan Manuel; Melero-Garcia, Emilio; Hyde, Stephen T.			Morphogenesis of Self-Assembled Nanocrystalline Materials of Barium Carbonate and Silica	SCIENCE			English	Article							SPHERULITIC CRYSTALLIZATION; PRECIPITATION; MARS; FORM	The precipitation of barium or strontium carbonates in alkaline silica-rich environments leads to crystalline aggregates that have been named silica/carbonate biomorphs because their morphology resembles that of primitive organisms. These aggregates are self-assembled materials of purely inorganic origin, with an amorphous phase of silica intimately intertwined with a carbonate nanocrystalline phase. We propose a mechanism that explains all the morphologies described for biomorphs. Chemically coupled coprecipitation of carbonate and silica leads to fibrillation of the growing front and to laminar structures that experience curling at their growing rim. These curls propagate in a surflike way along the rim of the laminae. We show that all observed morphologies with smoothly varying positive or negative Gaussian curvatures can be explained by the combined growth of counterpropagating curls and growing laminae.	[Garcia-Ruiz, Juan Manuel; Melero-Garcia, Emilio] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Lab Estud Cristalograf, Armilla 18100, Spain; [Hyde, Stephen T.] Australian Natl Univ, Dept Appl Math, Res Sch Phys Sci, Canberra, ACT 0200, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Australian National University	Garcia-Ruiz, JM (corresponding author), Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Lab Estud Cristalograf, Ave Conocimiento,Parque Tecnol Ciencias Salud, Armilla 18100, Spain.		Hyde, Stephen/F-9248-2010; García-Ruiz, Juan Manuel/U-1085-2019; Garcia-Ruiz, Juan Manuel/C-4389-2015; Hyde, Stephen T/N-2928-2019	Hyde, Stephen/0000-0003-2003-9992; García-Ruiz, Juan Manuel/0000-0002-4743-8718; Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Hyde, Stephen T/0000-0003-2003-9992	Spanish Ministry of Education and Science [MAT2006-11701]; Consolider-Ingenio 2010 project Factoria Espanola de Cristalizacion; Ministerio de Innovacion y Ciencia; Australian Research Council	Spanish Ministry of Education and Science(Spanish Government); Consolider-Ingenio 2010 project Factoria Espanola de Cristalizacion; Ministerio de Innovacion y Ciencia(Spanish Government); Australian Research Council(Australian Research Council)	We are grateful to N. J. Welham (Australian National University, now at the University of Ballarat) for some of the videomicroscopy recordings. This work was supported by the Spanish Ministry of Education and Science (project MAT2006-11701) and is part of the Consolider-Ingenio 2010 project Factoria Espanola de Cristalizacion. E. M.-G. acknowledges financial support from the program Juan de la Cierva (Ministerio de Innovacion y Ciencia). S. T. H. acknowledges the Australian Research Council for a Federation Fellowship.	Andersen C.B., 2018, J GEOSCIENCE ED, V50, P389, DOI [10.5408/1089-9995-50.4.389, DOI 10.5408/1089-9995-50.4.389]; Bittarello E, 2007, EUR J MINERAL, V19, P345, DOI 10.1127/0935-1221/2007/0019-1730; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Colfen H, 2003, CURR OPIN COLLOID IN, V8, P23, DOI 10.1016/S1359-0294(03)00012-8; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 1998, GEOLOGY, V26, P843; GARCIARUIZ JM, 1985, J CRYST GROWTH, V73, P251, DOI 10.1016/0022-0248(85)90301-X; GARCIARUIZ JM, 1981, J CRYST GROWTH, V55, P379, DOI 10.1016/0022-0248(81)90038-5; GOLDENFELD N, 1987, J CRYST GROWTH, V84, P601, DOI 10.1016/0022-0248(87)90051-0; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Grigoriev D. P., 1965, ONTOGENY MINERALS; Hyde ST, 2004, PHYSICA A, V339, P24, DOI 10.1016/j.physa.2004.03.045; Iler R. K, 1979, CHEM SILICA; KEITH HD, 1963, J APPL PHYS, V34, P2409, DOI 10.1063/1.1702757; Li CC, 2002, J AM CERAM SOC, V85, P2977; Lippmann F, 1973, SEDIMENTARY CARBONAT; MALEEV MN, 1972, TSCHERMAKS MINERAL P, V18, P1; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; PHILIPS P., 1993, HDB CRYSTAL GROWTH, V2, P1169; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; Sunagawa I., 2005, CRYSTALS GROWTH MORP; Terada T, 2003, J CRYST GROWTH, V253, P435, DOI 10.1016/S0022-0248(03)01008-X; Thompson D. W., 1917, GROWTH FORM; Voinescu AE, 2007, J CRYST GROWTH, V306, P152, DOI 10.1016/j.jcrysgro.2007.03.060; Westall F, 2008, SPACE SCI REV, V135, P95, DOI 10.1007/s11214-008-9354-z	28	187	193	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					362	365		10.1126/science.1165349	http://dx.doi.org/10.1126/science.1165349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150841				2022-12-28	WOS:000262481400033
J	Sanchez-Garcia, I				Sanchez-Garcia, Isidro			The Crossroads of Oncogenesis and Metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Sanchez-Garcia, Isidro] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sanchez-Garcia, I (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain.		SANCHEZ-GARCIA, ISIDRO/A-5631-2019; 2009, Secribsal/A-1266-2012	SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905				Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2008, NATURE, V454, P794, DOI 10.1038/nature07196	6	43	44	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					297	299		10.1056/NEJMcibr0808031	http://dx.doi.org/10.1056/NEJMcibr0808031			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144947				2022-12-28	WOS:000262434500016
J	Whitman, CT; Wirth, TE; Meselson, M; Nissen, SE; Juma, C; Daley, G				Whitman, Christine Todd; Wirth, Timothy E.; Meselson, Matthew; Nissen, Steven E.; Juma, Calestous; Daley, George			Your inbox, Mr President	NATURE			English	Editorial Material									[Whitman, Christine Todd] US EPA, Washington, DC 20460 USA; [Wirth, Timothy E.] United Nations Fdn, Washington, DC USA; [Meselson, Matthew] Harvard Univ, Harvard Sussex Program, Cambridge, MA 02138 USA; [Nissen, Steven E.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Juma, Calestous] Harvard Univ, John F Kennedy Sch Govt, Sci Technol & Globalizat Project, Cambridge, MA 02138 USA; [Daley, George] Childrens Hosp, Boston, MA 02115 USA	United States Environmental Protection Agency; Harvard University; Cleveland Clinic Foundation; Harvard University; Harvard University; Boston Children's Hospital									0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					258	261		10.1038/457258a	http://dx.doi.org/10.1038/457258a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	394IR	19148081				2022-12-28	WOS:000262440900019
J	Grocott, MPW; Martin, DS; Levett, DZH; McMorrow, R; Windsor, J; Montgomery, HE				Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.		Caudwell Xtreme Everest Res Grp	Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALTITUDE PULMONARY-EDEMA; SIMULATED ALTITUDE; EXTREME ALTITUDE; SUPPLEMENTAL OXYGEN; MT EVEREST; SEA-LEVEL; EXERCISE; EXCHANGE; HUMANS; HYPOXIA	Background The level of environmental hypobaric hypoxia that affects climbers at the summit of Mount Everest ( 8848 m [ 29,029 ft]) is close to the limit of tolerance by humans. We performed direct field measurements of arterial blood gases in climbers breathing ambient air on Mount Everest. Methods We obtained samples of arterial blood from 10 climbers during their ascent to and descent from the summit of Mount Everest. The partial pressures of arterial oxygen ( PaO2) and carbon dioxide ( PaCO2), pH, and hemoglobin and lactate concentrations were measured. The arterial oxygen saturation ( SaO(2)), bicarbonate concentration, base excess, and alveolar - arterial oxygen difference were calculated. Results PaO2 fell with increasing altitude, whereas SaO(2) was relatively stable. The hemoglobin concentration increased such that the oxygen content of arterial blood was maintained at or above sea- level values until the climbers reached an elevation of 7100 m ( 23,294 ft). In four samples taken at 8400 m ( 27,559 ft) - at which altitude the barometric pressure was 272 mm Hg ( 36.3 kPa) - the mean PaO2 in subjects breathing ambient air was 24.6 mm Hg ( 3.28 kPa), with a range of 19.1 to 29.5 mm Hg ( 2.55 to 3.93 kPa). The mean PaCO2 was 13.3 mm Hg ( 1.77 kPa), with a range of 10.3 to 15.7 mm Hg ( 1.37 to 2.09 kPa). At 8400 m, the mean arterial oxygen content was 26% lower than it was at 7100 m ( 145.8 ml per liter as compared with 197.1 ml per liter). The mean calculated alveolar - arterial oxygen difference was 5.4 mm Hg ( 0.72 kPa). Conclusions The elevated alveolar - arterial oxygen difference that is seen in subjects who are in conditions of extreme hypoxia may represent a degree of subclinical high- altitude pulmonary edema or a functional limitation in pulmonary diffusion.	[Grocott, Michael P. W.; Martin, Daniel S.; Levett, Denny Z. H.; McMorrow, Roger; Windsor, Jeremy; Montgomery, Hugh E.] UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, London N19 5LW, England	University of London; University College London	Grocott, MPW (corresponding author), UCL, Inst Human Hlth & Performance, Ctr Altitude Space & Extreme Environm Med, 1st Fl,Charterhouse Bldg,Archway Campus,Highgate, London N19 5LW, England.	mike.grocott@ucl.ac.uk	o'dwyer, michael/D-6561-2012; Levett, Denny/D-2239-2017; Levett, Denny Zelda Hope/AAY-4627-2021; Mythen, Michael G/G-8682-2011; Edwards, Lindsay M/B-3727-2010; Murray, Andrew/B-3130-2010; Cooke, Debbie/D-6605-2011; Levett, Denny/F-4474-2011; Grocott, Michael/C-4394-2008; Martin, Daniel S/F-7997-2010; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Levett, Denny/0000-0002-8418-1675; Levett, Denny Zelda Hope/0000-0002-8418-1675; Murray, Andrew/0000-0002-0929-9315; Levett, Denny/0000-0002-8418-1675; Grocott, Michael/0000-0002-9484-7581; Montgomery, Hugh/0000-0001-8797-5019; Richardson, Alan/0000-0001-8931-2518; O'Dwyer, Michael J/0000-0003-4038-5745; Martin, Daniel/0000-0001-6220-8235	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; Siemens	BOC Medical (now part of Linde Gas Therapeutics); Eli Lilly(Eli Lilly); London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; Fellow of the Association of Anaesthetists of Great Britain and Ireland; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Siemens(Siemens AG)	Supported by Mr. John Caudwell, BOC Medical (now part of Linde Gas Therapeutics), Eli Lilly, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation, and the Sir Halley Stewart Trust. Dr. Martin is a Critical Care Scholar of the London Clinic, and Dr. Levett is a Fellow of the Association of Anaesthetists of Great Britain and Ireland. Some of this work was undertaken at University College London Hospital-University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. Caudwell Xtreme Everest is a research project coordinated by the Centre for Altitude, Space, and Extreme Environment Medicine, University College London. Membership, roles, and responsibilities of the Caudwell Xtreme Everest Research Group can be found at www. caudwell-xtreme-everest.co.uk/team.; Dr. Grocott reports receiving lecture fees from Eli Lilly and BOC Medical and grant support from BOC Medical, Eli Lilly, and Smiths Medical; Dr. Martin, lecture fees from Siemens; and Dr. McMorrow, grant support from Smiths Medical. No other potential conflict of interest relevant to this article was reported.; We thank the staff of Siemens, in particular Robert Mayall and Steve Carey, for their continual support to us in carrying out these measurements; Pasang Tenzing Sherpa for carrying the samples from the Balcony to Camp 2 in less than 2 hours; the Caudwell Xtreme Everest volunteers who trekked to the Everest base camp; and Tom Hornbein, Erik Swenson, Monty Mythen, and Mervyn Singer for their advice during the preparation of the manuscript.	BARTSCH P, 1987, J APPL PHYSIOL, V63, P752, DOI 10.1152/jappl.1987.63.2.752; Catron Thomas F, 2006, BMC Physiol, V6, P3, DOI 10.1186/1472-6793-6-3; CERRETELLI P, 1976, J APPL PHYSIOL, V40, P658, DOI 10.1152/jappl.1976.40.5.658; Cerretelli P, 2003, EUR J APPL PHYSIOL, V90, P431, DOI 10.1007/s00421-003-0928-x; EHRMEYER S, 1997, C25A NCCLS, V12; ERNSTING J, 1988, AVIATION MED, P46; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5921; HAMMOND MD, 1986, J APPL PHYSIOL, V61, P1749, DOI 10.1152/jappl.1986.61.5.1749; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; Huey RB, 2000, JAMA-J AM MED ASSOC, V284, P181, DOI 10.1001/jama.284.2.181-a; HUEY RB, 2000, JAMA-J AM MED ASSOC, V284, P2999; JACKSON RM, 1985, CHEST, V88, P900, DOI 10.1378/chest.88.6.900; KRONENBERG RS, 1971, J CLIN INVEST, V50, P827, DOI 10.1172/JCI106554; Lindholm P, 2006, UNDERSEA HYPERBAR M, V33, P463; Messner R., 1979, EVEREST EXPEDITION U, V1st Edn; Proffitt F, 2005, SCIENCE, V308, P1541, DOI 10.1126/science.308.5728.1541; REEVES JT, 1969, J APPL PHYSIOL, V27, P658, DOI 10.1152/jappl.1969.27.5.658; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Richalet JP, 1999, ADV EXP MED BIOL, V474, P297; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; SCHOENE RB, 1984, J APPL PHYSIOL, V56, P1478, DOI 10.1152/jappl.1984.56.6.1478; SMITH CA, 2001, HIGH ALTITUDE, P139; SUTTON JR, 1988, J APPL PHYSIOL, V64, P1309, DOI 10.1152/jappl.1988.64.4.1309; TORREBUENO JR, 1985, J APPL PHYSIOL, V58, P989, DOI 10.1152/jappl.1985.58.3.989; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; WEST JB, 1983, J APPL PHYSIOL, V55, P678, DOI 10.1152/jappl.1983.55.3.678; WEST JB, 1983, J APPL PHYSIOL, V54, P1188, DOI 10.1152/jappl.1983.54.5.1188; Windsor JS, 2007, AVIAT SPACE ENVIR MD, V78, P426	36	287	301	0	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					140	149		10.1056/NEJMoa0801581	http://dx.doi.org/10.1056/NEJMoa0801581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129527	Green Published			2022-12-28	WOS:000262258300007
J	Taieb, A; Picardo, M				Taieb, Alain; Picardo, Mauro			Vitiligo	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							308-NM EXCIMER-LASER; DOUBLE-BLIND TRIAL; TACROLIMUS OINTMENT; UV-B; GENERALIZED VITILIGO; SEGMENTAL VITILIGO; REPIGMENTATION; THERAPY; PLACEBO; EPIDEMIOLOGY		[Taieb, Alain] Ctr Hosp Univ Bordeaux, Natl Reference Ctr Rare Skin Dis, Dept Dermatol & Pediat Dermatol, Bordeaux, France; [Picardo, Mauro] San Gallicano Dermatol Inst, Rome, Italy	CHU Bordeaux; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Taieb, A (corresponding author), Hop St Andre, Dept Dermatol, 1 Rue Jean Burguet, F-33075 Bordeaux, France.	alain.taieb@chu-bordeaux.fr	TAIEB, ALAIN/AAB-1085-2021; Picardo, Mauro/A-6978-2011	Picardo, Mauro/0000-0003-4899-6639	Pierre Fabre Laboratories; Galderma Laboratories	Pierre Fabre Laboratories; Galderma Laboratories	Drs. Taieb and Picardo are coordinators of the VETF, whose meetings in Paris have been supported by Pierre Fabre Laboratories. Dr. Picardo serves as the president of the European Society for Pigment Cell Research, which received a donation from Galderma Laboratories to organize a workshop on vitiligo at the 2008 International Pigment Cell Conference. No other potential conflict of interest relevant to this article was reported. We thank Dr. Yvon Gauthier for providing an earlier version of Figure 3 and for discussing an earlier draft of the manuscript and Alida de Pase for offering advice on camouflage techniques.	Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Anbar TS, 2006, PHOTODERMATOL PHOTO, V22, P157, DOI 10.1111/j.1600-0781.2006.00222.x; Attili VR, 2008, INT J DERMATOL, V47, P663, DOI 10.1111/j.1365-4632.2008.03672.x; BARONA MI, 1995, J AM ACAD DERMATOL, V33, P621, DOI 10.1016/0190-9622(95)91282-7; BETTERLE C, 1985, DERMATOLOGICA, V171, P419, DOI 10.1159/000249466; Boisseau-Garsaud AM, 2000, INT J DERMATOL, V39, P18, DOI 10.1046/j.1365-4362.2000.00880.x; Boissy RE, 2004, PIGM CELL RES, V17, P208, DOI 10.1111/j.1600-0749.2004.00130.x; Caron-Schreinemachers ALDB, 2005, ACTA DERM-VENEREOL, V85, P24, DOI 10.1080/00015550410022203; Casacci M, 2007, J EUR ACAD DERMATOL, V21, P956, DOI 10.1111/j.1468-3083.2007.02151.x; Chiaverini C, 2002, J EUR ACAD DERMATOL, V16, P137, DOI 10.1046/j.1468-3083.2002.00407.x; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; FALABELLA R, 1988, ARCH DERMATOL, V124, P1649, DOI 10.1001/archderm.124.11.1649; Forschner Tobias, 2007, J Dtsch Dermatol Ges, V5, P467, DOI 10.1111/j.1610-0387.2007.06280.x; Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x; GAUTHIER Y, 1992, J AM ACAD DERMATOL, V26, P191, DOI 10.1016/0190-9622(92)70024-A; Gauthier Y, 1995, EUR J DERMATOL, V5, P704; Gawkrodger DJ, 2008, BRIT J DERMATOL, V159, P1051, DOI 10.1111/j.1365-2133.2008.08881.x; Hamzavi I, 2004, ARCH DERMATOL, V140, P677, DOI 10.1001/archderm.140.6.677; Hann SK, 1996, J AM ACAD DERMATOL, V35, P671, DOI 10.1016/S0190-9622(96)90718-5; Hartmann A, 2008, ACTA DERM-VENEREOL, V88, P474, DOI 10.2340/00015555-0464; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kakourou T, 2005, J AM ACAD DERMATOL, V53, P220, DOI 10.1016/j.jaad.2005.03.032; LAN C, 2008, J EUR ACAD DERM 0623; Lan CCE, 2005, BRIT J DERMATOL, V153, P498, DOI 10.1111/j.1365-2133.2005.06739.x; Lee HS, 1999, J AM ACAD DERMATOL, V40, P21, DOI 10.1016/S0190-9622(99)70524-4; Liu JB, 2005, CLIN EXP DERMATOL, V30, P327, DOI 10.1111/j.1365-2230.2005.01813.x; Mason CP, 2005, CLIN EXP DERMATOL, V30, P344, DOI 10.1111/j.1365-2230.2005.01779.x; Mehrabi D, 2006, ARCH DERMATOL, V142, P927, DOI 10.1001/archderm.142.7.927; Njoo MD, 1998, ARCH DERMATOL, V134, P1532, DOI 10.1001/archderm.134.12.1532; Njoo MD, 2000, J AM ACAD DERMATOL, V42, P760, DOI 10.1067/mjd.2000.103813; Njoo MD, 2000, J AM ACAD DERMATOL, V42, P245, DOI 10.1016/S0190-9622(00)90133-6; Olsson MJ, 1997, ACTA DERM-VENEREOL, V77, P463; Ongenae K, 2005, DERMATOLOGY, V210, P279, DOI 10.1159/000084751; Parsad D, 2004, J AM ACAD DERMATOL, V50, P63, DOI 10.1016/S0190-9622(03)00786-2; Parsad D, 2008, INDIAN J DERMATOL VE, V74, pS37; Passeron T, 2004, ARCH DERMATOL, V140, P1065, DOI 10.1001/archderm.140.9.1065; Radakovic-Fijan S, 2001, J AM ACAD DERMATOL, V44, P814, DOI 10.1067/mjd.2001.113475; Rajatanavin N, 2008, INT J DERMATOL, V47, P402, DOI 10.1111/j.1365-4632.2008.03356.x; Rustin MHA, 2007, BRIT J DERMATOL, V157, P861, DOI 10.1111/j.1365-2133.2007.08177.x; Seiter S, 2000, INT J DERMATOL, V39, P624, DOI 10.1046/j.1365-4362.2000.00006.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; van Geel N, 2004, ARCH DERMATOL, V140, P1203, DOI 10.1001/archderm.140.10.1203; Westerhof W, 1997, ARCH DERMATOL, V133, P1525; WHITTON ME, 2006, COCHRANE DB SYST REV, V1; Yones SS, 2007, ARCH DERMATOL, V143, P578, DOI 10.1001/archderm.143.5.578; Yu HS, 2003, J INVEST DERMATOL, V120, P56, DOI 10.1046/j.1523-1747.2003.12011.x	48	242	255	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					160	U100		10.1056/NEJMcp0804388	http://dx.doi.org/10.1056/NEJMcp0804388			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129529				2022-12-28	WOS:000262258300009
J	Weaver, FM; Follett, K; Stern, M; Hur, K; Harris, C; Marks, WJ; Rothlind, J; Sagher, O; Reda, D; Moy, CS; Pahwa, R; Burchiel, K; Hogarth, P; Lai, EC; Duda, JE; Holloway, K; Samii, A; Horn, S; Bronstein, J; Stoner, G; Heemskerk, J; Huang, GD				Weaver, Frances M.; Follett, Kenneth; Stern, Matthew; Hur, Kwan; Harris, Crystal; Marks, William J., Jr.; Rothlind, Johannes; Sagher, Oren; Reda, Domenic; Moy, Claudia S.; Pahwa, Rajesh; Burchiel, Kim; Hogarth, Penelope; Lai, Eugene C.; Duda, John E.; Holloway, Kathryn; Samii, Ali; Horn, Stacy; Bronstein, Jeff; Stoner, Gatana; Heemskerk, Jill; Huang, Grant D.		CSP 468 Study Grp	Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; SUBTHALAMIC STIMULATION; ADVERSE EVENTS; NUCLEUS; METAANALYSIS; VALIDATION	Context Deep brain stimulation is an accepted treatment for advanced Parkinson disease ( PD), although there are few randomized trials comparing treatments, and most studies exclude older patients. Objective To compare 6- month outcomes for patients with PD who received deep brain stimulation or best medical therapy. Design, Setting, and Patients Randomized controlled trial of patients who received either deep brain stimulation or best medical therapy, stratified by study site and patient age ( < 70 years vs >= 70 years) at 7 Veterans Affairs and 6 university hospitals between May 2002 and October 2005. A total of 255 patients with PD ( Hoehn and Yahr stage >= 2 while not taking medications) were enrolled; 25% were aged 70 years or older. The final 6- month follow- up visit occurred in May 2006. Intervention Bilateral deep brain stimulation of the subthalamic nucleus ( n= 60) or globus pallidus ( n= 61). Patients receiving best medical therapy ( n= 134) were actively managed by movement disorder neurologists. Main Outcome Measures The primary outcome was time spent in the "on" state ( good motor control with unimpeded motor function) without troubling dyskinesia, using motor diaries. Other outcomes included motor function, quality of life, neurocognitive function, and adverse events. Results Patients who received deep brain stimulation gained a mean of 4.6 h/ d of on time without troubling dyskinesia compared with 0 h/ d for patients who received best medical therapy ( between group mean difference, 4.5 h/ d [ 95% CI, 3.7- 5.4 h/ d]; P <. 001). Motor function improved significantly ( P <. 001) with deep brain stimulation vs best medical therapy, such that 71% of deep brain stimulation patients and 32% of best medical therapy patients experienced clinically meaningful motor function improvements ( >= 5 points). Compared with the best medical therapy group, the deep brain stimulation group experienced significant improvements in the summary measure of quality of life and on 7 of 8 PD quality- of- life scores ( P <. 001). Neurocognitive testing revealed small decrements in some areas of information processing for patients receiving deep brain stimulation vs best medical therapy. At least 1 serious adverse event occurred in 49 deep brain stimulation patients and 15 best medical therapy patients ( P <. 001), including 39 adverse events related to the surgical procedure and 1 death secondary to cerebral hemorrhage. Conclusion In this randomized controlled trial of patients with advanced PD, deep brain stimulation was more effective than best medical therapy in improving on time without troubling dyskinesias, motor function, and quality of life at 6 months, but was associated with an increased risk of serious adverse events. Trial Registration clinicaltrials. gov Identifier: NCT00056563.	[Weaver, Frances M.] Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, Hines, IL 60141 USA; [Hur, Kwan; Reda, Domenic] Edward Hines Jr VA Hosp, Cooperat Studies Coordinating Ctr, Hines, IL 60141 USA; [Weaver, Frances M.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Follett, Kenneth] Univ Nebraska, Dept Neurosurg, Omaha, NE 68182 USA; [Stern, Matthew; Duda, John E.; Horn, Stacy] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA; [Stern, Matthew; Duda, John E.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Harris, Crystal] Clin Res Pharm, VA Cooperat Studies Program, Albuquerque, NM USA; [Marks, William J., Jr.; Rothlind, Johannes] San Francisco VA Med Ctr, San Francisco, CA USA; [Marks, William J., Jr.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rothlind, Johannes] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Sagher, Oren] Univ Michigan, Med Ctr, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Moy, Claudia S.; Heemskerk, Jill] NINDS, Rockville, MD USA; [Pahwa, Rajesh] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Burchiel, Kim; Hogarth, Penelope] Portland VA Med Ctr, Portland, OR USA; [Burchiel, Kim] Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; [Hogarth, Penelope] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Lai, Eugene C.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Lai, Eugene C.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Holloway, Kathryn] Richmond VA Med Ctr, Richmond, VA USA; [Holloway, Kathryn] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Samii, Ali] Puget Sound Hlth Care Syst, Seattle, WA USA; [Bronstein, Jeff] W Los Angeles VA Med Ctr, Los Angeles, CA USA; [Stoner, Gatana] Univ Iowa Health Care, Dept Neurosurg, Iowa City, IA USA; [Huang, Grant D.] VA Off Res & Dev, Dept Vet Affairs, Cooperat Studies Program Cent Off, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; University of Nebraska System; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine; Baylor College of Medicine; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Weaver, FM (corresponding author), Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, 5000 S 5th Ave 151H, Hines, IL 60141 USA.	Frances.Weaver@va.gov	Larson, Paul/AAT-9415-2020; Weaver, Frances/S-1540-2019	, Domenic/0000-0003-1831-4270; Holloway, Kathryn/0000-0003-3777-0060	The Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development; National Institute of Neurological Disorders and Stroke; Medtronic Neuromodulation	The Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medtronic Neuromodulation	The Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development, the National Institute of Neurological Disorders and Stroke, and Medtronic Neuromodulation provided financial support for this study.	Alegret M, 2001, ARCH NEUROL-CHICAGO, V58, P1223, DOI 10.1001/archneur.58.8.1223; [Anonymous], 1997, Ann Neurol, V42, P747; Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Burchiel KJ, 1999, NEUROSURGERY, V45, P1375, DOI 10.1097/00006123-199912000-00024; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Fahn S., 1987, RECENT DEV PARKINSON, P153; Follett KA, 2000, ANNU REV MED, V51, P135, DOI 10.1146/annurev.med.51.1.135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 1997, MOVEMENT DISORD, V12, P1039, DOI 10.1002/mds.870120631; Hariz MI, 2008, MOVEMENT DISORD, V23, P416, DOI 10.1002/mds.21888; Hauser RA, 2004, MOVEMENT DISORD, V19, P1409, DOI 10.1002/mds.20248; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Just H, 2002, MOVEMENT DISORD, V17, P539, DOI 10.1002/mds.10111; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Mattis S., 1973, DEMENTIA RATING SCAL; Pahwa R, 2003, J NEUROSURG, V99, P71, DOI 10.3171/jns.2003.99.1.0071; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Rodriguez RL, 2007, NEUROLOGIST, V13, P253, DOI 10.1097/NRL.0b013e318095a4d5; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Schwab R.S., 1969, 3 S PARK DIS, P152; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; SHOULSON I, 1989, ARCH NEUROL-CHICAGO, V46, P1052, DOI 10.1001/archneur.1989.00520460028009; Straits-Troster K, 2000, BRAIN COGNITION, V42, P399, DOI 10.1006/brcg.1999.1112; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5	31	1016	1040	1	102	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					63	73		10.1001/jama.2008.929	http://dx.doi.org/10.1001/jama.2008.929			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126811	Bronze, Green Accepted			2022-12-28	WOS:000262220400021
J	Thornicroft, G; Brohan, E; Rose, D; Sartorius, N; Leese, M				Thornicroft, Graham; Brohan, Etaine; Rose, Diana; Sartorius, Norman; Leese, Morven		INDIGO Study Grp	Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey	LANCET			English	Article							MENTAL-ILLNESS; STIGMA	Background Many people with schizophrenia experience stigma caused by other peoples knowledge, attitudes, and behaviour; this can lead to impoverishment, social marginalisation, and low quality of life. We aimed to describe the nature, direction, and severity of anticipated and experienced discrimination reported by people with schizophrenia. Methods We did a cross-sectional survey in 27 countries, in centres affiliated to the INDIGO Research Network, by use of face-to-face interviews with 732 participants with schizophrenia. Discrimination was measured with the newly validated discrimination and stigma scale (DISC), which produces three subscores: positive experienced discrimination; negative experienced discrimination; and anticipated discrimination. Findings Negative discrimination was experienced by 344 (47%) of 729 participants in making or keeping friends, by 315 (43%) of 728 from family members, by 209 (29%) of 724 in finding a job, 215 (29%) of 730 in keeping a job, and by 196 (27%) of 724 in intimate or sexual relationships. Positive experienced discrimination was rare. Anticipated discrimination affected 469 (64%) in applying for work, training, or education and 402 (55%) looking for a close relationship; 526 (72%) felt the need to conceal their diagnosis. Over a third of participants anticipated discrimination for job seeking and close personal relationships when no discrimination was experienced. Interpretation Rates of both anticipated and experienced discrimination are consistently high across countries among people with mental illness. Measures such as disability discrimination laws might, therefore, not be effective without interventions to improve self-esteem of people with mental illness. Funding South London and Maudsley NHS Foundation Trustees, UK Department of Health SHiFT programme, German Ministry of Education and Research.	[Thornicroft, Graham; Brohan, Etaine; Rose, Diana; Leese, Morven] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London SE5 8AF, England	University of London; King's College London	Thornicroft, G (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Crespigny Park, London SE5 8AF, England.	g.thornicroft@iop.kcl.ac.uk	Brohan, Elaine M/E-4177-2010; Germanavicius, Arunas/A-5084-2017; Rose, Diana S/D-1387-2010; Law, Ann/B-4043-2010; Thornicroft, Graham/B-4027-2010; Leese, Morven N/E-4195-2010; Vargas-Moniz, Maria/AGU-8767-2022; Tansella, Michele/B-4106-2010; Rose, Diana/HGE-8574-2022	Brohan, Elaine M/0000-0001-7400-6884; Germanavicius, Arunas/0000-0002-1226-1449; Rose, Diana S/0000-0002-6393-6389; Thornicroft, Graham/0000-0003-0662-0879; Vargas-Moniz, Maria/0000-0002-4875-9118; Rossler, Wulf/0000-0003-0049-4533	National Institute for Health Research; South London and Maudsley NHS Foundation Trust; NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London	National Institute for Health Research(National Institute for Health Research (NIHR)); South London and Maudsley NHS Foundation Trust; NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London	This study is related to a National Institute for Health Research (NIHR) Applied Programme grant awarded to the South London and Maudsley NHS Foundation Trust (EB, DR, GT), and to the NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust (DR, GT).	Al-Krenawi A, 2004, INT J SOC PSYCHIATR, V50, P102, DOI 10.1177/0020764004040957; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P40, DOI 10.1111/j.1600-0447.1999.tb10693.x; [Anonymous], 2005, SIGMA MENTAL ILLNESS; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P481, DOI 10.1093/oxfordjournals.schbul.a007096; Crocker J., 1998, HDB SOCIAL PSYCHOL, V4th ed, P504, DOI DOI 10.1002/9780470561119; Falk G., 2001, STIGMA WE TREAT OUTS; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Hinshaw Stephen P., 2007, MARK SHAME; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Kadri N, 2004, CAN J PSYCHIAT, V49, P625, DOI 10.1177/070674370404900909; King M, 2007, BRIT J PSYCHIAT, V190, P248, DOI 10.1192/bjp.bp.106.024638; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Link BG, 2004, SCHIZOPHRENIA BULL, V30, P511, DOI 10.1093/oxfordjournals.schbul.a007098; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Littlewood R, 1998, LANCET, V352, P1056, DOI 10.1016/S0140-6736(98)07471-6; Littlewood Roland, 2007, Transcult Psychiatry, V44, P171, DOI 10.1177/1363461507077720; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Peluso ED, 2004, SOC PSYCH PSYCH EPID, V39, P955, DOI 10.1007/s00127-004-0820-y; Peters KF, 2005, CLIN GENET, V68, P6, DOI 10.1111/j.1399-0004.2005.00446.x; Ritsher JB, 2004, PSYCHIAT RES, V129, P257, DOI 10.1016/j.psychres.2004.08.003; Rose D., 2001, USERS VOICES PERSPEC; Rusch N, 2005, PSYCHIAT PRAX, V32, P221, DOI 10.1055/s-2004-834566; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Sartorius N., 2005, REDUCING STIGMA MENT; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Thara R, 2003, INT J SOC PSYCHIATR, V49, P233, DOI 10.1177/00207640030493009; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Thornicroft G, 2007, LANCET, V370, P807, DOI 10.1016/S0140-6736(07)61392-0; Weiss M.G., 2001, ANTHROPOL MED, V8, P71, DOI DOI 10.1080/13648470120063906; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	31	689	701	6	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					408	415		10.1016/S0140-6736(08)61817-6	http://dx.doi.org/10.1016/S0140-6736(08)61817-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19162314	Green Submitted			2022-12-28	WOS:000262912100032
J	Pincock, S				Pincock, Stephen			Profile Christos Karapetis: making a difference with oncology trials	LANCET			English	Biographical-Item												stephen.pincock@journalist.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2105	2105		10.1016/S0140-6736(08)61911-X	http://dx.doi.org/10.1016/S0140-6736(08)61911-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101374				2022-12-28	WOS:000261894000015
J	Mullighan, CG; Su, XP; Zhang, JH; Radtke, I; Phillips, LAA; Miller, CB; Ma, J; Liu, W; Cheng, C; Schulman, BA; Harvey, RC; Chen, I; Clifford, RJ; Carroll, WL; Reaman, G; Bowman, WP; Devidas, M; Gerhard, DS; Yang, WJ; Relling, MV; Shurtleff, SA; Campana, D; Borowitz, MJ; Pui, C; Smith, M; Hunger, SP; Willman, CL; Downing, JR				Mullighan, Charles G.; Su, Xiaoping; Zhang, Jinghui; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Ma, Jing; Liu, Wei; Cheng, Cheng; Schulman, Brenda A.; Harvey, Richard C.; Chen, I-Ming; Clifford, Robert J.; Carroll, William L.; Reaman, Gregory; Bowman, W. Paul; Devidas, Meenakshi; Gerhard, Daniela S.; Yang, Wenjian; Relling, Mary V.; Shurtleff, Sheila A.; Campana, Dario; Borowitz, Michael J.; Pui, Ching-Hon; Smith, Malcolm; Hunger, Stephen P.; Willman, Cheryl L.; Downing, James R.		Childrens Oncology Grp	Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; TOTAL THERAPY; IKAROS GENE; CHILDHOOD; CHILDREN; EXPRESSION; TRANSCRIPTION	Background: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. Methods: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of single-nucleotide-polymorphism microarrays, transcriptional profiling, and resequencing of samples obtained at diagnosis. Children with known very-high-risk ALL subtypes (i.e., BCR-ABL1-positive ALL, hypodiploid ALL, and ALL in infants) were excluded from this cohort. A copy-number abnormality was identified as a predictor of poor outcome, and it was then tested in an independent validation cohort of 258 patients with B-cell-progenitor ALL. Results: More than 50 recurring copy-number abnormalities were identified, most commonly involving genes that encode regulators of B-cell development (in 66.8% of patients in the original cohort); PAX5 was involved in 31.7% and IKZF1 in 28.6% of patients. Using copy-number abnormalities, we identified a predictor of poor outcome that was validated in the independent validation cohort. This predictor was strongly associated with alteration of IKZF1, a gene that encodes the lymphoid transcription factor IKAROS. The gene-expression signature of the group of patients with a poor outcome revealed increased expression of hematopoietic stem-cell genes and reduced expression of B-cell-lineage genes, and it was similar to the signature of BCR-ABL1-positive ALL, another high-risk subtype of ALL with a high frequency of IKZF1 deletion. Conclusions: Genetic alteration of IKZF1 is associated with a very poor outcome in B-cell-progenitor ALL. N Engl J Med 2009;360:470-80.	[Mullighan, Charles G.; Su, Xiaoping; Radtke, Ina; Phillips, Letha A. A.; Miller, Christopher B.; Shurtleff, Sheila A.; Campana, Dario; Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Liu, Wei; Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Yang, Wenjian; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Campana, Dario; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Zhang, Jinghui] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Clifford, Robert J.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; [Smith, Malcolm] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA; [Schulman, Brenda A.] Johns Hopkins Med Inst, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Harvey, Richard C.; Chen, I-Ming; Willman, Cheryl L.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Reaman, Gregory] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Dept Hematol & Oncol, Ft Worth, TX USA; [Devidas, Meenakshi] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Devidas, Meenakshi] Childrens Oncol Grp, Gainesville, FL USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of New Mexico; New York University; Children's National Health System; Cook Children's Medical Center; State University System of Florida; University of Florida; Children's Oncology Group (COG); University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Downing, JR (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl,MS 271, Memphis, TN 38105 USA.	james.downing@stjude.org	Devidas, Meenakshi/H-1170-2019; Zhang, Jing/GWZ-7332-2022; Mullighan, Charles/H-3253-2011; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018; Zhang, Jing/HII-4294-2022; Downing, James R./N-8102-2018	Devidas, Meenakshi/0000-0002-1099-3478; Mullighan, Charles/0000-0002-1871-1850; Pui, Ching-Hon/0000-0003-0303-5658; Harvey, Richard/0000-0002-4904-9767; Clifford, Robert/0000-0001-8888-897X	Children's Oncology Group Chair's Award [CA098543]; Strategic Partnering to Evaluate Cancer Signatures Program [CA114762]; National Cancer Institute; National Institute of General Medical Sciences Pharmacogenetics Research Network and Database [U01 GM61393, U01GM61374]; Cancer Center [21765]; National Institutes of Health [R01 CA86011, N01-C0-12400]; Leukemia and Lymphoma Society Specialized Center of Research [7388-06]; CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NCI; Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE [U10CA098413, ZIHBC010470, R01CA086011, ZIACP010141, U10CA098543, P30CA021765, U01CA157937, U01CA114762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	Children's Oncology Group Chair's Award; Strategic Partnering to Evaluate Cancer Signatures Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences Pharmacogenetics Research Network and Database(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); CureSearch National Childhood Cancer Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australia) C. J. Martin Traveling Fellowship; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Becton Dickinson Biosciences; Xanthus Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by funds provided as a supplement to the Children's Oncology Group Chair's Award (CA098543, to Dr. Hunger); a Strategic Partnering to Evaluate Cancer Signatures Program award (CA114762, to Drs. Carroll, Chen, Harvey, and Willman) from the National Cancer Institute ( NCI); grants from the National Institute of General Medical Sciences Pharmacogenetics Research Network and Database (U01 GM61393 and U01GM61374, to Dr. Relling), a Cancer Center core grant (21765, to Drs. Downing, Mullighan, and Pui), and a grant R01 CA86011, to Dr. Borowitz) from the National Institutes of Health ( NIH); a Leukemia and Lymphoma Society Specialized Center of Research grant (7388-06, to Dr. Willman); a grant from CureSearch National Childhood Cancer Foundation; a National Health and Medical Research Council (Australia) C. J. Martin Traveling Fellowship ( to Dr. Mullighan); and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The sequencing was supported by funds from the NCI and NIH to Agencourt Bioscience under contract N01-C0-12400.; Dr. Cheng reports serving on the advisory board for Enzon Pharmaceuticals; Dr. Borowitz, receiving consulting fees and grant support from Becton Dickinson Biosciences; Dr. Reaman, serving on the advisory board for Enzon Pharmaceuticals; Dr. Willman, receiving grant support from Xanthus Pharmaceuticals; and Drs. Downing and Mullighan, being co-inventors on a pending patent application concerning tests for IKZF1 mutations that was filed by St. Jude Children's Research Hospital, which has not entered into any licenses related to this application. No other potential conflict of interest relevant to this article was reported.; We thank Zhongling Cai and Claire Boltz for technical assistance and Stephen Smale for helpful discussions.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Buhl AM, 2000, IMMUNOL REV, V176, P141; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kishi S, 2003, J CLIN ONCOL, V21, P3084, DOI 10.1200/JCO.2003.07.056; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Mirebeau D, 2006, HAEMATOL-HEMATOL J, V91, P881; Moreno TMC, 2002, LEUKEMIA, V16, P2037, DOI 10.1038/sj.leu.2402697; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2006, ANN HEMATOL, V85, P88; Pui CH, 2000, LEUKEMIA, V14, P2286, DOI 10.1038/sj.leu.2401938; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; Shuster J, 1999, CANC RES THER CONTRO, V9, P101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tonnelle C, 2001, BLOOD, V98, P2673, DOI 10.1182/blood.V98.9.2673; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1	34	951	1006	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2009	360	5					470	480		10.1056/NEJMoa0808253	http://dx.doi.org/10.1056/NEJMoa0808253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399PS	19129520	Green Accepted			2022-12-28	WOS:000262812400006
J	Szidat, S				Szidat, Sonke			ATMOSPHERE Sources of Asian Haze	SCIENCE			English	Editorial Material							CARBONACEOUS AEROSOLS; CLIMATE		[Szidat, Sonke] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Szidat, S (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	szidat@iac.unibe.ch	Szidat, Sönke/D-6706-2011	Szidat, Sönke/0000-0002-1824-6207				Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Bond TC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003697; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Fuzzi S, 2006, ATMOS CHEM PHYS, V6, P2017, DOI 10.5194/acp-6-2017-2006; Gelencser A, 2007, J GEOPHYS RES-ATMOS, V112, DOI DOI 10.1029/2006JD008094; Gustafsson O, 2009, SCIENCE, V323, P495, DOI 10.1126/science.1164857; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Mayol-Bracero OL, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000039; Poschl U, 2005, ANGEW CHEM INT EDIT, V44, P7520, DOI 10.1002/anie.200501122; Ramanathan V, 2003, ATMOS ENVIRON, V37, P4033, DOI 10.1016/S1352-2310(03)00536-3; Szidat S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006590; Szidat S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028325; Viana M, 2008, J AEROSOL SCI, V39, P827, DOI 10.1016/j.jaerosci.2008.05.007	14	53	55	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					470	471		10.1126/science.1169407	http://dx.doi.org/10.1126/science.1169407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164737				2022-12-28	WOS:000262587900030
J	Eggleston, AK				Eggleston, Angela K.			RNA SILENCING	NATURE			English	Editorial Material														Eggleston, Angela/0000-0001-8682-397X					0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					395	395		10.1038/457395a	http://dx.doi.org/10.1038/457395a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158784	Bronze			2022-12-28	WOS:000262519200031
J	Miller, JC; Blake, MA; Boland, GWL				Miller, J. C.; Blake, M. A.; Boland, G. W. L.			Definitive characterisation of adrenal lesions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTRAST-ENHANCED CT; MASSES; INCIDENTALOMA; PREVALENCE; MANAGEMENT; BENIGN		[Miller, J. C.; Blake, M. A.; Boland, G. W. L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Boland, GWL (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	gboland@partners.org	Boland, Giles wl/M-9856-2018					Barzon L, 2003, EUR J ENDOCRINOL, V149, P273, DOI 10.1530/eje.0.1490273; Blake MA, 2006, RADIOLOGY, V238, P970, DOI 10.1148/radiol.2383042164; Blake MA, 2006, RADIOLOGY, V238, P578, DOI 10.1148/radiol.2382041514; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Caoili EM, 2002, RADIOLOGY, V222, P629, DOI 10.1148/radiol.2223010766; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Haider MA, 2004, RADIOLOGY, V231, P711, DOI 10.1148/radiol.2313030676; Harisinghani MG, 2002, CLIN RADIOL, V57, P898, DOI 10.1053/crad.2002.1054; Korobkin M, 1998, AM J ROENTGENOL, V170, P747, DOI 10.2214/ajr.170.3.9490968; Kumar R, 2004, J NUCL MED, V45, P2058; Manser R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004699.pub2; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Mayo-Smith WW, 2001, RADIOGRAPHICS, V21, P995, DOI 10.1148/radiographics.21.4.g01jl21995; Pena CS, 2000, RADIOLOGY, V217, P798, DOI 10.1148/radiology.217.3.r00dc29798; Szolar DH, 2005, RADIOLOGY, V234, P479, DOI 10.1148/radiol.2342031876; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470	16	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2009	338								a3092	10.1136/bmj.a3092	http://dx.doi.org/10.1136/bmj.a3092			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BO	19153128				2022-12-28	WOS:000263197300001
J	Graham, SM; English, M				Graham, Stephen M.; English, Mike			Non-typhoidal salmonellae: a management challenge for children with community-acquired invasive disease in tropical African countries	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; MALAWIAN CHILDREN; SEVERE PNEUMONIA; BACTEREMIA; INFECTIONS; MENINGITIS; RESISTANCE; ETIOLOGY; MALARIA; GAMBIA		[Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia; [Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [English, Mike] Ctr Geog Med Res, Kenya Med Res Inst, Nairobi, Kenya	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Kenya Medical Research Institute	Graham, SM (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Parkville, Vic 3052, Australia.	steve.graham@rch.org.au		Graham, Stephen/0000-0003-3525-2294; English, Michael/0000-0002-7427-0826	Wellcome Trust [076827, 097170, 074124/Z/04/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bahwere P, 2004, PEDIATR INFECT DIS J, V23, P739, DOI 10.1097/01.inf.0000135663.17018.51; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; KABRA SK, 2006, COCHRANE DB SYST REV, V3, P4874; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; World Health Organization, 2005, POCK HOSP CAR CHILDR	23	38	39	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					267	269		10.1016/S0140-6736(09)60073-8	http://dx.doi.org/10.1016/S0140-6736(09)60073-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150705	Green Accepted			2022-12-28	WOS:000262537500029
J	Donskey, CJ; Eckstein, BC				Donskey, Curtis J.; Eckstein, Brittany C.			The Hands Give It Away	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Donskey, Curtis J.; Eckstein, Brittany C.] Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA		Donskey, CJ (corresponding author), Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					E3	E3		10.1056/NEJMicm0707259	http://dx.doi.org/10.1056/NEJMicm0707259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144932				2022-12-28	WOS:000262434500011
J	Tigges, M; Marquez-Lago, TT; Stelling, J; Fussenegger, M				Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin			A tunable synthetic mammalian oscillator	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; CLOCK	Autonomous and self- sustained oscillator circuits mediating the periodic induction of specific target genes are minimal genetic time- keeping devices found in the central and peripheral circadian clocks(1,2). They have attracted significant attention because of their intriguing dynamics and their importance in controlling critical repair(3), metabolic(4) and signalling pathways(5). The precise molecular mechanism and expression dynamics of this mammalian circadian clock are still not fully understood. Here we describe a synthetic mammalian oscillator based on an auto- regulated sense - antisense transcription control circuit encoding a positive and a time- delayed negative feedback loop, enabling autonomous, self- sustained and tunable oscillatory gene expression. After detailed systems design with experimental analyses and mathematical modelling, we monitored oscillating concentrations of green fluorescent protein with tunable frequency and amplitude by time- lapse microscopy in real time in individual Chinese hamster ovary cells. The synthetic mammalian clock may provide an insight into the dynamics of natural periodic processes and foster advances in the design of prosthetic networks in future gene and cell therapies.	[Tigges, Marcel; Marquez-Lago, Tatiana T.; Stelling, Joerg; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; [Marquez-Lago, Tatiana T.; Stelling, Joerg] ETH, Swiss Inst Bioinformat, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	joerg.stelling@bsse.ethz.ch; fussenegger@bsse.ethz.ch	Stelling, Joerg/F-7499-2010	Stelling, Joerg/0000-0002-1145-891X	Swiss National Science Foundation; EC Framework 6 (COBIOS)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 6 (COBIOS)(European Commission)	We thank H. Meyer for providing pcDNA3.1-Ub<SUP>V76</SUP>-GFP; and B. Kramer, M. Gitzinger, D. Greber and W. Weber for conceptual input and/or critical comments on the manuscript. This work was supported by the Swiss National Science Foundation and the EC Framework 6 (COBIOS).	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Chilov D, 2004, BIOTECHNOL BIOENG, V87, P234, DOI 10.1002/bit.20143; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crosthwaite SK, 2004, FEBS LETT, V567, P49, DOI 10.1016/j.febslet.2004.04.073; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P1203, DOI 10.1038/81208; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Fux C, 2001, Nucleic Acids Res, V29, pE19, DOI 10.1093/nar/29.4.e19; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kramer Beat P., 2005, V308, P123; LAHAV G, 2004, SCI STKE, pPE55, DOI DOI 10.1126/STKE.2642004PE55; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Moser S, 2001, J GENE MED, V3, P529, DOI 10.1002/jgm.219; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rossmanith W, 2002, DNA CELL BIOL, V21, P847, DOI 10.1089/104454902320908496; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Wu YH, 2006, FASEB J, V20, P1874, DOI 10.1096/fj.05-4446fje	29	420	448	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					309	312		10.1038/nature07616	http://dx.doi.org/10.1038/nature07616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148099				2022-12-28	WOS:000262440900038
J	Walsh, S; Fan, SL				Walsh, Stephen; Fan, Stanley L.			Visualising rhabdomyolysis	LANCET			English	Editorial Material									[Walsh, Stephen] UCL, Royal Free & Univ Coll Med Sch, Ctr Neprhol, London, England; [Fan, Stanley L.] Barts & London Hosp NHS Trust, Dept Renal Med & Transplantat, London, England	University of London; University College London; Barts Health NHS Trust	Walsh, S (corresponding author), Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	stephen.walsh@ucl.ac.uk	Walsh, Stephen Benedict/AAB-9930-2020; Fan, Stanley/ABA-1363-2020	Fan, Stanley/0000-0002-7323-1489; Walsh, Stephen/0000-0002-8693-1353					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					154	154		10.1016/S0140-6736(09)60039-8	http://dx.doi.org/10.1016/S0140-6736(09)60039-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135612				2022-12-28	WOS:000262340900030
J	Costello, DJ; Eichler, FS; Grant, PE; Auluck, PK; Bianchi, MT				Costello, Daniel J.; Eichler, Florian S.; Grant, P. Ellen; Auluck, Pavan K.; Bianchi, Matthew T.			A Man with Progressive Cognitive Decline Adult cerebral form of X-linked adrenoleukodystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIC LEUKOENCEPHALOPATHY; HALF-TRANSPORTERS; BRAIN; DEMENTIA		[Costello, Daniel J.; Eichler, Florian S.] Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA; [Grant, P. Ellen] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Auluck, Pavan K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Costello, Daniel J.; Eichler, Florian S.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Grant, P. Ellen] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Auluck, Pavan K.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Costello, DJ (corresponding author), Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA.		Grant, Peter/HIR-3733-2022; Auluck, Pavan K/A-1160-2010	Grant, Patricia/0000-0003-1005-4013	Shire Pharmaceuticals	Shire Pharmaceuticals	Dr. Eichler reports receiving lecture fees from Shire Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Barnett MH, 2001, J CLIN NEUROSCI, V8, P165, DOI 10.1054/jocn.2000.0769; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; COKER SB, 1991, NEUROLOGY, V41, P794, DOI 10.1212/WNL.41.6.794; Eichler F, 2007, ARCH NEUROL-CHICAGO, V64, P659, DOI 10.1001/archneur.64.5.659; Filley CM, 2001, NEW ENGL J MED, V345, P425, DOI 10.1056/NEJM200108093450606; Kemp S, 2007, MOL GENET METAB, V90, P268, DOI 10.1016/j.ymgme.2006.10.001; KORNFELD M, 1994, J NEUROPATH EXP NEUR, V53, P389, DOI 10.1097/00005072-199407000-00011; Kriegstein AR, 1999, NEUROLOGY, V53, P1765, DOI 10.1212/WNL.53.8.1765; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; Moser Hugo W, 2006, NeuroRx, V3, P246, DOI 10.1007/BF03207054; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; PROCKOP L, 1979, NEUROLOGY, V29, P862, DOI 10.1212/WNL.29.6.862; Ryan A, 2005, J NEUROL NEUROSUR PS, V76, P1014, DOI 10.1136/jnnp.2004.047134; Schenker S, 1998, Adv Intern Med, V43, P27; SCHLOTE W, 1987, J NEUROL, V235, P1, DOI 10.1007/BF00314189; Simon DK, 1998, J NEUROL NEUROSUR PS, V65, P251, DOI 10.1136/jnnp.65.2.251; Szpak GM, 1996, FOLIA NEUROPATHOL, V34, P92; TAKEDA S, 1989, ACTA NEUROPATHOL, V78, P124, DOI 10.1007/BF00688199; van Geel BM, 2001, ANN NEUROL, V49, P186, DOI 10.1002/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R; Visser I, 2008, ANN NEUROL, V63, P572, DOI 10.1002/ana.21364; WOLTERS EC, 1982, LANCET, V2, P1233	23	5	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					171	U116		10.1056/NEJMcpc0807820	http://dx.doi.org/10.1056/NEJMcpc0807820			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129531				2022-12-28	WOS:000262258300012
J	Eller, AG; Fisher, B				Eller, Alexandra Grosvenor; Fisher, Barbra			Diagnosis of Uterine Rupture on CT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eller, Alexandra Grosvenor; Fisher, Barbra] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Eller, AG (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84132 USA.								0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					170	170		10.1056/NEJMicm075079	http://dx.doi.org/10.1056/NEJMicm075079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129530				2022-12-28	WOS:000262258300010
J	King, CH				King, Charles H.			GLOBAL HEALTH Toward the Elimination of Schistosomiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	Case Western Reserve University	King, CH (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.			King, Charles/0000-0001-8349-9270				[Anonymous], 2006, PREV CHEM HUM HELM C; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; Humphreys M., 2001, MALARIA POVERTY RACE; Jia TW, 2007, B WORLD HEALTH ORGAN, V85, P458, DOI 10.2471/BLT.06.033035; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407	5	109	119	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					106	109		10.1056/NEJMp0808041	http://dx.doi.org/10.1056/NEJMp0808041			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391UG	19129524				2022-12-28	WOS:000262258300003
J	Yu, DS; Lee, YB				Yu, Dong-Soo; Lee, Young-Bok			Medication-Induced Gingival Hypertrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yu, Dong-Soo; Lee, Young-Bok] Uijeongbu St Marys Hosp, Uijongbu, South Korea		Yu, DS (corresponding author), Uijeongbu St Marys Hosp, Uijongbu, South Korea.	lyb80@catholic.ac.kr	LEE, YOUNG BOK/AAZ-6426-2021	Lee, Young Bok/0000-0002-8642-2479					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					E2	E2		10.1056/NEJMicm075343	http://dx.doi.org/10.1056/NEJMicm075343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129521				2022-12-28	WOS:000262258300011
J	Shalm, LK; Adamson, RBA; Steinberg, AM				Shalm, L. K.; Adamson, R. B. A.; Steinberg, A. M.			Squeezing and over-squeezing of triphotons	NATURE			English	Article							QUANTUM LIMIT; STATE; SEPARABILITY	Quantum mechanics places a fundamental limit on the accuracy of measurements. In most circumstances, the measurement uncertainty is distributed equally between pairs of complementary properties; this leads to the 'standard quantumlimit' for measurement resolution. Using a technique known as 'squeezing', it is possible to reduce the uncertainty of one desired property below the standard quantumlimit at the expense of increasing that of the complementary one. Squeezing is already being used to enhance the sensitivity of gravity- wave detectors(1) and may play a critical role in other high precision applications, such as atomic clocks(2) and optical communications(3). Spin squeezing ( the squeezing of angular momentum variables) is a powerful tool, particularly in the context of quantum light - matter interfaces(4-9). Although impressive gains in squeezing have been made, optical spin- squeezed systems are still many orders of magnitude away from the maximum possible squeezing, known as the Heisenberg uncertainty limit. Here we demonstrate how an optical system can be squeezed essentially all the way to this fundamental bound. Weconstruct spin- squeezed states by overlapping three indistinguishable photons in an optical fibre and manipulating their polarization ( spin), resulting in the formation of a squeezed composite particle known as a 'triphoton'. The symmetry properties of polarization imply that the measured triphoton states can be most naturally represented by quasi- probability distributions on the surface of a sphere. In this work we show that the spherical topology of polarization imposes a limit on how much squeezing can occur, leading to the quasi- probability distributions wrapping around the sphere - a phenomenon we term 'oversqueezing'. Our observations of spin- squeezing in the few- photon regime could lead to new quantum resources for enhanced measurement, lithography and information processing that can be precisely engineered photon- by- photon.	[Shalm, L. K.; Adamson, R. B. A.; Steinberg, A. M.] Univ Toronto, Dept Phys, Inst Opt Sci, Ctr Comp Informat & Quantum Control, Toronto, ON M5S 1A7, Canada	University of Toronto	Shalm, LK (corresponding author), Univ Toronto, Dept Phys, Inst Opt Sci, Ctr Comp Informat & Quantum Control, 60 St George St, Toronto, ON M5S 1A7, Canada.	lshalm@physics.utoronto.ca	Steinberg, Aephraim M/C-3226-2008; Shalm, Lynden/AAC-2274-2020	Steinberg, Aephraim M/0000-0002-7737-8971; 	Natural Sciences and Engineering Research Council of Canada; Ontario Centres of Excellence; Canadian Institute for Photonic Innovations; Quantum Works; Canadian Institute for Advanced Research.	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Centres of Excellence; Canadian Institute for Photonic Innovations; Quantum Works; Canadian Institute for Advanced Research.(Canadian Institute for Advanced Research (CIFAR))	We thank S. Ghose and P. Jessen for discussions. This work was supported by the Natural Sciences and Engineering Research Council of Canada, Ontario Centres of Excellence, Canadian Institute for Photonic Innovations, Quantum Works, and the Canadian Institute for Advanced Research.	Adamson RBA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043601; Adamson RBA, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033832; AGARWAL GS, 1981, PHYS REV A, V24, P2889, DOI 10.1103/PhysRevA.24.2889; ARECCHI FT, 1972, PHYS REV A, V6, P2211, DOI 10.1103/PhysRevA.6.2211; Bowen WP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.093601; Chaudhury S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163002; DOWLING JP, 1994, PHYS REV A, V49, P4101, DOI 10.1103/PhysRevA.49.4101; Dowling JP, 1998, PHYS REV A, V57, P4736, DOI 10.1103/PhysRevA.57.4736; Durkin GA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070801; Fiurasek J, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.053818; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Ghose S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042318; Goda K, 2008, NAT PHYS, V4, P472, DOI 10.1038/nphys920; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Heersink J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013815; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Lee H, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.030101; Luis A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.053801; Luis A, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063806; Marquardt C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220401; Miranowicz A, 2004, J OPT B-QUANTUM S O, V6, P542, DOI 10.1088/1464-4266/6/12/009; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Ou ZY, 1997, PHYS REV A, V55, P2598, DOI 10.1103/PhysRevA.55.2598; Peres A, 1996, PHYS REV LETT, V77, P1413, DOI 10.1103/PhysRevLett.77.1413; Resch KJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.223601; STRATONOVICH RL, 1956, DOKL AKAD NAUK SSSR+, V109, P72; Takeuchi S, 2001, OPT LETT, V26, P843, DOI 10.1364/OL.26.000843; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	30	36	36	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					67	70		10.1038/nature07624	http://dx.doi.org/10.1038/nature07624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122637				2022-12-28	WOS:000262104900031
J	Trowell, J				Trowell, Joan			Students whose behaviour causes concern: The GMC's view	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Trowell, Joan] Gen Med Council, London NW1 3JN, England		Trowell, J (corresponding author), Gen Med Council, London NW1 3JN, England.	jtrowell@gmc-uk.org						*GEN MED COUNC, 2003, TOM DOCT; *GEN MED COUNC MED, 2007, MED STUD PROF BEH FI; General Medical Council, 2006, GOOD MED PRACT	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 29	2008	337								a2876	10.1136/bmj.a2876	http://dx.doi.org/10.1136/bmj.a2876			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401MV	19114452				2022-12-28	WOS:000262945900005
J	Scrima, A; Konickova, R; Czyzewski, BK; Kawasaki, Y; Jeffrey, PD; Groisman, R; Nakatani, Y; Iwai, S; Pavletich, NP; Thoma, NH				Scrima, Andrea; Konickova, Renata; Czyzewski, Bryan K.; Kawasaki, Yusuke; Jeffrey, Philip D.; Groisman, Regina; Nakatani, Yoshihiro; Iwai, Shigenori; Pavletich, Nikola P.; Thomae, Nicolas H.			Structural Basis of UV DNA-Damage Recognition by the DDB1-DDB2 Complex	CELL			English	Article							PIGMENTOSUM GROUP-E; GROUP-E CELLS; XERODERMA-PIGMENTOSUM; UBIQUITIN LIGASE; BINDING-PROTEIN; PYRIMIDINE DIMERS; DIFFRACTION DATA; REPAIR; DDB2; P48	Ultraviolet (UV) light-induced pyrimidine photodimers are repaired by the nucleotide excision repair pathway. Photolesions have biophysical parameters closely resembling undamaged DNA, impeding discovery through damage surveillance proteins. The DDB1-DDB2 complex serves in the initial detection of UV lesions in vivo. Here we present the structures of the DDB1-DDB2 complex alone and bound to DNA containing either a 6-4 pyrimidine-pyrimidone photodimer (6-4PP) lesion or an abasic site. The structure shows that the lesion is held exclusively by the WD40 domain of DDB2. A DDB2 hairpin inserts into the minor groove, extrudes the photodimer into a binding pocket, and kinks the duplex by similar to 40 degrees. The tightly localized probing of the photolesions, combined with proofreading in the photodimer pocket, enables DDB2 to detect lesions refractory to detection by other damage surveillance proteins. The structure provides insights into damage recognition in chromatin and suggests a mechanism by which the DDB1-associated CUL4 ubiquitin ligase targets proteins surrounding the site of damage.	[Czyzewski, Bryan K.; Jeffrey, Philip D.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Scrima, Andrea; Konickova, Renata; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kawasaki, Yusuke; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan; [Groisman, Regina] Univ Paris Sud, Inst Andre Lwoff, CNRS, FRE 2944, F-94801 Villejuif, France; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Friedrich Miescher Institute for Biomedical Research; Osaka University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA.	pavletin@mskcc.org; nicolas.thoma@fmi.ch		Groisman, Sonia/0000-0003-1153-3841; Jeffrey, Philip/0000-0002-4351-5341; Groisman, Regina/0000-0003-3990-7622	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP); Swiss National Fond [31-120205]; Novartis Research Foundation; European Molecular Biology Organization (EMBO)	Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland; Human Frontier Science Program (HFSP)(Human Frontier Science Program); Swiss National Fond(Swiss National Science Foundation (SNSF)); Novartis Research Foundation; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	We thank Norman Kairies for crystallographic support. We would like to thank Fritz Thoma, Hanspeter Naegeli, and Susan Gasser for discussions relating to DNA repair in the context of chromatin. We thank Hans Widmer for help and support. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. Y.N. and S.I. acknowledge funding from the Human Frontier Science Program (HFSP). Funding in the laboratory of N.H.T. is provided by the Swiss National Fond (SNF;#31-120205) and the Novartis Research Foundation. A. S. gratefully acknowledges funding from the European Molecular Biology Organization (EMBO).	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barsky D, 2000, NUCLEIC ACIDS RES, V28, P2613, DOI 10.1093/nar/28.13.2613; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Davey CA, 2002, P NATL ACAD SCI USA, V99, P11169, DOI 10.1073/pnas.172271399; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELDBERG RS, 1976, BIOCHEMISTRY-US, V15, P2402, DOI 10.1021/bi00656a024; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fugmann SD, 2001, MOL CELL, V8, P899, DOI 10.1016/S1097-2765(01)00352-5; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Iwai S, 1996, J AM CHEM SOC, V118, P7642, DOI 10.1021/ja9603158; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; Maillard O, 2007, TRENDS BIOCHEM SCI, V32, P494, DOI 10.1016/j.tibs.2007.08.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; O'Neil LL, 2007, J PHYS CHEM B, V111, P11843, DOI 10.1021/jp074043e; Otrin VR, 1998, MOL CELL BIOL, V18, P3182, DOI 10.1128/MCB.18.6.3182; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wittschieben BO, 2003, DNA REPAIR, V2, P1065, DOI 10.1016/S1568-7864(03)00113-7; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yasuda G, 2007, MOL CELL BIOL, V27, P6606, DOI 10.1128/MCB.02166-06; Yasuda T, 2005, DNA REPAIR, V4, P389, DOI 10.1016/j.dnarep.2004.10.008	59	294	302	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1213	1223		10.1016/j.cell.2008.10.045	http://dx.doi.org/10.1016/j.cell.2008.10.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109893	Bronze, Green Accepted			2022-12-28	WOS:000261989800013
J	Kelly, BT; McCoy, AJ; Spate, K; Miller, SE; Evans, PR; Honing, S; Owen, DJ				Kelly, Bernard T.; McCoy, Airlie J.; Spaete, Kira; Miller, Sharon E.; Evans, Philip R.; Hoening, Stefan; Owen, David J.			A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex	NATURE			English	Article							SORTING-SIGNAL RECOGNITION; CLATHRIN-COATED VESICLES; DI-LEUCINE MOTIF; ADAPTER; PHOSPHORYLATION; SUBUNIT; PROTEIN; CLUSTER; SOFTWARE; RECEPTOR	Most transmembrane proteins are selected as transport- vesicle cargo through the recognition of short, linear amino- acid motifs in their cytoplasmic portions by vesicle coat proteins. For clathrin-coated vesicles, the motifs are recognized by clathrin adaptors. The AP2 adaptor complex (subunits alpha, beta 2, mu 2 and sigma 2) recognizes both major endocytic motifs: Yxx Phi motifs(1) ( where Phi can be F, I, L, Mor V) and [ED] xxxL[ LI] acidic dileucine motifs. Here we describe the binding of AP2 to the endocytic dileucine motif from CD4 ( ref. 2). The major recognition events are the two leucine residues binding in hydrophobic pockets on sigma 2. The hydrophilic residue four residues upstream from the first leucine sits on a positively charged patch made from residues on the sigma 2 and a subunits. Mutations in key residues inhibit the binding of AP2 to 'acidic dileucine' motifs displayed in liposomes containing phosphatidylinositol-4,5-bisphosphate,but do not affect binding to Yxx Phi motifs through mu 2. In the 'inactive' AP2 core structure(3) both motif- binding sites are blocked by different parts of the beta 2 subunit. To allow a dileucine motif to bind, the beta 2 amino terminus is displaced and becomes disordered; however, in this structure the Yxx Phi-binding site on mu 2 remains blocked.	[Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kelly, Bernard T.; McCoy, Airlie J.; Miller, Sharon E.; Owen, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Spaete, Kira; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cologne; University of Cologne; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk			Wellcome Trust Senior Research Fellowship; Deutsche Forschungsgemeinschaft [SFB635, SFB670]; MRC [MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105178845] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the protein crystallography beamline staff at Diamond, especially E. Duke, K. McAuley and R. Flaig, for their support and assistance. D.J. O., B.T.K. and S.E.M. are funded by a Wellcome Trust Senior Research Fellowship to D.J.O.S.H. and K.S. are supported by grants from the Deutsche Forschungsgemeinschaft (SFB635 and SFB670).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; DORAY B, IDENTIFICAT IN PRESS; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a	27	224	231	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2008	456	7224					976	U81		10.1038/nature07422	http://dx.doi.org/10.1038/nature07422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	19140243	Green Accepted, Green Submitted			2022-12-28	WOS:000261768300051
J	Das, P; Samarasekera, U				Das, Pam; Samarasekera, Udani			What next for UNAIDS?	LANCET			English	News Item																			0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2099	2102		10.1016/S0140-6736(08)61908-X	http://dx.doi.org/10.1016/S0140-6736(08)61908-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19112650	Bronze			2022-12-28	WOS:000261894000012
J	Collet, JP; Hulot, JS; Pena, A; Villard, E; Esteve, JB; Silvain, J; Payot, L; Brugier, D; Cayla, G; Beygui, F; Bensimon, G; Funck-Brentano, C; Montalescot, G				Collet, Jean-Philippe; Hulot, Jean-Sebastien; Pena, Anna; Villard, Eric; Esteve, Jean-Baptiste; Silvain, Johanne; Payot, Laurent; Brugier, Delphine; Cayla, Guillaume; Beygui, Farzin; Bensimon, Gilbert; Funck-Brentano, Christian; Montalescot, Gilles			Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; PLATELET ADP RECEPTOR; ANTIPLATELET THERAPY; RESPONSE VARIABILITY; DIABETES-MELLITUS; ACTIVE METABOLITE; LONG-TERM; REACTIVITY; CYP2C19	Background Clopidogrel and low-dose aspirin have become the mainstay oral antiplatelet regimen to prevent recurrent ischaemic events after acute coronary syndromes or stent placement. The frequent genetic functional variant 681. G>A (*2) of cytochrome P450 209 (CYP2C19) is an important contributor to the wide variability between individuals of the antiplatelet effect of clopidogrel. We assessed whether the CYP2C19*2 polymorphism affected long-term prognosis of patients who were chronically treated with clopidogrel. Methods Between April 1, 1996, and April 1, 2008, 259 young patients (aged <45 years) who survived a first myocardial infarction and were exposed to clopidogrel treatment for at least a month, were enrolled in a multicentre registry and underwent CYP2C19*2 determination. The primary endpoint was a composite of death, myocardial infarction, and urgent coronary revascularisation occurring during exposure to clopidogrel. Follow-up was every 6 months. The key secondary endpoint was stent thrombosis proven by angiography. Findings Median clopidogrel exposure time was 1. 07 years (IQR 0 . 28-3 . 0). Baseline characteristics were balanced between carriers (heterozygous *1/*2, n=64; homozygous *2/*2, n=9) and non-carriers (n=186) of CYP2C19*2 variant. The primary endpoint occurred more frequently in carriers than in non-carriers (15 vs 11 events; hazard ratio [HR] 3.69 [95% Cl 1.69-8.05], p=0-0005), as did stent thrombosis (eight vs four events; HR 6.02 [1.81-20.04], p=0.0009). The detrimental effect of the CYP2C19*2 genetic variant persisted from 6 months after clopidogrel initiation tip to the end of follow-up (HR 3.00 [1.27-7.10], p=0.009). After multivariable analysis, the CYP2C19*2 genetic variant was the only independent predictor of cardiovascular events (HR 4.04 [1.81-9.02], p=0.0006). Interpretation The CYP2C19*2 genetic variant is a major determinant of prognosis in young patients who are receiving clopidogrel treatment after myocardial infarction. Funding Delegation A la Recherche Clinique, Assistance Publique-Hopitaux de Paris.	[Collet, Jean-Philippe; Pena, Anna; Esteve, Jean-Baptiste; Silvain, Johanne; Brugier, Delphine; Cayla, Guillaume; Beygui, Farzin; Montalescot, Gilles] Univ Paris 06, Inst Cardiol, INSERM 856, Hop La Pitie Salpetriere, Paris, France; [Hulot, Jean-Sebastien; Villard, Eric; Bensimon, Gilbert; Funck-Brentano, Christian] Hop La Pitie Salpetriere AP HP, Serv Pharmacol, Unite Pharmacogenet, INSERM 621, Paris, France; [Payot, Laurent] Hop Intercommunal Montreuil, Serv Cardiol, Montreuil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Montalescot, G (corresponding author), Hop La Pitie Salpetriere, Inst Cardiol, Bur 236, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Villard, Eric/AAI-2464-2021; villard, eric/AAH-2868-2021; Hulot, Jean-Sébastien/A-2278-2016; Funck-Brentano, Christian/V-4753-2019; Funck-Brentano, Christian/C-2126-2009; SILVAIN, Johanne/C-7521-2016	Villard, Eric/0000-0001-9801-7297; Hulot, Jean-Sébastien/0000-0001-5463-6117; Funck-Brentano, Christian/0000-0003-0406-5189; Funck-Brentano, Christian/0000-0003-0406-5189; SILVAIN, Johanne/0000-0002-1901-2808	Delegation la Recherche Clinique, Assistance Publique-Hopitaux de Paris;  [CRC 97109]	Delegation la Recherche Clinique, Assistance Publique-Hopitaux de Paris; 	This study was sponsored and funded by the Delegation la Recherche Clinique, Assistance Publique-Hopitaux de Paris (CRC #97109).	Andersson T, 2005, CLIN PHARMACOL THER, V78, P559, DOI 10.1016/j.clpt.2005.08.013; Angiolillo DJ, 2004, EUR HEART J, V25, P1903, DOI 10.1016/j.ehj.2004.07.036; Angiolillo DJ, 2008, THROMB HAEMOSTASIS, V99, P161, DOI 10.1160/TH07-09-0562; Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Bertrand-Thiebault C, 2008, ANN HUM GENET, V72, P178, DOI 10.1111/j.1469-1809.2007.00417.x; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Franco E, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-27; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Furuta T, 2001, CLIN PHARMACOL THER, V70, P484, DOI 10.1067/mcp.2001.119721; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; HARNSTEN A, 1985, NEW ENGL J MED, V313, P1557; Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Lotrionte M, 2007, AM J CARDIOL, V100, P1199, DOI 10.1016/j.amjcard.2007.05.048; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Rehmel JLF, 2006, DRUG METAB DISPOS, V34, P600, DOI 10.1124/dmd.105.007989; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Savi P, 2001, BIOCHEM BIOPH RES CO, V283, P379, DOI 10.1006/bbrc.2001.4816; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	43	725	777	3	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2009	373	9660					309	317		10.1016/S0140-6736(08)61845-0	http://dx.doi.org/10.1016/S0140-6736(08)61845-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19108880				2022-12-28	WOS:000262728100026
J	Beau-Salinas, F; Guitteny, MA; Donadieu, J; Jonville-Bera, AP; Autret-Leca, E				Beau-Salinas, F.; Guitteny, M. A.; Donadieu, J.; Jonville-Bera, A. P.; Autret-Leca, E.			High doses of deferiprone may be associated with cerebellar syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Beau-Salinas, F.; Jonville-Bera, A. P.] Bretonneau Hosp, CHRU Tours, Reg Ctr Pharmacovigilance, Dept Pharmacol, F-37044 Tours 9, France; [Guitteny, M. A.] Port Madeleine Hosp, CHR Orleans, Dept Pediat, F-45032 Orleans 1, France; [Donadieu, J.] Armand Trousseau Childrens Hosp, Dept Pediat Hematol & Oncol, F-75571 Paris 12, France; [Autret-Leca, E.] Univ Tours, Bretonneau Hosp, CHRU Tours, Reg Ctr Pharmacovigilance, F-37044 Tours, France	CHU Tours; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; Universite de Tours	Beau-Salinas, F (corresponding author), Bretonneau Hosp, CHRU Tours, Reg Ctr Pharmacovigilance, Dept Pharmacol, F-37044 Tours 9, France.	f.beau-salinas@chu-tours.fr						Balfour JAB, 1999, DRUGS, V58, P553, DOI 10.2165/00003495-199958030-00021; Fredenburg AM, 1996, TOXICOLOGY, V108, P191, DOI 10.1016/0300-483X(95)03301-U; Marciani MG, 1996, AM J HEMATOL, V51, P179, DOI 10.1002/(SICI)1096-8652(199602)51:2<179::AID-AJH23>3.0.CO;2-C	3	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2009	338								a2319	10.1136/bmj.a2319	http://dx.doi.org/10.1136/bmj.a2319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BS	19164394				2022-12-28	WOS:000263197700004
J	Cooper, C; Selwood, A; Blanchard, M; Walker, Z; Blizard, R; Livingston, G				Cooper, Claudia; Selwood, Amber; Blanchard, Martin; Walker, Zuzana; Blizard, Robert; Livingston, Gill			Abuse of people with dementia by family carers: representative cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							ELDER ABUSE; LASER-AD; PREVALENCE	Objective To determine the prevalence of abusive behaviours by family carers of people with dementia. Design Representative cross sectional survey Setting Community mental health teams in Essex and London. Participants 220 family carers of people newly referred to secondary psychiatric services with dementia who were living at home. Main outcome measure Psychological and physical abuse ( revised modified conflict tactics scale). Results 115 ( 52%, 95% confidence interval 46% to 59%) carers reported some abusive behaviour and 74 ( 34%, 27% to 40%) reported important levels of abuse. Verbal abuse was most commonly reported. Only three ( 1.4%) carers reported occasional physical abuse. Conclusions Abusive behaviour by family carers towards people with dementia is common, with a third reporting important levels of abuse and half some abusive behaviour. We found few cases of physical or frequent abuse, although those with the most abusive behaviour may have been reluctant to report it.	[Cooper, Claudia; Selwood, Amber; Blanchard, Martin; Walker, Zuzana; Blizard, Robert; Livingston, Gill] UCL, Dept Mental Hlth Sci, London W1W 7EJ, England	University of London; University College London	Cooper, C (corresponding author), UCL, Dept Mental Hlth Sci, London W1W 7EJ, England.	c.cooper@medsch.ucl.ac.uk	Cooper, Claudia A/C-1556-2008; Walker, Zuzana/B-8339-2009; Livingston, G/C-7081-2008	Cooper, Claudia A/0000-0002-2777-7616; Walker, Zuzana/0000-0001-7346-8200; Livingston, Gill/0000-0001-6741-5516	Medical Research Council; Medical Research Council [G0501866] Funding Source: researchfish; MRC [G0501866] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a research training fellowship awarded to CC by the Medical Research Council. The authors' work was carried out independently of the funders.	*ADM AG, 2008, ELD RIGHTS RES ELD A; [Anonymous], 2004, ELD AB; Beach SR, 2005, J AM GERIATR SOC, V53, P255, DOI 10.1111/j.1532-5415.2005.53111.x; Cooper C, 2008, INT J GERIATR PSYCH, V23, P283, DOI 10.1002/gps.1875; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; *CREAT RES SYST, 2008, SAMPL SIZ CALC; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; *DEP HLTH, 2008, CONS REV NO SECR GUI; FRATIGLIONI L, 1998, HLTH EC DEMENTIA, P13; Goode S. D., 2006, SPLENDOR LITTLE GIRL; Harris SB, 1996, J ELDER ABUSE NEGL, V8, P1, DOI 10.1300/J084v08n01_01; Oswald RA, 2004, J ELDER ABUSE NEGL, V16, P75, DOI 10.1300/J084v16n02_06; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Williamson GM, 2001, PSYCHOL AGING, V16, P217, DOI 10.1037//0882-7974.16.2.217	14	94	94	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 22	2009	338								b155	10.1136/bmj.b155	http://dx.doi.org/10.1136/bmj.b155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405BS	19164392	hybrid, Green Published			2022-12-28	WOS:000263197700001
J	Eckman, MH; Rosand, J; Greenberg, SM; Gage, BF				Eckman, Mark H.; Rosand, Jonathan; Greenberg, Steven M.; Gage, Brian F.			Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation	ANNALS OF INTERNAL MEDICINE			English	Article							ORAL ANTICOAGULANT TREATMENT; QUALITY-OF-LIFE; BLEEDING COMPLICATIONS; ORTHOPEDIC PATIENTS; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; ANTITHROMBOTIC THERAPY; CYTOCHROME-P450 CYP2C9; DECISION-ANALYSIS	Background: Variants in genes involved in warfarin metabolism and sensitivity affect individual warfarin requirements and the risk for bleeding. Testing for these variant alleles might allow more personalized dosing of warfarin during the induction phase. In 2007, the U. S. Food and Drug Administration changed the labeling for warfarin (Coumadin, Bristol-Myers Squibb, Princeton, New Jersey), suggesting that clinicians consider genetic testing before initiating therapy. Objective: To examine the cost-effectiveness of genotype-guided dosing versus standard induction of warfarin therapy for patients with nonvalvular atrial fibrillation. Design: Markov state transition decision model. Data Sources: MEDLINE searches and bibliographies from relevant articles of literature published in English. Target Population: Outpatients or inpatients requiring initiation of warfarin therapy. The base case was a man age 69 years with newly diagnosed nonvalvular atrial fibrillation and no contraindications to warfarin therapy. Time Horizon: Lifetime. Perspective: Societal. Intervention: Genotype-guided dosing consisting of genotyping for CYP2C9*2, CYP2C9*3, and/or VKORC1 versus standard warfarin induction. Outcome Measures: Effectiveness was measured in quality-adjusted life-years (QALYs), and costs were in 2007 U. S. dollars. Results: In the base case, genotype-guided dosing resulted in better outcomes, but at a relatively high cost. Overall, the marginal cost-effectiveness of testing exceeded $170 000 per QALY. On the basis of current data and cost of testing (about $ 400), there is only a 10% chance that genotype-guided dosing is likely to be cost-effective (that is, <$50 000 per QALY). Sensitivity analyses revealed that for genetic testing to cost less than $ 50 000 per QALY, it would have to be restricted to patients at high risk for hemorrhage or meet the following optimistic criteria: prevent greater than 32% of major bleeding events, be available within 24 hours, and cost less than $200. Limitation: Few published studies describe the effect of genotype-guided dosing on major bleeding events, and although these studies show a trend toward decreased bleeding, the results are not statistically significant. Conclusion: Warfarin-related genotyping is unlikely to be cost-effective for typical patients with nonvalvular atrial fibrillation, but may be cost-effective in patients at high risk for hemorrhage who are starting warfarin therapy.	[Eckman, Mark H.] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Washington Univ, St Louis, MO USA	University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Eckman, MH (corresponding author), Univ Cincinnati, Med Ctr, POB 670535, Cincinnati, OH 45267 USA.	mark.eckman@uc.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Gage, Brian/0000-0002-4727-8742; Eckman, Mark/0000-0001-8253-269X	The National Institute of Diabetes and Digestive and Kidney Diseases;; National Heart, Lung, and Blood Institute;; Foundation for Informed Medical Decision Making; National Institutes of Neurological Disorders and Stroke; Deane Institute for Integrative Study of Atrial Fibrillation and Stroke; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS042695] Funding Source: NIH RePORTER	The National Institute of Diabetes and Digestive and Kidney Diseases;(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute;; Foundation for Informed Medical Decision Making; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deane Institute for Integrative Study of Atrial Fibrillation and Stroke; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Foundation for Informed Medical Decision Making; National Institutes of Neurological Disorders and Stroke; Deane Institute for Integrative Study of Atrial Fibrillation and Stroke; and American Heart Association.	Adcock DM, 2004, ARCH PATHOL LAB MED, V128, P1360; *AEI REG MARK ORG, HLTH CAR SAV PERS ME; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; [Anonymous], 1997, Arch Intern Med, V157, P1237; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; Chen Q, 2000, INQUIRY-J HEALTH CAR, V37, P359; *CIGN HEALTHC, CIGN HEALTHC COV POS; CRITCHFIELD GC, 1986, COMPUT BIOMED RES, V19, P254, DOI 10.1016/0010-4809(86)90020-0; *CTR MED MED SERV, 2007, PHYS FEE SCHED; *CTR MED MED SERV, 2007, INP REH FAC PPS TOT; *CTR MED MED SERV, 2007, AC INP PPS AOR FY07; *CTR MED MED SERV, 2007, AC INP PPS TABL 5 DR; Detsky AS, 1997, MED DECIS MAKING, V17, P123, DOI 10.1177/0272989X9701700201; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; *DRUGST COM, WARF SOD COUM 5MG TA; Fang MC, 2006, J AM GERIATR SOC, V54, P1231, DOI 10.1111/j.1532-5415.2006.00828.x; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage Brian F, 2006, Hematology Am Soc Hematol Educ Program, P467; Gold MR, 1996, COST EFFECTIVENESS H; Grice GR, 2008, J THROMB HAEMOST, V6, P207; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Kamali F, 2006, BRIT J CLIN PHARMACO, V61, P746, DOI 10.1111/j.1365-2125.2006.02679.x; King CR, 2008, AM J CLIN PATHOL, V129, P876, DOI 10.1309/1E34UAPR06PJ6HML; Krynetskiy E, 2007, J PHARMACOL EXP THER, V322, P427, DOI 10.1124/jpet.106.117952; LAI SM, 1995, STROKE, V26, P2011, DOI 10.1161/01.STR.26.11.2011; LAU J, 1983, MED DECIS MAKING, V3, P39, DOI 10.1177/0272989X8300300110; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Lenzini PA, 2008, J THROMB HAEMOST, V6, P1655, DOI 10.1111/j.1538-7836.2008.03095.x; Lenzini PA, 2007, ANN PHARMACOTHER, V41, P1798, DOI 10.1345/aph.1K197; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Linder MW, 2001, CLIN CHIM ACTA, V308, P9, DOI 10.1016/S0009-8981(01)00420-X; Man-Son-Hing M, 2002, ARCH INTERN MED, V162, P541, DOI 10.1001/archinte.162.5.541; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; Marsh S, 2006, J THROMB HAEMOST, V4, P473, DOI 10.1111/j.1538-7836.2006.01759.x; MCCLAIN M, 2007, RAPID ACCE1 REV CYP2, P1; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Muszkat M, 2007, CLIN THER, V29, P427, DOI 10.1016/S0149-2918(07)80081-6; *NAT HEART LUNG BL, 2005, ARCH INTERN MED, V165, P1185; Ogg MS, 1999, LANCET, V354, P1124, DOI 10.1016/S0140-6736(05)76918-X; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Penado S, 2002, AM J MED, V112, P572, DOI 10.1016/S0002-9343(02)01063-X; *PGXL LAB, INT GUID; Reitsma PH, 2005, PLOS MED, V2, P996, DOI 10.1371/journal.pmed.0020312; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Stubbins MJ, 1996, PHARMACOGENETICS, V6, P429, DOI 10.1097/00008571-199610000-00007; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; Tengs TO, 2001, STROKE, V32, P964, DOI 10.1161/01.STR.32.4.964; *U PENNS SCH MED N, GEN GUID DOS WARF CL; *UD NAT I HLTH, PHARM STUD WARF DOS; *US DEP LAB BUR LA, CONS PRIC INC ARCH C; *US FDA, FDA APPR UPD WARF CO; Visser LE, 2004, THROMB HAEMOSTASIS, V92, P61, DOI 10.1160/th03-12-0741; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; WINTZEN AR, 1982, ARCH NEUROL-CHICAGO, V39, P69, DOI 10.1001/archneur.1982.00510140003001; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5; Yin T, 2007, THROMB RES, V120, P1, DOI 10.1016/j.thromres.2006.10.021; 1998, ANN INTERN MED, V158, P1316	76	225	230	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					73	U31		10.7326/0003-4819-150-2-200901200-00005	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153410				2022-12-28	WOS:000262655200002
J	Sokol, DK				Sokol, Daniel K.			When can doctors stay away?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE WORKERS; DUTY		[Sokol, Daniel K.] Univ London St Georges Hosp, London, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London, England.	daniel.sokol@talk21.com						*DEP HLTH, PAND FLU HUM RES GUI; *DEP HLTH, PAND FLU NAT FRAM RE; *DEP HLTH, RESP PAND INFL ETH F; Malm H, 2008, AM J BIOETHICS, V8, P4, DOI 10.1080/15265160802317974; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; SOKOL D, 2005, TIMES           0311; Sokol DK, 2006, EMERG INFECT DIS, V12, P1238, DOI 10.3201/eid1708.060360; *US DEP HHS, PAND PLANN ASS	8	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 16	2009	338								b165	10.1136/bmj.b165	http://dx.doi.org/10.1136/bmj.b165			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151063				2022-12-28	WOS:000263193500001
J	de Ruijter, W; Westendorp, RGJ; Assendelft, WJJ; den Elzen, WPJ; de Craen, AJM; le Cessie, S; Gussekloo, J				de Ruijter, Wouter; Westendorp, Rudi G. J.; Assendelft, Willem J. J.; den Elzen, Wendy P. J.; de Craen, Anton J. M.; le Cessie, Saskia; Gussekloo, Jacobijn			Use of Framinghamrisk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTORS; INFLAMMATORY MARKERS; PLASMA HOMOCYSTEINE; NATRIURETIC PEPTIDE; MULTIPLE BIOMARKERS; PRIMARY PREVENTION	Objectives To investigate the performance of classic risk factors, and of some new biomarkers, in predicting cardiovascular mortality in very old people from the general population with no history of cardiovascular disease. Design The Leiden 85-plus Study (1997-2004) is an observational prospective cohort study with 5 years of follow-up. Setting General population of the city of Leiden, the Netherlands. Participants Population based sample of participants aged 85 years (215 women and 87 men) with no history of cardiovascular disease; no other exclusion criteria. Main measurements Cause specific mortality was registered during follow-up. All classic risk factors included in the Framingham risk score (sex, systolic blood pressure, total and high density lipoprotein cholesterol, diabetes mellitus, smoking and electrocardiogram based left ventricular hypertrophy), as well as plasma concentrations of the new biomarkers homocysteine, folic acid, C reactive protein, and interleukin 6, were assessed at baseline. Results During follow-up, 108 of the 302 participants died; 32% (35/108) of deaths were from cardiovascular causes. Classic risk factors did not predict cardiovascular mortality when used in the Framingham risk score (area under receiver operating characteristic curve 0.53, 95% confidence interval 0.42 to 0.63) or in a newly calibrated model (0.53, 0.43 to 0.64). Of the new biomarkers studied, homocysteine had most predictive power (0.65, 0.55 to 0.75). Entering any additional risk factor or combination of factors into the homocysteine prediction model did not increase its discriminative power. Conclusions In very old people from the general population with no history of cardiovascular disease, concentrations of homocysteine alone can accurately identify those at high risk of cardiovascular mortality, whereas classic risk factors included in the Framingham risk score do not. These preliminary findings warrant validation in a separate cohort.	[Assendelft, Willem J. J.; den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RA Leiden, Netherlands; [Westendorp, Rudi G. J.; de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriat, NL-2300 RA Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Dept Med Stat, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	de Ruijter, W (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, PO Box 9600, NL-2300 RA Leiden, Netherlands.	w.de_ruijter@lumc.nl	Assendelft, W.J.J./H-8008-2014; le+Cessie, Saskia/HGC-8966-2022; de Ruijter, Wouter/GRF-3867-2022; assendelft, willem/AAW-1854-2021; Gussekloo, Jacobijn/ABE-3879-2021	Assendelft, W.J.J./0000-0002-2966-3778; assendelft, willem/0000-0002-2966-3778; Gussekloo, Jacobijn/0000-0001-7186-8278; le Cessie, Saskia/0000-0003-2154-4923; den Elzen, Wendy/0000-0002-6774-4077	Dutch Ministry of Health, Welfare and Sports	Dutch Ministry of Health, Welfare and Sports	The Leiden 85-plus Study was partly funded by an unrestricted grant from the Dutch Ministry of Health, Welfare and Sports. The funder played no role in study design, collection, analysis and interpretation of data, writing of the report, nor in the decision to submit the article for publication. Independence of researchers: All researchers were independent from the funder.	Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Ali Robin, 2007, Am J Geriatr Pharmacother, V5, P52, DOI 10.1016/j.amjopharm.2007.03.008; Ammar KA, 2004, AM HEART J, V148, P277, DOI 10.1016/j.ahj.2004.03.019; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Andrawes WF, 2005, DRUG AGING, V22, P859, DOI 10.2165/00002512-200522100-00005; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BEMMEL T, 2006, J HYPERTENS, V24, P287; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Boshuizen HC, 1998, BMJ-BRIT MED J, V316, P1780, DOI 10.1136/bmj.316.7147.1780; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Chobanian AV, 2007, NEW ENGL J MED, V357, P789, DOI 10.1056/NEJMcp071137; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Ruijter W, 2008, SCAND J PRIM HEALTH, V26, P147, DOI 10.1080/02813430802095812; de Ruijter W, 2007, J AM GERIATR SOC, V55, P872, DOI 10.1111/j.1532-5415.2007.01180.x; Dornbrook-Lavender KA, 2003, ANN PHARMACOTHER, V37, P1654, DOI 10.1345/aph.1D025; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; KAGAN A, 1962, FED PROC, V21, P52; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kannel William B., 1995, Am J Geriatr Cardiol, V4, P10; Kannel WB, 2006, AM J GERIATR CARDIOL, V15, P382, DOI 10.1111/j.1076-7460.2006.04397.x; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MCCULLY KS, 1969, AM J PATHOL, V56, P111; McDermott MM, 2007, JAMA-J AM MED ASSOC, V297, P1253, DOI 10.1001/jama.297.11.1253; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Oates DJ, 2007, J AM GERIATR SOC, V55, P383, DOI 10.1111/j.1532-5415.2007.01069.x; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PRINEAS RJ, 1982, MINNESOTA CODE MAN; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Sattar N, 2006, CIRCULATION, V114, P143; Schmitt J, 2005, EUR CARDIOL REV, DOI 10.15420/ecr.2005.1w; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; *WHO, 2006, INT CLASS DIS; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	64	236	240	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2009	338								a3083	10.1136/bmj.a3083	http://dx.doi.org/10.1136/bmj.a3083			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AA	19131384	hybrid, Green Published			2022-12-28	WOS:000263193100021
J	Fedoroff, NV				Fedoroff, Nina V.			Science Diplomacy in the 21(st) Century	CELL			English	Editorial Material								Science diplomacy is the use of scientific collaborations among nations to address the common problems facing 21(st) century humanity and to build constructive international partnerships. There are many ways that scientists can contribute to this process.	US Agcy Int Dev, US Dept State, Washington, DC 20520 USA	United States Agency for International Development (USAID)	Fedoroff, NV (corresponding author), US Agcy Int Dev, US Dept State, Washington, DC 20520 USA.	fedoroffnv@state.gov							0	40	45	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					9	11		10.1016/j.cell.2008.12.030	http://dx.doi.org/10.1016/j.cell.2008.12.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135879	Green Published, Bronze			2022-12-28	WOS:000262318400005
J	Saksena, S; Wahlman, J; Teis, D; Johnson, AE; Emr, SD				Saksena, Suraj; Wahlman, Judit; Teis, David; Johnson, Arthur E.; Emr, Scott D.			Functional Reconstitution of ESCRT-III Assembly and Disassembly	CELL			English	Article							STRUCTURAL BASIS; VPS4; RECOGNITION; FILAMENTS; PROTEINS; DOMAIN	Receptor downregulation in the MVB pathway is mediated by the ESCRT complexes. ESCRT-III is composed of four protein subunits that are monomeric in the cytosol and oligomerize into a protein lattice only upon membrane binding. Recent studies have shown that the ESCRT-III protein Snf7 can form a filament by undergoing homo-oligomerization. To examine the role of membrane binding and of interactions with other ESCRT components in initiating Snf7 oligomerization, we used fluorescence spectroscopy to directly detect and characterize the assembly of the Snf7 oligomer on liposomes using purified ESCRT components. The observed fluorescence changes reveal an obligatory sequence of membrane-protein and protein-protein interactions that generate the active conformation of Snf7. Also, we demonstrate that ESCRT-III assembly drives membrane deformation. Furthermore, usingan in vitro disassembly assay, we directly demonstrate that Vps24 and Vps2 function as adaptors in the ATP-dependent membrane disassembly of the ESCRT-III complex by recruiting the AAA ATPase Vps4.	[Wahlman, Judit; Johnson, Arthur E.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Saksena, Suraj; Teis, David; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu; sde26@cornell.edu	Johnson, Arthur E/G-3457-2012	Teis, David/0000-0002-8181-0253	American Heart Association (AHA) [0826060D]; HFSP [LT00634/2006-L]; National Institutes of Health [GM26494]; Robert A. Welch Foundation [BE-0017]; Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, T32GM007273] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); HFSP(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Weill Institute for Cell and Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Y. Miao, Y. Shao, and S. Weys for technical assistance; B. Judson for EM expertise; and E. V. MacGurn for assistance with graphics. S.S. and D.T. were supported by fellowships from American Heart Association (AHA 0826060D) and HFSP (LT00634/2006-L), respectively. This work was supported by National Institutes of Health grant GM26494 and the Robert A. Welch Foundation (Chair Grant BE-0017) (A.E.J.) and funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162	13	216	216	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					97	109		10.1016/j.cell.2008.11.013	http://dx.doi.org/10.1016/j.cell.2008.11.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135892	Bronze, Green Accepted			2022-12-28	WOS:000262318400018
J	Turanov, AA; Lobanov, AV; Fomenko, DE; Morrison, HG; Sogin, ML; Klobutcher, LA; Hatfield, DL; Gladyshev, VN				Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Morrison, Hilary G.; Sogin, Mitchell L.; Klobutcher, Lawrence A.; Hatfield, Dolph L.; Gladyshev, Vadim N.			Genetic Code Supports Targeted Insertion of Two Amino Acids by One Codon	SCIENCE			English	Article							SEQUENCE ELEMENT; TRANSFER-RNA; EXPRESSION	Strict one- to- one correspondence between codons and amino acids is thought to be an essential feature of the genetic code. However, we report that one codon can code for two different amino acids with the choice of the inserted amino acid determined by a specific 3 ' untranslated region structure and location of the dual- function codon within the messenger RNA ( mRNA). We found that the codon UGA specifies insertion of selenocysteine and cysteine in the ciliate Euplotes crassus, that the dual use of this codon can occur even within the same gene, and that the structural arrangements of Euplotes mRNA preserve location- dependent dual function of UGA when expressed in mammalian cells. Thus, the genetic code supports the use of one codon to code for multiple amino acids.	[Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Turanov, Anton A.; Lobanov, Alexey V.; Fomenko, Dmitri E.; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Morrison, Hilary G.; Sogin, Mitchell L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; [Klobutcher, Lawrence A.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Marine Biological Laboratory - Woods Hole; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013; Sogin, Mitchell/AAE-7186-2019	Morrison, Hilary/0000-0003-0281-326X; Gladyshev, Vadim/0000-0002-0372-7016; Klobutcher, Lawrence/0000-0001-9485-3482	NIH [GM061603, GM065204, AI058054]; NSF [0343813]; Intramural Research Program; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603, R01GM065204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hammar for constructing the EST library and I. Sorokina (Midwest Bio Services) for protein sequencing. This work was supported by NIH GM061603 and GM065204 to V.N.G., AI058054 to M.L.S., NSF 0343813 to L.A.K., and the Intramural Research Program, National Cancer Institute, NIH, to D.L.H. Sequences for tRNA and selenoprotein genes have been deposited in the GenBank database under accession numbers FJ440148 to FJ440159.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Atkins JF, 2007, NATURE, V448, P1004, DOI 10.1038/4481004a; Berry MJ, 2002, METHOD ENZYMOL, V347, P17; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122	10	83	93	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					259	261		10.1126/science.1164748	http://dx.doi.org/10.1126/science.1164748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131629	Green Accepted, Green Submitted			2022-12-28	WOS:000262290600040
J	Vasconcelos, C; McKenzie, JA				Vasconcelos, Crisogono; McKenzie, Judith A.			GEOCHEMISTRY The Descent of Minerals	SCIENCE			English	Editorial Material							MICROBIAL MATS		[Vasconcelos, Crisogono; McKenzie, Judith A.] ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland	ETH Zurich	Vasconcelos, C (corresponding author), ETH, Inst Geol, Geomicrobiol Lab, CH-8092 Zurich, Switzerland.	cris.vasconcelos@erdw.ethz.ch						Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Konhauser KO, 2005, GEOBIOLOGY, V3, P167, DOI 10.1111/j.1472-4669.2005.00055.x; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016	5	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					218	219		10.1126/science.1168807	http://dx.doi.org/10.1126/science.1168807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131619				2022-12-28	WOS:000262290600025
J	Christensen, UR; Holzwarth, V; Reiners, A				Christensen, Ulrich R.; Holzwarth, Volkmar; Reiners, Ansgar			Energy flux determines magnetic field strength of planets and stars	NATURE			English	Article							CORE-MANTLE BOUNDARY; T-TAURI STARS; M DWARFS; MASS; DYNAMOS	Themagnetic fields of Earth and Jupiter, along with those of rapidly rotating, low- mass stars, are generated by convection- driven dynamos that may operate similarly(1-4) ( the slowly rotating Sun generates its field through a different dynamo mechanism(5)). The field strengths of planets and stars vary over three orders of magnitude, but the critical factor causing that variation has hitherto been unclear(5,6). Here we report an extension of a scaling law derived from geodynamo models(7) to rapidly rotating stars that have strong density stratification. The unifying principle in the scaling law is that the energy flux available for generating the magnetic field sets the field strength. Our scaling law fits the observed field strengths of Earth, Jupiter, young contracting stars and rapidly rotating low-mass stars, despite vast differences in the physical conditions of the objects. We predict that the field strengths of rapidly rotating brown dwarfs and massive extrasolar planets are high enough to make them observable.	[Christensen, Ulrich R.; Holzwarth, Volkmar] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Reiners, Ansgar] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Christensen, UR (corresponding author), Max Planck Inst Sonnensyst Forsch, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	christensen@mps.mpg.de		Reiners, Ansgar/0000-0003-1242-5922				Baraffe I, 1996, ASTROPHYS J, V461, pL51, DOI 10.1086/309988; BLOXHAM J, 1992, J GEOPHYS RES-SOL EA, V97, P19537, DOI 10.1029/92JB01591; Browning MK, 2008, ASTROPHYS J, V676, P1262, DOI 10.1086/527432; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; Charbonneau P, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-3; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2006, NATURE, V444, P1056, DOI 10.1038/nature05342; CONNERNEY JEP, 1993, J GEOPHYS RES-PLANET, V98, P18659, DOI 10.1029/93JE00980; Dobler W, 2006, ASTROPHYS J, V638, P336, DOI 10.1086/498634; Donati JF, 2006, SCIENCE, V311, P633, DOI 10.1126/science.1121102; Drilling J.S., 2000, ALLENS ASTROPHYSICAL, P381; Granzer T, 2000, ASTRON ASTROPHYS, V355, P1087; Guillot T, 1999, PLANET SPACE SCI, V47, P1183, DOI 10.1016/S0032-0633(99)00043-4; GUILLOT T, 2005, JUPITER, P39; Johns-Krull CM, 2007, ASTROPHYS J, V664, P975, DOI 10.1086/519017; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Morin J, 2008, MON NOT R ASTRON SOC, V390, P567, DOI 10.1111/j.1365-2966.2008.13809.x; NEUHAUSER R, 1995, ASTRON ASTROPHYS, V297, P391; Nimmo F., 2015, TREATISE GEOPHYS, P27, DOI DOI 10.1016/B978-044452748-6.00128-0; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Pizzolato N, 2003, ASTRON ASTROPHYS, V397, P147, DOI 10.1051/0004-6361:20021560; Reiners A, 2007, ASTROPHYS J, V656, P1121, DOI 10.1086/510304; REINERS A, ASTROPHYS J IN PRESS; Saar SH, 1996, MAGNETODYNAMIC PHENOMENA IN THE SOLAR ATMOSPHERE, P367; Sanchez-Lavega A, 2004, ASTROPHYS J, V609, pL87, DOI 10.1086/422840; Sreenivasan B, 2006, GEOPHYS J INT, V164, P467, DOI 10.1111/j.1365-246X.2005.02845.x; Stanley S, 2004, NATURE, V428, P151, DOI 10.1038/nature02376; STEVENSON DJ, 1980, SCIENCE, V208, P746, DOI 10.1126/science.208.4445.746; Stevenson DJ, 2003, EARTH PLANET SC LETT, V208, P1, DOI 10.1016/S0012-821X(02)01126-3; Zarka P, 2007, PLANET SPACE SCI, V55, P598, DOI 10.1016/j.pss.2006.05.045	30	253	254	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 8	2009	457	7226					167	169		10.1038/nature07626	http://dx.doi.org/10.1038/nature07626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129842				2022-12-28	WOS:000262360200026
J	Attia, J; Ioannidis, JPA; Thakkinstian, A; McEvoy, M; Scott, RJ; Minelli, C; Thompson, J; Infante-Rivard, C; Guyatt, G				Attia, John; Ioannidis, John P. A.; Thakkinstian, Ammarin; McEvoy, Mark; Scott, Rodney J.; Minelli, Cosetta; Thompson, John; Infante-Rivard, Claire; Guyatt, Gordon			How to Use an Article About Genetic Association A: Background Concepts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; RISK; REVEALS; ALLELES; APOE; MAP	This is the first in a series of 3 articles serving as an introduction to clinicians wishing to read and critically appraise genetic association studies. We summarize the key concepts in genetics that clinicians must understand to review these studies, including the structure of DNA, transcription and translation, patterns of inheritance, Hardy- Weinberg equilibrium, and linkage disequilibrium. We review the types of DNA variation, including single- nucleotide polymorphisms ( SNPs), insertions, and deletions, and how these can affect protein function. We introduce the idea of genetic association for both single-candidate gene and genome- wide association studies, in which thousands of genetic variants are tested for association with disease. We use the APOE polymorphism and its association with dementia as a case study to demonstrate the concepts and introduce the terminology used in this field. The second and third articles will focus on issues of validity and applicability.	[Attia, John; McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Attia, John; McEvoy, Mark] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modelling, Tufts Med Ctr,Dept Med, Boston, MA 02111 USA; [Thakkinstian, Ammarin] Mahidol Univ, Clin Epidemiol Unit, Ramathibodi Hosp, Fac Med, Bangkok 10700, Thailand; [Scott, Rodney J.] John Hunter Hosp, Div Genet, Hunter Area Pathol Serv, New Lambton, Australia; [Scott, Rodney J.] Univ Newcastle, Ctr Informat Based Med, Fac Hlth, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Minelli, Cosetta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Infante-Rivard, Claire] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Ioannina; Tufts Medical Center; Tufts University; Mahidol University; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Leicester; McGill University; McMaster University	Attia, J (corresponding author), Univ Newcastle, Ctr Clin Epidemiol & Biostat, Hunter Med Res Inst, Level 3,David Maddison Bldg, Newcastle, NSW 2300, Australia.	john.attia@newcastle.edu.au	Scott, Rodney J/B-2827-2013; Attia, John R/F-5376-2013; Ioannidis, John P. A./G-9836-2011; Thakkinstian, Ammarin/J-4788-2019	Scott, Rodney J/0000-0001-7724-3404; Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Risch N, 1997, EPIDEMIOL REV, V19, P24, DOI 10.1093/oxfordjournals.epirev.a017942; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Teare MD, 2005, LANCET, V366, P1036, DOI 10.1016/S0140-6736(05)67382-5; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	19	84	87	0	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					74	81		10.1001/jama.2008.901	http://dx.doi.org/10.1001/jama.2008.901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126812				2022-12-28	WOS:000262220400022
J	Boztug, K; Appaswamy, G; Ashikov, A; Schaffer, AA; Salzer, U; Diestelhorst, J; Germeshausen, M; Brandes, G; Lee-Gossler, J; Noyan, F; Gatzke, AK; Minkov, M; Greil, J; Kratz, C; Petropoulou, T; Pellier, I; Bellanne-Chantelot, C; Rezaei, N; Monkemoller, K; Irani-Hakimeh, N; Bakker, H; Gerardy-Schahn, R; Zeidler, C; Grimbacher, B; Welte, K; Klein, C				Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Schaffer, Alejandro A.; Salzer, Ulrich; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Minkov, Milen; Greil, Johann; Kratz, Christian; Petropoulou, Theoni; Pellier, Isabelle; Bellanne-Chantelot, Christine; Rezaei, Nima; Moenkemoeller, Kirsten; Irani-Hakimeh, Noha; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl; Klein, Christoph			A Syndrome with Congenital Neutropenia and Mutations in G6PC3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-STORAGE-DISEASE; SUBUNIT-RELATED PROTEIN; GLUCOSE-LEVELS; GENE; ELASTASE; APOPTOSIS; MCL-1; IDENTIFICATION; DEFICIENCY	Background The main features of severe congenital neutropenia are the onset of severe bacterial infections early in life, a paucity of mature neutrophils, and an increased risk of leukemia. In many patients, the genetic causes of severe congenital neutropenia are unknown. Methods We performed genomewide genotyping and linkage analysis on two consanguineous pedigrees with a total of five children affected with severe congenital neutropenia. Candidate genes from the linkage interval were sequenced. Functional assays and reconstitution experiments were carried out. Results All index patients were susceptible to bacterial infections and had very few mature neutrophils in the bone marrow; structural heart defects, urogenital abnormalities, and venous angiectasia on the trunk and extremities were additional features. Linkage analysis of the two index families yielded a combined multipoint lod score of 5.74 on a linkage interval on chromosome 17q21. Sequencing of G6PC3, the candidate gene encoding glucose- 6- phosphatase, catalytic subunit 3, revealed a homozygous missense mutation in exon 6 that abolished the enzymatic activity of glucose- 6- phosphatase in all affected children in the two families. The patients' neutrophils and fibroblasts had increased susceptibility to apoptosis. The myeloid cells showed evidence of increased endoplasmic reticulum stress and increased activity of glycogen synthase kinase 3 beta (GSK-3 beta). We identified seven additional, unrelated patients who had severe congenital neutropenia with syndromic features and distinct biallelic mutations in G6PC3. Conclusions Defective function of glucose- 6- phosphatase, catalytic subunit 3, underlies a severe congenital neutropenia syndrome associated with cardiac and urogenital malformations.	[Boztug, Kaan; Appaswamy, Giridharan; Ashikov, Angel; Diestelhorst, Jana; Germeshausen, Manuela; Brandes, Gudrun; Lee-Gossler, Jacqueline; Noyan, Fatih; Gatzke, Anna-Katherina; Bakker, Hans; Gerardy-Schahn, Rita; Zeidler, Cornelia; Welte, Karl; Klein, Christoph] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-30625 Hannover, Germany; [Schaffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Salzer, Ulrich] Univ Med Ctr Freiburg, Freiburg, Germany; [Minkov, Milen] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Greil, Johann] Univ Heidelberg, Childrens Hosp, D-6900 Heidelberg, Germany; [Kratz, Christian] Univ Freiburg, Freiburg, Germany; [Petropoulou, Theoni] Univ Athens, Aghia Sophia Childrens Hosp, Athens, Greece; [Pellier, Isabelle] CHU Angers, Angers, France; [Bellanne-Chantelot, Christine] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Paris, France; [Rezaei, Nima] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; [Moenkemoeller, Kirsten] Childrens Hosp Amsterdamer Str, Cologne, Germany; [Irani-Hakimeh, Noha] St Georges Univ Hosp, Beirut, Lebanon; [Grimbacher, Bodo] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England	Hannover Medical School; National Institutes of Health (NIH) - USA; University of Freiburg; Saint Anna Children's Hospital; Ruprecht Karls University Heidelberg; University of Freiburg; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; University of Cologne; University of London; University College London	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol & Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Kratz, Christian/AAC-9726-2021; Ashikov, Angel/N-7714-2015; Boztug, Kaan/AAM-4161-2021; Noyan, Fatih/B-9449-2018; Rezaei, Nima/B-4245-2008; Schaffer, Alejandro A/F-2902-2012; Bakker, Hans/A-1787-2017; Schaffer, Alejandro/N-1222-2019; Bakker, Hans/AAA-1623-2020; isabelle, pellier/L-5683-2015	Ashikov, Angel/0000-0001-9679-7955; Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Bakker, Hans/0000-0002-1364-9154; Bakker, Hans/0000-0002-1364-9154; Minkov, Milen/0000-0001-6471-8423; Salzer, Ulrich/0000-0002-1769-1157	Deutsche Forschungsgemeinschaft [KliFo 110-2]; Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes; European Union [MEXT-CT-2006-042316]; Intramural Research Program of the National Institutes of Health; National Library of Medicine; Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Junior Research Group "Glycomics"; Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Else Kroner Memorial Fellowship; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by grants from the Deutsche Forschungsgemeinschaft (DFG KliFo 110-2, to Dr. Klein), the Junior Research Group "Glycomics" (to Dr. Gerardy-Schahn), the Bundesministerium fur Bildung und Forschung Bone Marrow Failure Syndromes (to Drs. Welte and Klein), and the European Union (MEXT-CT-2006-042316, to Dr. Grimbacher); and by the Intramural Research Program of the National Institutes of Health, National Library of Medicine (for Dr. Schaffer). Dr. Boztug is a recipient of an Else Kroner Memorial Fellowship. Drs. Klein and Gerardy-Schahn are members of REBIRTH, a Deutsche Forschungsgemeinschaft Cluster of Excellence.; Dr. Welte reports owning equity in Amgen and receiving royalties on a patent for rhG-CSF. No other potential conflict of interest relevant to this article was reported.; We thank the patients and their families for supporting our study; all colleagues referring and registering patients at the Severe Chronic Neutropenia International Registry; Francois-Loic Cosset for the kind gift of the RD114 plasmid; Edelgard Odenwald for analysis of bone marrow smears; Thomas Jack for his help with echocardiography; Jessica Pfannstiel, Maren Sievers, Marie Bohm, Marly Dalton, Martina Wackerhahn, Tanja Reinke, and Gwendoline Leroy for technical assistance; and Dr. Jean Donadieu at the Pediatric Hematology Oncology Service, Hopital Trousseau, Paris, and Dr. Roula Farah at the Department of Pediatrics, Saint Georges Hospital, Balamand University, Beirut, Lebanon, for excellent collaboration.	Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Boxer LA, 2007, PEDIATR BLOOD CANCER, V49, P609, DOI 10.1002/pbc.21282; Boztug K, 2008, IMMUNOL ALLERGY CLIN, V28, P259, DOI 10.1016/j.iac.2008.01.007; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Guionie O, 2003, FEBS LETT, V551, P159, DOI 10.1016/S0014-5793(03)00903-7; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Kostmann R., 1950, SVEN KARTDIN, V47, P2861; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Melis D, 2005, EUR J PEDIATR, V164, P501, DOI 10.1007/s00431-005-1657-4; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Wang YD, 2006, J BIOL CHEM, V281, P39982, DOI 10.1074/jbc.M605858200; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	47	248	251	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					32	43		10.1056/NEJMoa0805051	http://dx.doi.org/10.1056/NEJMoa0805051			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118303	Green Accepted, Bronze			2022-12-28	WOS:000262096800005
J	Buchholz, TA				Buchholz, Thomas A.			Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							20-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; CONSERVATION THERAPY; LOCAL RECURRENCE; FAMILY-HISTORY; IRRADIATION; WOMEN; RADIOTHERAPY; LUMPECTOMY; TAMOXIFEN		[Buchholz, Thomas A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Unit 97, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Buchholz, TA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Unit 97, 1515 Holcombe Blvd, Houston, TX 77030 USA.	tbuchhol@mdanderson.org			Merck; GlaxoSmithKline	Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline)	Dr. Buchholz reports receiving consulting fees from Merck and GlaxoSmithKline and grant support from Merck. No other potential conflict of interest relevant to this article was reported.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; *AM CANC SOC, 2008, BREAST CANC FACTS FI; American Cancer Society, 2008, CANC FACTS FIG 2008; Arthur DW, 2005, J CLIN ONCOL, V23, P1726, DOI 10.1200/JCO.2005.09.045; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Borghero YO, 2007, RADIOTHER ONCOL, V82, P324, DOI 10.1016/j.radonc.2006.10.011; Buchholz TA, 2002, SEMIN RADIAT ONCOL, V12, P285, DOI 10.1053/srao.2002.35248; Buchholz TA, 2001, J CLIN ONCOL, V19, P2240, DOI 10.1200/JCO.2001.19.8.2240; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Cabioglu N, 2005, CANCER-AM CANCER SOC, V104, P20, DOI 10.1002/cncr.21121; Carlson Robert W, 2007, J Natl Compr Canc Netw, V5, P246; Chabner E, 1998, J CLIN ONCOL, V16, P2045, DOI 10.1200/JCO.1998.16.6.2045; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; CLARKE D, 1983, INT J RADIAT ONCOL, V9, P1807, DOI 10.1016/0360-3016(83)90348-6; Collaborative Group on Hormonal Factors in Breast Cancer, 1997, LANCET, V350, P1484; Dewar JA, 2007, J CLIN ONCOL, V25; Donovan E, 2007, RADIOTHER ONCOL, V82, P254, DOI 10.1016/j.radonc.2006.12.008; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fisher J, 2000, INT J RADIAT ONCOL, V48, P1307, DOI 10.1016/S0360-3016(00)00782-3; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Giordano SH, 2005, JNCI-J NATL CANCER I, V97, P419, DOI 10.1093/jnci/dji067; Haas JA, 1998, CANCER J, V4, P308; Haffty BG, 2008, J CLIN ONCOL, V26, P2072, DOI 10.1200/JCO.2007.15.9442; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Halberg F E, 2000, Radiology, V215 Suppl, P1193; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris EER, 2006, J CLIN ONCOL, V24, P4100, DOI 10.1200/JCO.2005.05.1037; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; HUGHES KS, 2006, BREAST CANC RES TR S, V100, P11; Lambe M, 1996, CANCER CAUSE CONTROL, V7, P533, DOI 10.1007/BF00051886; Lambe M, 1997, CANCER CAUSE CONTROL, V8, P260; Liljegren G, 1997, ANN ONCOL, V8, P235, DOI 10.1023/A:1008200711466; Morris MM, 1997, J CLIN ONCOL, V15, P2728, DOI 10.1200/JCO.1997.15.7.2728; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Pignol JP, 2008, J CLIN ONCOL, V26, P2085, DOI 10.1200/JCO.2007.15.2488; Ries LAG, 2007, SEER CANC STAT REV 1; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1995, MED PHYS, V22, P1353, DOI 10.1118/1.597557; TAYLOR ME, 1995, INT J RADIAT ONCOL, V31, P753, DOI 10.1016/0360-3016(94)00480-3; Vaidya JS, 1996, BRIT J CANCER, V74, P820, DOI 10.1038/bjc.1996.442; Veronesi U, 2001, ANN ONCOL, V12, P997, DOI 10.1023/A:1011136326943; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Whelan T, 2002, J NATL CANCER I, V94, P1143	50	84	87	3	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					63	70		10.1056/NEJMct0803525	http://dx.doi.org/10.1056/NEJMct0803525			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118305				2022-12-28	WOS:000262096800008
J	Goodman, AA; Rosolowsky, EW; Borkin, MA; Foster, JB; Halle, M; Kauffmann, J; Pineda, JE				Goodman, Alyssa A.; Rosolowsky, Erik W.; Borkin, Michelle A.; Foster, Jonathan B.; Halle, Michael; Kauffmann, Jens; Pineda, Jaime E.			A role for self-gravity at multiple length scales in the process of star formation	NATURE			English	Article							TURBULENCE; CLOUDS	Self-gravity plays a decisive role in the final stages of star formation, where dense cores (size similar to 0.1 parsecs) inside molecular clouds collapse to form star- plus- disk systems(1). But self- gravity's role at earlier times ( and on larger length scales, such as similar to 1 parsec) is unclear; some molecular cloud simulations that do not include self- gravity suggest that 'turbulent fragmentation' alone is sufficient to create a mass distribution of dense cores that resembles, and sets, the stellar initial mass function(2). Here we report a 'dendrogram' (hierarchical tree- diagram) analysis that reveals that self- gravity plays a significant role over the full range of possible scales traced by (CO)-C-13 observations in the L1448 molecular cloud, but not everywhere in the observed region. In particular, more than 90 per cent of the compact 'pre- stellar cores' traced by peaks of dust emission(3) are projected on the sky within one of the dendrogram's self- gravitating 'leaves'. As these peaks mark the locations of already- forming stars, or of those probably about to form, a self- gravitating cocoon seems a critical condition for their existence. Turbulent fragmentation simulations without self- gravity even of unmagnetized isothermal material - can yield mass and velocity power spectra very similar to what is observed in clouds like L1448. But a dendrogram of such a simulation(4) shows that nearly all the gas in it ( much more than in the observations) appears to be self- gravitating. A potentially significant role for gravity in ` non- self- gravitating' simulations suggests inconsistency in simulation assumptions and output, and that it is necessary to include self- gravity in any realistic simulation of the star- formation process on subparsec scales.	[Goodman, Alyssa A.; Borkin, Michelle A.; Halle, Michael; Kauffmann, Jens] Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA; [Goodman, Alyssa A.; Rosolowsky, Erik W.; Foster, Jonathan B.; Kauffmann, Jens; Pineda, Jaime E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rosolowsky, Erik W.] Univ British Columbia, Dept Phys, Kelowna, BC V1V 1V7, Canada; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Surg Planning Lab, Boston, MA 02115 USA; [Halle, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Goodman, AA (corresponding author), Harvard Univ, Initiat Innovat Comp, Cambridge, MA 02138 USA.	agoodman@cfa.harvard.edu	Pineda, Jaime/AAX-3157-2021; Pineda, Jaime/J-7405-2013; Rosolowsky, Erik/ABI-3078-2020; Goodman, Alyssa A/A-6007-2010	Pineda, Jaime/0000-0002-3972-1978; Pineda, Jaime/0000-0002-3972-1978; Goodman, Alyssa A/0000-0003-1312-0477; Borkin, Michelle/0000-0002-8016-355X; Kauffmann, Jens/0000-0002-5094-6393	National Institutes of Health [U54-EB005149]; National Science Foundation [AST-0502605]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank A. Munshi for putting us in touch with M. Thomas and colleagues at Right Hemisphere, whose software and assistance enabled the interactive PDF in this paper; P. Padoan for providing the simulated data cube; R. Shetty for comments on the paper; F. Shu for suggesting we extend our analysis to measure boundedness of p-p-v 'bound' objects in p-p-p space using simulations; and S. Hyman, Provost of Harvard University, for supporting the start- up of the Initiative in Innovative Computing at Harvard, which substantially enabled the creation of this work. 3D Slicer is developed by the National Alliance for Medical Image Computing and funded by the National Institutes of Health grant U54-EB005149. The COMPLETE group is supported in part by the National Science Foundation. E.W.R. is supported by the NSF AST-0502605.	BERTOLDI F, 1992, ASTROPHYS J, V395, P140, DOI 10.1086/171638; di Francesco J., 2007, PROTOSTARS PLANETS, P17; Enoch ML, 2006, ASTROPHYS J, V638, P293, DOI 10.1086/498678; Foster JB, 2006, ASTROPHYS J, V636, pL105, DOI 10.1086/500131; GOODMAN A, 2008, ASTROPHYS J IN PRESS; Heine C, 2006, IEEE T VIS COMPUT GR, V12, P781, DOI 10.1109/TVCG.2006.196; HOULAHAN P, 1992, ASTROPHYS J, V393, P172, DOI 10.1086/171495; Jorgensen JK, 2008, ASTROPHYS J, V683, P822, DOI 10.1086/589956; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V261, P921, DOI 10.1093/mnras/261.4.921; KAUFFMANN J, ASTROPHYS J UNPUB; LARSON RB, 1981, MON NOT R ASTRON SOC, V194, P809, DOI 10.1093/mnras/194.4.809; Ostriker EC, 2001, ASTROPHYS J, V546, P980, DOI 10.1086/318290; Padoan P, 2002, ASTROPHYS J, V576, P870, DOI 10.1086/341790; Padoan P, 2006, ASTROPHYS J, V653, pL125, DOI 10.1086/510620; Pineda JE, 2008, ASTROPHYS J, V679, P481, DOI 10.1086/586883; Ridge NA, 2006, ASTRON J, V131, P2921, DOI 10.1086/503704; Rosolowsky EW, 2008, ASTROPHYS J, V679, P1338, DOI 10.1086/587685; Rosolowsky EW, 2008, ASTROPHYS J SUPPL S, V175, P509, DOI 10.1086/524299; STUTZKI J, 1990, ASTROPHYS J, V356, P513, DOI 10.1086/168859; Vliegen R, 2006, IEEE T VIS COMPUT GR, V12, P789, DOI 10.1109/TVCG.2006.200; WILLIAMS JP, 1994, ASTROPHYS J, V428, P693, DOI 10.1086/174279	21	103	104	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					63	66		10.1038/nature07609	http://dx.doi.org/10.1038/nature07609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122636	Green Accepted			2022-12-28	WOS:000262104900030
J	Galukande, M				Galukande, Moses			Students whose behaviour causes concern: Am I my brother's keeper?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		[Galukande, Moses] Makerere Univ, Kampala, Uganda	Makerere University	Galukande, M (corresponding author), Makerere Univ, Kampala, Uganda.	mosesg@img.co.ug						Bateman C, 2001, LANCET, V358, P1539, DOI 10.1016/S0140-6736(01)06586-2; Federico SG, 2006, ARCH PEDIAT ADOL MED, V160, P191, DOI 10.1001/archpedi.160.2.191; Haq C, 2000, FAM MED, V32, P566; MAZUR L, 1997, GLOBAL INTERDEPENDEN; MILLER WC, 1995, AM J MED, V99, P291, DOI 10.1016/S0002-9343(99)80162-4	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2008	337								a2875	10.1136/bmj.a2875	http://dx.doi.org/10.1136/bmj.a2875			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401MV	19114451				2022-12-28	WOS:000262945900004
J	Pagnoux, C; Mahr, A; Hamidou, MA; Boffa, JJ; Ruivard, M; Ducroix, JP; Kyndt, X; Lifermann, F; Papo, T; Lambert, M; Le Noach, J; Khellaf, M; Merrien, D; Puechal, X; Vinzio, S; Cohen, P; Mouthon, L; Cordier, JF; Guillevin, L				Pagnoux, Christian; Mahr, Alfred; Hamidou, Mohamed A.; Boffa, Jean-Jacques; Ruivard, Marc; Ducroix, Jean-Pierre; Kyndt, Xavier; Lifermann, Francois; Papo, Thomas; Lambert, Marc; Le Noach, Jose; Khellaf, Mehdi; Merrien, Dominique; Puechal, Xavier; Vinzio, Stephane; Cohen, Pascal; Mouthon, Luc; Cordier, Jean-Francois; Guillevin, Loic		French Vasculitis Study Grp	Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals	NOV 12-17, 2005	San Diego, CA	Amer Coll Rheumatol, Assoc Rheumatol Hlth Profess			ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ANTIBODY-ASSOCIATED VASCULITIS; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; RHEUMATOID-ARTHRITIS; RANDOMIZED-TRIAL; FOLLOW-UP; PULSE CYCLOPHOSPHAMIDE; POLYARTERITIS-NODOSA; SYSTEMIC VASCULITIS	Background: Current standard therapy for Wegener's granulomatosis and microscopic polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a less toxic immunosuppressant such as azathioprine or methotrexate for maintenance therapy. However, azathioprine and methotrexate have not been compared with regard to safety and efficacy. Methods: In this prospective, open-label, multicenter trial, we randomly assigned patients with Wegener's granulomatosis or microscopic polyangiitis who entered remission with intravenous cyclophosphamide and corticosteroids to receive oral azathioprine (at a dose of 2.0 mg per kilogram of body weight per day) or methotrexate (at a dose of 0.3 mg per kilogram per week, progressively increased to 25 mg per week) for 12 months. The primary end point was an adverse event requiring discontinuation of the study drug or causing death; the sample size was calculated on the basis of the primary hypothesis that methotrexate would be less toxic than azathioprine. The secondary end points were severe adverse events and relapse. Results: Among 159 eligible patients, 126 (79%) had a remission, were randomly assigned to receive a study drug in two groups of 63 patients each, and were followed for a mean (+/-SD) period of 29+/-13 months. Adverse events occurred in 29 azathioprine recipients and 35 methotrexate recipients (P=0.29); grade 3 or 4 events occurred in 5 patients in the azathioprine group and 11 patients in the methotrexate group (P=0.11). The primary end point was reached in 7 patients who received azathioprine as compared with 12 patients who received methotrexate (P=0.21), with a corresponding hazard ratio for methotrexate of 1.65 (95% confidence interval, 0.65 to 4.18; P=0.29). There was one death in the methotrexate group. Twenty-three patients who received azathioprine and 21 patients who received methotrexate had a relapse (P=0.71); 73% of these patients had a relapse after discontinuation of the study drug. Conclusions: These results do not support the primary hypothesis that methotrexate is safer than azathioprine. The two agents appear to be similar alternatives for maintenance therapy in patients with Wegener's granulomatosis and microscopic polyangiitis after initial remission. (ClinicalTrials.gov number, NCT00349674.).	[Pagnoux, Christian; Mahr, Alfred; Cohen, Pascal; Mouthon, Luc; Guillevin, Loic] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Paris, France; [Boffa, Jean-Jacques] Hop Tenon, F-75970 Paris, France; [Papo, Thomas] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Hamidou, Mohamed A.] Ctr Hosp Univ Hotel Dieu, Nantes, France; [Ruivard, Marc] Ctr Hosp Univ Hotel Dieu, Clermont Ferrand, France; [Ducroix, Jean-Pierre] Hop Nord Amiens, Amiens, France; [Kyndt, Xavier] Ctr Hosp Valenciennes, Valenciennes, France; [Lifermann, Francois] Ctr Hosp Dax, Dax, France; [Lambert, Marc] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; [Le Noach, Jose] Ctr Hosp Cholet, Cholet, France; [Khellaf, Mehdi] Hop Henri Mondor, F-94010 Creteil, France; [Merrien, Dominique] Ctr Hosp Compiegne, Compiegne, France; [Puechal, Xavier] Ctr Hosp Mans, Le Mans, France; [Vinzio, Stephane] Hop Hautepierre, Strasbourg, France; [Cordier, Jean-Francois] Univ Lyon 1, Hop Louis Pradel, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU Clermont Ferrand; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CH de Valenciennes; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre Hospitalier Le Mans; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pagnoux, C (corresponding author), Hop Cochin, Dept Internal Med, Natl Referral Ctr Rare Systemic & Autoimmune Dis, 27 Rue Faubourg St Jacques, F-75679 Paris 14, France.	christian.pagnoux@cch.aphp.fr	Launay, David/H-1674-2016; roudier, jean/A-8654-2011; Puechal, Xavier/P-1555-2017; lambert, marc/V-7380-2017	Launay, David/0000-0003-1840-1817; Ioos, Vincent/0000-0001-6959-5602; DAUGAS, Eric/0000-0001-7256-7979; roudier, jean/0000-0001-5435-8567; wislez, marie/0000-0001-7518-7859; Puechal, Xavier/0000-0003-3573-9203; Bergeron, Anne/0000-0003-2156-254X; Vrtovsnik, Francois/0000-0003-1554-314X; Mahr, Alfred/0000-0002-1564-9115; lambert, marc/0000-0002-3485-8238				Adu D, 1997, QJM-MON J ASSOC PHYS, V90, P401, DOI 10.1093/qjmed/90.6.401; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; de Groot K, 2001, NEPHROL DIAL TRANSPL, V16, P2018, DOI 10.1093/ndt/16.10.2018; deGroot K, 1996, ARTHRITIS RHEUM, V39, P2052, DOI 10.1002/art.1780391215; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; Haubitz M, 1998, ARTHRITIS RHEUM, V41, P1835, DOI 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; HOLLANDER D, 1967, ANN INTERN MED, V67, P393, DOI 10.7326/0003-4819-67-2-393; Ideguchi H, 2007, JCR-J CLIN RHEUMATOL, V13, P73, DOI 10.1097/01.rhu.0000260526.29331.a8; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Koldingsnes W, 2003, J RHEUMATOL, V30, P80; Langford CA, 1998, ANN INTERN MED, V128, P1021, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00012; Langford CA, 1999, ARTHRITIS RHEUM, V42, P2666, DOI 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E; Langford CA, 2003, AM J MED, V114, P463, DOI 10.1016/S0002-9343(03)00077-9; Langford CA, 1997, RHEUM DIS CLIN N AM, V23, P841, DOI 10.1016/S0889-857X(05)70363-X; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; LUQMANI RA, 1994, Q J MED, V87, P671; Price EJ, 1998, J RHEUMATOL, V25, P896; Sanders JF, 2003, NEW ENGL J MED, V349, P2072; Seo P, 2005, ARTHRITIS RHEUM-US, V52, P2168, DOI 10.1002/art.21117; SINGH G, 1989, ARTHRITIS RHEUM, V32, P837; SNELLER MC, 1995, ARTHRITIS RHEUM, V38, P608, DOI 10.1002/art.1780380505; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stone JH, 2005, NEW ENGL J MED, V352, P351; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wluka A, 2000, J RHEUMATOL, V27, P1864; World Health Organization, WHO TOX CRIT GRAD	31	412	435	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2790	2803		10.1056/NEJMoa0802311	http://dx.doi.org/10.1056/NEJMoa0802311			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	387KJ	19109574	Bronze			2022-12-28	WOS:000261950800006
J	Marraffini, LA; Sontheimer, EJ				Marraffini, Luciano A.; Sontheimer, Erik J.			CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA	SCIENCE			English	Article							PROVIDES ACQUIRED-RESISTANCE; EPIDERMIDIS STRAIN; PLASMID; AUREUS; GENOME; IDENTIFICATION; PROKARYOTES; INFECTIONS; RNAS; REPLICATION	Horizontal gene transfer (HGT) in bacteria and archaea occurs through phage transduction, transformation, or conjugation, and the latter is particularly important for the spread of antibiotic resistance. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci confer sequence- directed immunity against phages. A clinical isolate of Staphylococcus epidermidis harbors a CRISPR spacer that matches the nickase gene present in nearly all staphylococcal conjugative plasmids. Here we show that CRISPR interference prevents conjugation and plasmid transformation in S. epidermidis. Insertion of a self- splicing intron into nickase blocks interference despite the reconstitution of the target sequence in the spliced mRNA, which indicates that the interference machinery targets DNA directly. We conclude that CRISPR loci counteract multiple routes of HGT and can limit the spread of antibiotic resistance in pathogenic bacteria.	[Marraffini, Luciano A.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	The Jane Coffin Childs Memorial Fund for Medical Research; NIH [GM072830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072830] Funding Source: NIH RePORTER	The Jane Coffin Childs Memorial Fund for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to O. Schneewind (University of Chicago) for reagents and experimental assistance, B. Golden (Purdue University) for orf142-2 intron constructs and advice, and members of our laboratory for discussions and comments on the manuscript. Results described here are being used in support of a patent filing by Northwestern University. L.A.M. is a fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant (GM072830) from NIH to E. J. S.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Climo MW, 1996, J BACTERIOL, V178, P4975, DOI 10.1128/jb.178.16.4975-4983.1996; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROS MF, 1987, EMBO J, V6, P3863, DOI 10.1002/j.1460-2075.1987.tb02724.x; GROS MF, 1989, EMBO J, V8, P2711, DOI 10.1002/j.1460-2075.1989.tb08412.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; Lim SM, 2005, ANAESTHESIA, V60, P887, DOI 10.1111/j.1365-2044.2005.04220.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; MORTON TM, 1995, ANTIMICROB AGENTS CH, V39, P1272, DOI 10.1128/AAC.39.6.1272; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	28	1092	1286	22	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1843	1845		10.1126/science.1165771	http://dx.doi.org/10.1126/science.1165771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095942	Green Accepted			2022-12-28	WOS:000261799400054
J	Boos, CJ; Martin, U; Cherry, RC; Marshall, HJ				Boos, Christopher John; Martin, Una; Cherry, Russell C.; Marshall, Howard J.			Dangerous sandwiches	LANCET			English	Editorial Material							SWALLOW SYNCOPE		[Boos, Christopher John; Marshall, Howard J.] Univ Hosp Birmingham, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Martin, Una] Univ Hosp Birmingham, Dept Clin Pharmacol, Birmingham B15 2TH, W Midlands, England; [Cherry, Russell C.] Jiggins Lane Med Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Boos, CJ (corresponding author), Univ Hosp Birmingham, Dept Cardiol, Birmingham B15 2TH, W Midlands, England.	christopherboos@hotmail.com						AUSUBEL K, 1987, AM HEART J, V113, P831, DOI 10.1016/0002-8703(87)90730-7; Bajwa S, 2008, POSTGRAD MED J, V84, P160, DOI 10.1136/pgmj.2007.062869; JAMES AH, 1958, LANCET, V1, P771; Omi W, 2006, CARDIOLOGY, V105, P75, DOI 10.1159/000089543	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2164	2164		10.1016/S0140-6736(08)61932-7	http://dx.doi.org/10.1016/S0140-6736(08)61932-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101393				2022-12-28	WOS:000261894000040
J	Hammarlund, M; Nix, P; Hauth, L; Jorgensen, EM; Bastiani, M				Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael			Axon Regeneration Requires a Conserved MAP Kinase Pathway	SCIENCE			English	Article							ZIPPER-BEARING KINASE; GROWTH; OUTGROWTH; SYNAPTOGENESIS; NERVE; RPM-1; STAGE; GENE; CAMP	Regeneration of injured neurons can restore function, but most neurons regenerate poorly or not at all. The failure to regenerate in some cases is due to a lack of activation of cell- intrinsic regeneration pathways. These pathways might be targeted for the development of therapies that can restore neuron function after injury or disease. Here, we show that the DLK- 1 mitogen-activated protein ( MAP) kinase pathway is essential for regeneration in Caenorhabditis elegans motor neurons. Loss of this pathway eliminates regeneration, whereas activating it improves regeneration. Further, these proteins also regulate the later step of growth cone migration. We conclude that after axon injury, activation of this MAP kinase cascade is required to switch the mature neuron from an aplastic state to a state capable of growth.	[Hammarlund, Marc; Nix, Paola; Hauth, Linda; Jorgensen, Erik M.; Bastiani, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hammarlund, Marc; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bastiani, M (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	bastiani@bioscience.utah.edu		Nix, Paul/0000-0002-7284-710X	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH [1R21NS060275, NS034307]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060275, R01NS034307, R37NS034307] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0950955] Funding Source: National Science Foundation	Craig H. Neilsen Foundation; McKnight Endowment Fund for Neuroscience; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is dedicated to the memory of Craig H. Neilsen. We thank C.- B. Chen, D. Gard, W. Davis, J. White, and K. Schuske for helpful discussions. Supported by the Craig H. Neilsen Foundation, the McKnight Endowment Fund for Neuroscience, and NIH 1R21NS060275 to M. B. and NIH NS034307 to E. M.	Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Daviau A, 2006, J BIOL CHEM, V281, P31467, DOI 10.1074/jbc.M607612200; Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098; Ewbank Jonathan J, 2006, WormBook, P1; Gabel CV, 2008, DEVELOPMENT, V135, P1129, DOI 10.1242/dev.013995; Gitler D, 2002, J NEUROBIOL, V52, P267, DOI 10.1002/neu.10084; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	31	308	320	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					802	806		10.1126/science.1165527	http://dx.doi.org/10.1126/science.1165527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19164707	Green Accepted			2022-12-28	WOS:000263066800053
J	Goudsmit, J				Goudsmit, Jaap			Daniel Carleton Gajdusek (1923-2008) Obituary	NATURE			English	Biographical-Item									[Goudsmit, Jaap] Crucell Holland, Dept Res & Dev, NL-2301 GB Leiden, Netherlands; [Goudsmit, Jaap] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Johnson & Johnson; University of Amsterdam; Academic Medical Center Amsterdam	Goudsmit, J (corresponding author), Crucell Holland, Dept Res & Dev, POB 2048, NL-2301 GB Leiden, Netherlands.	j.goudsmit@crucell.com							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					394	394		10.1038/457394a	http://dx.doi.org/10.1038/457394a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158783	Bronze			2022-12-28	WOS:000262519200030
J	Davidoff, F; Batalden, P; Stevens, D; Ogrinc, G; Mooney, SE				Davidoff, Frank; Batalden, Paul; Stevens, David; Ogrinc, Greg; Mooney, Susan E.		SQUIRE Dev Grp	Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; STEP	In 2005 we published draft guidelines for reporting studies of quality improvement, as the initial step in a consensus process for development of a more definitive version. The current article contains the revised version, which we refer to as standards for quality improvement reporting excellence ( SQUIRE). This narrative progress report summarises the special features of improvement that are reflected in SQUIRE, and describes major differences between SQUIRE and the initial draft guidelines. It also briefly describes the guideline development process; considers the limitations of and unresolved questions about SQUIRE; describes ancillary supporting documents and alternative versions under development; and discusses plans for dissemination, testing, and further development of SQUIRE.	[Davidoff, Frank] Inst Healthcare Improvement, Wethersfield, CT 06109 USA; [Batalden, Paul; Stevens, David; Ogrinc, Greg; Mooney, Susan E.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Leadership & Improvement, Lebanon, NH 03766 USA; [Ogrinc, Greg] White River Junct VA Hosp, White River Jct, VT 05009 USA; [Mooney, Susan E.] Alice Peck Day Mem Hosp, Lebanon, NH 03766 USA	Dartmouth College	Davidoff, F (corresponding author), Inst Healthcare Improvement, 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net	Booth, Andrew/A-7872-2008; Greenhalgh, Trisha/B-1825-2015	Booth, Andrew/0000-0003-4808-3880; Greenhalgh, Trisha/0000-0003-2369-8088; Barbour, Virginia/0000-0002-2358-2440; von Elm, Erik/0000-0002-7412-0406; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	Robert Wood Johnson Foundation [58073]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	The SQUIRE project was supported in part by a grant from the Robert Wood Johnson Foundation (RWJF grant number 58073).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Baker GR, 2006, QUAL SAF HEALTH CARE, V15, P150, DOI 10.1136/qshc.2005.017103; Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Berwick DM, 2005, QUAL SAF HEALTH CARE, V14, P315, DOI 10.1136/qshc.2005.015669; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Chin MH, 2006, QUAL SAF HEALTH CARE, V15, P79, DOI 10.1136/qshc.2006.017749; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; DAY RA, 1989, J AM MED WRITERS ASS, V4, P16; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; *EQUATOR NETW, ENH QUALITY TRANSP H; Gawande Atul, 2007, New Yorker, P86; Glouberman S., 2002, COMPLICATED COMPLEX; HUTH EJ, 1999, WRITING PUBLISHING M, P63; JADAD AR, 2007, RANDOMIZED CONTROLLE; JANISSE T, 2007, PERMANENTE J, V11, P1; JENNINGS B, 2007, HLTH CARE QUALITY IM; Keech A., 2007, INTERPRETING REPORTI; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Lynn J, 2007, ANN INTERN MED, V146, P666, DOI 10.7326/0003-4819-146-9-200705010-00155; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Pawson R., 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Pronovost P, 2006, QUAL SAF HEALTH CARE, V15, P152, DOI 10.1136/qshc.2006.018432; *QUAL SAF HLTH CAR, GUID AUTH GUID SUBM; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054; RUTLEDGE A, CREATIVITY; *STROBE IN, 2007, STRENGTH REP OBS STU, V147, P573; Thomson RG, 2005, QUAL SAF HEALTH CARE, V14, P317, DOI 10.1136/qshc.2005.015727; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Walshe K, 2002, QUAL SAF HEALTH CARE, V11, P85, DOI 10.1136/qhc.11.1.85; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015	33	92	93	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2009	338								a3152	10.1136/bmj.a3152	http://dx.doi.org/10.1136/bmj.a3152			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BO	19153129	Green Published			2022-12-28	WOS:000263197300005
J	Filbin, MR; Ring, DC; Wessels, MR; Avery, LL; Kradin, RL; Binder, WD				Filbin, Michael R.; Ring, David C.; Wessels, Michael R.; Avery, Laura L.; Kradin, Richard L.; Binder, William D.			A Man with Pain and Swelling of the Right Hand and Hypotension Necrotizing fasciitis and the toxic shock syndrome, caused by group A streptococcal infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPY; SEPSIS; RISK		[Filbin, Michael R.] Massachusetts Gen Hosp, Dept Emergency Serv, Boston, MA 02114 USA; [Ring, David C.] Massachusetts Gen Hosp, Dept Orthopaed, Boston, MA 02114 USA; [Avery, Laura L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wessels, Michael R.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Filbin, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Ring, David C.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA 02115 USA; [Wessels, Michael R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Avery, Laura L.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kradin, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Filbin, MR (corresponding author), Massachusetts Gen Hosp, Dept Emergency Serv, Boston, MA 02114 USA.		Ring, David/AAV-9035-2021	Ring, David/0000-0002-6506-4879	Biosite; Small Bone Innovations; Smith and Nephew Richards; Wright Medical Technology; Joint Active Systems; Biomet; Medical Modeling; Tornier; Acumed; Hand Innovations	Biosite; Small Bone Innovations; Smith and Nephew Richards; Wright Medical Technology; Joint Active Systems; Biomet; Medical Modeling; Tornier; Acumed; Hand Innovations	Dr. Filbin reports receiving grant support from Biosite for a sepsis biomarker study and serving as an expert witness for litigation involving sepsis. Dr. Ring reports receiving unrestricted research grants from Small Bone Innovations, Smith and Nephew Richards, Wright Medical Technology, Joint Active Systems, Biomet, Medical Modeling, Tornier, and Acumed, receiving consulting fees from Smith and Nephew Richards, Wright Medical, Tornier, and Acumed, receiving royalties from Hand Innovations, and having stock options in Illuminos, MiMedx, and Simplicity Orthopedic Solutions. No other potential conflict of interest relevant to this article was reported.	Bakleh M, 2005, CLIN INFECT DIS, V40, P410, DOI 10.1086/427286; Basma H, 1999, INFECT IMMUN, V67, P1871; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Dunbar NM, 2007, J FORENSIC SCI, V52, P920, DOI 10.1111/j.1556-4029.2007.00452.x; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Eriksson BKG, 1999, J INFECT DIS, V180, P410, DOI 10.1086/314872; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kimura AC, 2004, CLIN INFECT DIS, V38, pE87, DOI 10.1086/383471; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Leibovici L, 1998, J INTERN MED, V244, P379; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; OFEK I, 1972, INFECT IMMUN, V6, P459, DOI 10.1128/IAI.6.4.459-464.1972; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shapiro N, 2006, ANN EMERG MED, V48, P583, DOI 10.1016/j.annemergmed.2006.07.007; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144	19	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					281	290		10.1056/NEJMcpc0807489	http://dx.doi.org/10.1056/NEJMcpc0807489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144944				2022-12-28	WOS:000262434500012
J	Scott, IA				Scott, Ian A.			Evaluating cardiovascular risk assessment for asymptomatic people	BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; C-REACTIVE PROTEIN; METABOLIC SYNDROME; ATHEROSCLEROSIS RISK; MULTIPLE BIOMARKERS; COMPUTED-TOMOGRAPHY; ARTERY-DISEASE; PRIMARY-CARE; PREDICTION		[Scott, Ian A.] Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Brisbane, Qld 4102, Australia		Scott, IA (corresponding author), Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Brisbane, Qld 4102, Australia.	ian_scott@health.qld.gov.au	Scott, Ian/Z-4577-2019; Scott, Ian A/F-1482-2011	Scott, Ian/0000-0002-7596-0837				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Astor BC, 2006, AM HEART J, V151, P492, DOI 10.1016/j.ahj.2005.03.055; Bachar GN, 2007, CORONARY ARTERY DIS, V18, P353, DOI 10.1097/MCA.0b013e3281286529; Blumenthal RS, 2003, CIRCULATION, V107, P702, DOI 10.1161/01.CIR.0000048127.93169.88; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Burt JR, 2008, ARCH INTERN MED, V168, P756, DOI 10.1001/archinte.168.7.756; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fowler-Brown Angela, 2004, Ann Intern Med, V140, pW9; Friedmann PD, 1996, ANN INTERN MED, V124, P414, DOI 10.7326/0003-4819-124-4-199602150-00005; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Grover SA, 2007, ARCH INTERN MED, V167, P2296, DOI 10.1001/archinte.167.21.2296; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Hall LML, 2003, BRIT MED J, V326, P251, DOI 10.1136/bmj.326.7383.251; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Montgomery AA, 2000, BRIT MED J, V320, P686, DOI 10.1136/bmj.320.7236.686; O'Malley PG, 2003, JAMA-J AM MED ASSOC, V289, P2215, DOI 10.1001/jama.289.17.2215; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; van Steenkiste B, 2007, EUR J CARDIOV PREV R, V14, P44, DOI 10.1097/01.hjr.0000239475.71805.1e; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	34	15	16	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2009	338								a2844	10.1136/bmj.a2844	http://dx.doi.org/10.1136/bmj.a2844			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PM	19124547				2022-12-28	WOS:000263165500002
J	Pincock, S				Pincock, Stephen			Profile Paulo Sergio Pinheiro: giving a voice to children	LANCET			English	Biographical-Item												stephen.pincock@journalist.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					21	21		10.1016/S0140-6736(08)61942-X	http://dx.doi.org/10.1016/S0140-6736(08)61942-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19121710				2022-12-28	WOS:000262183800013
J	Ohtsuki, H; Iwasa, Y; Nowak, MA				Ohtsuki, Hisashi; Iwasa, Yoh; Nowak, Martin A.			Indirect reciprocity provides only a narrow margin of efficiency for costly punishment	NATURE			English	Article							SOCIAL NORMS; ALTRUISTIC PUNISHMENT; COOPERATION; EVOLUTION; REPUTATION; HUMANS; RULES	Indirect reciprocity(1-5) is a key mechanism for the evolution of human cooperation. Our behaviour towards other people depends not only on what they have done to us but also on what they have done to others. Indirect reciprocity works through reputation(5-17). The standard model of indirect reciprocity offers a binary choice: people can either cooperate or defect. Cooperation implies a cost for the donor and a benefit for the recipient. Defection has no cost and yields no benefit. Currently there is considerable interest in studying the effect of costly (or altruistic) punishment on human behaviour(18-25). Punishment implies a cost for the punished person. Costly punishment means that the punisher also pays a cost. It has been suggested that costly punishment between individuals can promote cooperation. Here we study the role of costly punishment in an explicit model of indirect reciprocity. We analyse all social norms, which depend on the action of the donor and the reputation of the recipient. We allow errors in assigning reputation and study gossip as a mechanism for establishing coherence. We characterize all strategies that allow the evolutionary stability of cooperation. Some of those strategies use costly punishment; others do not. We find that punishment strategies typically reduce the average payoff of the population. Consequently, there is only a small parameter region where costly punishment leads to an efficient equilibrium. In most cases the population does better by not using costly punishment. The efficient strategy for indirect reciprocity is to withhold help for defectors rather than punishing them.	[Ohtsuki, Hisashi] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan; [Ohtsuki, Hisashi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Iwasa, Yoh] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Dept Organism & Evolut Biol, Dept Math, Cambridge, MA 02138 USA	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Kyushu University; Harvard University	Ohtsuki, H (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 1528552, Japan.	ohtsuki.h.aa@m.titech.ac.jp	Nowak, Martin A/A-6977-2008; Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852	John Templeton Foundation; Japan Society for the Promotion of Science; NSF/NIH joint program in mathematical biology; NIH [R01GM078986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF/NIH joint program in mathematical biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support from the John Templeton Foundation, the Japan Society for the Promotion of Science, the NSF/NIH joint program in mathematical biology (NIH grant R01GM078986) and J. Epstein is gratefully acknowledged.	Alexander R., 1987, BIOL MORAL SYSTEMS; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM, 2013, GAME THEORY ITS APPL; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dufwenberg Martin, 2001, HOMO OECON, V18, P19; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fishman MA, 2003, J THEOR BIOL, V225, P285, DOI 10.1016/S0022-5193(03)00246-7; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; OKUNOFUJIWARA M, 1995, GAME ECON BEHAV, V9, P79, DOI 10.1006/game.1995.1006; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sugden R, 1986, EC RIGHTS COOPERATIO; Suzuki S, 2005, P ROY SOC B-BIOL SCI, V272, P1373, DOI 10.1098/rspb.2005.3072; Takahashi N, 2006, J THEOR BIOL, V243, P418, DOI 10.1016/j.jtbi.2006.05.014; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P32, DOI 10.2307/2786982	30	225	230	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					79	82		10.1038/nature07601	http://dx.doi.org/10.1038/nature07601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122640	Green Accepted			2022-12-28	WOS:000262104900034
J	Colmone, A; Amorim, M; Pontier, AL; Wang, S; Jablonski, E; Sipkins, DA				Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.			Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells	SCIENCE			English	Article							STEM-CELLS; C-KIT; MOBILIZATION; ENGRAFTMENT; DIFFERENTIATION; REPOPULATION; EXPRESSION; REGULATOR; DISEASE; CXCR4	The host tissue microenvironment influences malignant cell proliferation and metastasis, but little is known about how tumor- induced changes in the microenvironment affect benign cellular ecosystems. Applying dynamic in vivo imaging to a mouse model, we show that leukemic cell growth disrupts normal hematopoietic progenitor cell ( HPC) bone marrow niches and creates abnormal microenvironments that sequester transplanted human CD34(+) (HPC- enriched) cells. CD34(+) cells in leukemic mice declined in number over time and failed to mobilize into the peripheral circulation in response to cytokine stimulation. Neutralization of stem cell factor ( SCF) secreted by leukemic cells inhibited CD34(+) cell migration into malignant niches, normalized CD34(+) cell numbers, and restored CD34(+) cell mobilization in leukemic mice. These data suggest that the tumor microenvironment causes HPC dysfunction by usurping normal HPC niches and that therapeutic inhibition of HPC interaction with tumor niches may help maintain normal progenitor cell function in the setting of malignancy.	[Colmone, Angela; Amorim, Maria; Pontier, Andrea L.; Wang, Sheng; Jablonski, Elizabeth; Sipkins, Dorothy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	dsipkins@medicine.bsd.uchicago.edu	de Amorim, Maria Galli/K-8259-2016; Colmone, Angela/GXA-0568-2022; wang, sheng/B-1969-2010	de Amorim, Maria Galli/0000-0002-1910-8770; 	Illinois Regenerative Medicine Institute; NIH K08 award [5K08CA112126-02]; NIH Director's DP2 award [1DP2OD002160-01]; NATIONAL CANCER INSTITUTE [K08CA112126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002160] Funding Source: NIH RePORTER	Illinois Regenerative Medicine Institute; NIH K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's DP2 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Chenn, K. Cohen, L. Godley, and R. Salgia for critical discussions and reading of the manuscript; A. Chenn for assistance with retroviral cell transduction; A. Wickrema for help with CD34+ purification; V. Bindokas for imaging expertise; and S. Gurbuxani for assistance with histopathology interpretation. Supported by a grant from the Illinois Regenerative Medicine Institute ( IRMI), an NIH ( National Cancer Institute) K08 award (5K08CA112126-02), and an NIH Director's DP2 award ( 1DP2OD002160-01). A patent application related to this work has been filed by the University of Chicago.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bellone G, 2006, INT J ONCOL, V29, P851; BENSINGER W, 1995, J CLIN ONCOL, V13, P2547, DOI 10.1200/JCO.1995.13.10.2547; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Giehl A, 2007, J CUTAN PATHOL, V34, P7, DOI 10.1111/j.1600-0560.2006.00569.x; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; Naveiras O, 2006, CELL MOL LIFE SCI, V63, P760, DOI 10.1007/s00018-005-5469-5; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Okumura N, 1996, BLOOD, V87, P4100, DOI 10.1182/blood.V87.10.4100.bloodjournal87104100; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Sharma S, 2006, STEM CELLS DEV, V15, P755, DOI 10.1089/scd.2006.15.755; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Tao M, 2000, CYTOKINE, V12, P699, DOI 10.1006/cyto.2000.0666; Theou-Anton N, 2006, BRIT J CANCER, V94, P1180, DOI 10.1038/sj.bjc.6603063; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X	26	446	473	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1861	1865		10.1126/science.1164390	http://dx.doi.org/10.1126/science.1164390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095944				2022-12-28	WOS:000261799400060
J	Knudson, MD; Desjarlais, MP; Dolan, DH				Knudson, M. D.; Desjarlais, M. P.; Dolan, D. H.			Shock-Wave Exploration of the High-Pressure Phases of Carbon	SCIENCE			English	Article							INITIO MOLECULAR-DYNAMICS; DIAGRAM; TEMPERATURES; COMPRESSION; NEPTUNE; DIAMOND; URANUS	The high-energy density behavior of carbon, particularly in the vicinity of the melt boundary, is of broad scientific interest and of particular interest to those studying planetary astrophysics and inertial confinement fusion. Previous experimental data in the several hundred gigapascal pressure range, particularly near the melt boundary, have only been able to provide data with accuracy capable of qualitative comparison with theory. Here we present shock- wave experiments on carbon ( using a magnetically driven flyer- plate technique with an order of magnitude improvement in accuracy) that enable quantitative comparison with theory. This work provides evidence for the existence of a diamond-bc8-liquid triple point on the melt boundary.	[Knudson, M. D.; Desjarlais, M. P.; Dolan, D. H.] Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Knudson, MD (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	mdknuds@sandia.gov	Dolan, Daniel/AAH-7677-2020					BARKER LM, 1972, J APPL PHYS, V43, P4669, DOI 10.1063/1.1660986; Benedetti LR, 1999, SCIENCE, V286, P100, DOI 10.1126/science.286.5437.100; Bradley DK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195506; Brygoo S, 2007, NAT MATER, V6, P274, DOI 10.1038/nmat1863; Correa AA, 2006, P NATL ACAD SCI USA, V103, P1204, DOI 10.1073/pnas.0510489103; DUVAL GE, 1977, REV MOD PHYS, V49, P523, DOI 10.1103/RevModPhys.49.523; Fried LE, 2000, PHYS REV B, V61, P8734, DOI 10.1103/PhysRevB.61.8734; Grumbach MP, 1996, PHYS REV B, V54, P15730, DOI 10.1103/PhysRevB.54.15730; Hubbard WB, 1995, SPACE SCI S, P109; HUBBARD WB, 1991, SCIENCE, V253, P648, DOI 10.1126/science.253.5020.648; Kerley G.I., 2001, SAND20012619; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Lemke RW, 2005, J APPL PHYS, V98, DOI 10.1063/1.2084316; Lindl J, 1998, INERTIAL CONFINEMENT; Matzen MK, 1997, PHYS PLASMAS, V4, P1519, DOI 10.1063/1.872323; MITCHELL AC, 1981, J APPL PHYS, V52, P3363, DOI 10.1063/1.329160; Molodets AM, 1998, AIP CONF PROC, V429, P91, DOI 10.1063/1.55613; Nagao H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2205194; PAVLOVSKII MN, 1971, FIZ TVERD TELA+, V13, P741; Romero NA, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.214113; ROSS M, 1981, NATURE, V292, P435, DOI 10.1038/292435a0; Taylor JR., 1982, INTRO ERROR ANAL, V2nd edition; VANTHIEL M, 1992, HIGH PRESSURE RES, V10, P607; Wang XF, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.185701	26	194	200	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2008	322	5909					1822	1825		10.1126/science.1165278	http://dx.doi.org/10.1126/science.1165278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095937				2022-12-28	WOS:000261799400048
J	Sen, A				Sen, Amartya			Why and how is health a human right?	LANCET			English	Editorial Material									[Sen, Amartya] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Sen, A (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	lgillen@fas.harvard.edu						BENTHAM J, 1918, WORKS J BENTHAM, V2, P523; *COMM SOC DET HLTH, 2007, INT STAT; Daniels N., 2007, JUST HLTH M HLTH NEE; Marmot M, 2006, B WORLD HEALTH ORGAN, V84, P267; Ruger JP, 2004, LANCET, V364, P1092, DOI 10.1016/S0140-6736(04)17067-0; Ruger JP, 2006, YALE J LAW HUMANITIE, V18, P273, DOI DOI 10.1016/J.HEALTHPOL.2010.06.019; Sen A, 2004, PHILOS PUBLIC AFF, V32, P315, DOI 10.1111/j.1088-4963.2004.00017.x; SEN A, 2006, DEV FREEDOM, V27, P2913; United Nations, 1948, UN DECL HUM RIGHTS	9	45	50	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2010	2010		10.1016/S0140-6736(08)61784-5	http://dx.doi.org/10.1016/S0140-6736(08)61784-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19097279	Green Submitted			2022-12-28	WOS:000261746900009
J	Sparer, M				Sparer, Michael			Health Care 2009: Medicaid and the US Path to National Health Insurance.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sparer, Michael] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA	Columbia University	Sparer, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.							Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW17, DOI 10.1377/hlthaff.28.1.w17; *KAIS COMM MED UN, 2008, MED PROGR GLANC; KENNEY G, 2008, STATE BUY IN PROGRAM; OBERLANDER J, 2003, HLTH AFF MILLWOOD S; Sparer MS, 2003, J HEALTH POLIT POLIC, V28, P245, DOI 10.1215/03616878-28-2-3-245	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					323	325		10.1056/NEJMp0809878	http://dx.doi.org/10.1056/NEJMp0809878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164184				2022-12-28	WOS:000262519900002
J	Broadfield, E; Doshi, N; Alexander, PDG; Greaves, M; Woodcock, A				Broadfield, Emma; Doshi, Neelam; Alexander, Peter D. G.; Greaves, Melanie; Woodcock, Ashley			Cunning and community-acquired pneumonia	LANCET			English	Editorial Material							ASSOCIATION; MRSA		[Broadfield, Emma; Alexander, Peter D. G.] Univ S Manchester Hosp, Dept Intens Care Med, Manchester M20 8LR, Lancs, England; [Doshi, Neelam] Univ S Manchester Hosp, Dept Med Microbiol, Manchester M20 8LR, Lancs, England; [Greaves, Melanie] Univ S Manchester Hosp, Dept Radiol, Manchester M20 8LR, Lancs, England; [Woodcock, Ashley] Univ S Manchester Hosp, Dept Resp Med, Manchester M20 8LR, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Broadfield, E (corresponding author), Wythenshawe Hosp, Univ S Manchester Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England.	emma@ejcbroad.fsnet.co.uk		Woodcock, Ashley/0000-0002-5428-8578				Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Nathwani D, 2008, J ANTIMICROB CHEMOTH, V61, P976, DOI 10.1093/jac/dkn096; Yamaoka Toshimori, 2007, Journal of Infection and Chemotherapy, V13, P141, DOI 10.1007/s10156-007-0521-z	4	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					270	270		10.1016/S0140-6736(09)60074-X	http://dx.doi.org/10.1016/S0140-6736(09)60074-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150706				2022-12-28	WOS:000262537500030
J	Klass, P				Klass, Perri			The Fast-Food Fund	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klass, Perri] NYU, New York, NY 10003 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10003 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					209	211		10.1056/NEJMp0810106	http://dx.doi.org/10.1056/NEJMp0810106			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144936				2022-12-28	WOS:000262434500003
J	Christmann, A; Grill, E				Christmann, Alexander; Grill, Erwin			Are GTGs ABA's Biggest Fans?	CELL			English	Editorial Material							ABSCISIC-ACID; MEMBRANE; CHANNELS	The search for receptors for abscisic acid (ABA), a phytohormone central to the response of plants to biotic and abiotic stress, has been controversial. In this issue, Pandey et al. (2009) report the identification of two membrane proteins from Arabidopsis, GTG1 and GTG2, that bind ABA in vitro and mediate ABA responses in vivo.	[Christmann, Alexander; Grill, Erwin] Tech Univ Munich, Lehrstuhl Bot, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Grill, E (corresponding author), Tech Univ Munich, Lehrstuhl Bot, Hochanger 4, D-85354 Freising Weihenstephan, Germany.	grill@wzw.tum.de	Christmann, Alexander/I-2655-2017	Christmann, Alexander/0000-0002-3242-0814				Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW143, DOI 10.1093/nar/gki351; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Eng ET, 2008, J MOL BIOL, V375, P1086, DOI 10.1016/j.jmb.2007.11.027; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Razem FA, 2008, NATURE, V456, P824, DOI 10.1038/nature07645; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608	9	12	14	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					21	23		10.1016/j.cell.2008.12.033	http://dx.doi.org/10.1016/j.cell.2008.12.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135884	Bronze			2022-12-28	WOS:000262318400010
J	Sundaram, JK; von Arnim, R				Sundaram, Jomo Kwame; von Arnim, Rudiger			ECONOMICS Trade Liberalization and Economic Development	SCIENCE			English	Editorial Material							MONOPOLISTIC COMPETITION		[Sundaram, Jomo Kwame] UN, Dept Econ & Social Affairs, New York, NY 10017 USA; [von Arnim, Rudiger] Univ Denver, Dept Econ, Denver, CO 80208 USA	University of Denver	Sundaram, JK (corresponding author), UN, Dept Econ & Social Affairs, 2 UN Plaza DC2-2324, New York, NY 10017 USA.	jomoks@yahoo.com; rudiarnim@gmail.com						ACKERMAN F, 2005, 0501 GDAE TUFTS U; Anderson K., 2005, AGR TRADE REFORM DOH; Bernard AB, 2007, J ECON PERSPECT, V21, P105, DOI 10.1257/jep.21.3.105; BHAGWATI J, 2005, FINANCIAL TIMES 0926; Blinder AS, 2006, FOREIGN AFF, V85, P113, DOI 10.2307/20031915; BONET A, 2004, MULTILATERAL AGR TRA; Chang H-J., 2007, BAD SAMARITANS MYTH; DIXIT AK, 1977, AM ECON REV, V67, P297; FRENKEL R, 2006, 19 DESA UN; GRUBEL HG, 1975, ECON J, V35, P646; *INT CTR TRAD SUST, 2008, BRIDGES, V12; Kraev Egor, 2005, ESTIMATING GDP EFFEC; KRUGMAN PR, 1979, J INT ECON, V9, P469, DOI 10.1016/0022-1996(79)90017-5; KRUGMAN PR, 1990, STRATEGIC TRADE POLI; Naastepad CWM, 2006, CAMBRIDGE J ECON, V30, P403, DOI 10.1093/cje/bei063; Ocampo JA, 2005, BEYOND REFORMS: STRUCTURAL DYNAMICS AND MACROECONOMIC VULNERABILITY, pXI; Polaski S., 2006, WINNERS LOSERS IMPAC; Reinert Erik S., 2008, RICH COUNTRIES GOT R; Ricardo D., 1821, PRINCIPLES POLITICAL; Samuelson PA, 2004, J ECON PERSPECT, V18, P135, DOI 10.1257/0895330042162403; Stiglitz J., 2003, GLOBALIZATION ITS DI; STIGLITZ JE, 2004, DEV FRIENDLY PRIORIT; Taylor L., 2006, MODELLING IMPACT TRA; ZOELLICK R, 2008, CHALLENGE EC STATECR	24	9	9	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					211	212		10.1126/science.1155337	http://dx.doi.org/10.1126/science.1155337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131614				2022-12-28	WOS:000262290600020
J	Ghosh, D; Griswold, J; Erman, M; Pangborn, W				Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter			Structural basis for androgen specificity and oestrogen synthesis in human aromatase	NATURE			English	Article							HUMAN PLACENTAL AROMATASE; CYTOCHROME-P450 AROMATASE; KINETIC-PROPERTIES; CRYSTAL-STRUCTURES; DIOXYGEN COMPLEX; WILD-TYPE; PURIFICATION; INHIBITORS; MODEL; MECHANISM	Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens(1-3). Aromatase inhibitors therefore constitute a front-line therapy for oestrogen- dependent breast cancer(3,4). In a three-step process, each step requiring 1 mol of O-2, 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16 alpha-hydroxytestosterone to oestrone, 17 beta-oestradiol and 17 beta, 16 alpha-oestriol, respectively(1-3). The first two steps are C19- methyl hydroxylation steps, and the third involves the aromatization of the steroid A- ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full- length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen- specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino- terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next- generation aromatase inhibitors.	[Ghosh, Debashis; Griswold, Jennifer; Erman, Mary; Pangborn, Walter] Hauptman Woodward Res Inst, Buffalo, NY 14203 USA; [Ghosh, Debashis] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Hauptman Woodward Medical Research Institute; Roswell Park Cancer Institute	Ghosh, D (corresponding author), Hauptman Woodward Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	ghosh@hwi.buffalo.edu			National Institutes of Health [GM62794, GM59450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM059450, R01GM086893, R01GM062794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Osawa, who pioneered aromatase research and its purification from human placenta at the institute, for many discussions and encouragement; past graduate students, postdoctoral scientists and research associates for contributions to the initial purification and crystallization efforts; H. Davies for discussions; D. Gewirth, V. Cody, G. DeTitta and J. Griffin for critically reading the manuscript; staff at the Women's and Children's Hospital of Buffalo for providing the placenta used in this work; and staffs of the Cornell High Energy Synchrotron Source and the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X- ray data collection. The research is supported in part by grants GM62794 and GM59450 (to D.G.) from the National Institutes of Health.	AKHTAR M, 1993, J STEROID BIOCHEM, V44, P375, DOI 10.1016/0960-0760(93)90241-N; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; AMARNEH B, 1995, MOL CELL ENDOCRINOL, V109, pR1, DOI 10.1016/0303-7207(95)03524-B; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen SA, 2003, J STEROID BIOCHEM, V86, P231, DOI 10.1016/S0960-0760(03)00361-3; CHEN SU, 1993, J STEROID BIOCHEM, V44, P347, DOI 10.1016/0960-0760(93)90238-R; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Eisen A, 2008, CANCER TREAT REV, V34, P157, DOI 10.1016/j.ctrv.2007.11.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Guallar V, 2003, P NATL ACAD SCI USA, V100, P6998, DOI 10.1073/pnas.0732000100; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; Hong Y, 2008, BIOCHEM PHARMACOL, V75, P1161, DOI 10.1016/j.bcp.2007.11.010; Johnston JO, 1998, CRIT REV BIOCHEM MOL, V33, P375; KADOHAMA N, 1992, J STEROID BIOCHEM, V43, P693, DOI 10.1016/0960-0760(92)90295-T; Kao YC, 2001, EUR J BIOCHEM, V268, P243, DOI 10.1046/j.1432-1327.2001.01886.x; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; Lala P, 2004, J STEROID BIOCHEM, V88, P235, DOI 10.1016/j.jsbmb.2003.12.010; LAUGHTON CA, 1993, J STEROID BIOCHEM, V44, P399, DOI 10.1016/0960-0760(93)90243-P; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; OH SS, 1993, J STEROID BIOCHEM, V44, P389, DOI 10.1016/0960-0760(93)90242-O; Omura T, 1978, CYTOCHROME P 450; OTNINOWSKI Z, 1995, HKL MANUAL; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, ARCH BIOCHEM BIOPHYS, V464, P197, DOI 10.1016/j.abb.2007.04.028; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; ZHOU DJ, 1991, P NATL ACAD SCI USA, V88, P410, DOI 10.1073/pnas.88.2.410	36	390	399	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					219	U119		10.1038/nature07614	http://dx.doi.org/10.1038/nature07614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129847	Green Accepted			2022-12-28	WOS:000262360200038
J	Kennett, DJ; Kennett, JP; West, A; Mercer, C; Hee, SSQ; Bement, L; Bunch, TE; Sellers, M; Wolbach, WS				Kennett, D. J.; Kennett, J. P.; West, A.; Mercer, C.; Hee, S. S. Que; Bement, L.; Bunch, T. E.; Sellers, M.; Wolbach, W. S.			Nanodiamonds in the Younger Dryas Boundary Sediment Layer	SCIENCE			English	Article							DIAMOND		[Kennett, D. J.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Kennett, J. P.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [West, A.] GeoSci Consulting, Dewey, AZ 86327 USA; [Mercer, C.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Hee, S. S. Que] Univ Calif Los Angeles, Dept Environm Hlth Sci, Ctr Occupat & Environm Hlth, Los Angeles, CA 90095 USA; [Bement, L.] Univ Oklahoma, Oklahoma Archeol Survey, Norman, OK 73019 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Geol, Flagstaff, AZ 86011 USA; [Bunch, T. E.; Sellers, M.] No Arizona Univ, Dept Sci Biol, Flagstaff, AZ 86011 USA; [Wolbach, W. S.] De Paul Univ, Dept Chem, Chicago, IL 60614 USA	University of Oregon; University of California System; University of California Santa Barbara; National Institute for Materials Science; University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma - Norman; Northern Arizona University; Northern Arizona University; DePaul University	Kennett, DJ (corresponding author), Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	dkennett@uoregon.edu	Kennett, Douglas J/I-7613-2015; MERCER, Christopher/H-2654-2011	Kennett, Douglas J/0000-0001-5133-9010; Wolbach, Wendy/0000-0003-4398-8269	NSF [ATM-0713769]	NSF(National Science Foundation (NSF))	This research was funded by the NSF (grant ATM-0713769). We thank three anonymous reviewers and V. Haynes for assistance.	Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Grady MM, 1995, EARTH PLANET SC LETT, V136, P677, DOI 10.1016/0012-821X(95)00162-6; Haynes CV, 2008, P NATL ACAD SCI USA, V105, P6520, DOI 10.1073/pnas.0800560105; Hough RM, 1997, GEOLOGY, V25, P1019, DOI 10.1130/0091-7613(1997)025<1019:DFTIRK>2.3.CO;2; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606; Wen B, 2007, INT MATER REV, V52, P131, DOI 10.1179/174328007X160236	7	117	123	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					94	94		10.1126/science.1162819	http://dx.doi.org/10.1126/science.1162819			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119227				2022-12-28	WOS:000262104100047
J	Cestari, DM; Metson, RB; Cunnane, ME; Faquin, WC; Savar, A; Murali, MR				Cestari, Dean M.; Metson, Ralph B.; Cunnane, Mary E.; Faquin, William C.; Savar, Aaron; Murali, Mandakolathur R.			Case 40-2008: A 26-Year-Old Man with Blurred Vision	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALLERGIC FUNGAL SINUSITIS; CHRONIC RHINOSINUSITIS		[Cestari, Dean M.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Metson, Ralph B.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Cunnane, Mary E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Faquin, William C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cestari, Dean M.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Metson, Ralph B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Cunnane, Mary E.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Faquin, William C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cestari, DM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.							FRISEN L, 1980, BRAIN, V103, P639, DOI 10.1093/brain/103.3.639; Gendelman HE, 2007, J NEUROIMMUNE PHARM, V2, P8, DOI 10.1007/s11481-006-9050-2; Gosepath J, 2004, AM J RHINOL, V18, P9, DOI 10.1177/194589240401800104; Gosepath Jan, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P9, DOI 10.1097/00020840-200502000-00004; Harvey R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006394; Kuhn Frederick A, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P1, DOI 10.1097/00020840-200302000-00001; Lagreze WDA, 1998, GRAEF ARCH CLIN EXP, V236, P401, DOI 10.1007/s004170050096; Lanza DC, 2006, ANN OTO RHINOL LARYN, V115, P27; Ponikau JU, 2003, J ALLERGY CLIN IMMUN, V112, P877, DOI 10.1016/j.jaci.2003.08.009; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Rizzo JF, 2002, OPHTHALMOLOGY, V109, P1679, DOI 10.1016/S0161-6420(02)01148-X; Schubert MS, 2004, OTOLARYNG CLIN N AM, V37, P301, DOI 10.1016/S0030-6665(03)00152-X; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896	13	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2825	2833		10.1056/NEJMcpc0805311	http://dx.doi.org/10.1056/NEJMcpc0805311			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109578				2022-12-28	WOS:000261950800012
J	Newnham, HH; Rivera-Woll, LM				Newnham, Harvey H.; Rivera-Woll, Livia M.			Hypogonadism Due to Pituicytoma in an Identical Twin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Newnham, Harvey H.; Rivera-Woll, Livia M.] Alfred Hosp, Prahran, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health	Newnham, HH (corresponding author), Alfred Hosp, Prahran, Vic 3181, Australia.		Newnham, Harvey H/I-2291-2014	Newnham, Harvey H/0000-0002-4732-0859					0	14	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2824	2824		10.1056/NEJMicm067848	http://dx.doi.org/10.1056/NEJMicm067848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109577				2022-12-28	WOS:000261950800010
J	[Anonymous]				[Anonymous]			Oh, what a year it was: a look back at medicine in 2008	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2087	2087						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101364	Bronze			2022-12-28	WOS:000261894000001
J	Lee, TH; Mongan, JJ; Oberlander, J; Rosenthal, MB				Lee, Thomas H.; Mongan, James J.; Oberlander, Jonathan; Rosenthal, Meredith B.			Perspective Roundtable: Health Care and the Recession.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Rosenthal, Meredith/0000-0003-3410-0184					0	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					E5	U19		10.1056/NEJMp0810969	http://dx.doi.org/10.1056/NEJMp0810969			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164182				2022-12-28	WOS:000262519900004
J	Bevan, G				Bevan, Gwyn			Have targets done more harm than good in the English NHS? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WAITING-TIMES; CARE		[Bevan, Gwyn] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England	University of London; London School Economics & Political Science	Bevan, G (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Management, Houghton St, London WC2A 2AE, England.	G.Bevan@lse.ac.uk						*AUD GEN WAL, 2005, NHS WAIT TIM WAL, V2, P40; *AUD GEN WAL, 2006, AMB SERV WAL; Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; Bevan G, 2006, NATL INST ECON REV, V197, P67, DOI 10.1177/002795010619700102; Bevan G, 2006, PUBLIC ADMIN, V84, P517, DOI 10.1111/j.1467-9299.2006.00600.x; Bevan G, 2009, J R STAT SOC A STAT, V172, P161, DOI 10.1111/j.1467-985X.2008.00557.x; Buffalo N.Y., 1908, NHS ENGL OP FRAM 200, V13; Conservative Party, 2008, DEL SOM BEST HLTH EU; *DEP HLTH SOC SERV, 2008, NO IR WAIT LISTS; Farrar S., 2004, PERFORMANCE ASSESSME; Hauck K, 2007, HEALTH ECON, V16, P275, DOI 10.1002/hec.1153; *HEALTHC COMM, 2005, PERF RAT METH 2004 0; Leatherman S, 2008, QUEST QUALITY REFINI; Leatherman S.T., 2003, QUEST QUALITY NHS MI; *NO IR AMB SERV HL, ANN REP 07 08; Propper C, 2008, BE J ECON ANAL POLI, V8, DOI 10.2202/1935-1682.1863; *ROYAL COLL PHYS, 2006, NAT SENT STROK AUD, P15; *SCOTT GOV, 2007, BETT HLTH BETT CAR A, P72; *SECR STAT HLTH, 2000, NHS PLAN CM 4818 I, P28; *SECR STAT HLTH, 2000, NHS CANC PLAN; Secretary of State for Health, 2008, HIGH QUAL CAR ALL NH; Secretary of State for Health, 1991, PAT CHART; *STAT WAL, 2008, AMB SERV WAL; Warden J, 1996, BRIT MED J, V313, P774; *WELSH ASS GOV, RAT SAFF TARG 2006 2; Willcox S, 2007, HEALTH AFFAIR, V26, P1078, DOI 10.1377/hlthaff.26.4.1078	26	25	25	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2009	338								a3129	10.1136/bmj.a3129	http://dx.doi.org/10.1136/bmj.a3129			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151061				2022-12-28	WOS:000263193500005
J	Farquhar, C				Farquhar, Cynthia			Do uterine fibroids cause infertility and should they be removed to increase fertility?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farquhar, Cynthia] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland	Farquhar, C (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	c.farquhar@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553				[Anonymous], 2004, FERT ASS TREATM PEOP; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Bradford Hill A., 1991, BRADFORD HILLS PRINC; Bulletti C, 1999, J AM ASSOC GYN LAP, V6, P441, DOI 10.1016/S1074-3804(99)80008-5; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Casini ML, 2006, GYNECOL ENDOCRINOL, V22, P106, DOI 10.1080/09513590600604673; DANGELO AG, 2006, COCHRANE DB SYST REV; Donnez J, 2002, HUM REPROD, V17, P1424, DOI 10.1093/humrep/17.6.1424; Gupta JK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005073.pub2; PRITTS EA, 2008, FERTIL STERIL   0311; VERKAUF BS, 1992, FERTIL STERIL, V58, P1	11	11	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 16	2009	338								b126	10.1136/bmj.b126	http://dx.doi.org/10.1136/bmj.b126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151067				2022-12-28	WOS:000263193500003
J	Aron, D; Pogach, L				Aron, David; Pogach, Leonard			Transparency Standards for Diabetes Performance Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TARGETS		[Aron, David] Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Aron, David] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Pogach, Leonard] New Jersey Vet Hlth Adm Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; New Jersey Department of Health & Senior Services; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University New Brunswick; Rutgers State University Medical Center	Aron, D (corresponding author), Louis Stokes Cleveland VA Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						*AG HEALTHC RES QU, ASS QUAL CAR DIAB; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; *BRIDG EXC, DIAB CAR LINK; *BURS, NAT DIAB CALL ACT BL; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hayward RA, 2007, AM J MANAG CARE, V13, P126; *NAT COMM QUAL ASS, QUAL MATT; *NAT QUAL FOR, NAT VOL CONS STAND 2; National Committee for Quality Assurance, 2008, HEDIS, V2; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Rose Johnie, 2008, Qual Manag Health Care, V17, P27, DOI 10.1097/01.QMH.0000308635.59108.29; SMITH PC, 2008, HLTH POLICY, V41, P37; WORKING GROUP, 1998, REP WORK GROUP TRANS	15	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					210	212		10.1001/jama.2008.930	http://dx.doi.org/10.1001/jama.2008.930			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141769				2022-12-28	WOS:000262405500023
J	Hirsch, IB				Hirsch, Irl B.			Sliding Scale Insulin-Time to Stop Sliding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIABETES-MELLITUS; HOSPITALIZED-PATIENTS; GLYCEMIC CONTROL; MANAGEMENT; THERAPY; HYPERGLYCEMIA; INPATIENTS; OUTCOMES; GLUCOSE		[Hirsch, Irl B.] Univ Washington, Sch Med, Diabet Care Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), UWMC Roosevelt, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@u.washington.edu						Becker T, 2007, DIABETES RES CLIN PR, V78, P392, DOI 10.1016/j.diabres.2007.05.003; Bolli Geremia B, 2003, Pediatr Endocrinol Rev, V1, P9; Braithwaite SS, 2008, CURR OPIN ENDOCRINOL, V15, P159, DOI 10.1097/MED.0b013e3282f827e7; Browning LA, 2004, AM J HEALTH-SYST PH, V61, P1611, DOI 10.1093/ajhp/61.15.1611; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; FORMAN BH, 1974, PEDIATRICS, V53, P257; Joslin EP, 1934, DIABETIC MANUAL MUTU, P108; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Mooradian AD, 2006, ANN INTERN MED, V145, P125, DOI 10.7326/0003-4819-145-2-200607180-00010; Queale WS, 1997, ARCH INTERN MED, V157, P545, DOI 10.1001/archinte.157.5.545; ROBBINS L, 1963, Med Rec Ann, V56, P201; Trence DL, 2003, J CLIN ENDOCR METAB, V88, P2430, DOI 10.1210/jc.2003-030347; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295	15	77	83	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					213	214		10.1001/jama.2008.943	http://dx.doi.org/10.1001/jama.2008.943			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141770				2022-12-28	WOS:000262405500024
J	McDermott, MM; Ades, P; Guralnik, JM; Dyer, A; Ferrucci, L; Liu, K; Nelson, M; Lloyd-Jones, D; Van Horn, L; Garside, D; Kibbe, M; Domanchuk, K; Stein, JH; Liao, YH; Tao, HM; Green, D; Pearce, WH; Schneider, JR; McPherson, D; Laing, ST; McCarthy, WJ; Shroff, A; Criqui, MH				McDermott, Mary M.; Ades, Philip; Guralnik, Jack M.; Dyer, Alan; Ferrucci, Luigi; Liu, Kiang; Nelson, Miriam; Lloyd-Jones, Donald; Van Horn, Linda; Garside, Daniel; Kibbe, Melina; Domanchuk, Kathryn; Stein, James H.; Liao, Yihua; Tao, Huimin; Green, David; Pearce, William H.; Schneider, Joseph R.; McPherson, David; Laing, Susan T.; McCarthy, Walter J.; Shroff, Adhir; Criqui, Michael H.			Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANKLE BRACHIAL INDEX; LOWER-EXTREMITY ISCHEMIA; PHYSICAL-ACTIVITY; LEG SYMPTOMS; CLINICAL CHARACTERISTICS; SUBSEQUENT DISABILITY; FUNCTIONAL IMPAIRMENT; CARDIOVASCULAR EVENTS; PERFORMANCE-MEASURES; SKELETAL-MUSCLE	Context Neither supervised treadmill exercise nor strength training for patients with peripheral arterial disease ( PAD) without intermittent claudication have been established as beneficial. Objective To determine whether supervised treadmill exercise or lower extremity resistance training improve functional performance of patients with PAD with or without claudication. Design, Setting, and Participants Randomized controlled clinical trial performed at an urban academic medical center between April 1, 2004, and August 8, 2008, involving 156 patients with PAD who were randomly assigned to supervised treadmill exercise, to lower extremity resistance training, or to a control group. Main Outcome Measures Six- minute walk performance and the short physical performance battery. Secondary outcomes were brachial artery flow- mediated dilation, treadmill walking performance, the Walking Impairment Questionnaire, and the 36- Item Short Form Health Survey physical functioning ( SF- 36 PF) score. Results For the 6- minute walk, those in the supervised treadmill exercise group increased their distance walked by 35.9 m ( 95% confidence interval [ CI], 15.3- 56.5 m; P <. 001) compared with the control group, whereas those in the resistance training group increased their distance walked by 12.4 m ( 95% CI, - 8.42 to 33.3 m; P=. 24) compared with the control group. Neither exercise group improved its short physical performance battery scores. For brachial artery flow- mediated dilation, those in the treadmill group had a mean improvement of 1.53% ( 95% CI, 0.35%- 2.70%; P=. 02) compared with the control group. The treadmill group had greater increases in maximal treadmill walking time ( 3.44 minutes; 95% CI, 2.05- 4.84 minutes; P <. 001); walking impairment distance score ( 10.7; 95% CI, 1.56- 19.9; P=. 02); and SF- 36 PF score ( 7.5; 95% CI, 0.00- 15.0; P=. 02) than the control group. The resistance training group had greater increases in maximal treadmill walking time ( 1.90 minutes; 95% CI, 0.49-3.31 minutes; P=. 009); walking impairment scores for distance ( 6.92; 95% CI, 1.07-12.8; P=. 02) and stair climbing ( 10.4; 95% CI, 0.00- 20.8; P=. 03); and SF- 36 PF score ( 7.5; 95% CI, 0.0- 15.0; P=. 04) than the control group. Conclusions Supervised treadmill training improved 6- minute walk performance, treadmill walking performance, brachial artery flow- mediated dilation, and quality of life but did not improve the short physical performance battery scores of PAD participants with and without intermittent claudication. Lower extremity resistance training improved functional performance measured by treadmill walking, quality of life, and stair climbing ability. Trial Registration clinicaltrials. gov Identifier: NCT00106327.	[McDermott, Mary M.; Lloyd-Jones, Donald; Domanchuk, Kathryn; Green, David] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Dyer, Alan; Liu, Kiang; Lloyd-Jones, Donald; Van Horn, Linda; Garside, Daniel; Liao, Yihua; Tao, Huimin] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Kibbe, Melina; Pearce, William H.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Ades, Philip] Univ Vermont, Dept Med, Burlington, VT USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Lab Clin Epidemiol, Baltimore, MD 21224 USA; [Nelson, Miriam] Tufts Univ, Medford, MA 02155 USA; [Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Schneider, Joseph R.] Cent DuPage Hosp, Dept Surg, Winfield, IL USA; [McPherson, David; Laing, Susan T.] Univ Texas Houston, Hlth Sci Ctr, Dept Med, Houston, TX USA; [McCarthy, Walter J.] Rush Univ, Sch Med, Dept Surg, Chicago, IL 60612 USA; [Shroff, Adhir] Univ Illinois, Dept Med, Chicago, IL USA; [Criqui, Michael H.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tufts University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego	McDermott, MM (corresponding author), 750 Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009	Lloyd-Jones, Donald/0000-0003-0847-6110; Stein, James/0000-0002-2770-8223; Laing, Susan/0000-0002-6504-6646	National Heart, Lung, and Blood Institute [R01-HL073551]; National Center for Research Resources [RR-00048]; National Institutes of Health; Intramural Research Program; National Institutes on Aging; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL073551, R44HL073551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG001050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants R01-HL073551 from the National Heart, Lung, and Blood Institute and by RR-00048 from the National Center for Research Resources, National Institutes of Health. This was also supported in part by the Intramural Research Program, National Institutes on Aging.	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Criqui M H, 1996, Vasc Med, V1, P65; Curb JD, 2006, J AM GERIATR SOC, V54, P737, DOI 10.1111/j.1532-5415.2006.00700.x; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; Garg PK, 2006, CIRCULATION, V114, P242, DOI 10.1161/CIRCULATIONAHA.105.605246; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; GREIG C, 1993, J AM GERIATR SOC, V41, P15, DOI 10.1111/j.1532-5415.1993.tb05941.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; HARRIS LM, 1995, AM J CARDIOL, V76, P207, DOI 10.1016/S0002-9149(99)80066-6; HIATT WR, 1994, CIRCULATION, V90, P1866, DOI 10.1161/01.CIR.90.4.1866; HIATT WR, 1990, CIRCULATION, V81, P602, DOI 10.1161/01.CIR.81.2.602; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Hollander M., 1973, NONPARAMETRIC STAT M; McDermott MM, 2008, J VASC SURG, V48, P1231, DOI 10.1016/j.jvs.2008.06.050; McDermott MM, 2008, J AM GERIATR SOC, V56, P724, DOI 10.1111/j.1532-5415.2008.01633.x; McDermott MM, 2007, J AM COLL CARDIOL, V50, P974, DOI 10.1016/j.jacc.2007.05.030; McDermott MM, 2007, J AM GERIATR SOC, V55, P400, DOI 10.1111/j.1532-5415.2007.01092.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2002, ANN INTERN MED, V136, P873, DOI 10.7326/0003-4819-136-12-200206180-00008; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2001, J AM GERIATR SOC, V49, P747, DOI 10.1046/j.1532-5415.2001.49151.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; MCDERMOTT MM, J VASC SURG IN PRESS; McGuigan MRM, 2001, J GERONTOL A-BIOL, V56, pB302, DOI 10.1093/gerona/56.7.B302; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; NOBLE BJ, 1982, MED SCI SPORT EXER, V14, P406; OURIEL K, 1982, ARCH SURG-CHICAGO, V117, P1297; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Philpott A, 2007, ARTERIOSCL THROM VAS, V27, P2065, DOI 10.1161/ATVBAHA.107.149740; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Rantanen T, 1999, J GERONTOL A-BIOL, V54, pM172, DOI 10.1093/gerona/54.4.M172; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; Rucker-Whitaker C, 2004, J AM GERIATR SOC, V52, P922, DOI 10.1111/j.1532-5415.2004.52259.x; Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; Wang JC, 2005, CIRCULATION, V112, P3501, DOI 10.1161/CIRCULATIONAHA.105.548099; Ware JE, 1993, SF36 HLTH SURVEY MAN; YAO ST, 1969, BRIT J SURG, V56, P676, DOI 10.1002/bjs.1800560910	49	284	292	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					165	174		10.1001/jama.2008.962	http://dx.doi.org/10.1001/jama.2008.962			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	393VV	19141764	Green Accepted, Bronze			2022-12-28	WOS:000262405500018
J	Cheianov, VV				Cheianov, Vadim V.			PHYSICS When Infinity Does Not Count	SCIENCE			English	Editorial Material									[Cheianov, Vadim V.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England	Lancaster University	Cheianov, VV (corresponding author), Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England.	v.cheianov@lancaster.ac.uk			Engineering and Physical Sciences Research Council [EP/C509358/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aristov DN, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085327; Feynman R.F., 1985, STRANGE THEORY LIGHT; GIAMARCHI T, 2003, QUANTUM PHYS 1 DIMEN; Imambekov A, 2009, SCIENCE, V323, P228, DOI 10.1126/science.1165403; Kleppner D, 2000, SCIENCE, V289, P893, DOI 10.1126/science.289.5481.893; MATTIS DC, 1965, J MATH PHYS, V6, P304, DOI 10.1063/1.1704281; Moritz H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250402; Pustilnik M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.196405; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Volovik GE, 2005, JETP LETT+, V82, P319, DOI 10.1134/1.2137368	10	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					213	214		10.1126/science.1168389	http://dx.doi.org/10.1126/science.1168389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131615				2022-12-28	WOS:000262290600021
J	Chuang, JS; Rivoire, O; Leibler, S				Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas			Simpson's Paradox in a Synthetic Microbial System	SCIENCE			English	Article							BACTERIAL-POPULATIONS; COOPERATION; COMMUNICATION; EVOLUTION; BEHAVIOR; COMPETITION	The maintenance of "public" or "common good" producers is a major question in the evolution of cooperation. Because nonproducers benefit from the shared resource without bearing its cost of production, they may proliferate faster than producers. We established a synthetic microbial system consisting of two Escherichia coli strains of common- good producers and nonproducers. Depending on the population structure, which was varied by forming groups with different initial compositions, an apparently paradoxical situation could be attained in which nonproducers grew faster within each group, yet producers increased overall. We show that a simple way to generate the variance required for this effect is through stochastic fluctuations via population bottlenecks. The synthetic approach described here thus provides a way to study generic mechanisms of natural selection.	[Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Chuang, John S.; Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Chuang, JS (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	chuangj@rockefeller.edu			NIH fellowship; Human Frontier Science Program	NIH fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program)	We are grateful to C. Bargmann, C. Guet, L. Keller, E. Kussell, R. Losick, and A. Murray for comments on the manuscript and members of our laboratory for advice and discussion. We also thank the Yale Coli Genetic Stock Center and the National BioResource Project (NIG, Japan) for strains and the Rockefeller Flow Cytometry Resource Center for help. J.S.C. was partly supported by a NIH fellowship and O.R. by a Human Frontier Science Program fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; BICKEL PJ, 1975, SCIENCE, V187, P398, DOI 10.1126/science.187.4175.398; BLYTH CR, 1972, J AM STAT ASSOC, V67, P364, DOI 10.2307/2284382; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brockhurst MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000634; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunny GM, 2008, BIOESSAYS, V30, P296, DOI 10.1002/bies.20740; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank, 1998, FDN SOCIAL EVOLUTION; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Haldane JB., 1990, CAUSES EVOLUTION; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1975, ASA STUDIES, V4, P133; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keller L, 1999, LEVELS SELECTION EVO; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Sober Elliott, 1998, OTHERS EVOLUTION PSY; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104	28	192	199	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					272	275		10.1126/science.1166739	http://dx.doi.org/10.1126/science.1166739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131632				2022-12-28	WOS:000262290600044
J	Wrana, JL				Wrana, Jeffrey L.			The Secret Life of Smad4	CELL			English	Editorial Material							SYNAPTIC GROWTH; PATHWAY	Smad4 is an important mediator of signaling by TGF beta family members that is presumed to be controlled by the phosphorylation status of its partners, the receptor-regulated R-Smads. In this issue, Dupont et al. (2009) now reveal that Smad4 itself is subject to cycles of ubiquitination and deubiquitination that regulate its interactions with the R-Smads.	[Wrana, Jeffrey L.] Mt Sinai Hosp, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Wrana, JL (corresponding author), Mt Sinai Hosp, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013					Carthew RW, 2000, CURR BIOL, V10, pR532, DOI 10.1016/S0960-9822(00)00587-X; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748	9	14	15	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					13	14		10.1016/j.cell.2008.12.028	http://dx.doi.org/10.1016/j.cell.2008.12.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135880	Bronze			2022-12-28	WOS:000262318400006
J	Gu, DF; Kelly, TN; Wu, XG; Chen, J; Samet, JM; Huang, JF; Zhu, ML; Chen, JC; Chen, CS; Duan, XF; Klag, MJ; He, J				Gu, Dongfeng; Kelly, Tanika N.; Wu, Xigui; Chen, Jing; Samet, Jonathan M.; Huang, Jian-Feng; Zhu, Manlu; Chen, Ji-Chun; Chen, Chung-Shiuan; Duan, Xiufang; Klag, Michael J.; He, Jiang			Mortality Attributable to Smoking in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EMERGING TOBACCO HAZARDS; CIGARETTE-SMOKING; RISK-FACTORS; REGIONAL BURDEN; PREVALENCE; DEATHS; DISEASE	Background Smoking is a risk factor for many diseases and has been increasingly prevalent in economically developing regions of the world. We aimed to estimate the number of deaths attributable to smoking in China. Methods We conducted a large, prospective cohort study in a nationally representative sample of 169,871 Chinese adults who were 40 years of age or older. Investigators for the China National Hypertension Survey collected data on smoking and other risk factors at a baseline examination in 1991 using a standard protocol. Follow- up evaluation was conducted in 1999 and 2000, with a response rate of 93.4%. We used multivariable- adjusted relative risk, prevalence of smoking, mortality, and population size in each age group, stratified according to sex, to calculate the number of deaths attributable to smoking in 2005. Results There was a significant, dose - response association between pack- years smoked and death from any cause in both men and women after adjustment for multiple risk factors ( P< 0.001 for trend). We estimated that in 2005, a total of 673,000 deaths ( 95% confidence interval [ CI], 564,700 to 781,400) were attributable to smoking in China: 538,200 ( 95% CI, 455,800 to 620,600) among men and 134,800 ( 95% CI, 108,900 to 160,800) among women. The leading causes of smoking- related deaths were as follows: cancer, 268,200 ( 95% CI, 214,500 to 321,900); cardiovascular disease, 146,200 ( 95% CI, 79,200 to 213,100); and respiratory disease, 66,800 ( 95% CI, 20,300 to 113,300). Conclusions Our study documents that smoking is a major risk factor for mortality in China. Continued strengthening of national programs and initiatives for smoking prevention and cessation is needed to reduce smoking- related deaths in China.	[Gu, Dongfeng; Wu, Xigui; Huang, Jian-Feng; Zhu, Manlu; Chen, Ji-Chun; Duan, Xiufang] Chinese Acad Med Sci, Fu Wai Hosp, Dept Evidence Based Med, Beijing 100037, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-Feng; Zhu, Manlu; Chen, Ji-Chun; Duan, Xiufang] Chinese Acad Med Sci, Cardiovasc Inst, Dept Evidence Based Med, Beijing 100037, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-Feng; Zhu, Manlu; Chen, Ji-Chun; Duan, Xiufang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-Feng; Zhu, Manlu; Chen, Ji-Chun; Duan, Xiufang] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Kelly, Tanika N.; Chen, Chung-Shiuan; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Chen, Jing; He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Samet, Jonathan M.; Klag, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Tulane University; Tulane University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gu, DF (corresponding author), Chinese Acad Med Sci, Fu Wai Hosp, Dept Evidence Based Med, 167 Beilishi Rd, Beijing 100037, Peoples R China.	gudf@yahoo.com	He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652	American Heart Association [9750612 N]; National Heart, Lung, and Blood Institute of the National Institutes of Health [U01-HL072507]; Ministry of Health, Beijing [1999-272]; Ministry of Science and Technology, Beijing [2006BAI01A01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health, Beijing; Ministry of Science and Technology, Beijing; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a national grant-in-aid (9750612 N) from the American Heart Association; a grant (U01-HL072507) from the National Heart, Lung, and Blood Institute of the National Institutes of Health; a grant (1999-272) from the Ministry of Health, Beijing; and a grant (2006BAI01A01) from the Ministry of Science and Technology, Beijing. No potential conflict of interest relevant to this article was reported.	[Anonymous], HLTH CONS SMOK REP S; Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Chen ZM, 1999, JAMA-J AM MED ASSOC, V281, P1893; *ECOSANTE, TOB CONS GRAMS PER C; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; FROHLICH ED, 1988, CIRCULATION, V77, pA502; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; HU TW, 2008, CHINA CROSSROADS EC, P305; INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; KAHN HA, 1989, STAT METHODS EPIDEMI, P73; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Lam TH, 1997, JAMA-J AM MED ASSOC, V278, P1505, DOI 10.1001/jama.278.18.1505; Lam TH, 1998, JAMA-J AM MED ASSOC, V279, P1350; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682; Sung HY, 2006, TOB CONTROL, V15, pI5, DOI 10.1136/tc.2005.015412; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2003, WHO FRAM CONV TOB CO; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Yang GH, 2008, SER CONTEMP CHINA, V12, P13; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; 1997, ATHEROSCLEROSIS RISK	34	265	326	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					150	159		10.1056/NEJMsa0802902	http://dx.doi.org/10.1056/NEJMsa0802902			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129528				2022-12-28	WOS:000262258300008
J	Wang, LD; Chen, HG; Guo, JG; Zeng, XJ; Hong, XL; Xiong, JJ; Wu, XH; Wang, XH; Wang, LY; Xia, G; Hao, Y; Chin, DP; Zhou, XN				Wang, Long-De; Chen, Hong-Gen; Guo, Jia-Gang; Zeng, Xiao-Jun; Hong, Xian-Lin; Xiong, Ji-Jie; Wu, Xiao-Hua; Wang, Xian-Hong; Wang, Li-Ying; Xia, Gang; Hao, Yang; Chin, Daniel P.; Zhou, Xiao-Nong			A Strategy to Control Transmission of Schistosoma japonicum in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REPUBLIC-OF-CHINA; DONGTING LAKE REGION; YANGTZE-RIVER VALLEY; CONTROL PROGRAM; ANHUI PROVINCE; POYANG LAKE; IMPLEMENTATION; EPIDEMIOLOGY; REINFECTION; CHALLENGES	Background Schistosoma japonicum causes an infection involving humans, livestock, and snails and is a significant cause of morbidity in China. Methods We evaluated a comprehensive control strategy in two intervention villages and two control villages along Poyang Lake in the southeastern province of Jiangxi, where annual synchronous chemotherapy is routinely used. New interventions, implemented from 2005 through 2007, included removing cattle from snail- infested grasslands, providing farmers with mechanized farm equipment, improving sanitation by supplying tap water and building lavatories and latrines, providing boats with fecal- matter containers, and implementing an intensive health- education program. During the intervention period, we observed changes in S. japonicum infection in humans, measured the rate of infection in snails, and tested the infectivity of lake water in mice. Results After three transmission seasons, the rate of infection in humans decreased to less than 1.0% in the intervention villages, from 11.3% to 0.7% in one village and from 4.0% to 0.9% in the other ( P< 0.001 for both comparisons). The rate of infection in humans in control villages fluctuated but remained at baseline levels. In intervention villages, the percentage of sampling sites with infected snails decreased from 2.2% to 0.1% in one grassland area and from 0.3% to no infection in the other ( P< 0.001 for both comparisons). The rate of infection in mice after exposure to lake water decreased from 79% to no infection ( P< 0.001). Conclusions A comprehensive control strategy based on interventions to reduce the rate of transmission of S. japonicum infection from cattle and humans to snails was highly effective. These interventions have been adopted as the national strategy to control schistosomiasis in China.	[Guo, Jia-Gang; Wu, Xiao-Hua; Wang, Xian-Hong; Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Wang, Long-De; Wang, Li-Ying; Xia, Gang; Hao, Yang] Minist Hlth, Beijing, Peoples R China; [Chen, Hong-Gen; Zeng, Xiao-Jun] Jiangxi Prov Inst Parasit Dis, Nanchang, Peoples R China; [Hong, Xian-Lin] Jinxian Antischistosomiasis Stn, Jinxian, Peoples R China; [Xiong, Ji-Jie] Jiangxi Prov Govt, Off Schistosomiasis Control, Nanchang, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn, China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Zhou, XN (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.	ipdzhouxn@sh163.net			Chinese Ministry of Health; Chinese National Natural Science Foundation [300070684, 30590373]	Chinese Ministry of Health; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Supported by the Chinese Ministry of Health, and by the Chinese National Natural Science Foundation (project numbers 300070684 and 30590373). No potential conflict of interest relevant to this article was reported.; We thank Wei-Sheng Jiang, Jing Zhang, Fang-Yu Yi, Jian Li, Zhe Tao, and Yu-Kun Yan from the Jiangxi Provincial Institute of Parasitic Diseases and Sheng-Zhu Hu, Xin-Ying Wang, Chang-Hua Deng, and Bai-Ren Huang from Jinxian County Antischistosomiasis Station for their participation in the field work; Dr. Robert Bergquist of the World Health Organization's Tropical Disease Research program for his assistance with the preparation of the manuscript; and Don McManus for providing baseline survey data for Aiguo village from the Wellcome Trust project.	Balen J, 2007, B WORLD HEALTH ORGAN, V85, P519, DOI 10.2471/BLT.06.034033; Chen HG, 2004, PARASITOL INT, V53, P115, DOI 10.1016/j.parint.2004.01.002; Chen MG, 1999, CHINESE MED J-PEKING, V112, P930; Chen XY, 2002, ACTA TROP, V82, P279, DOI 10.1016/S0001-706X(02)00019-0; *CHIN EXP ADV COMM, 1998, CHIN J PARASIT PARAS, V16, P84; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Engels D, 2005, ACTA TROP, V96, P67, DOI 10.1016/j.actatropica.2005.07.004; Fenwick A, 2006, ADV PARASIT, V61, P567, DOI 10.1016/S0065-308X(05)61013-5; Guo JG, 2006, AM J TROP MED HYG, V74, P335, DOI 10.4269/ajtmh.2006.74.335; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; LIU APL, 1991, ASIAN SURV, V31, P393, DOI 10.1525/as.1991.31.5.00p00542; MAO SB, 1986, CHINESE MED J-PEKING, V99, P439; McGarvey ST, 1999, PARASITOL TODAY, V15, P214, DOI 10.1016/S0169-4758(99)01409-X; *MIN HLTH, 2000, HDB SCHIST CONTR; Olds GR, 2006, CLIN INFECT DIS, V42, P1699, DOI 10.1086/504331; Ross AGP, 1997, AM J TROP MED HYG, V57, P302, DOI 10.4269/ajtmh.1997.57.302; Spear RC, 2006, SCIENCE, V314, P1081, DOI 10.1126/science.314.5802.1081c; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; SUN GF, 2001, CHIN J SCHISTO CONTR, V13, P242; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; WANG LD, 2006, INTRO NATL REGULATIO; WANG LD, 2006, EPIDEMIC STATUS SCHI; Wang Long-de, 2006, Zhonghua Yufang Yixue Zazhi, V40, P219; Wang TP, 2006, J PARASITOL, V92, P1088, DOI 10.1645/GE-806R.1; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; Williams GM, 2002, ACTA TROP, V82, P253, DOI 10.1016/S0001-706X(02)00017-7; Yang GJ, 2007, PARASITOL RES, V100, P695, DOI 10.1007/s00436-006-0315-8; Zhang SJ, 2002, ACTA TROP, V82, P289, DOI 10.1016/S0001-706X(02)00021-9; Zhao Gen-ming, 2006, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V24, P4; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; ZHOU XN, 2005, STUDIES ONCOMELANIA; 王陇德, 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P929	35	276	378	3	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					121	U44		10.1056/NEJMoa0800135	http://dx.doi.org/10.1056/NEJMoa0800135			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129526				2022-12-28	WOS:000262258300005
J	Mazur, E				Mazur, Eric			EDUCATION Farewell, Lecture?	SCIENCE			English	Editorial Material							PEER INSTRUCTION		[Mazur, Eric] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Mazur, E (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	mazur@physics.harvard.edu	Mazur, Eric/B-8918-2009					Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; Huff D., 1954, LIE STAT; Lasry N., 2008, PHYS TEACH, V46, P242, DOI DOI 10.1119/1.2895678; Lasry N, 2008, AM J PHYS, V76, P1066, DOI 10.1119/1.2978182; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; Mazur E., 2002, PHYS TEACH, V40, P206, DOI [DOI 10.1119/1.1474140, 10.1119/1.1474140]; Mazur E., 1997, PEER INSTRUCTION USE; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919	9	324	332	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					50	51		10.1126/science.1168927	http://dx.doi.org/10.1126/science.1168927			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119207				2022-12-28	WOS:000262104100031
J	Sharma, J; Chhabra, R; Cheng, A; Brownell, J; Liu, Y; Yan, H				Sharma, Jaswinder; Chhabra, Rahul; Cheng, Anchi; Brownell, Jonathan; Liu, Yan; Yan, Hao			Control of Self-Assembly of DNA Tubules Through Integration of Gold Nanoparticles	SCIENCE			English	Article							CONDUCTIVE NANOWIRES; ARRAYS; NANOSTRUCTURES; TEMPLATES; NANOTUBES; SURFACE; CRYSTALLIZATION; ORGANIZATION; TILES	The assembly of nanoparticles into three- dimensional ( 3D) architectures could allow for greater control of the interactions between these particles or with molecules. DNA tubes are known to form through either self- association of multi- helix DNA bundle structures or closing up of 2D DNA tile lattices. By the attachment of single- stranded DNA to gold nanoparticles, nanotubes of various 3D architectures can form, ranging in shape from stacked rings to single spirals, double spirals, and nested spirals. The nanoparticles are active elements that control the preference for specific tube conformations through size- dependent steric repulsion effects. For example, we can control the tube assembly to favor stacked- ring structures using 10- nanometer gold nanoparticles. Electron tomography revealed a left- handed chirality in the spiral tubes, double- wall tube features, and conformational transitions between tubes.	[Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA; [Sharma, Jaswinder; Chhabra, Rahul; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Cheng, Anchi; Brownell, Jonathan] Scripps Res Inst, La Jolla, CA 92037 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Scripps Research Institute	Liu, Y (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Biodesign Inst, Tempe, AZ 85287 USA.	yan_liu@asu.edu; hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606	National Science Foundation (NSF); Army Research Office ( ARO); Air Force Office of Scientific Research; Office of Naval Research; NSF; Alfred P. Sloan Fellowship; NIH [P41 RR000592, P41 RR-01081]; Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081, P41RR017573, P41RR000592] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Army Research Office ( ARO); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Technology and Research Institute Funds funds from Arizona State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank for financial support the National Science Foundation (NSF) and Army Research Office (ARO) (to Y.L.), the Air Force Office of Scientific Research, Office of Naval Research, NSF, Alfred P. Sloan Fellowship, ARO, and NIH (to H.Y.), and Technology and Research Institute Funds funds from Arizona State University (to H.Y. and Y.L.). Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by NIH though the National Center for Research Resources' P41 program (RR17573). We thank C. Potter and B. Carragher for helpful discussion and technical advice on the electron tomography work. IMOD software (Boulder Laboratory for 3D Electron Microscopy of Cells, Boulder, CO) used for tomographic reconstruction is supported by NIH grant P41 RR000592. 3D graphic images were produced using the University of California, San Francisco ( UCSF) Chimera package from the Resource for Biocomputing, Visualization, and Informatics at UCSF ( supported by NIH grant P41 RR-01081). We thank M. Palmer for technical assistance. We acknowledge the use of the EM facility in the School of Life Sciences at Arizona State University. We thank C. Lin for assistance in schematic figure drawings and Y. Ke for assistance in creating movies from the tomography reconstructions. We thank C. Flores for help proofreading the manuscript.	Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Aldaye FA, 2007, J AM CHEM SOC, V129, P4130, DOI 10.1021/ja070017i; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Deng Z., 2005, ANGEW CHEM, V117, P3648; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja046747x; Ke YG, 2006, J AM CHEM SOC, V128, P4414, DOI 10.1021/ja058145z; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Lee JH, 2007, ANGEW CHEM INT EDIT, V46, P9006, DOI 10.1002/anie.200702569; Liu D, 2004, P NATL ACAD SCI USA, V101, P717, DOI 10.1073/pnas.0305860101; Liu FR, 1999, J AM CHEM SOC, V121, P917, DOI 10.1021/ja982824a; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Mathieu F, 2005, NANO LETT, V5, P661, DOI 10.1021/nl050084f; Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SH, 2005, NANO LETT, V5, P693, DOI 10.1021/nl050108i; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485; Sharma J, 2008, J AM CHEM SOC, V130, P7820, DOI 10.1021/ja802853r; SIMON U, 2004, NANOPARTICLES THEORY, P328; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	27	590	626	8	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					112	116		10.1126/science.1165831	http://dx.doi.org/10.1126/science.1165831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119229	Green Accepted			2022-12-28	WOS:000262104100052
J	[Anonymous]				[Anonymous]			Students whose behaviour causes concern: Case history	BRITISH MEDICAL JOURNAL			English	Editorial Material																		*GEN MED COUNC, 2007, MED STUD PROF BEH FI	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 29	2008	337								a2874	10.1136/bmj.a2874	http://dx.doi.org/10.1136/bmj.a2874			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401MV	19114450				2022-12-28	WOS:000262945900003
J	Chu, G; Yang, W				Chu, Gilbert; Yang, Wei			Here Comes the Sun: Recognition of UV-Damaged DNA	CELL			English	Editorial Material							UBIQUITIN LIGASE; REPAIR; PROTEIN; LESION	The first step in the repair of DNA damage is lesion detection. In this issue, Scrima et al. (2008) report the structure of the complex of DNA Damage-Binding Protein 1 (DDB1) and DDB2 bound to a DNA photodimer, providing critical insight into the repair of DNA damage caused by ultraviolet light.	[Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Med Ctr, Dept Biochem, Div Oncol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University; Stanford University	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	Intramural NIH HHS [ZIA DK036146-08, ZIA DK075037-08] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155	9	12	12	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1172	1174		10.1016/j.cell.2008.12.015	http://dx.doi.org/10.1016/j.cell.2008.12.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109889	Green Accepted, Bronze			2022-12-28	WOS:000261989800009
J	Merkwirth, C; Langer, T				Merkwirth, Carsten; Langer, Thomas			Mitofusin 2 Builds a Bridge between ER and Mitochondria	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; DISEASE; MUTATIONS; PROTECTS	Mutations in mitofusin 2 (MFN2), a dynamin-like GTPase required for mitochondrial fusion, cause the peripheral neuropathy Charcot-Marie-Tooth type 2A. In a recent report in Nature, de Brito and Scorrano (2008) demonstrate a new function of MFN2-tethering the endoplasmic reticulum and mitochondria to control the efficiency of mitochondrial uptake of Ca(2+) ions.	[Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany; [Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Langer, T (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, D-50674 Cologne, Germany.	thomas.langer@uni-koeln.de	Merkwirth, Carsten/H-5992-2012	Merkwirth, Carsten/0000-0001-8895-3495; Langer, Thomas/0000-0003-1250-1462				Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	10	92	96	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1165	1167		10.1016/j.cell.2008.12.005	http://dx.doi.org/10.1016/j.cell.2008.12.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109886	Bronze			2022-12-28	WOS:000261989800006
J	Pisareva, VP; Pisarev, AV; Komar, AA; Hellen, CUT; Pestova, TV				Pisareva, Vera P.; Pisarev, Andrey V.; Komar, Anton A.; Hellen, Christopher U. T.; Pestova, Tatyana V.			Translation Initiation on Mammalian mRNAs with Structured 5 ' UTRs Requires DExH-Box Protein DHX29	CELL			English	Article							INTERNAL RIBOSOMAL ENTRY; SACCHAROMYCES-CEREVISIAE; HEPATITIS-C; FACTOR EIF3; BINDING; SUBUNIT; CODON; HELICASES; ROLES; SITE	Eukaryotic protein synthesis begins with assembly of 48S initiation complexes at the initiation codon of mRNA, which requires at least seven initiation factors (eIFs). First, 43S preinitiation complexes comprising 40S ribosomal subunits, eIFs 3, 2, 1, and 1A, and tRNA(i)(Met) attach to the 5'-proximal region of mRNA and then scan along the 50 untranslated region (5'UTR) to the initiation codon. Attachment of 43S complexes is mediated by three other eIFs, 4F, 4A, and 4B, which cooperatively unwind the cap-proximal region of mRNA and later also assist 43S complexes during scanning. We now report that these seven eIFs are not sufficient for efficient 48S complex formation on mRNAs with highly structured 5'UTRs, and that this process requires the DExH-box protein DHX29. DHX29 binds 40S subunits and hydrolyzes ATP, GTP, UTP, and CTP. NTP hydrolysis by DHX29 is strongly stimulated by 43S complexes and is required for DHX29's activity in promoting 48S complex formation.	[Pisareva, Vera P.; Pisarev, Andrey V.; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; [Komar, Anton A.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Cleveland State University	Pestova, TV (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	tatyana.pestova@downstate.edu		Komar, Anton/0000-0003-4188-0633	NIH [GM059660, AI051340]; HFSP [RPG0055/2006-C]; National American Heart Association [0730120N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI051340, R01AI051340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); National American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Gauss for the NCF2 vector and A. Marintchev for helpful discussions. This work was supported by NIH grant GM059660 and HFSP grant RPG0055/2006-C to T.V.P., NIH grant AI051340 to C.U.T.H., and National American Heart Association grant 0730120N to A.A.K.	Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; De Breyne S, 2008, RNA, V14, P367, DOI 10.1261/rna.696508; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Svitkin YV, 2001, RNA, V7, P1743; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	37	167	169	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1237	1250		10.1016/j.cell.2008.10.037	http://dx.doi.org/10.1016/j.cell.2008.10.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109895	Green Accepted, Bronze			2022-12-28	WOS:000261989800015
J	Leon, H; Shibata, MC; Sivakumaran, S; Dorgan, M; Chatterley, T; Tsuyuki, RT				Leon, Hernando; Shibata, Marcelo C.; Sivakumaran, Soori; Dorgan, Marlene; Chatterley, Trish; Tsuyuki, Ross T.			Effect of fish oil on arrhythmias and mortality: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POLYUNSATURATED FATTY-ACIDS; PREMATURE VENTRICULAR COMPLEXES; RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; CARDIOVASCULAR-DISEASE; DOUBLE-BLIND; METAANALYSIS; OMEGA-3-FATTY-ACIDS	Objective To synthesise the literature on the effects of fish oil - docosahexaenoic acid ( DHA) and eicosapentaenoic acid ( EPA) - on mortality and arrhythmias and to explore dose response and formulation effects. Design Systematic review and meta- analysis. Data sources Medline, Embase, the Cochrane Library, PubMed, CINAHL, IPA, Web of Science, Scopus, Pascal, Allied and Complementary Medicine, Academic OneFile, ProQuest Dissertations and Theses, Evidence- Based Complementary Medicine, and LILACS. Studies reviewed Randomised controlled trials of fish oil as dietary supplements in humans. Data extraction The primary outcomes of interest were the arrhythmic end points of appropriate implantable cardiac defibrillator intervention and sudden cardiac death. The secondary outcomes were all cause mortality and death from cardiac causes. Subgroup analyses included the effect of formulations of EPA and DHA on death from cardiac causes and effects of fish oil in patients with coronary artery disease or myocardial infarction. Data synthesis 12 studies totalling 32 779 patientsmet the inclusion criteria. A neutral effect was reported in three studies ( n= 1148) for appropriate implantable cardiac defibrillator intervention ( odds ratio 0.90, 95% confidence interval 0.55 to 1.46) and in six studies ( n= 31 111) for sudden cardiac death ( 0.81, 0.52 to 1.25). 11 studies ( n= 32 439 and n= 32 519) provided data on the effects of fish oil on all cause mortality ( 0.92, 0.82 to 1.03) and a reduction in deaths from cardiac causes ( 0.80, 0.69 to 0.92). The dose- response relation for DHA and EPA on reduction indeaths from cardiac causes was not significant. Conclusions Fish oil supplementation was associated with a significant reduction in deaths from cardiac causes but had no effect on arrhythmias or all cause mortality. Evidence to recommend an optimal formulation of EPA or DHA to reduce these outcomes is insufficient. Fish oils are a heterogeneous product, and the optimal formulations for DHA and EPA remain unclear.	[Leon, Hernando; Shibata, Marcelo C.; Sivakumaran, Soori; Tsuyuki, Ross T.] Epidemiol Coordinating & Res EPICORE Ctr, Edmonton, AB, Canada; [Leon, Hernando; Shibata, Marcelo C.; Sivakumaran, Soori; Tsuyuki, Ross T.] Univ Alberta, Dept Med, Div Cardiol, Fac Med & Dent, Edmonton, AB T6G 2C8, Canada; [Dorgan, Marlene; Chatterley, Trish] Univ Alberta, Inst Hlth Econ, Edmonton, AB T6G 2C8, Canada; [Dorgan, Marlene; Chatterley, Trish] Univ Alberta, John W Scott Hlth Sci Lib, Edmonton, AB T6G 2C8, Canada	University of Alberta; University of Alberta; University of Alberta	Tsuyuki, RT (corresponding author), Epidemiol Coordinating & Res EPICORE Ctr, Edmonton, AB, Canada.	ross.tsuyuki@ualberta.ca	Tsuyuki, Ross T/E-2462-2016; Shibata, Marcelo/AAS-9521-2021	Tsuyuki, Ross T/0000-0002-3724-598X; 				Aarsetoy H, 2006, THROMB HAEMOSTASIS, V95, P329, DOI 10.1016/TH05-07-0497; BANG HO, 1976, ACTA MED SCAND, V200, P69; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Caldwell LL, 2005, BRIT J GUID COUNS, V33, P7, DOI 10.1080/03069880412331335939; CHARNOCK JS, 1992, COMP BIOCHEM PHYS A, V101, P387, DOI 10.1016/0300-9629(92)90551-Z; Christensen J H, 1997, Ugeskr Laeger, V159, P5525; CHRISTENSEN JH, 1995, NUTR RES, V15, P1, DOI 10.1016/0271-5317(95)91647-U; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P46; Davidson MH, 2007, CLIN THER, V29, P1354, DOI 10.1016/j.clinthera.2007.07.018; Doolan GK, 2002, FASEB J, V16, P1662, DOI 10.1096/fj.02-0084fje; Geelen A, 2005, BRIT J NUTR, V93, P787, DOI 10.1079/BJN20051429; Geelen A, 2005, AM J CLIN NUTR, V81, P416; Grundt H, 2003, PATHOPHYSIOL HAEMO T, V33, P88, DOI 10.1159/000073852; Higgins JPT, COCHRANE HDB SYSTEMA, P4; HONORE E, 1994, P NATL ACAD SCI USA, V91, P1937, DOI 10.1073/pnas.91.5.1937; Hooper L, 2006, BMJ-BRIT MED J, V332, P752, DOI 10.1136/bmj.38755.366331.2F; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jenkins DJA, 2008, CAN MED ASSOC J, V178, P157, DOI 10.1503/cmaj.070261; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; MILNER MR, 1989, AM J CARDIOL, V64, P294, DOI 10.1016/0002-9149(89)90522-5; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Rauch B, 2006, CARDIOVASC DRUG THER, V20, P365, DOI 10.1007/s10557-006-0495-6; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456, DOI DOI 10.1001/JAMA.1995.03530180050029; Singer P, 2004, PROSTAG LEUKOTR ESS, V71, P153, DOI 10.1016/j.plefa.2004.03.003; SINGER P, 2003, MED WELT, V54, P68; Singleton CB, 1999, BRIT J PHARMACOL, V127, P941, DOI 10.1038/sj.bjp.0702638; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Torrejon C, 2007, PROSTAG LEUKOTR ESS, V77, P319, DOI 10.1016/j.plefa.2007.10.014; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Yzebe D, 2004, FUND CLIN PHARMACOL, V18, P581, DOI 10.1111/j.1472-8206.2004.00268.x	30	153	155	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2008	337								a2931	10.1136/bmj.a2931	http://dx.doi.org/10.1136/bmj.a2931			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394EL	19106137	Green Published, hybrid			2022-12-28	WOS:000262428400002
J	Lincoln, TA; Joyce, GF				Lincoln, Tracey A.; Joyce, Gerald F.			Self-Sustained Replication of an RNA Enzyme	SCIENCE			English	Article							LIGASE RIBOZYME; ORIGIN	An RNA enzyme that catalyzes the RNA-templated joining of RNA was converted to a format whereby two enzymes catalyze each other's synthesis from a total of four oligonucleotide substrates. These cross-replicating RNA enzymes undergo self-sustained exponential amplification in the absence of proteins or other biological materials. Amplification occurs with a doubling time of about 1 hour and can be continued indefinitely. Populations of various cross-replicating enzymes were constructed and allowed to compete for a common pool of substrates, during which recombinant replicators arose and grew to dominate the population. These replicating RNA enzymes can serve as an experimental model of a genetic system. Many such model systems could be constructed, allowing different selective outcomes to be related to the underlying properties of the genetic system.	[Lincoln, Tracey A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	gjoyce@scripps.edu			NASA [NNX07AJ23G]; NIH [R01GM065130]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065130] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Orgel for many stimulating discussions. This research was supported by grants from NASA (NNX07AJ23G) and NIH (R01GM065130) and by the Skaggs Institute for Chemical Biology.	CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kim DE, 2004, CHEM BIOL, V11, P1505, DOI 10.1016/j.chembiol.2004.08.021; Kim KS, 2008, FEBS LETT, V582, P2745, DOI 10.1016/j.febslet.2008.07.013; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176	8	413	431	17	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1229	1232		10.1126/science.1167856	http://dx.doi.org/10.1126/science.1167856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19131595	Green Accepted			2022-12-28	WOS:000263687600043
J	Brown, SP; Hestrin, S				Brown, Solange P.; Hestrin, Shaul			Intracortical circuits of pyramidal neurons reflect their long-range axonal targets	NATURE			English	Article							VISUAL-CORTEX; LAYER-V; CORTICOSTRIATAL NEURONS; SYNAPTIC CONNECTIONS; PROJECTION NEURONS; MORPHOLOGY; CELLS; CORTICOPONTINE; ORGANIZATION; PATTERNS	Cortical columns generate separate streams of information that are distributed to numerous cortical and subcortical brain regions(1). We asked whether local intracortical circuits reflect these different processing streams by testing whether the intracortical connectivity among pyramidal neurons reflects their long-range axonal targets. We recorded simultaneously from up to four retrogradely labelled pyramidal neurons that projected to the superior colliculus, the contralateral striatum or the contralateral cortex to assess their synaptic connectivity. Here we show that the probability of synaptic connection depends on the functional identities of both the presynaptic and postsynaptic neurons. We first found that the frequency of monosynaptic connections among corticostriatal pyramidal neurons is significantly higher than among corticocortical or corticotectal pyramidal neurons. We then show that the probability of feed-forward connections from corticocortical neurons to corticotectal neurons is approximately three- to four-fold higher than the probability of monosynaptic connections among corticocortical or corticotectal cells. Moreover, we found that the average axodendritic overlap of the presynaptic and postsynaptic pyramidal neurons could not fully explain the differences in connection probability that we observed. The selective synaptic interactions we describe demonstrate that the organization of local networks of pyramidal cells reflects the long-range targets of both the presynaptic and postsynaptic neurons.	[Brown, Solange P.; Hestrin, Shaul] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University	Hestrin, S (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, 300 Pasteur Dr,Edwards Bldg,R314, Stanford, CA 94305 USA.	shaul.hestrin@stanford.edu	Brown, Solange/H-1615-2012; Hestrin, Shaul/F-4410-2010		National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY009120, R01EY012114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Li and S. Pak for technical assistance. This work was supported by National Institutes of Health grants to S. P. B and to S. H.	Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frick A, 2008, CEREB CORTEX, V18, P397, DOI 10.1093/cercor/bhm074; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larsen DD, 2008, FRONT NEURAL CIRCUIT, V1, DOI 10.3389/neuro.04.005.2007; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WANG Z, 1993, J NEUROSCI, V13, P2199; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	36	239	242	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1133	U89		10.1038/nature07658	http://dx.doi.org/10.1038/nature07658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151698	Green Accepted			2022-12-28	WOS:000263680100041
J	Petreanu, L; Mao, TY; Sternson, SM; Svoboda, K				Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel			The subcellular organization of neocortical excitatory connections	NATURE			English	Article							RAT BARREL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PYRAMIDAL NEURONS; SYNAPTIC CONNECTIVITY; VISUAL-CORTEX; MOTOR CORTEX; DENDRITES; CIRCUIT; CHANNELRHODOPSIN-2; PROJECTIONS	Understanding cortical circuits will require mapping the connections between specific populations of neurons(1), as well as determining the dendritic locations where the synapses occur(2). The dendrites of individual cortical neurons overlap with numerous types of local and long-range excitatory axons, but axodendritic overlap is not always a good predictor of actual connection strength(3-5). Here we developed an efficient channelrhodopsin-2 (ChR2)-assisted method(6-8) to map the spatial distribution of synaptic inputs, defined by presynaptic ChR2 expression, within the dendritic arborizations of recorded neurons. We expressed ChR2 in two thalamic nuclei, the whisker motor cortex and local excitatory neurons and mapped their synapses with pyramidal neurons in layers 3, 5A and 5B (L3, L5A and L5B) in the mouse barrel cortex. Within the dendritic arborizations of L3 cells, individual inputs impinged onto distinct single domains. These domains were arrayed in an orderly, monotonic pattern along the apical axis: axons from more central origins targeted progressively higher regions of the apical dendrites. In L5 arborizations, different inputs targeted separate basal and apical domains. Input to L3 and L5 dendrites in L1 was related to whisker movement and position, suggesting that these signals have a role in controlling the gain of their target neurons(9). Our experiments reveal high specificity in the subcellular organization of excitatory circuits.	[Petreanu, Leopoldo; Mao, Tianyi; Sternson, Scott M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Petreanu, Leopoldo/0000-0003-1434-4691; Mao, Tianyi/0000-0002-3532-8319	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Liao GY, 2008, GENESIS, V46, P289, DOI 10.1002/dvg.20393; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	34	670	674	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1142	U100		10.1038/nature07709	http://dx.doi.org/10.1038/nature07709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19151697	Green Accepted			2022-12-28	WOS:000263680100043
J	Oda, T; Iwasa, M; Aihara, T; Maeda, Y; Narita, A				Oda, Toshiro; Iwasa, Mitsusada; Aihara, Tomoki; Maeda, Yuichiro; Narita, Akihiro			The nature of the globular-to fibrous-actin transition	NATURE			English	Article							FIBER DIFFRACTION DATA; F-ACTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC ACTIN; ARP2/3 COMPLEX; ELECTRON CRYOMICROSCOPY; MOLECULAR-DYNAMICS; NORMAL-MODES; YEAST ACTIN	Actin plays crucial parts in cell motility through a dynamic process driven by polymerization and depolymerization, that is, the globular ( G) to fibrous ( F) actin transition. Although our knowledge about the actin- based cellular functions and the molecules that regulate the G- to F- actin transition is growing, the structural aspects of the transition remain enigmatic. We created a model of F- actin using X- ray fibre diffraction intensities obtained from well oriented sols of rabbit skeletal muscle F- actin to 3.3 A in the radial direction and 5.6 A along the equator. Here we show that the G- to F- actin conformational transition is a simple relative rotation of the two major domains by about 20 degrees. As a result of the domain rotation, the actin molecule in the filament is flat. The flat form is essential for the formation of stable, helical F- actin. Our F- actin structure model provides the basis for understanding actin polymerization as well as its molecular interactions with actin- binding proteins.	[Oda, Toshiro; Aihara, Tomoki] RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Oda, Toshiro; Iwasa, Mitsusada; Maeda, Yuichiro] Japan Sci & Technol Agcy, ERATO Project Actin Filament Dynam, Mikazuki, Hyogo 6795148, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648601, Japan; [Maeda, Yuichiro; Narita, Akihiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University	Oda, T (corresponding author), RIKEN, Harima Inst, Xray Struct Anal Res Team, SPring 8 Ctr, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	toda@spring8.or.jp	Oda, Toshiro/F-6151-2011		Kazato Research Foundation	Kazato Research Foundation(Kazato Research Foundation)	We thank K. C. Holmes for continuous encouragement and D. Hanein for the gift of the atomic coordinates of the Volkmann et al. model ( ref. 24). We thank K. Namba, K. Makino and K. Hasegwa for comments on the manuscript, the gift of software package for the fibre analysis and help with recording the diffraction patterns. We also thank S. Fujiwara and K. Mihashi for comments on the manuscript. We finally thank beam- line staffs at SPring-8 BL40B2, BL41XU and BL45XU-SAX, especially M. Kawamoto and K. Ito. The electron microscopy section of this study is partially supported by the Kazato Research Foundation (A.N.).	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FURUHASHI K, 1992, J BIOL CHEM, V267, P9326; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kudryashov DS, 2005, P NATL ACAD SCI USA, V102, P13105, DOI 10.1073/pnas.0506429102; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 1998, BIOPHYS J, V75, P2672, DOI 10.1016/S0006-3495(98)77712-4; Oda T, 2007, ADV EXP MED BIOL, V592, P385; Oosawa F., 1975, THERMODYNAMICS POLYM; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rizvi SA, 2006, J AM CHEM SOC, V128, P3882, DOI 10.1021/ja058319c; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Straub F.B., 1942, STUDIES I MED CHEM U, P3; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WERTMAN KF, 1992, GENETICS, V132, P337; Wu YH, 2004, BIOPHYS J, V86, P116, DOI 10.1016/S0006-3495(04)74089-8; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200	50	446	448	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					441	445		10.1038/nature07685	http://dx.doi.org/10.1038/nature07685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158791				2022-12-28	WOS:000262519200038
J	Siomi, H; Siomi, MC				Siomi, Haruhiko; Siomi, Mikiko C.			On the road to reading the RNA-interference code	NATURE			English	Review							PIWI-INTERACTING RNAS; DOUBLE-STRANDED-RNA; C-ELEGANS; MESSENGER-RNA; ENDOGENOUS SIRNAS; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; MICRORNA BIOGENESIS; ARGONAUTE PROTEINS	The finding that sequence- specific gene silencing occurs in response to the presence of double- stranded RNAs has had an enormous impact on biology, uncovering an unsuspected level of regulation of gene expression. This process, known as RNA interference ( RNAi) or RNA silencing, involves small non- coding RNAs, which associate with nuclease- containing regulatory complexes and then pair with complementary messenger RNA targets, thereby preventing the expression of these mRNAs. Remarkable progress has been made towards understanding the underlying mechanisms of RNAi, raising the prospect of deciphering the 'RNAi code' that, like transcription factors, allows the fine- tuning and networking of complex suites of gene activity, thereby specifying cellular physiology and development.	[Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Siomi, Mikiko C.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Keio University; Japan Science & Technology Agency (JST)	Siomi, H (corresponding author), Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	awa403@sc.itc.keio.ac.jp; siomim@sc.itc.keio.ac.jp	li, ran/K-1896-2012; Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822	Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan); New Energy and Industrial Technology Development Organization (Japan)	Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (Japan)(New Energy and Industrial Technology Development Organization (NEDO))	We apologize to colleagues whose relevant primary publications were not cited because of space constraints. We thank Y. Tomari, K. Aoki, Y. Watanabe and all the members of the Siomi laboratory for their comments and critical reading of the manuscript. Work in our laboratory is supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan) and the New Energy and Industrial Technology Development Organization (Japan). M. C. S. is associate professor of the Global Centre of Excellence for Human Metabolomics Systems Biology ( MEXT).	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Faehnle CR, 2007, CURR OPIN CHEM BIOL, V11, P569, DOI 10.1016/j.cbpa.2007.08.032; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	100	466	521	6	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					396	404		10.1038/nature07754	http://dx.doi.org/10.1038/nature07754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158785				2022-12-28	WOS:000262519200032
J	Hawkes, N				Hawkes, Nigel			Resource allocation-it's a jungle out there	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 14	2009	338								b77	10.1136/bmj.b77	http://dx.doi.org/10.1136/bmj.b77			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405AA	19147475				2022-12-28	WOS:000263193100014
J	Montoya, JP				Montoya, Joseph P.			OCEAN SCIENCE Old New Nitrogen	SCIENCE			English	Editorial Material							DISTRIBUTIONS; FIXATION		[Montoya, Joseph P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30306 USA	University System of Georgia; Georgia Institute of Technology	Montoya, JP (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30306 USA.	montoya@gatech.edu	Montoya, Joseph/C-3115-2013	Montoya, Joseph/0000-0001-7197-4660				Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; [Anonymous], 2008, MICROBIAL ECOLOGY OC; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Galbraith ED, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1497, DOI 10.1016/B978-0-12-372522-6.00034-7; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Meckler AN, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002893; Montoya JP, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1277, DOI 10.1016/B978-0-12-372522-6.00029-3; Ren H, 2009, SCIENCE, V323, P244, DOI 10.1126/science.1165787; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169	11	2	3	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					219	220		10.1126/science.1168246	http://dx.doi.org/10.1126/science.1168246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131620				2022-12-28	WOS:000262290600026
J	Young, LJ				Young, Larry J.			Being Human: Love: Neuroscience reveals all	NATURE			English	Editorial Material									[Young, Larry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022						0	52	56	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					148	148		10.1038/457148a	http://dx.doi.org/10.1038/457148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129828				2022-12-28	WOS:000262360200017
J	De'ath, G; Lough, JM; Fabricius, KE				De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.			Declining Coral Calcification on the Great Barrier Reef	SCIENCE			English	Article							MASSIVE PORITES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; GROWTH; VARIABILITY; CENTURIES; SEAWATER; CARBON	Reef- building corals are under increasing physiological stress from a changing climate and ocean absorption of increasing atmospheric carbon dioxide. We investigated 328 colonies of massive Porites corals from 69 reefs of the Great Barrier Reef ( GBR) in Australia. Their skeletal records show that throughout the GBR, calcification has declined by 14.2% since 1990, predominantly because extension ( linear growth) has declined by 13.3%. The data suggest that such a severe and sudden decline in calcification is unprecedented in at least the past 400 years. Calcification increases linearly with increasing large- scale sea surface temperature but responds nonlinearly to annual temperature anomalies. The causes of the decline remain unknown; however, this study suggests that increasing temperature stress and a declining saturation state of seawater aragonite may be diminishing the ability of GBR corals to deposit calcium carbonate.	[De'ath, Glenn; Lough, Janice M.; Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	De'ath, G (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	g.death@aims.gov.au	Gates, Audrey/AAD-2165-2019; Lough, Janice M/L-1682-2013; Fabricius, Katharina E/F-1759-2010	Lough, Janice M/0000-0002-3789-1009; Fabricius, Katharina E/0000-0001-7671-4358	Australian Institute of Marine Science	Australian Institute of Marine Science	We thank M. Devereux, E. Matson, D. Thomson, T. Cooper, and R. Berkelmans for collecting and preparing coral samples. This study was funded by the Australian Institute of Marine Science. The long coral core growth data are lodged with the National Oceanographic and Atmospheric Administration Paleoclimatology Data Center (www.ncdc.noaa.gov/paleo/).	Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CHALKER BE, 1990, CORAL REEFS, V9, P11, DOI 10.1007/BF00686717; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI [10.1039/b714627m, 10.1039/B714627M]; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Veron J.E.N., 2008, REEF TIME GREAT BARR	28	461	467	5	535	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					116	119		10.1126/science.1165283	http://dx.doi.org/10.1126/science.1165283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119230				2022-12-28	WOS:000262104100053
J	Yu, Y; Maroney, PA; Denker, JA; Zhang, XHF; Dybkov, O; Luhrmann, R; Jankowsky, E; Chasin, LA; Nilsen, TW				Yu, Yang; Maroney, Patricia A.; Denker, John A.; Zhang, Xiang H. -F.; Dybkov, Olexandr; Luehrmann, Reinhard; Jankowsky, Eckhard; Chasin, Lawrence A.; Nilsen, Timothy W.			Dynamic Regulation of Alternative Splicing by Silencers that Modulate 5 ' Splice Site Competition	CELL			English	Article							PRE-MESSENGER-RNA; SEX-LETHAL; U1 SNRNP; PREMESSENGER RNA; EXON RECOGNITION; GENE-EXPRESSION; SR PROTEINS; HNRNP A1; IN-VIVO; COMPLEX	Alternative splicing makes a major contribution to proteomic diversity in higher eukaryotes with similar to 70% of genes encoding two or more isoforms. In most cases, the molecular mechanisms responsible for splice site choice remain poorly understood. Here, we used a randomization-selection approach in vitro to identify sequence elements that could silence a proximal strong 5' splice site located downstream of a weakened 5' splice site. We recovered two exonic and four intronic motifs that effectively silenced the proximal 5' splice site both in vitro and in vivo. Surprisingly, silencing was only observed in the presence of the competing upstream 5' splice site. Biochemical evidence strongly suggests that the silencing motifs function by altering the U1 snRNP/5' splice site complex in a manner that impairs commitment to specific splice site pairing. The data indicate that perturbations of non-ratelimiting step(s) in splicing can lead to dramatic shifts in splice site choice.	[Yu, Yang; Maroney, Patricia A.; Denker, John A.; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Yu, Yang; Jankowsky, Eckhard; Nilsen, Timothy W.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zhang, Xiang H. -F.; Chasin, Lawrence A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Dybkov, Olexandr; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Abt Zellulare Biochem, D-37077 Gottingen, Germany	Case Western Reserve University; Case Western Reserve University; Columbia University; Max Planck Society	Nilsen, TW (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	twn@case.edu	Yu, Yang/E-8245-2010	Zhang, Xiang/0000-0002-5674-8670; Jankowsky, Eckhard/0000-0001-7677-7412; Yu, Yang/0000-0003-0536-2783	Sixth Framework Program of the European Union; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM031528] Funding Source: NIH RePORTER	Sixth Framework Program of the European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bruzik, B. Chabot, and P. Grabowski for providing constructs, and S. Gunderson and I. Mattai for anti-U1A antiserum. We also thank D. Black, C. Burge, M. Caprara, X.D. Fu, B. Graveley, K. Hertel, B. Konforti, A. Krainer, K. Lynch, J. Manley, D. Rio, and J. Steitz as well as the anonymous reviewers for constructive comments, and A. M. Micenmacher for preparing the manuscript. The research was supported by a grant from the Sixth Framework Program of the European Union via The Network of Excellence "EURASNET'' to R.L. and NIH grants to E.J., L.A.C., and T.W.N.	AGRIS CH, 1989, MOL CELL BIOL, V9, P259, DOI 10.1128/MCB.9.1.259; BARABINO SML, 1990, CELL, V63, P293, DOI 10.1016/0092-8674(90)90162-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-317; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Chen CD, 1999, RNA, V5, P290, DOI 10.1017/S1355838299980743; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donmez G, 2007, MOL CELL, V25, P399, DOI 10.1016/j.molcel.2006.12.019; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Giles KE, 2005, MOL CELL BIOL, V25, P4397, DOI 10.1128/MCB.25.11.4397-4405.2005; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kheli AH, 2008, FEBS J, V275, P1150, DOI 10.1111/j.1742-4658.2008.06276.x; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Manabe T, 2007, GENES CELLS, V12, P1179, DOI 10.1111/j.1365-2443.2007.01123.x; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maroney PA, 2000, RNA, V6, P1905, DOI 10.1017/S1355838200001308; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1988, MOL CELL BIOL, V8, P4484, DOI 10.1128/MCB.8.10.4484; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RUSKIN B, 1985, CELL, V43, P131, DOI 10.1016/0092-8674(85)90018-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; TAKACS AM, 1988, P NATL ACAD SCI USA, V85, P7932, DOI 10.1073/pnas.85.21.7932; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhang XHF, 2003, GENOME RES, V13, P2637, DOI 10.1101/gr.1679003; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	70	102	104	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1224	1236		10.1016/j.cell.2008.10.046	http://dx.doi.org/10.1016/j.cell.2008.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109894	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000261989800014
J	Possner, A				Possner, Adam			Trying Not to Miss the Point	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												apossne1@jhmi.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2836	2836						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109104				2022-12-28	WOS:000261920900001
J	Qato, DM; Alexander, GC; Conti, RM; Johnson, M; Schumm, P; Lindau, ST				Qato, Dima M.; Alexander, G. Caleb; Conti, Rena M.; Johnson, Michael; Schumm, Phil; Lindau, Stacy Tessler			Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; NATIONAL-HEALTH	Context Despite concerns about drug safety, current information on older adults' use of prescription and over- the- counter medications and dietary supplements is limited. Objective To estimate the prevalence and patterns of medication use among older adults ( including concurrent use), and potential major drug- drug interactions. Design, Setting, and Participants Three thousand five community- residing individuals, aged 57 through 85 years, were drawn from a cross- sectional, nationally representative probability sample of the United States. In- home interviews, including medication logs, were administered between June 2005 and March 2006. Medication use was defined as prescription, over- the- counter, and dietary supplements used "on a regular schedule, like every day or every week." Concurrent use was defined as the regular use of at least 2 medications. Main Outcome Measure Population estimates of the prevalence of medication use, concurrent use, and potential major drug- drug interactions, stratified by age group and gender. Results The unweighted survey response rate was 74.8% ( weighted response rate, 75.5%). Eighty- one percent ( 95% confidence interval [ CI], 79.4%- 83.5%) used at least 1 prescription medication, 42% ( 95% CI, 39.7%- 44.8%) used at least 1 over- the-counter medication, and 49%( 95% CI, 46.2%- 52.7%) used a dietary supplement. Twenty-nine percent ( 95% CI, 26.6%- 30.6%) used at least 5 prescription medications concurrently; this was highest among men ( 37.1%; 95% CI, 31.7%- 42.4%) and women( 36.0%; 95% CI, 30.2%- 41.9%) aged 75 to 85 years. Among prescription medication users, concurrent use of over- the- counter medications was 46%( 95% CI, 43.4%- 49.1%) and concurrent use of dietary supplements was 52% ( 95% CI, 48.8%- 55.5%). Overall, 4% of individuals were potentially at risk of having a major drug- drug interaction; half of these involved the use of nonprescription medications. These regimens were most prevalent among men in the oldest age group ( 10%; 95% CI, 6.4%- 13.7%) and nearly half involved anticoagulants. No contraindicated concurrent drug use was identified. Conclusions In this sample of community- dwelling older adults, prescription and nonprescription medications were commonly used together, with nearly 1 in 25 individuals potentially at risk for a major drug- drug interaction.	[Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA; [Alexander, G. Caleb; Lindau, Stacy Tessler] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb; Conti, Rena M.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Conti, Rena M.] Univ Chicago, Sect Pediat Hematol Oncol, Chicago, IL 60637 USA; [Johnson, Michael; Schumm, Phil] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lindau, Stacy Tessler] Univ Chicago, Sect Geriatr, Dept Med, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Qato, Dima M.; Lindau, Stacy Tessler] Univ Chicago, NORC, Chicago Core Biomarkers Populat Based Res, Chicago, IL 60637 USA; [Qato, Dima M.] Univ Illinois, Dept Hlth Policy & Adm, Sch Publ Hlth, Chicago, IL USA; [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Sch Pharm, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Qato, DM (corresponding author), Univ Chicago, Dept Obstet & Gynecol, 5841 S Maryland Ave,MC 2050, Chicago, IL 60637 USA.	dqato@babies.bsd.uchicago.edu		Schumm, Phil/0000-0002-3050-2429; Qato, Dima/0000-0001-5411-6998; Conti, Rena/0000-0002-4190-1839	National Institutes of Health; National Institute on Aging; Office of Research on Women's Health; Office of AIDS Research; Office of Behavioral and Social Sciences Research [5R01AG021487]; NORC; Merck Foundation; Agency for Healthcare Research and Quality [K08 HS1569901A1]; Robert Wood Johnson Physician Faculty Scholars Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032870, R01AG021487, P30AG012857] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC; Merck Foundation(Merck & Company); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The National Social Life, Health and Aging Project ( NSHAP) is supported by the National Institutes of Health, including the National Institute on Aging, the Office of Research on Women's Health, the Office of AIDS Research, and the Office of Behavioral and Social Sciences Research (5R01AG021487). NSHAP is also supported by NORC, whose staff was responsible for the data collection. The National Institutes of Health, National Institute on Aging University of Chicago - NORC Center on Demography and Economics of Aging Core on Biomarkers in Population-Based Health and Aging Research ( 5 P30 AG 012857) and the University of Chicago Program in Pharmaceutical Policy ( David Meltzer, principal investigator) also supported the effort of Dr Qato and Mssrs Schumm and Johnson on this article with a pilot grant ( Dr Lindau, principal investigator). The University of Chicago Program in Pharmaceutical Policy is supported by the Merck Foundation. Dr Alexander has career development awards from the Agency for Healthcare Research and Quality (K08 HS1569901A1) and the Robert Wood Johnson Physician Faculty Scholars Program. Supplies were donated to the NSHAP study by OraSure, Sunbeam, A&D Medical/LifeSource, Wilmer Eye Institute at the Johns Hopkins Bloomberg School of Public Health, Schleicher & Schuell Bioscience, BioMerieux, Roche Diagnostics, Digene, and Richard Williams.	Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Catlin A, 2008, HEALTH AFFAIR, V27, P14, DOI 10.1377/hlthaff.27.1.14; *CERN MULT INC, LEX PLUS DAT; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Elmer GW, 2007, ANN PHARMACOTHER, V41, P1617, DOI 10.1345/aph.1K221; FILLENBAUM GG, 1993, AM J PUBLIC HEALTH, V83, P1577, DOI 10.2105/AJPH.83.11.1577; Gardiner P, 2006, ARCH INTERN MED, V166, P1968, DOI 10.1001/archinte.166.18.1968; Gaskin Darrell J, 2006, Am J Geriatr Pharmacother, V4, P96, DOI 10.1016/j.amjopharm.2006.06.008; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 2001, DRUG AGING, V18, P123, DOI 10.2165/00002512-200118020-00005; Hensrud DD, 1999, MAYO CLIN PROC, V74, P443; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; *IMS, COMM REQ THER CLASS; *IMS, GEN MARK EXP SOAR 80; *IOM, 2006, FUT DRUG SAF PROM PR; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kris-Etherton, 2003, CIRCULATION, V107, P512, DOI 10.1161/01.CIR.0000054601.17182.B0; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; *NACDA, NAT SOC LIF HLTH AG; QATO D, NATL SOCIAL LIFE HLT; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; STAGNITTI MN, 2004, STAT BRIEF 180 TOP 5; *STATACORP, 2007, STAT COMP PROGR VERS; *THOMS REUT HEALTH, MICR HEALTHC SER; *US BUR CENS, POV THRESH 2006; *US FDA, CDER DRUG BIOL APPR; *US FDA, SENT IN NAT STRAT MO	33	630	665	4	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2867	2878						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109115	Green Accepted, Bronze			2022-12-28	WOS:000261920900020
J	Cheng, MH				Cheng, Margaret Harris			Profile Zhong Nan-Shan: leader of clinical research in China	LANCET			English	Biographical-Item												mharrisenator@gmail.com							0	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2108	2108		10.1016/S0140-6736(08)61914-5	http://dx.doi.org/10.1016/S0140-6736(08)61914-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101377	Green Published, Bronze			2022-12-28	WOS:000261894000018
J	Murphy, KE; Hannah, ME; Willan, AR; Hewson, SA; Ohlsson, A; Kelly, EN; Matthews, SG; Saigal, S; Asztalos, E; Ross, S; Delisle, MF; Amankwah, K; Guselle, P; Gafni, A; Lee, SK; Armson, BA				Murphy, Kellie E.; Hannah, Mary E.; Willan, Andrew R.; Hewson, Sheila A.; Ohlsson, Arne; Kelly, Edmond N.; Matthews, Stephen G.; Saigal, Saroj; Asztalos, Elizabeth; Ross, Susan; Delisle, Marie-France; Amankwah, Kofi; Guselle, Patricia; Gafni, Amiram; Lee, Shoo K.; Armson, B. Anthony		MACS Collaborative Grp	Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial	LANCET			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SINGLE; GLUCOCORTICOIDS; DELIVERY; BEHAVIOR; OUTCOMES; INFANTS; SHEEP; AGE	Background One course of antenatal corticosteroids reduces the risk of respiratory distress syndrome and neonatal death. Weekly doses given to women who remain undelivered after a single course may have benefits (less respiratory morbidity) or cause harm (reduced growth in utero). We aimed to find out whether multiple courses of antenatal corticosteroids would reduce neonatal morbidity and mortality without adversely affecting fetal growth. Methods 1.858 women at 25-32 weeks' gestation who remained undelivered 14-21 days after an initial course of antenatal corticosteroids and continued to be at high risk of preterm birth were randomly assigned to multiple courses of antenatal corticosteroids (n=937) or placebo (n=921), every 14 days until week 33 or delivery, whichever came first. The primary outcome was a composite of perinatal or neonatal mortality, severe respiratory distress syndrome, intraventricular haemorrhage (grade III or IV), periventricular leucomalacia, bronchopulmonary dysplasia, or necrotising enterocolitis. Analysis was by intention to treat. All patients and caregivers were unaware of the treatment given. This trial is registered as number ISRCTN2654148. Findings infants exposed to multiple courses of antenatal corticosteroids had similar morbidity and mortality to those exposed to placebo (150 [12.9%] vs 1.43 [12.5%]). Those receiving multiple doses of corticosteroids also weighed less at birth than those exposed to placebo (221.6 g vs 2330 g, p=0.0026), were shorter (44.5 cm vs 45.4 cm, p<0 . 001.), and had a smaller head circumference (31. 1 cm vs 31.7 cm, p<0 . 001). Interpretation Multiple courses of antenatal corticosteroids, every 14 days, do not improve preterm-birth Outcomes, and are associated with a decreased weight, length, and head circumference at birth. Therefore, this treatment schedule is not recommended. Funding Canadian Institutes of Health Research.	[Murphy, Kellie E.] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON M5R 1X5, Canada; [Hannah, Mary E.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Obstet & Gynaecol, Toronto, ON M5R 1X5, Canada; [Willan, Andrew R.] Univ Toronto, Programme Child Hlth Evaluat Sci, Sickkids Res Inst, Dept Publ Hlth Sci, Toronto, ON M5R 1X5, Canada; [Hewson, Sheila A.; Guselle, Patricia] Univ Toronto, Womens Coll Res Inst, Maternal Infant & Reprod Hlth Res Unit, Toronto, ON M5R 1X5, Canada; [Ohlsson, Arne; Kelly, Edmond N.] Univ Toronto, Mt Sinai Hosp, Dept Paediat, Toronto, ON M5R 1X5, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON M5R 1X5, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5R 1X5, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Med, Toronto, ON M5R 1X5, Canada; [Saigal, Saroj] McMaster Univ, Med Ctr, Dept Paediat, Hamilton, ON, Canada; [Asztalos, Elizabeth] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Newborn & Dev Paediat, Toronto, ON, Canada; [Ross, Susan] Univ Calgary, Dept Obstet & Gynaecol, Calgary, AB, Canada; [Delisle, Marie-France] Univ British Columbia, BC Womens Hosp, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Amankwah, Kofi] SUNY Buffalo, Dept Obstet & Gynaecol, Womens & Childrens Hosp, Buffalo, NY 14260 USA; [Gafni, Amiram] McMaster Univ, Dept Clin Epidemiol & Biostat, Ctr Hlth Econ & Policy Anal, Hamilton, ON, Canada; [Lee, Shoo K.] Univ Alberta, Dept Paediat, Edmonton, AB, Canada; [Lee, Shoo K.] Univ Alberta, Integrated Ctr Care Adv Res iCARE, Edmonton, AB, Canada; [Armson, B. Anthony] Dalhousie Univ, Dept Obstet & Gynaecol, IWK Hlth Ctr, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Calgary; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Women & Children's Hospital of Buffalo; McMaster University; University of Alberta; University of Alberta; Dalhousie University	Murphy, KE (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Room 3726,Ontario Power Generat Bldg,700 Univ Ave, Toronto, ON M5R 1X5, Canada.	kmurphy@mtsinai.on.ca	Matthews, Stephen/R-5147-2019; Kelly, Edmond/P-5857-2015; Asztalos, Elizabeth/L-8834-2019; Lee, Shoo K/P-3016-2015; Matthews, Stephen G/N-7555-2018; Abdulkadir, Rezan/C-5589-2008; Murphy, Kellie E/B-7616-2016; Duley, Lelia/E-8107-2015; de Sa, Renato Augusto Moreira/B-4778-2014	Matthews, Stephen/0000-0002-9654-9940; Asztalos, Elizabeth/0000-0002-9468-2860; Matthews, Stephen G/0000-0002-9654-9940; Duley, Lelia/0000-0001-6721-5178; JANCZEWSKA, IWONA/0000-0002-9128-797X; Roumen, Frans JME/0000-0003-2319-4808; Otano, Lucas/0000-0003-0172-1304; Simchen, Michal/0000-0003-3921-7461; Murphy, Kellie/0000-0002-7327-2600; Gembruch, Ulrich/0000-0001-8284-4669; Delisle, Marie-France/0000-0002-7045-3780	Canadian Institutes for Health Research [MCT 38142]; Sunnybrook Health Sciences Centre; Women's College Hospital; Department of Obstetrics and Gyneacology at the University of Toronto	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Sunnybrook Health Sciences Centre(University of Toronto); Women's College Hospital; Department of Obstetrics and Gyneacology at the University of Toronto(University of Toronto)	We thank all participants in the MACS trial; Caroline Crowther and Ron Wapner for their collaboration and support; the members of our data safety monitoring board for their guidance; and all the staff at the Maternal, Infant and Reproductive Health Research Unit in Toronto for their dedication and hard work. MACS was supported by a grant from the Canadian Institutes for Health Research (grant number MCT 38142). The data coordinating centre was supported by grants from Sunnybrook Health Sciences Centre, Women's College Hospital and the Department of Obstetrics and Gyneacology at the University of Toronto. Betamethasone and placebo were purchased from Schering-Plough Corporation (Madison, NJ, USA) and Eminent Services Corporation (Gaithersburg, MD, USA), respectively.	Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; [Anonymous], 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003935.pub2, DOI 10.1002/14651858.CD003935.PUB2]; Ballard PL, 1996, AM J RESP CELL MOL, V14, P599, DOI 10.1165/ajrcmb.14.6.8652188; BROWN ER, 1979, PEDIATR RES, V13, P491; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; HALLIDAY HL, 2003, COCHRANE DB SYST REV, V3; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Kapoor A, 2008, BRAIN RES REV, V57, P586, DOI 10.1016/j.brainresrev.2007.06.013; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; LIGGINS GC, 1972, PEDIATRICS, V50, P515; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Peltoniemi OM, 2007, PEDIATRICS, V119, P290, DOI 10.1542/peds.2006-1549; Quinlivan J A, 1998, J Obstet Gynaecol Res, V24, P173; Quinlivan JA, 1998, AUST NZ J OBSTET GYN, V38, P1, DOI 10.1111/j.1479-828X.1998.tb02947.x; TAEUSCH HW, 1981, AM J OBSTET GYNECOL, V140, P452; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wapner RJ, 2007, NEW ENGL J MED, V357, P1190, DOI 10.1056/NEJMoa071453; Wapner RJ, 2006, AM J OBSTET GYNECOL, V195, P633, DOI 10.1016/j.ajog.2006.03.087; World Health Organization, 2000, NEON PER MORT COUNTR	23	250	260	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2143	2151		10.1016/S0140-6736(08)61929-7	http://dx.doi.org/10.1016/S0140-6736(08)61929-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101390				2022-12-28	WOS:000261894000037
J	Jovanovic-Talisman, T; Tetenbaum-Novatt, J; McKenney, AS; Zilman, A; Peters, R; Rout, MP; Chait, BT				Jovanovic-Talisman, Tijana; Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Zilman, Anton; Peters, Reiner; Rout, Michael P.; Chait, Brian T.			Artificial nanopores that mimic the transport selectivity of the nuclear pore complex	NATURE			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; IMPORTIN-BETA; NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; MECHANISM; MEMBRANES; REVEALS; REGIONS; SITES	Nuclear pore complexes ( NPCs) act as effective and robust gateways between the nucleus and the cytoplasm, selecting for the passage of particular macromolecules across the nuclear envelope. NPCs comprise an elaborate scaffold that defines a similar to 30 nm diameter passageway connecting the nucleus and the cytoplasm. This scaffold anchors proteins termed 'phenylalanine- glycine' ( FG)- nucleoporins, the natively disordered domains of which line the passageway and extend into its lumen(1). Passive diffusion through this lined passageway is hindered in a size- dependent manner. However, transport factors and their cargo- bound complexes overcome this restriction by transient binding to the FG-nucleoporins(2-10). To test whether a simple passageway and a lining of transport- factor- binding FG- nucleoporins are sufficient for selective transport, we designed a functionalized membrane that incorporates just these two elements. Here we demonstrate that this membrane functions as a nanoselective filter, efficiently passing transport factors and transport- factor - cargo complexes that specifically bind FG- nucleoporins, while significantly inhibiting the passage of proteins that do not. This inhibition is greatly enhanced when transport factor is present. Determinants of selectivity include the passageway diameter, the length of the nanopore region coated with FG- nucleoporins, the binding strength to FG-nucleoporins, and the antagonistic effect of transport factors on the passage of proteins that do not specifically bind FG- nucleoporins. We show that this artificial system faithfully reproduces key features of trafficking through the NPC, including transport-factor-mediated cargo import.	[Jovanovic-Talisman, Tijana; Chait, Brian T.] Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, New York, NY 10065 USA; [Tetenbaum-Novatt, Jaclyn; McKenney, Anna Sophia; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Zilman, Anton] Los Alamos Natl Lab, Div Theoret, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Peters, Reiner] Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; [Peters, Reiner] Univ Munster, Ctr Nanotechnol CeNTech, D-48149 Munster, Germany	Rockefeller University; Rockefeller University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Munster; University of Munster	Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, 1230 York Ave, New York, NY 10065 USA.	chait@rockefeller.edu	Novatt, Jaclyn/H-3459-2013	Novatt, Jaclyn/0000-0002-3906-3469; Rout, Michael/0000-0003-2010-706X; McKenney, Anna Sophia/0000-0003-4464-6869; Jovanovic-Talisman, Tijana/0000-0003-1928-4763	NIH; DoE; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071329, T32GM007739, R01GM062427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Coutavas, S. Darst, G. Belfort and C. Martin for suggestions and comments, G. Blobel for use of his confocal microscope, D. Phillips for use of his sputtering device, P. Nahirney and A. Labissiere for electron microscopy work, J. M. Crawford for amino acid analysis, D. Gadsby and A. Gulyas Kovacs for providing Xenopus oocytes, J. Aitchison for Kap95-GST and Kap121-GST plasmids, K. Zerf and M. Kahms for providing RanGDP, K. Zerf for NTF2-YFP cloning assistance, R. Mironska for help in preparing measuring chambers, and other members of the Peters, Rout and Chait laboratories for their assistance. We gratefully acknowledge support from the NIH and DoE. J.T.-N. is a HHMI pre-doctoral fellow.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dutta AK, 2007, LANGMUIR, V23, P3088, DOI 10.1021/la0624743; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Jirage KB, 1999, ANAL CHEM, V71, P4913, DOI 10.1021/ac990615i; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	29	219	220	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1023	1027		10.1038/nature07600	http://dx.doi.org/10.1038/nature07600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19098896	Green Accepted			2022-12-28	WOS:000263425400045
J	Hanaguri, T; Kohsaka, Y; Ono, M; Maltseva, M; Coleman, P; Yamada, I; Azuma, M; Takano, M; Ohishi, K; Takagi, H				Hanaguri, T.; Kohsaka, Y.; Ono, M.; Maltseva, M.; Coleman, P.; Yamada, I.; Azuma, M.; Takano, M.; Ohishi, K.; Takagi, H.			Coherence Factors in a High-T-c Cuprate Probed by Quasi-Particle Scattering Off Vortices	SCIENCE			English	Article							DENSITY-OF-STATES; BI2SR2CACU2O8+DELTA; VORTEX; SUPERCONDUCTORS; CA2-XNAXCUO2CL2; INTERFERENCE; HEAT; GAP	When electrons pair in a superconductor, quasi-particles develop an acute sensitivity to different types of scattering potential that is described by the appearance of coherence factors in the scattering amplitudes. Although the effects of coherence factors are well established in isotropic superconductors, they are much harder to detect in their anisotropic counterparts, such as high- superconducting- transition- temperature cuprates. We demonstrate an approach that highlights the momentum- dependent coherence factors in Ca2-xNaxCuO2Cl2. We used Fourier- transform scanning tunneling spectroscopy to reveal a magnetic- field dependence in quasi- particle scattering interference patterns that is sensitive to the sign of the anisotropic gap. This result is associated with the d- wave coherence factors and quasi- particle scattering off vortices. Our technique thus provides insights into the nature of electron pairing as well as quasi- particle scattering processes in unconventional superconductors.	[Hanaguri, T.; Kohsaka, Y.; Ono, M.; Takagi, H.] RIKEN Adv Sci Inst, Magnet Mat Lab, Wako, Saitama 3510198, Japan; [Hanaguri, T.; Kohsaka, Y.; Ono, M.] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Maltseva, M.; Coleman, P.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Yamada, I.; Azuma, M.; Takano, M.] Kyoto Univ, Inst Chem Res, Uji 6010011, Japan; [Ohishi, K.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Ibaraki 3191195, Japan; [Takagi, H.] Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan	RIKEN; Japan Science & Technology Agency (JST); Rutgers State University New Brunswick; Kyoto University; Japan Atomic Energy Agency; University of Tokyo	Hanaguri, T (corresponding author), RIKEN Adv Sci Inst, Magnet Mat Lab, Wako, Saitama 3510198, Japan.	hanaguri@riken.jp	Kohsaka, Yuhki/A-4428-2009; TAKAGI, HIDENORI/Q-1041-2019; Hanaguri, Tetsuo/I-6710-2012; Azuma, Masaki/C-2945-2009; Ohishi, Kazuki/E-9592-2010; Yamada, Ikuya/AAV-4406-2020; Takagi, Hidenori/B-2935-2010; Yamada, Ikuya/O-8596-2015	Kohsaka, Yuhki/0000-0002-6459-2661; TAKAGI, HIDENORI/0000-0001-5700-3761; Hanaguri, Tetsuo/0000-0003-2896-0081; Azuma, Masaki/0000-0002-8378-321X; Ohishi, Kazuki/0000-0003-1494-6502; Yamada, Ikuya/0000-0003-2340-131X; Yamada, Ikuya/0000-0003-2340-131X	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank J. C. Davis, H. Eisaki, M. Franz, C.-M. Ho, K. Machida, T. Pereg-Barnea, and P. Wahl for valuable discussions and comments. T.H., M.T., and H.T. are supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	[Anonymous], 1990, SUPERFLUIDITY SUPERC; BULUT N, 1992, PHYS REV B, V45, P2371, DOI 10.1103/PhysRevB.45.2371; Fujita K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054510; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; HEBEL LC, 1959, PHYS REV, V113, P1504, DOI 10.1103/PhysRev.113.1504; Hoffman J.E., 2003, THESIS U CALIFORNIA; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Iwaya K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.057208; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kubert C, 1998, SOLID STATE COMMUN, V105, P459, DOI 10.1016/S0038-1098(97)10154-5; Markiewicz RS, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.214517; Matsuba K, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.063704; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; MOLER KA, 1994, PHYS REV LETT, V73, P2744, DOI 10.1103/PhysRevLett.73.2744; Nunner TS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104511; Pereg-Barnea T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.180506; Pereg-Barnea T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020509; Schrieffer JR, 1999, THEORY SUPERCONDUCTI; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; VOLOVIK GE, 1993, JETP LETT+, V58, P469; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Zheng GQ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077003	24	100	102	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					923	926		10.1126/science.1166138	http://dx.doi.org/10.1126/science.1166138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19164709	Green Submitted			2022-12-28	WOS:000263295400039
J	Baztan, JJ; Suarez-Garcia, FM; Lopez-Arrieta, J; Rodriguez-Manas, L; Rodriguez-Artalejo, F				Baztan, Juan J.; Suarez-Garcia, Francisco M.; Lopez-Arrieta, Jesus; Rodriguez-Manas, Leocadio; Rodriguez-Artalejo, Fernando			Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; ELDERS; ADULTS	Objective To assess the effectiveness of acute geriatric units compared with conventional care units in adults aged 65 or more admitted to hospital for acute medical disorders. Design Systematic review and meta- analysis. Data sources Medline, Embase, and the Cochrane Library up to 31 August 2008, and references from published literature. Review methods Randomised trials, non- randomised trials, and case- control studies were included. Exclusions were studies based on administrative databases, those that assessed care for a single disorder, those that evaluated acute and subacute care units, and those in which patients were admitted to the acute geriatric unit after three or more days of being admitted to hospital. Two investigators independently selected the studies and extracted the data. Results 11 studies were included of which five were randomised trials, four non- randomised trials, and two case- control studies. The randomised trials showed that compared with older people admitted to conventional care units those admitted to acute geriatric units had a lower risk of functional decline at discharge ( combined odds ratio 0.82, 95% confidence interval 0.68 to 0.99) and were more likely to live at home after discharge ( 1.30, 1.11 to 1.52), with no differences in case fatality ( 0.83, 0.60 to 1.14). The global analysis of all studies, including non-randomised trials, showed similar results. Conclusions Care of people aged 65 or more with acute medical disorders in acute geriatric units produces a functional benefit compared with conventional hospital care, and increases the likelihood of living at home after discharge.	[Baztan, Juan J.] Hosp Cent Cruz Roja, Dept Geriatr, Madrid, Spain; [Suarez-Garcia, Francisco M.] Dept Hlth, Oviedo, Spain; [Lopez-Arrieta, Jesus] La Paz Cantoblanco Univ Hosp, Dept Geriatr, Madrid, Spain; [Rodriguez-Manas, Leocadio] Univ Hosp, Dept Geriatr, Madrid, Spain; [Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, Madrid, Spain	Autonomous University of Madrid	Baztan, JJ (corresponding author), Hosp Cent Cruz Roja, Dept Geriatr, Madrid, Spain.	jbaztan.hccruzr@salud.madrid.org		Rodriguez-Manas, Leocadio/0000-0002-6551-1333	RETICEF [RD06/0013]; Instituto de Salud Carlos III; Ministry of Health and Consumer Affairs;  [FIS PI05/90212]	RETICEF; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Health and Consumer Affairs; 	This study was partially funded by grant No FIS PI05/90212 and research on fragility and the elderly (RETICEF) grant No RD06/0013, Instituto de Salud Carlos III, Ministry of Health and Consumer Affairs.	ALTMAN DG, 2000, EVIDENCE BASED MED, P211; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Bernabei R, 2002, AGING CLIN EXP RES, V14, P247; Calkins E, 1999, NEW WAYS TO CARE FOR OLDER PEOPLE, P99; Cameron I., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4020, DOI 10.3310/HTA4020]; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; DAY P, 2004, NZHTA REPORT, V7; De MNA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005955; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; EVANS JG, 1997, BMJ-BRIT MED J, V315, P556; GOMEZPAVON J, 2006, REV ESP GERIATR GERO, V41, P77; GONZALEZMONTALV.JI, 2007, REV ESP GERIATR GERO, V42, P240; Gray L, 2007, AGE AGEING, V36, P1, DOI 10.1093/ageing/afl125; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jayadevappa R, 2003, INT J TECHNOL ASSESS, V19, P220, DOI 10.1017/S0266462303000205; Marin PP, 2007, REV MED CHILE, V135, P392; Norris SL, 2008, J AM GERIATR SOC, V56, P149, DOI 10.1111/j.1532-5415.2007.01530.x; Palmer RM, 2003, DIS MANAG HEALTH OUT, V11, P507, DOI 10.2165/00115677-200311080-00004; Parker G, 2000, J Health Serv Res Policy, V5, P176; Parker SG, 2006, AGE AGEING, V35, P551, DOI 10.1093/ageing/afl070; Reuben DB, 2000, J AM GERIATR SOC, V48, P1728, DOI 10.1111/j.1532-5415.2000.tb03890.x; ROCKWOOD K, 2006, CAN J GERIATR, V9, P102; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; Salkeld G, 2000, BMJ-BRIT MED J, V320, P341, DOI 10.1136/bmj.320.7231.341; Shepperd S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000356.pub2; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754	30	218	220	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2009	338								b50	10.1136/bmj.b50	http://dx.doi.org/10.1136/bmj.b50			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BS	19164393	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000263197700002
J	Pope, CA; Ezzati, M; Dockery, DW				Pope, C. Arden, III; Ezzati, Majid; Dockery, Douglas W.			Fine-Particulate Air Pollution and Life Expectancy in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM EXPOSURE; MORTALITY; HEALTH; MATTER; ASSOCIATION; CANCER; RATES	Background: Exposure to fine-particulate air pollution has been associated with increased morbidity and mortality, suggesting that sustained reductions in pollution exposure should result in improved life expectancy. This study directly evaluated the changes in life expectancy associated with differential changes in fine particulate air pollution that occurred in the United States during the 1980s and 1990s. Methods: We compiled data on life expectancy, socioeconomic status, and demographic characteristics for 211 county units in the 51 U.S. metropolitan areas with matching data on fine-particulate air pollution for the late 1970s and early 1980s and the late 1990s and early 2000s. Regression models were used to estimate the association between reductions in pollution and changes in life expectancy, with adjustment for changes in socioeconomic and demographic variables and in proxy indicators for the prevalence of cigarette smoking. Results: A decrease of 10 microg per cubic meter in the concentration of fine particulate matter was associated with an estimated increase in mean (+/-SE) life expectancy of 0.61+/-0.20 year (P=0.004). The estimated effect of reduced exposure to pollution on life expectancy was not highly sensitive to adjustment for changes in socioeconomic, demographic, or proxy variables for the prevalence of smoking or to the restriction of observations to relatively large counties. Reductions in air pollution accounted for as much as 15% of the overall increase in life expectancy in the study areas. Conclusions: A reduction in exposure to ambient fine-particulate air pollution contributed to significant and measurable improvements in life expectancy in the United States. N Engl J Med 2009;360:376-86.	[Pope, C. Arden, III] Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; [Ezzati, Majid; Dockery, Douglas W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Initiat Global Hlth, Cambridge, MA USA	Brigham Young University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Pope, CA (corresponding author), Brigham Young Univ, Dept Econ, 142 FOB, Provo, UT 84602 USA.	cap3@byu.edu	Pope, C. Arden/ABD-5522-2021; , dwdockery/AAO-7272-2021	Dockery, Douglas/0000-0002-6052-4880	Association of Schools of Public Health [U36/CCU300430-23)]; Harvard Environmental Protection Agency (EPA) Particulate Matter Center [EPA RD832416]; National Institute of Environmental Health Sciences [ES0002]; Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Association of Schools of Public Health; Harvard Environmental Protection Agency (EPA) Particulate Matter Center(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Mary Lou Fulton Professorship; Brigham Young University; Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a cooperative agreement with the Centers for Disease Control and Prevention; by grants from the Association of Schools of Public Health (U36/CCU300430-23), the Harvard Environmental Protection Agency (EPA) Particulate Matter Center (EPA RD832416), and the National Institute of Environmental Health Sciences (ES0002); and funds from the Mary Lou Fulton Professorship, Brigham Young University.; Dr. Dockery reports receiving grant support from the Health Effects Institute. No other potential conflict of interest relevant to this article was reported.; The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Association of Schools of Public Health. Although funded in part by the EPA, this study has not been subjected to the agency's peer- and policy- review process and therefore does not necessarily reflect the views of the agency, and no official endorsement should be inferred.	Anderson HR, 2005, EPIDEMIOLOGY, V16, P155, DOI 10.1097/01.ede.0000152528.22746.0f; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; BURNETT RT, 2003, REVISED ANAL TIME SE, P85; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Eftim SE, 2008, EPIDEMIOLOGY, V19, P209, DOI 10.1097/EDE.0b013e3181632c09; EVANS JS, 1984, ENVIRON INT, V10, P55, DOI 10.1016/0160-4120(84)90233-2; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Krewski D., 2000, REANALYSIS HARVARD 6; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; LAVE LB, 1970, SCIENCE, V169, P723, DOI 10.1126/science.169.3947.723; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; OZKAYNAK H, 1987, RISK ANAL, V7, P449, DOI 10.1111/j.1539-6924.1987.tb00482.x; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Pope C. Arden III, 2000, Environmental Health Perspectives, V108, P713, DOI 10.2307/3454408; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Preston, 2001, DEMOGRAPHY; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; 1997, FED REG, V62, P5725	28	1475	1520	9	447	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					376	386		10.1056/NEJMsa0805646	http://dx.doi.org/10.1056/NEJMsa0805646			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395JH	19164188	Green Accepted			2022-12-28	WOS:000262519900009
J	Sloan, GC; Matsuura, M; Zijlstra, AA; Lagadec, E; Groenewegen, MAT; Wood, PR; Szyszka, C; Bernard-Salas, J; van Loon, JT				Sloan, G. C.; Matsuura, M.; Zijlstra, A. A.; Lagadec, E.; Groenewegen, M. A. T.; Wood, P. R.; Szyszka, C.; Bernard-Salas, J.; van Loon, J. Th.			Dust Formation in a Galaxy with Primitive Abundances	SCIENCE			English	Article							GIANT BRANCH STARS; MASS-LOSS RATES; CARBON STARS; AGB STARS; SPITZER SPECTROSCOPY; LOW-METALLICITY; PAH EMISSION; EVOLUTION; SUPERGIANTS; SUPERWIND	Interstellar dust plays a crucial role in the evolution of galaxies. It governs the chemistry and physics of the interstellar medium. In the local universe, dust forms primarily in the ejecta from stars, but its composition and origin in galaxies at very early times remain controversial. We report observational evidence of dust forming around a carbon star in a nearby galaxy with a low abundance of heavy elements, 25 times lower than the solar abundance. The production of dust by a carbon star in a galaxy with such primitive abundances raises the possibility that carbon stars contributed carbonaceous dust in the early universe.	[Sloan, G. C.; Bernard-Salas, J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Matsuura, M.] Natl Opt Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Matsuura, M.] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Zijlstra, A. A.; Lagadec, E.; Szyszka, C.] Univ Manchester, Sch Phys & Astron, Manchester M60 1QD, Lancs, England; [Groenewegen, M. A. T.] Observ Royal Belgique, B-1180 Brussels, Belgium; [Wood, P. R.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [van Loon, J. Th.] Univ Keele, Lennard Jones Labs, Astrophys Grp, Keele ST5 5BG, Staffs, England	Cornell University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of London; University College London; University of Manchester; Australian National University; Keele University	Sloan, GC (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	sloan@isc.astro.cornell.edu	Lagadec, Eric/AAH-3839-2020	Matsuura, Mikako/0000-0002-5529-5593; Groenewegen, Martin/0000-0003-2723-6075; Zijlstra, Albert/0000-0002-3171-5469; Wood, Peter/0000-0001-6434-6543; Lagadec, Eric/0000-0002-1335-5623	NASA [1257184]; Australian Research Council; Japan Society for the Promotion of Science fellowship; STFC [ST/G002355/1, PP/D000955/1, PP/F000057/1, ST/F003196/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003196/1, ST/G002355/1, PP/D000955/1, PP/F000057/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Australian Research Council(Australian Research Council); Japan Society for the Promotion of Science fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Support for G.C.S. was provided by NASA through contract number 1257184 issued by the Jet Propulsion Laboratory, California Institute of Technology, under NASA contract 1407. The Australian Research Council provided support to P.R.W., and M.M. was supported by a Japan Society for the Promotion of Science fellowship.	Babusiaux C, 2005, MON NOT R ASTRON SOC, V359, P985, DOI 10.1111/j.1365-2966.2005.08959.x; Bertoldi F, 2003, ASTRON ASTROPHYS, V406, pL55, DOI 10.1051/0004-6361:20030710; BLANCO BM, 1978, NATURE, V271, P638, DOI 10.1038/271638a0; BLANCO VM, 1980, ASTROPHYS J, V242, P938, DOI 10.1086/158527; BOWEN GH, 1991, ASTROPHYS J, V375, pL53, DOI 10.1086/186086; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; Dwek E, 2007, ASTROPHYS J, V662, P927, DOI 10.1086/518430; Elitzur M, 2001, MON NOT R ASTRON SOC, V327, P403, DOI 10.1046/j.1365-8711.2001.04706.x; Engelbracht CW, 2005, ASTROPHYS J, V628, pL29, DOI 10.1086/432613; FRENKLACH M, 1989, ASTROPHYS J, V341, P372, DOI 10.1086/167501; Gehrz R., 1989, IAU S, V135, P445, DOI DOI 10.1007/978-94-009-2462-8; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Greif TH, 2008, MON NOT R ASTRON SOC, V387, P1021, DOI 10.1111/j.1365-2966.2008.13326.x; Groenewegen MAT, 2007, MON NOT R ASTRON SOC, V376, P313, DOI 10.1111/j.1365-2966.2007.11428.x; Herwig F, 2004, ASTROPHYS J SUPPL S, V155, P651, DOI 10.1086/425419; Hines DC, 2006, ASTROPHYS J, V641, pL85, DOI 10.1086/504109; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; KALUZNY J, 1995, ASTRON ASTROPHYS SUP, V112, P407; Lagadec E, 2008, MON NOT R ASTRON SOC, V390, pL59, DOI 10.1111/j.1745-3933.2008.00535.x; Lagadec E, 2007, MON NOT R ASTRON SOC, V376, P1270, DOI 10.1111/j.1365-2966.2007.11517.x; Leisenring JM, 2008, ASTROPHYS J, V681, P1557, DOI 10.1086/588378; Levesque EM, 2005, ASTROPHYS J, V628, P973, DOI 10.1086/430901; Maiolino R, 2004, NATURE, V431, P533, DOI 10.1038/nature02930; Mathis JS, 1998, ASTROPHYS J, V497, P824, DOI 10.1086/305477; Matsuura M, 2007, MON NOT R ASTRON SOC, V382, P1889, DOI 10.1111/j.1365-2966.2007.12501.x; Matsuura M, 2006, MON NOT R ASTRON SOC, V371, P415, DOI 10.1111/j.1365-2966.2006.10664.x; Matsuura M, 2005, ASTRON ASTROPHYS, V434, P691, DOI 10.1051/0004-6361:20042305; Mauron N, 2004, ASTRON ASTROPHYS, V418, P77, DOI 10.1051/0004-6361:20034264; MEIKLE WPS, 2007, ASTROPHYS J, V508, P106; Morgan HL, 2003, MON NOT R ASTRON SOC, V343, P427, DOI 10.1046/j.1365-8711.2003.06681.x; Pitman KM, 2000, PUBL ASTRON SOC PAC, V112, P537, DOI 10.1086/316551; RENZINI A, 1981, ASTRON ASTROPHYS, V94, P175; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Sloan GC, 2008, ASTROPHYS J, V686, P1056, DOI 10.1086/591437; Sloan GC, 2006, ASTROPHYS J, V645, P1118, DOI 10.1086/504516; Speck AK, 2006, ASTROPHYS J, V650, P892, DOI 10.1086/507178; Sugerman BEK, 2006, SCIENCE, V313, P196, DOI 10.1126/science.1128131; Teplitz HI, 2007, ASTROPHYS J, V659, P941, DOI 10.1086/512802; Tolstoy E, 2001, MON NOT R ASTRON SOC, V327, P918, DOI 10.1046/j.1365-8711.2001.04785.x; van Loon JT, 1999, ASTRON ASTROPHYS, V346, P805; van Loon JT, 2000, ASTRON ASTROPHYS, V354, P125; Ventura P, 2002, ASTRON ASTROPHYS, V393, P215, DOI 10.1051/0004-6361:20021001; Woitke P, 2006, ASTRON ASTROPHYS, V460, pL9, DOI 10.1051/0004-6361:20066322; Wu YL, 2006, ASTROPHYS J, V639, P157, DOI 10.1086/499226; Zijlstra AA, 2006, MON NOT R ASTRON SOC, V370, P1961, DOI 10.1111/j.1365-2966.2006.10623.x	48	61	61	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					353	355		10.1126/science.1165626	http://dx.doi.org/10.1126/science.1165626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150838	Green Published			2022-12-28	WOS:000262481400030
J	Wilson, RW; Millero, FJ; Taylor, JR; Walsh, PJ; Christensen, V; Jennings, S; Grosell, M				Wilson, R. W.; Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Christensen, V.; Jennings, S.; Grosell, M.			Contribution of Fish to the Marine Inorganic Carbon Cycle	SCIENCE			English	Article							INTESTINAL BICARBONATE SECRETION; CALCIUM-CARBONATE; ACID-BASE; OCEAN; DISSOLUTION; ARAGONITE; IMPACT; CO2; SEDIMENTATION; CHEMISTRY	Oceanic production of calcium carbonate is conventionally attributed to marine plankton (coccolithophores and foraminifera). Here we report that marine fish produce precipitated carbonates within their intestines and excrete these at high rates. When combined with estimates of global fish biomass, this suggests that marine fish contribute 3 to 15% of total oceanic carbonate production. Fish carbonates have a higher magnesium content and solubility than traditional sources, yielding faster dissolution with depth. This may explain up to a quarter of the increase in titratable alkalinity within 1000 meters of the ocean surface, a controversial phenomenon that has puzzled oceanographers for decades. We also predict that fish carbonate production may rise in response to future environmental changes in carbon dioxide, and thus become an increasingly important component of the inorganic carbon cycle.	[Wilson, R. W.] Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England; [Millero, F. J.; Taylor, J. R.; Walsh, P. J.; Grosell, M.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Walsh, P. J.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Christensen, V.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Jennings, S.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Jennings, S.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Exeter; University of Miami; University of Ottawa; University of British Columbia; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia	Wilson, RW (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4PS, Devon, England.	r.w.wilson@ex.ac.uk; fmillero@rsmas.miami.edu; mgrosell@rsmas.miami.edu	Jennings, Simon/F-5085-2012; Christensen, Villy/C-3945-2009	Jennings, Simon/0000-0002-2390-7225; Christensen, Villy/0000-0003-0688-2633	UK Biotechnology and Biological Sciences Research Council [BB/D005108/1, BB/F009364/1, ISIS 1766]; The Royal Society [RSRG 24241]; Oceanographic Section of the U.S. National Science Foundation; Natural Sciences and Engineering Research Council; Canada and the Canada Research Chair; NSERC; Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission; UK Department of Environment, Food, and Rural Affairs; NSF [0416440, 0714024, 0743903]; BBSRC [BB/F009364/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F009364/1, BB/D005108/1] Funding Source: researchfish; Directorate For Geosciences [0752972] Funding Source: National Science Foundation	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Royal Society(Royal Society of London); Oceanographic Section of the U.S. National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada and the Canada Research Chair; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission); LME; The Pew Charitable Trusts; European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	R.W.W. acknowledges support from the UK Biotechnology and Biological Sciences Research Council (awards BB/D005108/1 , BB/F009364/1, and ISIS 1766) and The Royal Society (award RSRG 24241). F.J.M. acknowledges the Oceanographic Section of the U.S. National Science Foundation (NSF). P.J.W. is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada and the Canada Research Chair program. V. C. acknowledges support from NSERC, the Global Environment Facility's UNEP/UNESCO/IOC (Intergovernmental Oceanographic Commission) LME (Large Marine Ecosystem) activities, and from the Sea Around Us Project, initiated and funded by The Pew Charitable Trusts. S.J. thanks the European Commission and the UK Department of Environment, Food, and Rural Affairs for funding support, and A. Clarke (British Antarctic Survey, Cambridge) for providing a compilation of fish oxygen consumption data. M.G. and S.J. are supported by the NSF (awards 0416440, 0714024, and 0743903). We also thank referees for their insightful comments; K. Knapp (School of Physics, University of Exeter) for the fish x-ray images (Fig. 2); R. Walton (University of Warwick, UK) for the powder x-ray diffraction analysis (fig. S1); H. Stoll (Department of Geoscience, Williams College, Williamstown, MA) and A. Pritchard (University of Exeter, Biosciences) for the scanning electron micrographs of sediment trap samples and fish carbonates, respectively (fig. S3); R. Forster (Centre for Environment, Fisheries and Aquaculture Science, Lowestoft) for plotting fig. S4; FishBase (www.fishbase.org) for providing fish species' information; J. Whittamore for preparation of flounder for x-ray imaging; J. Corcoran and C. Cooper for the sheepshead minnow experiments in the Supporting Online Material; and R. van Aerle for assistance with graphical illustrations.	BISHOP JKB, 1986, PROG OCEANOGR, V17, P1, DOI 10.1016/0079-6611(86)90024-8; BROECKER WS, 1977, FATE FOSSIL CO2 OCEA, P207; BYRNE RH, 1984, NATURE, V312, P321, DOI 10.1038/312321a0; Christensen V, 2008, IOC TECHNICAL SERIES, V80; Chung SN, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002001; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; FABRY VJ, 1991, DEEP-SEA RES, V38, P713, DOI 10.1016/0198-0149(91)90008-4; FEELY RA, 1988, MAR CHEM, V25, P227, DOI 10.1016/0304-4203(88)90052-7; Feely RA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001866; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Genz J, 2008, J EXP BIOL, V211, P2327, DOI 10.1242/jeb.016832; Grosell M, 2005, AM J PHYSIOL-REG I, V288, pR936, DOI 10.1152/ajpregu.00684.2003; Grosell M, 2006, J EXP BIOL, V209, P2813, DOI 10.1242/jeb.02345; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jansen H, 2001, MAR ECOL PROG SER, V221, P199, DOI 10.3354/meps221199; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Millero F. J., 2006, CHEM OCEANOGRAPHY; Milliman JD, 1999, DEEP-SEA RES PT I, V46, P1653, DOI 10.1016/S0967-0637(99)00034-5; Milliman JD, 1996, GEOL RUNDSCH, V85, P496, DOI 10.1007/s005310050090; Morse J. W., 1990, GEOCHEMISTRY SEDIMEN; Morse JW, 2003, GEOCHIM COSMOCHIM AC, V67, P2819, DOI 10.1016/S0016-7037(03)00103-0; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; POND DW, 1995, MAR BIOL, V123, P75, DOI 10.1007/BF00350325; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Sabine CL, 2004, SCOPE SER, V62, P17; Sabine CL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001869; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; TAKAHASHI T, 1975, Cushman Foundation for Foraminiferal Research Special Publication, V13, P11; VANDERWAL P, 1995, MAR ECOL PROG SER, V126, P247, DOI 10.3354/meps126247; WALSH PJ, 1991, LIMNOL OCEANOGR, V36, P1227, DOI 10.4319/lo.1991.36.6.1227; Wilson RW, 2003, BBA-BIOMEMBRANES, V1618, P163, DOI 10.1016/j.bbamem.2003.09.014; Wilson RW, 2002, BBA-BIOMEMBRANES, V1566, P182, DOI 10.1016/S0005-2736(02)00600-4; Wilson RW, 1996, J EXP BIOL, V199, P2331	37	175	182	2	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					359	362		10.1126/science.1157972	http://dx.doi.org/10.1126/science.1157972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150840				2022-12-28	WOS:000262481400032
J	Chandler, RK; Fletcher, BW; Volkow, ND				Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.			Treating Drug Abuse and Addiction in the Criminal Justice System Improving Public Health and Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CLINICAL-TRIAL; HIV-INFECTED PRISONERS; METHADONE-MAINTENANCE; COCAINE ADDICTION; HEPATITIS-C; CORRECTIONAL POPULATIONS; COOCCURRING DISORDERS; ORBITOFRONTAL CORTEX; NEURAL SYSTEMS; SELF-CONTROL	Despite increasing evidence that addiction is a treatable disease of the brain, most individuals do not receive treatment. Involvement in the criminal justice system often results from illegal drug- seeking behavior and participation in illegal activities that reflect, in part, disrupted behavior ensuing from brain changes triggered by repeated drug use. Treating drug- involved offenders provides a unique opportunity to decrease substance abuse and reduce associated criminal behavior. Emerging neuroscience has the potential to transform traditional sanction- oriented public safety approaches by providing new therapeutic strategies against addiction that could be used in the criminal justice system. We summarize relevant neuroscientific findings and evidence- based principles of addiction treatment that, if implemented in the criminal justice system, could help improve public heath and reduce criminal behavior.	[Chandler, Redonna K.; Fletcher, Bennett W.; Volkow, Nora D.] Natl Inst Drug Abuse, Serv Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Serv Res Branch, 6001 Execut Blvd,Room 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABRAM KM, 1991, AM PSYCHOL, V46, P1036, DOI 10.1037/0003-066X.46.10.1036; Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079003002; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079004003; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bickel WK, 2007, DRUG ALCOHOL DEPEN, V90, pS85, DOI 10.1016/j.drugalcdep.2006.09.016; Binswanger IA, 2007, NEW ENGL J MED, V356, P536; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell AE, 2005, CLIN INFECT DIS, V40, pS367, DOI 10.1086/427455; Butzin CA, 2006, J CRIM JUST, V34, P557, DOI 10.1016/j.jcrimjus.2006.09.010; Chandler RK, 2004, BEHAV SCI LAW, V22, P431, DOI 10.1002/bsl.598; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Comer SD, 2002, PSYCHOPHARMACOLOGY, V159, P351, DOI 10.1007/s002130100909; Cropsey KL, 2005, SUBST USE MISUSE, V40, P1983, DOI 10.1080/10826080500294866; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; Daley M., 2004, J OFFENDER REHABILIT, V39, P69, DOI DOI 10.1300/J076V39N03_04; DELEON G, 1997, COMMUNITY METHOD THE, P3; Desai AA, 2002, AIDS EDUC PREV, V14, P45, DOI 10.1521/aeap.14.7.45.23867; Ersche KD, 2007, NEUROPSYCHOL REV, V17, P317, DOI 10.1007/s11065-007-9033-y; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; FIELD G, 2004, TREATING ADDICTED OF; FLETCHER BW, 2006, NIH PUBLICATION; Flynn PM, 1999, DRUG ALCOHOL DEPEN, V57, P167, DOI 10.1016/S0376-8716(99)00083-6; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; GLAZE LE, 2006, DEP JUSTICE PUBLICAT; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Gray MA, 2007, NEURON, V54, P183, DOI 10.1016/j.neuron.2007.03.024; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hammett TM, 2001, CRIME DELINQUENCY, V47, P390, DOI 10.1177/0011128701047003006; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Humphreys K, 2004, J SUBST ABUSE TREAT, V26, P151, DOI 10.1016/S0740-5472(03)00212-5; Inciardi JA, 1997, J DRUG ISSUES, V27, P261, DOI 10.1177/002204269702700206; Jensen EL., 2004, CRIMINAL JUSTICE POL, V15, P100, DOI [10.1177/0887403403255315, DOI 10.1177/0887403403255315]; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Karberg J. C., 2005, DEP JUSTICE PUBLICAT, VNCJ209588; Kinlock TW, 2008, CRIM JUSTICE BEHAV, V35, P34, DOI 10.1177/0093854807309111; Kinlock TW, 2007, DRUG ALCOHOL DEPEN, V91, P220, DOI 10.1016/j.drugalcdep.2007.05.022; Knight K, 2004, TREATING ADDICTED OF; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kosten TR, 1998, AM J PSYCHIAT, V155, P711; Kosten TR, 1998, J NERV MENT DIS, V186, P737, DOI 10.1097/00005053-199812000-00001; LANGAN PA, 2002, DEP JUSTICE PUBLICAT; LEUKEFELD CG, 2002, TREATMENT DRUG OFFEN; Logan TK, 2004, EVAL PROGRAM PLANN, V27, P381, DOI 10.1016/j.evalprogplan.2004.04.012; Lurigio AJ, 2000, CRIM JUSTICE BEHAV, V27, P495, DOI 10.1177/0093854800027004005; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; McCollister KE, 2004, JUSTICE Q, V21, P659, DOI 10.1080/07418820400095941; MITCHELL O, 2007, J EXPT CRIMINOLOGY, V0003; Mumola CJ, 2006, DEP JUSTICE PUBLICAT; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Peters RH, 2000, CRIM JUSTICE BEHAV, V27, P72, DOI 10.1177/0093854800027001005; Prendergast ML, 2002, DRUG ALCOHOL DEPEN, V67, P53, DOI 10.1016/S0376-8716(02)00014-5; Rich JD, 2005, J ADDICT DIS, V24, P49, DOI 10.1300/J069v24n03_04; Rich JD, 2005, J URBAN HEALTH, V82, P411, DOI 10.1093/jurban/jti072; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Sabin KM, 2001, J URBAN HEALTH, V78, P241, DOI 10.1093/jurban/78.2.241; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Shivy VA, 2007, J COUNS PSYCHOL, V54, P466, DOI 10.1037/0022-0167.54.4.466; Simpler AH, 2005, ADDICT RES THEORY, V13, P503, DOI 10.1080/16066350500151739; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; STEPHAN JJ, 2004, DEP JUSTICE PUBLICAT; Taxman FS, 2007, J SUBST ABUSE TREAT, V32, P239, DOI 10.1016/j.jsat.2006.12.019; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Uhl GR, 2004, ARCH GEN PSYCHIAT, V61, P223, DOI 10.1001/archpsyc.61.3.223; Vallabhaneni S, 2006, EPIDEMIOL INFECT, V134, P243, DOI 10.1017/S0950268805004991; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Wexler HK, 2007, PRISON J, V87, P9, DOI 10.1177/0032885506299036; Wilson DB, 2005, CRIM JUSTICE BEHAV, V32, P172, DOI 10.1177/0093854804272889; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Wormith JS, 2007, CRIM JUSTICE BEHAV, V34, P879, DOI 10.1177/0093854807301552; Yucel M, 2007, AUST NZ J PSYCHIAT, V41, P957, DOI 10.1080/00048670701689444; Zaller N, 2007, PUBLIC HEALTH REP, V122, P49, DOI 10.1177/003335490712200107; Zarkin GA, 2005, HEALTH ECON, V14, P1133, DOI 10.1002/hec.999	82	357	359	3	53	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					183	190		10.1001/jama.2008.976	http://dx.doi.org/10.1001/jama.2008.976			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	393VV	19141766	Green Accepted			2022-12-28	WOS:000262405500020
J	Chi, AS; Bernstein, BE				Chi, Andrew S.; Bernstein, Bradley E.			DEVELOPMENTAL BIOLOGY Pluripotent Chromatin State	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; POLYCOMB; TRANSCRIPTION; REGULATORS		[Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Chi, Andrew S.; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Dept Neurol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chi, AS (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bernstein.bradley@mgh.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG004570, U54 HG004570-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	17	43	43	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					220	221		10.1126/science.1166261	http://dx.doi.org/10.1126/science.1166261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131621	Green Accepted			2022-12-28	WOS:000262290600027
J	Dejardin, J; Kingston, RE				Dejardin, Jerome; Kingston, Robert E.			Purification of Proteins Associated with Specific Genomic Loci	CELL			English	Article							BINDING PROTEINS; HUMAN TELOMERES; HUMAN-CELLS; AFFINITY PURIFICATION; MAMMALIAN-CELLS; NUCLEIC-ACID; CHROMATIN; DNA; RECOMBINATION; COMPLEX	Eukaryotic DNA is bound and interpreted by numerous protein complexes in the context of chromatin. A description of the full set of proteins that regulate specific loci is critical to understanding regulation. Here, we describe a protocol called proteomics of isolated chromatin segments (PICh) that addresses this issue. PICh uses a specific nucleic acid probe to isolate genomic DNA with its associated proteins in sufficient quantity and purity to allow identification of the bound proteins. Purification of human telomeric chromatin using PICh identified the majority of known telomeric factors and uncovered a large number of novel associations. We compared proteins found at telomeres maintained by the alternative lengthening of telomeres (ALT) pathway to proteins bound at telomeres maintained by telomerase. We identified and validated several proteins, including orphan nuclear receptors, that specifically bind to ALT telomeres, establishing PICh as a useful tool for characterizing chromatin composition.	[Kingston, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu		DEJARDIN, Jerome/0000-0003-0151-1104	EMBO Long term fellowship; NIH [GM48405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM048405] Funding Source: NIH RePORTER	EMBO Long term fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Mike Blower for suggestions on the metaphase spread experiments, Matthew Simon, Rebecca Dunn, and Karim Bouazoune for critically reading the manuscript, the National Cell Culture Center for providing large-scale HeLa S3 cultures, Titia de Lange for providing the HeLa 1.2.11 cell line, Elliott Kieff for providing the HA-NXP2 construct, Joe Garlick for technical assistance, and the Taplin Mass Spectrometric Facility (Ross Tomaino) at Harvard Medical School for protein identifications. J.D. was supported by an EMBO Long term fellowship. This work is supported by NIH grant #GM48405 to R. E. K. This work is dedicated to the memory of Wolfram Horz, a gentleman and scientist.	Abbott DW, 2005, J BIOL CHEM, V280, P16437, DOI 10.1074/jbc.M500170200; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; BOFFA LC, 1995, P NATL ACAD SCI USA, V92, P1901, DOI 10.1073/pnas.92.6.1901; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chen S, 2006, CYTOGENET GENOME RES, V114, P131, DOI 10.1159/000093328; Chen WY, 2004, J BIOL CHEM, V279, P38730, DOI 10.1074/jbc.M405006200; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Fasching CL, 2007, CANCER RES, V67, P7072, DOI 10.1158/0008-5472.CAN-07-1556; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hirsch JD, 2002, ANAL BIOCHEM, V308, P343, DOI 10.1016/S0003-2697(02)00201-4; Jasinskas A, 1999, CHROMOSOME RES, V7, P341, DOI 10.1023/A:1009211929408; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kim SH, 2003, J BIOL CHEM, V278, P28038, DOI 10.1074/jbc.M302192200; Kornberg RD, 2007, NAT STRUCT MOL BIOL, V14, P986, DOI 10.1038/nsmb1107-986; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Morocho A. Michael, 2005, V288, P225; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Park SW, 2007, NAT STRUCT MOL BIOL, V14, P68, DOI 10.1038/nsmb1185; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Rose K, 2002, BIOTECHNIQUES, V33, P54, DOI 10.2144/02331st01; SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; WORKMAN JL, 1985, BIOCHEMISTRY-US, V24, P7486, DOI 10.1021/bi00346a068; Wu WS, 2002, ONCOGENE, V21, P3925, DOI 10.1038/sj.onc.1205491; ZHANG XY, 1982, NUCLEIC ACIDS RES, V10, P1481, DOI 10.1093/nar/10.5.1481	51	364	385	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					175	186		10.1016/j.cell.2008.11.045	http://dx.doi.org/10.1016/j.cell.2008.11.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135898	Green Accepted, Bronze			2022-12-28	WOS:000262318400024
J	Han, J; Pedersen, JS; Kwon, SC; Belair, CD; Kim, YK; Yeom, KH; Yang, WY; Haussler, D; Blelloch, R; Kim, VN				Han, Jinju; Pedersen, Jakob S.; Kwon, S. Chul; Belair, Cassandra D.; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Haussler, David; Blelloch, Robert; Kim, V. Narry			Posttranscriptional Crossregulation between Drosha and DGCR8	CELL			English	Article							MICROPROCESSOR COMPLEX; MICRORNA BIOGENESIS; ALZHEIMERS-DISEASE; RNA INTERFERENCE; EXPRESSION; PROLIFERATION; DROSOPHILA; MIR-222; PATHWAY; CELLS	The Drosha-DGCR8 complex, also known as Microprocessor, is essential for microRNA (miRNA) maturation. Drosha functions as the catalytic subunit, while DGCR8 (also known as Pasha) recognizes the RNA substrate. Although the action mechanism of this complex has been intensively studied, it remains unclear how Drosha and DGCR8 are regulated and if these proteins have any additional role(s) apart from miRNA processing. Here, we report that Drosha and DGCR8 regulate each other posttranscriptionally. The Drosha-DGCR8 complex cleaves the hairpin structures embedded in the DGCR8 mRNA and thereby destabilizes the mRNA. We further find that DGCR8 stabilizes the Drosha protein via protein-protein interaction. This crossregulation between Drosha and DGCR8 may contribute to the homeostatic control of miRNA biogenesis. Furthermore, microarray analyses suggest that a number of mRNAs may be downregulated in a Microprocessor-dependent, miRNA-independent manner. Our study reveals a previously unsuspected function of Microprocessor in mRNA stability control.	[Han, Jinju; Kwon, S. Chul; Kim, Young-Kook; Yeom, Kyu-Hyeon; Yang, Woo-Young; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Pedersen, Jakob S.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Belair, Cassandra D.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA	Seoul National University (SNU); University of Copenhagen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Pedersen, Jakob/C-4985-2009; Pedersen, Jakob/G-3382-2012; Han, Jinju/D-9091-2017; Kim, Young-Kook/AAE-8306-2020	Kwon, S. Chul/0000-0002-9519-5132; Pedersen, Jakob/0000-0002-7236-4001; Kim, Young-Kook/0000-0001-6434-2235; Kim, Young Kook/0000-0002-6037-8449; HAN, Jinju/0000-0003-1844-2301	Creative Research Initiatives Program [R16-2007-073-01000-0]; BK21 Research Fellowships; Ministry of Education, Science, and Technology of Korea; Danish Medical Research Council [271-06-0711]; University of California, San Francisco, Urology Developmental Award; Prostate Cancer Foundation; National Institutes of Health [K08 NS48118, RO1 NS057221]; Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS057221] Funding Source: NIH RePORTER	Creative Research Initiatives Program; BK21 Research Fellowships(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science, and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of California, San Francisco, Urology Developmental Award(University of California System); Prostate Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stem Cell Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. Seogang Hyun for help with S2 transfection, to Dr. Chirlmin Joo for critical reading of this manuscript, and to members of our laboratory for helpful discussion. We also thank Dr. Young-Joon Kim for kindly providing S2 cell. This work was supported by the Creative Research Initiatives Program (R16-2007-073-01000-0) (V.N.K.) and the BK21 Research Fellowships (J.H. and S.C.K.) from the Ministry of Education, Science, and Technology of Korea. J.S.P. was supported by the Danish Medical Research Council (271-06-0711). C.B. was supported through a University of California, San Francisco, Urology Developmental Award and the Prostate Cancer Foundation. R.B. is a Pew Scholar and was supported by National Institutes of Health grants (K08 NS48118, RO1 NS057221), the Prostate Cancer Foundation, and Stem Cell Research Foundation. J.H., S.C.K., Y.K.K., K.H.Y., and W.Y.Y. performed the experiments and analyzed the data. C.B. and R.B. carried out experiments with Dgcr8 KO mES cells, generated Dgcr8 KO MEF, and helped with manuscript preparation. J.S.P. performed bioinformatics analyses with D.H. and helped with editing of paper. J.H. and V.N.K. designed the study and wrote the paper.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2008, BRAIN PATHOL, V18, P113, DOI 10.1111/j.1750-3639.2007.00121.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	41	308	324	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					75	84		10.1016/j.cell.2008.10.053	http://dx.doi.org/10.1016/j.cell.2008.10.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135890	Green Accepted, Bronze			2022-12-28	WOS:000262318400016
J	Pandey, S; Nelson, DC; Assmann, SM				Pandey, Sona; Nelson, David C.; Assmann, Sarah M.			Two Novel GPCR-Type G Proteins Are Abscisic Acid Receptors in Arabidopsis	CELL			English	Article							EARLY SEEDLING DEVELOPMENT; COUPLED RECEPTORS; BINDING PROTEIN; GUARD-CELLS; ABA CONTROL; SUBUNIT; GERMINATION; EXPRESSION; GCR2; RICE	In plants, G proteins modulate signaling by the stress hormone, abscisic acid (ABA). We identify and characterize two novel Arabidopsis proteins that show homology to an orphan vertebrate GPCR (GPR89) and interact with the sole Arabidopsis G protein a subunit, GPA1, but also have intrinsic GTP-binding and GTPase activity. We have named these proteins GPCR-type G proteins (GTG1 and GTG2). Arabidopsis mutants lacking both GTG1 and GTG2 exhibit ABA hyposensitivity. GTG1 and GTG2 bind ABA specifically. The GDP-bound form of the GTGs exhibits greater ABA binding than the GTP-bound form, the GTPase activity of the GTGs is inhibited by GPA1, and gpa1 null mutants exhibit ABA-hypersensitive phenotypes. These results predict that, unusually, it is the GDP-bound, not the GTP-ound, form of the GTGs that actively relays the signal. We propose that GTG proteins function both as a new type of G protein and as a class of membrane-localized ABA receptors.	[Pandey, Sona; Assmann, Sarah M.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Nelson, David C.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Nelson, David C.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Donald Danforth Plant Science Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sma3@psu.edu	Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120; Nelson, David/0000-0001-9792-5015	UW College of Agricultural and Life Sciences, the Morgridge family; NSF [0209694]	UW College of Agricultural and Life Sciences, the Morgridge family; NSF(National Science Foundation (NSF))	Single gtg1-1 and gtg2-1 mutants were isolated and the gtg1 gtg2 mutant created by D.C.N. in the laboratory of Professor Michael R. Sussman at the University of Wisconsin-Madison, under the support of funds from the UW College of Agricultural and Life Sciences, the Morgridge family, and an NIH Graduate Fellowship Training Grant administered through the Department of Genetics. Other research was performed at Penn State and supported by NSF grant 0209694 and the Penn State Waller Professorship to S. M. A. Technical assistance from Ms. Liza A. Wilson, Ms. Anne Gibson, and Ms. Heather Burch, the pGW series of binary vectors from Dr. Tsuyoshi Nakagawa, modified pEarleyGate 102 vector from Dr. Gabriele Monshausen, advice on phylogenetic analysis from Professor Claude dePamphilis, and access to the FLx800 from Professor Doug Cavener are gratefully acknowledged. D.C.N. isolated the single gtg1-1 and gtg2-1mutants and created the gtg1 gtg2 double mutant. S.P. and D.C.N. performed initial phenotypic analyses. S. P. and S. M. A. designed, performed, and interpreted all other experiments. S. P. and S. M. A. wrote the paper, with input from all authors.	ASSMANN SM, 1994, PLANT CELL, V6, P1187, DOI 10.1105/tpc.6.9.1187; ASSMANN SM, 2004, SCI STKE, V264, pRE20; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chow B, 2006, GENE DEV, V20, P1998, DOI 10.1101/gad.1432806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; FAIRLEYGRENOT K, 1991, PLANT CELL, V3, P1037; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Jang YH, 2008, PLANT CELL PHYSIOL, V49, P1898, DOI 10.1093/pcp/pcn151; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Mhaouty-Kodja S, 2004, BIOL CELL, V96, P363, DOI 10.1016/j.biolcel.2004.03.003; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo HS, 1997, BIOCHEM J, V324, P273, DOI 10.1042/bj3240273; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Sutton F, 2000, PLANT PHYSIOL, V124, P223, DOI 10.1104/pp.124.1.223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	46	323	368	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					136	148		10.1016/j.cell.2008.12.026	http://dx.doi.org/10.1016/j.cell.2008.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135895	Bronze			2022-12-28	WOS:000262318400021
J	Seidel, HM				Seidel, Henry M.			Drama in Medicine?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hmsmrs@comcast.net						Lee TH, 2008, NEW ENGL J MED, V359, P2085, DOI 10.1056/NEJMp0805766	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					18	19		10.1001/jama.2008.942	http://dx.doi.org/10.1001/jama.2008.942			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126803				2022-12-28	WOS:000262220400001
J	Dentzer, S				Dentzer, Susan			Communicating Medical News-Pitfalls of Health Care Journalism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER		[Dentzer, Susan] Off Hlth Affairs, Bethesda, MD USA		Dentzer, S (corresponding author), Off Hlth Affairs, Bethesda, MD USA.							Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1977; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Voss M, 2002, AM J PUBLIC HEALTH, V92, P1158, DOI 10.2105/AJPH.92.7.1158	6	62	62	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					1	3		10.1056/NEJMp0805753	http://dx.doi.org/10.1056/NEJMp0805753			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	389MI	19118299				2022-12-28	WOS:000262096800001
J	Gingerich, O				Gingerich, Owen			Year of astronomy: Mankind's place in the Universe	NATURE			English	Editorial Material									[Gingerich, Owen] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Gingerich, O (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ginger@cfa.harvard.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					28	29		10.1038/457028a	http://dx.doi.org/10.1038/457028a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122622	Bronze			2022-12-28	WOS:000262104900016
J	Muscat, M; Bang, H; Wohlfahrt, J; Glismann, S; Molbak, K				Muscat, Mark; Bang, Henrik; Wohlfahrt, Jan; Glismann, Steffen; Molbak, Kare		EUVAC NET Grp	Measles in Europe: an epidemiological assessment	LANCET			English	Article							DEATH CERTIFICATION; ELIMINATION	Background Measles persists in Europe despite the incorporation of the measles vaccine into routine childhood vaccination programmes more than 20 years ago. Our aim was therefore to review the epidemiology of measles in relation to the goal of elimination by 2010. Methods National surveillance institutions from 32 European countries submitted data for 2006-07. Data for age-group, diagnosis confirmation, vaccination, hospital treatment, the presence of acute encephalitis as a complication of disease, and death were obtained. 30 countries also supplied data about importation of disease. Clinical, laboratory-confirmed, and epidemiologically linked cases that met the requirements for national surveillance were analysed. Cases were separated by age: younger than 1 year, 1-4 years, 5-9 years, 10-14 years, 15-19 years, and older than 20 years. Countries with indigenous measles incidence per 100000 inhabitants per year of 0, less than 0.1, 0 . 1-1, and more than 1 were grouped into categories of zero, low, moderate, and high incidence, respectively. Findings For the 2 years of the study, 12132 cases of measles were recorded with most cases (n=10329; 85%) from five countries: Romania, Germany, UK, Switzerland, and Italy. Most cases were unvaccinated or incompletely vaccinated children; however, almost a fifth were aged 20 years or older. For the same 2 years, seven measles-related deaths were recorded. High measles incidence in some European countries revealed suboptimum vaccination coverage. Of the 210 cases that were reported as being imported, 117 (56%) came from another country within Europe and 43 (20%) from Asia. Interpretation The suboptimum vaccination coverage raises serious doubts that the goal of elimination by 2010 can be attained. Achievement and maintenance of optimum vaccination coverage and improved surveillance are the cornerstones of the measles elimination plan for Europe. Funding European Commission and the Statens Serum Institut, Denmark.	[Muscat, Mark; Bang, Henrik; Glismann, Steffen; Molbak, Kare] Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, DK-2300 Copenhagen S, Denmark; [Wohlfahrt, Jan] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut; Statens Serum Institut	Muscat, M (corresponding author), Statens Serum Inst, Dept Epidemiol, EUVAC NET Hub, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	mmc@ssi.dk		Molbak, Kare/0000-0002-3100-4990	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the following collaborators within various public health and surveillance institutions: Vanya Mehandzhieva (Bulgaria); Jitka Castkova and Marcela SmelhausovA (Czech Republic); Ulpu Elonsalo (Finland); Theano Georgakopoulou and Elem Kalamara (Greece); Massimo De Crescenzo, Corrado Cenci, and Lucia Virtuani, (Italy); leleria Curikova (Latvia); Andrew Amato Gauci (Malta), and Miroslaw P Czarkowski (Poland); Judite Catarino (Portugal); Mateja Blasko Markic (Slovenia); Eva Miderovd and Alexandra Zampachova (Slovakia); Solveig Olsson (Sweden); and Kevin Brown, Claire Cameron, and Mary Ramsay (UK). We also thank Paolo Guglielmetti (SANCO C3, European Commission) for contributing valuable suggestions and Hannah Lewis (Statens Serum Insfitut) for proof-reading the first submitted version and adding useful comments. EUVAC.NET is jointly funded by the European Commission under the public health programme 2003-08 (DG SANCO) under grant agreement number 2004205 and the Statens Serum Institut, Denmark. The network is co-ordinated by the EUVAC.NET hub within the Department of Epidemiology, Statens Serum Instimt, and is composed ofpublic health and surveillance institutions from the 27 EU member states together with Croatia, Iceland, Norway, Switzerland, and Turkey.	Andrews N, 2008, B WORLD HEALTH ORGAN, V86, P197, DOI 10.2471/BLT.07.041129; Armour A, 1997, ULSTER MED J, V66, P13; Atti MLC, 2004, VACCINE, V22, P4351, DOI 10.1016/j.vaccine.2004.04.026; Bernard H, 2008, Euro Surveill, V13; COLNUET S, 2007, EURO SURVEILL, V12; *COMM DIS CTR I PU, ANN REP COV 1999 200; Filia A, 2006, EUROSURVEILLANCE, V11; Filia Antonietta, 2008, Euro Surveill, V13; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; GEORGAKOPOULOU T, 2006, EUROSURVEILLANCE, V11; *HLTH PROT AG, CONF MEASL MUMPS RUB; *HLTH PROT AG UK, CONF MEASL CAS ENGL; *HLTH PROT AG UK, ANN COV VACC EV RAP; *HLTH PROT AG UK, INCR MEASL CAS 2006; *HLTH PROT SURV CT, ANN REP 2006; *HUNG CENTR STAT O, YB HLTH STAT 2000 20; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; IOVOLL O, 2007, EURO SURVEILL, V12; Kalies H, 2006, EUR J PEDIATR, V165, P30, DOI 10.1007/s00431-005-1758-0; Kremer JR, 2008, EMERG INFECT DIS, V14, P107, DOI 10.3201/eid1401.070778; LERNOUT T, 2007, EUROSURVEILLANCE, V12; *MIN HLTH, 2007, DGPREVV10606P14CA9 P; *MIN HLTH IT, VACC COV; Mulders MN, 2001, VACCINE, V19, P2245, DOI 10.1016/S0264-410X(00)00453-9; Muscat M, 2007, VACCINE, V25, P6232, DOI 10.1016/j.vaccine.2007.05.063; *NAT PUBL HLTH I F, VACC COV; Pritt BS, 2005, ARCH PATHOL LAB MED, V129, P1476; *PUBL HLTH AUTH SL, EV ADM INSP VACC SLO; Richard J l, 2008, Euro Surveill, V13; RICHARD JL, 2007, EUROSURVEILLANCE, V12; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Schmid D., 2008, Eurosurveillance, V13, P18838; TORNER N, 2007, EUROSURVEILLANCE, V12; *WHO, 2005, EL MEASL RUB PREV CO; World Health Organization, 2003, SURV GUID MEASL CONG	35	158	164	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					383	389		10.1016/S0140-6736(08)61849-8	http://dx.doi.org/10.1016/S0140-6736(08)61849-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401BC	19131097				2022-12-28	WOS:000262912100029
J	Chiang, AC; Massague, J				Chiang, Anne C.; Massague, Joan			Molecular Origins of Cancer Molecular Basis of Metastasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER; LUNG METASTASIS; TUMOR PROGRESSION; STEM-CELLS; THERAPEUTIC OPPORTUNITIES; GENETIC-ANALYSIS; PIVOTAL ROLE; E-CADHERIN; EXPRESSION	N Engl J Med 2008;359:2814-23.	[Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Chiang, Anne C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Box 116,1275 York Ave, New York, NY 10065 USA.	massaguj@mskcc.org		Massague, Joan/0000-0001-9324-8408	Acceleron Pharmaceuticals; Eli Lilly; Genzyme; Eisai; NATIONAL CANCER INSTITUTE [T32CA009207] Funding Source: NIH RePORTER	Acceleron Pharmaceuticals; Eli Lilly(Eli Lilly); Genzyme(Sanofi-AventisGenzyme Corporation); Eisai(Eisai Co Ltd); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Massagu, reports receiving consulting fees from Acceleron Pharmaceuticals, lecture fees from Eli Lilly, Genzyme, and Eisai. No other potential conflict of interest relevant to this article was reported.; We thank D. Nguyen, G. Riely, K. Politi, and D. Spriggs for insightful discussions.	Aguirre-Ghiso JA, 2006, CELL CYCLE, V5, P1740, DOI 10.4161/cc.5.16.3165; Bertucci F, 2007, NEW ENGL J MED, V356, P1887; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Billingsley KG, 1999, ANN SURG, V229, P602, DOI 10.1097/00000658-199905000-00002; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Clark EA, 2001, NATURE, V411, P974, DOI 10.1038/35082119; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Leiter U, 2004, J SURG ONCOL, V86, P172, DOI 10.1002/jso.20079; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; LING V, 1985, CANCER METAST REV, V4, P173, DOI 10.1007/BF00050694; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WAGHORNE C, 1988, CANCER RES, V48, P6109; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Weinberg RA, 2007, BIOL CANC; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	70	750	795	1	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2814	2823		10.1056/NEJMra0805239	http://dx.doi.org/10.1056/NEJMra0805239			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109576	Green Accepted			2022-12-28	WOS:000261950800008
J	Vinson, EN				Vinson, Emily N.			Occult Hip Fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Vinson, EN (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.		Vinson, Emily N/O-1407-2015	Vinson, Emily N/0000-0002-7676-829X					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					E33	E33		10.1056/NEJMicm0707701	http://dx.doi.org/10.1056/NEJMicm0707701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109570				2022-12-28	WOS:000261950800011
J	Mumma, MJ; Villanueva, GL; Novak, RE; Hewagama, T; Bonev, BP; DiSanti, MA; Mandell, AM; Smith, MD				Mumma, Michael J.; Villanueva, Geronimo L.; Novak, Robert E.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.			Strong Release of Methane on Mars in Northern Summer 2003	SCIENCE			English	Article							MARTIAN DUST DEVILS; MU-M; OXIDANT ENHANCEMENT; ATMOSPHERE; ORIGIN; LIFE; SPECTRUM; SEARCH; STORMS; MODEL	Living systems produce more than 90% of Earth's atmospheric methane; the balance is of geochemical origin. On Mars, methane could be a signature of either origin. Using high- dispersion infrared spectrometers at three ground- based telescopes, we measured methane and water vapor simultaneously on Mars over several longitude intervals in northern early and late summer in 2003 and near the vernal equinox in 2006. When present, methane occurred in extended plumes, and the maxima of latitudinal profiles imply that the methane was released from discrete regions. In northern midsummer, the principal plume contained similar to 19,000 metric tons of methane, and the estimated source strength (>= 0.6 kilogram per second) was comparable to that of the massive hydrocarbon seep at Coal Oil Point in Santa Barbara, California.	[Mumma, Michael J.; Villanueva, Geronimo L.; Hewagama, Tilak; Bonev, Boncho P.; DiSanti, Michael A.; Mandell, Avi M.; Smith, Michael D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Villanueva, Geronimo L.; Bonev, Boncho P.] Univ Amer, Dept Phys, Washington, DC 20008 USA; [Novak, Robert E.] Iona Coll, Dept Phys, New Rochelle, NY 10801 USA; [Hewagama, Tilak] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Iona College; University System of Maryland; University of Maryland College Park	Mumma, MJ (corresponding author), NASA, Goddard Space Flight Ctr, Mailstop 690-3, Greenbelt, MD 20771 USA.	michael.j.mumma@nasa.gov	mumma, michael j/I-2764-2013; Mandell, Avi M/F-9361-2012; Smith, Michael/C-8875-2012; Hewagama, T/C-8488-2012	mumma, michael j/0000-0003-4627-750X; Mandell, Avi M/0000-0002-8119-3355; 	NASA the Planetary Astronomy Program [RTOP 344-32-07]; Astrobiology Institute [RTOP 344-53-51]; NSF Research at Undergraduate Institutions Program [AST-0505765]	NASA the Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); Astrobiology Institute; NSF Research at Undergraduate Institutions Program(National Science Foundation (NSF))	We thank T. C. Onstott and L. M. Pratt for helpful comments and two anonymous referees for their comments and suggestions. This work was supported by NASA [the Planetary Astronomy Program (RTOP 344-32-07 to M.J.M), Astrobiology Institute (RTOP 344-53-51, to M.J.M), and Postdoctoral Program (G.L.V.)] by NSF (Research at Undergraduate Institutions Program AST-0505765 to R.E.N.). We thank the director and staff of NASA's InfraRed Telescope Facility (operated for NASA by the University of Hawaii) for exceptional support throughout our long Mars observing program. Data were also obtained at the W. M. Keck Observatory, operated as a scientific partnership by CalTech, the University of California Los Angeles, and NASA.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Encrenaz T, 2008, ICARUS, V195, P547, DOI 10.1016/j.icarus.2008.01.022; Farrell WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027210; Formisano V, 2005, PLANET SPACE SCI, V53, P1043, DOI 10.1016/j.pss.2005.03.009; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; HECHT MH, 2008, EOS S, V89; Hiesinger H, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002143; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; KOUNAVES SP, 2008, EOS S, V89; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Krasnopolsky VA, 2007, ICARUS, V190, P93, DOI 10.1016/j.icarus.2007.02.014; Lellouch E, 2000, PLANET SPACE SCI, V48, P1393, DOI 10.1016/S0032-0633(00)00118-5; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Lyons JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022161; MAGUIRE WC, 1977, ICARUS, V32, P85, DOI 10.1016/0019-1035(77)90051-3; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; Max MD, 2000, J GEOPHYS RES-PLANET, V105, P4165, DOI 10.1029/1999JE001119; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; MUMMA M. J., 2003, B AM ASTRON SOC, V35, P937; Mumma M.J., 2004, AM ASTRON SOC DPS ME, V36, P1127; MUMMA MJ, 2008, B AM ASTRON SOC, V40, P396; MUMMA MJ, 2007, B AM ASTRON SOC, V39, P471; MUMMA MJ, 2005, B AM ASTRON SOC, V37, P669; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; NAIR H, 1994, ICARUS, V111, P124, DOI 10.1006/icar.1994.1137; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott TC, 2006, ASTROBIOLOGY, V6, P377, DOI 10.1089/ast.2006.6.377; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Pellenbarg RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001901; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; Villanueva GL, 2008, ICARUS, V195, P34, DOI 10.1016/j.icarus.2007.11.014; Wille C, 2008, GLOBAL CHANGE BIOL, V14, P1395, DOI 10.1111/j.1365-2486.2008.01586.x; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003	42	422	434	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1041	1045		10.1126/science.1165243	http://dx.doi.org/10.1126/science.1165243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19150811				2022-12-28	WOS:000263478400036
J	Chen, MJ; Yokomizo, T; Zeigler, BM; Dzierzak, E; Speck, NA				Chen, Michael J.; Yokomizo, Tomomasa; Zeigler, Brandon M.; Dzierzak, Elaine; Speck, Nancy A.			Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter	NATURE			English	Article							STEM-CELLS; MOUSE EMBRYO; ADULT HEMATOPOIESIS; FETAL LIVER; MURINE ALLANTOIS; VE-CADHERIN; EXPRESSION; VASCULOGENESIS; CIRCULATION; COMPARTMENT	Haematopoietic stem cells ( HSCs) are the founder cells of the adult haematopoietic system, and thus knowledge of the molecular program directing their generation during development is important for regenerative haematopoietic strategies. Runx1 is a pivotal transcription factor required for HSC generation in the vascular regions of the mouse conceptus - the aorta, vitelline and umbilical arteries, yolk sac and placenta(1,2). It is thought that HSCs emerge from vascular endothelial cells through the formation of intra-arterial clusters(3) and that Runx1 functions during the transition from 'haemogenic endothelium' to HSCs4,5. Here we show by conditional deletion that Runx1 activity in vascular- endothelial- cadherin-positive endothelial cells is indeed essential for intra-arterial cluster, haematopoietic progenitor and HSC formation in mice. In contrast, Runx1 is not required in cells expressing Vav1, one of the first pan- haematopoietic genes expressed in HSCs. Collectively these data show that Runx1 function is essential in endothelial cells for haematopoietic progenitor and HSC formation from the vasculature, but its requirement ends once or before Vav is expressed.	[Chen, Michael J.; Zeigler, Brandon M.; Speck, Nancy A.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Chen, Michael J.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Yokomizo, Tomomasa; Dzierzak, Elaine] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Dartmouth College; Dartmouth College; Erasmus University Rotterdam; Erasmus MC	Speck, NA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nancyas@exchange.upenn.edu		Zeigler, Brandon/0000-0002-1258-7780	Norris Cotton Cancer Center [NIH CA23108]; Abramson Family Cancer Research Institute;  [R01HL091724];  [R01DK54077];  [T32 AI-07519]; NATIONAL CANCER INSTITUTE [R01CA058343, P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077, R01DK054077] Funding Source: NIH RePORTER	Norris Cotton Cancer Center; Abramson Family Cancer Research Institute; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank G. Ward for his assistance with flow, K. Downs for technical advice, T. Graf for the Vav-Cre mice, and P. Huber for the Cdh5 sequences. This work was supported by R01HL091724 (N.A.S.), R01DK54077 (E.D.) and T32 AI-07519 (B.M.Z.). Core services were supported in part by the Norris Cotton Cancer Center (NIH CA23108) and the Abramson Family Cancer Research Institute.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Downs KM, 2004, DEVELOPMENT, V131, P37, DOI 10.1242/dev.00906; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inman KE, 2006, DEVELOPMENT, V133, P2947, DOI 10.1242/dev.02454; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ogilvy S, 1999, BLOOD, V94, P1855; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596	31	683	707	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					887	891		10.1038/nature07619	http://dx.doi.org/10.1038/nature07619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19129762	Green Accepted			2022-12-28	WOS:000263266700046
J	Schroeder, SA				Schroeder, Steven A.			A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIORAL TREATMENT; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; TOBACCO USE; CIGARETTE-SMOKING; MENTAL-ILLNESS; NICOTINE DEPENDENCE; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; CESSATION		[Schroeder, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schroeder, Steven A.] Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 430, San Francisco, CA 94143 USA.	schroeder@medicine.ucsf.edu			Robert Wood Johnson; American Legacy Foundations	Robert Wood Johnson(Robert Wood Johnson Foundation (RWJF)); American Legacy Foundations	Dr Schroeder is funded by the Robert Wood Johnson and American Legacy Foundations.	*AM ASS MED COLL, PHYS BEH PRACT PATT; Apollonio DE, 2005, TOB CONTROL, V14, P409, DOI 10.1136/tc.2005.011890; Audrain-McGovern J, 2004, AM J PSYCHIAT, V161, P1224, DOI 10.1176/appi.ajp.161.7.1224; BECKHAM JC, 1995, J TRAUMA STRESS, V8, P461, DOI 10.1002/jts.2490080308; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; BENOWITZ NL, 1992, MED CLIN N AM, V76, P415, DOI 10.1016/S0025-7125(16)30360-1; Borrelli B, 2007, NICOTINE TOB RES, V9, P653, DOI 10.1080/14622200701365202; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brown RA, 2001, J CONSULT CLIN PSYCH, V69, P471, DOI 10.1037/0022-006X.69.3.471; Brown RA, 2007, NICOTINE TOB RES, V9, P721, DOI 10.1080/14622200701416955; BURKE M, 2006, 12 NAT ASS STAT MENT; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P642; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Colton CW, 2006, PREV CHRONIC DIS; D'Mello DA, 2001, AM J DRUG ALCOHOL AB, V27, P525, DOI 10.1081/ADA-100104516; David S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003086.pub2; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Dierker LC, 2001, J AM ACAD CHILD PSY, V40, P929, DOI 10.1097/00004583-200108000-00015; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1166, DOI 10.1176/appi.ps.53.9.1166; Fiore MC, 2008, TREATING TOBACCO USE; Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; GLASSMAN AH, 1993, AM J PSYCHIAT, V150, P546; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hall SM, 2004, AM J PSYCHIAT, V161, P2100, DOI 10.1176/appi.ajp.161.11.2100; Hamlett-Berry K, 2005, VA VANGUARD BUILDING, P7; Hitsman B, 2003, J CONSULT CLIN PSYCH, V71, P657, DOI 10.1037/0022-006X.71.4.657; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hurt RD, 1996, JAMA-J AM MED ASSOC, V275, P1097, DOI 10.1001/jama.275.14.1097; Institute for Safe Medication Practices, STRONG SAF SIGN SEEN; ISAACS SL, VA VANGUARD BUILDING; Johnson EO, 2006, NICOTINE TOB RES, V8, P257, DOI 10.1080/14622200600576644; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; JOSEPH AM, 2005, VA VANGUARD BUILDING, P207; Kalman D, 2005, AM J ADDICTION, V14, P106, DOI 10.1080/10550490590924728; Kandel DB, 2001, DRUG ALCOHOL DEPEN, V64, P233, DOI 10.1016/S0376-8716(01)00126-0; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Killen JD, 2000, J CONSULT CLIN PSYCH, V68, P883, DOI 10.1037//0022-006X.68.5.883; Kohen I, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07010173; Kollins SH, 2005, ARCH GEN PSYCHIAT, V62, P1142, DOI 10.1001/archpsyc.62.10.1142; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lerman C, 1998, HEALTH PSYCHOL, V17, P56, DOI 10.1037/0278-6133.17.1.56; LESHNER AI, 1997, HOSP PRACT OFF ED SP, P2; Levin A., 2007, PSYCHIAT NEWS, V42, P4, DOI 10.1176/pn.42.2.0004a; Lucksted A, 2004, AM J ADDICTION, V13, P128, DOI 10.1080/10550490490436000; Lyons M, 2008, NICOTINE TOB RES, V10, P97, DOI 10.1080/14622200701705332; MAUER B, 2006, 13 NAT ASS STAT MENT; McCaffery JM, 2003, NICOTINE TOB RES, V5, P77, DOI 10.1080/14622200307259; McNally L, 2006, J PUBLIC HEALTH-UK, V28, P192, DOI 10.1093/pubmed/fdl029; Mechanic D, 2002, HEALTH AFFAIR, V21, P242, DOI 10.1377/hlthaff.21.5.242; MONIHAN KM, COMP ANAL SMOKING PO; Morris CD, 2006, PSYCHIAT SERV, V57, P1035, DOI 10.1176/appi.ps.57.7.1035; Munoz RF, 2006, NICOTINE TOB RES, V8, P77, DOI 10.1080/14622200500431940; National Center for Health Statistics, EARL REL SEL EST BAS; Newcomer JW, 2007, JAMA-J AM MED ASSOC, V298, P1794, DOI 10.1001/jama.298.15.1794; Ossip-Klein DJ, 2003, AM J MED SCI, V326, P201, DOI 10.1097/00000441-200310000-00010; Paperwalla KN, 2004, MED CLIN N AM, V88, P1483, DOI 10.1016/j.mcna.2004.06.007; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Prochaska JJ, 2006, AM J ADDICTION, V15, P15, DOI 10.1080/10550490500419011; Prochaska JJ, 2004, DRUG ALCOHOL DEPEN, V76, P143, DOI 10.1016/j.drugalcdep.2004.04.017; PROCHASKA JJ, ACAD PSYCHI IN PRESS; Prochaska JJ, 2008, SCHIZOPHRENIA BULL, V34, P555, DOI 10.1093/schbul/sbm117; Prochaska JJ, 2008, AM J PUBLIC HEALTH, V98, P446, DOI 10.2105/AJPH.2006.101147; *REG U CAL U SO CA, RX CHANG CLIN ASS TO; Reilly P, 2006, INT J MENT HEALTH NU, V15, P272, DOI 10.1111/j.1447-0349.2006.00434.x; Sanchez-Villegas A, 2008, MED CLIN-BARCELONA, V130, P405, DOI 10.1157/13117850; Satcher DS, 2000, PUBLIC HEALTH REP, V115, P89, DOI 10.1093/phr/115.1.89; SAXON AJ, 2006, PRECEPTOR TRAINING P, P13; Schroeder SA, 2005, JAMA-J AM MED ASSOC, V294, P482, DOI 10.1001/jama.294.4.482; SCHROEDER SA, 2007, WASHINGTIN POST 1118; Schroeder S, 2008, NEW ENGL J MED, V358, P2284, DOI 10.1056/NEJMe0802708; Schroeder SA, 2006, ANN INTERN MED, V145, P784, DOI 10.7326/0003-4819-145-10-200611210-00013; Stapleton JA, 2008, ADDICTION, V103, P146, DOI 10.1111/j.1360-0443.2007.02083.x; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001007.PUB2; Steinberg ML, 2004, TOB CONTROL, V13, P206; Thorndike A N, 2001, Nicotine Tob Res, V3, P85, DOI 10.1080/14622200020032132; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tsoh JY, 2000, AM J PSYCHIAT, V157, P368, DOI 10.1176/appi.ajp.157.3.368; Tsoh JY, 2004, ADDICT BEHAV, V29, P801, DOI 10.1016/j.addbeh.2004.02.011; Warner K. E., 2007, TOBACCO CONTROL POLI, P3; Williams JM, 2008, JAMA-J AM MED ASSOC, V299, P571, DOI 10.1001/jama.299.5.571; Williams JM, 2004, ADDICT BEHAV, V29, P1067, DOI 10.1016/j.addbeh.2004.03.009; Williams KE, 2007, CURR MED RES OPIN, V23, P793, DOI 10.1185/030079907X182185; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660; ZHU SH, 2005, VA VANGUARD BUILDING, P207; ZIEDONIS DM, 1994, HOSP COMMUNITY PSYCH, V45, P204; ZIEDONIS DM, 2005, VA VANGUARD BUILDING	93	45	45	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2009	301	5					522	531						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402CS	19126801				2022-12-28	WOS:000262992400022
J	Renfrew, C				Renfrew, Colin			ANTHROPOLOGY Where Bacteria and Languages Concur	SCIENCE			English	Editorial Material									[Renfrew, Colin] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England	University of Cambridge	Renfrew, C (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England.	renfrew@mcdonald.cam.ac.uk						ALLEN J, 1984, J PAC HIST, V19, P186, DOI 10.1080/00223348408572494; Bellwood P., 2005, 1 FARMERS ORIGINS AG, P128; BLUST RA, AUSTRONESIA IN PRESS; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Hurles ME, 2003, AM J HUM GENET, V72, P1282, DOI 10.1086/374827; KIRCH PV, 1997, LAPITA PEOPLES; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; PAWLEY A, 2002, EXAMINING FARMING LA, P251; Renfrew C, 2000, NAT GENET, V26, P253, DOI 10.1038/81518; RENFREW C, 2006, PHYLOGENETIC METHODS; RUHLEN M, 1991, GUIDE WORLDS LANGUAG, P160; Schleicher August, 1863, DARWINISCHE THEORIE	15	13	13	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					467	468		10.1126/science.1168953	http://dx.doi.org/10.1126/science.1168953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	396JL	19164735				2022-12-28	WOS:000262587900028
J	Steig, EJ; Schneider, DP; Rutherford, SD; Mann, ME; Comiso, JC; Shindell, DT				Steig, Eric J.; Schneider, David P.; Rutherford, Scott D.; Mann, Michael E.; Comiso, Josefino C.; Shindell, Drew T.			Warming of the Antarctic ice-sheet surface since the 1957 International Geophysical Year	NATURE			English	Article							SOUTHERN-HEMISPHERE CLIMATE; IN-SITU; VARIABILITY; TRENDS; TEMPERATURES; SIMULATION; LENGTH; SEASON	Assessments of Antarctic temperature change have emphasized the contrast between strong warming of the Antarctic Peninsula and slight cooling of the Antarctic continental interior in recent decades(1). This pattern of temperature change has been attributed to the increased strength of the circumpolar westerlies, largely in response to changes in stratospheric ozone(2). This picture, however, is substantially incomplete owing to the sparseness and short duration of the observations. Here we show that significant warming extends well beyond the Antarctic Peninsula to cover most of West Antarctica, an area of warming much larger than previously reported. West Antarctic warming exceeds 0.1 degrees C per decade over the past 50 years, and is strongest in winter and spring. Although this is partly offset by autumn cooling in East Antarctica, the continent- wide average near- surface temperature trend is positive. Simulations using a general circulation model reproduce the essential features of the spatial pattern and the long- term trend, and we suggest that neither can be attributed directly to increases in the strength of the westerlies. Instead, regional changes in atmospheric circulation and associated changes in sea surface temperature and sea ice are required to explain the enhanced warming in West Antarctica.	[Steig, Eric J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Steig, Eric J.] Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; [Schneider, David P.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Rutherford, Scott D.] Roger Williams Univ, Dept Environm Sci, Bristol, RI 02809 USA; [Mann, Michael E.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Mann, Michael E.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Comiso, Josefino C.] NASA, Goddard Space Flight Ctr, NASA Lab Hydrospher & Biospher Sci, Greenbelt, MD 20771 USA; [Shindell, Drew T.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Shindell, Drew T.] Columbia Univ, Ctr Climate Syst Res, New York, NY 10025 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Center Atmospheric Research (NCAR) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University	Steig, EJ (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	steig@ess.washington.edu	Schneider, David/E-2726-2010; Mann, Michael E/B-8472-2017; Steig, Eric J/G-9088-2015; Shindell, Drew/D-4636-2012	Schneider, David/0000-0001-5308-1834; Mann, Michael E/0000-0003-3067-296X; Steig, Eric J/0000-0002-8191-5549; Shindell, Drew/0000-0003-1552-4715	US National Science Foundation [OPP-0440414, OPP-0126161, OPP-0125670]; US ITASE	US National Science Foundation(National Science Foundation (NSF)); US ITASE	E.J.S. and D.P.S. were supported by the US National Science Foundation, grant numbers OPP-0440414 and OPP-0126161, as part of the US ITASE programme. M.E.M. was supported by the US National Science Foundation, grant number OPP-0125670. We thank D. Winebrenner, A. Monaghan, D. Bromwich, J. Turner, P. Mayewski, T. Scambos, E. Bard and O. Bellier.	Bromwich DH, 2004, J CLIMATE, V17, P4603, DOI 10.1175/3241.1; Bromwich DH, 2008, EOS; Chapman WL, 2007, J CLIMATE, V20, P4096, DOI 10.1175/JCLI4236.1; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; CONOLLEY WM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2007GL031648; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; Fierro RD, 1997, SIAM J SCI COMPUT, V18, P1223, DOI 10.1137/S1064827594263837; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Holland MM, 2006, CLIM DYNAM, V26, P229, DOI 10.1007/s00382-005-0087-3; Johanson CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029108; Jones PD, 2003, J CLIMATE, V16, P206, DOI 10.1175/1520-0442(2003)016<0206:HALSSA>2.0.CO;2; Keeley SPE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031238; Kwok R, 2002, J CLIMATE, V15, P487, DOI 10.1175/1520-0442(2002)015<0487:SOCASI>2.0.CO;2; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Monaghan AJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009094; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; Schneider DP, 2008, P NATL ACAD SCI USA, V105, P12154, DOI 10.1073/pnas.0803627105; Schneider DP, 2004, J CLIMATE, V17, P1569, DOI 10.1175/1520-0442(2004)017<1569:RCVIAF>2.0.CO;2; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020724; Shuman CA, 2001, J CLIMATE, V14, P1977, DOI 10.1175/1520-0442(2001)014<1977:DLCIWA>2.0.CO;2; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2006, SCIENCE, V311, P1914, DOI 10.1126/science.1121652; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991	30	493	517	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					459	462		10.1038/nature07669	http://dx.doi.org/10.1038/nature07669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158794	Green Published			2022-12-28	WOS:000262519200042
J	Garrick-Bethell, I; Weiss, BP; Shuster, DL; Buz, J				Garrick-Bethell, Ian; Weiss, Benjamin P.; Shuster, David L.; Buz, Jennifer			Early Lunar Magnetism	SCIENCE			English	Article							METAL GRAINS; CORE DYNAMO; FIELDS; EVOLUTION; SURFACE; APATITE	It is uncertain whether the Moon ever formed a metallic core or generated a core dynamo. The lunar crust and returned samples are magnetized, but the source of this magnetization could be meteoroid impacts rather than a dynamo. Here, we report magnetic measurements and 40Ar/39Ar thermochronological calculations for the oldest known unshocked lunar rock, troctolite 76535. These data imply that there was a long- lived field on the Moon of at least 1 microtesla similar to 4.2 billion years ago. The early age, substantial intensity, and long lifetime of this field support the hypothesis of an ancient lunar core dynamo.	[Garrick-Bethell, Ian; Weiss, Benjamin P.; Buz, Jennifer] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Shuster, David L.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA	Massachusetts Institute of Technology (MIT); Berkeley Geochronolgy Center	Garrick-Bethell, I (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-521,77 Massachusetts Ave, Cambridge, MA 02139 USA.	iang@mit.edu	Shuster, David/A-4838-2011; Garrick-Bethell, Ian/E-7051-2013	Garrick-Bethell, Ian/0000-0002-6327-5867	Charles E. Reed Faculty Initiatives Fund; Ann and Gordon Getty Foundation	Charles E. Reed Faculty Initiatives Fund; Ann and Gordon Getty Foundation	We thank the Johnson Space Center staff and the Curation and Analysis Planning Team for Extraterrestrial Materials for allocating 76535; V. Fernandes for insights into lunar <SUP>40</SUP>Ar/<SUP>39</SUP>Ar geochronology; I.S. McCallum for discussions about thermobarometry; S. Slotznick and S. Pedersen for help with the paleomagnetic analyses; M. Zuber and T. Bosak for suggestions; and K. Willis for administrative help. B.P.W., D.L.S., and I.G.-B. thank the NASA Lunar Advanced Science and Exploration Research Program; B.P.W. thanks the Charles E. Reed Faculty Initiatives Fund for support; and D.L.S. thanks the Ann and Gordon Getty Foundation.	Artemieva N, 2004, ICARUS, V171, P84, DOI 10.1016/j.icarus.2004.05.003; BISCHOFF A, 1992, EUR J MINERAL, V4, P707; BOGARD DD, 1975, EARTH PLANET SC LETT, V26, P69, DOI 10.1016/0012-821X(75)90178-8; BOZORTH RM, 1951, FERROMAGNETISM, P968; BRADDY D, 1975, P LUNAR PLANET SCI C, V6, P3587; Carporzen L, 2005, NATURE, V435, P198, DOI 10.1038/nature03560; COLLINSON DW, 1993, SURV GEOPHYS, V14, P89, DOI 10.1007/BF01044078; Crawford DA, 1999, INT J IMPACT ENG, V23, P169, DOI 10.1016/S0734-743X(99)00070-6; DOELL RR, 1970, SCIENCE, V167, P695, DOI 10.1126/science.167.3918.695; DYAL P, 1970, SCIENCE, V169, P762, DOI 10.1126/science.169.3947.762; Dymek R., 1975, P LUN SCI C 6, VVI, P301; Fechtig H., 1966, POTASSIUM ARGON DATI, P68, DOI DOI 10.1007/978-3-642-87895-4_4; Fuller M., 1987, GEOMAGN AERON, V2, P307; Gattacceca J, 2008, PHYS EARTH PLANET IN, V166, P1, DOI 10.1016/j.pepi.2007.09.005; Gattacceca J, 2004, EARTH PLANET SC LETT, V227, P377, DOI 10.1016/j.epsl.2004.09.013; GOOLEY R, 1974, GEOCHIM COSMOCHIM AC, V38, P1329, DOI 10.1016/0016-7037(74)90091-X; Goossens S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031960; Halekas JS, 2003, METEORIT PLANET SCI, V38, P565, DOI 10.1111/j.1945-5100.2003.tb00027.x; HERZBERG CT, 1979, LUNAR PLANET SCI, V10, P537; HEWINS RH, 1975, LUNAR PLANET SCI, V6, P356; Hood LL, 2008, ICARUS, V193, P485, DOI 10.1016/j.icarus.2007.08.023; HUNEKE JC, 1975, LUNAR SCI, V6, P417; HUSAIN L, 1975, GEOPHYS RES LETT, V2, P29, DOI 10.1029/GL002i001p00029; Ketcham RA, 1999, AM MINERAL, V84, P1235; Kletetschka G, 2006, PHYS EARTH PLANET IN, V154, P290, DOI 10.1016/j.pepi.2005.07.005; Lawrence K, 2008, PHYS EARTH PLANET IN, V168, P71, DOI 10.1016/j.pepi.2008.05.007; LINDSLEY DH, 1983, P LUNAR PLANET SCI, V13, pA887; LUGMAIR GW, 1976, P LUNAR PLANET SCI C, P2009; McCallum IS, 2006, GEOCHIM COSMOCHIM AC, V70, P6068, DOI 10.1016/j.gca.2006.08.009; McCallum IS, 2001, J GEOPHYS RES-PLANET, V106, P27969, DOI 10.1029/2000JE001397; Meibom A, 2000, SCIENCE, V288, P839, DOI 10.1126/science.288.5467.839; Merrill R., 1998, MAGNETIC FIELD EARTH, P531; Mitchell DL, 2008, ICARUS, V194, P401, DOI 10.1016/j.icarus.2007.10.027; NAESER CW, 1969, J GEOPHYS RES, V74, P705, DOI 10.1029/JB074i002p00705; NESS NF, 1967, J GEOPHYS RES, V72, P5769, DOI 10.1029/JZ072i023p05769; NORD GL, 1976, P LUNAR PLANET SCI C, V7, P1875; PAPANASTASSIOU DA, 1976, P LUNAR PLANET SCI C, P2035; Pearce G. W., 1972, NASA, P7; POHL J, 1981, LUNAR PLANET SCI, V12, P851; PREMO WR, 1992, P LUNAR PLANET SCI, V22, P381; Righter K, 2005, GEOCHIM COSMOCHIM AC, V69, P3145, DOI 10.1016/j.gca.2005.01.010; RUCORN SK, 1978, NATURE, V275, P430; RUNCORN SK, 1970, SCIENCE, V167, P697, DOI 10.1126/science.167.3918.697; Ryder G., 1980, P LUN PLAN SCI C, V11, P471; Shuster DL, 2005, SCIENCE, V309, P594, DOI 10.1126/science.1113077; SMYTH JR, 1986, P LUNAR PLANET SCI C, V17, pE91; SRNKA LJ, 1977, P LUNAR PLANET SCI C, V8, P785; Stegman DR, 2003, NATURE, V421, P143, DOI 10.1038/nature01267; STEVENSON DJ, 1983, REP PROG PHYS, V46, P555, DOI 10.1088/0034-4885/46/5/001; Sugiura N., 1979, LUNAR PLANET SCI C P, V10, P2189; UREY HC, 1951, GEOCHIM COSMOCHIM AC, V1, P209, DOI 10.1016/0016-7037(51)90001-4; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Wilhelms D.E., 1987, USGS PROFESSIONAL PA; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; WOLFE EW, 1981, GEOLOGIC INVESTIGATI	55	119	121	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					356	359		10.1126/science.1166804	http://dx.doi.org/10.1126/science.1166804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150839				2022-12-28	WOS:000262481400031
J	Li, S; Makovets, S; Matsuguchi, T; Blethrow, JD; Shokat, KM; Blackburn, EH				Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blethrow, Justin D.; Shokat, Kevan M.; Blackburn, Elizabeth H.			Cdk1-Dependent Phosphorylation of Cdc13 Coordinates Telomere Elongation during Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; DEPENDENT KINASE CDK1; DNA-BINDING PROTEIN; LENGTH REGULATION; YEAST TELOMERES; END PROTECTION; IN-VIVO; REPLICATION; EST1P; MEC1	Elongation of telomeres by telomerase replenishes the loss of terminal telomeric DNA repeats during each cell cycle. In budding yeast, Cdc13 plays an essential role in telomere length homeostasis, partly through its interactions with both the telomerase complex and the competing Stn1-Ten1 complex. Previous studies in yeast have shown that telomere elongation by telomerase is cell cycle dependent, but the mechanism underlying this dependence is unclear. In S. cerevisiae, a single cyclin-dependent kinase Cdk1 (Cdc28) coordinates the serial events required for the cell division cycle, but no Cdk1 substrate has been identified among telomerase and telomere-associated factors. Here we show that Cdk1-dependent phosphorylation of Cdc13 is essential for efficient recruitment of the yeast telomerase complex to telomeres by favoring the interaction of Cdc13 with Est1 rather than the competing Stn1-Ten1 complex. These results provide a direct mechanistic link between coordination of telomere elongation and cell-cycle progression in vivo.	[Li, Shang; Makovets, Svetlana; Matsuguchi, Tetsuya; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Blethrow, Justin D.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Box 2200, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu	Matsuguchi, Tetsuya/HGU-0412-2022; LI, SHANG/HII-4989-2022	LI, SHANG/0000-0002-6226-3362; Matsuguchi, Tetsuya/0000-0003-2018-4575; Makovets, Svetlana/0000-0002-0226-2093	NIH; UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC BREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bradley Stohr, Jennifer Fung, Jeff Seidel, and Tanya Williams for critical reading of the manuscript. This work was supported by grants from the NIH to E.H.B. and K.M.S. J.D.B. was supported by a UC BREP great fellowship.	Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Frank CJ, 2006, MOL CELL, V24, P423, DOI 10.1016/j.molcel.2006.10.020; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Goudsouzian LK, 2006, MOL CELL, V24, P603, DOI 10.1016/j.molcel.2006.10.005; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano Y, 2007, MOL BIOL CELL, V18, P2026, DOI 10.1091/mbc.E06-12-1074; Hsu CL, 2004, NUCLEIC ACIDS RES, V32, P511, DOI 10.1093/nar/gkh203; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lendvay TS, 1996, GENETICS, V144, P1399; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2007, GENETICS, V177, P1459, DOI 10.1534/genetics.107.078840; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	52	102	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					50	61		10.1016/j.cell.2008.11.027	http://dx.doi.org/10.1016/j.cell.2008.11.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135888	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000262318400014
J	Jacob, K; Trainer, PJ				Jacob, K.; Trainer, P. J.			Topiramate can induce hypoadrenalism in patients taking oral corticosteroid replacement	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jacob, K.; Trainer, P. J.] Christie Hosp NHS Trust, Dept Endocrinol, Manchester M20 4BX, Lancs, England	Christie NHS Foundation Trust; Christie Hospital	Jacob, K (corresponding author), Christie Hosp NHS Trust, Dept Endocrinol, Manchester M20 4BX, Lancs, England.	drkoshyjacob@gmail.com						MICHELE Y, 2005, SPLINTER J PHARM PRA, V18, P444; Nallani SC, 2003, EPILEPSIA, V44, P1521, DOI 10.1111/j.0013-9580.2003.06203.x	2	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2009	338								a1788	10.1136/bmj.39588.561840.BD	http://dx.doi.org/10.1136/bmj.39588.561840.BD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PQ	19131388				2022-12-28	WOS:000263165900004
J	Hines, PJ; Jasny, BR; Mervis, J				Hines, Pamela J.; Jasny, Barbara R.; Mervis, Jeffrey			Adding a T to the Three R's Introduction	SCIENCE			English	Editorial Material																			0	20	20	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					53	53						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119209				2022-12-28	WOS:000262104100033
J	Dale, DC; Link, DC				Dale, David C.; Link, Daniel C.			FOCUS ON RESEARCH The Many Causes of Severe Congenital Neutropenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; MUTATIONS; ELASTASE		[Dale, David C.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Link, Daniel C.] Washington Univ, Div Oncol, Sect Stem Cell Biol, St Louis, MO USA	University of Washington; University of Washington Seattle; Washington University (WUSTL)	Dale, DC (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI049393] Funding Source: NIH RePORTER; NIAID NIH HHS [R24 AI049393] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Rosenberg PS, 2008, BRIT J HAEMATOL, V140, P210, DOI 10.1111/j.1365-2141.2007.06897.x	5	52	55	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					3	5		10.1056/NEJMp0806821	http://dx.doi.org/10.1056/NEJMp0806821			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118300	Green Accepted			2022-12-28	WOS:000262096800002
J	Li, P; Tong, C; Mehrian-Shai, R; Jia, L; Wu, N; Yan, Y; Maxson, RE; Schulze, EN; Song, H; Hsieh, CL; Pera, MF; Ying, QL				Li, Ping; Tong, Chang; Mehrian-Shai, Ruty; Jia, Li; Wu, Nancy; Yan, Youzhen; Maxson, Robert E.; Schulze, Eric N.; Song, Houyan; Hsieh, Chih-Lin; Pera, Martin F.; Ying, Qi-Long			Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts	CELL			English	Article							MOUSE EMBRYOS; SELF-RENEWAL; LINE TRANSMISSION; EGG-CYLINDERS; ES CELLS; GENE; PLURIPOTENT; DIFFERENTIATION; GENOME; GROWTH	Rats have important advantages over mice as an experimental system for physiological and pharmacological investigations. The lack of rat embryonic stem (ES) cells has restricted the availability of transgenic technologies to create genetic models in this species. Here, we show that rat ES cells can be efficiently derived, propagated, and genetically manipulated in the presence of small molecules that specifically inhibit GSK3, MEK, and FGF receptor tyrosine kinases. These rat ES cells express pluripotency markers and retain the capacity to differentiate into derivatives of all three germ layers. Most importantly, they can produce high rates of chimerism when reintroduced into early stage embryos and can transmit through the germline. Establishment of authentic rat ES cells will make possible sophisticated genetic manipulation to create models for the study of human diseases.	[Li, Ping; Tong, Chang; Schulze, Eric N.; Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty; Maxson, Robert E.; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Mehrian-Shai, Ruty] Univ So Calif, Keck Sch Med, Custom Microarray Core Facil, Inst Med Genet, Los Angeles, CA 90033 USA; [Wu, Nancy; Yan, Youzhen; Maxson, Robert E.] Univ So Calif, Keck Sch Med, Knockout Core Facil, Norris Canc Ctr Transgen, Los Angeles, CA 90033 USA; [Pera, Martin F.; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Jia, Li; Hsieh, Chih-Lin] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Dept Urol, Los Angeles, CA 90033 USA; [Li, Ping; Song, Houyan] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 20032, Peoples R China	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Fudan University	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@keck.usc.edu	Jia, li/GPW-8015-2022; PERA, MARTIN/A-9812-2012; Mehrian-Shai, Ruty/AAF-8008-2019; li, jia/GVT-7587-2022	PERA, MARTIN/0000-0001-6239-0428; 	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) [RS1-00327-1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016320] Funding Source: NIH RePORTER	USC Startup fund; California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Jing Du, Yu Su, Robin Wesselschmidt, Hongjun Zhang, and Shelley Hough for technical assistance; Gerald Chester for ordering animals; Ramiro Montano, Gloria Martinez, and colleagues for rat husbandry; and Dr. Wange Lu for sharing research materials. This work was supported by USC Startup fund (Q.-L.Y.) and in part by California Institute for Regenerative Medicine (CIRM) Scientific Excellence through Exploration and Development (SEED) grants RS1-00327-1 (Q.-L.Y.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; DAMJANOV I, 1977, J NATL CANCER I, V58, P1523, DOI 10.1093/jnci/58.5.1523; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P303; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; HSIEH CL, 1997, CELL BIOL LAB HDB, P391; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kuramoto T, 2001, MAMM GENOME, V12, P469, DOI 10.1007/s003350020010; Liu X, 1997, DEV DYNAM, V209, P85; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nagy A., 2003, MANIPULATING MOUSE E; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Nichols Jennifer, 2006, V329, P91; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ostertag EM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S16; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	492	570	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1299	1310		10.1016/j.cell.2008.12.006	http://dx.doi.org/10.1016/j.cell.2008.12.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109898	Green Accepted, Bronze			2022-12-28	WOS:000261989800020
J	Solstad, T; Boccara, CN; Kropff, E; Moser, MB; Moser, EI				Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.			Representation of Geometric Borders in the Entorhinal Cortex	SCIENCE			English	Article							SPATIAL REPRESENTATION; PARIETAL CORTEX; PLACE CELLS; HIPPOCAMPUS; DIRECTION; MEMORY; MAP	We report the existence of an entorhinal cell type that fires when an animal is close to the borders of the proximal environment. The orientation- specific edge- apposing activity of these " border cells" is maintained when the environment is stretched and during testing in enclosures of different size and shape in different rooms. Border cells are relatively sparse, making up less than 10% of the local cell population, but can be found in all layers of the medial entorhinal cortex as well as the adjacent parasubiculum, often intermingled with head- direction cells and grid cells. Border cells may be instrumental in planning trajectories and anchoring grid fields and place fields to a geometric reference frame.	[Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Solstad, Trygve; Boccara, Charlotte N.; Kropff, Emilio; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol & Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Kropff, Emilio/0000-0001-5996-8436; Boccara, Claude/0000-0002-9603-0700	Kavli Foundation; Norwegian Research Council; European Commission Framework 7 project (SPACEBRAIN)	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); European Commission Framework 7 project (SPACEBRAIN)(European Commission)	We thank N. Burgess and a number of other colleagues for helpful discussion and suggestions; M.P. Witter for advice about electrode location; M. Fyhn for donating an implanted animal; and A.M. Amundsgard, E. Sjulstad, I.M.F. Hammer, K. Haugen, K. Jenssen, R. Skjerpeng, H. Waade, and T.A smul for technical assistance. The work was supported by the Kavli Foundation, the Centre of Excellence scheme of the Norwegian Research Council, and a European Commission Framework 7 project (SPACEBRAIN).	Barry C, 2006, REV NEUROSCIENCE, V17, P71; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006	19	637	652	6	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1865	1868		10.1126/science.1166466	http://dx.doi.org/10.1126/science.1166466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095945				2022-12-28	WOS:000261799400061
J	Boseley, S				Boseley, Sarah			Profile Abdullah Baqui: saving newborn lives in Bangladesh and globally	LANCET			English	Biographical-Item												sarah.boseley@guardian.co.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2106	2106		10.1016/S0140-6736(08)61912-1	http://dx.doi.org/10.1016/S0140-6736(08)61912-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101375				2022-12-28	WOS:000261894000016
J	Laurance, J				Laurance, Jeremy			Profile Martin Birchall: using stem cells to help make transplant history	LANCET			English	Biographical-Item												J.Laurance@independent.co.uk							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2104	2104		10.1016/S0140-6736(08)61910-8	http://dx.doi.org/10.1016/S0140-6736(08)61910-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101373				2022-12-28	WOS:000261894000014
J	Sumara, G; Formentini, I; Collins, S; Sumara, I; Windak, R; Bodenmiller, B; Ramracheya, R; Caille, D; Jiang, HP; Platt, KA; Meda, P; Aebersold, R; Rorsman, P; Ricci, R				Sumara, Grzegorz; Formentini, Ivan; Collins, Stephan; Sumara, Izabela; Windak, Renata; Bodenmiller, Bernd; Ramracheya, Reshma; Caille, Dorothee; Jiang, Huiping; Platt, Kenneth A.; Meda, Paolo; Aebersold, Rudolf; Rorsman, Patrik; Ricci, Romeo			Regulation of PKD by the MAPK p38 delta in Insulin Secretion and Glucose Homeostasis	CELL			English	Article							PROTEIN-KINASE-D; BETA-CELL; NEUROTENSIN SECRETION; TRANSPORT CARRIERS; DIABETES-MELLITUS; SKELETAL-MUSCLE; P38 MAPK; P38-ALPHA; MECHANISMS; RESISTANCE	Dysfunction and loss of insulin-producing pancreatic beta cells represent hallmarks of diabetes mellitus. Here, we show that mice lacking the mitogen-activated protein kinase (MAPK) p38 delta display improved glucose tolerance due to enhanced insulin secretion from pancreatic beta cells. Deletion of p38 delta results in pronounced activation of protein kinase D (PKD), the latter of which we have identified as a pivotal regulator of stimulated insulin exocytosis. p38 delta catalyzes an inhibitory phosphorylation of PKD1, thereby attenuating stimulated insulin secretion. In addition, p38 delta null mice are protected against high-fat-feeding induced insulin resistance and oxidative stress-mediated b cell failure. Inhibition of PKD1 reverses enhanced insulin secretion from p38 delta-deficient islets and glucose tolerance in p38 delta null mice as well as their susceptibility to oxidative stress. In conclusion, the p38 delta-PKD pathway integrates regulation of the insulin secretory capacity and survival of pancreatic b cells, pointing to a pivotal role for this pathway in the development of overt diabetes mellitus.	[Sumara, Grzegorz; Formentini, Ivan; Windak, Renata; Ricci, Romeo] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Collins, Stephan; Ramracheya, Reshma; Rorsman, Patrik] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Sumara, Izabela] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Bodenmiller, Bernd; Aebersold, Rudolf] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland; [Caille, Dorothee; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Jiang, Huiping] Boehringer Ingelheim Pharmaceut Inc, Dept Biotherapeut & Integrat Biol, Ridgefield, CT 06877 USA; [Platt, Kenneth A.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Aebersold, Rudolf] Inst Syst Physiol, Seattle, WA 98103 USA; [Aebersold, Rudolf; Ricci, Romeo] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Geneva; Boehringer Ingelheim; Lexicon Pharmaceuticals	Ricci, R (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	romeo.ricci@cell.biol.ethz.ch	collins, stephan c/P-4409-2016; Rorsman, Patrik/A-4331-2016; Ricci, Romeo/K-3009-2013	collins, stephan c/0000-0002-1533-3380; Rorsman, Patrik/0000-0001-7578-0767; Ricci, Romeo/0000-0002-9766-4369; Sumara, Izabela/0000-0002-5968-3358; Sumara, Grzegorz/0000-0003-1502-6265; Ramracheya, Reshma/0000-0001-6117-1936	Boehringer Ingelheim Pharmeaceuticals, Inc; Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF) [PP00A114856]; Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ; Boehringer Ingelheim Fonds; Swiss National Science Foundation [310000-122430]; Juvenile Diabetes Research Foundation [1-2007-158]; Novo Nordisk; SNF [31000-10767]; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust; European Union (Eurodia);  [337-2004];  [FP-7 BETAIMAGE 222980]	Boehringer Ingelheim Pharmeaceuticals, Inc(Boehringer Ingelheim); Ridgefield, CT; Forschungskredit 2003 of the University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Roche Research Foundation; Bonizzi-Theler Foundation; ETHZ(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Novo Nordisk(Novo Nordisk); SNF; Competence Center for Systems Physiology and Metabolic Diseases, Zurich; Wellcome Trust(Wellcome TrustEuropean Commission); European Union (Eurodia)(European Commission); ; 	We are grateful to Boehringer Ingelheim Pharmeaceuticals, Inc., Ridgefield, CT, for their generous financial support. We also would like to thank Markus Stoffel and Arne Ittner for numerous fruitful scientific discussions; Olga Herdzina for careful reading; Ana Cuenda for providing us with an antibody against p38d; David Engelberg for providing us with plasmids to express constitutive active p38d; Angelika Hausser and Vivek Malhotra for providing us with PKD plasmids; and Mary McFarland and Lynn Pantages-Torok for organizing mouse shipments. G. S. was supported by the Forschungskredit 2003 of the University of Zurich, the Swiss National Science Foundation (SNF) (PP00A114856), and the Roche Research Foundation (337-2004). I. F. was supported by the Bonizzi-Theler Foundation. I. S. is a senior research associate in the M. Peter laboratory, and her work was supported by grants from the SNF and the ETHZ to M. Peter. B. B. is the recipient of a fellowship by the Boehringer Ingelheim Fonds. The Meda team is supported by grants from the Swiss National Science Foundation (310000-122430), the Juvenile Diabetes Research Foundation (1-2007-158), the European Union (FP-7 BETAIMAGE 222980), and Novo Nordisk. The R. A. team is supported by the SNF (31000-10767) and by the Competence Center for Systems Physiology and Metabolic Diseases, Zurich. Work in Oxford was funded by the Wellcome Trust and the European Union (Eurodia).	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; Fridlyand LE, 2006, CURR DIABETES REV, V2, P241, DOI 10.2174/157339906776818541; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Haxhinasto SA, 2003, J IMMUNOL, V171, P4655, DOI 10.4049/jimmunol.171.9.4655; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Makeeva N, 2006, BIOCHEM J, V393, P129, DOI 10.1042/BJ20050814; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WIEDENKELLER DE, 1983, ENDOCRINOLOGY, V113, P2311, DOI 10.1210/endo-113-6-2311; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	46	177	190	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 23	2009	136	2					235	248		10.1016/j.cell.2008.11.018	http://dx.doi.org/10.1016/j.cell.2008.11.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	397FR	19135240	hybrid, Green Published			2022-12-28	WOS:000262648800013
J	Ducharme, FM; Lemire, C; Noya, FJD; Davis, GM; Alos, N; Leblond, H; Savdie, C; Collet, JP; Khomenko, L; Rivard, G; Platt, RW				Ducharme, Francine M.; Lemire, Chantal; Noya, Francisco J. D.; Davis, G. Michael; Alos, Nathalie; Leblond, Helene; Savdie, Cheryl; Collet, Jean-Paul; Khomenko, Lyudmyla; Rivard, Georges; Platt, Robert W.			Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			QUALITY-OF-LIFE; PRESCHOOL-CHILDREN; INHALED CORTICOSTEROIDS; CHILDHOOD ASTHMA; VIRAL WHEEZE; INTERMITTENT; EXACERBATIONS; INFECTIONS; MONTELUKAST; MANAGEMENT	Background: Although virus-induced wheezing is common in preschool-age children, optimal management remains elusive. We examined the efficacy and safety of preemptive treatment with high-dose fluticasone in reducing the severity of recurrent virus-induced wheezing in children. Methods: We randomly assigned 129 children who were 1 to 6 years of age to receive 750 microg of fluticasone propionate (ex-valve [manufacturer-measured] dose) or placebo twice daily, beginning at the onset of an upper respiratory tract infection and continuing for a maximum of 10 days, over a period of 6 to 12 months. The primary outcome was rescue oral corticosteroid use. Secondary outcomes included symptoms, use of (beta)(sub 2)-agonists, acute care visits, hospitalizations, discontinuation of the study drug, change in growth and bone mineral density, basal cortisol level, and adverse events. Results: Over a median period of 40 weeks, 8% of upper respiratory tract infections in the fluticasone group led to treatment with rescue systemic corticosteroids, as compared with 18% in the placebo group (odds ratio, 0.49; 95% confidence interval [CI], 0.30 to 0.83). Children who were treated with fluticasone, as compared with those who were given placebo, had smaller mean (+/-SD) gains from baseline in height (6.23+/-2.62 cm [unadjusted value]; z score, -0.19 +/-0.42 vs. 6.56+/-2.90 cm [unadjusted value]; z score, 0.00+/-0.48; difference between groups in z score from baseline to end point, -0.24 [95% CI, -0.40 to -0.08]) and in weight (1.53+/-1.17 kg [unadjusted value]; z score, -0.15+/-0.48 vs. 2.17+/-1.79 kg [unadjusted value]; z score, 0.11+/-0.43; difference between groups in z score from baseline to end point, -0.26 [95% CI, -0.41 to -0.09]). There were no significant differences between the groups in basal cortisol level, bone mineral density, or adverse events. Conclusions: In preschool-age children with moderate-to-severe virus-induced wheezing, preemptive treatment with high-dose fluticasone as compared with placebo reduced the use of rescue oral corticosteroids. Treatment with fluticasone was associated with a smaller gain in height and weight. Given the potential for overuse, this preventive approach should not be adopted in clinical practice until long-term adverse effects are clarified.	[Ducharme, Francine M.; Alos, Nathalie; Savdie, Cheryl; Khomenko, Lyudmyla] Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine, Appl Clin Res Unit,Res Ctr, Montreal, PQ H3T 1C5, Canada; [Ducharme, Francine M.; Alos, Nathalie; Savdie, Cheryl; Khomenko, Lyudmyla] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lemire, Chantal] CHU Sherbrooke, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; [Noya, Francisco J. D.; Davis, G. Michael] McGill Univ, Ctr Hlth, Dept Pediat, Res Inst,Montreal Childrens Hosp, Montreal, PQ, Canada; [Leblond, Helene] Univ Montreal, Dept Pediat, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Rivard, Georges] Univ Laval, Dept Pediat, Quebec City, PQ, Canada; [Collet, Jean-Paul] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Collet, Jean-Paul] Univ British Columbia, Dept Healthcare & Epidemiol, Vancouver, BC V6T 1W5, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; University of Sherbrooke; McGill University; Universite de Montreal; Laval University; University of British Columbia; University of British Columbia	Ducharme, FM (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ St Justine, Appl Clin Res Unit,Res Ctr, Rm 7939,3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	francine.m.ducharme@umontreal.ca	Ducharme, Francine/N-8332-2013	Ducharme, Francine/0000-0001-5096-0614; Platt, Robert/0000-0002-5981-8443				Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Bacharier LB, 2007, J ALLERGY CLIN IMMUN, V119, P604, DOI 10.1016/j.jaci.2006.12.607; BASSALI RW, 2006, WEBMD           0425; Bender B, 2000, ANN ALLERG ASTHMA IM, V85, P416, DOI 10.1016/S1081-1206(10)62557-4; Bisgaard H, 2005, AM J RESP CRIT CARE, V171, P315, DOI 10.1164/rccm.200407-894OC; BRUNETTE MG, 1988, PEDIATRICS, V81, P624; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1; CONNETT G, 1995, ARCH DIS CHILD, V8, P483; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; DEMERS LM, 1999, TIETZ TXB CLIN CHEM, P1530; Doull IJM, 1997, BMJ-BRIT MED J, V315, P858, DOI 10.1136/bmj.315.7112.858; DUCHARME FM, 2007, PRESCHOOL ASTHMA DIA; *GINA, 2007, GLOB STRAT ASTHM MAN; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Horner CC, 2007, CURR OPIN ALLERGY CL, V7, P180, DOI 10.1097/ACI.0b013e32807fafd2; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; KUCZMARSKI RJ, 2000, DHHS PUBL; Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Malozowski S, 2001, CURR THER RES CLIN E, V62, P796, DOI 10.1016/S0011-393X(01)80086-2; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McKean M, 2000, Cochrane Database Syst Rev, pCD001107, DOI 10.1002/14651858.CD001107; Muthu Vivek, 2003, Evid Based Ment Health, V6, P72; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Pao CS, 2002, AM J RESP CRIT CARE, V166, P945, DOI 10.1164/rccm.200203-265OC; Pyle SI, 1971, RADIOGRAPHIC STANDAR; Robertson CF, 2007, AM J RESP CRIT CARE, V175, P323, DOI 10.1164/rccm.200510-1546OC; RUBIN DH, 1990, PEDIATRICS, V85, P464; Stevens CA, 2002, THORAX, V57, P39, DOI 10.1136/thorax.57.1.39; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Svedmyr J, 1999, ACTA PAEDIATR, V88, P42; Vuillermin PJ, 2007, J PAEDIATR CHILD H, V43, P438, DOI 10.1111/j.1440-1754.2007.01107.x; WALD ER, 1991, J PEDIATR-US, V118, P509, DOI 10.1016/S0022-3476(05)83370-0; WILSON N, 1995, ARCH DIS CHILD, V72, P317, DOI 10.1136/adc.72.4.317; Wilson Nicola M, 2003, Paediatr Respir Rev, V4, P184, DOI 10.1016/S1526-0542(03)00052-6; WILSON NM, 1990, ARCH DIS CHILD, V65, P407, DOI 10.1136/adc.65.4.407	42	209	220	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					339	353		10.1056/NEJMoa0808907	http://dx.doi.org/10.1056/NEJMoa0808907			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	395JH	19164187	Bronze			2022-12-28	WOS:000262519900006
J	Berenson, RA; Cassel, CK				Berenson, Robert A.; Cassel, Christine K.			Consumer-Driven Health Care May Not Be What Patients Need-Caveat Emptor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL PROFESSIONALISM; PHYSICIANS; MARKET		[Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA	American Board of Internal Medicine; Urban Institute	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						ARROW KJ, 1963, AM ECON REV, V53, P941; Bloche MG, 2001, J HEALTH POLIT POLIC, V26, P1099, DOI 10.1215/03616878-26-5-1099; BULGER RJ, 1998, QUEST MERCY FORGOTTE; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Cassel CK, 2007, JAMA-J AM MED ASSOC, V297, P2518, DOI 10.1001/jama.297.22.2518; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gabel JR, 2008, HEALTH AFFAIR, V27, pW165, DOI 10.1377/hlthaff.27.3.w165; Grant David C, 2005, Thorac Surg Clin, V15, P533, DOI 10.1016/j.thorsurg.2005.06.004; Hall MA, 2001, J HEALTH POLIT POLIC, V26, P1131, DOI 10.1215/03616878-26-5-1131; Herzlinger R., 2007, WHO KILLED HLTH CARE; INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604; Jost T., 2007, HLTH CARE RISK CRITI; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	15	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					321	323		10.1001/jama.2008.994	http://dx.doi.org/10.1001/jama.2008.994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395IV	19155460				2022-12-28	WOS:000262518700024
J	Bulun, SE				Bulun, Serdar E.			Mechanisms of Disease Endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-2 EXPRESSION; STEROIDOGENIC-FACTOR-I; MATRIX-METALLOPROTEINASE EXPRESSION; PROSTAGLANDIN-E SYNTHASE; ACUTE REGULATORY PROTEIN; PROGESTERONE-RECEPTOR; STROMAL CELLS; AROMATASE EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; DEHYDROGENASE-ACTIVITIES		[Bulun, Serdar E.] Northwestern Univ, Div Reprod Biol Res, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Bulun, SE (corresponding author), Northwestern Univ, Div Reprod Biol Res, Dept Obstet & Gynecol, Feinberg Sch Med, 303 E Superior St,Rm 4-123, Chicago, IL 60611 USA.	s-bulun@northwestern.edu			National Institutes of Health [HD38691, HD40093]; Friends of Prentice; Meditrina Pharmaceuticals; GlaxoSmithKline; Novartis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD038691] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038691, U54HD040093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Prentice; Meditrina Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by grants from the National Institutes of Health (HD38691 and HD40093) and from the Friends of Prentice. Dr. Bulun reports receiving consultation fees from Meditrina Pharmaceuticals, GlaxoSmithKline, and Novartis. No other potential conflict of interest relevant to this article was reported. I thank Dr. Sherman Elias for helpful discussions.	Akoum A, 2000, J CLIN ENDOCR METAB, V85, P896, DOI 10.1210/jc.85.2.896; Attar E, 2006, FERTIL STERIL, V85, P1307, DOI 10.1016/j.fertnstert.2005.09.064; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6; Beliard A, 2004, FERTIL STERIL, V82, P80, DOI 10.1016/j.fertnstert.2003.11.048; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Brandenberger AW, 1999, MOL HUM REPROD, V5, P651, DOI 10.1093/molehr/5.7.651; Brosens I, 2004, HUM REPROD, V19, P1689, DOI 10.1093/humrep/deh314; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Bruner KL, 1997, J CLIN INVEST, V99, P2851, DOI 10.1172/JCI119478; Bulun S. E., 2003, WILLIAMS TXB ENDOCRI, P587; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Bulun SE, 2001, J STEROID BIOCHEM, V79, P19, DOI 10.1016/S0960-0760(01)00134-0; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; CASEY ML, 1994, J CLIN INVEST, V94, P2135, DOI 10.1172/JCI117569; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; Cheng YH, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.014; Chwalisz K, 2005, ENDOCR REV, V26, P703; Chwalisz K, 2005, ENDOCR REV, V26, P423, DOI 10.1210/er.2005-0001; D'Hooghe TM, 2002, HUM REPROD UPDATE, V8, P84, DOI 10.1093/humupd/8.1.84; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; DMOWSKI WP, 1989, OBSTET GYN CLIN N AM, V16, P93; Fazleabas AT, 2003, FERTIL STERIL, V80, P820, DOI 10.1016/S0015-0282(03)00982-8; FERGUSON BR, 1969, OBSTET GYNECOL, V33, P617; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garry R, 2004, HUM REPROD, V19, P760, DOI 10.1093/humrep/deh147; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guzick DS, 1997, FERTIL STERIL, V67, P822, DOI 10.1016/S0015-0282(97)81392-1; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hayes EC, 2002, OBSTET GYNECOL SURV, V57, P768, DOI 10.1097/00006254-200211000-00023; Hornung D, 1997, J CLIN ENDOCR METAB, V82, P1621, DOI 10.1210/jc.82.5.1621; Jabbour HN, 2006, MOL CELL ENDOCRINOL, V252, P191, DOI 10.1016/j.mce.2006.03.025; Jabbour HN, 2001, BRIT J CANCER, V85, P1023; Jackson KS, 2007, REPROD SCI, V14, P137, DOI 10.1177/1933719106298409; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kettel LM, 1996, FERTIL STERIL, V65, P23; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; Missmer SA, 2004, OBSTET GYNECOL, V104, P965, DOI 10.1097/01.AOG.0000142714.54857.f8; Montgomery GW, 2008, HUM REPROD UPDATE, V14, P447, DOI 10.1093/humupd/dmn016; MURPHY AA, 1994, CURR OPIN OBSTET GYN, V6, P269; Mustonen MVJ, 1998, J CLIN ENDOCR METAB, V83, P1319, DOI 10.1210/jc.83.4.1319; Nair AS, 2008, FERTIL STERIL, V90, P1487, DOI 10.1016/j.fertnstert.2007.09.047; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Noble LS, 1997, J CLIN ENDOCR METAB, V82, P600, DOI 10.1210/jc.82.2.600; Noble LS, 1996, J CLIN ENDOCR METAB, V81, P174, DOI 10.1210/jc.81.1.174; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; Osteen KG, 2005, FERTIL STERIL, V83, P529, DOI 10.1016/j.fertnstert.2004.11.026; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Osteen KG, 1997, SEMIN REPROD ENDOCR, V15, P301, DOI 10.1055/s-2008-1068760; Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561; ROCK JA, 1982, OBSTET GYNECOL, V59, P448; Ryan I P, 1997, Obstet Gynecol Surv, V52, P365, DOI 10.1097/00006254-199706000-00021; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sampson JA, 1927, AM J PATHOL, V3, P93; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; SATYASWAROOP PG, 1982, ENDOCRINOLOGY, V111, P743, DOI 10.1210/endo-111-3-743; Sharpe-Timms KL, 2002, ANN NY ACAD SCI, V955, P147, DOI 10.1111/j.1749-6632.2002.tb02775.x; SIMPSON JL, 1980, AM J OBSTET GYNECOL, V137, P327, DOI 10.1016/0002-9378(80)90917-5; Somigliana E, 2006, GYNECOL ONCOL, V101, P331, DOI 10.1016/j.ygyno.2005.11.033; Soysal S, 2004, HUM REPROD, V19, P160, DOI 10.1093/humrep/deh035; Stovall DW, 1997, FERTIL STERIL, V68, P13, DOI 10.1016/S0015-0282(97)81468-9; Stovall DW, 1998, FERTIL STERIL, V69, P979; Sun HS, 2003, ENDOCRINOLOGY, V144, P3934, DOI 10.1210/en.2003-0289; Sun T, 2004, REPRODUCTION, V127, P465, DOI 10.1530/rep.1.00121; Surrey ES, 2006, J MINIM INVAS GYN, V13, P528, DOI 10.1016/j.jmig.2006.06.008; Takayama K, 1998, FERTIL STERIL, V69, P709, DOI 10.1016/S0015-0282(98)00022-3; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3504, DOI 10.1210/jc.87.7.3504; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tamura M, 2002, J BIOL CHEM, V277, P26208, DOI 10.1074/jbc.M201347200; Taylor RN, 2002, ANN NY ACAD SCI, V955, P89, DOI 10.1111/j.1749-6632.2002.tb02769.x; Treloar SA, 2005, AM J HUM GENET, V77, P365, DOI 10.1086/432960; Tsai SJ, 2001, J CLIN ENDOCR METAB, V86, P5765, DOI 10.1210/jc.86.12.5765; Tseng JF, 1996, J CLIN ENDOCR METAB, V81, P1118, DOI 10.1210/jc.81.3.1118; TSENG L, 1974, ENDOCRINOLOGY, V94, P419, DOI 10.1210/endo-94-2-419; TSENG L, 1975, ENDOCRINOLOGY, V97, P825, DOI 10.1210/endo-97-4-825; Ulukus M, 2005, HUM REPROD, V20, P794, DOI 10.1093/humrep/deh675; Utsunomiya H, 2008, MOL ENDOCRINOL, V22, P904, DOI 10.1210/me.2006-0302; Vercellini P, 1997, FERTIL STERIL, V68, P393, DOI 10.1016/S0015-0282(97)00193-3; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; Wu MH, 2005, J CLIN ENDOCR METAB, V90, P286, DOI 10.1210/jc.2004-1612; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yang SJ, 2001, MOL ENDOCRINOL, V15, P2093, DOI 10.1210/me.15.12.2093; Zeitoun K, 1998, J CLIN ENDOCR METAB, V83, P4474, DOI 10.1210/jc.83.12.4474; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3	95	1349	1452	3	318	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					268	279		10.1056/NEJMra0804690	http://dx.doi.org/10.1056/NEJMra0804690			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144942				2022-12-28	WOS:000262434500009
J	Dennis, CL; Hodnett, E; Kenton, L; Weston, J; Zupancic, J; Stewart, DE; Kiss, A				Dennis, C-L; Hodnett, E.; Kenton, L.; Weston, J.; Zupancic, J.; Stewart, D. E.; Kiss, A.			Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STRUCTURED CLINICAL INTERVIEW; DSM-III-R; POSTPARTUM DEPRESSION; SOCIAL SUPPORT; ACCULTURATIVE STRESS; JAPANESE WOMEN; MOTHERS; IMPACT; TELEPHONE; SYMPTOMS	Objective To evaluate the effectiveness of telephone based peer support in the prevention of postnatal depression. Design Multisite randomised controlled trial. Setting Seven health regions across Ontario, Canada. Participants 701 women in the first two weeks postpartum identified as high risk for postnatal depression with the Edinburgh postnatal depression scale and randomised with an internet based randomisation service. Intervention Proactive individualised telephone based peer ( mother to mother) support, initiated within 48- 72 hours of randomisation, provided by a volunteer recruited from the community who had previously experienced and recovered from self reported postnatal depression and attended a four hour training session. Main outcome measures Edinburgh postnatal depression scale, structured clinical interview- depression, state- trait anxiety inventory, UCLA loneliness scale, and use of health services. Results After web based screening of 21 470 women, 701 ( 72%) eligible mothers were recruited. A blinded research nurse followed up more than 85% by telephone, including 613 at 12 weeks and 600 at 24 weeks postpartum. At 12 weeks, 14% ( 40/ 297) of women in the intervention group and 25% ( 78/ 315) in the control group had an Edinburgh postnatal depression scale score > 12 (X-2= 12.5, P< 0.001; number need to treat 8.8, 95% confidence interval 5.9 to 19.6; relative risk reduction 0.46, 95% confidence interval 0.24 to 0.62). There was a positive trend in favour of the intervention group for maternal anxiety but not loneliness or use of health services. For ethical reasons, participants identified with clinical depression at 12 weeks were referred for treatment, resulting in no differences between groups at 24 weeks. Of the 221 women in the intervention group who received and evaluated their experience of peer support, over 80% were satisfied and would recommend this support to a friend. Conclusion Telephone based peer support can be effective in preventing postnatal depression among women at high risk. Trial registration ISRCTN68337727.	[Dennis, C-L; Hodnett, E.; Kenton, L.; Weston, J.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Dennis, C-L; Stewart, D. E.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Zupancic, J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kiss, A.] Sunnybrook Hlth Sci Ctr, Dept Res Design & Biostat, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dennis, CL (corresponding author), Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada.	cindylee.dennis@utoronto.ca	Zupancic, John/G-2009-2018; Stewart, Donna Eileen E/J-2844-2016; Dennis, Cindy-Lee/ABA-2860-2020	Zupancic, John/0000-0003-1734-7193; Stewart, Donna Eileen E/0000-0002-8157-7746; Dennis, Cindy-Lee/0000-0002-0135-7242	Canadian Institutes of Health Research [MCT 66874]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research grant number MCT 66874. This trial was conducted and data analysed with complete independence of the researchers from the Canadian Institutes of Health Research.	Affonso DD, 2000, J PSYCHOSOM RES, V49, P207, DOI 10.1016/S0022-3999(00)00176-8; Aroian KJ, 2002, ARCH PSYCHIAT NURS, V16, P245, DOI 10.1053/apnu.2002.37279; BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97; Beck C T, 1992, J Obstet Gynecol Neonatal Nurs, V21, P287, DOI 10.1111/j.1552-6909.1992.tb01739.x; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Brown G., 2001, HLTH SERVICE UTILIZA; Brugha TS, 1998, PSYCHOL MED, V28, P63, DOI 10.1017/S0033291797005655; Buist A, 1998, AUST NZ J PSYCHIAT, V32, P479, DOI 10.3109/00048679809068320; Chabrol H, 2002, ENCEPHALE, V28, P65; Chen Chung-Hey, 2000, Kaohsiung Journal of Medical Sciences, V16, P156; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Constantine MG, 2004, AM J ORTHOPSYCHIAT, V74, P230, DOI 10.1037/0002-9432.74.3.230; Cooper PJ, 1997, ARCH DIS CHILD, V77, P97, DOI 10.1136/adc.77.2.97; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CUMMINGS EM, 1994, J CHILD PSYCHOL PSYC, V35, P73, DOI 10.1111/j.1469-7610.1994.tb01133.x; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis C-L, 2004, Arch Womens Ment Health, V7, P183; Dennis CL, 2007, SOC PSYCH PSYCH EPID, V42, P389, DOI 10.1007/s00127-007-0172-5; Dennis CL, 2003, CAN J PSYCHIAT, V48, P115, DOI 10.1177/070674370304800209; Dennis CLE, 2004, CAN J PSYCHIAT, V49, P526, DOI 10.1177/070674370404900804; Dennis CL, 2005, BMJ-BRIT MED J, V331, P15, DOI 10.1136/bmj.331.7507.15; Dennis CL, 2004, J AFFECT DISORDERS, V78, P163, DOI 10.1016/S0165-0327(02)00299-9; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Dennis CL, 2002, BIRTH-ISS PERINAT C, V29, P169, DOI 10.1046/j.1523-536X.2002.00184.x; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; Dennis CLE, 2004, CAN J PSYCHIAT, V49, P467, DOI 10.1177/070674370404900708; Dennis CLE, 2004, J CLIN PSYCHIAT, V65, P1242, DOI 10.4088/JCP.v65n0914; Dennis CLE, 2004, J CLIN PSYCHIAT, V65, P1252, DOI 10.4088/JCP.v65n0915; Dennis CLE, 2004, ACTA PSYCHIAT SCAND, V110, P338, DOI 10.1111/j.1600-0447.2004.00337.x; Fossey L, 1997, J PSYCHOSOM OBST GYN, V18, P17, DOI 10.3109/01674829709085564; Galinsky MJ, 1997, HEALTH SOC WORK, V22, P181, DOI 10.1093/hsw/22.3.181; HANNAH P, 1992, BRIT J PSYCHIAT, V160, P777, DOI 10.1192/bjp.160.6.777; HAPGOOD CC, 1988, AUST NZ J PSYCHIAT, V22, P299, DOI 10.3109/00048678809161211; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hipwell AE, 2000, DEV PSYCHOPATHOL, V12, P157, DOI 10.1017/S0954579400002030; HOLDEN JM, 1989, BRIT MED J, V298, P223, DOI 10.1136/bmj.298.6668.223; Horton R, 1997, ARTHRIT CARE RES, V10, P257, DOI 10.1002/art.1790100407; Hovey JD, 2000, PSYCHOL REP, V86, P1237, DOI 10.2466/PR0.86.3.1237-1240; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Lane A, 1997, BRIT J PSYCHIAT, V171, P550, DOI 10.1192/bjp.171.6.550; Lin N, 1999, J HEALTH SOC BEHAV, V40, P344, DOI 10.2307/2676330; Mayberry L J, 1993, Health Care Women Int, V14, P201; Miller AM, 2002, NURS RES, V51, P26, DOI 10.1097/00006199-200201000-00005; MILLS EP, 1995, S AFR MED J, V85, P99; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; Nicol-Harper R, 2007, INFANT BEHAV DEV, V30, P161, DOI 10.1016/j.infbeh.2006.08.005; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Oh YJ, 2002, J SOC PSYCHOL, V142, P511, DOI 10.1080/00224540209603915; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; OHARA MW, 1983, J NERV MENT DIS, V171, P336, DOI 10.1097/00005053-198306000-00002; PAYKEL ES, 1980, BRIT J PSYCHIAT, V136, P339, DOI 10.1192/bjp.136.4.339; Romito P, 1999, SOC SCI MED, V49, P1651, DOI 10.1016/S0277-9536(99)00238-5; Ross LE, 2006, J CLIN PSYCHIAT, V67, P1285, DOI 10.4088/JCP.v67n0818; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SEGAL DL, 1994, COMPR PSYCHIAT, V35, P316, DOI 10.1016/0010-440X(94)90025-6; Small R, 1997, BIRTH-ISS PERINAT C, V24, P109, DOI 10.1111/j.1523-536X.1997.tb00350.x; Small R, 2007, SOC PSYCH PSYCH EPID, V42, P70, DOI 10.1007/s00127-006-0134-3; Spielberger C., 1983, STAI MANUAL; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stewart DE, 2008, CAN J PSYCHIAT, V53, P121, DOI 10.1177/070674370805300208; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; Thome M, 1999, J ADV NURS, V29, P128, DOI 10.1046/j.1365-2648.1999.00872.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; VEGA WA, 1987, INT MIGR REV, V21, P512, DOI 10.2307/2546608; Wickberg B, 1996, J AFFECT DISORDERS, V39, P209, DOI 10.1016/0165-0327(96)00034-1; WILLIAMS CL, 1991, AM PSYCHOL, V46, P632, DOI 10.1037/0003-066X.46.6.632; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; Yoshida K, 1997, J AFFECT DISORDERS, V43, P69, DOI 10.1016/S0165-0327(96)01419-X; ZELKOWITZ P, 1995, CAN J PSYCHIAT, V40, P80, DOI 10.1177/070674379504000205; [No title captured]	75	197	198	1	67	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2009	338								a3064	10.1136/bmj.a3064	http://dx.doi.org/10.1136/bmj.a3064			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	405AD	19147637	Green Published, hybrid			2022-12-28	WOS:000263193400003
J	Attia, J; Ioannidis, JPA; Thakkinstian, A; McEvoy, M; Scott, RJ; Minelli, C; Thompson, J; Infante-Rivard, C; Guyatt, G				Attia, John; Ioannidis, John P. A.; Thakkinstian, Ammarin; McEvoy, Mark; Scott, Rodney J.; Minelli, Cosetta; Thompson, John; Infante-Rivard, Claire; Guyatt, Gordon			How to Use an Article About Genetic Association B: Are the Results of the Study Valid?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HARDY-WEINBERG EQUILIBRIUM; GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; GENOTYPING ERRORS; POPULATION STRATIFICATION; EMPIRICAL-EVALUATION; MEDICAL LITERATURE; ALZHEIMER-DISEASE; METAANALYSIS; REPLICATION	In the first article of this series, we reviewed the basic genetics concepts necessary to understand genetic association studies. In this second article, we enumerate the major issues in judging the validity of these studies, framed as critical appraisal questions. Was the disease phenotype properly defined and accurately recorded by someone blind to the genetic information? Have any potential differences between disease and nondisease groups, particularly ethnicity, been properly addressed? In genetic studies, one potential cause of spurious associations is differences between cases and controls in ethnicity, a situation termed population stratification. Was measurement of the genetic variants unbiased and accurate? Methods for determining DNA sequence variation are not perfect and may have some measurement error. Do the genotype proportions observe Hardy- Weinberg equilibrium? This simple mathematic rule about the distribution of genetic groups may be one way to check for errors in reading DNA information. Have the investigators adjusted their inferences for multiple comparisons? Given the thousands of genetic markers tested in genome- wide association studies, the potential for false- positive and false-negative results is much higher than in traditional medical studies, and it is particularly important to look for replication of results.	[Attia, John] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Attia, John] John Hunter Hosp, Hunter Med Res Inst, Newcastle, NSW, Australia; [Attia, John] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr,Dept Med, Boston, MA 02111 USA; [Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Clin Epidemiol Unit, Bangkok 10400, Thailand; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Genet, New Lambton, Australia; [Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Ctr Informat Based Med, Newcastle, NSW 2308, Australia; [Minelli, Cosetta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Infante-Rivard, Claire] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; John Hunter Hospital; University of Ioannina; Tufts Medical Center; Tufts University; Mahidol University; University of Newcastle; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Leicester; McGill University; McMaster University	Attia, J (corresponding author), Univ Newcastle, Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, Level 3,David Maddison Bldg, Newcastle, NSW 2300, Australia.	john.attia@newcastle.edu.au	Scott, Rodney J/B-2827-2013; Attia, John R/F-5376-2013; Ioannidis, John P. A./G-9836-2011; Thakkinstian, Ammarin/J-4788-2019	Scott, Rodney J/0000-0001-7724-3404; Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557				Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Evangelou E, 2006, PLOS GENET, V2, P1147, DOI 10.1371/journal.pgen.0020123; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; *HUM GEN EP NETW, NAV HUM GEN EP; Ioannidis JPA, 2008, AM J MED GENET B, V147B, P964, DOI 10.1002/ajmg.b.30721; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Levine M, 2008, USERS GUIDES MED LIT; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; LITTLE J, 2008, HUGENET HUGHE REV HD; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mein CA, 2000, GENOME RES, V10, P330, DOI 10.1101/gr.10.3.330; Montoya-Delgado LE, 2001, GENETICS, V158, P875; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Province MA, 2001, ADV GENET, V42, P499, DOI 10.1016/S0065-2660(01)42039-6; Randolph A, 2008, USERS GUIDES MED LIT; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rubinsztein DC, 1999, DEMENT GERIATR COGN, V10, P199, DOI 10.1159/000017120; Sabatti Chiara, 2007, Methods Mol Biol, V376, P195; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; *TUFTS U COMP MOL, SIMPL CALC DET WHETH; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; WACHOLDER S, ASSESSING PROBABILIT; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	59	121	125	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					191	197		10.1001/jama.2008.946	http://dx.doi.org/10.1001/jama.2008.946			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141767				2022-12-28	WOS:000262405500021
J	Chen, B; Cepko, CL				Chen, Bo; Cepko, Constance L.			HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas	SCIENCE			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTOR; CELL-DEATH; INTRACELLULAR TRAFFICKING; RETINITIS-PIGMENTOSA; BETA-SUBUNIT; MOUSE; PHOSPHODIESTERASE; DIFFERENTIATION; DEGENERATION	Histone deacetylase 4 ( HDAC4) shuttles between the nucleus and cytoplasm and serves as a nuclear co- repressor that regulates bone and muscle development. We report that HDAC4 regulates the survival of retinal neurons in the mouse in normal and pathological conditions. Reduction in HDAC4 expression during normal retinal development led to apoptosis of rod photoreceptors and bipolar ( BP) interneurons, whereas overexpression reduced naturally occurring cell death of the BP cells. HDAC4 overexpression in a mouse model of retinal degeneration prolonged photoreceptor survival. The survival effect was due to the activity of HDAC4 in the cytoplasm and relied at least partly on the activity of hypoxia- inducible factor 1 alpha (HIF1 alpha). These data provide evidence that HDAC4 plays an important role in promoting the survival of retinal neurons.	[Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Chen, Bo; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chen, B (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bochen@genetics.med.harvard.edu; cepko@genetics.med.harvard.edu			NIH [EYO 14466]; Foundation for Retinal Research; Merck; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY014466] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Retinal Research; Merck(Merck & Company); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J.R. Lu for providing HDAC4, HDAC5, and HDAC6 expression constructs; T.P. Yao for providing HDAC4-3SA mutant; X.J. Yang for providing HDAC4-L175A mutant; G.L. Semenza for providing dnHIF1 alpha constructs and K.W. Kim for providing HIF1 alpha and HIF1 alpha K532R constructs; and T. Matsuda for assistance with various techniques. Supported by NIH grant EYO 14466, the Foundation for Retinal Research, a gift from Merck, and the Howard Hughes Medical Institute (HHMI). C.L.C. is an Investigator of HHMI and B.C. is a postdoctoral fellow of HHMI. C.L.C. and B.C. have filed a U.S. patent application, 61/088,455, based on the work in this paper.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	22	157	180	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 9	2009	323	5911					256	259		10.1126/science.1166226	http://dx.doi.org/10.1126/science.1166226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131628	Green Accepted			2022-12-28	WOS:000262290600039
J	Rabosky, DL; Sorhannus, U				Rabosky, Daniel L.; Sorhannus, Ulf			Diversity dynamics of marine planktonic diatoms across the Cenozoic	NATURE			English	Article							PHYTOPLANKTON FUNCTIONAL-GROUPS; MACROEVOLUTIONARY PATTERNS; EUKARYOTIC PHYTOPLANKTON; SAMPLING-STANDARDIZATION; CARBON-DIOXIDE; NORTH-AMERICA; FOSSIL RECORD; SILICA; RADIATION; CYCLE	Diatoms are the dominant group of phytoplankton in the modern ocean. They account for approximately 40% of oceanic primary productivity and over 50% of organic carbon burial in marine sediments(1). Owing to their role as a biological carbon pump(2) and effects on atmospheric CO2 levels(3-5), there is great interest in elucidating factors that influenced the rapid rise in diatom diversity during the past 40 million years(6,7). Two biotic controls on diversification have been proposed to explain this diversity increase: ( 1) geochemical coupling between terrestrial grasslands and marine ecosystems through the global silicon cycle; and ( 2) competitive displacement of other phytoplankton lineages. However, these hypotheses have not been tested using sampling-standardized fossil data. Here we show that reconstructions of species diversity in marine phytoplankton reject these proposed controls and suggest a new pattern for oceanic diatom diversity across the Cenozoic. Peak species diversity in marine planktonic diatoms occurred at the Eocene - Oligocene boundary and was followed by a pronounced decline, from which diversity has not recovered. Although the roles of abiotic and biotic drivers of diversification remain unclear, major features of oceanic diatom evolution are decoupled from both grassland expansion and competition among phytoplankton groups.	[Rabosky, Daniel L.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Rabosky, Daniel L.] Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA; [Sorhannus, Ulf] Edinboro Univ Penn, Dept Biol & Hlth Serv, Edinboro, PA 16444 USA	Cornell University; Cornell University; Pennsylvania State System of Higher Education (PASSHE); Edinboro University	Rabosky, DL (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	DLR32@cornell.edu	Rabosky, Daniel L/G-4530-2015		NSF-OSIEE-0612855; Microsoft Corporation	NSF-OSIEE-0612855(National Science Foundation (NSF)); Microsoft Corporation(Microsoft)	We thank J. Alroy for comments on our statistical analyses and for suggesting the binomial approximation for confidence limits on diversity; and M. Foote, I. Lovette, A. McCune, A. Agrawal, N. Hairston and the BK Discussion Group for comments on the manuscript. This research was supported in part by NSF-OSIEE-0612855. Part of this work used the resources of the Computational Biology Service Unit from Cornell University, which is partly funded by the Microsoft Corporation.	Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Bown PR, 2005, MICROPALEONTOLOGY, V51, P299, DOI 10.2113/gsmicropal.51.4.299; Bush AM, 2004, PALEOBIOLOGY, V30, P666, DOI 10.1666/0094-8373(2004)030<0666:RBFDCT>2.0.CO;2; Falkowski PG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P429; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finkel ZV, 2005, P NATL ACAD SCI USA, V102, P8927, DOI 10.1073/pnas.0409907102; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Katz ME, 2004, ANNU REV ECOL EVOL S, V35, P523, DOI 10.1146/annurev.ecolsys.35.112202.130137; Kidder DL, 2005, PALAIOS, V20, P198, DOI 10.2110/palo.2003.p03-108; Kidder DL, 2001, J GEOL, V109, P509, DOI 10.1086/320794; Margalef R., 1997, OUR BIOSPHERE, DOI [10.1002/iroh.19970820411, DOI 10.1002/IROH.19970820411]; MCFADDEN BJ, 1992, FOSSIL HORSES; Miller AI, 1996, PALEOBIOLOGY, V22, P304, DOI 10.1017/S0094837300016237; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PAUL CRC, 1982, ADEQUACY FOSSIL RECO, P1; Prothero D.R., 2003, GREENHOUSE ICEHOUSE; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Sellner KG, 2001, MAR ECOL PROG SER, V220, P93, DOI 10.3354/meps220093; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; SMITH EP, 1985, HYDROBIOLOGIA, V120, P167, DOI 10.1007/BF00032138; Spencer-Cervato Cinzia, 1999, Palaeontologia Electronica, V2, pUnpaginated; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Tozzi S, 2004, MAR ECOL PROG SER, V274, P123, DOI 10.3354/meps274123; Treguer P, 2000, NATURE, V406, P358, DOI 10.1038/35019236; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	34	106	113	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					183	U73		10.1038/nature07435	http://dx.doi.org/10.1038/nature07435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129846				2022-12-28	WOS:000262360200030
J	Baid, SK; Lai, EW; Wesley, RA; Ling, A; Timmers, HJLM; Adams, KT; Kozupa, A; Pacak, K				Baid, Smita K.; Lai, Edwin W.; Wesley, Robert A.; Ling, Alex; Timmers, Henri J. L. M.; Adams, Karen T.; Kozupa, Anna; Pacak, Karel			Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Contrast-enhanced computed tomography (CT) is useful for localizing pheochromocytoma. However, in patients with suspected pheochromocytoma, CT is often canceled or not performed because of the strong belief that intravenous contrast may induce hypertensive crisis. Objective: To examine whether intravenous low-osmolar contrast administration during CT induces catecholamine release that increases blood pressure or heart rate. Design: Prospective study. Setting: Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland. Participants: 22 patients with pheochromocytoma (15 nonadrenal and 7 adrenal) and 8 unmatched control participants without pheochromocytoma. Measurements: Plasma catecholamine levels, blood pressure, and heart rate. Results: Plasma catecholamine levels within and between groups did not significantly differ before and after intravenous administration of low-osmolar CT contrast. Patients with pheochromocytoma experienced a clinically and statistically significant increase in diastolic blood pressure that was not accompanied by corresponding increases in plasma catecholamine levels. The difference became non -statistically significant after adjustment for use of alpha-and beta-blockers. Limitation: The study lacked a placebo group, and the sample was relatively small. Conclusion: Intravenous low-osmolar contrast-enhanced CT can safely be used in patients with pheochromocytoma who are not receiving alpha-or beta-blockers.	[Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, Adult Endocrinol Program, Sect Med Neuroendocrinol, NIH, Bldg 10,CRC,Room 1E-1-3140,10 Ctr Dr,MSC-1109, Bethesda, MD 20892 USA.	karel@mail.nih.gov	Timmers, Henri JLM/A-4641-2010		Eunice Kennedy Shriver National Institute of Child Health and Development; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health.	Aspelin P, 2006, EUR RADIOL, V16, P1041, DOI 10.1007/s00330-005-0081-5; EISENHOFER G, 1986, CLIN CHEM, V32, P2030; Ilias I, 2004, J CLIN ENDOCR METAB, V89, P479, DOI 10.1210/jc.2003-031091; Mukherjee JJ, 1997, RADIOLOGY, V202, P227, DOI 10.1148/radiology.202.1.8988215; ROSSI P, 1968, J AMER MED ASSOC, V205, P547, DOI 10.1001/jama.205.8.547	5	20	21	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					27	W6		10.7326/0003-4819-150-1-200901060-00006	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124817	Green Accepted			2022-12-28	WOS:000262655100004
J	Bradshaw, N; Neher, SB; Booth, DS; Walter, P				Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter			Signal Sequences Activate the Catalytic Switch of SRP RNA	SCIENCE			English	Article							RECOGNITION PARTICLE; CONFORMATIONAL-CHANGES; PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; 4.5S RNA; RECEPTOR; BINDING; PEPTIDES; RIBONUCLEOPROTEIN; SUBUNIT	The signal recognition particle ( SRP) recognizes polypeptide chains bearing a signal sequence as they emerge from the ribosome, and then binds its membrane- associated receptor ( SR), thereby delivering the ribosome- nascent chain complex to the endoplasmic reticulum in eukaryotic cells and the plasma membrane in prokaryotic cells. SRP RNA catalytically accelerates the interaction of SRP and SR, which stimulates their guanosine triphosphatase ( GTPase) activities, leading to dissociation of the complex. We found that although the catalytic activity of SRP RNA appeared to be constitutive, SRP RNA accelerated complex formation only when SRP was bound to a signal sequence. This crucial control step was obscured because a detergent commonly included in the reaction buffer acted as a signal peptide mimic. Thus, SRP RNA is a molecular switch that renders the SRP- SR GTPase engine responsive to signal peptide recruitment, coupling GTP hydrolysis to productive protein targeting.	[Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bradshaw, Niels; Neher, Saskia B.; Booth, David S.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	pwalter@biochem.ucsf.edu	Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Booth, David/0000-0002-4724-4702; Neher, Saskia/0000-0003-4165-6674; Bradshaw, Niels/0000-0002-6845-4717	NIH [ROI GM32384]; NSF; Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences [R25 GM56847]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032384, R25GM056847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Weissman, C. Gross, P. Egea, C. Gallagher, A. Korennykh, A. Acevedo, W. Weare, and J. Kardon for assistance and comments. Supported by NIH grant ROI GM32384 (P.W.), an NSF predoctoral fellowship (N.B.), the Jane Coffin Childs Memorial Fund (S.B.N.), and National Institute of General Medical Sciences fellowship R25 GM56847 (D.S.B.). P.W. is an Investigator of the Howard Hughes Medical Institute.	Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Swain JF, 2001, J BIOL CHEM, V276, P12222, DOI 10.1074/jbc.M011128200; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	19	67	67	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					127	130		10.1126/science.1165971	http://dx.doi.org/10.1126/science.1165971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119234	Green Accepted			2022-12-28	WOS:000262104100057
J	Soderblom, DR				Soderblom, David R.			ASTRONOMY How Old Is That Star?	SCIENCE			English	Editorial Material							GALAXY		[Soderblom, David R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Soderblom, DR (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	soderblom@stsci.edu						Barnes SA, 2007, ASTROPHYS J, V669, P1167, DOI 10.1086/519295; Bedin LR, 2004, ASTROPHYS J, V605, pL125, DOI 10.1086/420847; GILMORE G, 1989, ANNU REV ASTRON ASTR, V27, P555; Montgomery MH, 2008, SCIENCE, V322, P536, DOI 10.1126/science.1164633; Sneden C, 2008, ANNU REV ASTRON ASTR, V46, P241, DOI 10.1146/annurev.astro.46.060407.145207; 2008, INT ASTR UN S AG STA, V258	6	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					45	46		10.1126/science.1168230	http://dx.doi.org/10.1126/science.1168230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119203				2022-12-28	WOS:000262104100027
J	Smith, M				Smith, Malcolm			Year of astronomy: Time to turn off the lights	NATURE			English	Editorial Material							POLLUTION; NIGHT		[Smith, Malcolm] Cerro Tololo Interamer Observ, La Serena, Chile	National Optical Astronomy Observatory	Smith, M (corresponding author), Cerro Tololo Interamer Observ, Casilla 603, La Serena, Chile.	msmith@ctio.noao.edu						Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; DEDA P, 2007, STARLIGHT COMMON HER, P177; Isobe S, 2000, ASTROPHYS SPACE SCI, V273, P289, DOI 10.1023/A:1002719404278; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Marin C., 2007, STARLIGHT COMMON HER; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Rich C., 2006, ECOLOGICAL CONSEQUEN; UNFPA, 2007, STAT WORLD POP 2007	8	38	39	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					27	27		10.1038/457027a	http://dx.doi.org/10.1038/457027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122621				2022-12-28	WOS:000262104900015
J	Yang, AHJ; Moore, SD; Schmidt, BS; Klug, M; Lipson, M; Erickson, D				Yang, Allen H. J.; Moore, Sean D.; Schmidt, Bradley S.; Klug, Matthew; Lipson, Michal; Erickson, David			Optical manipulation of nanoparticles and biomolecules in sub-wavelength slot waveguides	NATURE			English	Article							DNA-MOLECULES; MICROPARTICLES; PARTICLES; CELLS; TWEEZERS; PARALLEL; FORCES; LIGHT	The ability to manipulate nanoscopic matter precisely is critical for the development of active nanosystems. Optical tweezers(1-4) are excellent tools for transporting particles ranging in size fromseveral micrometres to a few hundred nanometres. Manipulation of dielectric objects with much smaller diameters, however, requires stronger optical confinement and higher intensities than can be provided by these diffraction- limited(5) systems. Here we present an approach to optofluidic transport that overcomes these limitations, using sub-wavelength liquid- core slot waveguides(6). The technique simultaneously makes use of near- field optical forces to confine matter inside the waveguide and scattering/ adsorption forces to transport it. The ability of the slot waveguide to condense the accessible electromagnetic energy to scales as small as 60 nm allows us also to overcome the fundamental diffraction problem. We apply the approach here to the trapping and transport of 75- nm dielectric nanoparticles and lambda-DNA molecules. Because trapping occurs along a line, rather than at a point as with traditional point traps(7,8), the method provides the ability to handle extended biomolecules directly. We also carry out a detailed numerical analysis that relates the near- field optical forces to release kinetics. We believe that the architecture demonstrated here will help to bridge the gap between optical manipulation and nanofluidics.	[Moore, Sean D.; Klug, Matthew; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Yang, Allen H. J.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Schmidt, Bradley S.; Lipson, Michal] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Erickson, D (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	de54@cornell.edu	Erickson, David/A-3319-2009; Yang, Allen/A-7155-2008; Han, Kyuhee/B-6201-2009; Abrams, William R/A-5782-2008	Erickson, David/0000-0002-1624-9711; Yang, Allen/0000-0003-3733-4066; 	US National Science Foundation NIRT [0708599]	US National Science Foundation NIRT(National Science Foundation (NSF))	We thank A. Stroock for discussions, and A. Nitkowski and S. Manipatruni for technical support. This work was done in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the US National Science Foundation. This work was funded by the US National Science Foundation NIRT: Active Nanophotofluidic Systems for Single Molecule/Particle Analysis (award number 0708599).	Almeida VR, 2004, OPT LETT, V29, P1209, DOI 10.1364/OL.29.001209; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Born M., 2003, PRINCIPLES OPTICS; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Chiu DT, 1996, J AM CHEM SOC, V118, P6512, DOI 10.1021/ja960978p; Cizmar T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035105; Dholakia K, 2008, STRUCTURED LIGHT AND ITS APPLICATIONS: AN INTRODUCTION TO PHASE-STRUCTURED BEAMS AND NANOSCALE OPTICAL FORCES, P107, DOI 10.1016/B978-0-12-374027-4.00005-0; Gaugiran S, 2007, OPT EXPRESS, V15, P8146, DOI 10.1364/OE.15.008146; Gaugiran S, 2005, OPT EXPRESS, V13, P6956, DOI 10.1364/OPEX.13.006956; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Grujic K, 2005, OPT EXPRESS, V13, P1, DOI 10.1364/OPEX.13.000001; Hart SJ, 2006, ANAL CHEM, V78, P3221, DOI 10.1021/ac052221z; Hirano K, 2008, ANAL CHEM, V80, P5197, DOI 10.1021/ac8003538; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Marchington RF, 2008, OPT EXPRESS, V16, P3712, DOI 10.1364/OE.16.003712; Monat C, 2007, NAT PHOTONICS, V1, P106, DOI 10.1038/nphoton.2006.96; Neale SL, 2005, NAT MATER, V4, P530, DOI 10.1038/nmat1411; Ng LN, 2002, OPT COMMUN, V208, P117, DOI 10.1016/S0030-4018(02)01590-0; Ng LN, 2000, J LIGHTWAVE TECHNOL, V18, P388, DOI 10.1109/50.827512; Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060; Righini M, 2007, NAT PHYS, V3, P477, DOI 10.1038/nphys624; Schmidt BS, 2007, OPT EXPRESS, V15, P14322, DOI 10.1364/OE.15.014322; Sinclair G, 2004, OPT EXPRESS, V12, P5475, DOI 10.1364/OPEX.12.005475; SVOBODA K, 1994, OPT LETT, V19, P930, DOI 10.1364/OL.19.000930; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Yang AHJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045704	30	634	648	5	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					71	75		10.1038/nature07593	http://dx.doi.org/10.1038/nature07593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122638				2022-12-28	WOS:000262104900032
J	Konstantinides, S				Konstantinides, Stavros			Acute Pulmonary Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; INTRAVENOUS UNFRACTIONATED HEPARIN; RIGHT-VENTRICULAR DYSFUNCTION; COMPUTED-TOMOGRAPHY; D-DIMER; INDUCED THROMBOCYTOPENIA; CLINICAL PROBABILITY; INITIAL TREATMENT; CONTROLLED-TRIALS; PROGNOSTIC VALUE	A 62- year- old man presented with a 5- day history of progressively worsening dyspnea and orthopnea after returning from a 3- day business trip to the Far East. On physical examination, the heart rate was 102 beats per minute, and the blood pressure 110/ 60 mm Hg. The arterial oxygen saturation was 86% while the patient was breathing ambient air. The neck veins were distended. There was no heart murmur. The lungs were clear, and the extremities appeared normal. The D- dimer level was 5.13 mg per liter ( normal level, less than 0.5), and the troponin T level was less than 0.01 g per liter. A computed tomographic ( CT) scan showed multiple thrombi in the pulmonary arteries and a dilated right ventricle. How should this case be managed?	Univ Gottingen, Sch Med, Dept Cardiol & Pulmonol, D-37099 Gottingen, Germany	University of Gottingen	Konstantinides, S (corresponding author), Univ Gottingen, Sch Med, Dept Cardiol & Pulmonol, D-37099 Gottingen, Germany.	skonstan@med.uni-goettingen.de	Konstantinides, Stavros/AAL-3174-2021	Konstantinides, Stavros/0000-0001-6359-7279				Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; Aujesky D, 2006, EUR HEART J, V27, P476, DOI 10.1093/eurheartj/ehi588; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Buller HR, 2003, NEW ENGL J MED, V349, P1695; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Daniels LB, 1997, AM J CARDIOL, V80, P184, DOI 10.1016/S0002-9149(97)00315-9; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Hunsaker AR, 2008, AM J ROENTGENOL, V190, P322, DOI 10.2214/AJR.07.2568; Jimenez D, 2007, CHEST, V132, P24, DOI 10.1378/chest.06-2921; Kasper W, 1997, J AM COLL CARDIOL, V30, P1165, DOI 10.1016/S0735-1097(97)00319-7; Kearon C, 2008, CHEST, V134, P892, DOI DOI 10.1378/CHEST.08-0658; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Klok FA, 2008, AM J RESP CRIT CARE, V178, P425, DOI 10.1164/rccm.200803-459OC; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; KONSTANTINIDES S, 2006, HEMOSTASIS THROMBOSI, P1317; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2005, ARCH INTERN MED, V165, P1777, DOI 10.1001/archinte.165.15.1777; Kucher N, 2005, CIRCULATION, V112, pE28, DOI 10.1161/CIRCULATIONAHA.105.551374; Kucher N, 2007, CHEST, V132, P657, DOI 10.1378/chest.07-0665; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Leacche M, 2005, J THORAC CARDIOV SUR, V129, P1018, DOI 10.1016/j.jtcvs.2004.10.023; *OFF SURG GEN, 2008, ACT SURG GEN ISS CAL; Palla A, 2004, NEW ENGL J MED, V350, P423; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 2001, ANN INTERN MED, V135, P88, DOI 10.7326/0003-4819-135-2-200107170-00008; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Raschke RA, 1996, ARCH INTERN MED, V156, P1645, DOI 10.1001/archinte.156.15.1645; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Schoepf UJ, 2004, CIRCULATION, V110, P3276, DOI 10.1161/01.CIR.0000147612.59751.4C; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stein PD, 2007, RADIOLOGY, V242, P15, DOI 10.1148/radiol.2421060971; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Wan S, 2004, CIRCULATION, V110, P744, DOI 10.1161/01.CIR.0000137826.09715.9C; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	45	169	186	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2804	2813		10.1056/NEJMcp0804570	http://dx.doi.org/10.1056/NEJMcp0804570			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109575				2022-12-28	WOS:000261950800007
J	Mathews, SC; Pronovost, PJ				Mathews, Simon C.; Pronovost, Peter J.			Physician Autonomy and Informed Decision Making Finding the Balance for Patient Safety and Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; HEALTH-CARE; PERFORMANCE; PROGRESS		[Mathews, Simon C.; Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Dept Surg, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Publ Hlth, Dept Hlth Policy Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Amalberti R, 2005, ANN INTERN MED, V142, P756, DOI 10.7326/0003-4819-142-9-200505030-00012; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; FRIEDSON E, 1988, PROFESSION MED STUDY, P384; KOHN LT, 1999, TO ERR IS HUMAN BUIL; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Pronovost PJ, 2006, JAMA-J AM MED ASSOC, V296, P696, DOI 10.1001/jama.296.6.696; Shortell SM, 2008, JAMA-J AM MED ASSOC, V299, P445, DOI 10.1001/jama.299.4.445; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007	15	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2913	2915						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109120				2022-12-28	WOS:000261920900025
J	Frisancho, A; Goulden, J				Frisancho, Ariel; Goulden, Jay			Rights-based approaches to improve people's health in Peru	LANCET			English	Editorial Material									[Frisancho, Ariel; Goulden, Jay] CARE Peru, Lima 11, Peru		Frisancho, A (corresponding author), CARE Peru, Lima 11, Peru.	afrisanchoarroyo@yahoo.es						*AMN INT, 2006, PER POOR EXCL WOM DE, P21; ARROYO J, 2007, FOROSALUD MEMORIA EX; COTLEAR D, 2006, NEW SOCIAL CONTRACT, P110; EYBEN R, 2006, RELATIONSHIPS AID, P124; FRISANCHO A, 2008, HLTH CAPITAL SUSTAIN; *PER INEI, 2007, NAT DEM HLTH SURV EN; Physicians for Human Rights, 2007, DEADLY DELAYS MATERN; Potts H, 2008, ACCOUNTABILITY RIGHT; SUYAMA B, 2008, MUTUAL ACCOUNTABILIT, P16; *UK DEP INT DEV, 2005, ALL POV DFIDS EXP PE; *UK INT GROUP HUM, 2007, IMP RIGHTS BAS APPR; *UN HIGH COMM HUM, 2008, UN SPEC RAPP RIGHT E	12	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2007	2008		10.1016/S0140-6736(08)61785-7	http://dx.doi.org/10.1016/S0140-6736(08)61785-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	384LS	19097277				2022-12-28	WOS:000261746900007
J	Liu, J; Ghanim, M; Xue, L; Brown, CD; Iossifov, I; Angeletti, C; Hua, SJ; Negre, N; Ludwig, M; Stricker, T; Al-Ahmadie, HA; Tretiakova, M; Camp, RL; Perera-Alberto, M; Rimm, DL; Xu, T; Rzhetsky, A; White, KP				Liu, Jiang; Ghanim, Murad; Xue, Lei; Brown, Christopher D.; Iossifov, Ivan; Angeletti, Cesar; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria; Camp, Robert L.; Perera-Alberto, Montse; Rimm, David L.; Xu, Tian; Rzhetsky, Andrey; White, Kevin P.			Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer	SCIENCE			English	Article							CARBONIC-ANHYDRASE-IX; RENAL-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; UBIQUITIN LIGASE; GENE-EXPRESSION; MELANOGASTER; PROTEINS; MARKERS; SYSTEM; MAP	We constructed a large-scale functional network model in Drosophila melanogaster built around two key transcription factors involved in the process of embryonic segmentation. Analysis of the model allowed the identification of a new role for the ubiquitin E3 ligase complex factor SPOP. In Drosophila, the gene encoding SPOP is a target of segmentation transcription factors. Drosophila SPOP mediates degradation of the Jun kinase phosphatase Puckered, thereby inducing tumor necrosis factor (TNF)/Eiger-dependent apoptosis. In humans, we found that SPOP plays a conserved role in TNF-mediated JNK signaling and was highly expressed in 99% of clear cell renal cell carcinomas (RCCs), the most prevalent form of kidney cancer. SPOP expression distinguished histological subtypes of RCC and facilitated identification of clear cell RCC as the primary tumor for metastatic lesions.	[Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Iossifov, Ivan; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; Rzhetsky, Andrey; White, Kevin P.] Argonne Natl Lab, Chicago, IL 60637 USA; [Liu, Jiang; Ghanim, Murad; Brown, Christopher D.; Hua, Sujun; Negre, Nicolas; Ludwig, Michael; Stricker, Thomas; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Xue, Lei; Xu, Tian] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Iossifov, Ivan; Rzhetsky, Andrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Angeletti, Cesar; Camp, Robert L.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Ludwig, Michael; White, Kevin P.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Stricker, Thomas; Al-Ahmadie, Hikmat A.; Tretiakova, Maria] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Perera-Alberto, Montse] Univ La Laguna, Dept Anat, E-38320 Tenerife, Spain	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Howard Hughes Medical Institute; Yale University; University of Chicago; Yale University; University of Chicago; University of Chicago; Universidad de la Laguna	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	rzhetsky, andrey/B-6118-2012; Tretiakova, Maria/U-3320-2019	rzhetsky, andrey/0000-0001-6959-7405; Rimm, David/0000-0001-5820-4397; Negre, Nicolas/0000-0001-9727-3416; Brown, Christopher/0000-0002-3785-5008; Liu, Jiang/0000-0002-5687-5047	Vaadia-BARD Postdoctoral Fellowship Award; United States Israel Binational Agricultural Research and Development Fund; Lilly [Life Science Research Fellowship]; W. M. Keck Foundation; Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium;  [FI-315-2001]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	Vaadia-BARD Postdoctoral Fellowship Award(US-Israel Binational Science Foundation); United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Lilly(Eli Lilly); W. M. Keck Foundation(W.M. Keck Foundation); Arnold and Mabel Beckman Foundation; Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jiang, M. Van Lohuizen, C. Chung, D. McEwen for providing expression vectors. Microarray data described in this paper have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession code GSE14086 (expression data) and GSE14289 (ChIP data). M.G. was supported by Vaadia-BARD Postdoctoral Fellowship Award No. FI-315-2001 from BARD, The United States Israel Binational Agricultural Research and Development Fund. C.D.B was supported by a Lilly Life Science Research Fellowship. This work was supported by grants from the W. M. Keck Foundation, the Arnold and Mabel Beckman Foundation, and the Searle Funds at The Chicago Community Trust from the Chicago Biomedical Consortium to K.P.W.	Al-Ahmadie HA, 2008, AM J SURG PATHOL, V32, P377, DOI 10.1097/PAS.0b013e3181570343; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HARDING K, 1986, SCIENCE, V233, P953, DOI 10.1126/science.3755551; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Potter C, 2004, CELL CYCLE, V3, P164; Potter CJ, 2000, TRENDS GENET, V16, P33, DOI 10.1016/S0168-9525(99)01878-8; Rosai J., 2004, RJ ROSAI ACKERMANS S, Vninth; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Skinnider BF, 2005, SEMIN DIAGN PATHOL, V22, P51, DOI 10.1053/j.semdp.2005.11.004; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Weiss C, 2004, CELL CYCLE, V3, P111; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhou M, 2005, CLIN LAB MED, V25, P247, DOI 10.1016/j.cll.2005.01.004	29	96	105	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1218	1222		10.1126/science.1157669	http://dx.doi.org/10.1126/science.1157669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19164706	Green Accepted, Green Submitted			2022-12-28	WOS:000263687600040
J	Ray, PS; Jia, J; Yao, P; Majumder, M; Hatzoglou, M; Fox, PL				Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Majumder, Mithu; Hatzoglou, Maria; Fox, Paul L.			A stress-responsive RNA switch regulates VEGFA expression	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; TRANSLATIONAL CONTROL; BACILLUS-SUBTILIS; MESSENGER-RNAS; NONCANONICAL FUNCTION; LEADER RNA; HYPOXIA; PROTEIN; RIBOSWITCHES	Ligand binding to structural elements in the non- coding regions of messenger RNA modulates gene expression(1,2). Ligands such as free metabolites or other small molecules directly bind and induce conformational changes in regulatory RNA elements known as riboswitches(1-4). Other types of RNA switches are activated by complexed metabolites - for example, RNA- ligated metabolites such as aminoacyl- charged transfer RNA in the T- box system(5), or protein-bound metabolites in the glucose- or amino- acid- stimulated terminator-anti- terminator systems(6,7). All of these switch types are found in bacteria, fungi and plants(8-10). Here we report an RNA switch in human vascular endothelial growth factor- A ( VEGFA, also known as VEGF) mRNA 39 untranslated region ( UTR) that integrates signals from interferon ( IFN)-gamma and hypoxia to regulate VEGFA translation in myeloid cells. Analogous to riboswitches, the VEGFA 3 ' UTR undergoes a binary conformational change in response to environmental signals. However, the VEGFA 3 ' UTR switch is metabolite independent, and the conformational change is dictated by mutually exclusive, stimulus- dependent binding of proteins, namely, the IFN-gamma-activated inhibitor of translation complex(11,12) and heterogeneous	[Ray, Partho Sarothi; Jia, Jie; Yao, Peng; Fox, Paul L.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Ray, Partho Sarothi] Indian Inst Sci Educ & Res, Dept Biol, Kolkata 700106, India; [Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Indian Institute of Science Education & Research (IISER) - Kolkata; Case Western Reserve University	Fox, PL (corresponding author), Cleveland Clin, Dept Cell Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Yao, Peng/G-5218-2015; Yao, Peng/Y-8047-2019; Ray, Partho Sarothi/H-3020-2019; Yao, Peng/J-4492-2013	Yao, Peng/0000-0003-1022-3948; Yao, Peng/0000-0002-1145-3967; Ray, Partho Sarothi/0000-0002-8795-3060; Yao, Peng/0000-0002-7029-8629; Jia, Jie/0000-0002-9583-1055	National Institutes of Health [P01 HL29582, R01 HL67725, P01 HL76491, R01 DK60596]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to D. Driscoll and T. M. Henkin for helpful discussions. This work was supported by National Institutes of Health grants P01 HL29582, R01 HL67725 and P01 HL76491 ( to P. L. F.), and R01 DK60596 ( to M. H.).	Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schilling O, 2004, NUCLEIC ACIDS RES, V32, P2853, DOI 10.1093/nar/gkh611; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	31	194	198	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					915	919		10.1038/nature07598	http://dx.doi.org/10.1038/nature07598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19098893	Green Accepted			2022-12-28	WOS:000263266700052
J	Moffitt, JR; Chemla, YR; Aathavan, K; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Moffitt, Jeffrey R.; Chemla, Yann R.; Aathavan, K.; Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.; Bustamante, Carlos			Intersubunit coordination in a homomeric ring ATPase	NATURE			English	Article							DNA PACKAGING MOTOR; REPLICATIVE HEXAMERIC HELICASE; OPTICAL TWEEZERS; PORTAL MOTOR; BACTERIOPHAGE PHI-29; TERMINATION FACTOR; INTERNAL FORCE; MECHANISM; TRANSLOCATION; MECHANOCHEMISTRY	Homomeric ring ATPases perform many vital and varied tasks in the cell, ranging from chromosome segregation to protein degradation. Here we report the direct observation of the intersubunit coordination and step size of such a ring ATPase, the double- stranded- DNA packaging motor in the bacteriophage phi 29. Using high- resolution optical tweezers, we find that packaging occurs in increments of 10 base pairs ( bp). Statistical analysis of the preceding dwell times reveals that multiple ATPs bind during each dwell, and application of high force reveals that these 10- bp increments are composed of four 2.5- bp steps. These results indicate that the hydrolysis cycles of the individual subunits are highly coordinated by means of a mechanism novel for ring ATPases. Furthermore, a step size that is a non- integer number of base pairs demands new models for motor - DNA interactions.	[Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Aathavan, K.; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Anderson, Dwight L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Jardine, Paul/0000-0002-1090-0550; Chemla, Yann/0000-0001-9167-0234; Bustamante, Carlos/0000-0002-2970-0073	National Science Foundation's Graduate Research Fellowship; Burroughs Welcome Fund's Career Awards at the Scientific Interface; NIH [GM-071552, DE-003606, GM-059604]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE003606, R01DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	National Science Foundation's Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Welcome Fund's Career Awards at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Hetherington, M. Nollmann and G. Chistol for a critical reading of the manuscript; C. L. Hetherington, A. Politzer, M. Strycharska, M. Kopaczynska and J. Yu for critical discussions; and J. Choy, S. Grill and S. Smith for advice regarding instrumentation. J.R.M. acknowledges the National Science Foundation's Graduate Research Fellowship and Y.R.C. the Burroughs Welcome Fund's Career Awards at the Scientific Interface for funding. This research was supported in part by NIH grants GM-071552, DE-003606 and GM-059604. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; BLOCK SM, 1995, BIOPHYS J, V68, pS230; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Bustamante C., 2008, SINGLE MOL TECHNIQUE, P297; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chemla YR, 2008, J PHYS CHEM B, V112, P6025, DOI 10.1021/jp076153r; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P11245, DOI 10.1073/pnas.0701323104; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kainov DE, 2006, CELL MOL LIFE SCI, V63, P1095, DOI 10.1007/s00018-005-5450-3; Kellner L., 1937, P ROY SOC LOND A MAT, V159, P0410; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Koza Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031905; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I.H., 1975, ENZYME KINETICS; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; YANAGI K, 1991, J MOL BIOL, V217, P201, DOI 10.1016/0022-2836(91)90620-L	50	215	218	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					446	U2		10.1038/nature07637	http://dx.doi.org/10.1038/nature07637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19129763	Green Accepted			2022-12-28	WOS:000262519200039
J	Vaughn, DJ; Flaherty, K; Lal, P; Gallagher, M; O'Dwyer, P; Wilner, K; Chen, I; Schwartz, G				Vaughn, David J.; Flaherty, Keith; Lal, Priti; Gallagher, Maryann; O'Dwyer, Peter; Wilner, Keith; Chen, Isan; Schwartz, Gary			Treatment of Growing Teratoma Syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Vaughn, David J.; Flaherty, Keith; Lal, Priti; Gallagher, Maryann; O'Dwyer, Peter] Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Wilner, Keith; Chen, Isan] Pfizer, La Jolla, CA 92121 USA; [Schwartz, Gary] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Pennsylvania; Pennsylvania Medicine; Pfizer; Memorial Sloan Kettering Cancer Center	Vaughn, DJ (corresponding author), Abramson Canc Ctr, Philadelphia, PA 19104 USA.	david.vaughn@uphs.upenn.edu						Bartkova J, 2003, J PATHOL, V200, P149, DOI 10.1002/path.1353; LOGOTHETIS CJ, 1982, CANCER, V50, P1629, DOI 10.1002/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1; O'Dwyer P. J., 2007, J CLIN ONCOL S, V25, p150S; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Speis PE, 2007, J UROLOGY, V177, P1330	5	60	60	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					423	424		10.1056/NEJMc0808558	http://dx.doi.org/10.1056/NEJMc0808558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19164198				2022-12-28	WOS:000262519900030
J	Do, MTH; Kang, SH; Xue, T; Zhong, HN; Liao, HW; Bergles, DE; Yau, KW				Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai			Photon capture and signalling by melanopsin retinal ganglion cells	NATURE			English	Article							CONE PHOTORECEPTORS; LIGHT RESPONSES; MICE; PHOTOPIGMENT; REFLEX; EXPRESSION; RODS; SET	A subset of retinal ganglion cells has recently been discovered to be intrinsically photosensitive, with melanopsin as the pigment. These cells project primarily to brain centres for non- image- forming visual functions such as the pupillary light reflex and circadian photoentrainment. How well they signal intrinsic light absorption to drive behaviour remains unclear. Here we report fundamental parameters governing their intrinsic light responses and associated spike generation. The membrane density of melanopsin is 10(4)-fold lower than that of rod and cone pigments, resulting in a very low photon catch and a phototransducing role only in relatively bright light. Nonetheless, each captured photon elicits a large and extraordinarily prolonged response, with a unique shape among known photoreceptors. Notably, like rods, these cells are capable of signalling single- photon absorption. A flash causing a few hundred isomerized melanopsin molecules in a retina is sufficient for reaching threshold for the pupillary light reflex.	[Do, Michael Tri H.; Kang, Shin H.; Xue, Tian; Zhong, Haining; Liao, Hsi-Wen; Bergles, Dwight E.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Do, Michael Tri H.; Xue, Tian; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Do, MTH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	mdo@jhmi.edu; kwyau@mail.jhmi.edu	Xue, Tian/G-9009-2018; Bergles, Dwight/U-8343-2019; H, Michael Tri/A-5917-2009	Bergles, Dwight/0000-0002-7133-7378; H, Michael Tri/0000-0001-6418-0977; Zhong, Haining/0000-0002-7109-4724	NRSA; VNTP Training Grant; NIH; NATIONAL EYE INSTITUTE [R01EY014596, F32EY016959, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VNTP Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by an NRSA fellowship and a VNTP Training Grant to M. T. H. D., and NIH grants to K.-W.Y. and D. E. B. We thank Y. Koutalos, V. Bhandawat, D.-G. Luo, V. Kefalov, D. Liu, G. Maimon and C.-Y. Su for discussions, and Y. Wang, J. Hsieh and N. Nishiyama for technical assistance. We also thank J. Nathans and R. Reeves for suggestions on transgenic lines, J. Nathans and H. Cahill for the Gnat1<SUP>-/-</SUP> cl mouse line, and T. Shelley for machining. We dedicate this work to the Champalimaud Foundation, Portugal.	BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dartnell HJA, 1972, PHOTOCHEMISTRY VISIO, P122; Dorlochter M, 1997, PROG NEUROBIOL, V53, P451, DOI 10.1016/S0301-0082(97)00046-4; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; HARDIE RC, 2008, COMPREHENSIVE REFERE; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; KRAFT TW, 1988, J PHYSIOL-LONDON, V404, P199, DOI 10.1113/jphysiol.1988.sp017286; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LISMAN JE, 1977, J GEN PHYSIOL, V70, P621, DOI 10.1085/jgp.70.5.621; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; LUO DG, 2008, SENSES COMPREHENSIVE; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QIU X, 2007, INVEST OPHTHALMOL VI, V48; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; WONG KY, 2008, INVEST OPHTHALMOL VI, V49; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	50	206	215	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					281	U2		10.1038/nature07682	http://dx.doi.org/10.1038/nature07682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19118382	Green Accepted			2022-12-28	WOS:000262440900032
J	Ballard, JO				Ballard, J. O.			Provenance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jballard@psu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					140	141		10.1001/jama.2008.978	http://dx.doi.org/10.1001/jama.2008.978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141755				2022-12-28	WOS:000262405500001
J	Malerod, L; Stenmark, H				Malerod, Lene; Stenmark, Harald			ESCRTing Membrane Deformation	CELL			English	Editorial Material							STRUCTURAL BASIS; AUTOINHIBITION; FILAMENTS; PROTEINS; COMPLEX; CHMP3	The ESCRT-III complex mediates membrane budding away from the cytosol in endosome biogenesis, cytokinesis, and viral budding. In this issue, Saksena et al. (2009) use an elegant fluorescence-based approach to define the sequential activation, recruitment, and disassembly of ESCRT-III subunits during membrane involution in vitro.	[Malerod, Lene; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway; [Malerod, Lene; Stenmark, Harald] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway	University of Oslo; University of Oslo	Stenmark, H (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0310 Oslo, Norway.	stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008	Malerod, Lene/0000-0001-9075-3652				Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	9	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					15	17		10.1016/j.cell.2008.12.029	http://dx.doi.org/10.1016/j.cell.2008.12.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135881	Bronze			2022-12-28	WOS:000262318400007
J	Nicolet, A; Zolla, F				Nicolet, Andre; Zolla, Frederic			PHYSICS Cloaking with Curved Spaces	SCIENCE			English	Editorial Material							INVISIBILITY		[Nicolet, Andre; Zolla, Frederic] Univ Aix Marseille 1, Domaine Univ St Jerome, Inst Fresnel, CNRS,UMR 6133, F-13397 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Nicolet, A (corresponding author), Univ Aix Marseille 1, Domaine Univ St Jerome, Inst Fresnel, CNRS,UMR 6133, F-13397 Marseille, France.	andre.nicolet@fresnel.fr; frederic.zolla@fresnel.fr	nicolet, andre/A-3654-2008; Nicolet, Andre/AAC-5784-2019	nicolet, andre/0000-0001-6795-160X; 				Farhat M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.134501; Felbacq D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183902; Gralak B, 2001, OPT EXPRESS, V9, P567, DOI 10.1364/OE.9.000567; Jiang WX, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3026532; Leonhardt U, 2009, SCIENCE, V323, P110, DOI 10.1126/science.1166332; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Zolla F, 2007, OPT LETT, V32, P1069, DOI 10.1364/OL.32.001069	7	11	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					46	47		10.1126/science.1168456	http://dx.doi.org/10.1126/science.1168456			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119204				2022-12-28	WOS:000262104100028
J	Zucker, AA; Light, D				Zucker, Andrew A.; Light, Daniel			Laptop Programs for Students	SCIENCE			English	Editorial Material									[Zucker, Andrew A.] Concord Consortium, Concord, MA 01742 USA; [Light, Daniel] Educ Dev Ctr, Ctr Children & Technol, New York, NY 10014 USA		Zucker, AA (corresponding author), Concord Consortium, 25 Love Lane, Concord, MA 01742 USA.	azucker@concord.org; dlight@edc.org		Zucker, Andrew/0000-0002-9191-6561				[Anonymous], 2003, NEVER MIND LAPTOPS K; Astiz MF, 2002, COMP EDUC REV, V46, P66, DOI 10.1086/324050; AZINIAN H, 2007, MAPA DEBATE INICIATI; *BRIT ED COMM TECH, 2007, HARN TECHN REV 2007, P80; *COM CTR, 2008, INF FIN ENL PORT ABR; Cuban L, 2001, AM EDUC RES J, V38, P813, DOI 10.3102/00028312038004813; Davis D., 2005, HENRICO COUNTY PUBLI; DURANDO M, 2007, EMATURE SCH EUROPE; EFA Global Monitoring Report Team, 2008, ED ALL 2015 WILL WE; FERRER G, 2002, ASPECTOS CURRICULUM; Finkelstein ND, 2005, PHYS REV SPEC TOP-PH, V1, DOI 10.1103/PhysRevSTPER.1.010101; GOLDBERG A, 2003, J TECHNOL LEARN ASSE; Hepp P., 2004, TECHNOLOGY SCH ED IC; Kozma R, 2004, INT J EDUC DEV, V24, P361, DOI 10.1016/j.ijedudev.2003.11.014; *NCOMPUTING INC, 2008, REP MAC 1 NAT PROV C; Penuel WR, 2006, J RES TECHNOL EDUC, V38, P329, DOI 10.1080/15391523.2006.10782463; Pianta RC, 2007, SCIENCE, V315, P1795, DOI 10.1126/science.1139719; Plomp T, 2008, CERC STUD COMP EDUC, V23, P1, DOI 10.1007/978-1-4020-8928-2; *PROGR INT ASS, 2005, AR STUD READ TECHN R; REIMERS F, 2000, PERSPECTIVAS REFORMA; Shapley K., 2007, EVALUATION TEXAS TEC; SILVERNAIL DL, 2004, IMPACT MAINES 1 1 LA; Subbarao C. S, 1958, PUBL REP BAS ED IND; *UN DEV PROGR, 2004, AR HUM DEV REP BUILD; *VIT WAV CONS, 2008, AFF COMP SCH DEV COU, P14; Vital Wave Consulting, 2008, AFF COMP SCH DEV COU; Zucker A., 2004, Journal of Educational Computing Research, V30, P371, DOI 10.2190/BYR8-CGFC-WVHV-T0TL; ZUCKER AA, 2005, STUDY 1 1 COMPUTER U; Zucker Andrew, 2008, TRANSFORMING SCH TEC; Zucker AA, 2008, J SCI EDUC TECHNOL, V17, P586, DOI 10.1007/s10956-008-9125-3	30	53	55	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					82	85		10.1126/science.1167705	http://dx.doi.org/10.1126/science.1167705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119224				2022-12-28	WOS:000262104100044
J	Weinstein, RS; Roberson, PK; Manolagas, SC				Weinstein, Robert S.; Roberson, Paula K.; Manolagas, Stavros C.			Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; BONE LOSS; ALENDRONATE; OSTEOPOROSIS; METABOLISM; HISTOMORPHOMETRY; OSTEOCALCIN; RISEDRONATE	Background Bisphosphonates decrease bone resorption and are commonly used to treat or prevent osteoporosis. However, the effect of bisphosphonates on their target cells remains enigmatic, since in patients benefiting from therapy, little change, if any, has been observed in the number of osteoclasts, which are the cells responsible for bone resorption. Methods We examined 51 bone- biopsy specimens obtained after a 3- year, double- blind, randomized, placebo- controlled, dose- ranging trial of oral alendronate to prevent bone resorption among healthy postmenopausal women 40 through 59 years of age. The patients were assigned to one of five groups: those receiving placebo for 3 years; alendronate at a dose of 1, 5, or 10 mg per day for 3 years; or alendronate at a dose of 20 mg per day for 2 years, followed by placebo for 1 year. Formalin- fixed, undecalcified planar sections were assessed by bone histomorphometric methods. Results The number of osteoclasts was increased by a factor of 2.6 in patients receiving 10 mg of alendronate per day for 3 years as compared with the placebo group ( P< 0.01). Moreover, the number of osteoclasts increased as the cumulative dose of the drug increased ( r = 0.50, P< 0.001). Twenty- seven percent of these osteoclasts were giant cells with pyknotic nuclei that were adjacent to superficial resorption cavities. Furthermore, giant, hypernucleated, detached osteoclasts with 20 to 40 nuclei were found after alendronate treatment had been discontinued for 1 year. Of these large cells, 20 to 37% were apoptotic, according to both their morphologic features and positive findings from in situ end labeling. Conclusions Long- term alendronate treatment is associated with an increase in the number of osteoclasts, which include distinctive giant, hypernucleated, detached osteoclasts that are undergoing protracted apoptosis.	[Weinstein, Robert S.; Manolagas, Stavros C.] Univ Arkansas Med Sci, Div Endocrinol & Metab, Little Rock, AR 72205 USA; [Weinstein, Robert S.; Roberson, Paula K.; Manolagas, Stavros C.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Weinstein, Robert S.; Manolagas, Stavros C.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Roberson, Paula K.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Weinstein, Robert S.; Manolagas, Stavros C.] Univ Arkansas Med Sci, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Weinstein, RS (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, 4301 W Markham St,Slot 587, Little Rock, AR 72205 USA.	weinsteinroberts@uams.edu			Department of Veterans Affairs Merit Review Grants; National Institutes of Health, and Tobacco Settlement Funds [P01-AG13918]; College of Medicine of the University of Arkansas for Medical Sciences; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000436] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Grants(US Department of Veterans Affairs); National Institutes of Health, and Tobacco Settlement Funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine of the University of Arkansas for Medical Sciences; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	Supported by the Department of Veterans Affairs Merit Review Grants, a grant (P01-AG13918) from the National Institutes of Health, and Tobacco Settlement Funds provided by the College of Medicine of the University of Arkansas for Medical Sciences. The original clinical trial, which included transilial bone-biopsy specimens, was supported by Merck.; No potential conflict of interest relevant to this article was reported.; We thank Tony Chambers, Erin Hogan, William Webb, and Chester Wicker III for their technical support; Michael Parfitt for helpful discussions; and Charles O'Brien and Robert Jilka for their careful reading of an earlier version of the manuscript.	Balemans W, 2005, CALCIFIED TISSUE INT, V77, P263, DOI 10.1007/s00223-005-0027-6; BALENA R, 1993, J CLIN INVEST, V92, P2577, DOI 10.1172/JCI116872; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; BOLLERSLEV J, 1989, ENDOCR REV, V10, P45, DOI 10.1210/edrv-10-1-45; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; Chavassieux PM, 1997, J CLIN INVEST, V100, P1475, DOI 10.1172/JCI119668; Dempster DW, 2007, J BONE MINER RES, V22, pS29; FALLON MD, 1983, LAB INVEST, V49, P159; Fisher JE, 2000, ENDOCRINOLOGY, V141, P4793, DOI 10.1210/en.141.12.4793; Fleisch H, 2000, BISPHOSPHONATES BONE, P42; GUNDBERG CM, 1986, J CLIN INVEST, V77, P1762, DOI 10.1172/JCI112499; Halasy-Nagy JM, 2001, BONE, V29, P553, DOI 10.1016/S8756-3282(01)00615-9; Jilka RL, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P237, DOI 10.1016/B978-0-12-373884-4.00032-X; KANIS JA, 1991, PATHOPHYSIOLOGY TREA, P26; Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935; KOUSTENI S, 2003, SCIENCE, V299, P1184; Li CY, 2005, BONE, V37, P287, DOI 10.1016/j.bone.2005.04.041; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229; McClung M, 1998, ANN INTERN MED, V128, P253, DOI 10.7326/0003-4819-128-4-199802150-00001; MILLER SC, 1977, CALC TISS RES, V22, P243, DOI 10.1007/BF02010363; Muche B, 2003, J BONE MINER RES, V18, pS371; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nielsen RH, 2007, BIOCHEM BIOPH RES CO, V360, P834, DOI 10.1016/j.bbrc.2007.06.145; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Recker R R, 2004, Osteoporos Int, V15, P231, DOI 10.1007/s00198-003-1530-0; REITSMA PH, 1980, CALCIFIED TISSUE INT, V32, P145, DOI 10.1007/BF02408534; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; *SAS I, 2002, SAS STAT VERS 9 1; Semba I, 2000, BONE, V27, P389, DOI 10.1016/S8756-3282(00)00330-6; SPJUT HJ, 1971, ATLAS TUMOR PATHOLOG; *STAT CORP, 2005, STATCORP STAT STAT S; Weinstein RS, 2007, J BONE MINER RES, V22, pS17; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; WEINSTEIN RS, 1988, NEW ENGL J MED, V319, P1698, DOI 10.1056/NEJM198812293192603; Weinstein RS, 2004, ENDOCRINOLOGY, V145, P1980, DOI 10.1210/en.2003-1133; WEINSTEIN RS, 1982, CALCIFIED TISSUE INT, V34, P224, DOI 10.1007/BF02411241; Whyte MP, 2003, NEW ENGL J MED, V349, P457, DOI 10.1056/NEJMoa023110; Woo SB, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-10-200611210-00023	45	259	271	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					53	62		10.1056/NEJMoa0802633	http://dx.doi.org/10.1056/NEJMoa0802633			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118304	Green Accepted			2022-12-28	WOS:000262096800007
J	Gupta, A; Khaw, FM; Stokle, EL; George, RC; Pebody, R; Stansfield, RE; Sheppard, CL; Slack, M; Gorton, R; Spencer, DA				Gupta, Atul; Khaw, F-M; Stokle, E. L.; George, R. C.; Pebody, R.; Stansfield, R. E.; Sheppard, C. L.; Slack, M.; Gorton, R.; Spencer, D. A.			Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PNEUMOCOCCAL PNEUMONIA; PARAPNEUMONIC EMPYEMA; INVASIVE DISEASE; BURKINA-FASO; MENINGITIS; INFECTION; EPIDEMIC		[Khaw, F-M; Stokle, E. L.; Gorton, R.] Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England; [Gupta, Atul; Spencer, D. A.] Freeman Rd Hosp, Pediat Resp Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [George, R. C.; Pebody, R.; Sheppard, C. L.; Slack, M.] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England; [Stansfield, R. E.] N Tyneside Gen Hosp, Microbiol Lab Serv, Northumbria Healthcare NHS Fdn Trust, North Shields NE29 8NH, England	Newcastle Freeman Hospital; Newcastle University - UK; Health Protection Agency	Khaw, FM (corresponding author), Hlth Protect Agcy NE, No Off, Newcastle Upon Tyne NE1 4WH, Tyne & Wear, England.	Meng.khaw@hpa.org.uk		Pebody, Richard/0000-0002-9069-2885				*BIN, NOW STREPT PNEUM TES; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Cashman P, 2007, COMMUN DIS INTELL, V31, P296; Crum NF, 2003, AM J PREV MED, V25, P107, DOI 10.1016/S0749-3797(03)00114-4; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Eltringham G, 2003, J CLIN MICROBIOL, V41, P521, DOI 10.1128/JCM.41.1.521-522.2003; GRATTEN M, 1993, MED J AUSTRALIA, V158, P340, DOI 10.5694/j.1326-5377.1993.tb121794.x; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Proulx J F, 2002, Can Commun Dis Rep, V28, P129; Ramphul N, 2006, PEDIATR PULM, V41, P750, DOI 10.1002/ppul.20434; RAUCH AM, 1990, AM J DIS CHILD, V144, P923, DOI 10.1001/archpedi.1990.02150320087033; SHEPPARD CL, 2006, THESIS ST MARYS COLL; SHEPPARD CL, 2006, 5 INT S PNEUM PNEUM; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	25	15	17	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2008	337								a2964	10.1136/bmj.a2964	http://dx.doi.org/10.1136/bmj.a2964			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MZ	19118084				2022-12-28	WOS:000262946300001
J	Buehr, M; Meek, S; Blair, K; Yang, J; Ure, J; Silva, J; Mclay, R; Hall, J; Ying, QL; Smith, A				Buehr, Mia; Meek, Stephen; Blair, Kate; Yang, Jian; Ure, Janice; Silva, Jose; McLay, Renee; Hall, John; Ying, Qi-Long; Smith, Austin			Capture of Authentic Embryonic Stem Cells from Rat Blastocysts	CELL			English	Article							PRIMORDIAL GERM-CELLS; DIFFERENTIATION INHIBITING ACTIVITY; SELF-RENEWAL; X-CHROMOSOME; TRANSCRIPTIONAL NETWORK; MOUSE EPIBLAST; PLURIPOTENCY; ESTABLISHMENT; LINES; FGF	Embryonic stem (ES) cells have been available from inbred mice since 1981 but have not been validated for other rodents. Failure to establish ES cells from a range of mammals challenges the identity of cultivated stem cells and our understanding of the pluripotent state. Here we investigated derivation of ES cells from the rat. We applied molecularly defined conditions designed to shield the ground state of authentic pluripotency from inductive differentiation stimuli. Undifferentiated cell lines developed that exhibited diagnostic features of ES cells including colonization of multiple tissues in viable chimeras. Definitive ES cell status was established by transmission of the cell line genome to offspring. Derivation of germline-competent ES cells from the rat paves the way to targeted genetic manipulation in this valuable biomedical model species. Rat ES cells will also provide a refined test-bed for functional evaluation of pluripotent stem cell-derived tissue repair and regeneration.	[Blair, Kate; Yang, Jian; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Buehr, Mia; Meek, Stephen; Ure, Janice; McLay, Renee; Ying, Qi-Long] Univ Edinburgh, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Buehr, Mia; Meek, Stephen] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Blair, Kate; Silva, Jose; Hall, John; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Yang, Jian] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Cambridge; Fudan University	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk	Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019	Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Blair, Kate/0000-0003-0766-0952; Smith, Austin/0000-0002-3029-4682	National Institute on Drug Abuse at National Institutes of Health; Biotechnology and Biological Sciences Research Council of the United Kingdom; European Commission project EuroStemCell; Gates Cambridge Scholar; Medical Research Council; MRC [G9806702] Funding Source: UKRI; Medical Research Council [G9806702] Funding Source: researchfish	National Institute on Drug Abuse at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission project EuroStemCell(European CommissionEuropean Commission Joint Research Centre); Gates Cambridge Scholar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Jennifer Nichols provided advice throughout and comments on the manuscript. We thank Carolyn Manson, John Agnew, and Andrew Dyer for expert animal care and Rachel Walker for flow cytometry. We are indebted to Frances Lovell and Willem Rens at the Cambridge Resource Centre for Comparitive Genomics for FISH. We are grateful to Philip Cohen and colleagues at the Division of Signal Transduction Therapy, University of Dundee, for inhibitors and Thomas Jenuwein for H3K27me3 antibody. This research was funded by the National Institute on Drug Abuse at National Institutes of Health, the Biotechnology and Biological Sciences Research Council of the United Kingdom, and the European Commission project EuroStemCell. K. B. is a Gates Cambridge Scholar. A.S. is a Medical Research Council Professor. A.S., Q.L.Y., and M. B. conceived and planned the study. M. B. characterized ICM explants and derived cell lines; S. M. performed molecular expression profiling, transfections, and genotyping; K. B. analyzed feeder-free culture and LIF responsiveness; J.Y., J.S., and J.H. performed additional characterization experiments; J.U. and R.M. generated chimeras; and A.S. wrote the paper. A.S. and Q.-L.Y. are inventors on a patent relating to this study filed by the University of Edinburgh and licensed to Stem Cell Sciences LTD. A.S. is a remunerated scientific advisor to the Stem Cell Sciences LTD.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BATLLEMORERA L, 2008, GENESIS         1006, DOI DOI 10.1002/DVG.20442; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nichols J, 1998, REPROD FERT DEVELOP, V10, P517, DOI 10.1071/RD98075; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Prelle K, 1999, CELLS TISSUES ORGANS, V165, P220, DOI 10.1159/000016683; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YAMAMURA K, 1981, DEV GENET, V2, P131, DOI 10.1002/dvg.1020020111; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	63	583	658	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1287	1298		10.1016/j.cell.2008.12.007	http://dx.doi.org/10.1016/j.cell.2008.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109897	Bronze			2022-12-28	WOS:000261989800019
J	Williams, RS; Williams, GJ; Tainer, JA				Williams, R. Scott; Williams, Gareth J.; Tainer, John A.			A Charged Performance by gp17 in Viral Packaging	CELL			English	Editorial Material							DNA; ATPASE; REPAIR; MOTOR	Packaging of viral genomes into virus capsids requires powerful motors to overcome the repulsive force that builds as the nucleic acids are compressed. Through structural analyses of the T4 bacteriophage packaging motor gp17, Sun et al. (2008) now propose a packaging mechanism in which electrostatic forces cause the motor to alternate between tensed and relaxed conformational states.	[Williams, R. Scott; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Williams, Gareth J.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Dept Mol Biol, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tainer, JA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	jat@scripps.edu	Tainer, John/GWQ-4878-2022; Williams, R Scott/A-6059-2015	Tainer, John/0000-0003-1659-2429; Williams, R Scott/0000-0002-4610-8397				Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Petrov AS, 2007, STRUCTURE, V15, P21, DOI 10.1016/j.str.2006.11.013; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069	8	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1169	1171		10.1016/j.cell.2008.12.011	http://dx.doi.org/10.1016/j.cell.2008.12.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109888	Bronze			2022-12-28	WOS:000261989800008
J	Blein, T; Pulido, A; Vialette-Guiraud, A; Nikovics, K; Morin, H; Hay, A; Johansen, IE; Tsiantis, M; Laufs, P				Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Hay, Angela; Johansen, Ida Elisabeth; Tsiantis, Miltos; Laufs, Patrick			A Conserved Molecular Framework for Compound Leaf Development	SCIENCE			English	Article							RELATIVE CARDAMINE-HIRSUTA; CUP-SHAPED-COTYLEDON; ARABIDOPSIS-THALIANA; ORGAN BOUNDARIES; AUXIN TRANSPORT; APICAL MERISTEM; GENETIC-CONTROL; MORPHOGENESIS; TOMATO	Diversity in leaf shape is produced by alterations of the margin: for example, deep dissection leads to leaflet formation and less- pronounced incision results in serrations or lobes. By combining gene silencing and mutant analyses in four distantly related eudicot species, we show that reducing the function of NAM/CUC boundary genes (NO APICAL MERISTEM and CUP-SHAPED COTYLEDON) leads to a suppression of all marginal outgrowths and to fewer and fused leaflets. We propose that NAM/CUC genes promote formation of a boundary domain that delimits leaflets. This domain has a dual role promoting leaflet separation locally and leaflet formation at distance. In this manner, boundaries of compound leaves resemble boundaries functioning during animal development.	[Blein, Thomas; Pulido, Amada; Vialette-Guiraud, Aurelie; Nikovics, Krisztina; Morin, Halima; Laufs, Patrick] INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Hay, Angela; Tsiantis, Miltos] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Johansen, Ida Elisabeth] Univ Aarhus, Dept Genet & Biotechnol, DK-1871 Frederiksberg C, Denmark	INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Aarhus University	Laufs, P (corresponding author), INRA, Biol Cellulaire Lab, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	laufs@versailles.inra.fr	Johansen, Ida E/F-7792-2014; Blein, Thomas/L-8508-2019; Pulido, Amada/B-8199-2011	Johansen, Ida E/0000-0001-8660-2018; Blein, Thomas/0000-0001-9788-5201; Pulido, Amada/0000-0003-4241-7042; Laufs, Patrick/0000-0003-4459-3445	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME [TRIL-046]; Ministere de l'Enseignement Superieur et de la Recherche; Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion); Region Ile-de-France; UK Biotechnology and Biological	Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Region Ile-de-France(Region Ile-de-France); UK Biotechnology and Biological	This work was partly supported by an Action Concertee Incitative "Jeunes Chercheuses et Jeunes Chercheurs" and the trilateral Genoplante GENOSOME program TRIL-046. T.B. was supported by a Ph. D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche, and A.P. was supported by the Fundacion Espanola para la Ciencia y la Tecnologia (Ministerio de Ciencia e Innovacion) and the Region Ile-de-France. M.T. is supported by the UK Biotechnology and Biological	Aida M, 2006, CURR OPIN PLANT BIOL, V9, P72, DOI 10.1016/j.pbi.2005.11.011; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Aida M, 2006, PLANT MOL BIOL, V60, P915, DOI 10.1007/s11103-005-2760-7; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Brand A, 2007, PLANTA, V226, P941, DOI 10.1007/s00425-007-0540-0; Breuil-Broyer S, 2004, PLANT J, V38, P182, DOI 10.1111/j.1365-313X.2004.02026.x; Champagne C, 2004, DEVELOPMENT, V131, P4401, DOI 10.1242/dev.01338; Champagne CEM, 2007, PLANT CELL, V19, P3369, DOI 10.1105/tpc.107.052886; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	23	246	268	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2008	322	5909					1835	1839		10.1126/science.1166168	http://dx.doi.org/10.1126/science.1166168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385FF	19095941				2022-12-28	WOS:000261799400052
J	Pillay, N				Pillay, Navanethem			Right to health and the Universal Declaration of Human Rights	LANCET			English	Editorial Material									[Pillay, Navanethem] United Nations Off Geneva, Off High Commissioner Human Rights, CH-1211 Geneva, Switzerland		Pillay, N (corresponding author), United Nations Off Geneva, Off High Commissioner Human Rights, CH-1211 Geneva, Switzerland.							Council of Europe, 1996, EUR SOC CHART; *INT COMM HUM RIGH, 1988, ADD PROT AM CONV HUM; *OFF UN HIGH COMM, 2007, NEW COR INT HUM RIGH; Office of the United Nations High Commissioner for Human Rights, 2006, COR INT HUM RIGHTS T; *UN, 1948, UN DECL HUM RIGHTS; *UN EC SOC COUNC C, 2000, GEN COMM; United Nations, 1966, INT COV EC SOC CULT	7	23	23	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 13	2008	372	9655					2005	2006		10.1016/S0140-6736(08)61783-3	http://dx.doi.org/10.1016/S0140-6736(08)61783-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	384LS	19097276				2022-12-28	WOS:000261746900006
J	Frenk, J				Frenk, Julio			Strengthening health systems to promote security	LANCET			English	Editorial Material							MEXICO		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	jfrenk@hsph.harvard.edu						Commission on Human Security, 2003, HUM SEC NOW; Cutler DM, 2002, J PUBLIC ECON, V84, P279, DOI 10.1016/S0047-2727(01)00127-X; Knaul FM, 2005, SALUD PUBLICA MEXICO, V47, P430; KNAUL FM, 2005, PREVENTING IMPOVERIS; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1	5	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2009	373	9682					2181	2182		10.1016/S0140-6736(09)60002-7	http://dx.doi.org/10.1016/S0140-6736(09)60002-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	463PQ	19150131	Green Submitted			2022-12-28	WOS:000267444500009
J	Du, LQ; Ali, GS; Simons, KA; Hou, JG; Yang, TB; Reddy, ASN; Poovaiah, BW				Du, Liqun; Ali, Gul S.; Simons, Kayla A.; Hou, Jingguo; Yang, Tianbao; Reddy, A. S. N.; Poovaiah, B. W.			Ca2+/calmodulin regulates salicylic-acid-mediated plant immunity	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; CALMODULIN-BINDING PROTEIN; DISEASE-RESISTANCE; TRANSCRIPTIONAL REGULATION; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; CELL-DEATH; DEFENSE; FAMILY	Intracellular calcium transients during plant-pathogen interactions are necessary early events leading to local and systemic acquired resistance(1). Salicylic acid, a critical messenger, is also required for both of these responses(2,3), but whether and how salicylic acid level is regulated by Ca2+ signalling during plant-pathogen interaction is unclear. Here we report a mechanism connecting Ca2+ signal to salicylic-acid-mediated immune response through calmodulin, AtSR1 (also known as CAMTA3), a Ca2+/calmodulin-binding transcription factor, and EDS1, an established regulator of salicylic acid level. Constitutive disease resistance and elevated levels of salicylic acid in loss-of-function alleles of Arabidopsis AtSR1 suggest that AtSR1 is a negative regulator of plant immunity. This was confirmed by epistasis analysis with mutants of compromised salicylic acid accumulation and disease resistance. We show that AtSR1 interacts with the promoter of EDS1 and represses its expression. Furthermore, Ca2+/calmodulin-binding to AtSR1 is required for suppression of plant defence, indicating a direct role for Ca2+/calmodulin in regulating the function of AtSR1. These results reveal a previously unknown regulatory mechanism linking Ca2+ signalling to salicylic acid level.	[Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA; [Du, Liqun; Simons, Kayla A.; Yang, Tianbao; Poovaiah, B. W.] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Hou, Jingguo] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Ali, Gul S.; Reddy, A. S. N.] Colorado State Univ, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Washington State University; Washington State University; Washington State University; Colorado State University; Colorado State University	Poovaiah, BW (corresponding author), Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA.	poovaiah@wsu.edu			United States Department of Agriculture [2002-00741, 2005-01107, 2008-01034]; National Science Foundation [MCB-0424898, MCB-0424895, DBI 0743097, IOS-0642146]; Colorado Sate University Academic Enrichment Program [180470]; Office of Naval Research [N0014-08-1-0470]; Washington State University Agricultural Research Center	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Colorado Sate University Academic Enrichment Program; Office of Naval Research(Office of Naval Research); Washington State University Agricultural Research Center	Constructs and transgenic lines produced in this research are available on request. This research was supported by United States Department of Agriculture grants 2002-00741, 2005-01107 and 2008-01034, National Science Foundation grants MCB-0424898, MCB-0424895, DBI 0743097 and IOS-0642146, Colorado Sate University Academic Enrichment Program grant 180470, Office of Naval Research N0014-08-1-0470 and the Washington State University Agricultural Research Center. We also thank I. Day for her comments on the manuscript and A. Mochel for her help in preparing the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Du LQ, 2005, NATURE, V437, P741, DOI 10.1038/nature03973; Du LQ, 2004, PLANT MOL BIOL, V54, P549, DOI 10.1023/B:PLAN.0000038269.98972.bb; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hernandez JM, 2007, P NATL ACAD SCI USA, V104, P17222, DOI 10.1073/pnas.0705629104; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xing DH, 2006, PLANT SCI, V171, P251, DOI 10.1016/j.plantsci.2006.03.022; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819	40	365	414	11	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1154	U116		10.1038/nature07612	http://dx.doi.org/10.1038/nature07612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19122675				2022-12-28	WOS:000263680100046
J	Reich, MR; Takemi, K				Reich, Michael R.; Takemi, Keizo			G8 and strengthening of health systems: follow-up to the Toyako summit	LANCET			English	Article; Proceedings Paper	International Conference on Global Action for Health System Strengthening	NOV 03-04, 2008	Tokyo, JAPAN				GLOBAL HEALTH; FOREIGN-POLICY; DIAGONAL APPROACH; TIME; STATISTICS	The 2008 G8 summit in Toyako, Japan, produced a strong commitment for collective action to strengthen health systems in developing countries, indicating Japan's leadership on, and the G8's increasing engagement with, global health policy. This paper describes the context for the G8's role in global health architecture and analyses three key components-financing, information, and the health workforce that affect the performance of health systems. We propose recommendations for actions by G8 leaders to strengthen health systems by making the most effective use of existing resources and increasing available resources. We recommend increased attention by G8 leaders to country capacity and country ownership in policy making and implementation. The G8 should also implement a yearly review for actions in this area, so that changes in health-system performance can be monitored and better understood.	[Reich, Michael R.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Takemi, Keizo] Tokai Univ, Res Inst Sci & Technol, Tokyo 151, Japan	Harvard University; Harvard T.H. Chan School of Public Health; Tokai University	Reich, MR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 677 Huntington Ave, Boston, MA 02115 USA.	michael_reich@harvard.edu						Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; [Anonymous], 2008, KAMP DECL AG GLOB AC; [Anonymous], 2004, HUM RES HLTH OV CRIS; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; BOERMA T, 2008, COMMON FRAMEWORK MON; Bossert T, 2007, ASSESSING FINANCING; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; Chan M, 2009, LANCET, V373, P1586, DOI 10.1016/S0140-6736(09)60003-9; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; Commission on Human Security, 2003, HUMAN SECURITY NOW P; Frenk J, 2009, LANCET, V373, P2181, DOI 10.1016/S0140-6736(09)60002-7; G8 Health Expert Group, 2008, TOYAK FRAM ACT GLOB; Gottret P. E., 2006, HLTH FINANCING REVIS; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; KIRTON JJ, 2005, C GLOB HLTH GOV PRAC; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Lopez AD, 2007, LANCET, V370, P1744, DOI 10.1016/S0140-6736(07)61419-6; Mills A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P87; *MIN FOR AFF JAP, 1980, SUMM HOKK TOYAK SUMM; MITNICK J, 2008, CHRISTIAN SCI M 1015, P4; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; NAIMOLI JF, 2008, INT J HEALTH PLAN MA, V21, P1; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; R Atun, 2008, WHEN DO VERTICAL STA; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Roberts MJ., 2004, GETTING HLTH REFORM; *SEL COMM INT ORG, 2008, 1431 HL AUTH HOUS LO; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shibuya K, 2008, LANCET, V371, P789, DOI 10.1016/S0140-6736(08)60356-6; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; *WHO, 2007, TECHN M PROV HLTH IN; *WHO, 2007, INF M GLOB HLTH LEAD; WHO, 2008, PHARMAFORUM 0121; WHO, 2007, EV BUS STRENGTH HLTH; *WHO UNICEF, 1978, PRIM HLTH CAR REP IN; World Bank, 2007, HEALTHY DEVELOPMENT: THE WORLD BANK STRATEGY FOR HEALTH, NUTRITION, AND POPULATION RESULTS, P1, DOI 10.1596/978-0-8213-7193-0; World Health Organization, 2005, HLTH MILL DEV GOALS; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2007, WORLD HLTH REP 2007; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	45	58	61	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					508	515		10.1016/S0140-6736(08)61899-1	http://dx.doi.org/10.1016/S0140-6736(08)61899-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	404EF	19150128				2022-12-28	WOS:000263132800034
J	MacFarlane, R				MacFarlane, Ross			Tabloid	LANCET			English	Editorial Material									[MacFarlane, Ross] Wellcome Lib, London NW1 2BE, England		MacFarlane, R (corresponding author), Wellcome Lib, London NW1 2BE, England.	r.macfarlane@wellcome.ac.uk							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					205	205		10.1016/S0140-6736(09)60060-X	http://dx.doi.org/10.1016/S0140-6736(09)60060-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19150694				2022-12-28	WOS:000262537500013
J	Lee, SSJ; Mudaliar, A				Lee, Sandra Soo-Jin; Mudaliar, Ashwin			MEDICINE Racing Forward: The Genomics and Personalized Medicine Act	SCIENCE			English	Editorial Material							RACE; GENETICS		[Lee, Sandra Soo-Jin; Mudaliar, Ashwin] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA	Stanford University	Lee, SSJ (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA.	sandra.lee@stanford.edu		Lee, Sandra Soo-Jin/0000-0002-2312-9814	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389, K01HG002883] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003389, K01 HG002883, K01 HG002883-05] Funding Source: Medline; NHLBI NIH HHS [K01 HL72465] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; *KAIS FAM FDN, 2008, TOD TOP HLTH DISP RA; Lee SSJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-404; Lee SSJ, 2005, AM J PUBLIC HEALTH, V95, P2133, DOI 10.2105/AJPH.2005.068676; *PHARM RES MAN ASS, 2007, MED DEV MAJ DIS AFF; Rotimi CN, 2004, NAT GENET, V36, pS43, DOI 10.1038/ng1439; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; Yancy CW, 2008, CURR HYPERTENS REP, V10, P276, DOI 10.1007/s11906-008-0052-8	8	23	25	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					342	342		10.1126/science.1165768	http://dx.doi.org/10.1126/science.1165768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150830	Green Accepted			2022-12-28	WOS:000262481400022
J	King, EM; Stellmach, S; Noir, J; Hansen, U; Aurnou, JM				King, Eric M.; Stellmach, Stephan; Noir, Jerome; Hansen, Ulrich; Aurnou, Jonathan M.			Boundary layer control of rotating convection systems	NATURE			English	Article							RAYLEIGH-BENARD CONVECTION; SPHERICAL-SHELLS; PRANDTL NUMBER; THERMAL TURBULENCE; HEAT-TRANSFER; ZONAL FLOW; DRIVEN; DYNAMOS; MODEL; TEMPERATURE	Turbulent rotating convection controls many observed features of stars and planets, such as magnetic fields, atmospheric jets and emitted heat flux patterns(1-6). It has long been argued that the influence of rotation on turbulent convection dynamics is governed by the ratio of the relevant global- scale forces: the Coriolis force and the buoyancy force(7-12). Here, however, we present results from laboratory and numerical experiments which exhibit transitions between rotationally dominated and non- rotating behaviour that are not determined by this global force balance. Instead, the transition is controlled by the relative thicknesses of the thermal ( nonrotating) and Ekman ( rotating) boundary layers. We formulate a predictive description of the transition between the two regimes on the basis of the competition between these two boundary layers. This transition scaling theory unifies the disparate results of an extensive array of previous experiments(8-15), and is broadly applicable to natural convection systems.	[King, Eric M.; Noir, Jerome; Aurnou, Jonathan M.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Stellmach, Stephan; Hansen, Ulrich] Univ Munster, Inst Geophys, D-48149 Munster, Germany	University of California System; University of California Los Angeles; University of Munster	King, EM (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	eric.king@ucla.edu	King, Eric M/A-2274-2009; Noir, jerome/AAD-1022-2019	Noir, jerome/0000-0001-9977-0360	US National Science Foundation Earth Sciences Division Geophysics Program; NASA Planetary Atmospheres Program; German Research Foundation; NASA Solar and Heliospheric Physics Program	US National Science Foundation Earth Sciences Division Geophysics Program(National Science Foundation (NSF)); NASA Planetary Atmospheres Program(National Aeronautics & Space Administration (NASA)); German Research Foundation(German Research Foundation (DFG)); NASA Solar and Heliospheric Physics Program(National Aeronautics & Space Administration (NASA))	Salary support for E.M.K., J.N. and J.M.A. was provided by the US National Science Foundation Earth Sciences Division Geophysics Program and the NASA Planetary Atmospheres Program. Support for S.S. and U.H. was provided by the German Research Foundation and for S.S. by the NASA Solar and Heliospheric Physics Program. Support for laboratory experiment fabrication was provided by the US National Science Foundation Instrumentation & Facilities Program. Computational resources were provided by the John von Neumann-Institut fur Computing. E.M.K., J.N. and J.M.A. would like to thank J. Frydman, J. Neal, A. Yaghmaei and R.M. Aurnou for engineering support in experimental development. E.M.K. and J.M.A. would like to thank H.T. Rossby for making his thesis data available to them, J. McWilliams for discussion and S.R. Dickman for introducing them to geophysics.	Aurnou JM, 2007, GEOPHYS ASTRO FLUID, V101, P327, DOI 10.1080/03091920701472568; Aurnou J, 2008, GEOPHYS J INT, V173, P793, DOI 10.1111/j.1365-246X.2008.03764.x; Aurnou J, 2007, ICARUS, V190, P110, DOI 10.1016/j.icarus.2007.02.024; BELMONTE A, 1994, PHYS REV E, V50, P269, DOI 10.1103/PhysRevE.50.269; BOUBNOV BM, 1990, J FLUID MECH, V219, P215, DOI 10.1017/S0022112090002920; Busse FH, 2002, PHYS FLUIDS, V14, P1301, DOI 10.1063/1.1455626; CHANDRASEKHAR S, 1953, PROC R SOC LON SER-A, V217, P306, DOI 10.1098/rspa.1953.0065; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2002, J FLUID MECH, V470, P115, DOI 10.1017/S0022112002002008; Gilman P.A., 1977, GEOPHYS ASTRO FLUID, V8, P93, DOI [10.1080/03091927708240373, DOI 10.1080/03091927708240373]; Glazier JA, 1999, NATURE, V398, P307, DOI 10.1038/18626; Greenspan H. P., 1968, THEORY ROTATING FLUI; HATHAWAY DH, 1984, ASTROPHYS J, V276, P316, DOI 10.1086/161615; Heimpel M, 2005, NATURE, V438, P193, DOI 10.1038/nature04208; HIGNETT P, 1981, J FLUID MECH, V109, P161, DOI 10.1017/S0022112081000992; Julien K, 1996, PHYS REV E, V53, pR5557, DOI 10.1103/PhysRevE.53.R5557; Julien K, 1996, J FLUID MECH, V322, P243, DOI 10.1017/S0022112096002789; Kunnen RPJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056306; Kutzner C, 2002, PHYS EARTH PLANET IN, V131, P29, DOI 10.1016/S0031-9201(02)00016-X; Liu YM, 1997, PHYS REV LETT, V79, P2257, DOI 10.1103/PhysRevLett.79.2257; Nimmo F, 2004, GEOPHYS J INT, V156, P363, DOI 10.1111/j.1365-246X.2003.02157.x; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Read PL, 2001, SURV GEOPHYS, V22, P265, DOI 10.1023/A:1013790802740; ROSSBY HT, 1969, J FLUID MECH, V36, P309, DOI 10.1017/S0022112069001674; Schmalzl J, 2002, GEOPHYS ASTRO FLUID, V96, P381, DOI 10.1080/0309192021000049929; SPIEGEL EA, 1971, ANNU REV ASTRON ASTR, V9, P323, DOI 10.1146/annurev.aa.09.090171.001543; Takeshita T, 1996, PHYS REV LETT, V76, P1465, DOI 10.1103/PhysRevLett.76.1465; Tilgner A, 1996, PHYS REV E, V53, P4847, DOI 10.1103/PhysRevE.53.4847; Verzicco R, 1999, J FLUID MECH, V383, P55, DOI 10.1017/S0022112098003619	30	154	157	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 15	2009	457	7227					301	304		10.1038/nature07647	http://dx.doi.org/10.1038/nature07647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148097	Green Published			2022-12-28	WOS:000262440900036
J	Tonino, PAL; De Bruyne, B; Pijls, NHJ; Siebert, U; Ikeno, F; van 't Veer, M; Klauss, V; Manoharan, G; Engstrom, T; Oldroyd, KG; Lee, PNV; MacCarthy, PA; Fearon, WF				Tonino, Pim A. L.; De Bruyne, Bernard; Pijls, Nico H. J.; Siebert, Uwe; Ikeno, Fumiaki; van 't Veer, Marcel; Klauss, Volker; Manoharan, Ganesh; Engstrom, Thomas; Oldroyd, Keith G.; Lee, Peter N. Ver; MacCarthy, Philip A.; Fearon, William F.		FAME Study Investigators	Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PACLITAXEL-ELUTING STENTS; OPTIMAL MEDICAL THERAPY; CLINICAL-OUTCOMES; ARTERY-DISEASE; FOLLOW-UP; REVASCULARIZATION; STENOSIS; CARDIOLOGY; RATIONALE; PERFUSION	Background In patients with multivessel coronary artery disease who are undergoing percutaneous coronary intervention ( PCI), coronary angiography is the standard method for guiding the placement of the stent. It is unclear whether routine measurement of fractional flow reserve ( FFR; the ratio of maximal blood flow in a stenotic artery to normal maximal flow), in addition to angiography, improves outcomes. Methods In 20 medical centers in the United States and Europe, we randomly assigned 1005 patients with multivessel coronary artery disease to undergo PCI with implantation of drug- eluting stents guided by angiography alone or guided by FFR measurements in addition to angiography. Before randomization, lesions requiring PCI were identified on the basis of their angiographic appearance. Patients assigned to angiography- guided PCI underwent stenting of all indicated lesions, whereas those assigned to FFR- guided PCI underwent stenting of indicated lesions only if the FFR was 0.80 or less. The primary end point was the rate of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. Results The mean (+/- SD) number of indicated lesions per patient was 2.7+/- 0.9 in the angiography group and 2.8+/- 1.0 in the FFR group ( P = 0.34). The number of stents used per patient was 2.7+/- 1.2 and 1.9+/- 1.3, respectively ( P< 0.001). The 1- year event rate was 18.3% ( 91 patients) in the angiography group and 13.2% ( 67 patients) in the FFR group ( P = 0.02). Seventy- eight percent of the patients in the angiography group were free from angina at 1 year, as compared with 81% of patients in the FFR group ( P = 0.20). Conclusions Routine measurement of FFR in patients with multivessel coronary artery disease who are undergoing PCI with drug- eluting stents significantly reduces the rate of the composite end point of death, nonfatal myocardial infarction, and repeat revascularization at 1 year. (ClinicalTrials.gov number, NCT00267774.).	[Tonino, Pim A. L.; Pijls, Nico H. J.; van 't Veer, Marcel] Catharina Hosp, Dept Cardiol, NL-5623 EJ Eindhoven, Netherlands; [De Bruyne, Bernard] Cardiovasc Ctr Aalst, Aalst, Belgium; [Siebert, Uwe] Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria; [Siebert, Uwe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Ikeno, Fumiaki; Fearon, William F.] Palo Alto Vet Affairs Hlth Care Syst, Stanford, CA USA; [Klauss, Volker] Univ Hosp Munich, Med Poliklin, Munich, Germany; [Manoharan, Ganesh] Royal Victoria Hosp, Ctr Heart, Belfast BT12 6BA, Antrim, North Ireland; [Engstrom, Thomas] Rigshosp, DK-2100 Copenhagen, Denmark; [Oldroyd, Keith G.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland; [Lee, Peter N. Ver] NE Cardiol Assoc, Bangor, ME USA; [MacCarthy, Philip A.] Kings Coll Hosp London, London, England	Catharina Hospital; Cardiovascular Center Aalst; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Munich; Rigshospitalet; University of Copenhagen; University of Glasgow; King's College Hospital NHS Foundation Trust; King's College Hospital	Pijls, NHJ (corresponding author), Catharina Hosp, Dept Cardiol, Michelangelolaan 2, NL-5623 EJ Eindhoven, Netherlands.	nico.pijls@inter.nl.net	Nightingale, Angus/O-5205-2019; Oldroyd, Keith G/C-2281-2014; Siebert, Uwe/M-5057-2019	Nightingale, Angus/0000-0001-9435-726X; Oldroyd, Keith G/0000-0002-7842-3463; Siebert, Uwe/0000-0001-6425-7671; Engstrom, Thomas/0000-0001-5436-9194; Wijns, William/0000-0002-7267-4376; Barbato, Emanuele/0000-0002-0050-5178; IKENO, FUMIAKI/0000-0003-2905-0311; Baumbach, Andreas/0000-0001-7707-2254; Saunamaki, Kari/0000-0001-5953-5243	Radi Medical Systems; Stichting Vrienden van het Hart Zuidoost Brabant; Medtronic; Catharina Hospital Eindhoven from Radi Medical Systems; Nycomed Denmark; Boston Scientific; Cordis; Abbott Vascular	Radi Medical Systems; Stichting Vrienden van het Hart Zuidoost Brabant; Medtronic(Medtronic); Catharina Hospital Eindhoven from Radi Medical Systems; Nycomed Denmark; Boston Scientific(Boston Scientific); Cordis; Abbott Vascular(Abbott Laboratories)	Supported by unrestricted research grants from Radi Medical Systems and Stichting Vrienden van het Hart Zuidoost Brabant. Medtronic provided limited financial support to some centers by tailoring the price of the Endeavor stents to the local reimbursement system.; Dr. Pijls reports receiving an institutional research grant for the Catharina Hospital Eindhoven from Radi Medical Systems; Dr. Engstrom, lecture fees from Nycomed Denmark; Dr. Oldroyd, consulting fees from Radi Medical Systems, Boston Scientific, and Cordis and lecture fees and grant support from Boston Scientific; Dr. Ver Lee, lecture fees from Radi Medical Systems; and Dr. Fearon, consulting fees from Abbott Vascular. No other potential conflict of interest relevant to this article was reported.	Beller GA, 2000, CIRCULATION, V101, P1465, DOI 10.1161/01.CIR.101.12.1465; Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; De Bruyne B, 2001, CIRCULATION, V104, P157, DOI 10.1161/01.CIR.104.2.157; Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985; Fearon WF, 2007, AM HEART J, V154, P1243, DOI 10.1016/j.ahj.2007.10.035; Fearon WF, 2007, AM HEART J, V154, P632, DOI 10.1016/j.ahj.2007.06.012; Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hannan EL, 2006, CIRCULATION, V113, P2406, DOI 10.1161/CIRCULATIONAHA.106.612267; Kaiser C, 2005, LANCET, V366, P2086; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819; Legalery P, 2005, EUR HEART J, V26, P2623, DOI 10.1093/eurheartj/ehi484; Lima RSL, 2003, J AM COLL CARDIOL, V42, P64, DOI 10.1016/S0735-1097(03)00562-X; Moses JW, 2006, J AM COLL CARDIOL, V47, P2164, DOI 10.1016/j.jacc.2006.01.068; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Ong ATL, 2006, J AM COLL CARDIOL, V47, P1356, DOI 10.1016/j.jacc.2005.05.102; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Pijls NHJ, 2004, HEART, V90, P1085, DOI 10.1136/hrt.2003.032151; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Sianos Georgios, 2005, EuroIntervention, V1, P219; Stankovic G, 2006, AM J CARDIOL, V98, P362, DOI 10.1016/j.amjcard.2006.01.104; Tanimoto S, 2007, CATHETER CARDIO INTE, V69, P94, DOI 10.1002/ccd.20907; Teirstein PS, 2006, CIRCULATION, V113, P2380, DOI 10.1161/CIRCULATIONAHA.106.623140; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; Wongpraparut N, 2005, AM J CARDIOL, V96, P877, DOI 10.1016/j.amjcard.2005.05.040	39	2744	2917	6	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					213	224		10.1056/NEJMoa0807611	http://dx.doi.org/10.1056/NEJMoa0807611			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394GR	19144937	Bronze			2022-12-28	WOS:000262434500004
J	Tita, ATN; Landon, MB; Spong, CY; Lai, YL; Leveno, KJ; Varner, MW; Moawad, AH; Caritis, SN; Meis, PJ; Wapner, RJ; Sorokin, Y; Miodovnik, M; Carpenter, M; Peaceman, AM; O'Sullivan, MJ; Sibai, BM; Langer, O; Thorp, JM; Ramin, SM; Mercer, BM				Tita, Alan T. N.; Landon, Mark B.; Spong, Catherine Y.; Lai, Yinglei; Leveno, Kenneth J.; Varner, Michael W.; Moawad, Atef H.; Caritis, Steve N.; Meis, Paul J.; Wapner, Ronald J.; Sorokin, Yoram; Miodovnik, Menachem; Carpenter, Marshall; Peaceman, Alan M.; O'Sullivan, Mary J.; Sibai, Baha M.; Langer, Oded; Thorp, John M.; Ramin, Susan M.; Mercer, Brian M.		Eunice Kennedy Shriver NICHD	Timing of Elective Repeat Cesarean Delivery at Term and Neonatal Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY MORBIDITY; SECTION; RISK; LABOR; STILLBIRTH; INFANTS; TRIAL; MODE	Background Because of increased rates of respiratory complications, elective cesarean delivery is discouraged before 39 weeks of gestation unless there is evidence of fetal lung maturity. We assessed associations between elective cesarean delivery at term ( 37 weeks of gestation or longer) but before 39 weeks of gestation and neonatal outcomes. Methods We studied a cohort of consecutive patients undergoing repeat cesarean sections performed at 19 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal - Fetal Medicine Units Network from 1999 through 2002. Women with viable singleton pregnancies delivered electively ( i. e., before the onset of labor and without any recognized indications for delivery before 39 weeks of gestation) were included. The primary outcome was the composite of neonatal death and any of several adverse events, including respiratory complications, treated hypoglycemia, newborn sepsis, and admission to the neonatal intensive care unit ( ICU). Results Of 24,077 repeat cesarean deliveries at term, 13,258 were performed electively; of these, 35.8% were performed before 39 completed weeks of gestation ( 6.3% at 37 weeks and 29.5% at 38 weeks) and 49.1% at 39 weeks of gestation. One neonatal death occurred. As compared with births at 39 weeks, births at 37 weeks and at 38 weeks were associated with an increased risk of the primary outcome ( adjusted odds ratio for births at 37 weeks, 2.1; 95% confidence interval [ CI], 1.7 to 2.5; adjusted odds ratio for births at 38 weeks, 1.5; 95% CI, 1.3 to 1.7; P for trend < 0.001). The rates of adverse respiratory outcomes, mechanical ventilation, newborn sepsis, hypoglycemia, admission to the neonatal ICU, and hospitalization for 5 days or more were increased by a factor of 1.8 to 4.2 for births at 37 weeks and 1.3 to 2.1 for births at 38 weeks. Conclusions Elective repeat cesarean delivery before 39 weeks of gestation is common and is associated with respiratory and other adverse neonatal outcomes.	[Tita, Alan T. N.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, Birmingham, AL 35249 USA; [Landon, Mark B.] Ohio State Univ, Columbus, OH 43210 USA; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Lai, Yinglei] George Washington Univ, Ctr Biostat, Washington, DC USA; [Leveno, Kenneth J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Varner, Michael W.] Univ Utah, Salt Lake City, UT USA; [Moawad, Atef H.] Univ Chicago, Chicago, IL 60637 USA; [Caritis, Steve N.] Univ Pittsburgh, Pittsburgh, PA USA; [Meis, Paul J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Wapner, Ronald J.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Sorokin, Yoram] Wayne State Univ, Detroit, MI USA; [Miodovnik, Menachem] Univ Cincinnati, Cincinnati, OH USA; [Miodovnik, Menachem] Columbia Univ, New York, NY USA; [Carpenter, Marshall] Brown Univ, Providence, RI 02912 USA; [Peaceman, Alan M.] Northwestern Univ, Chicago, IL 60611 USA; [O'Sullivan, Mary J.] Univ Miami, Miami, FL USA; [Sibai, Baha M.] Univ Tennessee, Memphis, TN USA; [Langer, Oded] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Thorp, John M.] Univ N Carolina, Chapel Hill, NC USA; [Ramin, Susan M.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX USA; [Mercer, Brian M.] Case Western Reserve Univ, Cleveland, OH 44106 USA	University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utah System of Higher Education; University of Utah; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center; Jefferson University; Wayne State University; University System of Ohio; University of Cincinnati; Columbia University; Brown University; Northwestern University; University of Miami; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Health San Antonio; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; Case Western Reserve University	Tita, ATN (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, 619 19th St S, Birmingham, AL 35249 USA.	alan.tita@obgyn.uab.edu	; Varner, Michael/K-9890-2013	caritis, steve/0000-0002-2169-0712; Peaceman, Alan/0000-0002-4515-4850; Varner, Michael/0000-0001-9455-3973; Tita, Alan/0000-0002-7244-9056	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD034116, U10HD040560, UG1HD027915, U10HD040500, UG1HD034208, UG1HD027869, U10HD027917, U10HD040512, U10HD034208, UG1HD034116, U10HD027869, U10HD040485, UG1HD040545, K12HD001258, UG1HD040560, UG1HD040485, UG1HD040544, UG1HD040500, U10HD036801, UG1HD040512, U10HD040545, U10HD040544, U10HD021410, R24HD050924, U10HD027915] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021414, U01HD021410, U01HD021414, U10HD027861, U10HD034122, U01HD036801, U10HD034210, U10HD027905, U10HD034136, U10HD027860] Funding Source: NIH RePORTER; NICHD NIH HHS [UG1 HD034208, UG1 HD040512, HD40545, U10 HD034116, HD34210, HD21410, U10 HD027869, U10 HD027917, HD34116, U10 HD034122, U10 HD027915, UG1 HD040545, UG1 HD040485, U10 HD027860, HD40500, U10 HD034208, K12 HD001258, HD34208, HD27915, UG1 HD040500, R24 HD050924, U10 HD040512, HD27917, U10 HD021410, U10 HD036801, U10 HD040545, HD40544, HD36801, UG1 HD027869, U10 HD040544, U10 HD034136, U10 HD040485, HD40485, HD40560, U10 HD040560, U10 HD027869-19, HD001258, U01 HD036801, U10 HD040500, HD27861, UG1 HD034116, HD27869, HD34136, UG1 HD040560, HD27860, UG1 HD027915, HD21414, U10 HD027905, HD40512, UG1 HD040544] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACOG, 2000, INT J GYNECOL OBSTET, V68, P165; *ACOG COMM OP, 1992, INT J GYNECOL OBSTET, V38, P327; Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P1501, DOI [DOI 10.1097/01.AOG.0000291577.01569.4C, 10.1097/01.AOG.0000291577.01569.4c]; American College of Obstetricians and Gynecologists, 2007, GUID PER CAR, V6; ANNIBALE DJ, 1995, ARCH PEDIAT ADOL MED, V149, P862, DOI 10.1001/archpedi.1995.02170210036006; BOWERS SK, 1982, AM J OBSTET GYNECOL, V143, P186, DOI 10.1016/0002-9378(82)90653-6; COHEN M, 1985, OBSTET GYNECOL, V65, P818; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; Graziosi G C, 1998, Ned Tijdschr Geneeskd, V142, P2300; Gregory KD, 1998, AM J PUBLIC HEALTH, V88, P1384, DOI 10.2105/AJPH.88.9.1384; HALES KA, 1993, INT J GYNECOL OBSTET, V43, P35, DOI 10.1016/0020-7292(93)90271-W; Hamilton BE, 2007, NATL VITAL STAT REP, V56, P1; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Hansen AK, 2007, ACTA OBSTET GYN SCAN, V86, P389, DOI 10.1080/00016340601159256; Hook B, 1997, PEDIATRICS, V100, P348, DOI 10.1542/peds.100.3.348; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Laye MR, 2006, AM J OBSTET GYNECOL, V195, P577, DOI 10.1016/j.ajog.2006.03.078; Levine EM, 2001, OBSTET GYNECOL, V97, P439, DOI 10.1016/S0029-7844(00)01150-9; MARTIN JA, 2002, NATL VITAL STAT REP, V52, P1; Meikle SF, 2005, OBSTET GYNECOL, V105, P751, DOI 10.1097/01.AOG.0000157435.67138.78; Menacker F, 2006, SEMIN PERINATOL, V30, P235, DOI 10.1053/j.semperi.2006.07.002; Menacker Fay, 2005, Natl Vital Stat Rep, V54, P1; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Richardson BS, 2005, AM J OBSTET GYNECOL, V192, P219, DOI 10.1016/j.ajog.2004.06.034; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Szklo M., 2019, EPIDEMIOLOGY BASICS, V4; van den Berg A, 2001, EUR J OBSTET GYN R B, V98, P9, DOI 10.1016/S0301-2115(01)00292-5; Wood SL, 2008, BJOG-INT J OBSTET GY, V115, P726, DOI 10.1111/j.1471-0528.2008.01705.x; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	30	576	610	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					111	U29		10.1056/NEJMoa0803267	http://dx.doi.org/10.1056/NEJMoa0803267			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391UG	19129525	Green Accepted			2022-12-28	WOS:000262258300004
J	Ainsworth, S; Jones, W				Ainsworth, Sean; Jones, Wendy			It sticks in our throats too	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ainsworth, Sean] Forth Pk Hosp, Kirkcaldy, Fife, Scotland; [Jones, Wendy] Breastfeeding Network, Paisley, Renfrew, Scotland		Ainsworth, S (corresponding author), Forth Pk Hosp, Kirkcaldy, Fife, Scotland.	sean.ainsworth@nhs.net						*DEP HLTH, NURS PRESCR FAQ; DEVRIES TW, 2006, NED TIDSCHR GENEESKD, V148, P1598; HEY E, 2007, NEONATAL FORMULARY, P158; Hoppe JE, 1997, PEDIATR INFECT DIS J, V16, P288, DOI 10.1097/00006454-199703000-00007; *JANSS CIL, DAKT OR GEL; *MED HEALTHC PROD, OUR MISS VAL	6	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2009	338								a3178	10.1136/bmj.a3178	http://dx.doi.org/10.1136/bmj.a3178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PM	19124549				2022-12-28	WOS:000263165500004
J	Sheather, J				Sheather, Julian			Landscape and health	LANCET			English	Editorial Material									[Sheather, Julian] British Med Assoc, London WC1H 9JP, England		Sheather, J (corresponding author), British Med Assoc, London WC1H 9JP, England.	JSheather@bma.org.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					22	23		10.1016/S0140-6736(08)61943-1	http://dx.doi.org/10.1016/S0140-6736(08)61943-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19125445				2022-12-28	WOS:000262183800014
J	Whitney, HM; Kolle, M; Andrew, P; Chittka, L; Steiner, U; Glover, BJ				Whitney, Heather M.; Kolle, Mathias; Andrew, Piers; Chittka, Lars; Steiner, Ullrich; Glover, Beverley J.			Floral Iridescence, Produced by Diffractive Optics, Acts As a Cue for Animal Pollinators	SCIENCE			English	Article							ULTRAVIOLET SIGNAL; COLIAS-EURYTHEME; FLOWER COLOR; CELL-SHAPE; BUMBLEBEES; LIGHT; FLUORESCENCE; PREFERENCES; ANTIRRHINUM; BUTTERFLIES	Iridescence, the change in hue of a surface with varying observation angles, is used by insects, birds, fish, and reptiles for species recognition and mate selection. We identified iridescence in flowers of Hibiscus trionum and Tulipa species and demonstrated that iridescence is generated through diffraction gratings that might be widespread among flowering plants. Although iridescence might be expected to increase attractiveness, it might also compromise target identification because the object's appearance will vary depending on the viewer's perspective. We found that bumblebees (Bombus terrestris) learn to disentangle flower iridescence from color and correctly identify iridescent flowers despite their continuously changing appearance. This ability is retained in the absence of cues from polarized light or ultraviolet reflectance associated with diffraction gratings.	[Kolle, Mathias; Steiner, Ullrich] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Whitney, Heather M.; Glover, Beverley J.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Kolle, Mathias; Andrew, Piers; Steiner, Ullrich] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0HE, England; [Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Cambridge; University of Cambridge; University of Cambridge; University of London; Queen Mary University London	Steiner, U (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	u.steiner@phy.cam.ac.uk; bjg26@cam.ac.uk	Andrew, Piers/F-8188-2013; Chittka, Lars/C-3110-2012; Steiner, Ullrich/K-4777-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Kolle, Mathias/E-3313-2013	Andrew, Piers/0000-0001-5601-5322; Chittka, Lars/0000-0001-8153-1732; Steiner, Ullrich/0000-0001-5936-339X; Kolle, Mathias/0000-0001-7395-8824	Natural Environment Research Council [NE/C000552/1]; Engineering and Physical Sciences Research Council [EP/D040884/1]; European RTN-6 Network Patterns; Cambridge University Research Exchange; German Academic Exchange Service DAAD; EPSRC [EP/D040884/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European RTN-6 Network Patterns; Cambridge University Research Exchange(University of Cambridge); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Rands, P. Rudall, R. Bateman, P. Cicuta, and J. Baumberg for discussions and Syngenta for bees. Funded by Natural Environment Research Council grant NE/C000552/1, Engineering and Physical Sciences Research Council grant EP/D040884/1, the European RTN-6 Network Patterns, the Cambridge University Research Exchange, and German Academic Exchange Service DAAD.	CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gorton HL, 1996, PLANT PHYSIOL, V112, P879, DOI 10.1104/pp.112.3.879; GREEN PB, 1990, PROTOPLASMA, V158, P33, DOI 10.1007/BF01323271; HEBANT C, 1984, AM J BOT, V71, P216, DOI 10.2307/2443748; Heuschen B, 2005, PLANT SYST EVOL, V252, P121, DOI 10.1007/s00606-004-0249-5; JOKIEL PL, 1984, LIMNOL OCEANOGR, V29, P192, DOI 10.4319/lo.1984.29.1.0192; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Kemp DJ, 2007, P R SOC B, V274, P1043, DOI 10.1098/rspb.2006.0043; KETTLER JE, 1991, AM J PHYS, V59, P367, DOI 10.1119/1.16553; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1976, SCIENCE, V194, P341, DOI 10.1126/science.194.4262.341; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Kevan PG, 2001, J EXP BIOL, V204, P2571; Morehouse NI, 2007, P ROY SOC B-BIOL SCI, V274, P359, DOI 10.1098/rspb.2006.3730; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Palmer CA, 2005, DIFFRACTION GRATING; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Parker AR, 2003, J OPT A-PURE APPL OP, V5, pS111, DOI 10.1088/1464-4258/5/4/364; Prum RO, 2006, BIRD COLORATION, V1, P295; Rutowski RL, 2005, P ROY SOC B-BIOL SCI, V272, P2329, DOI 10.1098/rspb.2005.3216; Rutowski RL, 2007, BIOL J LINN SOC, V90, P349, DOI 10.1111/j.1095-8312.2007.00749.x; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Sweeney A, 2003, NATURE, V423, P31, DOI 10.1038/423031a; THORP RW, 1975, SCIENCE, V189, P476, DOI 10.1126/science.189.4201.476; VOGELMANN TC, 1993, ANNU REV PLANT PHYS, V44, P231, DOI 10.1146/annurev.pp.44.060193.001311; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9	30	263	277	12	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					130	133		10.1126/science.1166256	http://dx.doi.org/10.1126/science.1166256			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119235				2022-12-28	WOS:000262104100058
J	Clare, DK; Bakkes, PJ; van Heerikhuizen, H; van der Vies, SM; Saibil, HR				Clare, D. K.; Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.; Saibil, H. R.			Chaperonin complex with a newly folded protein encapsulated in the folding chamber	NATURE			English	Article							GROEL-GROES; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CENTRAL CAVITY; HEAD PROTEIN; BINDING; CAGE; ATP	A subset of essential cellular proteins requires the assistance of chaperonins (in Escherichia coli, GroEL and GroES), double-ring complexes in which the two rings act alternately to bind, encapsulate and fold a wide range of nascent or stress- denatured proteins(1-5). This process starts by the trapping of a substrate protein on hydrophobic surfaces in the central cavity of a GroEL ring(6-10). Then, binding of ATP and co- chaperonin GroES to that ring ejects the non- native protein from its binding sites, through forced unfolding or other major conformational changes, and encloses it in a hydrophilic chamber for folding(11-15). ATP hydrolysis and subsequent ATP binding to the opposite ring trigger dissociation of the chamber and release of the substrate protein(3). The bacteriophage T4 requires its own version of GroES, gp31, which forms a taller folding chamber, to fold the major viral capsid protein gp23 ( refs 16-20). Polypeptides are known to fold inside the chaperonin complex, but the conformation of an encapsulated protein has not previously been visualized. Here we present structures of gp23-chaperonin complexes, showing both the initial captured state and the final, close-to-native state with gp23 encapsulated in the folding chamber. Although the chamber is expanded, it is still barely large enough to contain the elongated gp23 monomer, explaining why the GroEL-GroES complex is not able to fold gp23 and showing how the chaperonin structure distorts to enclose a large, physiological substrate protein.	[Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Clare, D. K.; Saibil, H. R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Bakkes, P. J.; van Heerikhuizen, H.; van der Vies, S. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	University of London; Birkbeck University London; University of London; Birkbeck University London; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Saibil, HR (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.	vdvies@vumc.nl; h.saibil@mail.cryst.bbk.ac.uk		Bakkes, Patrick/0000-0003-1876-7384; Clare, daniel/0000-0002-3372-8378	Wellcome Trust programme; EU 3D EM Network of Excellence; 3D Repertoire	Wellcome Trust programme(Wellcome Trust); EU 3D EM Network of Excellence(European Commission); 3D Repertoire	We thank R. Westlake, D. Houldershaw and L. Wang for computing and EM support. This work was carried out at the School of Crystallography, Birkbeck College, and was supported by a Wellcome Trust programme grant, EU 3D EM Network of Excellence and 3D Repertoire grants.	Bakkes PJ, 2005, P NATL ACAD SCI USA, V102, P8144, DOI 10.1073/pnas.0500048102; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Clare DK, 2006, J MOL BIOL, V358, P905, DOI 10.1016/j.jmb.2006.02.033; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Snyder L, 2005, J MOL BIOL, V345, P375, DOI 10.1016/j.jmb.2004.10.052; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; van Duijn E, 2006, J AM CHEM SOC, V128, P4694, DOI 10.1021/ja056756l; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Van Duijn E, 2007, PROTEIN SCI, V16, P956, DOI 10.1110/ps.062713607; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	36	76	77	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					107	U113		10.1038/nature07479	http://dx.doi.org/10.1038/nature07479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122642	Green Accepted			2022-12-28	WOS:000262104900040
J	Beard, K				Beard, Keith			Commentary: The balance between marketing and safety	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Beard, Keith] Victoria Infirm, Glasgow G41 3DX, Lanark, Scotland		Beard, K (corresponding author), Victoria Infirm, Glasgow G41 3DX, Lanark, Scotland.	keith.beard@ggc.scot.nhs.uk						Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; *EUR COMM ENT IND, 2008, KEU ID LEG PROP INF; *EUR COMM ENT IND, 2008, RUL GOV MED PROD EUR; *I MED NAT AC, FUT DRUG SAF PROM PR; Kao DP, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2591; Layton D, 2006, DRUG SAFETY, V29, P687, DOI 10.2165/00002018-200629080-00005; *SCOTT MED CONS, 2007, ASS REP SIT; SMYTH RL, 1994, LANCET, V343, P85, DOI 10.1016/S0140-6736(94)90817-6; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862	10	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 24	2008	337								a2996	10.1136/bmj.a2996	http://dx.doi.org/10.1136/bmj.a2996			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394EO	19109322				2022-12-28	WOS:000262428700003
J	Raoult, D				Raoult, Didier			Creationism-remember the principle of falsifiability	LANCET			English	Editorial Material									[Raoult, Didier] Univ Aix Marseille 2, Fac Med, Marseille 05, France	UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), Univ Aix Marseille 2, Fac Med, Marseille 05, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Darwin C., 1877, ORIGIN SPECIES; Dawkins Richard, 1976, SELFISH GENE; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Popper K., 2002, LOGIC SCI DISCOVERY; Trivers R. L., 2006, GENES CONFLICT	6	3	4	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2095	2096		10.1016/S0140-6736(08)61904-2	http://dx.doi.org/10.1016/S0140-6736(08)61904-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386PB	19101368				2022-12-28	WOS:000261894000008
J	Chan, M				Chan, Margaret			Primary health care as a route to health security	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int						*AFR DEV BANK, 2008, GEND POV ENV IND AFR, V9; Cruz RV, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P469; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Freedman LP, 2005, WHOS GOT POWER TRANS; JACK A, 2007, FINANCIAL TIMES 0928; Maxwell D., 2000, URBAN LIVELIHOODS FO; Stern Nicholas, 2006, STERN REV EC CLIMATE; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; *WHO, 2008, MON ACH HLTH REL MIL; WHO, 2008, PHARMAFORUM 0121; World Health Organization, 2008, UN ACC SCAL PRIOR HI	11	23	24	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1586	1587		10.1016/S0140-6736(09)60003-9	http://dx.doi.org/10.1016/S0140-6736(09)60003-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	445QJ	19150127				2022-12-28	WOS:000266066300008
J	Feau, S; Schoenberger, SP				Feau, Sonia; Schoenberger, Stephen P.			IMMUNOLOGY Ex Uno Plura	SCIENCE			English	Editorial Material							T-CELL MEMORY; SECONDARY EXPANSION; EFFECTOR; PRECURSOR; HELP		[Feau, Sonia; Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Feau, S (corresponding author), La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA 92037 USA.	sps@liai.org			NCI NIH HHS [R01 CA081261-02, R01 CA081261-10, R01 CA081261] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081261] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	17	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					466	467		10.1126/SCIENCE.1169409	http://dx.doi.org/10.1126/SCIENCE.1169409			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164734	Green Accepted			2022-12-28	WOS:000262587900027
J	Jensen, GJ				Jensen, Grant J.			CELL BIOLOGY Protein Filaments Caught in the Act	SCIENCE			English	Editorial Material							BACTERIAL CYTOSKELETON; SEGREGATION		[Jensen, Grant J.] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Jensen, GJ (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	jensen@caltech.edu						Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Amos LA, 2004, CURR OPIN CELL BIOL, V16, P24, DOI 10.1016/j.ceb.2003.11.005; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Jensen GJ, 2007, CURR OPIN STRUC BIOL, V17, P260, DOI 10.1016/j.sbi.2007.03.002; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Margolin W, 1998, TRENDS MICROBIOL, V6, P233, DOI 10.1016/S0966-842X(98)01280-3; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Morris DM, 2008, ANNU REV BIOCHEM, V77, P583, DOI 10.1146/annurev.biochem.77.061206.173846; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346	13	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					472	473		10.1126/science.1169829	http://dx.doi.org/10.1126/science.1169829			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164739				2022-12-28	WOS:000262587900032
J	Jinnah, S; Jungcurt, S				Jinnah, Sikina; Jungcurt, Stefan			GLOBAL BIOLOGICAL RESOURCES Could Access Requirements Stifle Your Research?	SCIENCE			English	Editorial Material							GENETIC-RESOURCES; SCIENCE; PREDICAMENT		[Jinnah, Sikina] Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; [Jungcurt, Stefan] Int Inst Sustainable Dev, Winnipeg, MB R3B 0Y4, Canada	Brown University	Jinnah, S (corresponding author), Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA.	sikina_jinnah@brown.edu; stefan@iisd.org	Jungcurt, Stefan/AAI-9864-2020; Jinnah, Sikina/AAI-9231-2020	Jungcurt, Stefan/0000-0001-9520-613X; Jinnah, Sikina/0000-0003-4528-3000				Bawa KS, 2006, CURR SCI INDIA, V91, P1005; Check E, 2007, NATURE, V448, P634, DOI 10.1038/448634a; Cooper H. D., 2002, REV EUROPEAN COMMUNI, V11, P1, DOI DOI 10.1111/1467-9388.00298; Fowler C, 2004, GENET RESOUR CROP EV, V51, P609, DOI 10.1023/B:GRES.0000024646.81612.1f; Fowler C, 2002, SCIENCE, V297, P157, DOI 10.1126/science.297.5579.157; Gaillard J.F., 1994, KNOWL TECH POL, V7, P31, DOI [DOI 10.1007/BF02692761, https://doi.org/10.1007/BF02692761]; *INT I SUST DEV, 2007, EARTH NEG B, V398; *INT I SUST DEV, 2008, EARTH NEG B, V452; *INT I SUST DEV, 2008, EARTH NEG B, V416; Jayaraman KS, 2008, NATURE, V452, P7, DOI 10.1038/452007a; Jungcurt S., 2008, I INTERPLAY INT ENV; Madhusudan MD, 2006, CURR SCI INDIA, V91, P1015; MASOOD E, 2004, SCIDEVNET NEWS  0415; Pethiyagoda R, 2007, CURR SCI INDIA, V92, P426; Prathapan KD, 2008, CURR SCI INDIA, V94, P170; REVKIN A, 2002, NY TIMES        1203, pF1; Sauve R, 2003, AGR SYST, V78, P307, DOI 10.1016/S0308-521X(03)00131-8; ten Kate K, 2002, SCIENCE, V295, P2371, DOI 10.1126/science.1070725	18	33	35	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2009	323	5913					464	465		10.1126/science.1167234	http://dx.doi.org/10.1126/science.1167234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396JL	19164733				2022-12-28	WOS:000262587900026
J	Lenze, EJ; Rollman, BL; Shear, MK; Dew, MA; Pollock, BG; Ciliberti, C; Costantino, M; Snyder, S; Shi, PC; Spitznagel, E; Andreescu, C; Butters, MA; Reynolds, CF				Lenze, Eric J.; Rollman, Bruce L.; Shear, M. Katherine; Dew, Mary Amanda; Pollock, Bruce G.; Ciliberti, Caroline; Costantino, Michelle; Snyder, Sara; Shi, Peichang; Spitznagel, Edward; Andreescu, Carmen; Butters, Meryl A.; Reynolds, Charles F., III			Escitalopram for Older Adults With Generalized Anxiety Disorder A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN REUPTAKE INHIBITORS; BENZODIAZEPINE USE; MAJOR DEPRESSION; MENTAL-DISORDERS; PRIMARY-CARE; DOUBLE-BLIND; LIFE; RISK; IMPAIRMENT; THERAPY	Context Generalized anxiety disorder ( GAD) is one of the most common psychiatric disorders in older adults; however, few data exist to guide clinicians in efficacious and safe treatment. Selective serotonin reuptake inhibitors ( SSRIs) are efficacious for younger adults with GAD, but benefits and risks may be different in older adults. Objective To examine the efficacy, safety, and tolerability of the SSRI escitalopram in older adults with GAD. Design, Setting, and Participants A randomized controlled trial in primary care practices and related specialty clinics in Pittsburgh, Pennsylvania, of 177 participants aged 60 years or older with a principal diagnosis of GAD randomized to receive either escitalopram or placebo and conducted between January 2005 and January 2008. Interventions Twelve weeks of 10 to 20 mg/ d of escitalopram ( n= 85) or matching placebo ( n= 92). Main Outcome Measures Cumulative response defined by Clinical Global Impressions-Improvement score of much or very much improved; time to response; and anxiety and role functioning changes measured by the Clinical Global Impressions- Improvement scale, Hamilton Anxiety Rating Scale, Penn State Worry Questionnaire, Late- Life Function and Disability Instrument activity limitations subscale, and the role- emotional impairment and social function subscales of the Medical Outcome Survey 36- item Short Form. Results In the primary analytic strategy in which participants ( n= 33) were censored at the time of dropout, mean cumulative response rate for escitalopram was 69% ( 95% confidence interval [ CI], 58%- 80%) vs 51%( 95% CI, 40%- 62%) for placebo ( P=. 03). Aconservative intention- to- treat analysis showed no difference in mean cumulative response rate between escitalopram and placebo( 57%; 95% CI, 46%- 67%; vs 45%; 95% CI, 35%-55%; P=. 11). Participants treated with escitalopram showed greater improvement than with placebo in anxiety symptoms and role functioning ( Clinical Global Impressions Improvement scale: effect size, 0.93; 95% CI, 0.50- 1.36; P <. 001; Penn State Worry Questionnaire: 0.30; 95% CI, 0.23- 0.48; P=. 01; activity limitations: 0.32; 95% CI, 0.01- 0.63; P=. 04; and the role- emotional impairment and social function: 0.96; 95% CI, 0.03- 1.90; P=. 04). Adverse effects of escitalopram ( P <. 05 vs placebo) were fatigue or somnolence ( 35 patients [ 41.1%]), sleep disturbance ( 12 [ 14.1%]), and urinary symptoms ( 8 [ 9.4%]). Conclusions Older adults with GAD randomized to escitalopram had a higher cumulative response rate for improvement vs placebo over 12 weeks; however, response rates were not significantly different using an intention- to- treat analysis. Further study is required to assess efficacy and safety over longer treatment durations. Trial Registration clinicaltrials. gov Identifier: NCT00105586.	[Lenze, Eric J.; Shi, Peichang; Spitznagel, Edward] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Rollman, Bruce L.] Univ Pittsburgh, Dept Internal Med, Pittsburgh, PA USA; [Dew, Mary Amanda; Ciliberti, Caroline; Costantino, Michelle; Snyder, Sara; Andreescu, Carmen; Butters, Meryl A.; Reynolds, Charles F., III] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Shear, M. Katherine] Columbia Univ, Sch Social Work, New York, NY USA; [Pollock, Bruce G.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of Toronto	Lenze, EJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid,Box 8134, St Louis, MO 63110 USA.	lenzee@wustl.edu	Butters, Meryl/AAR-2863-2021; Lenze, Eric J/AAW-8652-2021; Andreescu, Carmen/J-2379-2016	Andreescu, Carmen/0000-0003-3767-5127; Lenze, Eric/0000-0002-0471-9368	National Institutes of Health [R01 MH070547]; Center for Mental Health Services Research [P30 MH068579]; Advanced Center for Interventions and Services Research in Late-Life Mood Disorders [P30 MH71944]; John A. Hartford Center of Excellence in Geriatric Psychiatry; University of Pittsburgh Medical Center; Forest Laboratories Inc; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072947, R01MH070547, P30MH068579, P30MH071944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Mental Health Services Research; Advanced Center for Interventions and Services Research in Late-Life Mood Disorders; John A. Hartford Center of Excellence in Geriatric Psychiatry; University of Pittsburgh Medical Center; Forest Laboratories Inc; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants R01 MH070547 from the National Institutes of Health, P30 MH068579 from the Center for Mental Health Services Research (Enola Proctor, PhD, principal investigator), and P30 MH71944 from the Advanced Center for Interventions and Services Research in Late-Life Mood Disorders (Dr Reynolds, principal investigator); the John A. Hartford Center of Excellence in Geriatric Psychiatry (Dr Reynolds, principal investigator); and the University of Pittsburgh Medical Center endowment in geriatric psychiatry (Dr Reynolds). Forest Laboratories Inc, which holds the US patent for escitalopram, provided escitalopram and matching placebo for the study.	Allgulander C, 2003, CNS SPECTR, V8, P53, DOI 10.1017/S1092852900006945; Andreescu C, 2007, BRIT J PSYCHIAT, V190, P344, DOI 10.1192/bjp.bp.106.027169; Beck JG, 1996, BEHAV RES THER, V34, P225, DOI 10.1016/0005-7967(95)00064-X; Beekman ATF, 1998, INT J GERIATR PSYCH, V13, P717, DOI 10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M; Benitez CIP, 2008, AM J GERIAT PSYCHIAT, V16, P5, DOI 10.1097/JGP.0b013e31815aff5c; Bose A, 2008, AM J GERIAT PSYCHIAT, V16, P14, DOI 10.1097/JGP.0b013e3181591c09; Caudle DD, 2007, AM J GERIAT PSYCHIAT, V15, P680, DOI 10.1097/JGP.0b013e31803c550d; Chen YHJ, 2006, J BIOPHARM STAT, V16, P313, DOI 10.1080/10543400600614791; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Davidson J, 2008, HUM PSYCHOPHARM CLIN, V23, P519, DOI 10.1002/hup.949; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Diefenbach GJ, 2003, BEHAV RES THER, V41, P481, DOI 10.1016/S0005-7967(02)00130-4; Endicott J, 2007, J CLIN PSYCHIAT, V68, P518, DOI 10.4088/JCP.v68n0405; Ettner SL, 1997, HEALTH CARE FINANC R, V18, P43; Fabian TJ, 2004, ARCH INTERN MED, V164, P327, DOI 10.1001/archinte.164.3.327; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GILLINGS D, 1991, DRUG INF J, V25, P411, DOI DOI 10.1177/009286159102500311; Goodman WK, 2005, J AFFECT DISORDERS, V87, P161, DOI 10.1016/j.jad.2004.11.011; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hanlon JT, 1998, CLIN PHARMACOL THER, V64, P684, DOI 10.1016/S0009-9236(98)90059-5; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Hidalgo RB, 2007, J PSYCHOPHARMACOL, V21, P864, DOI 10.1177/0269881107076996; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Katz IR, 2002, J AM GERIATR SOC, V50, P18, DOI 10.1046/j.1532-5415.2002.50003.x; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kessler RC, 2002, INT J METH PSYCH RES, V11, P99, DOI 10.1002/mpr.128; Kessler RC, 2001, PSYCHIAT CLIN N AM, V24, P19, DOI 10.1016/S0193-953X(05)70204-5; KOEPKE HH, 1982, PSYCHOSOMATICS, V23, P641; Lenze EJ, 2005, AM J PSYCHIAT, V162, P146, DOI 10.1176/appi.ajp.162.1.146; Mantella RC, 2007, AM J GERIAT PSYCHIAT, V15, P673, DOI 10.1097/JGP.0b013e31803111f2; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; POLLOCK BG, 2005, KAPLAN SADOCKS COMPR, P3716; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Rollman BL, 2008, J GEN INTERN MED, V23, P447, DOI 10.1007/s11606-007-0449-0; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Rynn MA, 2004, CNS SPECTRUMS, V9, P716, DOI 10.1017/S1092852900022367; Schuurmans J, 2006, AM J GERIAT PSYCHIAT, V14, P255, DOI 10.1097/01.JGP.0000196629.19634.00; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Stanley MA, 2003, J CONSULT CLIN PSYCH, V71, P309, DOI 10.1037/0022-006X.71.2.309; Steffens DC, 2005, AM J GERIAT PSYCHIAT, V13, P40; Swenson JR, 2006, CAN J PSYCHIAT, V51, P923, DOI 10.1177/070674370605101408; Tolin DF, 2005, AM J GERIAT PSYCHIAT, V13, P150; U.S. Department of Health Education and Welfare, 1976, US DHEW PUBL; Ware JE, 1993, SF36 HLTH SURVEY MAN; Wetherell JL, 2004, J PSYCHIAT RES, V38, P305, DOI 10.1016/j.jpsychires.2003.09.003; Whyte EM, 2004, DRUG AGING, V21, P531, DOI 10.2165/00002512-200421080-00004; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	55	79	83	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					295	303		10.1001/jama.2008.977	http://dx.doi.org/10.1001/jama.2008.977			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395IV	19155456	Green Accepted, Bronze			2022-12-28	WOS:000262518700020
J	Bredas, JL; Silbey, R				Bredas, Jean-Luc; Silbey, Robert			CHEMISTRY Excitons Surf Along Conjugated Polymer Chains	SCIENCE			English	Editorial Material							COHERENCE		[Bredas, Jean-Luc] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Bredas, Jean-Luc] Georgia Inst Technol, Ctr Organ Photon & Elect, Atlanta, GA 30332 USA; [Silbey, Robert] MIT, Dept Chem, Cambridge, MA 02139 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT)	Bredas, JL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	jean-luc.bredas@chemistry.gatech.edu; silbey@mit.edu	Bredas, Jean-Luc E/A-3431-2008	Bredas, Jean-Luc E/0000-0001-7278-4471				Bredas JL, 2004, CHEM REV, V104, P4971, DOI 10.1021/cr040084k; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Dubin F, 2006, NAT PHYS, V2, P32, DOI 10.1038/nphys196; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; SARICIFTCI NS, 1997, PRIMARY EXCITATIONS; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; SEBASTIAN L, 1981, PHYS REV LETT, V46, P1156, DOI 10.1103/PhysRevLett.46.1156; Sun S-S., 2005, ORGANIC PHOTOVOLTAIC; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339	9	54	54	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2009	323	5912					348	349		10.1126/science.1168821	http://dx.doi.org/10.1126/science.1168821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150835				2022-12-28	WOS:000262481400027
J	Morrow, TJ; Li, MW; Kim, J; Mayer, TS; Keating, CD				Morrow, Thomas J.; Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.; Keating, Christine D.			Programmed Assembly of DNA-Coated Nanowire Devices	SCIENCE			English	Article							ARRAYS; BOTTOM		[Li, Mingwei; Kim, Jaekyun; Mayer, Theresa S.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Morrow, Thomas J.; Keating, Christine D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mayer, TS (corresponding author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.	tsm2@psu.edu; keating@chem.psu.edu		Keating, Christine/0000-0001-6039-1961	NIH; NSF; Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Semiconductor Research Corporation-Nanoelectronics Research Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Supported by NIH, NSF, and Semiconductor Research Corporation-Nanoelectronics Research Initiative.	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Ho TT, 2008, NANO LETT, V8, P4359, DOI 10.1021/nl8022059; Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233; Li MW, 2008, NAT NANOTECHNOL, V3, P88, DOI 10.1038/nnano.2008.26; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640	6	99	105	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					352	352		10.1126/science.1165921	http://dx.doi.org/10.1126/science.1165921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150837	Green Accepted			2022-12-28	WOS:000262481400029
J	Hauser, W; Bernardy, K; Uceyler, N; Sommer, C				Haeuser, Winfried; Bernardy, Kathrin; Ueceyler, Nurcan; Sommer, Claudia			Treatment of Fibromyalgia Syndrome With Antidepressants A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; COCHRANE COLLABORATION; SYSTEMATIC REVIEWS; AMITRIPTYLINE; MANAGEMENT; PAROXETINE; EFFICACY; WOMEN	Context Fibromyalgia syndrome ( FMS) is a chronic pain disorder associated with multiple debilitating symptoms and high disease- related costs. Effective treatment options are needed. Objectives To determine the efficacy of antidepressants in the treatment of FMS by performing a meta- analysis of randomized controlled clinical trials. Data Sources MEDLINE, PsycINFO, Scopus, and the Cochrane Library databases were searched through August 2008. Reference sections of original studies, meta-analyses, and reviews on antidepressants in FMS were reviewed. Study Selection Randomized placebo- controlled trials with tricyclic and tetracyclic antidepressants ( TCAs), selective serotonin reuptake inhibitors ( SSRIs), serotonin and noradrenaline reuptake inhibitors ( SNRIs), and monoamine oxidase inhibitors ( MAOIs) were analyzed. Data Extraction and Data Synthesis Two authors independently extracted data. Effects were summarized using standardized mean differences ( SMDs) by a random-effects model. Results Eighteen randomized controlled trials ( median duration, 8 weeks; range, 4- 28 weeks) involving 1427 participants were included. Overall, there was strong evidence for an association of antidepressants with reduction in pain ( SMD, - 0.43; 95% confidence interval [ CI], - 0.55 to - 0.30), fatigue ( SMD, - 0.13; 95% CI, - 0.26 to - 0.01), depressed mood (SMD, - 0.26; 95% CI, - 0.39 to - 0.12), and sleep disturbances (SMD, - 0.32; 95% CI, - 0.46 to - 0.18). There was strong evidence for an association of antidepressants with improved health- related quality of life (SMD, - 0.31; 95% CI, - 0.42 to - 0.20). Effect sizes for pain reduction were large for TCAs (SMD, - 1.64; 95% CI, - 2.57 to - 0.71), medium for MAOIs (SMD, - 0.54; 95% CI, - 1.02 to - 0.07), and small for SSRIs (SMD, - 0.39; 95% CI, - 0.77 to - 0.01) and SNRIs (SMD, - 0.36; 95% CI, - 0.46 to - 0.25). Conclusion Antidepressant medications are associated with improvements in pain, depression, fatigue, sleep disturbances, and health- related quality of life in patients with FMS.	[Haeuser, Winfried] Klinikum Saarbrucken, Dept Internal Med, D-66119 Saarbrucken, Germany; [Bernardy, Kathrin] Univ Saarland, Dept Anesthesiol Emergency Med & Pain Therapy, D-6600 Saarbrucken, Germany; [Bernardy, Kathrin] MediClin Bliestal Clin, Dept Psychosomat Med, Blieskastel, Germany; [Ueceyler, Nurcan; Sommer, Claudia] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	Saarland University; University of Wurzburg	Hauser, W (corresponding author), Klinikum Saarbrucken, Dept Internal Med, Winterberg 1, D-66119 Saarbrucken, Germany.	whaeuser@klinikum-saarbruecken.de	Häuser, Winfried/AAX-6231-2021; Sommer, Claudia/A-9820-2010; Häuser, Winfried/AAH-6633-2021	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428; Hauser, Winfried/0000-0002-3742-729X	German Rheumatology League; German Fibromyalgia Association; German Ministry of Education and Research ( Bundesministerium fur Bildung und Forschung); German Research Network on Neuropathic Pain; University of Wurzburg (Germany)	German Rheumatology League; German Fibromyalgia Association; German Ministry of Education and Research ( Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Research Network on Neuropathic Pain; University of Wurzburg (Germany)	The study was supported by grants from the German Rheumatology League and German Fibromyalgia Association, German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung), German Research Network on Neuropathic Pain, and intramural funds of the University of Wurzburg (Germany).	Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; Anderberg UM, 2000, EUR J PAIN-LONDON, V4, P27, DOI 10.1053/eujp.1999.0148; Arnold LM, 2000, PSYCHOSOMATICS, V41, P104, DOI 10.1176/appi.psy.41.2.104; Arnold LM, 2005, PAIN, V119, P5, DOI 10.1016/j.pain.2005.06.031; Arnold LM, 2004, ARTHRITIS RHEUM, V50, P2974, DOI 10.1002/art.20485; Arnold LM, 2002, AM J MED, V112, P191, DOI 10.1016/S0002-9343(01)01089-0; ATAOGLU S, 1997, TURK J MED SCI, V27, P535; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; BIBOLOTTI E, 1986, CLIN TRIALS J, V23, P269; Boonen A, 2005, ANN RHEUM DIS, V64, P396, DOI 10.1136/ard.2003.019711; Cantini F, 1994, Minerva Med, V85, P97; Capaci K, 2002, PAIN CLINIC, V14, P223, DOI 10.1163/156856902320761423; CARETTE S, 1986, ARTHRITIS RHEUM-US, V29, P655, DOI 10.1002/art.1780290510; CARETTE S, 1994, ARTHRITIS RHEUM, V37, P32, DOI 10.1002/art.1780370106; CARETTE S, 1995, ARTHRITIS RHEUM, V38, P1211, DOI 10.1002/art.1780380906; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fors EA, 2002, J PSYCHIATR RES, V36, P179, DOI 10.1016/S0022-3956(02)00003-1; Gendreau RM, 2005, J RHEUMATOL, V32, P1975; Ginsberg F, 1998, J MUSCULOSKELET PAIN, V6, P5, DOI 10.1300/J094v06n02_02; GINSBERG F, 1996, J MUSCULOSKELET PAIN, V4, P37; Giordano N, 1999, CURR THER RES CLIN E, V60, P696, DOI 10.1016/S0011-393X(99)90008-5; Goldenberg D, 1996, ARTHRITIS RHEUM, V39, P1852, DOI 10.1002/art.1780391111; GOLDENBERG DL, 1986, ARTHRITIS RHEUM, V29, P1371, DOI 10.1002/art.1780291110; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Gonzalez-Viejo M. A., 2005, Annales de Readaptation et de Medecine Physique, V48, P610, DOI 10.1016/j.annrmp.2005.03.012; Gran JT, 2003, BEST PRACT RES CL RH, V17, P547, DOI 10.1016/S1521-6942(03)00042-1; Gur A, 2002, RHEUMATOL INT, V22, P188, DOI 10.1007/s00296-002-0221-z; Hauser W, 2008, SCHMERZ, V22, P176, DOI 10.1007/s00482-007-0602-z; Hannonen P, 1998, BRIT J RHEUMATOL, V37, P1279; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Henriksson CM, 2005, DISABIL REHABIL, V27, P685, DOI 10.1080/09638280400009089; Heymann RE, 2001, CLIN EXP RHEUMATOL, V19, P697; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; ISOMERI R, 1993, J MUSCULOSKELET PAIN, V1, P253; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JAESCHKE R, 1991, J RHEUMATOL, V18, P447; KEMPENAERS C, 1994, NEUROPSYCHOBIOLOGY, V30, P66, DOI 10.1159/000119138; Knapp G, 2006, BIOMETRICAL J, V48, P271, DOI 10.1002/bimj.200510175; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; *NORD COCHR CTR CO, 2003, REV MAN REVMAN VERS; NORREGAARD J, 1995, PAIN, V61, P445, DOI 10.1016/0304-3959(94)00218-4; O'Malley PG, 2000, J GEN INTERN MED, V15, P659, DOI 10.1046/j.1525-1497.2000.06279.x; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Ozerbil O, 2006, CLIN RHEUMATOL, V25, P495, DOI 10.1007/s10067-005-0076-2; Patkar AA, 2007, AM J MED, V120, P448, DOI 10.1016/j.amjmed.2006.06.006; Penrod JR, 2004, J RHEUMATOL, V31, P1391; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Robinson RL, 2006, EXPERT OPIN PHARMACO, V7, P1027, DOI 10.1517/14656566.7.8.1027; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Russell IJ, 2008, PAIN, V136, P432, DOI 10.1016/j.pain.2008.02.024; Scudds R A, 1989, J Rheumatol Suppl, V19, P98; Sencan S, 2004, J BACK MUSCULOSKELET, V17, P57, DOI 10.3233/BMR-2004-17204; SMYTHE H A, 1977, Bulletin on the Rheumatic Diseases, V28, P928; Targino RA, 2008, J REHABIL MED, V40, P582, DOI 10.2340/16501977-0216; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Uceyler N, 2008, ARTHRIT RHEUM-ARTHR, V59, P1279, DOI 10.1002/art.24000; *US FDA, LIV FIBR DRUGS APPR; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vitton O, 2004, HUM PSYCHOPHARM CLIN, V19, pS27, DOI 10.1002/hup.622; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, J RHEUMATOL, V24, P1171; WOLFE F, 1994, SCAND J RHEUMATOL, V23, P255, DOI 10.3109/03009749409103725; YAVUZER G, 1998, EUR J PHYS MED REHAB, V8, P35; YUNUS MB, 1989, Z RHEUMATOL, V48, P217	69	217	228	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					198	209						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	393VV	19141768	Bronze			2022-12-28	WOS:000262405500022
J	Ofri, D				Ofri, Danielle			Thoughts on a G string	LANCET			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University	Ofri, D (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	dofri@BLReview.org		Ofri, Danielle/0000-0001-9865-7104				Bernstein Leonard, 1954, JOY MUSIC; Copeland A., 1957, WHAT LISTEN MUSIC; JOURDAIN R, 2004, MUSIC BRAIN ECSTASY; Levitin DJ., 2006, THIS IS YOUR BRAIN M; O'Brien Sharon, 1997, W CATHER EMERGING VO; Sacks O, 2007, MUSICOPHILIA TALES M; Storr Anthony, 1992, MUSIC MIND	7	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					116	117		10.1016/S0140-6736(09)60026-X	http://dx.doi.org/10.1016/S0140-6736(09)60026-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19140268	Bronze			2022-12-28	WOS:000262340900014
J	Kawakami, K; Dunn, E; Karmali, F; Dovidio, JF				Kawakami, Kerry; Dunn, Elizabeth; Karmali, Francine; Dovidio, John F.			Mispredicting Affective and Behavioral Responses to Racism	SCIENCE			English	Article							DURABILITY BIAS; PREJUDICE; SAY	Contemporary race relations are marked by an apparent paradox: Overt prejudice is strongly condemned, yet acts of blatant racism still frequently occur. We propose that one reason for this inconsistency is that people misunderstand how they would feel and behave after witnessing racism. The present research demonstrates that although people predicted that they would be very upset by a racist act, when people actually experienced this event they showed relatively little emotional distress. Furthermore, people overestimated the degree to which a racist comment would provoke social rejection of the racist. These findings suggest that racism may persevere in part because people who anticipate feeling upset and believe that they will take action may actually respond with indifference when faced with an act of racism.	[Kawakami, Kerry; Karmali, Francine] York Univ, Dept Psychol, N York, ON M3J 1P3, Canada; [Dunn, Elizabeth] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Dovidio, John F.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	York University - Canada; University of British Columbia; Yale University	Kawakami, K (corresponding author), York Univ, Dept Psychol, 4700 Keele St, N York, ON M3J 1P3, Canada.	kawakami@yorku.ca		Dovidio, John/0000-0002-6110-8344	Social Science and Humanities Council of Canada	Social Science and Humanities Council of Canada	This research was supported by Social Science and Humanities Council of Canada grants to K.K. and E.D.	AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Devine P.G., 1993, AFFECT COGNITION STE, P317; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Dovidio JF, 2004, ADV EXP SOC PSYCHOL, V36, P1, DOI 10.1016/S0065-2601(04)36001-6; DOVIDIO JF, 2009, IMPLICIT MEASURES AT, P165; Dunn EW, 2008, J EXP SOC PSYCHOL, V44, P692, DOI 10.1016/j.jesp.2007.04.011; Dunn EW, 2003, PERS SOC PSYCHOL B, V29, P1421, DOI 10.1177/0146167203256867; DUNN EW, HDB IMAGINA IN PRESS; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; FISKE ST, 1998, HDB SOCIAL PSYCHOL, V2; Gaertner S. L., 1986, PREJUDICE DISCRIMINA, P61; Gilbert DT, 1998, J PERS SOC PSYCHOL, V75, P617, DOI 10.1037/0022-3514.75.3.617; Gilbert DT, 2002, EMO SOC BEH, P114; GILBERT DT, 2006, STUMBLING HAPPINESS, P277; Kameda T, 2003, PERS SOC PSYCHOL REV, V7, P2, DOI 10.1207/S15327957PSPR0701_1; Kawakami K, 1998, PERS SOC PSYCHOL B, V24, P407, DOI 10.1177/0146167298244007; Kawakami K, 2000, J PERS SOC PSYCHOL, V78, P871, DOI 10.1037/0022-3514.78.5.871; Kawakami K, 2007, J PERS SOC PSYCHOL, V92, P957, DOI 10.1037/0022-3514.92.6.957; Mackie DianeM., 2002, PREJUDICE INTERGROUP; *NOV, 2007, 1 3 REP SEX REM WORK; Pew Research Center, 2007, BLACKS SEE GROW VAL; Pinker S., 2007, STUFF THOUGHT LANGUA; PRONIN E, ADV EXPT SO IN PRESS; Sommers SR, 2006, GROUP PROCESS INTERG, V9, P117, DOI 10.1177/1368430206059881; Swim JK, 1999, J EXP SOC PSYCHOL, V35, P68, DOI 10.1006/jesp.1998.1370; Wilson TD, 2000, J PERS SOC PSYCHOL, V78, P821, DOI 10.1037/0022-3514.78.5.821; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Woodzicka JA, 2001, J SOC ISSUES, V57, P15, DOI 10.1111/0022-4537.00199; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	138	138	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					276	278		10.1126/science.1164951	http://dx.doi.org/10.1126/science.1164951			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131633				2022-12-28	WOS:000262290600045
J	Day, JMD; Ash, RD; Liu, Y; Bellucci, JJ; Rumble, D; McDonough, WF; Walker, RJ; Taylor, LA				Day, James M. D.; Ash, Richard D.; Liu, Yang; Bellucci, Jeremy J.; Rumble, Douglas, III; McDonough, William F.; Walker, Richard J.; Taylor, Lawrence A.			Early formation of evolved asteroidal crust	NATURE			English	Article							OXYGEN-ISOTOPE; FRACTIONATION; CONSTRAINTS; DIFFERENTIATION; OCEANS; AGE	Mechanisms for the formation of crust on planetary bodies remain poorly understood(1). It is generally accepted that Earth's andesitic continental crust is the product of plate tectonics(1,2), whereas the Moon acquired its feldspar- rich crust by way of plagioclase flotation in a magma ocean(3,4). Basaltic meteorites provide evidence that, like the terrestrial planets, some asteroids generated crust and underwent large- scale differentiation processes(5). Until now, however, no evolved felsic asteroidal crust has been sampled or observed. Here we report age and compositional data for the newly discovered, paired and differentiated meteorites Graves Nunatak ( GRA) 06128 and GRA 06129. These meteorites are feldspar- rich, with andesite bulk compositions. Their age of 4.5+/-0.06 Gyr demonstrates formation early in Solar System history. The isotopic and elemental compositions, degree of metamorphic re-equilibration and sulphide- rich nature of the meteorites are most consistent with an origin as partial melts from a volatile- rich, oxidized asteroid. GRA 06128 and 06129 are the result of a newly recognized style of evolved crust formation, bearing witness to incomplete differentiation of their parent asteroid and to previously unrecognized diversity of early- formed materials in the Solar System.	[Day, James M. D.; Ash, Richard D.; Bellucci, Jeremy J.; McDonough, William F.; Walker, Richard J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Liu, Yang; Taylor, Lawrence A.] Univ Tennessee, Dept Earth & Planetary Sci, Planetary Geosci Inst, Knoxville, TN 37996 USA; [Rumble, Douglas, III] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	University System of Maryland; University of Maryland College Park; University of Tennessee System; University of Tennessee Knoxville; Carnegie Institution for Science	Day, JMD (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	jamesday@umd.edu	Liu, Yang/F-3775-2017; McDonough, William F/I-7720-2012; Day, James/A-5099-2010; McDonough, William F/C-4791-2009; Liu, Yang/A-4708-2012; Ash, Richard/AAD-4888-2021; Rumble, Douglas/AAU-3930-2020; Walker, Richard/K-6869-2016	Liu, Yang/0000-0003-0308-0942; McDonough, William F/0000-0001-9154-3673; Day, James/0000-0001-9520-3465; McDonough, William F/0000-0001-9154-3673; Ash, Richard/0000-0003-2144-5917; Rumble, Douglas/0000-0002-7440-9189; Walker, Richard/0000-0003-0348-2407	NASA Cosmochemistry Program [NNX07AM29G, NNX08AH76G, NNG05GG03G]	NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA))	We thank the ANSMET 2006/2007 field team, the Meteorite Working Group and the Smithsonian Institution of Washington for collection and provision of the GRA 06128/9 and Brachina meteorites. D. Mittlefehldt and R. Greenwood provided reviews that improved the quality of this paper. A. Patchen and P. Piccoli provided assistance with electron microprobe analysis. Portions of this study were supported by the NASA Cosmochemistry Program: NNX07AM29G (R.J.W.), NNX08AH76G (W.F.M.), NNG05GG03G (L.A.T.).	Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Ash RD, 1996, NATURE, V380, P57, DOI 10.1038/380057a0; Baker J, 2004, CHEM GEOL, V211, P275, DOI 10.1016/j.chemgeo.2004.06.030; BIRCK JL, 1994, EARTH PLANET SC LETT, V124, P139, DOI 10.1016/0012-821X(94)00086-7; Bockrath C, 2004, SCIENCE, V305, P1951, DOI 10.1126/science.1100160; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; CAMPBELL IH, 1985, GEOPHYS RES LETT, V10, P1064; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; CHERNIAK DJ, 1991, GEOCHIM COSMOCHIM AC, V55, P1663, DOI 10.1016/0016-7037(91)90137-T; Clark BE, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002200; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Day JMD, 2006, GEOCHIM COSMOCHIM AC, V70, P1581, DOI 10.1016/j.gca.2005.11.015; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Horan MF, 2003, CHEM GEOL, V196, P5, DOI 10.1016/S0009-2541(02)00405-9; JUREWICZ AJG, 1993, GEOCHIM COSMOCHIM AC, V57, P2123, DOI 10.1016/0016-7037(93)90098-H; Keil K, 1997, METEORIT PLANET SCI, V32, P349, DOI 10.1111/j.1945-5100.1997.tb01278.x; KUSHIRO I, 1975, AM J SCI, V275, P411, DOI 10.2475/ajs.275.4.411; LUDWIG KR, 2000, 91445 US; MIKOUCHI T, 2008, LUNAR PLANET SCI, V39, P2297; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Mittlefehldt D. W., 1998, PLANETARY MAT; Mittlefehldt DW, 2003, METEORIT PLANET SCI, V38, P1601, DOI 10.1111/j.1945-5100.2003.tb00004.x; Morse S.A., 1980, BASALTS PHASE DIAGRA; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Rumble D, 2007, GEOCHIM COSMOCHIM AC, V71, P3592, DOI 10.1016/j.gca.2007.05.011; RUMBLE D, 2008, LUNAR PLANET SCI C, V39, P1974; SHARP ZD, 1990, GEOCHIM COSMOCHIM AC, V54, P1353, DOI 10.1016/0016-7037(90)90160-M; SHEARER CK, 2008, LUNAR PLANET SCI C, V39, P1825; Smith J. A., 1970, P AP 11 LUN SCI C, P1149; Spicuzza MJ, 2007, EARTH PLANET SC LETT, V253, P254, DOI 10.1016/j.epsl.2006.10.030; STROM RG, 1994, J GEOPHYS RES-PLANET, V99, P10899, DOI 10.1029/94JE00388; TAYLOR GJ, 1992, J GEOPHYS RES-PLANET, V97, P14717, DOI 10.1029/92JE01501; TAYLOR GJ, 2003, METEORITES COMETS PL, V1, P477; TUTTLE OF, 1958, GEOL SOC AM MEM, V74, pP153; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; WILSON L, 1991, EARTH PLANET SC LETT, V140, P191; Wood J.A., 1970, GEOCHIM COSMOCHIM AC, V1, P965; ZIEGLER RA, 2008, LUNAR PLANET SCI C, V39, P2456	40	73	73	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					179	U68		10.1038/nature07651	http://dx.doi.org/10.1038/nature07651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129845				2022-12-28	WOS:000262360200029
J	Dore, DD; Lapane, KL; Trivedi, AN; Mor, V; Weinstock, MA				Dore, David D.; Lapane, Kate L.; Trivedi, Amal N.; Mor, Vincent; Weinstock, Martin A.			Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE ATORVASTATIN; PROSTATE-CANCER; COLORECTAL-CANCER; UNITED-STATES; REDUCTASE INHIBITORS; MULTIPLE-SCLEROSIS; MORTALITY-RATES	Background: Recent evidence suggests that statins may prevent cancer. Objective: To quantify the association between statin use and the occurrence of keratinocyte carcinoma in high- risk veterans. Design: Cohort study. Setting: 6 Veterans Affairs medical centers. Participants: 1037 participants of the Veterans Affairs Topical Tretinoin Chemoprevention Trial, a randomized, multicenter, double-blind, vehicle-controlled trial of topical tretinoin, 0.1%, for prevention of keratinocyte carcinoma conducted from November 1998 to November 2004. Measurements: Time to first occurrence of keratinocyte carcinoma on the face or ears. Participants using a statin at randomization, according to the Veterans Affairs Pharmacy Benefits Management database, were considered exposed. Study dermatologists conducted physical examinations at baseline and every 6 months during follow-up. The association between statin use at randomization and the outcome was evaluated by using propensity score matching (n = 608) and Cox proportional hazards regression (n = 1037). Results: Among the 1037 participants, 37% used a statin at randomization (n = 397) for a median duration of at least 900 days over a median follow-up of 3.5 years. In the propensity score matched analysis, statin use at randomization was not associated with keratinocyte carcinoma (rate ratio, 0.92 [95% CI, 0.73 to 1.16]), a finding that was consistent with the estimates derived from the Cox proportional hazards regression (rate ratio, 0.84 [CI, 0.70 to 1.02]). Limitations: The extent of residual confounding is unknown, and the confidence bounds around the measures of association were wide. These data may not be generalizable to lower-risk populations. Conclusion: These data show no conclusive or consistent relationship between long-term statin use and risk for keratinocyte carcinoma.	[Dore, David D.] i3 Drug Safety, Waltham, MA 02451 USA; [Lapane, Kate L.; Trivedi, Amal N.; Mor, Vincent] Brown Univ, Providence, RI 02903 USA; [Weinstock, Martin A.] Vet Affairs Med Ctr, Dermatoepidemiol Unit, Providence, RI 02908 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Dore, DD (corresponding author), i3 Drug Safety, 950 Winter St,Suite 3800, Waltham, MA 02451 USA.	david.dore@i3drugsafety.com		Dore, David/0000-0003-0810-6662	Department of Veterans Affairs; Agency for Healthcare Research and Quality; American Cancer Society; National Institutes of Health; Department of Veterans Affairs Office of Research and Development [CSP 402]; Agency for Healthcare Research and Quality [5T32HS000011-21]; National Institutes of Health [R01CA106592, R01CA106807, R25CA087972, R01AR49342]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA106592, R01CA106807, R25CA087972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049342] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Department of Veterans Affairs, Agency for Healthcare Research and Quality, American Cancer Society, and National Institutes of Health.; Dr. Weinstock was supported by the Department of Veterans Affairs Office of Research and Development (CSP 402), and Dr. Dore was supported by the Agency for Healthcare Research and Quality (grant 5T32HS000011-21). Additional support was received from the American Cancer Society. Dr. Weinstock also received support from the National Institutes of Health (grants R01CA106592, R01CA106807, R25CA087972, and R01AR49342).	*AM CANC SOC, 2006, CAN FACTS FIG; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Boudreau DM, 2008, CANCER CAUSE CONTROL, V19, P767, DOI 10.1007/s10552-008-9139-4; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coogan PF, 2007, EPIDEMIOLOGY, V18, P213, DOI 10.1097/01.ede.0000254694.03027.a1; Coogan PF, 2007, JNCI-J NATL CANCER I, V99, P32, DOI 10.1093/jnci/djk003; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Dellavalle RP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003697.pub2; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dulak J, 2005, CURR CANCER DRUG TAR, V5, P579, DOI 10.2174/156800905774932824; Etminan M, 2003, PHARMACOTHERAPY, V23, P726, DOI 10.1592/phco.23.6.726.32184; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Fortina AB, 2004, ARCH DERMATOL, V140, P1079, DOI 10.1001/archderm.140.9.1079; Freeman MR, 2006, JAMA-J AM MED ASSOC, V295, P2720, DOI 10.1001/jama.295.23.2720-b; FREEMAN MR, 2006, JAMA-J AM MED ASSOC, V295, P2721; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P164, DOI 10.1001/archderm.131.2.164; Grau MV, 2006, INT J CANCER, V119, P682, DOI 10.1002/ijc.21878; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Jagdeo J, 2007, J AM ACAD DERMATOL, V57, P279, DOI 10.1016/j.jaad.2007.03.021; Karagas MR, 2006, CANC EPIDEMIOLOGY PR, P1230, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0064; Karp I, 2008, AM J MED, V121, P302, DOI 10.1016/j.amjmed.2007.12.011; Khurana V, 2008, UROLOGY, V71, P118, DOI 10.1016/j.urology.2007.08.039; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lear JT, 1997, J ROY SOC MED, V90, P371, DOI 10.1177/014107689709000704; Lewis KG, 2007, J INVEST DERMATOL, V127, P2323, DOI 10.1038/sj.jid.5700897; Mehta JL, 2006, AM J CARDIOL, V98, P923, DOI 10.1016/j.amjcard.2006.04.033; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Neuhaus O, 2004, LANCET NEUROL, V3, P369, DOI 10.1016/S1474-4422(04)00770-7; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Parsons LS., 2001, P 26 ANN SAS US GROU, P214; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Salinas CA, 2006, JAMA-J AM MED ASSOC, V295, P2721, DOI 10.1001/jama.295.23.2721-a; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Setoguchi S, 2007, CIRCULATION, V115, P27, DOI 10.1161/CIRCULATIONAHA.106.650176; Sloan KL, 2003, MED CARE, V41, P761, DOI 10.1097/00005650-200306000-00009; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Stein EA, 2006, INT J CLIN PRACT, V60, P1028, DOI 10.1111/j.1742-1241.2006.01071.x; Vinogradova Y, 2007, GASTROENTEROLOGY, V133, P393, DOI 10.1053/j.gastro.2007.05.023; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211; WEINSTOCK MA, 1991, ARCH DERMATOL, V127, P1194, DOI 10.1001/archderm.127.8.1194; WEINSTOCK MA, 1993, ARCH DERMATOL, V129, P1286, DOI 10.1001/archderm.129.10.1286; Weinstock MA, 2001, ARCH DERMATOL, V137, P1055; Zhou B, 2007, DEMENT GERIATR COGN, V23, P194, DOI 10.1159/000099037	58	15	15	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					9	W2		10.7326/0003-4819-150-1-200901060-00004	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124815	Green Accepted			2022-12-28	WOS:000262655100002
J	Read, AF; Thomas, MB				Read, Andrew F.; Thomas, Matthew B.			MICROBIOLOGY Mosquitoes Cut Short	SCIENCE			English	Editorial Material							AEDES-AEGYPTI; MALARIA; TEMPERATURE		[Read, Andrew F.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Read, Andrew F.; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Read, AF (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA.	a.read@psu.edu						Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Koella JC, 1999, MICROBES INFECT, V1, P303, DOI 10.1016/S1286-4579(99)80026-4; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Michalakis Y, 2005, NATURE, V435, P891, DOI 10.1038/435891a; Rasgon JL, 2008, ADV EXP MED BIOL, V627, P114, DOI 10.1007/978-0-387-78225-6_10; Reynolds KT, 2003, GENETICS, V164, P1027; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	13	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					51	52		10.1126/science.1168659	http://dx.doi.org/10.1126/science.1168659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119208				2022-12-28	WOS:000262104100032
J	Audet, P; Bostock, MG; Christensen, NI; Peacock, SM				Audet, Pascal; Bostock, Michael G.; Christensen, Nikolas I.; Peacock, Simon M.			Seismic evidence for overpressured subducted oceanic crust and megathrust fault sealing	NATURE			English	Article							ZONE; SERPENTINIZATION; PERMEABILITY; PRESSURE; TREMORS; MOHO	Water and hydrous minerals play a key part in geodynamic processes at subduction zones(1-3) by weakening the plate boundary, aiding slip and permitting subduction - and indeed plate tectonics - to occur(4). The seismological signature of water within the forearc mantle wedge is evident in anomalies with low seismic shear velocity marking serpentinization(5-7). However, seismological observations bearing on the presence of water within the subducting plate itself are less well documented. Here we use converted teleseismic waves to obtain observations of anomalously high Poisson's ratios within the subducted oceanic crust from the Cascadia continental margin to its intersection with forearc mantle. On the basis of pressure, temperature and compositional considerations, the elevated Poisson's ratios indicate that water is pervasively present in fluid format pore pressures near lithostatic values. Combined with observations of a strong negative velocity contrast at the top of the oceanic crust, our results imply that the megathrust is a low- permeability boundary. The transition from a low- to high- permeability plate interface down dip into the mantle wedge is explained by hydrofracturing of the seal by volume changes across the interface caused by the onset of crustal eclogitization and mantle serpentinization. These results may have important implications for our understanding of seismogenesis, subduction zone structure and the mechanism of episodic tremor and slip.	[Audet, Pascal; Bostock, Michael G.; Christensen, Nikolas I.; Peacock, Simon M.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Christensen, Nikolas I.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	University of British Columbia; University of Wisconsin System; University of Wisconsin Madison	Audet, P (corresponding author), Univ Calif Berkeley, Seismol Lab, 215 McCone Hall, Berkeley, CA 94720 USA.	paudet@berkeley.edu		Audet, Pascal/0000-0003-2364-9454				Abers GA, 2006, EARTH PLANET SC LETT, V241, P387, DOI 10.1016/j.epsl.2005.11.055; AHRENS TJ, 1975, REV GEOPHYS, V13, P383, DOI 10.1029/RG013i002p00383; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; Christensen NI, 2004, INT GEOL REV, V46, P795, DOI 10.2747/0020-6814.46.9.795; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V79, P411, DOI 10.1111/j.1365-246X.1984.tb02232.x; COLEMAN RG, 1971, GEOL SOC AM BULL, V82, P897, DOI 10.1130/0016-7606(1971)82[897:PAGNOS]2.0.CO;2; Fisher AT, 1998, REV GEOPHYS, V36, P143, DOI 10.1029/97RG02916; GERVER M, 1966, GEOPHYS J ROY ASTR S, V11, P165, DOI 10.1111/j.1365-246X.1966.tb03498.x; Hyndman RD, 2003, EARTH PLANET SC LETT, V212, P417, DOI 10.1016/S0012-821X(03)00263-2; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kato A., 2003, EARTHQ RES, V78, P83; Kawakatsu H, 2007, SCIENCE, V316, P1468, DOI 10.1126/science.1140855; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; Meneghini F, 2007, GEOL SOC AM BULL, V119, P174, DOI 10.1130/B25807.1; MOORE JC, 1992, REV GEOPHYS, V30, P113, DOI 10.1029/92RG00201; Nicholson T, 2005, GEOPHYS J INT, V161, P849, DOI 10.1111/j.1365-246X.2005.02605.x; O'Neill C, 2007, EARTH PLANET SC LETT, V261, P20, DOI 10.1016/j.epsl.2007.05.038; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Ramachandran K, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003258; Rondenay S, 2008, GEOLOGY, V36, P275, DOI 10.1130/G24112A.1; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; Wang Z, 2006, EARTH PLANET SC LETT, V251, P66, DOI 10.1016/j.epsl.2006.08.025; WIELANDT E, 1987, SEISMIC TOMOGRAPHY, P85; Yuan X, 2000, NATURE, V408, P958, DOI 10.1038/35050073; ZANDT G, 1995, NATURE, V374, P152, DOI 10.1038/374152a0; Zhu LP, 2000, J GEOPHYS RES-SOL EA, V105, P2969, DOI 10.1029/1999JB900322	30	394	397	5	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2009	457	7225					76	78		10.1038/nature07650	http://dx.doi.org/10.1038/nature07650			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122639				2022-12-28	WOS:000262104900033
J	Viale, A; De Franco, F; Orleth, A; Cambiaghi, V; Giuliani, V; Bossi, D; Ronchini, C; Ronzoni, S; Muradore, I; Monestiroli, S; Gobbi, A; Alcalay, M; Minucci, S; Pelicci, PG				Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe			Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM; REPOPULATING ABILITY; PROGENITOR CELLS; GENE-TRANSFER; REPAIR; REPLICATION; EXPRESSION; BREAKS	Rare cells with the properties of stem cells are integral to the development and perpetuation of leukaemias. A defining characteristic of stem cells is their capacity to self- renew, which is markedly extended in leukaemia stem cells. The underlying molecular mechanisms, however, are largely unknown. Here we demonstrate that expression of the cell- cycle inhibitor p21 is indispensable for maintaining self- renewal of leukaemia stem cells. Expression of leukaemia- associated oncogenes in mouse haematopoietic stem cells ( HSCs) induces DNA damage and activates a p21- dependent cellular response, which leads to reversible cell- cycle arrest and DNA repair. Activated p21 is critical in preventing excess DNA- damage accumulation and functional exhaustion of leukaemic stem cells. These data unravel the oncogenic potential of p21 and suggest that inhibition of DNA repair mechanisms might function as potent strategy for the eradication of the slowly proliferating leukaemia stem cells.	[Viale, Andrea; De Franco, Francesca; Orleth, Annette; Cambiaghi, Valeria; Giuliani, Virginia; Bossi, Daniela; Ronchini, Chiara; Ronzoni, Simona; Muradore, Ivan; Monestiroli, Silvia; Gobbi, Alberto; Alcalay, Myriam; Minucci, Saverio; Pelicci, Pier Giuseppe] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [De Franco, Francesca; Orleth, Annette] Univ Perugia, Dipartimento Med Clin & Sperimentale, Monteluce Policlin, I-06100 Perugia, Italy; [Minucci, Saverio] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20100 Milan, Italy; [Alcalay, Myriam; Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20100 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Perugia; University of Milan; University of Milan	Viale, A (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, I-20141 Milan, Italy.	andrea.viale@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it	Pelicci, Pier Giuseppe/AAL-6572-2020; Alcalay, Myriam/B-3182-2016; Minucci, Saverio/J-9669-2012; Bossi, Daniela/G-2401-2015; Ronzoni, Simona/AAQ-1669-2020; Ronchini, Chiara/K-3935-2013; Alcalay, Myriam/AAB-4300-2019	Alcalay, Myriam/0000-0002-5558-4272; Bossi, Daniela/0000-0002-8507-6754; Ronchini, Chiara/0000-0003-3908-4021; Alcalay, Myriam/0000-0002-5558-4272	Italian Association on Cancer Research; Ministero Italiano della Salute, Cariplo; European Community (FP6: EPITRON and GENICA); Vollaro Foundation	Italian Association on Cancer Research(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute, Cariplo(Fondazione Cariplo); European Community (FP6: EPITRON and GENICA)(European Commission); Vollaro Foundation	We thank L. Luzi, D. Shing and M. Faretta for discussions and suggestions; M. Capillo, M. Stendardo and D. Sardella for assistance in maintenance of mouse colonies and for mouse genotyping; B. Amati, G. McVie, P. P. Di Fiore and C. Basilico for reviewing the manuscript; and P. Dalton for editing the manuscript. This study was supported by grants from the Italian Association on Cancer Research (AIRC), Ministero Italiano della Salute, Cariplo and the European Community (FP6: EPITRON and GENICA) to P. G.P.A.V. is a fellow of the Vollaro Foundation.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; Grignani F, 1998, CANCER RES, V58, P14; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; HEYTING C, 1980, CARCINOGENESIS, V1, P769, DOI 10.1093/carcin/1.9.769; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Livneh Z, 2001, J BIOL CHEM, V276, P25639, DOI 10.1074/jbc.R100019200; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; SZILVASSY SJ, 1989, BLOOD, V74, P930; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	46	237	251	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 1	2009	457	7225					51	U52		10.1038/nature07618	http://dx.doi.org/10.1038/nature07618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OR	19122635				2022-12-28	WOS:000262104900028
J	Schwaber, MJ; Carmeli, Y				Schwaber, Mitchell J.; Carmeli, Yehuda			Carbapenem-Resistant Enterobacteriaceae A Potential Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; NEW-YORK; INFECTIONS; MORTALITY; SPREAD		[Schwaber, Mitchell J.] Minist Hlth, Natl Ctr Infect Control, IL-64239 Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Med Ctr & Sch Med, Div Epidemiol & Prevent Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Schwaber, MJ (corresponding author), Minist Hlth, Natl Ctr Infect Control, 6 Weizmann St, IL-64239 Tel Aviv, Israel.	mitchells@tasmc.health.gov.il	Schwaber, Mitchell/AAI-2486-2019					Appelbaum PC, 2007, CLIN INFECT DIS, V45, pS165, DOI 10.1086/519474; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Bratu S, 2007, CLIN INFECT DIS, V44, P972, DOI 10.1086/512370; Daikos GL, 2007, INT J ANTIMICROB AG, V29, P471, DOI 10.1016/j.ijantimicag.2006.11.006; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; SCHWABER MJ, 2008, 48 ANN INT C ANT AG; Urban C, 2008, CLIN INFECT DIS, V46, pE127, DOI 10.1086/588048; Vatopoulos A, 2008, Euro Surveill, V13	14	201	210	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2911	2913						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109119	Green Accepted			2022-12-28	WOS:000261920900024
J	Krantz, MJ; Martin, J; Stimmel, B; Mehta, D; Haigney, MCP				Krantz, Mori J.; Martin, Judith; Stimmel, Barry; Mehta, Davendra; Haigney, Mark C. P.			QTc Interval Screening in Methadone Treatment	ANNALS OF INTERNAL MEDICINE			English	Article							TORSADE-DE-POINTES; HIGH-DOSE METHADONE; CARDIAC REPOLARIZATION; INTRAVENOUS METHADONE; POTASSIUM CHANNEL; PROLONGATION; THERAPY; PATIENT; BRADYCARDIA; SAFETY	Description: An independent panel developed cardiac safety recommendations for physicians prescribing methadone. Methods: Expert panel members reviewed and discussed the following sources regarding methadone: pertinent English-language literature identified from MEDLINE and EMBASE searches (1966 to June 2008), national substance abuse guidelines from the United States and other countries, information from regulatory authorities, and physician awareness of adverse cardiac effects. Recommendation 1 (Disclosure): Clinicians should inform patients of arrhythmia risk when they prescribe methadone. Recommendation 2 (Clinical History): Clinicians should ask patients about any history of structural heart disease, arrhythmia, and syncope. Recommendation 3 (Screening): Obtain a pretreatment electrocardiogram for all patients to measure the QTc interval and a follow-up electrocardiogram within 30 days and annually. Additional electrocardiography is recommended if the methadone dosage exceeds 100 mg/d or if patients have unexplained syncope or seizures. Recommendation 4 (Risk Stratification): If the QTc interval is greater than 450 ms but less than 500 ms, discuss the potential risks and benefits with patients and monitor them more frequently. If the QTc interval exceeds 500 ms, consider discontinuing or reducing the methadone dose; eliminating contributing factors, such as drugs that promote hypokalemia; or using an alternative therapy. Recommendation 5 (Drug Interactions): Clinicians should be aware of interactions between methadone and other drugs that possess QT interval-prolonging properties or slow the elimination of methadone.	[Krantz, Mori J.] Colorado Prevent Ctr, Denver, CO 80203 USA; Univ Colorado, Denver, CO 80202 USA; BAART Turk St Clin, San Francisco, CA USA; Mt Sinai Sch Med, New York, NY USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	University of Colorado System; University of Colorado Denver; Icahn School of Medicine at Mount Sinai; Uniformed Services University of the Health Sciences - USA	Krantz, MJ (corresponding author), Colorado Prevent Ctr, 789 Sherman St,Suite 200, Denver, CO 80203 USA.							Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Almehmi Ammar, 2004, W V Med J, V100, P147; Ashwath ML, 2005, J EMERG MED, V29, P73, DOI 10.1016/j.jemermed.2004.10.022; Atkinson D, 2007, ANAESTHESIA, V62, P952, DOI 10.1111/j.1365-2044.2007.05129.x; Ballesteros MF, 2003, JAMA-J AM MED ASSOC, V290, P40, DOI 10.1001/jama.290.1.40; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Bednar MM, 2002, AM J CARDIOL, V89, P1316, DOI 10.1016/S0002-9149(02)02337-8; Benmebarek M, 2004, CLIN PHARMACOL THER, V76, P55, DOI 10.1016/j.clpt.2004.03.007; Brendorp B, 2001, CIRCULATION, V103, P1422, DOI 10.1161/01.CIR.103.10.1422; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; Chiang CE, 2000, J AM COLL CARDIOL, V36, P1, DOI 10.1016/S0735-1097(00)00716-6; Chugh SS, 2008, AM J MED, V121, P66, DOI 10.1016/j.amjmed.2007.10.009; Committee for Proprietary Medicinal Products, 1997, POINTS CONS ASS POT; Cruciani RA, 2005, J PAIN SYMPTOM MANAG, V29, P385, DOI 10.1016/j.jpainsymman.2004.06.012; *DASIS, 2006, FAC OP OP TREATM PRO; De Bels David, 2003, Ann Intern Med, V139, pE156; De Ponti F, 2002, DRUG SAFETY, V25, P263; Decerf JA, 2004, INTENS CARE MED, V30, P1690, DOI 10.1007/s00134-004-2335-0; Department of Health (England) and the devolved administrations, 2007, DRUG MIS DEP UK GUID; DEVOS JW, 1995, EUR J CLIN PHARMACOL, V48, P361, DOI 10.1007/BF00194951; *DRUG AB WARN NETW, 2006, DAWN REP OP REL DRUG; Eap CB, 2007, CLIN PHARMACOL THER, V81, P719, DOI 10.1038/sj.clpt.6100120; Eap CB, 2002, CLIN PHARMACOKINET, V41, P1153, DOI 10.2165/00003088-200241140-00003; Ebert SN, 1998, J WOMENS HEALTH, V7, P547, DOI 10.1089/jwh.1998.7.547; Ehret GB, 2006, ARCH INTERN MED, V166, P1280, DOI 10.1001/archinte.166.12.1280; EIKENBURG DC, 1979, GEN PHARMACOL, V10, P195, DOI 10.1016/0306-3623(79)90089-2; Falconer M, 2007, Ir Med J, V100, P631; Fanoe S, 2007, HEART, V93, P1051, DOI 10.1136/hrt.2006.100180; *FDA CDER OFF SURV, 2008, VER TOT PAT TRACK YE; Ferreira S, 2001, J PHARMACOL EXP THER, V299, P220; Fredheim OMS, 2006, J PAIN SYMPTOM MANAG, V32, P180, DOI 10.1016/j.jpainsymman.2006.02.010; Gagajewski A, 2003, J FORENSIC SCI, V48, P668; GARSON A, 1993, AM J CARDIOL, V72, pB14, DOI 10.1016/0002-9149(93)90034-A; George S, 2007, BRIT J HOSP MED, V68, P221, DOI 10.12968/hmed.2007.68.4.221; Gil M, 2003, AM J CARDIOL, V92, P995, DOI 10.1016/S0002-9149(03)00906-8; Huber A, 2001, DRUG ALCOHOL DEPEN, V63, pS70; Iskandar Said B, 2007, Tenn Med, V100, P35; ISKANDAR SB, 2007, TENN MED, V100, P42; Karir V, 2002, PHARMACOTHERAPY, V22, P1196, DOI 10.1592/phco.22.13.1196.33511; Katchman AN, 2002, J PHARMACOL EXP THER, V303, P688, DOI 10.1124/jpet.102.038240; Kornick CA, 2003, PAIN, V105, P499, DOI 10.1016/S0304-3959(03)00205-7; Krantz MJ, 2005, PHARMACOTHERAPY, V25, P1523, DOI 10.1592/phco.2005.25.11.1523; Krantz MJ, 2005, PHARMACOTHERAPY, V25, P611, DOI 10.1592/phco.25.4.611.61020; Krantz MJ, 2005, J ADDICT DIS, V24, P53, DOI 10.1300/J069v24n01_05; Krantz MJ, 2003, PHARMACOTHERAPY, V23, P802, DOI 10.1592/phco.23.6.802.32186; Krantz MJ, 2002, ANN INTERN MED, V137, P501, DOI 10.7326/0003-4819-137-6-200209170-00010; Krantz MJ, 2007, J ADDICT DIS, V26, P79, DOI 10.1300/J069v26n04_10; Krantz MJ, 2006, LANCET, V368, P556, DOI 10.1016/S0140-6736(06)69173-3; KURITA T, 1993, PACE, V16, P33, DOI 10.1111/j.1540-8159.1993.tb01532.x; Lamont P, 2006, J GEN INTERN MED, V21, pC9, DOI 10.1111/j.1525-1497.2006.00588.x; Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; LEE CH, 1977, J PHARMACOL EXP THER, V202, P646; LIPSKI J, 1973, AM HEART J, V86, P663, DOI 10.1016/0002-8703(73)90344-X; Lucchini A, 2004, AM J CARDIOL, V94, P147, DOI 10.1016/j.amjcard.2003.12.071; Luthi B, 2007, EUR J CLIN MICROBIOL, V26, P367, DOI 10.1007/s10096-007-0293-5; Maremmani I, 2005, EUR ADDICT RES, V11, P44, DOI 10.1159/000081416; Martell BA, 2005, AM J CARDIOL, V95, P915, DOI 10.1016/j.amjcard.2004.11.055; *MED HEALTHC PROD, 2006, CURR PROBL PHARM, V31; Milon D, 1982, Ann Fr Anesth Reanim, V1, P513, DOI 10.1016/S0750-7658(82)80094-4; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ower Katherine, 2005, J Opioid Manag, V1, P73; Patel AM, 2008, AM J CARDIOL, V101, P209, DOI 10.1016/j.amjcard.2007.07.068; Pearson EC, 2005, PHARMACOEPIDEM DR S, V14, P747, DOI 10.1002/pds.1112; Peles E, 2007, ADDICTION, V102, P289, DOI 10.1111/j.1360-0443.2006.01668.x; Piguet V, 2004, J CLIN PSYCHOPHARM, V24, P446, DOI 10.1097/01.jcp.0000132347.81455.57; Pimentel L, 2008, J EMERG MED, V34, P287, DOI 10.1016/j.jemermed.2007.03.053; Porter BO, 2005, AM J HEMATOL, V78, P316, DOI 10.1002/ajh.20304; Rademacher S, 2005, ANN PHARMACOTHER, V39, P1762, DOI 10.1345/aph.1G277; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; RENDIG SV, 1980, J PHARMACOL EXP THER, V215, P259; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Routhier DD, 2007, J EMERG MED, V32, P275, DOI 10.1016/j.jemermed.2006.07.027; SALLE P, 1985, ANN CARDIOL ANGEIOL, V34, P381; SEYLER DE, 1983, FUND APPL TOXICOL, V3, P536, DOI 10.1016/S0272-0590(83)80101-8; Shah N, 2005, ADDICTION, V100, P176, DOI 10.1111/j.1360-0443.2004.00956.x; Shaiova Lauren, 2008, Palliat Support Care, V6, P165, DOI 10.1017/S1478951508000254; SORG MH, 2003, MAINE DRUG RELATED M; SOYKA LF, 1990, AM J CARDIOL, V65, pA74; Sticherling C, 2005, SWISS MED WKLY, V135, P282; STICKNEY JL, 1977, TOXICOL APPL PHARM, V40, P23, DOI 10.1016/0041-008X(77)90112-0; *SUBS AB MENT HLTH, 2003, METH ASS MORT REP NA; *SUBS AB MENT HLTH, 2007, METH MORT REASS; The College of Physicians of Ontario Canada, 2005, METH MAINT GUID; *U AR CTR ED RES T, 2008, DRUGS RISK TORS POIN; US Department of Health and Human Services Food and Drug Administration Centre for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2005, GUID IND E14 CLIN EV; Viskin S, 1999, LANCET, V354, P1625, DOI 10.1016/S0140-6736(99)02107-8; Walker PW, 2003, PAIN, V103, P321, DOI 10.1016/S0304-3959(02)00461-X; Wedam EF, 2007, ARCH INTERN MED, V167, P2469, DOI 10.1001/archinte.167.22.2469; WESLEY RC, 1992, AM HEART J, V123, P794, DOI 10.1016/0002-8703(92)90525-Z; Wheeler AD, 2006, PEDIATR CRIT CARE ME, V7, P83, DOI 10.1097/01.PCC.0000192337.00842.1E; Wong SC, 2007, J MED TOXICOL, V3, P190, DOI 10.1007/BF03160939	93	209	215	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					387	W69		10.7326/0003-4819-150-6-200903170-00103	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19153406				2022-12-28	WOS:000264468500004
J	Nozawa, K; O'Donoghue, P; Gundllapalli, S; Araiso, Y; Ishitani, R; Umehara, T; Soll, D; Nureki, O				Nozawa, Kayo; O'Donoghue, Patrick; Gundllapalli, Sarath; Araiso, Yuhei; Ishitani, Ryuichiro; Umehara, Takuya; Soell, Dieter; Nureki, Osamu			Pyrrolysyl-tRNA synthetase-tRNA(Pyl) structure reveals the molecular basis of orthogonality	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; GENETIC-CODE; IN-VITRO; SYNTHETASES; RECOGNITION; TRNA(PHE); PROTEINS; ARCHAEA	Pyrrolysine (Pyl), the 22nd natural amino acid, is genetically encoded by UAG and inserted into proteins by the unique suppressor tRNA(Pyl) (ref.1). The Methanosarcinaceae produce Pyl and express Pyl-containing methyltransferases that allow growth on methylamines(2). Homologous methyltransferases and the Pyl biosynthetic and coding machinery are also found in two bacterial species(1,3). Pyl coding is maintained by pyrrolysyl-tRNA synthetase (PylRS), which catalyses the formation of Pyl-tRNA(Pyl) (refs 4, 5). Pyl is not a recent addition to the genetic code. PylRS was already present in the last universal common ancestor(6); it then persisted in organisms that utilize methylamines as energy sources. Recent protein engineering efforts added non-canonical amino acids to the genetic code(7,8). This technology relies on the directed evolution of an 'orthogonal' tRNA synthetase-tRNA pair in which an engineered aminoacyl-tRNA synthetase (aaRS) specifically and exclusively acylates the orthogonal tRNA with a non-canonical amino acid. For Pyl the natural evolutionary process developed such a system some 3 billion years ago. When transformed into Escherichia coli, Methanosarcina barkeri PylRS and tRNA(Pyl) function as an orthogonal pair in vivo(5,9). Here we show that Desulfitobacterium hafniense PylRS-tRNA(Pyl) is an orthogonal pair in vitro and in vivo, and present the crystal structure of this orthogonal pair. The ancient emergence of PylRS tRNA(Pyl) allowed the evolution of unique structural features in both the protein and the tRNA. These structural elements manifest an intricate, specialized aaRS-tRNA interaction surface that is highly distinct from those observed in any other known aaRS-tRNA complex; it is this general property that underlies the molecular basis of orthogonality.	[O'Donoghue, Patrick; Gundllapalli, Sarath; Umehara, Takuya; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nozawa, Kayo; Araiso, Yuhei; Nureki, Osamu] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan	Yale University; Yale University; Tokyo Institute of Technology; University of Tokyo	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; nureki@ims.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014	Nozawa, Kayo/0000-0001-6677-7195; O'Donoghue, Patrick/0000-0002-9500-8640	National Science Foundation; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology; Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Kurata Memorial Hitachi Science and Technology Foundation; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NW12 of PF-AR (Tsukuba, Japan) for technical help during data collection. P.O. holds a National Science Foundation postdoctoral fellowship in Biological Informatics. This work was supported by grants from the Japan Science and Technology Agency (to O.N.), from the National Project on Protein Structural and Functional Analyses of the Ministry of Education, Culture, Sports, Science and Technology (to O.N.), from the Ministry of Education, Culture, Sports, Science and Technology (to R.I. and O.N.), from the Mitsubishi Foundation (to O.N.), from the Kurata Memorial Hitachi Science and Technology Foundation (to O.N.), from the National Institute of General Medical Sciences (to D. S.), from the Department of Energy (to D. S.), and from the National Science Foundation (to D. S.).	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Briand C, 2000, J MOL BIOL, V299, P1051, DOI 10.1006/jmbi.2000.3819; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Herring S, 2007, FEBS LETT, V581, P3197, DOI 10.1016/j.febslet.2007.06.004; Herring S, 2007, NUCLEIC ACIDS RES, V35, P1270, DOI 10.1093/nar/gkl1151; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Lee MM, 2008, BIOCHEM BIOPH RES CO, V374, P470, DOI 10.1016/j.bbrc.2008.07.074; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Moor N, 2006, BIOCHEMISTRY-US, V45, P10572, DOI 10.1021/bi060491l; MURGOLA EJ, 1985, ANNU REV GENET, V19, P57, DOI 10.1146/annurev.genet.19.1.57; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Theobald-Dietrich A, 2004, NUCLEIC ACIDS RES, V32, P1091, DOI 10.1093/nar/gkh266; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasil'eva IA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P247, DOI 10.1134/S0006297907030029; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; YANOFSKY C, 1972, J BIOL CHEM, V247, P4494; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514	35	130	140	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1163	U127		10.1038/nature07611	http://dx.doi.org/10.1038/nature07611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19118381	Green Accepted			2022-12-28	WOS:000263680100048
J	Kim, MS; Cho, JY				Kim, M. S.; Cho, Jaeyoon			PHYSICS Teleporting a Quantum State to Distant Matter	SCIENCE			English	Editorial Material							ATOMIC ENSEMBLES; PHOTON PAIRS; INTERFERENCE; COMMUNICATION; MEMORY		[Kim, M. S.; Cho, Jaeyoon] Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Kim, MS (corresponding author), Queens Univ Belfast, Sch Math & Phys, Belfast BT7 1NN, Antrim, North Ireland.	m.s.kim@qub.ac.uk; choooir@gmail.com	Cho, Jaeyoon/H-1864-2011; Kim, Myungshik/G-6046-2010	Cho, Jaeyoon/0000-0002-2347-9013; 				BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Chen YA, 2008, NAT PHYS, V4, P103, DOI 10.1038/nphys832; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; Maunz P, 2007, NAT PHYS, V3, P538, DOI 10.1038/nphys644; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	15	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					469	470		10.1126/science.1169279	http://dx.doi.org/10.1126/science.1169279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164736				2022-12-28	WOS:000262587900029
J	Dekel, A; Birnboim, Y; Engel, G; Freundlich, J; Goerdt, T; Mumcuoglu, M; Neistein, E; Pichon, C; Teyssier, R; Zinger, E				Dekel, A.; Birnboim, Y.; Engel, G.; Freundlich, J.; Goerdt, T.; Mumcuoglu, M.; Neistein, E.; Pichon, C.; Teyssier, R.; Zinger, E.			Cold streams in early massive hot haloes as the main mode of galaxy formation	NATURE			English	Article							INTEGRAL FIELD SPECTROSCOPY; SUBMILLIMETER GALAXIES; MAJOR MERGERS; DISK GALAXIES; DARK-MATTER; TO 2; EVOLUTION; ACCRETION; Z-SIMILAR-TO-2.3; SIMULATIONS	Massive galaxies in the young Universe, ten billion years ago, formed stars at surprising intensities(1,2). Although this is commonly attributed to violent mergers, the properties of many of these galaxies are incompatible with such events, showing gas- rich, clumpy, extended rotating disks not dominated by spheroids(1-5). Cosmological simulations(6) and clustering theory(6,7) are used to explore how these galaxies acquired their gas. Here we report that they are 'stream- fed galaxies', formed from steady, narrow, cold gas streams that penetrate the shock- heated media of massive dark matter haloes(8,9). A comparison with the observed abundance of star- forming galaxies implies that most of the input gas must rapidly convert to stars. One- third of the stream mass is in gas clumps leading to mergers of mass ratio greater than 1: 10, and the rest is in smoother flows. With a merger duty cycle of 0.1, three- quarters of the galaxies forming stars at a given rate are fed by smooth streams. The rarer, submillimetre galaxies that form stars even more intensely(2,12,13) are largely merger- induced starbursts. Unlike destructive mergers, the streams are likely to keep the rotating disk configuration intact, although turbulent and broken into giant star- forming clumps that merge into a central spheroid(4,10,11). This stream- driven scenario for the formation of discs and spheroids is an alternative to the merger picture.	[Dekel, A.; Birnboim, Y.; Engel, G.; Freundlich, J.; Goerdt, T.; Mumcuoglu, M.; Neistein, E.; Zinger, E.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Birnboim, Y.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Freundlich, J.] Ecole Normale Super, Dept Phys, F-75231 Paris, France; [Neistein, E.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Pichon, C.] Inst Astrophys, F-75014 Paris, France; [Pichon, C.] UPMC, F-75014 Paris, France; [Teyssier, R.] CEA Saclay, DSM IRFU, UMR AIM, F-91191 Gif Sur Yvette, France; [Teyssier, R.] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland	Hebrew University of Jerusalem; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Zurich	Dekel, A (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	dekel@phys.huji.ac.il	Freundlich, Jonathan/AAG-4080-2021; Teyssier, Romain/ABI-4449-2020; Zinger, Elad/AAM-9956-2021; Dekel, Avishai/ABF-9516-2021; Birnboim, Yuval/AAM-8719-2021	Freundlich, Jonathan/0000-0002-5245-7796; Zinger, Elad/0000-0002-6316-3996; Dekel, Avishai/0000-0003-4174-0374; Birnboim, Yuval/0000-0002-6547-8545; Teyssier, Romain/0000-0001-7689-0933	France-Israel Teamwork in Sciences; German-Israel Science Foundation; Israel Science Foundation; NASA Theory Program at UCSC; Minerva fellowship	France-Israel Teamwork in Sciences; German-Israel Science Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); NASA Theory Program at UCSC(National Aeronautics & Space Administration (NASA)); Minerva fellowship	We acknowledge discussions with N.Bouche, S. M. Faber, R. Genzel, D. Koo, A. Kravtsov, A. Pope, J. R. Primack, J. Prochaska, A. Sternberg and J. Wall. This research was supported by the France-Israel Teamwork in Sciences, the German-Israel Science Foundation, the Israel Science Foundation, a NASA Theory Program at UCSC, and a Minerva fellowship (T.G.). We thank the Barcelona Centro Nacional de Supercomputacion for computer resources and technical support. The simulation is part of the Horizon collaboration.	Adelberger KL, 2004, ASTROPHYS J, V607, P226, DOI 10.1086/383221; Birnboim Y, 2003, MON NOT R ASTRON SOC, V345, P349, DOI 10.1046/j.1365-8711.2003.06955.x; Birnboim Y, 2007, MON NOT R ASTRON SOC, V380, P339, DOI 10.1111/j.1365-2966.2007.12074.x; Chapman SC, 2004, ASTROPHYS J, V614, P671, DOI 10.1086/423833; Cox TJ, 2008, MON NOT R ASTRON SOC, V384, P386, DOI 10.1111/j.1365-2966.2007.12730.x; Daddi E, 2004, ASTROPHYS J, V617, P746, DOI 10.1086/425569; Dekel A, 2003, MON NOT R ASTRON SOC, V344, P1131, DOI 10.1046/j.1365-8711.2003.06923.x; Dekel A, 2006, MON NOT R ASTRON SOC, V368, P2, DOI 10.1111/j.1365-2966.2006.10145.x; Dekel A, 2008, MON NOT R ASTRON SOC, V383, P119, DOI 10.1111/j.1365-2966.2007.12569.x; Elmegreen BG, 2008, ASTROPHYS J, V688, P67, DOI 10.1086/592190; Elmegreen DM, 2004, ASTROPHYS J, V604, pL21, DOI 10.1086/383312; Finlator K, 2006, ASTROPHYS J, V639, P672, DOI 10.1086/499349; Genel S, 2008, ASTROPHYS J, V688, P789, DOI 10.1086/592241; Genzel R, 2008, ASTROPHYS J, V687, P59, DOI 10.1086/591840; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; KERES D, 2008, GALAXIES SIMULATED A; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Kriek M, 2006, ASTROPHYS J, V649, pL71, DOI 10.1086/508371; NAGAMINE K, 2008, LYMAN ALPHA EMITTERS; Neistein E, 2008, MON NOT R ASTRON SOC, V388, P1792, DOI 10.1111/j.1365-2966.2008.13525.x; Neistein E, 2008, MON NOT R ASTRON SOC, V383, P615, DOI 10.1111/j.1365-2966.2007.12570.x; Neistein E, 2006, MON NOT R ASTRON SOC, V372, P933, DOI 10.1111/j.1365-2966.2006.10918.x; Noguchi M, 1999, ASTROPHYS J, V514, P77, DOI 10.1086/306932; Ocvirk P, 2008, MON NOT R ASTRON SOC, V390, P1326, DOI 10.1111/j.1365-2966.2008.13763.x; ROBERTSON BE, 2004, ASTROPHYS J, V685, pL27; Schreiber NMF, 2006, ASTROPHYS J, V645, P1062, DOI 10.1086/504403; Stark DP, 2008, NATURE, V455, P775, DOI 10.1038/nature07294; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; Wall JV, 2008, MON NOT R ASTRON SOC, V383, P435, DOI 10.1111/j.1365-2966.2007.12547.x	33	1222	1224	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					451	454		10.1038/nature07648	http://dx.doi.org/10.1038/nature07648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158792	Green Accepted, Green Submitted			2022-12-28	WOS:000262519200040
J	Stine, AR; Huybers, P; Fung, IY				Stine, A. R.; Huybers, P.; Fung, I. Y.			Changes in the phase of the annual cycle of surface temperature	NATURE			English	Article							SOIL-MOISTURE; GLOBAL DISTRIBUTION; SEMIANNUAL CYCLES; MEAN TEMPERATURE; AIR-TEMPERATURE; CLIMATE; MODEL; RADIATION; DATASET; SEASONS	The annual cycle in the Earth's surface temperature is extremely large - comparable in magnitude to the glacial - interglacial cycles over most of the planet. Trends in the phase and the amplitude of the annual cycle have been observed, but the causes and significance of these changes remain poorly understood - in part because we lack an understanding of the natural variability. Here we show that the phase of the annual cycle of surface temperature over extratropical land shifted towards earlier seasons by 1.7 days between 1954 and 2007; this change is highly anomalous with respect to earlier variations, which we interpret as being indicative of the natural range. Significant changes in the amplitude of the annual cycle are also observed between 1954 and 2007. These shifts in the annual cycles appear to be related, in part, to changes in the northern annular mode of climate variability, although the land phase shift is significantly larger than that predicted by trends in the northern annular mode alone. Few of the climate models presented by the Intergovernmental Panel on Climate Change reproduce the observed decrease in amplitude and none reproduce the shift towards earlier seasons.	[Stine, A. R.; Fung, I. Y.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Huybers, P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Harvard University	Stine, AR (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	zan@atmos.berkeley.edu	Stine, Alexander/O-8104-2016	Stine, Alexander/0000-0002-1676-5572; Huybers, Peter/0000-0002-3734-8145	Chancellor's Fellowship; University of California; US National Science Foundation [0645936, 0628278]; Office of Science, US Department of Energy	Chancellor's Fellowship; University of California(University of California System); US National Science Foundation(National Science Foundation (NSF)); Office of Science, US Department of Energy(United States Department of Energy (DOE))	We thank M. Tingley, A. Swann and L. Morgan for comments that improved the manuscript. A. R. S. was funded in part by a Chancellor's Fellowship from the University of California. P.H. was funded in part by US National Science Foundation award 0645936. I. Y. F. acknowledges support from US National Science Foundation award 0628278. We acknowledge the Program for Climate Model Diagnosis and Intercomparison and the WCRP's Working Group on Coupled Modelling for their roles in making available the WCRP Coupled Model Intercomparison Project Phase 3 multi- model simulations. Support for these simulations is provided by the Office of Science, US Department of Energy.	Balling RC, 1998, CLIMATE RES, V9, P175, DOI 10.3354/cr009175; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cohen J, 1999, GEOPHYS RES LETT, V26, P345, DOI 10.1029/1998GL900321; Cohen J, 2005, J CLIMATE, V18, P973, DOI 10.1175/JCLI-3305.1; CUMING MJ, 1981, M254 MIL MET INT; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Eliseev AV, 2006, IZV ATMOS OCEAN PHY+, V42, P300, DOI 10.1134/S0001433806030030; GATES WL, 1992, B AM METEOROL SOC, V73, P1962, DOI 10.1175/1520-0477(1992)073<1962:ATAMIP>2.0.CO;2; GOODY RM, 1995, PRINCIPLES ATMOSPHER, pCH5; HSU CPF, 1976, MON WEATHER REV, V104, P1093, DOI 10.1175/1520-0493(1976)104<1093:TGDOTA>2.0.CO;2; Jain S, 1999, J CLIMATE, V12, P1086, DOI 10.1175/1520-0442(1999)012<1086:SAIVON>2.0.CO;2; Jones PD, 1997, J CLIMATE, V10, P2548, DOI 10.1175/1520-0442(1997)010<2548:ESEILS>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; Karl TR, 1996, SCIENCE, V271, P1879, DOI 10.1126/science.271.5257.1879; KENDREW WG, 1961, CLIMATE CONTINENTS; Li HB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007455; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; MADDEN RA, 1993, J CLIMATE, V6, P1057, DOI 10.1175/1520-0442(1993)006<1057:TEOISA>2.0.CO;2; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Mann ME, 1996, GEOPHYS RES LETT, V23, P1111, DOI 10.1029/96GL01066; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; PARKER DE, 1994, J GEOPHYS RES-ATMOS, V99, P14373, DOI 10.1029/94JD00548; PRESCOTT JA, 1951, Q J ROY METEOR SOC, V77, P121, DOI 10.1002/qj.49707733112; Quadrelli R, 2004, J CLIMATE, V17, P3728, DOI 10.1175/1520-0442(2004)017<3728:ASLFFI>2.0.CO;2; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Robock A, 2000, B AM METEOROL SOC, V81, P1281, DOI [10.1175/1520-0477(2000)081<1281:TGSMDB>2.3.CO;2, 10.1175/1520-0477(2000)081&lt;1281:TGSMDB&gt;2.3.CO;2]; Saito K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016341; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Shell KM, 2005, J CLIMATE, V18, P1753, DOI 10.1175/JCLI3373.1; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; THOMPSON R, 1995, INT J CLIMATOL, V15, P175, DOI 10.1002/joc.3370150204; THOMSON DJ, 1995, SCIENCE, V268, P59, DOI 10.1126/science.268.5207.59; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; VANLOON H, 1972, METEOROL MONOGR, V35, P25; VINNIKOV KY, 1991, J CLIMATE, V4, P66, DOI 10.1175/1520-0442(1991)004<0066:SMEDAM>2.0.CO;2; Wallace CJ, 2002, CLIMATE RES, V22, P1, DOI 10.3354/cr022001; Wallace JM, 1996, J CLIMATE, V9, P249, DOI 10.1175/1520-0442(1996)009<0249:IOITIN>2.0.CO;2; WALLACE JM, 1995, SCIENCE, V270, P780, DOI 10.1126/science.270.5237.780; WARD R, 1900, B AM GEOGR SOC, V38, P401; WHITE GH, 1978, MON WEATHER REV, V106, P901, DOI 10.1175/1520-0493(1978)106<0901:TGDOTA>2.0.CO;2; WIGLEY TML, 1981, NATURE, V292, P205, DOI 10.1038/292205a0; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; YEH TC, 1984, MON WEATHER REV, V112, P474, DOI 10.1175/1520-0493(1984)112<0474:TEOSMO>2.0.CO;2	51	172	177	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					435	U1		10.1038/nature07675	http://dx.doi.org/10.1038/nature07675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158790	Green Published			2022-12-28	WOS:000262519200037
J	Jack, A				Jack, Andrew			Drug Industry: Radical treatments for difficult times	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*ASTRAZENECA, 2008, REALIGN SUPPLY CHAIN; *ASTRAZENECA, 2008, SETT US PULMICORT RE; *ASTRAZENECA, 2008, COND CONSOL INCOME; *ASTRAZENECA, 2008, CRESTOR DEMONSTR; BERGER R, 2008, GLOB PHARM IND; *GSK, 2008, GSK PROPOSE CLOSE	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2009	338								a2955	10.1136/bmj.a2955	http://dx.doi.org/10.1136/bmj.a2955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405BQ	19141500				2022-12-28	WOS:000263197500023
J	Sorrell, MF; Belongia, EA; Costa, J; Gareen, IF; Grem, JL; Inadomi, JM; Kern, ER; McHugh, JA; Petersen, GM; Rein, MF; Strader, DB; Trotter, HT				Sorrell, Michael F.; Belongia, Edward A.; Costa, Jose; Gareen, Ilana F.; Grem, Jean L.; Inadomi, John M.; Kern, Earl R.; McHugh, James A.; Petersen, Gloria M.; Rein, Michael F.; Strader, Doris B.; Trotter, Hartwell T.			National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B	ANNALS OF INTERNAL MEDICINE			English	Article									[Sorrell, Michael F.] Univ Nebraska Med Ctr, Omaha, NE USA; Marshfield Clin Res Fdn, Marshfield, WI USA; Yale Univ, Sch Med, New Haven, CT USA; Brown Univ, Providence, RI 02912 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; Univ Washington, Sch Med, Seattle, WA USA; Swedish Phys Cent Seattle Clin, Seattle, WA USA; Mayo Clin, Rochester, MN USA; Univ Vermont, Coll Med, Burlington, VT USA; Amer Melanoma Fdn, San Diego, CA USA; Univ Virginia, Charlottesville, VA USA	University of Nebraska System; University of Nebraska Medical Center; Yale University; Brown University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Swedish Medical Center; Mayo Clinic; University of Vermont; University of Virginia	Sorrell, MF (corresponding author), Univ Nebraska Med Ctr, Omaha, NE USA.		Inadomi, John/A-6221-2014; Gareen, Ilana/I-2816-2014	Inadomi, John/0000-0001-6776-8661; Belongia, Edward/0000-0001-7478-0415; Gareen, Ilana/0000-0002-0457-5595				Shamliyan TA, 2009, ANN INTERN MED, V150, P111, DOI 10.7326/0003-4819-150-2-200901200-00101	1	202	215	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					104	U63		10.7326/0003-4819-150-2-200901200-00100	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19124811				2022-12-28	WOS:000262655200005
J	Iglehart, JK				Iglehart, John K.			Visions for Change in U. S. Health Care-The Players and the Possibilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Baucus M., 2008, CALL ACTION HLTH REF; DASCHLE T, 2008, CRITICAL WHAT WE CAN; Iglehart JK, 2007, NEW ENGL J MED, V356, P734, DOI 10.1056/NEJMhpr066650; OBAMA B, B OBAMA J BIDENS PLA; Wyden R, 2008, HEALTH AFFAIR, V27, P689, DOI 10.1377/hlthaff.27.3.689	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					205	207		10.1056/NEJMp0810593	http://dx.doi.org/10.1056/NEJMp0810593			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144934				2022-12-28	WOS:000262434500001
J	Pirkola, S; Sund, R; Sailas, E; Wahlbeck, K				Pirkola, Sami; Sund, Reijo; Sailas, Eila; Wahlbeck, Kristian			Community mental-health services and suicide rate in Finland: a nationwide small-area analysis	LANCET			English	Article							UNITED-STATES; PSYCHOLOGICAL AUTOPSY; ALCOHOL-CONSUMPTION; MAPPING SCHEDULE; RISK; CARE; UNEMPLOYMENT; ASSOCIATION; PREVENTION; DISORDERS	Background In many countries, psychiatric services have been reformed by reducing the size of hospitals and developing community mental-health services. We investigated this reform by assessing the relation between suicide risk and different ways of organising rnental-health services. Methods We did a nationwide comprehensive survey of Finnish adult mental-health service units between Sept 1, 2004, and March 31, 2005. From health-care or social-care officers of 428 municipalities, we asked for information, classified according to the European service mapping schedule, about adult mental-health services. For each municipality, we measured age-adjusted and sex-adjusted suicide risk, pooled between 2000 and 2004, and then adjusted for register-derived socioeconomic factors. Findings A wide variety of outpatient services (relative risk [RR] 0 . 92, 95% CI 0.- 87-0.96), prominence of outpatient versus inpatient services (0 . 93, 0.89-0.97), and 24-h emergency services (0 . 84, 0.75-0.92) were associated with decreased death rates from suicide. However, after adjustment for socioeconomic factors, only the prominence of outpatient services was associated with low suicide rate (0.94, 0.90-0.98). We replicated this finding even after adjustment for organisational changes and inpatient treatment. Interpretation Well-developed community mental-health services are associated with lower suicide rates than are services oriented towards inpatient treatment provision. These data are consistent with the idea that population mental health can be improved by use of multifaceted, community-based, specialised mental-health services. Funding Academy of Finland.	[Pirkola, Sami] Univ Helsinki, Cent Hosp, Dept Psychiat, FIN-00029 Helsinki, Finland; [Pirkola, Sami; Sailas, Eila; Wahlbeck, Kristian] Natl Res & Dev Ctr Welf & Hlth STAKES, Mental Hlth Grp, Helsinki, Finland; [Sund, Reijo] STAKES, Hlth Serv & Policy Res, Helsinki, Finland; [Sailas, Eila] Helsinki & Uusimaa Hosp Dist, Helsinki, Finland; [Wahlbeck, Kristian] Vaasa Cent Hosp, Vaasa, Finland	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; Vaasa Central Hospital	Pirkola, S (corresponding author), Univ Helsinki, Cent Hosp, Dept Psychiat, POB 590, FIN-00029 Helsinki, Finland.	sami.pirkola@hus.fi	Sund, Reijo/N-5471-2016; Wahlbeck, Kristian/F-8394-2011	Sund, Reijo/0000-0002-6268-8117; Wahlbeck, Kristian/0000-0003-3754-3933; Pirkola, Sami/0000-0003-0138-3130	Academy of Finland; MERTTU [105218]	Academy of Finland(Academy of Finland); MERTTU	Mirja Asikainen and Marko Ekqvist were the most the important collaborators in data collection and data management. This study has been supported by the Academy of Finland (MERTTU project, grant number 105218).	Appleby L, 1999, BRIT J PSYCHIAT, V175, P168, DOI 10.1192/bjp.175.2.168; APPLEBY L, 1992, BRIT J PSYCHIAT, V161, P749, DOI 10.1192/bjp.161.6.749; Beautrais AL, 1998, PSYCHOL MED, V28, P209, DOI 10.1017/S0033291797005990; Beecham J, 2000, ACTA PSYCHIAT SCAND, V102, P33, DOI 10.1111/j.0902-4441.2000.t01-1-acp28[dash]02.x; Berk M, 2006, PSYCHOL MED, V36, P181, DOI 10.1017/S0033291705006665; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Congdon P, 2000, EUR J POPUL, V16, P251, DOI 10.1023/A:1026587810551; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Johnson S, 2000, ACTA PSYCHIAT SCAND, V102, P14, DOI 10.1111/j.0902-4441.2000.t01-1-acp28[dash]03.x; LEENAARS AA, 1994, SUICIDE LIFE-THREAT, V24, P184; Leff H Stephen, 2004, Ment Health Serv Res, V6, P93, DOI 10.1023/B:MHSR.0000024353.30425.ab; MALONE D, 2007, COCHRANE DB SYST REV, V4; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mechanic D, 1998, ARCH GEN PSYCHIAT, V55, P785, DOI 10.1001/archpsyc.55.9.785; Middleton N, 2006, J EPIDEMIOL COMMUN H, V60, P1040, DOI 10.1136/jech.2005.045302; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nemtsov A, 2003, DRUG ALCOHOL DEPEN, V71, P161, DOI 10.1016/S0376-8716(03)00094-2; Pincock S, 2003, LANCET, V362, P1126, DOI 10.1016/S0140-6736(03)14502-3; Pirkola S., 2005, ATLAS MENTAL HLTH ST; Pirkola S, 2007, PSYCHIAT SERV, V58, P221, DOI 10.1176/appi.ps.58.2.221; Pirkola SP, 2000, ALCOHOL ALCOHOLISM, V35, P70, DOI 10.1093/alcalc/35.1.70; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Salvador-Carulla L, 2005, SOC PSYCH PSYCH EPID, V40, P149, DOI 10.1007/s00127-005-0860-y; Swahn MH, 2008, AM J PREV MED, V34, P30, DOI 10.1016/j.amepre.2007.09.020; Thornicroft G, 2004, BRIT J PSYCHIAT, V185, P283, DOI 10.1192/bjp.185.4.283; Tondo L, 2006, J CLIN PSYCHIAT, V67, P517, DOI 10.4088/JCP.v67n0402	31	117	120	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					147	153		10.1016/S0140-6736(08)61848-6	http://dx.doi.org/10.1016/S0140-6736(08)61848-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19097638				2022-12-28	WOS:000262340900029
J	Dupont, S; Mamidi, A; Cordenonsi, M; Montagner, M; Zacchigna, L; Adorno, M; Martello, G; Stinchfield, MJ; Soligo, S; Morsut, L; Inui, M; Moro, S; Modena, N; Argenton, F; Newfeld, SJ; Piccolo, S				Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Stinchfield, Michael J.; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Moro, Stefano; Modena, Nicola; Argenton, Francesco; Newfeld, Stuart J.; Piccolo, Stefano			FAM/USP9x, a Deubiquitinating Enzyme Essential for TGF beta Signaling, Controls Smad4 Monoubiquitination	CELL			English	Article							GROWTH-FACTOR-BETA; FAT-FACETS GENE; UBIQUITIN LIGASE; TUMOR-CELLS; INDUCTION; CANCER; PHOSPHORYLATION; PATHWAYS; RECEPTOR; P53	The assembly of the Smad complex is critical for TGF beta signaling, yet the mechanisms that inactivate or empower nuclear Smad complexes are less understood. By means of siRNA screen we identified FAM (USP9x), a deubiquitinase acting as essential and evolutionarily conserved component in TGFb and bone morphogenetic protein signaling. Smad4 is monoubiquitinated in lysine 519 in vivo, a modification that inhibits Smad4 by impeding association with phospho-Smad2. FAM reverts this negative modification, re-empowering Smad4 function. FAM opposes the activity of Ectodermin/Tif1 gamma (Ecto), a nuclear factor for which we now clarify a prominent role as Smad4 monoubiquitin ligase. Our study points to Smad4 monoubiquitination and deubiquitination as a way for cells to set their TGF beta responsiveness: loss of FAM disables Smad4-dependent responses in several model systems, with Ecto being epistatic to FAM. This defines a regulative ubiquitination step controlling Smads that is parallel to those impinging on R-Smad phosphorylation.	[Dupont, Sirio; Mamidi, Anant; Cordenonsi, Michelangelo; Montagner, Marco; Zacchigna, Luca; Adorno, Maddalena; Martello, Graziano; Soligo, Sandra; Morsut, Leonardo; Inui, Masafumi; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Stinchfield, Michael J.; Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Modena, Nicola; Argenton, Francesco] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Moro, Stefano] Univ Padua, Dept Pharmaceut Sci, Mol Modeling Sect, I-35131 Padua, Italy	University of Padua; Arizona State University; Arizona State University-Tempe; University of Padua; University of Padua	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	piccolo@civ.bio.unipd.it	Montagner, Marco/AAY-3236-2020; Argenton, Francesco/AAS-8494-2021; Stinchfield, Michael/AAW-8983-2020; Inui, Masafumi/GWZ-2521-2022; Martello, Graziano/AAM-3325-2021; Cordenonsi, Michelangelo/K-7692-2016; Moro, Stefano/A-2979-2012; 高, 雨莉/HGU-8187-2022; Dupont, Sirio/AAP-8133-2021	Montagner, Marco/0000-0003-3080-2138; Argenton, Francesco/0000-0002-0803-8236; Inui, Masafumi/0000-0003-4720-007X; Cordenonsi, Michelangelo/0000-0002-8253-5724; Moro, Stefano/0000-0002-7514-3802; Mamidi, Anant/0000-0001-7953-7991; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966; Martello, Graziano/0000-0001-5520-085X	TELETHON-Italy [GGP07218]; Cariparo Foundation Excellence Grant, ASI; Swissbridge; AIRC; Marie Curie Epiplast Carcinoma RTN; NIH [CA095875]; SFAz [CAA0285-08]; EU [LSH-CT-2003-503496]; NATIONAL CANCER INSTITUTE [R01CA095875] Funding Source: NIH RePORTER	TELETHON-Italy(Fondazione Telethon); Cariparo Foundation Excellence Grant, ASI(Agenzia Spaziale Italiana (ASI)); Swissbridge; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie Curie Epiplast Carcinoma RTN(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFAz; EU(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are indebted to Caroline Hill for thoughtful discussions. We are grateful to S. Wood, K. Kaibuchi, F. Francis, A. Moustakas, P. Ten Dijke, C. Hill, M. Brattain, J. Massague, and C. Chang for gifts of reagents and Angela Bachi for comments. A special thanks to Anna Cabrelle for technical assistance with the FACS. Thanks to Oliver Wessely and Giorgio Bressan for reading the manuscript. We are also grateful to Chemical Computing Group and in particular to Dr. Andrea Bortolato for his assistance in molecular modeling. This work is supported by TELETHON-Italy (GGP07218), Cariparo Foundation Excellence Grant, ASI, and Swissbridge grants (to S. P.), and by an AIRC grant (to S. D.). A. M. is recipient of a Marie Curie Epiplast Carcinoma RTN network fellowship. S.J.N. is supported by the NIH (grant CA095875) and SFAz (grant CAA0285-08); F. A. is supported by EU grant LSH-CT-2003-503496.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; De Bosscher K, 2004, BIOCHEM J, V379, P209, DOI 10.1042/BJ20031886; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heldin CH, 2006, DEV CELL, V10, P685, DOI 10.1016/j.devcel.2006.05.006; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KONIKOFF EC, 2008, J MOL EVOL IN PRESS, DOI DOI 10.1007/S00239-008-9159-4; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Marquez RM, 2001, GENETICS, V157, P1639; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	36	387	398	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					123	135		10.1016/j.cell.2008.10.051	http://dx.doi.org/10.1016/j.cell.2008.10.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135894	Bronze			2022-12-28	WOS:000262318400020
J	Kanungo, M; Lu, H; Malliaras, GG; Blanchet, GB				Kanungo, Mandakini; Lu, Helen; Malliaras, George G.; Blanchet, Graciela B.			Suppression of Metallic Conductivity of Single-Walled Carbon Nanotubes by Cycloaddition Reactions	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; SIDEWALL FUNCTIONALIZATION; SPECTROSCOPY; NETWORKS	The high carrier mobility of films of semiconducting single- walled carbon nanotubes ( SWNTs) is attractive for electronics applications, but the presence of metallic SWNTs leads to high off- currents in transistor applications. The method presented here, cycloaddition of fluorinated olefins, represents an effective approach toward converting the "as grown" commercial SWNT mats into high- mobility semiconducting tubes with high yield and without further need for carbon nanotube separation. Thin- film transistors, fabricated from percolating arrays of functionalized carbon nanotubes, exhibit mobilities > 100 square centimeters per volt- second and on- off ratios of 100,000. This method should allow for the use of semiconducting carbon nanotubes in commercial electronic devices and provide a low- cost route to the fabrication of electronic inks.	[Lu, Helen; Blanchet, Graciela B.] DuPont Co Inc, Mat Sci & Engn, Wilmington, DE 19880 USA; [Kanungo, Mandakini; Malliaras, George G.] Cornell Univ, Dept Mat Sci, Ithaca, NY 14850 USA	DuPont; Cornell University	Blanchet, GB (corresponding author), DuPont Co Inc, Mat Sci & Engn, Wilmington, DE 19880 USA.	graciela.b.blanchet@usa.dupont.com	Malliaras, George/HDM-2006-2022	Malliaras, George/0000-0002-4582-8501	Air Force [FA9550-071-0411]	Air Force	Supported by Air Force grant FA9550-071-0411. We thank H. L. Stormer and G. D. Jaycox for careful reading of the manuscript; R. Wheland for many interesting discussions; and D. Walls, J. Wyre, and N. G. Tassi for Raman, x-ray photoelectron spectroscopy, and high-resolution AFM inset at c = 0.038, respectively.	An KH, 2002, APPL PHYS LETT, V80, P4235, DOI 10.1063/1.1482801; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Artukovic E, 2005, NANO LETT, V5, P757, DOI 10.1021/nl050254o; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Bettinger HF, 2001, J AM CHEM SOC, V123, P12849, DOI 10.1021/ja010977j; Bo XZ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132063; Chen ZY, 2006, J PHYS CHEM B, V110, P11624, DOI 10.1021/jp057494c; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Hagen A, 2004, APPL PHYS A-MATER, V78, P1137, DOI 10.1007/s00339-003-2465-1; Hu H, 2003, J AM CHEM SOC, V125, P14893, DOI 10.1021/ja0356737; Kamaras K, 2003, SCIENCE, V301, P1501, DOI 10.1126/science.1088083; Kim KS, 2002, ADV MATER, V14, P1818, DOI 10.1002/adma.200290008; Lee YS, 2008, J PHYS CHEM C, V112, P4480, DOI 10.1021/jp073067i; Lee YS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.116801; LeMieux MC, 2008, SCIENCE, V321, P101, DOI 10.1126/science.1156588; Lu J, 2006, J PHYS CHEM B, V110, P5655, DOI 10.1021/jp055829k; McLean RS, 2006, NANO LETT, V6, P55, DOI 10.1021/nl051952b; Menard-Moyon C, 2006, J AM CHEM SOC, V128, P6552, DOI 10.1021/ja060802f; Nair N, 2007, J AM CHEM SOC, V129, P3946, DOI 10.1021/ja068018i; Park H, 2006, NANO LETT, V6, P916, DOI 10.1021/nl052488d; Park KA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045429; Peng HQ, 2006, J AM CHEM SOC, V128, P8396, DOI 10.1021/ja0621501; Snow ES, 2004, J VAC SCI TECHNOL B, V22, P1990, DOI 10.1116/1.1768185; Snow ES, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1854721; Snow ES, 2003, APPL PHYS LETT, V82, P2145, DOI 10.1063/1.1564291; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Vavro J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155410; Veloso MV, 2006, CHEM PHYS LETT, V430, P71, DOI 10.1016/j.cplett.2006.08.082; Wang CJ, 2005, J AM CHEM SOC, V127, P11460, DOI 10.1021/ja0526564; Yang CM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.075419; Zhao JJ, 2004, J PHYS CHEM B, V108, P4227, DOI 10.1021/jp036814u; Zhao JJ, 2005, CHEMPHYSCHEM, V6, P598, DOI 10.1002/cphc.200400593	33	124	131	5	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					234	237		10.1126/science.1166087	http://dx.doi.org/10.1126/science.1166087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131624				2022-12-28	WOS:000262290600033
J	Natoli, G				Natoli, Gioacchino			When Sirtuins and NF-kappa B Collide	CELL			English	Editorial Material							SIRT6; CHROMATIN	Both the sirtuins and certain transcription factors of the NF-kappa B/Rel family control aging-associated changes in gene expression. Kawahara et al. (2009) now show a requirement in mice for the sirtuin SIRT6 in dampening NF-kappa B-dependent gene expression, thus unveiling a potential link between inflammation, aging, and metabolism.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Natoli, G (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM-IEO Campus, I-20139 Milan, Italy.	gioacchino.natoli@ifom-ieo-campus.it	Natoli, gioacchino/ABB-8679-2020; Natoli, gioacchino/J-2100-2018	Natoli, Gioacchino/0000-0003-0711-2411				Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617	9	29	30	2	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					19	21		10.1016/j.cell.2008.12.034	http://dx.doi.org/10.1016/j.cell.2008.12.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135883	Bronze			2022-12-28	WOS:000262318400009
J	Spletter, ML; Luo, LQ				Spletter, Maria L.; Luo, Liqun			A New Family of Odorant Receptors in Drosophila	CELL			English	Editorial Material							CHANNELS	In the fruit fly Drosophila, not all olfactory sensory neurons express a seven transmembrane odorant receptor, suggesting that other types of odorant receptors might exist. Benton et al. (2009) now present evidence that a family of proteins related to ionotropic glutamate receptors is a previously unrecognized class of odorant receptors.	[Spletter, Maria L.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Spletter, Maria L.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Spletter, Maria Lynn/T-5917-2018	Spletter, Maria Lynn/0000-0002-2068-3350; Luo, Liqun/0000-0001-5467-9264	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F31 DC008277] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC008277] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	8	9	11	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					23	25		10.1016/j.cell.2008.12.031	http://dx.doi.org/10.1016/j.cell.2008.12.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135885	Bronze			2022-12-28	WOS:000262318400011
J	Chassagneux, Y; Colombelli, R; Maineult, W; Barbieri, S; Beere, HE; Ritchie, DA; Khanna, SP; Linfield, EH; Davies, AG				Chassagneux, Y.; Colombelli, R.; Maineult, W.; Barbieri, S.; Beere, H. E.; Ritchie, D. A.; Khanna, S. P.; Linfield, E. H.; Davies, A. G.			Electrically pumped photonic-crystal terahertz lasers controlled by boundary conditions	NATURE			English	Article							QUANTUM-CASCADE LASERS; SEMICONDUCTOR-LASERS; WAVE-GUIDES; DESIGN; RESONATORS; CAVITIES	Semiconductor lasers based on two-dimensional photonic crystals(1,2) generally rely on an optically pumped central area, surrounded by un- pumped, and therefore absorbing, regions(3). This ideal configuration is lost when photonic- crystal lasers are electrically pumped, which is practically more attractive as an external laser source is not required. In this case, in order to avoid lateral spreading of the electrical current, the device active area must be physically defined by appropriate semiconductor processing. This creates an abrupt change in the complex dielectric constant at the device boundaries, especially in the case of lasers operating in the far- infrared, where the large emission wavelengths impose device thicknesses of several micrometres. Here we show that such abrupt boundary conditions can dramatically influence the operation of electrically pumped photonic- crystal lasers. By demonstrating a general technique to implement reflecting or absorbing boundaries, we produce evidence that whispering- gallery- like modes or true photonic- crystal states can be alternatively excited. We illustrate the power of this technique by fabricating photonic- crystal terahertz ( THz) semiconductor lasers, where the photonic crystal is implemented via the sole patterning of the device top metallization. Single- mode laser action is obtained in the 2.55-2.88 THz range, and the emission far field exhibits a small angular divergence, thus providing a solution for the quasi- total lack of directionality typical of THz semiconductor lasers based on metal - metal waveguides(4).	[Chassagneux, Y.; Colombelli, R.] Univ Paris 11, Inst Elect Fondamentale, F-91405 Orsay, France; [Chassagneux, Y.; Colombelli, R.] CNRS, UMR 8622, F-91405 Orsay, France; [Maineult, W.; Barbieri, S.] Univ Paris 07, Lab MPQ, F-75013 Paris, France; [Maineult, W.; Barbieri, S.] CNRS, UMR 7162, F-75013 Paris, France; [Beere, H. E.; Ritchie, D. A.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Khanna, S. P.; Linfield, E. H.; Davies, A. G.] Univ Leeds, Sch Elect & Elect Engn, Leeds LS2 9JT, W Yorkshire, England	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; University of Leeds	Colombelli, R (corresponding author), Univ Paris 11, Inst Elect Fondamentale, F-91405 Orsay, France.	raffaele.colombelli@u-psud.fr	Khanna, Suraj Parkash/Q-2209-2019; khanna, Suraj P/K-4191-2015; Ritchie, David/K-2206-2014	Khanna, Suraj Parkash/0000-0002-2733-6538; Ritchie, David/0000-0002-9844-8350; Colombelli, Raffaele/0000-0002-1540-9920; Chassagneux, Yannick/0000-0002-0588-2458; Linfield, Edmund/0000-0001-6912-0535; Davies, Alexander/0000-0002-1987-4846	Conseil General de l'Essonne; EPSRC [EP/D025532/1, EP/E048811/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E048811/1, EP/C002881/1, EP/D025532/1] Funding Source: researchfish	Conseil General de l'Essonne; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J.-M. Lourtioz, F. Julien, C. Sirtori, L. Sirigu, G. Scalari and V. Moreau for discussions, P. Gellie for technical help, and J. Alton for the Golay cell. Device fabrication was performed at the CTU-IEF-Minerve, which was partially funded by the Conseil General de l'Essonne. This work was conducted as part of a EURYI scheme award (www.esf.org/euryi).	Adam AJL, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194889; Bahriz M, 2007, OPT EXPRESS, V15, P5948, DOI 10.1364/OE.15.005948; Barbieri S, 2004, APPL PHYS LETT, V85, P1674, DOI 10.1063/1.1784874; Chassagneux Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710754; Chuma A. V, 1987, PHYS REV LETT, V58, P2486; Ciuti C, 2007, J APPL PHYS, V101, DOI 10.1063/1.2722757; Colombelli R, 2005, SEMICOND SCI TECH, V20, P985, DOI 10.1088/0268-1242/20/10/001; Colombelli R, 2003, SCIENCE, V302, P1374, DOI 10.1126/science.1090561; Dunbar LA, 2005, OPT EXPRESS, V13, P8960, DOI 10.1364/OPEX.13.008960; Kim SH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235117; Kohen S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1855394; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; Kumar S, 2007, OPT EXPRESS, V15, P113, DOI 10.1364/OE.15.000113; Letartre X, 2005, J OPT SOC AM B, V22, P2581, DOI 10.1364/JOSAB.22.002581; Mahler L, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2120901; MITTLEMAN D, 2004, SPRINGER SERIES OPTI, V85; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; SAKAI K, 2005, TOPICS APPL PHYS, V97; Sakai K, 2007, OPT EXPRESS, V15, P3981, DOI 10.1364/OE.15.003981; Schartner S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2361186; Sirigu L, 2008, OPT EXPRESS, V16, P5206, DOI 10.1364/OE.16.005206; Sirtori C, 1998, OPT LETT, V23, P1366, DOI 10.1364/OL.23.001366; Srinivasan K, 2002, OPT EXPRESS, V10, P670, DOI 10.1364/OE.10.000670; Unterrainer K, 2002, APPL PHYS LETT, V80, P3060, DOI 10.1063/1.1469657; Vuckovic J, 2000, IEEE J QUANTUM ELECT, V36, P1131, DOI 10.1109/3.880653; Wiersig J, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.023807; Williams BS, 2007, NAT PHOTONICS, V1, P517, DOI 10.1038/nphoton.2007.166; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yu NF, 2008, NAT PHOTONICS, V2, P564, DOI 10.1038/nphoton.2008.152; Zhang H, 2007, OPT EXPRESS, V15, P16818, DOI 10.1364/OE.15.016818	30	241	252	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					174	178		10.1038/nature07636	http://dx.doi.org/10.1038/nature07636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129844				2022-12-28	WOS:000262360200028
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			Money and the Changing Culture of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hartzband, Pamela; Groopman, Jerome] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Hartzband, Pamela; Groopman, Jerome] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							*AM AC FAM PHYS AM, 2007, JOINT PRINC PAT CTR; Ariely D., 2008, PREDICTABLY IRRATION; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491	5	30	32	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					101	103		10.1056/NEJMp0806369	http://dx.doi.org/10.1056/NEJMp0806369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391UG	19129522				2022-12-28	WOS:000262258300001
J	Astuto, M; Minardi, C; Rizzo, G; Gullo, A				Astuto, Marinella; Minardi, Carmelo; Rizzo, Giuliana; Gullo, Antonino			Unexplained seizures in an infant	LANCET			English	Editorial Material									[Astuto, Marinella; Minardi, Carmelo; Rizzo, Giuliana; Gullo, Antonino] Catania Univ Hosp, Dept Anaesthesia & Intens Care, Catania, Italy		Astuto, M (corresponding author), Catania Univ Hosp, Dept Anaesthesia & Intens Care, Catania, Italy.	astmar@tiscali.it	Astuto, Marinella/AAE-7766-2021; astuto, marinella/AAP-6994-2020	astuto, marinella/0000-0002-9365-1309				Ash SR, 2002, ADV RENAL REPLACE TH, V9, P31, DOI 10.1053/jarr.2001.30475; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; Caksen H, 2006, HUM EXP TOXICOL, V25, P107, DOI 10.1191/0960327106ht511oa; Schreier H, 2002, PEDIATRICS, V110, P985, DOI 10.1542/peds.110.5.985; Turner J, 2002, LANCET, V359, P346, DOI 10.1016/S0140-6736(02)07502-5	5	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					94	94		10.1016/S0140-6736(08)61958-3	http://dx.doi.org/10.1016/S0140-6736(08)61958-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19121723				2022-12-28	WOS:000262183800035
J	Mayo, MJ				Mayo, Merrilea J.			Video Games: A Route to Large-Scale STEM Education?	SCIENCE			English	Editorial Material									[Mayo, Merrilea J.] Ewing Marion Kauffman Fdn, Kansas City, MO 64110 USA		Mayo, MJ (corresponding author), Ewing Marion Kauffman Fdn, 4801 Rockhill Rd, Kansas City, MO 64110 USA.	mmayo@kauffman.org						Barab S, 2005, ETR&D-EDUC TECH RES, V53, P86, DOI 10.1007/BF02504859; Barab S, 2007, SCI EDUC, V91, P750, DOI 10.1002/sce.20217; Begg M., 2005, INNOVATE J ONLINE ED, V1; BLOOM BENJAMIN S., 1956, HDB 1 COGNITIVE DOMA; BOWER J, 2008, GRANTM ED ANN M BALT; Bransford JD., 2000, PEOPLE LEARN; COLLER BD, 2006, SER GAM SUMM WASH DC; Druckman D., 1994, LEARNING REMEMBERING; Gee JP, 2003, WHAT VIDEO GAMES HAVE TO TEACH US ABOUT LEARNING AND LITERACY, P1; GRAESSER AC, 1994, AM EDUC RES J, V31, P104, DOI 10.2307/1163269; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hays R., 2005, 2005004 NAV AIR WARF; Hewitt Nancy M., 1997, TALKING LEAVING; Hutchison D, 2007, BRIT J EDUC TECHNOL, V38, P977, DOI 10.1111/j.1467-8535.2006.00686.x; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; Kebritchi M., 2008, THESIS U CENTRAL FLO; KEBRITCHI M, EFFECTS MODERN MATH; Ketelhut D. J., 2006, 2006 AERA ANN M SAN; Kukich K, 2000, COMPARING VALIDITY A; McClean P, 2001, SELECTED PAPERS FROM THE 12TH INTERNATIONAL CONFERENCE ON COLLEGE TEACHING AND LEARNING, P111; *NAT SCI BOARD, 2008, NSF SCI ENG IND 2008; Oblinger D. G., 2004, J INTERACTIVE MEDIA, V8; Peck AC, 2000, HUM FACTORS, V42, P379, DOI 10.1518/001872000779698150; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Sax L.J., 2001, AM FRESHMAN NATL NOR; Squire K, 2004, ICLS2004: INTERNATIONAL CONFERENCE OF THE LEARNING SCIENCES, PROCEEDINGS, P513; Vogel J. J., 2006, Journal of Educational Computing Research, V34, P229, DOI 10.2190/FLHV-K4WA-WPVQ-H0YM; Willinsky J, 2009, SCIENCE, V323, P39, DOI 10.1126/science.1167970	28	182	187	8	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					79	82		10.1126/science.1166900	http://dx.doi.org/10.1126/science.1166900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119223				2022-12-28	WOS:000262104100043
J	Ellman, MH				Ellman, Michael H.			Chondrocalcinosis and Hypomagnesemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ellman, Michael H.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Ellman, MH (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	mellman@medicine.bsd.uchicago.edu							0	4	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					71	71		10.1056/NEJMicm050004	http://dx.doi.org/10.1056/NEJMicm050004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118306				2022-12-28	WOS:000262096800009
J	Moers, C; Smits, JM; Maathuis, MHJ; Treckmann, J; van Gelder, F; Napieralski, BP; van Kasterop-Kutz, M; van der Heide, JJH; Squifflet, JP; van Heurn, E; Kirste, GR; Rahmel, A; Leuvenink, HGD; Paul, A; Pirenne, J; Ploeg, RJ				Moers, Cyril; Smits, Jacqueline M.; Maathuis, Mark-Hugo J.; Treckmann, Juergen; van Gelder, Frank; Napieralski, Bogdan P.; van Kasterop-Kutz, Margitta; van der Heide, Jaap J. Homan; Squifflet, Jean-Paul; van Heurn, Ernest; Kirste, Guenter R.; Rahmel, Axel; Leuvenink, Henri G. D.; Paul, Andreas; Pirenne, Jacques; Ploeg, Rutger J.			Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELAYED GRAFT FUNCTION; HEART-BEATING DONORS; CADAVERIC RENAL-TRANSPLANTATION; EXPANDED CRITERIA DONORS; ACUTE REJECTION; ORGAN DONATION; PRESERVATION; PERSPECTIVES; REGRESSION; SURVIVAL	BACKGROUND Static cold storage is generally used to preserve kidney allografts from deceased donors. Hypothermic machine perfusion may improve outcomes after transplantation, but few sufficiently powered prospective studies have addressed this possibility. METHODS In this international randomized, controlled trial, we randomly assigned one kidney from 336 consecutive deceased donors to machine perfusion and the other to cold storage. All 672 recipients were followed for 1 year. The primary end point was delayed graft function ( requiring dialysis in the first week after transplantation). Secondary end points were the duration of delayed graft function, delayed graft function defined by the rate of the decrease in the serum creatinine level, primary nonfunction, the serum creatinine level and clearance, acute rejection, toxicity of the calcineurin inhibitor, the length of hospital stay, and allograft and patient survival. RESULTS Machine perfusion significantly reduced the risk of delayed graft function. Delayed graft function developed in 70 patients in the machine- perfusion group versus 89 in the cold- storage group ( adjusted odds ratio, 0.57; P = 0.01). Machine perfusion also significantly improved the rate of the decrease in the serum creatinine level and reduced the duration of delayed graft function. Machine perfusion was associated with lower serum creatinine levels during the first 2 weeks after transplantation and a reduced risk of graft failure ( hazard ratio, 0.52; P = 0.03). One- year allograft survival was superior in the machine- perfusion group ( 94% vs. 90%, P = 0.04). No significant differences were observed for the other secondary end points. No serious adverse events were directly attributable to machine perfusion. CONCLUSIONS Hypothermic machine perfusion was associated with a reduced risk of delayed graft function and improved graft survival in the first year after transplantation. (Current Controlled Trials number, ISRCTN83876362.).	[Moers, Cyril; Maathuis, Mark-Hugo J.; Leuvenink, Henri G. D.; Ploeg, Rutger J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 GZ Groningen, Netherlands; [van der Heide, Jaap J. Homan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 GZ Groningen, Netherlands; [Smits, Jacqueline M.; van Kasterop-Kutz, Margitta; Rahmel, Axel] Eurotransplant Int Fdn, Leiden, Netherlands; [van Heurn, Ernest] Univ Hosp Maastricht, Dept Surg, Maastricht, Netherlands; [Treckmann, Juergen; Napieralski, Bogdan P.; Paul, Andreas] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Kirste, Guenter R.] Deutsch Stiftung Organtransplantat, Frankfurt, Germany; [van Gelder, Frank; Pirenne, Jacques] Univ Hosp Leuven, Dept Abdominal Transplant Surg Transplant Coordin, Louvain, Belgium; [Squifflet, Jean-Paul] CHU Sart Tilman, Dept Abdominal Surg & Transplantat, B-4000 Liege, Belgium; [Squifflet, Jean-Paul] Univ Liege, Liege, Belgium	University of Groningen; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Duisburg Essen; KU Leuven; University Hospital Leuven; University of Liege; University of Liege	Moers, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, CMC V,Y2-144,Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	c.moers@chir.umcg.nl	Pirenne, Jacques/I-3728-2018; liu, xin/B-8971-2012	Pirenne, Jacques/0000-0002-8147-8801; Leuvenink, Henri/0000-0001-5036-2999	Organ Recovery Systems; government of Flanders, Belgium; Bristol-Myers Squibb; Dutch Kidney Foundation; Eurotrans-Bio pro-donor project	Organ Recovery Systems; government of Flanders, Belgium; Bristol-Myers Squibb(Bristol-Myers Squibb); Dutch Kidney Foundation; Eurotrans-Bio pro-donor project	We thank Jan Schouten for his help with R software analyses, all transplantation coordinators and procurement teams in the three trial regions, and all 60 collaborating transplantation centers within Eurotransplant for their invaluable contributions to this study.	BELZER FO, 1982, TRANSPLANTATION, V33, P322; Boom H, 2004, TRANSPLANT REV, V18, P139; BUYSE ME, 1992, CANC CLIN TRIALS MET; Cohen B, 2005, NEPHROL DIAL TRANSPL, V20, P34, DOI 10.1093/ndt/gfh506; Cohen B, 1997, TRANSPLANT INT, V10, P1, DOI 10.1111/j.1432-2277.1997.tb00528.x; COX DR, 1972, J R STAT SOC B, V34, P187; Daemen JHC, 1997, TRANSPLANT INT, V10, P317, DOI 10.1007/s001470050063; Daly PJA, 2005, BJU INT, V96, P498, DOI 10.1111/j.1464-410X.2005.05673.x; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Kwiatkowski A, 2007, AM J TRANSPLANT, V7, P1942, DOI 10.1111/j.1600-6143.2007.01877.x; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; MATSUNO N, 1994, TRANSPLANTATION, V57, P293; Matsuno N, 2006, TRANSPLANTATION, V82, P1425, DOI 10.1097/01.tp.0000243733.77706.99; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; MERION RM, 1990, TRANSPLANTATION, V50, P230, DOI 10.1097/00007890-199008000-00011; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Moers C, 2007, TRANSPL INT, V20, P567, DOI 10.1111/j.1432-2277.2007.00455.x; OOSTERLEE A, 2006, EUROTRANSPLANT ANN R; Opelz G, 2007, TRANSPLANTATION, V83, P247, DOI 10.1097/01.tp.0000251781.36117.27; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; PLOEG RJ, 1992, LANCET, V340, P129, DOI 10.1016/0140-6736(92)93212-6; RUTTEN FFH, 1993, TRANSPLANTATION, V56, P854, DOI 10.1097/00007890-199310000-00015; Saidi RF, 2007, AM J TRANSPLANT, V7, P2769, DOI 10.1111/j.1600-6143.2007.01993.x; Schold JD, 2005, AM J TRANSPLANT, V5, P1681, DOI 10.1111/j.1600-6143.2005.00910.x; Snoeijs MGJ, 2006, AM J TRANSPLANT, V6, P1066, DOI 10.1111/j.1600-6143.2006.01312.x; St Peter SD, 2002, LANCET, V359, P604, DOI 10.1016/S0140-6736(02)07749-8; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; van der Vliet JA, 2001, TRANSPLANT P, V33, P847, DOI 10.1016/S0041-1345(00)02343-5; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wight J, 2003, Health Technol Assess, V7, P1; Wight JP, 2003, CLIN TRANSPLANT, V17, P293, DOI 10.1034/j.1399-0012.2003.00077.x	32	691	733	2	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					7	19		10.1056/NEJMoa0802289	http://dx.doi.org/10.1056/NEJMoa0802289			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118301				2022-12-28	WOS:000262096800003
J	Schulze, B				Schulze, Beate			Mental-health stigma: expanding the focus, joining forces	LANCET			English	Editorial Material							SUPPORTED EMPLOYMENT; SCHIZOPHRENIA; PEOPLE; TRIAL		[Schulze, Beate] Univ Zurich, Res Unit Clin & Social Psychiat, CDMP, CH-8057 Zurich, Switzerland	University of Zurich	Schulze, B (corresponding author), Univ Zurich, Res Unit Clin & Social Psychiat, CDMP, CH-8057 Zurich, Switzerland.	beate.schulze@bli.uzh.ch	Corbin, Melody/B-8937-2009					Benedetti F, 2003, J NEUROSCI, V23, P4315; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Corrigan P. W., 2001, DONT CALL ME NUTS CO; Drake RE, 1999, ARCH GEN PSYCHIAT, V56, P627, DOI 10.1001/archpsyc.56.7.627; Hamann J, 2003, ACTA PSYCHIAT SCAND, V107, P403, DOI 10.1034/j.1600-0447.2003.00130.x; Mueser KT, 2001, SCHIZOPHRENIA BULL, V27, P281, DOI 10.1093/oxfordjournals.schbul.a006874; Sartorius N., 2005, REDUCING STIGMA MENT; Schuchert A, 2007, J INTERV CARD ELECTR, V19, P55, DOI 10.1007/s10840-007-9130-0; Schulze B, 2003, ACTA PSYCHIAT SCAND, V107, P142, DOI 10.1034/j.1600-0447.2003.02444.x; Stuber J, 2008, SOC SCI MED, V67, P351, DOI 10.1016/j.socscimed.2008.03.023; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6	11	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					362	363		10.1016/S0140-6736(08)61818-8	http://dx.doi.org/10.1016/S0140-6736(08)61818-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19162313	Green Submitted			2022-12-28	WOS:000262912100008
J	Stuckler, D; King, L; Mckee, M				Stuckler, David; King, Lawrence; McKee, Martin			Mass privatisation and the post-communist mortality crisis: a cross-national analysis	LANCET			English	Article							FORMER SOVIET-UNION; EASTERN-EUROPE; HEALTH; RUSSIA; TRANSITION; MARKET; UNEMPLOYMENT; COUNTRIES; ALCOHOL; LESSONS	Background During the early-1990s, adult mortality rates rose inmost post-communist European countries. Substantial differences across countries and over time remain unexplained. Although previous studies have suggested that the pace of economic transition was a key driver of increased mortality rates, to our knowledge no study has empirically assessed the role of specific components of transition policies. We investigated whether mass privatisation can account for differences in adult mortality rates in such countries. Methods We used multivariate longitudinal regression to analyse age-standardised mortality rates in working-age men (15-59 years) in post-communist countries of eastern Europe and the former Soviet Union from 1989 to 2002. We defined mass privatisation programmes as transferring at least 25% of large state-owned enterprises to the private sector within 2 years with the use of vouchers and give-aways to firm insiders. To isolate the effect of mass privatisation, we used models to control for price and trade liberalisation, income change, initial country conditions, structural predispositions to higher mortality, and other potential confounders. Findings Mass privatisation programmes were associated with an increase in short-term adult male mortality rates of 12.8% (95% CI 7.9-17.7; p<0 . 0001), with similar results for the alternative privatisation indices from the European Batik for Reconstruction and Development (7.8% [95% C1 2.8-13.0]). One mediating factor could be male unemployment rates, which were increased substantially by mass privatisation (56.3% [28.3-84.3]; p<0.0001). Each 1% increase in the percentage of population who were members of at least one social Organisation decreased the association of privatisation with mortality by 0 . 27%; when more than 45% of a population was a member of at least one social Organisation, privatisation was no longer significantly associated with increased mortality rates (3.4% [95% C1 -5.4 to 12.3]; p=0.44). Interpretation Rapid mass privatisation as an economic transition strategy was a crucial determinant of differences in adult mortality trends in post-communist countries; the effect of privatisation was reduced if social capital was high. These findings might be relevant to other countries in which similar policies are being considered. Funding None.	[Stuckler, David; King, Lawrence] Univ Cambridge, Dept Sociol, Fac Social & Polit Sci, Cambridge, England; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Oxford Christ Church, Dept Sociol, Oxford OX1 1DP, England.	david.stuckler@aya.yale.edu	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; King, Lawrence/0000-0002-5714-406X; Stuckler, David/0000-0002-1288-8401	European Observatory on Health Systems and Policies; Wellcome Trust	European Observatory on Health Systems and Policies; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Erica Richardson for assistance on, and comments and criticisms of, various drafts of this paper; John Powles for helpful editorial advice in the preparation of this article; Greg Patton for valuable research assistance on the country-specific firm privatisation estimates; and three anonymous reviewers for their constructive feedback which has improved the analysis. MM's work in transition countries is supported by the European Observatory on Health Systems and Policies and the Wellcome Trust.	Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; Barton HA, 2006, SCAND STUD, V78, P96; BAUM A, 1986, SOC SCI MED, V22, P509, DOI 10.1016/0277-9536(86)90016-X; Bobak M, 1999, INT J EPIDEMIOL, V28, P46, DOI 10.1093/ije/28.1.46; Bobak M, 2007, J EPIDEMIOL COMMUN H, V61, P990, DOI 10.1136/jech.2006.052134; Brainerd E, 2001, EUR ECON REV, V45, P1007, DOI 10.1016/S0014-2921(01)00108-8; Cornia GA, 2000, MORTALITY CRISIS TRA; Denizer Cevdet, 1996, PLAN MARKET PATTERNS; DEWATRIPONT M, 1992, ECON J, V2, P291; Durkheim E, 1897, SUICIDE ETUDE SOCIOL; Ellerman D., 2001, CHALLENGE, V44, P14; *EUR BANK REC DEV, 2007, TRANS IND METH; European Bank for Reconstruction and Development, 2007, TRANS REP 2007 PEOPL; FISCHER S, 1991, J ECON PERSPECT, V5, P91, DOI 10.1257/jep.5.4.91; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; Ivaschenko E, 2005, J COMP ECON, V33, P788, DOI 10.1016/j.jce.2005.03.012; Kennedy BP, 1998, WORLD DEV, V26, P2029, DOI 10.1016/S0305-750X(98)00094-1; King L, 2003, POLIT SOC, V31, P3, DOI 10.1177/0032329202250157; King L, 2002, STUD COMP INT DEV, V37, P3, DOI 10.1007/BF02686229; King LP, 2006, AM J SOCIOL, V112, P751, DOI 10.1086/507851; Kogut B, 2002, IND CORP CHANGE, V11, P1, DOI 10.1093/icc/11.1.1; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; Murrell P, 1996, J ECON PERSPECT, V10, P25, DOI 10.1257/jep.10.2.25; MURRELL P, 1991, J ECON PERSPECT, V5, P59, DOI 10.1257/jep.5.4.59; Parna K, 2007, INT J PUBLIC HEALTH, V52, P402, DOI 10.1007/s00038-007-6112-z; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rechel B, 2005, HEALTH POLICY, V73, P339, DOI 10.1016/j.healthpol.2004.12.010; Rechel B, 2004, B WORLD HEALTH ORGAN, V82, P539; Sachs J., 1990, ECONOMIST       0113, P19; Sachs J., 1994, UNDERSTANDING SHOCK; SACHS J, 2001, POSTCOMMUNIST PARTIE; Shkolnikov V, 1999, EUR J EPIDEMIOL, V15, P203, DOI 10.1023/A:1007546800982; Stuckler D, 2008, J EPIDEMIOL COMMUN H, V62, P664, DOI 10.1136/jech.2007.070201; *UNDP, 1999, TRANS 1999 HUM DEV R; UNICEF, 2007, DAT CHILDR CENTR E E; *UNICEF, 2001, DEC TRANS MON CENTR; VANDERWILK EA, 2008, EUPHIX EUPHACT; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Wasserman D, 1998, ACTA PSYCHIAT SCAND, V98, P34, DOI 10.1111/j.1600-0447.1998.tb10763.x; World Bank, 2022, WORLD DEV IND 2022	44	229	244	1	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2009	373	9661					399	407		10.1016/S0140-6736(09)60005-2	http://dx.doi.org/10.1016/S0140-6736(09)60005-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19150132				2022-12-28	WOS:000262912100031
J	Bowman, D				Bowman, Deborah			Students whose behaviour causes concern: Ethical perspective	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-EDUCATION; CORE CURRICULUM; LAW		[Bowman, Deborah] Univ London St Georges Hosp, Ctr Med & Healthcare Educ, London SW17 0RE, England	St Georges University London	Bowman, D (corresponding author), Univ London St Georges Hosp, Ctr Med & Healthcare Educ, London SW17 0RE, England.	dbowman@sgul.ac.uk						Ashcroft R, 1998, J MED ETHICS, V24, P188; BOSELEY S, 2005, GUARDIAN        0510, P9; Doyal L, 1998, BRIT MED J, V316, P1623, DOI 10.1136/bmj.316.7145.1623; *GEN MED COUNC, 2008, MED STUD PROF BEH FI	4	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 29	2008	337								a2882	10.1136/bmj.a2882	http://dx.doi.org/10.1136/bmj.a2882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401MV	19114453				2022-12-28	WOS:000262945900006
J	Dwyer, DJ; Kohanski, MA; Collins, JJ				Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.			Networking Opportunities for Bacteria	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; ESCHERICHIA-COLI; CELL-CYCLE; CIRCUIT; MOTIFS	In this post-genomic era, our capacity to explore biological networks and predict network architectures has been greatly expanded, accelerating interest in systems biology. Here, we highlight recent systems biology studies in prokaryotes, consider the challenges ahead, and suggest opportunities for future studies in bacterial models.	[Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Dwyer, Daniel J.; Kohanski, Michael A.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Dept Biomed Engn, Boston, MA 02215 USA; [Kohanski, Michael A.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Howard Hughes Medical Institute; Boston University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Ctr BioDynam, Ctr Adv Biotechnol, Boston, MA 02215 USA.	jcollins@engc.bu.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003644, DP1 OD003644-02] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018	15	15	16	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1153	1156		10.1016/j.cell.2008.12.016	http://dx.doi.org/10.1016/j.cell.2008.12.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109881	Green Accepted, Bronze			2022-12-28	WOS:000261989800001
J	Hitomi, JI; Christofferson, DE; Ng, A; Yao, JH; Degterev, A; Xavier, RJ; Yuan, JY				Hitomi, Junichi; Christofferson, Dana E.; Ng, Aylwin; Yao, Jianhua; Degterev, Alexei; Xavier, Ramnik J.; Yuan, Junying			Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEGATIVE REGULATOR; L929 CELLS; APOPTOSIS; PROTEIN; DATABASE; DOMAIN; RIP1; CYLD	Stimulation of death receptors by agonists such as FasL and TNF alpha activates apoptotic cell death in apoptotic-competent conditions or a type of necrotic cell death dependent on RIP1 kinase, termed necroptosis, in apoptotic-deficient conditions. In a genomewide siRNA screen for regulators of necroptosis, we identify a set of 432 genes that regulate necroptosis, a subset of 32 genes that act downstream and/or as regulators of RIP1 kinase, 32 genes required for death-receptor-mediated apoptosis, and 7 genes involved in both necroptosis and apoptosis. We show that the expression of subsets of the 432 genes is enriched in the immune and nervous systems, and cellular sensitivity to necroptosis is regulated by an extensive signaling network mediating innate immunity. Interestingly, Bmf, a BH3-only Bcl-2 family member, is required for death-receptor-induced necroptosis. Our study defines a cellular signaling network that regulates necroptosis and the molecular bifurcation that controls apoptosis and necroptosis.	[Hitomi, Junichi; Christofferson, Dana E.; Yao, Jianhua; Degterev, Alexei; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Ng, Aylwin/AAQ-6478-2020		National Institute of Health [DP1OD000580]; National Institute on Aging [R37 AG012859-14]; National Institute on Neurological Disorders and Stroke [U01NS050560]; NIH Director's Pioneer Award; National Institute of Allergy and Infectious Diseases [AI062773, DK43351]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Japan Society for Promotion of Science; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS050560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012859, R37AG012859] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000580] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dodzie Sogah, Marta Lipinski, and Caroline Yi for helpful comments on this manuscript. We are grateful for the support of Caroline Shamu, Stewart Rudnicki, Sean Johnston, and David Wrobel at the ICCB Longwood Facility during screening. We thank S. C. Sun (University of Texas, M. D. Anderson Cancer Center) and J. Blenis (Harvard Medical School) for CYLD antibody and FADD def Jurkat cells, respectively. This work was supported in part by grants from the National Institute of Health (DP1OD000580), the National Institute on Aging (R37 AG012859-14), the National Institute on Neurological Disorders and Stroke (U01NS050560), NIH Director's Pioneer Award (to J.Y.), and the National Institute of Allergy and Infectious Diseases (AI062773) and DK43351 (to R. J. X.). J. H. was supported in part by fellowships from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Uehara Memorial Foundation, and the Japan Society for Promotion of Science. A.N. is a recipient of a Fellowship Award from the Crohn's and Colitis Foundation of America.	Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Fiers W., 1995, Journal of Inflammation, V47, P67; Fukushima K, 2004, ARCH BIOCHEM BIOPHYS, V426, P298, DOI 10.1016/j.abb.2004.02.028; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim JW, 2000, J CELL SCI, V113, P955; Kurth I, 2006, BIOCHEM J, V393, P277, DOI 10.1042/BJ20051094; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Simonson SJS, 2007, DEV CELL, V13, P601, DOI 10.1016/j.devcel.2007.10.009; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu XS, 2007, J NEUROCHEM, V103, P2004, DOI 10.1111/j.1471-4159.2007.04884.x; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	49	744	783	5	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1311	1323		10.1016/j.cell.2008.10.044	http://dx.doi.org/10.1016/j.cell.2008.10.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109899	Green Accepted, Bronze			2022-12-28	WOS:000261989800021
J	Colman, I; Abbott, RA; Jones, PB				Colman, Ian; Abbott, Rosemary A.; Jones, Peter B.			Teenage conduct problems, later Authors' reply	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									[Colman, Ian] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 2G3, Canada; [Abbott, Rosemary A.; Jones, Peter B.] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England	University of Alberta; University of Cambridge	Colman, I (corresponding author), Univ Alberta, Sch Publ Hlth, 13-130D Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.	ian.colman@ualberta.ca		Colman, Ian/0000-0001-5924-0277; Maughan, Barbara/0000-0002-8887-3484; Jones, Peter Brian/0000-0002-0387-880X; Murray, Joseph/0000-0002-5511-3454; Croudace, Tim/0000-0001-8346-7463	ESRC [ES/E025390/1] Funding Source: UKRI; MRC [G0500953] Funding Source: UKRI; Medical Research Council [G0500953] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health [PHCS/C4/4/002] Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health		Colman I, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2981; McClusky J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b775	2	71	71	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2009	338								b777	10.1136/bmj.b777	http://dx.doi.org/10.1136/bmj.b777			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EB	19131382				2022-12-28	WOS:000264058200006
J	Wei, CL; Wang, XH; Chen, M; Ouyang, K; Song, LS; Cheng, HP				Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Song, Long-Sheng; Cheng, Heping			Calcium flickers steer cell migration	NATURE			English	Article							CATION CHANNELS; CHEMOTAXIS; ACTIVATION; DICTYOSTELIUM; TRANSIENT; MOVEMENT; SIGNALS; BACK; LOOP; RAC	Directional movement is a property common to all cell types during development and is critical to tissue remodelling and regeneration after damage(1-3). In migrating cells, calcium has a multifunctional role in directional sensing, cytoskeleton redistribution, traction force generation, and relocation of focal adhesions(1,4) (-7). Here we visualize high- calcium microdomains ('calcium flickers') and their patterned activation in migrating human embryonic lung fibroblasts. Calcium flicker activity is dually coupled to membrane tension ( by means of TRPM7, a stretch-activated Ca2(+)permeant channel of the transient receptor potential superfamily(8)) and chemoattractant signal transduction ( by means of type 2 inositol-1,4,5-trisphosphate-receptors). Interestingly, calcium flickers are most active at the leading lamella of migrating cells, displaying a 4: 1 front- to- rear polarization opposite to the global calcium gradient(6). When exposed to a platelet- derived growth factor gradient perpendicular to cell movement, asymmetric calcium flicker activity develops across the lamella and promotes the turning of migrating fibroblasts. These findings show how the exquisite spatiotemporal organization of calcium microdomains can orchestrate complex cellular processes such as cell migration.	[Wei, Chaoliang; Wang, Xianhua; Chen, Min; Ouyang, Kunfu; Cheng, Heping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Song, Long-Sheng] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Internal Med, Iowa City, IA 52242 USA	Peking University; University of Iowa	Cheng, HP (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	chaoliang.wei@gmail.com; chengp@pku.edu.cn	Heping, Cheng/AAE-2680-2019; Song, Long-Sheng/D-5899-2012; Wei, Chaoliang/A-9008-2013	Heping, Cheng/0000-0002-9604-6702; Song, Long-Sheng/0000-0002-6035-8106; ouyang, kunfu/0000-0003-0292-375X	Major State Basic Research Development Program of China [2007CB512100]; National Natural Science Foundation of China [30630021, 30800371]; NIH [HL090905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank I. C. Bruce, X. Zhu, J. J. Ma, H. Q. Cao, J. Liu, M. Zheng, X. D. Fu and R. P. Xiao for discussions, andM. Gorospe, Z. C. Liang, Q. Du, C. M. Cao, H. Huang, X. M. Lan, N. Lin, Y. R. Wang, R. S. Song and Y. Zhang for technical support. Special thanks to X. D. Fu for making his laboratory facility available to us. This work was supported by the Major State Basic Research Development Program of China (2007CB512100), and the National Natural Science Foundation of China (30630021 and 30800371) and an NIH grant (HL090905).	BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; HAHN K, 1992, NATURE, V359, P736, DOI 10.1038/359736a0; Hamill OP, 1996, PHARMACOL REV, V48, P231; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; Thomas GH, 2000, TRENDS MICROBIOL, V8, P15, DOI 10.1016/S0966-842X(99)01668-6; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Ware MF, 1998, J CELL SCI, V111, P2423; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Zou H, 2002, P NATL ACAD SCI USA, V99, P6404, DOI 10.1073/pnas.092654999	30	439	449	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					901	905		10.1038/nature07577	http://dx.doi.org/10.1038/nature07577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19118385	Green Accepted			2022-12-28	WOS:000263266700049
J	Liu, R; Ji, C; Mock, JJ; Chin, JY; Cui, TJ; Smith, DR				Liu, R.; Ji, C.; Mock, J. J.; Chin, J. Y.; Cui, T. J.; Smith, D. R.			Broadband Ground-Plane Cloak	SCIENCE			English	Article							ELECTROMAGNETIC-FIELDS; METAMATERIALS; DESIGN	The possibility of cloaking an object from detection by electromagnetic waves has recently become a topic of considerable interest. The design of a cloak uses transformation optics, in which a conformal coordinate transformation is applied to Maxwell's equations to obtain a spatially distributed set of constitutive parameters that define the cloak. Here, we present an experimental realization of a cloak design that conceals a perturbation on a flat conducting plane, under which an object can be hidden. To match the complex spatial distribution of the required constitutive parameters, we constructed a metamaterial consisting of thousands of elements, the geometry of each element determined by an automated design process. The ground-plane cloak can be realized with the use of nonresonant metamaterial elements, resulting in a structure having a broad operational bandwidth (covering the range of 13 to 16 gigahertz in our experiment) and exhibiting extremely low loss. Our experimental results indicate that this type of cloak should scale well toward optical wavelengths.	[Chin, J. Y.; Cui, T. J.] SE Univ, State Key Lab Millimeter Waves, Nanjing 210096, Peoples R China; [Liu, R.; Mock, J. J.; Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Ji, C.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA	Southeast University - China; Duke University; Duke University	Cui, TJ (corresponding author), SE Univ, State Key Lab Millimeter Waves, Nanjing 210096, Peoples R China.	tjcui@seu.edu.cn; drsmith@duke.edu	Cui, Tie Jun/Y-3224-2019; Smith, David R/E-4710-2012		Raytheon Missile Systems (Tucson); Air Force Office of Scientific Research [FA9550-06-1-0279]; InnovateHan Technology, National Science Foundation of China [60871016, 60671015]; National Basic Research Program (973) of China [2004CB719802]; Natural Science Foundation of Jiangsu Province [BK2008031]; 111 Project [111-2-05]	Raytheon Missile Systems (Tucson); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); InnovateHan Technology, National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by a gift from Raytheon Missile Systems (Tucson), and the rapid design approach was supported by a Multiple University Research Initiative supported by the Air Force Office of Scientific Research, contract no. FA9550-06-1-0279. T. J. C. acknowledges the support from InnovateHan Technology, National Science Foundation of China ( 60871016 and 60671015), National Basic Research Program (973) of China ( 2004CB719802), Natural Science Foundation of Jiangsu Province (BK2008031), and the 111 Project (111-2-05). We thank C. Harrison, N. Kundtz, and J. Allen for assistance for the experimental apparatus; A. Degiron for careful reading of the manuscript; Q. Cheng for the nonresonant element metamaterials technique development; and H. Schmitt, D. Barker ( Raytheon Missile Systems), and M. West for helpful discussions.	Alu A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113901; Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Chen HS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.063903; Hendi A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.073902; Jiang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066607; Jiang WX, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2951485; Justice BJ, 2006, OPT EXPRESS, V14, P8694, DOI 10.1364/OE.14.008694; Kildishev AV, 2008, OPT LETT, V33, P43, DOI 10.1364/OL.33.000043; Knupp P., 1994, FUNDAMENTALS GRID GE; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Li JS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203901; Liu RP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026606; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Rahm M, 2008, OPT EXPRESS, V16, P11555, DOI 10.1364/OE.16.011555; Rahm M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.063903; Rahm M, 2008, PHOTONIC NANOSTRUCT, V6, P87, DOI 10.1016/j.photonics.2007.07.013; Ruan Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.113903; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036617; Thompson JF, 1999, HDB GRID GENERATION	20	1193	1244	38	671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					366	369		10.1126/science.1166949	http://dx.doi.org/10.1126/science.1166949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150842				2022-12-28	WOS:000262481400034
J	Reddy, KC; Andersen, EC; Kruglyak, L; Kim, DH				Reddy, Kirthi C.; Andersen, Erik C.; Kruglyak, Leonid; Kim, Dennis H.			A Polymorphism in npr-1 Is a Behavioral Determinant of Pathogen Susceptibility in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; NEURONS; EXPERIENCE; HOMOLOG; PATHWAY; OXYGEN	The nematode Caenorhabditis elegans responds to pathogenic bacteria with conserved innate immune responses and pathogen avoidance behaviors. We investigated natural variation in C. elegans resistance to pathogen infection. With the use of quantitative genetic analysis, we determined that the pathogen susceptibility difference between the laboratory wild-type strain N2 and the wild isolate CB4856 is caused by a polymorphism in the npr-1 gene, which encodes a homolog of the mammalian neuropeptide Y receptor. We show that the mechanism of NPR-1-mediated pathogen resistance is through oxygen-dependent behavioral avoidance rather than direct regulation of innate immunity. For C. elegans, bacteria represent food but also a potential source of infection. Our data underscore the importance of behavioral responses to oxygen levels in finding an optimal balance between these potentially conflicting cues.	[Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Andersen, Erik C.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reddy, Kirthi C.; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; Massachusetts Institute of Technology (MIT)	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu; dhkim@mit.edu		Andersen, Erik/0000-0003-0229-9651	NIH [GM084477, HG004321, GM071508]; Burroughs Wellcome Fund; Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084477, P50GM071508] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Jane Coffin Childs Fund for Medical Research; James S. McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center, C. Bargmann, M. de Bono, and D. Omura for strains; S. Skrovanek for technical assistance; L. Dietrich for facilitating the oxygen assay; E. Alvarez-Saavedra, J. Shapiro, and members of our laboratories for advice; and C. Bargmann for comments on the manuscript. This work was supported by grants from NIH (GM084477 to D. H. K., HG004321 to L. K., and GM071508 to the Lewis-Sigler Institute), the Burroughs Wellcome Fund (to D. H. K.), the Jane Coffin Childs Fund for Medical Research (to K. C. R.), the James S. McDonnell Foundation (to L. K.), and the Howard Hughes Medical Institute (to L. K.).	AVERY L, 1993, GENETICS, V133, P897; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Darby C., 2005, WORMBOOK; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; PUJOL N, 2007, TOLL TOLL LIKE RECEP; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TRENT C, 1983, GENETICS, V104, P619; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	22	162	178	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					382	384		10.1126/science.1166527	http://dx.doi.org/10.1126/science.1166527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150845	Green Submitted, Green Accepted			2022-12-28	WOS:000262481400039
J	Amo, A; Sanvitto, D; Laussy, FP; Ballarini, D; del Valle, E; Martin, MD; Lemaitre, A; Bloch, J; Krizhanovskii, DN; Skolnick, MS; Tejedor, C; Vina, L				Amo, A.; Sanvitto, D.; Laussy, F. P.; Ballarini, D.; del Valle, E.; Martin, M. D.; Lemaitre, A.; Bloch, J.; Krizhanovskii, D. N.; Skolnick, M. S.; Tejedor, C.; Vina, L.			Collective fluid dynamics of a polariton condensate in a semiconductor microcavity	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; CAVITY; FLOW	Semiconductor microcavities offer unique systems in which to investigate the physics of weakly interacting bosons. Their elementary excitations, polaritons - mixtures of excitons and photons - can accumulate in macroscopically degenerate states to form various types of condensate in a wide range of experimental configurations, under either incoherent(1,2) or coherent(3,4) excitation. Condensates of polaritons have been put forward as candidates for superfluidity(5,6), and the formation of vortices(7) as well as elementary excitations with linear dispersion(8) are actively sought as evidence to support this. Here, using a coherent excitation triggered by a short optical pulse, we have created and set in motion a macroscopically degenerate state of polaritons that can be made to collide with a variety of defects present in the microcavity. Our experiments show striking manifestations of a coherent light - matter packet, travelling at high speed ( of the order of one per cent of the speed of light) and displaying collective dynamics consistent with superfluidity, although one of a highly unusual character as it involves an out- of- equilibrium dissipative system. Our main results are the observation of a linear polariton dispersion accompanied by diffusionless motion; flow without resistance when crossing an obstacle; suppression of Rayleigh scattering; and splitting into two fluids when the size of the obstacle is comparable to the size of the wave packet. This work opens the way to the investigation of new phenomenology of out- of- equilibrium condensates.	[Amo, A.; Sanvitto, D.; Ballarini, D.; Martin, M. D.; Vina, L.] Univ Autonoma Madrid, Dept Fis Mat, E-28049 Madrid, Spain; [Laussy, F. P.; del Valle, E.; Tejedor, C.] Univ Autonoma Madrid, Dept Fis Teor Mat Condensada, E-28049 Madrid, Spain; [Lemaitre, A.; Bloch, J.] LPN CNRS, F-91460 Marcoussis, France; [Krizhanovskii, D. N.; Skolnick, M. S.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England	Autonomous University of Madrid; Autonomous University of Madrid; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Sheffield	Sanvitto, D (corresponding author), Univ Autonoma Madrid, Dept Fis Mat, E-28049 Madrid, Spain.	daniele.sanvitto@uam.es	Skolnick, Maurice S/G-7250-2016; Ballarini, Dario/R-4866-2016; Krizhanovskii, Dmitry/AAN-1901-2020; Lemaitre, Aristide/B-9899-2009; Bloch, Jacqueline/S-2062-2017; Vina, Luis/E-9415-2012; del Valle, Elena/G-1144-2011; del Valle, Elena/X-5435-2019; Amo, Alberto/M-3722-2017; Laussy, Fabrice/C-3646-2016; Martin, Maria Dolores D/L-5970-2013; Tejedor, Carlos/H-9537-2014; Sanvitto, Daniele/B-5785-2013	Skolnick, Maurice S/0000-0002-3972-8344; Ballarini, Dario/0000-0002-2453-5849; Lemaitre, Aristide/0000-0003-1892-9726; Bloch, Jacqueline/0000-0001-7823-8420; Vina, Luis/0000-0002-6376-6703; del Valle, Elena/0000-0002-0221-282X; del Valle, Elena/0000-0002-0221-282X; Amo, Alberto/0000-0002-2508-8315; Laussy, Fabrice/0000-0002-1070-7128; Martin, Maria Dolores D/0000-0003-2256-1418; Tejedor, Carlos/0000-0002-4577-358X; Sanvitto, Daniele/0000-0002-3831-8829	Spanish Ministerio de Educacion y Ciencia [MAT2005-01388, NAN2004-09109-C04-04, QOIT-CSD2006-00019]; Comunidad Autonoma de Madrid [S-0505/ESP-0200]; IMDEA-Nanociencia; Formacion de Profesorado Universitario; EPSRC [EP/E051448/1, EP/D505712/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E051448/1, EP/D505712/1] Funding Source: researchfish	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); IMDEA-Nanociencia; Formacion de Profesorado Universitario(Spanish Government); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank I. Carusotto, M. Wouters and N. Berloff for discussions and D. Steel for a critical reading of the manuscript. This work was partially supported by the Spanish Ministerio de Educacion y Ciencia (MEC) (MAT2005-01388, NAN2004-09109-C04-04 & QOIT-CSD2006-00019), the Comunidad Autonoma de Madrid (S-0505/ESP-0200) and the IMDEA-Nanociencia. D.B. and E.d.V. acknowledge a scholarship (Formacion de Profesorado Universitario) of the Spanish MEC. D.S. and M.D.M. thank the Ramon y Cajal Programme.	Abo-Shaeer JR, 2001, SCIENCE, V292, P476, DOI 10.1126/science.1060182; Bajoni D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.201305; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; BALLARINI D, 2008, OBSERVATION LONG LIV; Bolda EL, 2001, PHYS REV LETT, V86, P416, DOI 10.1103/PhysRevLett.86.416; Carusotto I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.260403; Carusotto I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166401; Freixanet T, 2000, PHYS REV B, V61, P7233, DOI 10.1103/PhysRevB.61.7233; Gurioli M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183901; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kavokin A, 2003, PHYS LETT A, V306, P187, DOI 10.1016/S0375-9601(02)01579-7; Krizhanovskii DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.097402; Lagoudakis KG, 2008, NAT PHYS, V4, P706, DOI 10.1038/nphys1051; Lai CW, 2007, NATURE, V450, P529, DOI 10.1038/nature06334; Langbein W, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075323; Malpuech G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206402; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Perrin M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075340; Porras D, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161310; Saba M, 2001, NATURE, V414, P731, DOI 10.1038/414731a; Sanvitto D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.241308; Sanvitto D, 2005, PHYS STATUS SOLIDI A, V202, P353, DOI 10.1002/pssa.200460302; Steinhauer J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120407; Stevenson RM, 2000, PHYS REV LETT, V85, P3680, DOI 10.1103/PhysRevLett.85.3680; Szymanska MH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230602; Utsunomiya S, 2008, NAT PHYS, V4, P700, DOI 10.1038/nphys1034; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314	27	436	440	5	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					291	U3		10.1038/nature07640	http://dx.doi.org/10.1038/nature07640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19148095	Green Submitted, Green Accepted			2022-12-28	WOS:000262440900034
J	Benton, R; Vannice, KS; Gomez-Diaz, C; Vosshall, LB				Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.			Variant Ionotropic Glutamate Receptors as Chemosensory Receptors in Drosophila	CELL			English	Article							LIGAND-BINDING CORE; OLFACTORY SENSE-ORGANS; CRYSTAL-STRUCTURES; ODORANT RECEPTORS; PRONEURAL GENE; ION CHANNELS; MEMBRANE TOPOLOGY; ANTENNAL LOBE; MECHANISMS; KAINATE	Ionotropic glutamate receptors (iGluRs) mediate neuronal communication at synapses throughout vertebrate and invertebrate nervous systems. We have characterized a family of iGluR-related genes in Drosophila, which we name ionotropic receptors (IRs). These receptors do not belong to the well-described kainate, AMPA, or NMDA classes of iGluRs, and they have divergent ligand-binding domains that lack their characteristic glutamate-interacting residues. IRs are expressed in a combinatorial fashion in sensory neurons that respond to many distinct odors but do not express either insect odorant receptors (ORs) or gustatory receptors (GRs). IR proteins accumulate in sensory dendrites and not at synapses. Misexpression of IRs in different olfactory neurons is sufficient to confer ectopic odor responsiveness. Together, these results lead us to propose that the IRs comprise a novel family of chemosensory receptors. Conservation of IR/iGlu-Rrelated proteins in bacteria, plants, and animals suggests that this receptor family represents an evolutionarily ancient mechanism for sensing both internal and external chemical cues.	[Benton, Richard; Vannice, Kirsten S.; Gomez-Diaz, Carolina; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Lausanne	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099; Benton, Richard/0000-0003-4305-8301; Gomez-Diaz, Carolina/0000-0003-2131-6074	European Molecular Biology Organization Long-Term Fellowship; Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [RO1 DC008600]; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Maclyn McCarty Fellow of the Helen Hay Whitney Foundation; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Andrew Jarman, Hugo Bellen, the Bloomington Drosophila Stock Center, and the Developmental Studies Hybridoma Bank for Drosophila strains and antibodies, and Raphael Rytz for identifying an additional IR pseudogene. Richard Axel, Kevin Lee, Sophie Martin, Charles Zuker, and members of the Vosshall Lab provided invaluable advice, discussion, and comments on the manuscript. R. B. was supported by a European Molecular Biology Organization Long-Term Fellowship and was the Maclyn McCarty Fellow of the Helen Hay Whitney Foundation. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and by grants to L. B. V. from the National Institutes of Health (RO1 DC008600) and the McKnight Endowment Fund for Neuroscience. R. B. designed and carried out all the experiments in the paper, with the exception of the in situ hybridization in Figures 3C-3F, which was carried out by K.S.V.C.G.-D. performed the gene-targeting screen for IR25a and the initial characterization of the IR25a antibodies. L.B.V. and R.B. together conceived and directed the project, interpreted the results, and wrote the paper.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chiu J, 1999, MOL BIOL EVOL, V16, P826, DOI 10.1093/oxfordjournals.molbev.a026167; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Lam HM, 1998, NATURE, V396, P125, DOI 10.1038/24066; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Warr CG, 2000, CELL, V102, P145; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	53	823	878	23	213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					149	162		10.1016/j.cell.2008.12.001	http://dx.doi.org/10.1016/j.cell.2008.12.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135896	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000262318400022
J	Fronzes, R; Schafer, E; Wang, LC; Saibil, HR; Orlova, EV; Waksman, G				Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel			Structure of a Type IV Secretion System Core Complex	SCIENCE			English	Article							AGROBACTERIUM-TUMEFACIENS; PROTEIN SUBASSEMBLIES; ESCHERICHIA-COLI; VIRB9; DNA; BIOGENESIS; MACHINERY; SUBSTRATE; MEMBRANES; COMPONENT	Type IV secretion systems (T4SSs) are important virulence factors used by Gram- negative bacterial pathogens to inject effectors into host cells or to spread plasmids harboring antibiotic resistance genes. We report the 15 angstrom resolution cryo- electron microscopy structure of the core complex of a T4SS. The core complex is composed of three proteins, each present in 14 copies and forming a similar to 1.1- megadalton two-chambered, double membrane- spanning channel. The structure is double- walled, with each component apparently spanning a large part of the channel. The complex is open on the cytoplasmic side and constricted on the extracellular side. Overall, the T4SS core complex structure is different in both architecture and composition from the other known double membrane- spanning secretion system that has been structurally characterized.	[Fronzes, Remi; Schafer, Eva; Wang, Luchun; Saibil, Helen R.; Orlova, Elena V.; Waksman, Gabriel] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, London WC1E 7HX, England; [Waksman, Gabriel] UCL, Div Biosci, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; University College London	Waksman, G (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, Malet St, London WC1E 7HX, England.	g.waksman@ucl.ac.uk	Fronzes, Rémi/GLS-0406-2022; Fronzes, Remi/T-2578-2019; fronzes, Rémi/A-4311-2009; Orlova, Elena/CAF-8290-2022	Orlova, Elena/0000-0003-3371-415X; Fronzes, Remi/0000-0003-3031-9824	Wellcome Trust; UK Biotechnology and Biological Sciences Research Council; European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM); Biotechnology and Biological Sciences Research Council [BB/C516144/1, BB/C516179/1, BB/F010281/1] Funding Source: researchfish; BBSRC [BB/C516179/1, BB/C516144/1, BB/F010281/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM)(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grants from the Wellcome Trust to G.W. and UK Biotechnology and Biological Sciences Research Council to H.R.S. and by an equipment grant from the Wellcome Trust to H.R.S and E.V.O. Also, H.R.S. and E.V.O. thank the European Union Network of Excellence in Three-Dimensional Electron Microscopy (3DEM) for support. EM maps have been deposited to the EM data bank under the entry codes EMD-5031 to EMD5035 for cryo-EM wild-type, negative-stain EM wild-type, negative-stain EM D1, cryo-EM D2, and negative-stain DL2 complexes, respectively.	Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997; Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Fernandez D, 1996, J BACTERIOL, V178, P3156, DOI 10.1128/jb.178.11.3156-3167.1996; Harris RL, 2001, MOL MICROBIOL, V42, P757, DOI 10.1046/j.1365-2958.2001.02667.x; Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Liu ZY, 2003, J BACTERIOL, V185, P3259, DOI 10.1128/JB.185.11.3259-3269.2003; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	17	235	240	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					266	268		10.1126/science.1166101	http://dx.doi.org/10.1126/science.1166101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131631	Green Accepted			2022-12-28	WOS:000262290600042
J	Pokroy, B; Kang, SH; Mahadevan, L; Aizenberg, J				Pokroy, Boaz; Kang, Sung H.; Mahadevan, L.; Aizenberg, Joanna			Self-Organization of a Mesoscale Bristle into Ordered, Hierarchical Helical Assemblies	SCIENCE			English	Article							ADHESION; DEFENSE; BONE	Mesoscale hierarchical helical structures with diverse functions are abundant in nature. Here we show how spontaneous helicity can be induced in a synthetic polymeric nanobristle assembling in an evaporating liquid. We use a simple theoretical model to characterize the geometry, stiffness, and surface properties of the pillars that favor the adhesive self- organization of bundles with pillars wound around each other. The process can be controlled to yield highly ordered helical clusters with a unique structural hierarchy that arises from the sequential assembly of self- similar coiled building blocks over multiple length scales. We demonstrate their function in the context of self- assembly into previously unseen structures with uniform, periodic patterns and controlled handedness and as an efficient particle- trapping and adhesive system.	[Pokroy, Boaz; Kang, Sung H.; Mahadevan, L.; Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University	Aizenberg, J (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Kang, Sung H/B-1084-2010; Kang, Sung Hoon/AAA-9959-2020; Pokroy, Boaz/C-8878-2011	Kang, Sung H/0000-0002-9156-3348; Kang, Sung Hoon/0000-0002-9156-3348; 	Materials Research Science and Engineering Cente; NSF [DMR-0213805, ECS-0335765]; Fulbright Visiting Scholar Program	Materials Research Science and Engineering Cente(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Fulbright Visiting Scholar Program	This work was partially supported by the Materials Research Science and Engineering Center under NSF award no. DMR-0213805. We acknowledge the use of the facilities at the Harvard Center for Nanoscale Systems supported by NSF award no. ECS-0335765. B.P. is grateful to the Fulbright Visiting Scholar Program for financial support.	Ahuja A, 2008, LANGMUIR, V24, P9, DOI 10.1021/la702327z; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Betz O, 2004, ARTHROPOD STRUCT DEV, V33, P3, DOI 10.1016/j.asd.2003.10.002; Bico J, 2004, NATURE, V432, P690, DOI 10.1038/432690a; Cohen AE, 2003, P NATL ACAD SCI USA, V100, P12141, DOI 10.1073/pnas.1534600100; Collings P. J., 1997, INTRO LIQUID CRYSTAL; Dev A, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/17/175607; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Gier TE, 1998, NATURE, V395, P154, DOI 10.1038/25960; GREEN MM, 2003, TOPICS STEREOCHEMIST, V24; Huang YGY, 2005, LANGMUIR, V21, P8058, DOI 10.1021/la0502185; Hui CY, 2002, LANGMUIR, V18, P1394, DOI 10.1021/la0113567; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; Kim HY, 2006, J FLUID MECH, V548, P141, DOI 10.1017/S0022112005007718; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Lichtenegger H, 1999, J APPL CRYSTALLOGR, V32, P1127, DOI 10.1107/S0021889899010961; Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b; MOORE JS, 1992, J AM CHEM SOC, V114, P3429, DOI 10.1021/ja00035a041; Neukirch S, 2002, J ELASTICITY, V69, P41, DOI 10.1023/A:1027390700610; NICOLSON MM, 1949, P CAMB PHILOS SOC, V45, P288, DOI 10.1017/S0305004100024841; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432; Rubin N, 2008, J AM CHEM SOC, V130, P4602, DOI 10.1021/ja800328y; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Sone ED, 2002, ANGEW CHEM INT EDIT, V41, P1705, DOI 10.1002/1521-3773(20020517)41:10<1705::AID-ANIE1705>3.0.CO;2-M; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zhu J, 2008, NAT NANOTECHNOL, V3, P477, DOI 10.1038/nnano.2008.179	31	328	347	6	324	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					237	240		10.1126/science.1165607	http://dx.doi.org/10.1126/science.1165607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131625				2022-12-28	WOS:000262290600034
J	Wang, XN; Schwarz, TL				Wang, Xinnan; Schwarz, Thomas L.			The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility	CELL			English	Article							FAST AXONAL-TRANSPORT; HEAVY-CHAIN; RHO GTPASES; DROSOPHILA; NEURONS; PROTEIN; SYNAPSES; BINDING; ACTIN; ORGANIZATION	Mitochondria are mobile organelles and cells regulate mitochondrial movement in order to meet the changing energy needs of each cellular region. Ca2+ signaling, which halts both anterograde and retrograde mitochondrial motion, serves as one regulatory input. Anterograde mitochondrial movement is generated by kinesin-1, which interacts with the mitochondrial protein Miro through an adaptor protein, milton. We show that kinesin is present on all axonal mitochondria, including those that are stationary or moving retrograde. We also show that the EF-hand motifs of Miro mediate Ca2+-dependent arrest of mitochondria and elucidate the regulatory mechanism. Rather than dissociating kinesin-1 from mitochondria, Ca2+-binding permits Miro to interact directly with the motor domain of kinesin-1, preventing motor/microtubule interactions. Thus, kinesin-1 switches from an active state in which it is bound to Miro only via milton, to an inactive state in which direct binding to Miro prevents its interaction with microtubules. Disrupting Ca2+-dependent regulation diminishes neuronal resistance to excitotoxicity.	[Schwarz, Thomas L.] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu	Wang, Xinnan/B-2393-2013		NIH [RO1GM069808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069808] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Rappley, Drs. F. Sun, Z. Wills, P. Aspenstrom, K. J. Verhey, A. M. Craig, T. Pawson, G. W. Hart, and F. A. Stephenson for reagents; S. Vasquez, Drs. Z. Wills, M. Greenberg, and Z. He for assistance with hippocampal cultures, Dr. L. Bu and the Developmental Disorders Research Center Imaging Core and E. Pogoda for technical assistance; Dr. Y. Chu for assistance with Matlab script and a Labview macro. This work was supported by NIH RO1GM069808.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; BRADY ST, 1984, NATURE, V310, P56, DOI 10.1038/310056a0; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Cox RT, 2006, DEVELOPMENT, V133, P3371, DOI 10.1242/dev.02514; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hurd DD, 1996, GENETICS, V144, P1075; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; MURREY HE, 2008, CHEM REV IN PRESS; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Overly CC, 1996, J CELL SCI, V109, P971; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Yang ZK, 2000, J PHYSIOL-LONDON, V523, P29, DOI 10.1111/j.1469-7793.2000.00029.x; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	44	602	616	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					163	174		10.1016/j.cell.2008.11.046	http://dx.doi.org/10.1016/j.cell.2008.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135897	Green Accepted, Bronze			2022-12-28	WOS:000262318400023
J	Bobak, M; Marmot, M				Bobak, Martin; Marmot, Michael			Societal transition and health	LANCET			English	Editorial Material							EDUCATIONAL-LEVEL; MORTALITY		[Bobak, Martin; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Bobak, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.bobak@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Bobak, Martin/0000-0002-2633-6851	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CORNIA GA, 1997, 4 UNU WIDER; Cornia GA, 2000, MORTALITY CRISIS TRA; Haynes M., 2003, CENTURY STATE MURDER; Jozan P, 1999, BRIT MED J, V318, P914, DOI 10.1136/bmj.318.7188.914; Leinsalu M, 2003, INT J EPIDEMIOL, V32, P1081, DOI 10.1093/ije/dyg192; Marmot M, 2000, BMJ-BRIT MED J, V321, P1124, DOI 10.1136/bmj.321.7269.1124; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Nicholson A, 2005, SOC SCI MED, V61, P2345, DOI 10.1016/j.socscimed.2005.07.034; Pomer Marshall, 2001, NEW RUSSIA TRANSITIO; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; *UNICEF, 2001, 8 IRC UNICEF	12	14	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					360	362		10.1016/S0140-6736(09)60043-x	http://dx.doi.org/10.1016/S0140-6736(09)60043-x			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19150129				2022-12-28	WOS:000262912100007
J	Whincup, PH; Kaye, SJ; Owen, CG; Huxley, R; Cook, DG; Anazawa, S; Barrett-Connor, E; Bhargava, SK; Birgisdottir, BSE; Carlsson, S; de Rooij, SR; Dyck, RF; Eriksson, JG; Falkner, B; Fall, C; Forsen, T; Grill, V; Gudnason, V; Hulman, S; Hypponen, E; Jeffreys, M; Lawlor, DA; Leon, DA; Minami, J; Mishra, G; Osmond, C; Power, C; Rich-Edwards, JW; Roseboom, TJ; Sachdev, HS; Syddall, H; Thorsdottir, I; Vanhala, M; Wadsworth, M; Yarbrough, DE				Whincup, Peter H.; Kaye, Samantha J.; Owen, Christopher G.; Huxley, Rachel; Cook, Derek G.; Anazawa, Sonoko; Barrett-Connor, Elizabeth; Bhargava, Santosh K.; Birgisdottir, Bryndi S. E.; Carlsson, Sofia; de Rooij, Susanne R.; Dyck, Roland F.; Eriksson, Johan G.; Falkner, Bonita; Fall, Caroline; Forsen, Tom; Grill, Valdemar; Gudnason, Vilmundur; Hulman, Sonia; Hypponen, Elina; Jeffreys, Mona; Lawlor, Debbie A.; Leon, David A.; Minami, Junichi; Mishra, Gita; Osmond, Clive; Power, Chris; Rich-Edwards, Janet W.; Roseboom, Tessa J.; Sachdev, Harshpal Singh; Syddall, Holly; Thorsdottir, Inga; Vanhala, Mauno; Wadsworth, Michael; Yarbrough, Donald E.			Birth Weight and Risk of Type 2 Diabetes A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMPAIRED GLUCOSE-TOLERANCE; ADULT CHRONIC DISEASE; BRITISH WOMENS HEART; BODY-MASS INDEX; FETAL-GROWTH; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; MATERNAL SMOKING; LATER LIFE; METABOLIC SYNDROME	Context Low birth weight is implicated as a risk factor for type 2 diabetes. However, the strength, consistency, independence, and shape of the association have not been systematically examined. Objective To conduct a quantitative systematic review examining published evidence on the association of birth weight and type 2 diabetes in adults. Data Sources and Study Selection Relevant studies published by June 2008 were identified through literature searches using EMBASE ( from 1980), MEDLINE ( from 1950), and Web of Science ( from 1980), with a combination of text words and Medical Subject Headings. Studies with either quantitative or qualitative estimates of the association between birth weight and type 2 diabetes were included. Data Extraction Estimates of association ( odds ratio [ OR] per kilogram of increase in birth weight) were obtained from authors or from published reports in models that allowed the effects of adjustment ( for body mass index and socioeconomic status) and the effects of exclusion ( for macrosomia and maternal diabetes) to be examined. Estimates were pooled using random- effects models, allowing for the possibility that true associations differed between populations. Data Synthesis Of 327 reports identified, 31 were found to be relevant. Data were obtained from 30 of these reports ( 31 populations; 6090 diabetes cases; 152 084 individuals). Inverse birth weight - type 2 diabetes associations were observed in 23 populations ( 9 of which were statistically significant) and positive associations were found in 8 ( 2 of which were statistically significant). Appreciable heterogeneity between populations (l(2)= 66%; 95% confidence interval [ CI], 51%- 77%) was largely explained by positive associations in 2 native North American populations with high prevalences of maternal diabetes and in 1 other population of young adults. In the remaining 28 populations, the pooled OR of type 2 diabetes, adjusted for age and sex, was 0.75 ( 95% CI, 0.70- 0.81) per kilogram. The shape of the birth weight - type 2 diabetes association was strongly graded, particularly at birth weights of 3 kg or less. Adjustment for current body mass index slightly strengthened the association ( OR, 0.76 [ 95% CI, 0.70-0.82] before adjustment and 0.70 [ 95% CI, 0.65- 0.76] after adjustment). Adjustment for socioeconomic status did not materially affect the association ( OR, 0.77 [ 95% CI, 0.70- 0.84] before adjustment and 0.78 [ 95% CI, 0.72- 0.84] after adjustment). There was no strong evidence of publication or small study bias. Conclusion In most populations studied, birth weight was inversely related to type 2 diabetes risk.	[Whincup, Peter H.; Kaye, Samantha J.; Owen, Christopher G.; Cook, Derek G.] Univ London St Georges Hosp, Div Community Hlth Sci, London SW17 0RE, England; [Hypponen, Elina; Power, Chris] UCL, MRC Ctr Epidemiol Child Hlth, Inst Child Hlth, London, England; [Leon, David A.] UCL, London Sch Hyg & Trop Med, London, England; [Mishra, Gita; Wadsworth, Michael] UCL, MRC Unit Lifelong Hlth & Ageing, Dept Epidemiol & Publ Hlth, London, England; [Huxley, Rachel] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Anazawa, Sonoko] Saiseikai Cent Hosp, Dept Internal Med, Tokyo, Japan; [Barrett-Connor, Elizabeth] Univ Calif San Diego, Sch Med, Div Epidemiol, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Bhargava, Santosh K.] SL Jain Hosp, Dept Paediat, Delhi, India; [Birgisdottir, Bryndi S. E.; Gudnason, Vilmundur; Thorsdottir, Inga] Univ Iceland, Unit Nutr Res, Fac Food Sci & Nutr, Reykjavik, Iceland; [Birgisdottir, Bryndi S. E.; Thorsdottir, Inga] Landspitali Univ Hosp, Reykjavik, Iceland; [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Reykjavik, Iceland; [Carlsson, Sofia] Karolinska Inst, Div Epidemiol, Stockholm Ctr Publ Hlth, Stockholm, Sweden; [Carlsson, Sofia] Karolinska Inst, Dept Epidemiol, Inst Environm Med, Stockholm, Sweden; [de Rooij, Susanne R.; Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Dyck, Roland F.] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada; [Eriksson, Johan G.; Forsen, Tom] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, Helsinki, Finland; [Eriksson, Johan G.; Forsen, Tom] Vasa Cent Hosp, Vaasa, Finland; [Falkner, Bonita] Thomas Jefferson Univ, Dept Med & Paediat, Philadelphia, PA 19107 USA; [Fall, Caroline; Osmond, Clive; Syddall, Holly] Univ Southampton, MRC Epidemiol Resource Ctr, Southampton, Hants, England; [Grill, Valdemar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Biol, N-7034 Trondheim, Norway; [Grill, Valdemar] Univ Trondheim Hosp, Dept Internal Med, Trondheim, Norway; [Hulman, Sonia] Crozer Keystone Hlth Syst, Crozer Chester Med Ctr, Div Neonatol, Upland, PA USA; [Jeffreys, Mona] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Minami, Junichi] Dokkyo Univ, Sch Med, Dept Hypertens & Cardiorenal Med, Tochigi, Japan; [Rich-Edwards, Janet W.] Harvard Univ, Sch Med, Div Womens Hlth, Boston, MA USA; [Rich-Edwards, Janet W.] Harvard Univ, Sch Med, Connors Ctr Womens Hlth & Gender Biol, Boston, MA USA; [Rich-Edwards, Janet W.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, Dept Paediat & Clin Epidemiol, New Delhi, India; [Vanhala, Mauno] Cent Hosp Cent Finland, Jyvaskyla, Finland; [Vanhala, Mauno] Univ Kuopio, Unit Family Practice, Cent Hosp Middle Finland, FIN-70211 Kuopio, Finland; [Vanhala, Mauno] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Yarbrough, Donald E.] Sacred Heart Med Ctr, Eugene, OR USA	St Georges University London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London; University of London; University College London; University of Sydney; Tokyo Saiseikai Central Hospital; University of California System; University of California San Diego; University of Iceland; Landspitali National University Hospital; Icelandic Heart Association; Karolinska Institutet; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam; University of Saskatchewan; Finland National Institute for Health & Welfare; Vaasa Central Hospital; Jefferson University; University of Southampton; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bristol; University of Bristol; Dokkyo Medical University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Sitaram Bhartia Institute of Science & Research; Central Finland Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Whincup, PH (corresponding author), Univ London St Georges Hosp, Div Community Hlth Sci, Cranmer Terrace, London SW17 0RE, England.	p.whincup@sgul.ac.uk	Huxley, Rachel R/J-4638-2013; Birgisdottir, Bryndis E/M-1504-2015; Mishra, Gita D/F-8052-2011; Leon, David A/G-2195-2010; Falkner, Bonita/Y-8451-2019; Hypponen, Elina/B-2596-2014; Huxley, Rachel R/C-7032-2013; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Jeffreys, Mona/W-3425-2019; Thorsdottir, Inga/M-3260-2015	Huxley, Rachel R/0000-0002-2705-6616; Mishra, Gita D/0000-0001-9610-5904; Leon, David A/0000-0001-9747-1762; Hypponen, Elina/0000-0003-3670-9399; Huxley, Rachel R/0000-0002-2705-6616; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Sachdev, Harshpal Singh/0000-0002-4956-9391; carlsson, sofia/0000-0002-9497-2331; de Rooij, Susanne Rosalie/0000-0001-7382-5749; Osmond, Clive/0000-0002-9054-4655; Cook, Derek/0000-0002-9723-5759; Whincup, Peter/0000-0002-5589-4107; Roseboom, Tessa/0000-0003-0564-5994; Birgisdottir, Bryndis Eva/0000-0002-5788-4551; Owen, Christopher/0000-0003-1135-5977; Lawlor, Debbie A/0000-0002-6793-2262; Eriksson, Johan/0000-0002-2516-2060; Thorsdottir, Inga/0000-0002-2946-287X; Fall, Caroline/0000-0003-4402-5552; Jeffreys, Mona/0000-0002-2617-0361	Diabetes UK [RD 050003099]; British Heart Foundation [PG/04/072]; Medical Research Council [MC_U120063239, MC_U147585821, G0600705, U1475000003, G0400519] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; MRC [G0600705, MC_U120063239, MC_U147585821, G0400519] Funding Source: UKRI	Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a research grant from Diabetes UK (grant RD 050003099), with additional support from the British Heart Foundation ( grant PG/04/072).	Al Mamun A, 2006, TOB CONTROL, V15, P452, DOI 10.1136/tc.2006.016790; Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anazawa S, 2003, DIABETES CARE, V26, P2210, DOI 10.2337/diacare.26.7.2210; Baird J, 2001, DIABETOLOGIA, V44, P33, DOI 10.1007/s001250051577; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENSHLOMO Y, 1991, LANCET, V337, P530, DOI 10.1016/0140-6736(91)91307-G; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Birgisdottir BE, 2002, AM J CLIN NUTR, V76, P399, DOI 10.1093/ajcn/76.2.399; Burke JP, 2004, DIABETES CARE, V27, P2512, DOI 10.2337/diacare.27.10.2512; Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; de Rooij SR, 2006, DIABETOLOGIA, V49, P637, DOI 10.1007/s00125-005-0136-9; Dyck R, 2002, DIABETES CARE, V25, P487, DOI 10.2337/diacare.25.3.487; Dyck RF, 2001, CAN J PUBLIC HEALTH, V92, P340, DOI 10.1007/BF03404975; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELFORD J, 1991, INT J EPIDEMIOL, V20, P833, DOI 10.1093/ije/20.4.833; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; Eriksson M, 2004, J INTERN MED, V255, P236, DOI 10.1046/j.1365-2796.2003.01289.x; Fall CHD, 1998, DIABETIC MED, V15, P220, DOI 10.1002/(SICI)1096-9136(199803)15:3<220::AID-DIA544>3.0.CO;2-O; Ferrara A, 2007, DIABETOLOGIA, V50, P298, DOI 10.1007/s00125-006-0517-8; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gillman MW, 2002, INT J EPIDEMIOL, V31, P294, DOI 10.1093/ije/31.2.294; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hulman S, 1998, J PEDIATR-US, V132, P90, DOI 10.1016/S0022-3476(98)70491-3; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Huxley RR, 2004, BRIT J NUTR, V91, P459, DOI 10.1079/BJN20031052; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Jeffreys M, 2006, INT J OBESITY, V30, P507, DOI 10.1038/sj.ijo.0803161; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; Kramer MS, 2000, AM J EPIDEMIOL, V152, P605, DOI 10.1093/aje/152.7.605; Kuh D., 2004, LIFE COURSE APPROACH, DOI DOI 10.1093/ACPROF:OSO/9780198578154.003.0017; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lawlor DA, 2003, DIABETES CARE, V26, P97, DOI 10.2337/diacare.26.1.97; LIEBERMAN E, 1994, AM J PUBLIC HEALTH, V84, P1127, DOI 10.2105/AJPH.84.7.1127; LIGHTRJ, 1984, SUMMING SCI REVISING; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Martyn CN, 1998, DIABETIC MED, V15, P688, DOI 10.1002/(SICI)1096-9136(199808)15:8<688::AID-DIA649>3.3.CO;2-9; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; PETTITT DJ, 1991, DIABETES, V40, P126, DOI 10.2337/diab.40.2.S126; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Shiell AW, 2000, BRIT J OBSTET GYNAEC, V107, P890, DOI 10.1111/j.1471-0528.2000.tb11088.x; *STAT CAN, 2001 CENS CAN; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suzuki T, 2000, AM J HYPERTENS, V13, P907, DOI 10.1016/S0895-7061(00)00276-4; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tian JY, 2006, EUR J ENDOCRINOL, V155, P601, DOI 10.1530/eje.1.02265; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Vanhala MJ, 1999, INT J OBESITY, V23, P656, DOI 10.1038/sj.ijo.0800898; Wadsworth M, 2005, DIABETOLOGIA, V48, P2505, DOI 10.1007/s00125-005-0007-4; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Yarbrough DE, 1998, DIABETES CARE, V21, P1652, DOI 10.2337/diacare.21.10.1652; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	78	667	684	0	77	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2886	2897						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386ZG	19109117				2022-12-28	WOS:000261920900022
J	Newnham, JP; Simmer, K				Newnham, John P.; Simmer, Karen			Multiple courses of antenatal corticosteroids	LANCET			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; BETAMETHASONE; SINGLE; TRIAL		[Newnham, John P.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6008, Australia; [Simmer, Karen] King Edward Hosp, Neonatal Clin Care Unit, Perth, WA, Australia; [Simmer, Karen] Princess Margaret Hosp, Neonatal Clin Care Unit, Perth, WA, Australia	University of Western Australia; King Edward Memorial Hospital	Newnham, JP (corresponding author), Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6008, Australia.	john.newnham@uwa.edu.au	Simmer, Karen N/H-5834-2014	Simmer, Karen/0000-0003-4777-9069; Newnham, John/0000-0001-9983-7457				Aghajafari F, 2002, AM J OBSTET GYNECOL, V186, P843, DOI 10.1067/mob.2002.121624; Crowther CA, 2006, LANCET, V367, P1913, DOI 10.1016/S0140-6736(06)68846-6; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; Ikegami M, 1997, AM J RESP CRIT CARE, V156, P178, DOI 10.1164/ajrccm.156.1.9612036; JOHNSON JWC, 1979, AM J OBSTET GYNECOL, V133, P677, DOI 10.1016/0002-9378(79)90018-8; LIGGINS GC, 1968, J ENDOCRINOL, V42, P323, DOI 10.1677/joe.0.0420323; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Moss TJM, 2005, AM J OBSTET GYNECOL, V192, P146, DOI 10.1016/j.ajog.2004.06.065; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Peltoniemi OM, 2007, PEDIATRICS, V119, P290, DOI 10.1542/peds.2006-1549; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2	12	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2008	372	9656					2094	2095		10.1016/S0140-6736(08)61903-0	http://dx.doi.org/10.1016/S0140-6736(08)61903-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101367				2022-12-28	WOS:000261894000007
J	Chakravarti, A				Chakravarti, Aravinda			Kinship: Race relations	NATURE			English	Editorial Material									[Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Baltimore, MD 21205 USA	Johns Hopkins University	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Geriatr Med, Broadway Res Bldg,Room 579,733 N Broadway, Baltimore, MD 21205 USA.	aravinda@jhmi.edu							0	16	16	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 22	2009	457	7228					380	381		10.1038/457380a	http://dx.doi.org/10.1038/457380a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158772	Bronze			2022-12-28	WOS:000262519200019
J	Moran, NA; McLaughlin, HJ; Sorek, R				Moran, Nancy A.; McLaughlin, Heather J.; Sorek, Rotem			The Dynamics and Time Scale of Ongoing Genomic Erosion in Symbiotic Bacteria	SCIENCE			English	Article							EVOLUTION; SEQUENCE	Among cellular organisms, symbiotic bacteria provide the extreme examples of genome degradation and reduction. However, only isolated snapshots of eroding symbiont genomes have previously been available. We documented the dynamics of symbiont genome evolution by sequencing seven strains of Buchnera aphidicola from pea aphid hosts. We estimated a spontaneous mutation rate of at least 4 x 10(-9) substitutions per site per replication, which is more than 10 times as high as the rates previously estimated for any bacteria. We observed a high rate of small insertions and deletions associated with abundant DNA homopolymers, and occasional larger deletions. Although purifying selection eliminates many mutations, some persist, resulting in ongoing loss of genes and DNA from this already tiny genome. Our results provide a general model for the stepwise process leading to genome reduction.	[Moran, Nancy A.; McLaughlin, Heather J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Arizona; Weizmann Institute of Science	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	nmoran@email.arizona.edu	Moran, Nancy A/G-1591-2010		NSF [0723472]; Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy	NSF(National Science Foundation (NSF)); Y. Leon Benoziyo Institute for Molecular Medicine; U. S. Department of Energy(United States Department of Energy (DOE))	We thank staff at the Joint Genome Institute for the Solexa sequencing runs, E. Rubin for support and facilities, and H. Ochman for comments on the manuscript. Aphid samples were donated by G. Powell and J. C. Simon. K. Hammond maintained insect cultures, and B. Nankivell prepared figures. Funding was provided by NSF award 0723472 (to N.A.M.), the Y. Leon Benoziyo Institute for Molecular Medicine (to R. S.), and the U. S. Department of Energy (to the Joint Genome Institute supporting the sequencing). GenBank accession numbers are CP00158 and CP00161 for the genomic sequences and FJ357501 to FJ357538 for sequences used for the phylogeny of fig. S2.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Coenye T, 2005, DNA RES, V12, P221, DOI 10.1093/dnares/dsi009; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; HARPER AM, 1978, SPECIAL PUBLICATION, V50, P1; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	19	224	724	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					379	382		10.1126/science.1167140	http://dx.doi.org/10.1126/science.1167140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150844				2022-12-28	WOS:000262481400038
J	Ebert, AD; Yu, JY; Rose, FF; Mattis, VB; Lorson, CL; Thomson, JA; Svendsen, CN				Ebert, Allison D.; Yu, Junying; Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.; Thomson, James A.; Svendsen, Clive N.			Induced pluripotent stem cells from a spinal muscular atrophy patient	NATURE			English	Article							MOTOR-NEURON GENE; VALPROIC ACID INCREASES; PROTEIN-LEVEL; SMN; SURVIVAL; COMPLEX; MOUSE; NORMALIZATION; SPECIFICATION; PRODUCT	Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.	[Ebert, Allison D.; Svendsen, Clive N.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ebert, Allison D.; Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Stem Cell & Regenerat Med Ctr, Madison, WI 53705 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Yu, Junying; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Rose, Ferrill F., Jr.; Mattis, Virginia B.; Lorson, Christian L.] Univ Missouri, Dept Vet Pathobiol, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Thomson, James A.; Svendsen, Clive N.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Svendsen, Clive N.] Univ Wisconsin, Dept Neurol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ebert, AD (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	ebert@waisman.wisc.edu; cnsvendsen@wisc.edu			Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke [P01NS057778, R01NS41584]; National Institutes of Child Health and Human Development [R01HD054413]; National Institutes of General Medical Sciences [T32GM008396]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041584, P01NS057778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG027566] Funding Source: NIH RePORTER	Amyotrophic Lateral Sclerosis Association; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Meyer for helpful discussions and B. Shelley, B. Heins and E. McMillan for technical assistance. We also thank WiCell Research Institute for karyotypeanalysis, Cell LineGenetics for DNA fingerprinting, R. Stewart, S. Tian and V. Ruotti at the Morgridge Institute for Research for microarray analysis, and Promega Corp. for qRT-PCR analysis (all at Madison, Wisconsin). The MNR2/HB9 (81.5C10) and the ISLET1 (40.2D6) monoclonal antibodies (both developed by T. Jessell) were obtained from the Developmental Studies HybridomaBank. Funding support was provided by the Amyotrophic Lateral Sclerosis Association (to C.N.S.), the National Institutes of Neurological Disorders and Stroke (P01NS057778 to C.N.S. and R01NS41584 to C.L.L.), National Institutes of Child Health and Human Development (R01HD054413 to C.L.L.), and National Institutes of General Medical Sciences (T32GM008396 for F.F.R.).	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Carriedo SG, 1996, J NEUROSCI, V16, P4069; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Schmid A, 2007, J CHILD NEUROL, V22, P1004, DOI 10.1177/0883073807305667; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	41	1074	1207	2	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					277	U1		10.1038/nature07677	http://dx.doi.org/10.1038/nature07677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	19098894	Green Accepted			2022-12-28	WOS:000262440900031
J	Heath, I				Heath, Iona			The blame game	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												aque22@dsl.pipex.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2009	338								b7	10.1136/bmj.b7	http://dx.doi.org/10.1136/bmj.b7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	404PN	19126606				2022-12-28	WOS:000263165600021
J	Thompson, ND; Perz, JF; Moorman, AC; Holmberg, SD				Thompson, Nicola D.; Perz, Joseph F.; Moorman, Anne C.; Holmberg, Scott D.			Nonhospital Health Care-Associated Hepatitis B and C Virus Transmission: United States, 1998-2008	ANNALS OF INTERNAL MEDICINE			English	Review							NOSOCOMIAL TRANSMISSION; INFECTION-CONTROL; OUTBREAK; PREVALENCE	In the United States, transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) from health care exposures has been considered uncommon. However, a review of outbreak information revealed 33 outbreaks in nonhospital health care settings in the past decade: 12 in outpatient clinics, 6 in hemodialysis centers, and 15 in long-term care facilities, resulting in 448 persons acquiring HBV or HCV infection. In each setting, the putative mechanism of infection was patient-to-patient transmission through failure of health care personnel to adhere to fundamental principles of infection control and aseptic technique (for example, reuse of syringes or lancing devices). Difficult to detect and investigate, these recognized outbreaks indicate a wider and growing problem as health care is increasingly provided in outpatient settings in which infection control training and oversight may be inadequate. A comprehensive approach involving better viral hepatitis surveillance and case investigation, health care provider education and training, professional oversight, licensing, and public awareness is needed to ensure that patients are always afforded basic levels of protection against viral hepatitis transmission.	[Thompson, Nicola D.; Moorman, Anne C.; Holmberg, Scott D.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Perz, Joseph F.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, ND (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd,MS G-37, Atlanta, GA 30333 USA.	ndthompson@cdc.gov		Moorman, Anne/0000-0003-2411-2798				Abramson JS, 2000, PEDIATRICS, V105, P1361; Allos BM, 2007, J INFECT DIS, V195, P1245, DOI 10.1086/513436; Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P875; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bernstein AB, 2003, DHHS PUBLICATION, V2004-1031; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P901; Centers for Disease Control and Prevention (CDC), 1977, 41 US DEP HHS PHS CD, P12, DOI DOI 10.1111/J.1478-3231.2008.01699.X; Comstock RD, 2004, INFECT CONT HOSP EP, V25, P576, DOI 10.1086/502442; de Oliveira AM, 2005, ANN INTERN MED, V142, P898, DOI 10.7326/0003-4819-142-11-200506070-00007; Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123; GOODMAN RA, 1991, JAMA-J AM MED ASSOC, V265, P2377, DOI 10.1001/jama.265.18.2377; GUTELIUS BJ, 2008, 57 ANN EP INT SERV C; Henderson DK, 2008, INFECT CONT HOSP EP, V29, P294, DOI 10.1086/587440; Janowski MC, 2005, INF DIS SOC AM 43 AN; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; *JOINT COMM, 2008, NEW YORK STAT DEP HL; Khan AJ, 2002, INFECT CONT HOSP EP, V23, P313, DOI 10.1086/502057; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; Labus B., 2008, Morbidity and Mortality Weekly Report, V57, P513; Lee KC, 2005, INF DIS SOC AM 43 AN; Louie RF, 2005, POINT CARE, V4, P158, DOI 10.1097/01.poc.0000189933.35225.77; Maki DG, 2005, ARCH INTERN MED, V165, P2565, DOI 10.1001/archinte.165.22.2565; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Marx M, 2004, 53 ANN EP INT SERV C; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; National Center for Health Statistics, 2007, HLTH US 2007 CHARTB; PATEL AS, CONTROL HOS IN PRESS; Patel PR, 2006, JAMA-J AM MED ASSOC, V296, P2005, DOI 10.1001/jama.296.16.2005; Perz JF, 2006, J AM MED DIR ASSOC, V7, P65, DOI 10.1016/j.jamda.2005.09.008; Petrosillo N, 2001, AM J KIDNEY DIS, V37, P1004, DOI 10.1016/S0272-6386(05)80017-4; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Samandari T, 2005, INFECT CONT HOSP EP, V26, P745, DOI 10.1086/502612; Sanderson RA, 2006, AM J INFECT CONTROL, V34, pE90; Siegel J, 2007, GUIDELINES ISOLATION; SOUTHWICK KL, 2007, CLUSTER HEPATITIS B; Thompson N, 2008, NAT KIDN FDN SPRING; Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008; Webb R., 2005, Morbidity and Mortality Weekly Report, V54, P220; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; WILLIAMS IT, 2006, INF DIS SOC AM 44 AN	41	177	185	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2009	150	1					33	W7		10.7326/0003-4819-150-1-200901060-00007	http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397IC	19124818				2022-12-28	WOS:000262655100005
J	Som, R; Li, A; McIntosh, R; Lloyd, GW				Som, R.; Li, A.; McIntosh, R.; Lloyd, G. W.			Acute dyspnoea, dysphagia, and non-specific chest pain in a smoker	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LARGE PERICARDIAL-EFFUSIONS; CARDIAC-TAMPONADE; CONSTRICTIVE PERICARDITIS; MANAGEMENT; PERICARDIOCENTESIS; DIAGNOSIS; COLCHICINE; OUTCOMES; TRIAL; RISKS		[Som, R.; Li, A.; McIntosh, R.; Lloyd, G. W.] Eastbourne Dist Gen Hosp, Dept Cardiol, Eastbourne BN21 2UD, England		Som, R (corresponding author), Eastbourne Dist Gen Hosp, Dept Cardiol, Eastbourne BN21 2UD, England.	rsom@doctors.org.uk		Lloyd, Guy/0000-0003-1958-6606				Abraham K P, 1990, Am J Cardiovasc Pathol, V3, P195; Adler Y, 1998, CIRCULATION, V97, P2183, DOI 10.1161/01.CIR.97.21.2183; Akkerhuis JM, 2004, NEW ENGL J MED, V351, pE1, DOI 10.1056/ENEJMicm030059; Atar S, 1999, CHEST, V116, P1564, DOI 10.1378/chest.116.6.1564; Ben-Horin S, 2007, AM J CARDIOL, V99, P1294, DOI 10.1016/j.amjcard.2006.12.048; Bonnefoy E, 2000, EUR HEART J, V21, P832, DOI 10.1053/euhj.1999.1907; COREY GR, 1993, AM J MED, V95, P209, DOI 10.1016/0002-9343(93)90262-N; CURTISS EI, 1988, AM HEART J, V115, P391, DOI 10.1016/0002-8703(88)90487-5; DEVALERIA PA, 1991, ANN THORAC SURG, V52, P219, DOI 10.1016/0003-4975(91)91339-W; Drummond JB, 1998, J AM SOC ECHOCARDIOG, V11, P433, DOI 10.1016/S0894-7317(98)70022-7; Eisenberg MJ, 1993, J AM COLL CARDIOL, V22, P588, DOI 10.1016/0735-1097(93)90069-D; Eisenberg MJ, 1996, CHEST, V110, P318, DOI 10.1378/chest.110.2.318; Hakim JG, 2000, HEART, V84, P183, DOI 10.1136/heart.84.2.183; HOROWITZ MS, 1974, CIRCULATION, V50, P239, DOI 10.1161/01.CIR.50.2.239; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Laham RJ, 1996, HEART, V75, P67, DOI 10.1136/hrt.75.1.67; Maisch B, 2003, HEART, V89, P1096, DOI 10.1136/heart.89.9.1096; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Maisch B, 2002, EUR HEART J, V23, P1625, DOI 10.1053/euhj.2002.3328; MEYERS DG, 1993, CHEST, V104, P1422, DOI 10.1378/chest.104.5.1422; Rathore S, 2007, CARDIOLOGY, V108, P183, DOI 10.1159/000096666; Sagrista-Sauleda J, 2000, AM J MED, V109, P95, DOI 10.1016/S0002-9343(00)00459-9; SEFEROVIC PM, 2000, PERICARDIOLOGY CONT, P417; Soler-Soler J, 2001, HEART, V86, P235, DOI 10.1136/heart.86.2.235; STRIMEL WJ, 2008, PERICARDIAL EFFUSION; TIRILOMIS T, 1994, EUR J CARDIO-THORAC, V8, P487, DOI 10.1016/1010-7940(94)90020-5; Tsang TSM, 2000, MAYO CLIN PROC, V75, P248; Tsang TSM, 2002, MAYO CLIN PROC, V77, P429; TWEDDELL JS, 1989, J AM COLL CARDIOL, V14, P1074, DOI 10.1016/0735-1097(89)90492-0; VAITKUS PT, 1994, JAMA-J AM MED ASSOC, V272, P59, DOI 10.1001/jama.272.1.59	30	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2008	337								a2678	10.1136/bmj.a2678	http://dx.doi.org/10.1136/bmj.a2678			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401MV	19114445				2022-12-28	WOS:000262945900001
J	Backman, G; Hunt, P; Khosla, R; Jaramillo-Strouss, C; Fikre, BM; Rumble, C; Pevalin, D; Paez, DA; Pineda, MA; Frisancho, A; Tarco, D; Motlagh, M; Farcasanu, D; Vladescu, C				Backman, Gunilla; Hunt, Paul; Khosla, Rajat; Jaramillo-Strouss, Camila; Fikre, Belachew Mekuria; Rumble, Caroline; Pevalin, David; Paez, David Acurio; Pineda, Monica Armijos; Frisancho, Ariel; Tarco, Duniska; Motlagh, Mitra; Farcasanu, Dana; Vladescu, Cristian			Health systems and the right to health: an assessment of 194 countries	LANCET			English	Review							HIGHEST ATTAINABLE STANDARD; CARE	60 years ago, the Universal Declaration of Human Rights laid the foundations for the right to the highest attainable standard of health. This right is central to the creation of equitable health systems. We identify some of the right-to-health features of health systems, such as a comprehensive national health plan, and propose 72 indicators that reflect some of these features. We collect globally processed data on these indicators for 194 countries and national data for Ecuador, Mozambique, Peru, Romania, and Sweden. Globally processed data were not available for 18 indicators for any country, suggesting that organisations that obtain such data give insufficient attention to the right-to-health features of health systems. Where they are available, the indicators show where health systems need to be improved to better realise the right to health. We provide recommendations for governments, international bodies, civil-society organisations, and other institutions and suggest that these indicators and data, although not perfect, provide a basis for the monitoring of health systems and the progressive realisation of the right to health. Right-to-health features are not just good management, justice, or humanitarianism, they are obligations under human-rights law.	[Backman, Gunilla] Nord Sch Publ Hlth, SE-40242 Gothenburg, Sweden; [Hunt, Paul; Khosla, Rajat; Fikre, Belachew Mekuria; Rumble, Caroline] Univ Essex, Human Rights Ctr, Colchester CO4 3SQ, Essex, England; [Pevalin, David] Univ Essex, Sch Hlth & Human Sci, Colchester CO4 3SQ, Essex, England; [Jaramillo-Strouss, Camila] Off Mayor Bogota, Bogota, Colombia; [Paez, David Acurio; Pineda, Monica Armijos] Fdn Alterat Social Dev, Cuenca, Ecuador; [Frisancho, Ariel] CARE Peru, Lima, Peru; [Tarco, Duniska] Minist Hlth, Natl Hlth Council Secretariat, Lima, Peru; [Motlagh, Mitra] WHO, Western Pacific Reg Off, Manila, Philippines; [Farcasanu, Dana] Ctr Hlth Policies & Serv, Bucharest, Romania; [Vladescu, Cristian] Victor Babes Univ Med & Pharm, Dept Publ Hlth, Timisoara, Romania	University of Essex; University of Essex; WHO Western Pacific Regional Office; World Health Organization; Victor Babes University of Medicine & Pharmacy, Timisoara	Backman, G (corresponding author), Nord Sch Publ Hlth, SE-40242 Gothenburg, Sweden.	gunillabackman@yahoo.com	Pevalin, David/K-8679-2013; Vladescu, Cristian/AAF-9693-2019	Pevalin, David/0000-0002-0556-5380; Vladescu, Cristian/0000-0002-5324-3618; Acurio Paez, David/0000-0003-3258-2837; Tarco Virto, Duniska/0000-0003-1228-0807	Ford Foundation and Joseph Rowntree Charitable Trust	Ford Foundation and Joseph Rowntree Charitable Trust	We are extremely grateful to the following individuals who have provided us with assistance: Idris A Bawa, Alexandra Cameron, Edelisa D Cararidang, Judith Bueno de Mesquita, Aditi Das, Louise Finer, Malebkeng Forere, Jane Godsland, Sofia Gruskin, Hans Hogerzeil, Dragana Korljan, Richard Laing, Rhona MacDonald, Gillian MacNaughton, Maxwell Madzikanga, Paulo Marchi, Sophie Mathewson, Martin McKee, Ellen Nolte, Uju A Okereke, Lisa Oldring, Ching-Ling Pang, Genevieve Paul, Justina Pinkeviciute, Helen Potts, Anna Protano-Briggs, Mike Rowson, Julian Sheather, Christine Tapp, Daniel Tarantola, Michael Wilks. This report was researched with support from the Ford Foundation and Joseph Rowntree Charitable Trust. However, the content of the report is the sole responsibility of the authors and cannot be taken to reflect the views of either the foundation or trust.	*AB DECL, AIDS IS STAT EM CONT; Aboriginal and Torres Strait Islander Social Justice Commissioner, 2005, SOC JUST REP 2005; AKUNYILI D, 2006, TRANSPARENCY INT GLO, P96; Allotey P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-343; *AMN INT, 2006, PER POOR EXCL WOM DE; [Anonymous], 2008, COMM SOC DET HLTH FI; [Anonymous], UN MILL DEV GOALS IN; [Anonymous], 2007, GLOB PARTN M NEGL TR; ASHER J, 2004, RIGHT HLTH RESOURCE; ASHER J, 2007, RIGHT HLTH TOOLKIT H; BADERIN MA, 2006, EC SOCIAL CULTURAL R; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; BROWNLIE I, 2006, BASIC DOCUMENTS INT; Chapman A, 2002, CORE OBLIGATIONS BUI; CLAPHAM ANDREW, 2006, HUMAN RIGHTS OBLIGAT; *COMM EC SOC CULT, 2000, EC1220004 CESCR; *COMM EL DISCR WOM, A5438REV1 COMM EL DI, pCH1; Committee on the Rights of the Child, 2003, CRCGC20033; Cottrell J., 2004, Economic, Social &POUND;r Cultural Rights in Practice: The Role ofJudges in Implementing Economic, Social &POUND;r Cultural Rights; CRR (CENTRE FOR REPRODUCTIVE RIGHTS) and WARDC (WOMEN ADVOCATES RESEARCH DOCUMENTATION CENTRE), 2008, BROK PROM HUM RIGHTS; Darrow M, 2003, LIGHT SHADOW WORLD B; *DEM HLTH SURV, 2001, MOD A QUEST COMM HIG; *DEP HLTH, 2008, HUM RIGHTS HEALTHC E; DuBois M, 2008, HUMANITARIAN EXCH, V39, P12; Freedman LP., 2005, DEVELOPMENT, V48, P19, DOI DOI 10.1057/PALGRAVE.DEVELOPMENT.1100107; Gauri V, 2008, COURTING SOCIAL JUSTICE: JUDICIAL ENFORCEMENT OF SOCIAL AND ECONOMIC RIGHTS IN THE DEVELOPING WORLD, P1, DOI 10.1017/CBO9780511511240; *GAVI, HLTH SYST STRENGTH; Green A., 2007, INTRO HLTH PLANNING; Gruskin S., 2005, PERSPECTIVES HLTH HU; Gruskin S, 2007, LANCET, V370, P449, DOI 10.1016/S0140-6736(07)61200-8; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Horton R, 2008, LANCET, V371, P2213, DOI 10.1016/S0140-6736(08)60956-3; Howard G., DOMESTIC WATER QUANT; Hunt P, 2006, T ROY SOC TROP MED H, V100, P603, DOI 10.1016/j.trstmh.2006.03.001; Hunt P., 2008, AHRC711ADD2 UN; HUNT P, 2005, ECN4200551ADD3 UN; HUNT P, 2004, A59422 UN; HUNT P, 2005, ECN4200551 UN; HUNT P, 2008, A63263 UN; HUNT P, 2007, AHRC428ADD2 UN; HUNT P, 2007, EC SOCIAL CULTURAL R, P303; HUNT P, 2007, A62214 UN; HUNT P, 2006, REDUCING MATERNAL MO; HUNT P, IMPACT ASSESSMENTS P; HUNT P, 2008, SUR, V5, P99; Hunt P, 2007, NEGLECTED DIS HUMAN; Hunt P, 2006, HUM RIGHTS QUART, V28, P332, DOI 10.1353/hrq.2006.0019; Hunt Paul, 2008, Health Hum Rights, V10, P81; Hunt P, 2008, J LAW MED, V15, P714; Hunt Paul, 2006, ECN4200648 UN; Hunt Paul, 2006, A61338 UN; Hunt Paul, 2004, ECN4200449 UN; Hunt Paul, 2007, AHRC428 UN; *INT COUNC HUM RIG, 2003, DUT SANS FRONT HUM R; *INT HARM RED ASS, 2008, GLOB HARM RED REP; Inter-American Committee of Human Rights, 2007, ACC JUST GUAR EC SOC; Kinney ED, 2004, CORNELL INT LAW J, V37, P285; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mann J.M., 1999, HLTH HUMAN RIGHTS RE; MARKS S, 2006, HLTH HUMAN RIGHTS BA; *MIN HLTH GOV UG, 2008, REV HSSPII REL HUM R; *MIN SAL, 2005, NORM TECN AT PART VE; *NAT I STAT, 2006, ANN REP NAT I STAT; Neumayer E., 2005, J CONFLICT RESOLUT, V49, P6; *NEW VIS, 2008, HLTH RIGHTS UN LAUNC; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; NOLTE E, 2006, HDB HLTH RES METHODS, P12; *OECD, RAT CONV OECD; ohchr, 2005, EC SOC CULT RIGHTS H; Open Society Institute, 2005, MED ROM HLTH POL PRO; *PEOPL HLTH MOV, ASS RIGHT HLTH HLTH; *PHR, 2008, DEADL DEL MAT MORT P; *PHYS HUM RIGHTS, 2008, RIGHT HLTH HLTH WORK; Potts H, 2008, ACCOUNTABILITY RIGHT; POTTS H, PARTICIPATI IN PRESS; ROBERTSON D, LANCET, V360, P330; Sepulveda M. Magdalena, 2003, NATURE OBLIGATIONS I; Singh JA, 2007, LANCET, V370, P521, DOI 10.1016/S0140-6736(07)61236-7; Skogly S. I., 2006, NATL BORDERS STATES; SOPAC, 2008, WORLD WAT DAY SAN HE; Tarimo E., 1991, HLTH DISTRICT ORG MA; The Sphere Project, 2004, HUM CHART MIN STAND; *UN, 2008, HRIMC20083 UN; *UN, 1966, INT CONV EL FORMS RA; UN Committee on the Rights of the Child, 2003, CRCGC20034; *UN GEN ASS SPEC S, GUID CONSTR COR IND; *UN OFF HIGH COMM, 2007, PRINC GUID HUM RIGHT; *UN OHCHR, 1993, 19 UNOHCHR; *UNAIDS, 2008, ENH RES APPL PAR DEC; *UNAIDS, 2006, 2006 REP GLOB EP; *UNDP, MDG SER MET; UNDP, HUM DEV REP; UNDP, 2006, HUMAN DEV REPORT 200; *UNFPA, 2004, CULT MATT WORK COMM; *UNICEF, MON STAT COR IND DEP; United Nations, 1966, INT COV EC SOC CULT; United Nations, 1989, CONV RIGHTS CHILD CR; *US NAT LIB MED NI, 2005, INT COMM MED J ED UN; VANGENUGTEN W, 2003, WORLD BANK IMF HUMAN; Weissbrodt D, 2001, RIGHT FAIR TRIAL UNI; *WHO, DEP EC SOC AFF PRINC; WHO, 2005, SUMM REP WHO MULT ST; WHO, 2008, FRAM STAND COUNTR HL, V2; *WHO, 2006, WHOSDEHSD99; *WHO, WORLD HLTH SURV RES; *WHO, COUNTR HLTH INF SYST; *WHO, 2005, HUM RIGHTS HLTH POV; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2001, WHO MENT HLTH EV EUR; WHO Europe, 1978, DECL ALM AT; *WHO UNICEF, 2000, GLOB WAT ASS SAN REP; *WHO UNICEF, WHO VACC PREV DIS MO; *WHO UNICEF UNFPA, 2007, MAT MORT 2005; World Bank, 2022, WORLD DEV IND 2022; *WORLD BANK, DAT STAT 2008; *WORLD BANK, CUM IDA SUBSCR CONTR; *WORLD BANK, GOV MATT, V6; World Health Organization, 2005, BANGK CHART HLTH PRO; World Health Organization, 2005, WHO MULT STUD WOM HL; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, COUNTR; World Health Organization, 2004, MED STRAT 2004 2007; World Health Organization, WHO GUID DRINK WAT Q; World Health Organization, INT STAT CLASS DIS R, V10th; World Health Organization, 1978, DECL ALM AT INT C PR; World Health Organization, 1986, OTT CHART GES; World Health Organization, CONST WHO; World Health Organization, 2007, PEOPL CTR HLTH CAR H; Yamin AE, 2004, HUM RIGHTS QUART, V26, P519, DOI 10.1353/hrq.2004.0029; Yamin AE, 2008, ROLE COURTS DEFINING	133	246	249	3	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2008	372	9655					2047	2085		10.1016/S0140-6736(08)61781-X	http://dx.doi.org/10.1016/S0140-6736(08)61781-X			39	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384LS	19097280				2022-12-28	WOS:000261746900025
J	Cator, LJ; Arthur, BJ; Harrington, LC; Hoy, RR				Cator, Lauren J.; Arthur, Ben J.; Harrington, Laura C.; Hoy, Ronald R.			Harmonic Convergence in the Love Songs of the Dengue Vector Mosquito	SCIENCE			English	Article							STERILE INSECT TECHNIQUE; FEMALE AEDES-AEGYPTI; ATTRACTION; DIPTERA; FLIGHT; SOUND; ORGAN	The familiar buzz of flying mosquitoes is an important mating signal, with the fundamental frequency of the female's flight tone signaling her presence. In the yellow fever and dengue vector Aedes aegypti, both sexes interact acoustically by shifting their flight tones to match, resulting in a courtship duet. Matching is made not at the fundamental frequency of 400 hertz ( female) or 600 hertz ( male) but at a shared harmonic of 1200 hertz, which exceeds the previously known upper limit of hearing in mosquitoes. Physiological recordings from Johnston's organ ( the mosquito's "ear") reveal sensitivity up to 2000 hertz, consistent with our observed courtship behavior. These findings revise widely accepted limits of acoustic behavior in mosquitoes.	[Arthur, Ben J.; Hoy, Ronald R.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Cator, Lauren J.; Harrington, Laura C.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hoy, RR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	rrh3@cornell.edu			Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project [NTC-139432]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000103] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health; Grand Challenges in Global Health Initiative and Hatch Project; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Wyttenbach for the suggestion to look for sustained deflections in the neural response and are grateful to L. Ristroph and I. Cohen for high-speed video of males and females in free flight. Support was provided ( to L. C. H.) from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and Hatch Project NYC-139432.	BELTON P, 1979, ENTOMOL EXP APPL, V26, P105, DOI 10.1111/j.1570-7458.1979.tb02904.x; BELTON P, 1989, CAN J ZOOL, V67, P2625, DOI 10.1139/z89-371; BELTON P, 1994, J AM MOSQUITO CONTR, V10, P297; Belton P., 1986, P60; BELTON P, 1974, P139; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BOO KS, 1975, J INSECT PHYSIOL, V21, P1129, DOI 10.1016/0022-1910(75)90126-2; Borkent A, 2006, CAN ENTOMOL, V138, P91; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; CLEMENTS AN, 1999, BIOL MOSQUITOES SENS, P740; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Gibson G, 2006, CURR BIOL, V16, P1311, DOI 10.1016/j.cub.2006.05.053; Gopfert MC, 2001, P ROY SOC B-BIOL SCI, V268, P333, DOI 10.1098/rspb.2000.1376; Gopfert MC, 1999, J EXP BIOL, V202, P2727; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Haskell P. T., 1974, PHYSL INSECTA, VII, P353; Johnston C., 1855, Q J MICROSC SCI, V3, P97; KAHN MC, 1949, AM J TROP MED, V29, P811; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Mayer AM, 1874, AM NAT, V8, P577; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; SCHWARTZKOFF J, 1974, PHYSIOL INSECT, V2, P273; Scott TW, 2008, ADV EXP MED BIOL, V627, P151, DOI 10.1007/978-0-387-78225-6_13; Vreysen M.J.B., 2007, AREA WIDE CONTROL IN, P792; WILLIAMS RW, 1980, MOSQ NEWS, V40, P597; WISHART G., 1959, CANADIAN ENT, V91, P181; YOUNG ADM, 1982, PHYSIOL ENTOMOL, V7, P467, DOI 10.1111/j.1365-3032.1982.tb00323.x	28	188	198	6	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1077	1079		10.1126/science.1166541	http://dx.doi.org/10.1126/science.1166541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19131593	Green Accepted			2022-12-28	WOS:000263478400047
J	Myong, S; Cui, S; Cornish, PV; Kirchhofer, A; Gack, MU; Jung, JU; Hopfner, KP; Ha, T				Myong, Sua; Cui, Sheng; Cornish, Peter V.; Kirchhofer, Axel; Gack, Michaela U.; Jung, Jae U.; Hopfner, Karl-Peter; Ha, Taekjip			Cytosolic Viral Sensor RIG-I Is a 5 '-Triphosphate-Dependent Translocase on Double-Stranded RNA	SCIENCE			English	Article							HEPATITIS-C VIRUS; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; DNA; MECHANISM; HELICASE; RECOGNITION; DOMAIN; ROLES	Retinoic acid inducible- gene I ( RIG- I) is a cytosolic multidomain protein that detects viral RNA and elicits an antiviral immune response. Two N- terminal caspase activation and recruitment domains ( CARDs) transmit the signal, and the regulatory domain prevents signaling in the absence of viral RNA. 5 '- triphosphate and double- stranded RNA ( dsRNA) are two molecular patterns that enable RIG- I to discriminate pathogenic from self- RNA. However, the function of the DExH box helicase domain that is also required for activity is less clear. Using single- molecule protein- induced fluorescence enhancement, we discovered a robust adenosine 5 ' - triphosphate- powered dsRNA translocation activity of RIG- I. The CARDs dramatically suppress translocation in the absence of 5 '- triphosphate, and the activation by 5 '- triphosphate triggers RIG- I to translocate preferentially on dsRNA in cis. This functional integration of two RNA molecular patterns may provide a means to specifically sense and counteract replicating viruses.	[Myong, Sua; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Cui, Sheng; Kirchhofer, Axel; Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, Gene Ctr, D-81377 Munich, Germany; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Cornish, Peter V.; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA; [Gack, Michaela U.; Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.; Jung, Jae U.] Harvard Univ, Sch Med, Div Tumor Virol, New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gack, Michaela U.] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of Illinois System; University of Illinois Urbana-Champaign; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Southern California; Harvard University; Harvard University; University of Erlangen Nuremberg	Myong, S (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	smyong@uiuc.edu; hopfner@lmb.uni-muenchen.de; tjha@uiuc.edu	Sheng, CUI/M-6405-2013; Hopfner, Karl-Peter/B-6864-2014; Ha, Taekjip/B-9506-2009; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; Hopfner, Karl-Peter/0000-0002-4528-8357; Ha, Taekjip/0000-0003-2195-6258; 	NIH [R01-GM065367, CA82057]; NSF Physics Frontiers Center [0822613]; Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455; DFG graduate school 1202; Institute for Genomic Biology; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontiers Center(National Science Foundation (NSF)); Human Frontiers of Science; German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG) program project 455(German Research Foundation (DFG)); DFG graduate school 1202(German Research Foundation (DFG)); Institute for Genomic Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo and K. Ragunathan for careful review of the manuscript. This work was supported by NIH grant R01-GM065367 and NSF Physics Frontiers Center grant 0822613 to T.H., NIH grant CA82057 to J. U. J., and a Human Frontiers of Science grant to T.H. and K.-P. H.K.-P.H. acknowledges support from the German Excellence Initiative. S. C. is supported by Deutsche Forschungsgemeinschaft (DFG) program project 455 to K.- P. H. A. K. acknowledges support from the DFG graduate school 1202. T. H. is an investigator with Howard Hughes Medical Institute. S. M. is a fellow at the Institute for Genomic Biology.	Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	29	284	288	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1070	1074		10.1126/science.1168352	http://dx.doi.org/10.1126/science.1168352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19119185	Green Accepted			2022-12-28	WOS:000263478400045
J	Storey, RF				Storey, Robert F.			Clopidogrel in acute coronary syndrome: to genotype or not?	LANCET			English	Editorial Material							ACTIVE METABOLITE; RESPONSIVENESS; CYP2C19		[Storey, Robert F.] Univ Sheffield, Sch Med, Cardiovasc Res Unit, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Storey, RF (corresponding author), Univ Sheffield, Sch Med, Cardiovasc Res Unit, Sheffield S10 2RX, S Yorkshire, England.	R.F.Storey@sheffield.ac.uk	Storey, Robert/AAA-6853-2019	Storey, Robert/0000-0002-6677-6229				Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; COLLET JP, 2008, LANCET          1223, DOI DOI 10.1016/S0140-6736(08)61845-0; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Geisler T, 2008, PHARMACOGENOMICS, V9, P1251, DOI 10.2217/14622416.9.9.1251; Gurbel PA, 2006, REV CARDIOVASC MED, V7, pS20; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Storey RF, 2008, EUR HEART J SUPPL, V10, pD30, DOI 10.1093/eurheartj/sun008; Storey RF, 2006, CURR PHARM DESIGN, V12, P1255, DOI 10.2174/138161206776361318; van Giezen JJJ, 2005, SEMIN THROMB HEMOST, V31, P195, DOI 10.1055/s-2005-869525; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6	12	19	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 24	2009	373	9660					276	278		10.1016/S0140-6736(08)61846-2	http://dx.doi.org/10.1016/S0140-6736(08)61846-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398JJ	19108882				2022-12-28	WOS:000262728100006
J	Castanotto, D; Rossi, JJ				Castanotto, Daniela; Rossi, John J.			The promises and pitfalls of RNA-interference-based therapeutics	NATURE			English	Review							DOUBLE-STRANDED-RNA; IN-VIVO DELIVERY; DICER-SUBSTRATE SIRNA; HEPATITIS-C VIRUS; MAMMALIAN-CELLS; ENDOGENOUS SIRNAS; NEUROPATHIC PAIN; SYNTHETIC SIRNA; GENE-EXPRESSION; SOMATIC-CELLS	The discovery that gene expression can be controlled by the Watson - Crick base- pairing of small RNAs with messenger RNAs containing complementary sequence - a process known as RNA interference - has markedly advanced our understanding of eukaryotic gene regulation and function. The ability of short RNA sequences to modulate gene expression has provided a powerful tool with which to study gene function and is set to revolutionize the treatment of disease. Remarkably, despite being just one decade from its discovery, the phenomenon is already being used therapeutically in human clinical trials, and biotechnology companies that focus on RNA- interference- based therapeutics are already publicly traded.	[Castanotto, Daniela; Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA; [Castanotto, Daniela; Rossi, John J.] City Hope Natl Med Ctr, Beckman Res Inst, City Hope Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Rossi, JJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA.	jrossi@coh.org			National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029329, R01AI029329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I thank the National Institutes of Health for grant assistance.	Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Dore-Savard L, 2008, MOL THER, V16, P1331, DOI 10.1038/mt.2008.98; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dowler T, 2006, NUCLEIC ACIDS RES, V34, P1669, DOI 10.1093/nar/gkl033; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Farah Mohamed H., 2007, Current Drug Delivery, V4, P161, DOI 10.2174/156720107780362276; Fisher M, 2007, NUCLEIC ACIDS RES, V35, P1064, DOI 10.1093/nar/gkl1126; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Lorenz C, 2004, BIOORG MED CHEM LETT, V14, P4975, DOI 10.1016/j.bmcl.2004.07.018; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Pardridge WM, 2007, ADV DRUG DELIVER REV, V59, P141, DOI 10.1016/j.addr.2007.03.008; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641; Shishkina GT, 2004, NEUROSCIENCE, V129, P521, DOI 10.1016/j.neuroscience.2004.08.015; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Sioud M, 2008, FRONT BIOSCI, V13, P4379, DOI 10.2741/3011; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P2136, DOI 10.1093/nar/gkn042; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watts JK, 2007, NUCLEIC ACIDS RES, V35, P1441, DOI 10.1093/nar/gkl1153; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2006, CELL, V127, P1083, DOI 10.1016/j.cell.2006.12.001; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	95	962	1080	4	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					426	433		10.1038/nature07758	http://dx.doi.org/10.1038/nature07758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158789	Green Accepted			2022-12-28	WOS:000262519200036
J	El Harchaoui, K; Arsenault, BJ; Franssen, R; Despres, JP; Hovingh, K; Stroes, ESG; Otvos, JD; Wareham, NJ; Kastelein, JJP; Khaw, KT; Boekholdt, SM				El Harchaoui, Karim; Arsenault, Benoit J.; Franssen, Remco; Despres, Jean-Pierre; Hovingh, Kees; Stroes, Erik S. G.; Otvos, James D.; Wareham, Nicholas J.; Kastelein, John J. P.; Khaw, Kay-Tee; Boekholdt, S. Matthijs			High-Density Lipoprotein Particle Size and Concentration and Coronary Risk	ANNALS OF INTERNAL MEDICINE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; APOLIPOPROTEIN-A-I; INTIMA-MEDIA THICKNESS; ARTERY-DISEASE; EPIC-NORFOLK; INSULIN-RESISTANCE; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; HEART-DISEASE	Background: High-density lipoprotein (HDL) cholesterol levels are inversely related to risk for coronary artery disease (CAD). Because HDL particles are heterogeneous in size and composition, they may be differentially associated with other cardiovascular risk factors and with cardiovascular risk. Objective: To study the independent relationships of HDL size and particle concentration to risk for future CAD. Design: Nested case-control study within the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk cohort; baseline survey between 1993 and 1997, follow-up until November 2003. Setting: Norfolk, United Kingdom. Participants: Case patients were 822 apparently healthy men and women who developed CAD during follow-up. Control participants were 1401 participants who remained without CAD and were matched to case patients by sex, age, and enrollment time. Measurements: First CAD event leading to either hospitalization or death. Results: Nuclear magnetic resonance spectroscopy-measured HDL particle concentration (mean, 33.9 mu mol/L [SD, 5] vs. 32.9 mu mol/L [SD, 6]; P < 0.001) and HDL size (mean, 8.9 nm [SD, 0.5] vs. 8.8 nm [SD, 0.5]; P < 0.001), as well as gradient gel electrophoresis measured HDL size (mean, 8.9 nm [SD, 0.4] vs. 8.8 nm [SD, 0.4]; P = 0.005) were lower in case patients than in control participants. High-density lipoprotein size and HDL particle concentration were only weakly correlated (r = 0.08, for those measured with nuclear magnetic resonance spectroscopy; r = 0.10, for those measured with gradient gel electrophoresis). High-density lipoprotein size was strongly associated with risk factors characteristic of the metabolic syndrome, including waist-to-hip ratio, triglyceride level, and apolipoprotein B level, whereas HDL particle concentration was not. Both HDL size and HDL particle concentration were independently associated with CAD risk. The association between HDL size and CAD risk was abolished on adjustment for apolipoprotein B and triglyceride levels (adjusted odds ratio, 1.00 [95% CI, 0.71 to 1.39] for top vs. bottom quartile), whereas HDL particle concentration remained independently associated with CAD risk (adjusted odds ratio, 0.50 [CI, 0.37 to 0.66]). Limitation: Measurements were performed in nonfasting blood samples, and residual confounding cannot be excluded. Conclusion: Both HDL size and HDL particle concentration were independently associated with other cardiovascular risk factors and with the risk for CAD. The relationship between HDL size and CAD risk was explained by markers associated with the metabolic syndrome, indicating that part of the relationship between HDL cholesterol and CAD risk is merely a reflection of this metabolic risk.	[Boekholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada; LipoSci, Raleigh, NC USA; Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; Univ Cambridge, Inst Publ Hlth & Primary Care, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Laval University; LipoScience, Inc; University of Cambridge; University of Cambridge	Boekholdt, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	s.m.boekholdt@amc.uva.nl	Boekholdt, Matthijs S.M./G-7562-2014; Kastelein, John/AAF-7950-2020; Khaw, Kay-Tee/AAZ-3209-2021	Boekholdt, Matthijs/0000-0002-0861-0765	The Medical Research Council and Cancer Research UK; European Union; Stroke Association; British Heart Foundation; United Kingdom Department of Health; Food Standards Agency; Wellcome Trust; Future Forum	The Medical Research Council and Cancer Research UK; European Union(European Commission); Stroke Association; British Heart Foundation(British Heart Foundation); United Kingdom Department of Health; Food Standards Agency; Wellcome Trust(Wellcome TrustEuropean Commission); Future Forum	The Medical Research Council and Cancer Research UK, European Union, Stroke Association, British Heart Foundation, United Kingdom Department of Health, Food Standards Agency, the Wellcome Trust, and the Future Forum.	ALBERS JJ, 1992, CLIN CHEM, V38, P658; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Bruins P, 1997, CIRCULATION, V96, P3542; CHEUNG MC, 1991, J LIPID RES, V32, P383; Colhoun HM, 2002, DIABETES, V51, P1949, DOI 10.2337/diabetes.51.6.1949; Day N, 1999, BRIT J CANCER, V80, P95; Festa A, 2005, CIRCULATION, V111, P3465, DOI 10.1161/CIRCULATIONAHA.104.512079; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Freedman DS, 1998, ARTERIOSCL THROM VAS, V18, P1046, DOI 10.1161/01.ATV.18.7.1046; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Grundy SM, 1999, J LIPID RES, V40, P229; JOHANSSON J, 1991, ARTERIOSCLER THROMB, V11, P174, DOI 10.1161/01.ATV.11.1.174; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lyons TJ, 2006, DIABETIC MED, V23, P955, DOI 10.1111/j.1464-5491.2006.01905.x; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; MacLean PS, 2000, METABOLISM, V49, P285, DOI 10.1016/S0026-0495(00)80002-5; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P2416, DOI 10.1161/01.ATV.0000184760.95957.d6; Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Pascot A, 2001, J LIPID RES, V42, P2007; Perusse M, 2001, J LIPID RES, V42, P1331; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Shah PK, 2001, CIRCULATION, V103, P3047, DOI 10.1161/hc2501.092494; Syvanne M, 1998, CIRCULATION, V98, P1993, DOI 10.1161/01.CIR.98.19.1993; SYVANNE M, 1995, J LIPID RES, V36, P573; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; VANDERPOLL T, 1995, INFECT IMMUN, V63, P3396, DOI 10.1128/IAI.63.9.3396-3400.1995; Wang L, 2006, J AM COLL CARDIOL, V48, P1459, DOI 10.1016/j.jacc.2006.07.040; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200	42	186	190	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					84	U43		10.7326/0003-4819-150-2-200901200-00006	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153411				2022-12-28	WOS:000262655200003
J	Makrides, M; Gibson, RA; McPhee, AJ; Collins, CT; Davis, PG; Doyle, LW; Simmer, K; Colditz, PB; Morris, S; Smithers, LG; Willson, K; Ryan, P				Makrides, Maria; Gibson, Robert A.; McPhee, Andrew J.; Collins, Carmel T.; Davis, Peter G.; Doyle, Lex W.; Simmer, Karen; Colditz, Paul B.; Morris, Scott; Smithers, Lisa G.; Willson, Kristyn; Ryan, Philip			Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; LOW-BIRTH-WEIGHT; VISUAL-ACUITY DEVELOPMENT; CHILDREN BORN; BREAST-MILK; SUPPLEMENTED FORMULA; ARACHIDONIC-ACID; DOUBLE-BLIND; GROWTH; AGE	Context Uncertainty exists about the benefit of dietary docosahexaenoic acid ( DHA) on the neurodevelopment of preterm infants. Objective To determine the effect of meeting the estimated DHA requirement of preterm infants on neurodevelopment at 18 months' corrected age. Design, Setting, and Participants Randomized, double- blind controlled trial enrolling infants born at less than 33 weeks' gestation from April 2001 to October 2005 at 5 Australian tertiary hospitals, with follow- up to 18 months. Intervention High- DHA ( approximately 1% total fatty acids) enteral feeds compared with standard DHA ( approximately 0.3% total fatty acids) from day 2 to 4 of life until term corrected age. Main Outcome Measures Bayley Mental Development Index ( MDI) at 18 months' corrected age. A priori subgroup analyses were conducted based on randomization strata ( sex and birth weight < 1250 g vs >= 1250 g). Results Of the 657 infants enrolled, 93.5% completed the 18- month follow- up. Bayley MDI scores did not differ between the high- and standard- DHA groups ( mean difference, 1.9; 95% confidence interval [ CI], - 1.0 to 4.7). The MDI among girls fed the high- DHA diet was higher than girls fed standard DHA in unadjusted and adjusted analyses ( unadjusted mean difference, 4.7; 95% CI, 0.5- 8.8; adjusted mean difference, 4.5; 95% CI, 0.5- 8.5). The MDI among boys did not differ between groups. For infants born weighing less than 1250 g, the MDI in the high- DHA group was higher than with standard DHA in the unadjusted comparison ( mean difference, 4.7; 95% CI, 0.2- 9.2) but did not reach statistical significance following adjustment for gestational age, sex, maternal education, and birth order ( mean difference, 3.8; 95% CI, - 0.5 to 8.0). The MDI among infants born weighing at least 1250 g did not differ between groups. Conclusion A DHA dose of approximately 1% total fatty acids in early life did not increase MDI scores of preterm infants overall born earlier than 33 weeks but did improve the MDI scores of girls. Trial Registration anzctr.org.au Identifier: ACTRN12606000327583.	[Makrides, Maria; Gibson, Robert A.; Collins, Carmel T.; Smithers, Lisa G.] Womens & Childrens Hosp, Child Nutr Res Ctr, Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Makrides, Maria; Gibson, Robert A.; Collins, Carmel T.; Morris, Scott; Smithers, Lisa G.] Flinders Univ S Australia, Flinders Med Ctr, Ctr Perinatal Med, Adelaide, SA, Australia; [Makrides, Maria; Collins, Carmel T.; Smithers, Lisa G.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Gibson, Robert A.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Willson, Kristyn; Ryan, Philip] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [McPhee, Andrew J.] Flinders Univ S Australia, Dept Neonatal Med, Womens & Childrens Hosp, Adelaide, SA, Australia; [Makrides, Maria; Smithers, Lisa G.] Flinders Univ S Australia, Dept Paediat & Child Hlth, Adelaide, SA, Australia; [Davis, Peter G.; Doyle, Lex W.] Royal Hosp Women, Neonatal Serv, Melbourne, Vic, Australia; [Davis, Peter G.; Doyle, Lex W.] Univ Melbourne, Melbourne, Vic, Australia; [Simmer, Karen] King Edward Mem Hosp Women, Neonatal Unit, Perth, WA, Australia; [Simmer, Karen] Univ Western Australia, Perth, WA 6009, Australia; [Colditz, Paul B.] Royal Brisbane & Womens Hosp, Perinatal Res Ctr, Brisbane, Qld, Australia; [Colditz, Paul B.] Royal Brisbane & Womens Hosp, Neonatal Unit, Brisbane, Qld, Australia; [Colditz, Paul B.] Univ Queensland, Brisbane, Qld, Australia	Womens & Childrens Hospital Australia; Flinders Medical Centre; Flinders University South Australia; University of Adelaide; University of Adelaide; University of Adelaide; Flinders University South Australia; Womens & Childrens Hospital Australia; Flinders University South Australia; University of Melbourne; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; University of Queensland	Makrides, M (corresponding author), Womens & Childrens Hosp, Child Nutr Res Ctr, Womens & Childrens Hlth Res Inst, 72 King William Rd, Adelaide, SA 5006, Australia.	maria.makrides@cywhs.sa.gov.au	Doyle, Lex/AAJ-5205-2021; Makrides, Maria/B-6392-2014; Smithers, Lisa/D-1605-2009; Simmer, Karen N/H-5834-2014; Colditz, Paul B/F-6772-2010; Gibson, Robert Alan/E-7546-2012	Doyle, Lex/0000-0002-7667-7312; Makrides, Maria/0000-0003-3832-541X; Smithers, Lisa/0000-0002-6585-7836; Colditz, Paul B/0000-0002-6408-8238; Gibson, Robert Alan/0000-0002-8750-525X; Simmer, Karen/0000-0003-4777-9069	Australian National Health and Medical Research Council [250322]; Channel 7 Children's Research Foundation of South Australia Inc	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation of South Australia Inc	This study was supported by a grant from the Australian National Health and Medical Research Council (grant 250322) and by the Channel 7 Children's Research Foundation of South Australia Inc. Treatment and placebo capsules were donated by Clover Corp and infant formula was donated by Mead Johnson Nutritionals and Nutricia Australasia.	Abeywardana S., 2006, REPORT AUSTR NZ NEON; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Bayley N, 1993, BAYLEY SCALES INFANT; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; Blanco PG, 2004, AM J OBSTET GYNECOL, V190, P1369, DOI 10.1016/j.ajog.2003.11.001; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; CARLSON SE, 1992, LIPIDS, V27, P901, DOI 10.1007/BF02535870; Carlson SE, 1996, AM J CLIN NUTR, V63, P687, DOI 10.1093/ajcn/63.5.687; CARLSON SE, 1993, AM J CLIN NUTR, V58, P35, DOI 10.1093/ajcn/58.1.35; Chao AC, 2003, LIPIDS, V38, P425, DOI 10.1007/s11745-003-1079-8; Clandinin MT, 2005, J PEDIATR-US, V146, P461, DOI 10.1016/j.jpeds.2004.11.030; CLANDININ MT, 1981, EARLY HUM DEV, V5, P355, DOI 10.1016/0378-3782(81)90016-5; Fewtrell MS, 2004, J PEDIATR-US, V144, P471, DOI 10.1016/j.jpeds.2004.01.034; Fewtrell MS, 2002, PEDIATRICS, V110, P73, DOI 10.1542/peds.110.1.73; FRANKENBURG WK, 1986, J PEDIATR-US, V108, P624, DOI 10.1016/S0022-3476(86)80853-8; Gibson RA, 1997, EUR J CLIN NUTR, V51, P578, DOI 10.1038/sj.ejcn.1600446; Henriksen C, 2008, PEDIATRICS, V121, P1137, DOI 10.1542/peds.2007-1511; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Makrides M, 1996, EUR J CLIN NUTR, V50, P352; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; O'Connor DL, 2001, PEDIATRICS, V108, P359, DOI 10.1542/peds.108.2.359; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salt A, 2006, EARLY HUM DEV, V82, P185, DOI 10.1016/j.earlhumdev.2005.12.015; Simmer K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub3; Smithers LG, 2008, AM J CLIN NUTR, V87, P912, DOI 10.1093/ajcn/87.4.912; Vanderhoof J, 1999, J PEDIATR GASTR NUTR, V29, P318, DOI 10.1097/00005176-199909000-00015	34	261	271	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 14	2009	301	2					175	182		10.1001/jama.2008.945	http://dx.doi.org/10.1001/jama.2008.945			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393VV	19141765	Bronze			2022-12-28	WOS:000262405500019
J	Hawton, K; Saunders, KEA				Hawton, Keith; Saunders, Kate E. A.			Psychiatric service development and suicide	LANCET			English	Editorial Material									[Hawton, Keith; Saunders, Kate E. A.] Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England	University of Oxford	Hawton, K (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk		Saunders, kate/0000-0003-3448-9927				Appleby L., 1999, SAFER SERVICES REPOR; Burns T, 2007, BRIT MED J, V335, P336, DOI 10.1136/bmj.39251.599259.55; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2002, NAT SUIC PREV STRAT; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; *HEALTHC COMM, 2008, MENT HLTH LEARN DIS; Kapur N, 2006, PSYCHOL MED, V36, P1485, DOI 10.1017/S0033291706008373; Killaspy H, 2008, EPIDEMIOL PSICHIAT S, V17, P47, DOI 10.1017/S1121189X00002682; *MANCH U, 2006, AV DEATHS 5 YEAR REP; PIRKOLA S, 2008, LANCET          1222; Pirkola S, 2007, PSYCHIAT SERV, V58, P221, DOI 10.1176/appi.ps.58.2.221; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Scottish Office, 1997, FRAM MENT HLTH SERV	13	14	17	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 10	2009	373	9658					99	100		10.1016/S0140-6736(08)61871-1	http://dx.doi.org/10.1016/S0140-6736(08)61871-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19097637				2022-12-28	WOS:000262340900005
J	Bettencourt-Dias, M; Glover, DM				Bettencourt-Dias, Monica; Glover, David M.			SnapShot: Centriole Biogenesis	CELL			English	Editorial Material							CENTROSOME; DUPLICATION; CELLS		[Bettencourt-Dias, Monica] Gulbenkian Inst Sci, Oeiras, Portugal; [Glover, David M.] Univ Cambridge, Cambridge, England	University of Cambridge	Bettencourt-Dias, M (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.		Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103				Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985	9	11	11	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 9	2009	136	1					188	U1		10.1016/j.cell.2008.12.035	http://dx.doi.org/10.1016/j.cell.2008.12.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135899	Bronze			2022-12-28	WOS:000262318400025
J	Cochran, JC; Sindelar, CV; Mulko, NK; Collins, KA; Kong, SE; Hawley, RS; Kull, FJ				Cochran, Jared C.; Sindelar, Charles V.; Mulko, Natasha K.; Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott; Kull, F. Jon			ATPase Cycle of the Nonmotile Kinesin NOD Allows Microtubule End Tracking and Drives Chromosome Movement	CELL			English	Article							DROSOPHILA-MELANOGASTER; MONASTROL INHIBITION; MOTOR PROTEINS; EG5; SEGREGATION; MECHANISM; PATHWAY; BINDING; MYOSIN; MODEL	Segregation of nonexchange chromosomes during Drosophila melanogaster meiosis requires the proper function of NOD, a nonmotile kinesin-10. We have determined the X-ray crystal structure of the NOD catalytic domain in the ADP- and AMPPNP-bound states. These structures reveal an alternate conformation of the microtubule binding region as well as a nucleotide-sensitive relay of hydrogen bonds at the active site. Additionally, a cryo-electron microscopy reconstruction of the nucleotide-free microtubule-NOD complex shows an atypical binding orientation. Thermodynamic studies show that NOD binds tightly to microtubules in the nucleotide-free state, yet other nucleotide states, including AMPPNP, are weakened. Our pre-steady-state kinetic analysis demonstrates that NOD interaction with microtubules occurs slowly with weak activation of ADP product release. Upon rapid substrate binding, NOD detaches from the microtubule prior to the rate-limiting step of ATP hydrolysis, which is also atypical for a kinesin. We propose a model for NOD's microtubule plus-end tracking that drives chromosome movement.	[Cochran, Jared C.; Mulko, Natasha K.; Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Sindelar, Charles V.] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Collins, Kimberly A.; Kong, Stephanie E.; Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Physiol, Kansas City, KS 66160 USA	Dartmouth College; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Kull, FJ (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	f.jon.kull@dartmouth.edu		Hawley, R. Scott/0000-0002-6478-0494	National Institutes of Health (NIH) [F32AR054653 from the]; NIH [GM46033, GM51487, F32GM082104, GM-0080]; American Heart Association Scientist Development [0330345N]; U. S. Department of Energy [DE-AC02-98CH10886, DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487, R01GM046033, F32GM082104] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of National Synchrotron Light Source (NSLS) beamline X6A, particularly Vivian Stojanoff and Jean Jakoncic, for beam time and help with data collection. We also thank Susan P. Gilbert (Rensselaer Polytechnic Institute) and Heinrich J. Matthies (Vanderbilt University) for their insightful comments on this manuscript and our colleagues in the Kull lab for their intellectual discussions. The project described was supported by F32AR054653 from the National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases) to J.C.C., GM46033 and GM51487 from the NIH to C. V. S., F32GM082104 from the NIH (National Institute of General Medical Sciences [NIGMS]) to K. A. C., and also by American Heart Association Scientist Development Grant 0330345N to F.J.K. Research carried out at X6A beam line was funded by the NIH (NIGMS) under agreement GM-0080. The NSLS, Brookhaven National Laboratory is supported by the U. S. Department of Energy under contract DE-AC02-98CH10886. Lawrence Berkeley National Laboratory is supported by the U. S. DOE under contract DE-AC02-05CH11231.	AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARPENTER AT, 1973, GENETICS, V73, P393; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cui W, 2005, GENETICS, V171, P1823, DOI 10.1534/genetics.105.047464; Cui W, 2005, MOL BIOL CELL, V16, P5400, DOI 10.1091/mbc.E05-06-0582; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; JOHNSON KA, 1983, J BIOL CHEM, V258, P3825; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kull FJ, 2004, TRENDS BIOCHEM SCI, V29, P103, DOI 10.1016/j.tibs.2004.01.001; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; Matthies HJG, 1999, J CELL BIOL, V147, P1137, DOI 10.1083/jcb.147.6.1137; Meneely PM, 2002, GENETICS, V162, P1169; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; RASOOLY RS, 1994, MOL GEN GENET, V242, P145, DOI 10.1007/BF00391007; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	49	48	48	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					110	122		10.1016/j.cell.2008.11.048	http://dx.doi.org/10.1016/j.cell.2008.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135893	Bronze, Green Accepted			2022-12-28	WOS:000262318400019
J	Kawahara, TLA; Michishita, E; Adler, AS; Damian, M; Berber, E; Lin, M; McCord, RA; Ongaigui, KCL; Boxer, LD; Chang, HY; Chua, KF				Kawahara, Tiara L. A.; Michishita, Eriko; Adler, Adam S.; Damian, Mara; Berber, Elisabeth; Lin, Meihong; McCord, Ron A.; Ongaigui, Kristine C. L.; Boxer, Lisa D.; Chang, Howard Y.; Chua, Katrin F.			SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-kappa B-Dependent Gene Expression and Organismal Life Span	CELL			English	Article							CHROMATIN MODIFICATIONS; CELLULAR SENESCENCE; CALORIE RESTRICTION; TRANSCRIPTION; CELLS; REVEALS; MODULE	Members of the sirtuin (SIRT) family of NAD-dependent deacetylases promote longevity in multiple organisms. Deficiency of mammalian SIRT6 leads to shortened life span and an aging-like phenotype in mice, but the underlying molecular mechanisms are unclear. Here we show that SIRT6 functions at chromatin to attenuate NF-kappa B signaling. SIRT6 interacts with the NF-kappa B RELA subunit and deacetylates histone H3 lysine 9 (H3K9) at NF-kappa B target gene promoters. In SIRT6-deficient cells, hyperacetylation of H3K9 at these target promoters is associated with increased RELA promoter occupancy and enhanced NF-kappa B-dependent modulation of gene expression, apoptosis, and cellular senescence. Computational genomics analyses revealed increased activity of NF-kappa B-driven gene expression programs in multiple Sirt6-deficient tissues in vivo. Moreover, haploinsufficiency of RelA rescues the early lethality and degenerative syndrome of Sirt6-deficient mice. We propose that SIRT6 attenuates NF-kappa B signaling via H3K9 deacetylation at chromatin, and hyperactive NF-kappa B signaling may contribute to premature and normal aging.	[Kawahara, Tiara L. A.; Adler, Adam S.; Lin, Meihong; Ongaigui, Kristine C. L.; Chang, Howard Y.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA; [Kawahara, Tiara L. A.; Adler, Adam S.; McCord, Ron A.; Chang, Howard Y.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Canc Biol Program, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Dept Med, Stanford, CA 94305 USA; [Michishita, Eriko; Damian, Mara; Berber, Elisabeth; McCord, Ron A.; Boxer, Lisa D.; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; kfchua@stanford.edu		Boxer, Lisa/0000-0002-4402-1060; Adler, Adam/0000-0001-9301-0037	NIH; Department of Veterans Affairs Merit Review; Stanford Graduate Fellowship; California Breast Cancer Research Program; American Cancer Society; Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028867, K08AG028961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Stanford Graduate Fellowship(Stanford University); California Breast Cancer Research Program; American Cancer Society(American Cancer Society); Damon Runyon Cancer Research Foundation; Paul B. Beeson Aging Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Gozani, P. Khavari, R. Mostoslavsky, and T. Rando for comments or advice, T. Hong for assistance with primer design, Regeneron Pharmaceuticals for generation of the Sirt6 gene-targeted mouse embryonic stem cell line, and R. Mostoslavsky and F. W. Alt for generation of the Sirt6 mutant mice. This work was supported by the NIH (K.F.C., T.L.A.K., R.A.M.), Department of Veterans Affairs Merit Review (K.F.C.), Stanford Graduate Fellowship (T.L.A.K.), California Breast Cancer Research Program (A.S.A.), and American Cancer Society (H.Y.C.). H.Y.C. is the Kenneth G. and Elaine A. Langone Scholar of the Damon Runyon Cancer Research Foundation. K. F. C. is a Scholar of the Paul B. Beeson Aging Research Program.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	38	783	841	4	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					62	74		10.1016/j.cell.2008.10.052	http://dx.doi.org/10.1016/j.cell.2008.10.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135889	Green Accepted, Bronze			2022-12-28	WOS:000262318400015
J	Wright, CW; Duckett, CS				Wright, Casey W.; Duckett, Colin S.			The Aryl Hydrocarbon Nuclear Translocator Alters CD30-Mediated NF-kappa B-Dependent Transcription	SCIENCE			English	Article							ACTIVATION; CD30; RECEPTOR; FAMILY; RELB; CELL; EXPRESSION; INDUCTION; TRAF2; MICE	Expression and signaling of CD30, a tumor necrosis factor receptor family member, is up- regulated in numerous lymphoid- derived neoplasias, most notably anaplastic large- cell lymphoma ( ALCL) and Hodgkin's lymphoma. To gain insight into the mechanism of CD30 signaling, we used an affinity purification strategy that led to the identification of the aryl hydrocarbon receptor nuclear translocator ( ARNT) as a CD30- interacting protein that modulated the activity of the RelB subunit of the transcription factor nuclear factor kappa B (NF-kappa B). ALCL cells that were deficient in ARNT exhibited defects in RelB recruitment to NF-kappa B-responsive promoters, whereas RelA recruitment to the same sites was potentiated, resulting in the augmented expression of these NF-kappa B-responsive genes. These findings indicate that ARNT functions in concert with RelB in a CD30- induced negative feedback mechanism.	[Wright, Casey W.; Duckett, Colin S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Duckett, Colin S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duckett, CS (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	colind@umich.edu		Wright, Casey/0000-0002-9512-1264; Duckett, Colin/0000-0001-9413-2263	NIH [R01 GM067827]; Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Fund of the University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Burstein and members of the Duckett laboratory for helpful discussions, C. Duvauchelle for assistance with statistical analyses, and A. Savory for assistance with the manuscript. This work was supported by NIH grant R01 GM067827 and an award from the Cancer Research Fund of the University of Michigan Comprehensive Cancer Center to C. S. D.	Aizawa S, 1997, J BIOL CHEM, V272, P2042; Boucher LM, 1997, BIOCHEM BIOPH RES CO, V233, P592, DOI 10.1006/bbrc.1997.6509; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sutherland MSK, 2006, J BIOL CHEM, V281, P10540, DOI 10.1074/jbc.M510026200; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wolke C, 2006, INT J MOL MED, V17, P275; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Younes A, 2003, CANCER-AM CANCER SOC, V98, P458, DOI 10.1002/cncr.11524; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	27	41	42	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					251	255		10.1126/science.1162818	http://dx.doi.org/10.1126/science.1162818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131627	Green Accepted			2022-12-28	WOS:000262290600038
J	Evens, RG				Evens, Ronald G.			Roentgenologic Examination of the Gallbladder (Cholecystography) The Article That Launched a New Era of Radiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Evens, Ronald G.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Evens, RG (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, 510 S Kingshighway, St Louis, MO 63110 USA.	rgevens5556@bjc.org						BERK RN, 1978, INVEST RADIOL, V13, P477, DOI 10.1097/00004424-197811000-00002; COLE WH, 1978, AM J SURG, V136, P541, DOI 10.1016/0002-9610(78)90310-0; CONNAUGHTON D, 1991, W COLE MD ASCENT SCI; EVENS RG, 1993, AM J ROENTGENOL, V160, P1343, DOI 10.2214/ajr.160.6.8498259; Graham EA, 1924, J AMER MED ASSOC, V82, P613, DOI 10.1001/jama.1924.02650340023007; JACOBSON HG, 1983, JAMA-J AM MED ASSOC, V250, P2977, DOI 10.1001/jama.250.21.2977; Mueller C, 2002, EA GRAHAM LIFE LIVES; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917	8	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					100	101		10.1001/jama.2008.893	http://dx.doi.org/10.1001/jama.2008.893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126816	Bronze			2022-12-28	WOS:000262220400027
J	Deshpande, VV; Chandra, B; Caldwell, R; Novikov, DS; Hone, J; Bockrath, M				Deshpande, Vikram V.; Chandra, Bhupesh; Caldwell, Robert; Novikov, Dmitry S.; Hone, James; Bockrath, Marc			Mott Insulating State in Ultraclean Carbon Nanotubes	SCIENCE			English	Article							TRANSPORT; GAPS	The Mott insulating state is a manifestation of strong electron interactions in nominally metallic systems. Using transport spectroscopy, we showed that an energy gap exists in nominally metallic carbon nanotubes and occurs in addition to the band gap in small- band- gap nanotubes, indicating that carbon nanotubes are never metallic. This gap has a magnitude of similar to 10 to 100 milli- electron volts and a nanotube radius ( r) dependence of similar to 1/r, which is in good agreement with predictions for a nanotube Mott insulating state. We also observed neutral excitations within the gap, as predicted for this state. Our results underscore nanotubes' exceptional capabilities for use in studying correlated electron phenomena in one dimension.	[Chandra, Bhupesh; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Deshpande, Vikram V.; Bockrath, Marc] CALTECH, Pasadena, CA 91125 USA; [Caldwell, Robert] Columbia Univ, Dept Appl Phys, New York, NY 10027 USA; [Novikov, Dmitry S.] Yale Univ, Dept Phys, New Haven, CT 06511 USA	Columbia University; California Institute of Technology; Columbia University; Yale University	Hone, J (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	jh2228@columbia.edu; mwb@caltech.edu	Novikov, Dmitry/E-5957-2011; Hone, James C/E-1879-2011	Hone, James C/0000-0002-8084-3301; Novikov, Dmitry/0000-0002-4213-3050	Office of Naval Research; Sloan Foundation; Ross Brown; NSF [DMR-0749220, DMR-0754613]	Office of Naval Research(Office of Naval Research); Sloan Foundation(Alfred P. Sloan Foundation); Ross Brown; NSF(National Science Foundation (NSF))	We acknowledge Micro Nano Laboratory at Caltech and Nanotech at the University of California, Santa Barbara where fabrication was performed. We thank A. Andreev, D. Cobden, M. Garst, L. Glazman, S. Ilani, P. King, K. Le Hur, L. Levitov, G. Refael, and G. Steele for helpful discussions. M.B. and V.V.D. acknowledge the support of the Office of Naval Research, the Sloan Foundation, and the Ross Brown. D.N. was supported by NSF grants DMR-0749220 and DMR-0754613.	Balents L, 1997, PHYS REV B, V55, P11973, DOI 10.1103/PhysRevB.55.R11973; Cao J, 2005, NAT MATER, V4, P745, DOI 10.1038/nmat1478; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Chen W, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.246802; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; De Franceschi S, 2001, PHYS REV LETT, V86, P878, DOI 10.1103/PhysRevLett.86.878; Deshpande VV, 2008, NAT PHYS, V4, P314, DOI 10.1038/nphys895; Garst M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035128; Huang XMH, 2005, NANO LETT, V5, P1515, DOI 10.1021/nl050886a; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jarillo-Herrero P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.156802; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kane C, 1997, PHYS REV LETT, V79, P5086, DOI 10.1103/PhysRevLett.79.5086; Krotov YA, 1997, PHYS REV LETT, V78, P4245, DOI 10.1103/PhysRevLett.78.4245; Kuemmeth F, 2008, NATURE, V452, P448, DOI 10.1038/nature06822; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Levitov LS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016401; Liang WJ, 2001, NATURE, V411, P665, DOI 10.1038/35079517; Lin HH, 1998, PHYS REV B, V58, P4963, DOI 10.1103/PhysRevB.58.4963; MANN D, 2006, THESIS STANFORD U; Minot ED, 2004, NATURE, V428, P536, DOI 10.1038/nature02425; MOTT NF, 1968, REV MOD PHYS, V40, P677, DOI 10.1103/RevModPhys.40.677; Nersesyan AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.235419; Odintsov AA, 1999, PHYS REV B, V59, P10457, DOI 10.1103/PhysRevB.59.R10457; Ouyang M, 2001, SCIENCE, V292, P702, DOI 10.1126/science.1058853; White SR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165122; Wu JQ, 2006, NANO LETT, V6, P2313, DOI 10.1021/nl061831r; Zhou CW, 2000, PHYS REV LETT, V84, P5604, DOI 10.1103/PhysRevLett.84.5604	28	134	134	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					106	110		10.1126/science.1165799	http://dx.doi.org/10.1126/science.1165799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119228				2022-12-28	WOS:000262104100050
J	Hawkesworth, C; Cawood, P; Kemp, T; Storey, C; Dhuime, B				Hawkesworth, Chris; Cawood, Peter; Kemp, Tony; Storey, Craig; Dhuime, Bruno			GEOCHEMISTRY A Matter of Preservation	SCIENCE			English	Editorial Material							SUPERCONTINENTS; GROWTH; OXYGEN		[Hawkesworth, Chris; Storey, Craig; Dhuime, Bruno] Univ Bristol, Dept Earth Sci, Bristol B58 1RJ, Avon, England; [Cawood, Peter] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Kemp, Tony] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	University of Bristol; University of Western Australia; James Cook University	Hawkesworth, C (corresponding author), Univ Bristol, Dept Earth Sci, Bristol B58 1RJ, Avon, England.	c.j.hawkesworth@bristol.ac.uk	Dhuime, Bruno/A-6262-2016; Storey, Craig/AAC-7832-2020	Dhuime, Bruno/0000-0002-4146-4739; Cawood, Peter/0000-0003-1200-3826; Kemp, Anthony/0000-0003-1642-0360; Storey, Craig/0000-0002-4945-7381	NERC [NE/E005225/1, NE/D008891/2] Funding Source: UKRI; Natural Environment Research Council [NE/E005225/1, NE/D008891/2] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Campbell IH, 2008, NAT GEOSCI, V1, P554, DOI 10.1038/ngeo259; Clift P, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000127; Collins WJ, 2002, TECTONICS, V21, DOI 10.1029/2000TC001272; Condie K.C, 2011, EARTH EVOLVING PLANE; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; GASTIL G, 1960, AM J SCI, V258, P775; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; RUDNICK RL, 1995, NATURE, V378, P573; Smith AB, 2007, PALEOBIOLOGY, V33, P310, DOI 10.1666/06073.1	9	257	266	6	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					49	50		10.1126/science.1168549	http://dx.doi.org/10.1126/science.1168549			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119206				2022-12-28	WOS:000262104100030
J	McDonald-Madden, E; Gordon, A; Wintle, BA; Walker, S; Grantham, H; Carvalho, S; Bottrill, M; Joseph, L; Ponce, R; Stewart, R; Possingham, HP				McDonald-Madden, Eve; Gordon, Ascelin; Wintle, Brendan A.; Walker, Susan; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.			ENVIRONMENT "True" Conservation Progress	SCIENCE			English	Editorial Material							PROTECTED AREAS; BIODIVERSITY; TRENDS		[McDonald-Madden, Eve; Grantham, Hedley; Carvalho, Silvia; Bottrill, Madeleine; Joseph, Liana; Ponce, Rocio; Stewart, Romola; Possingham, Hugh P.] Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia; [Gordon, Ascelin] RMIT Univ, Melbourne, Vic 3001, Australia; [Wintle, Brendan A.] Univ Melbourne, Ctr Appl Environm Decis Anal, Sch Bot, Melbourne, Vic 3010, Australia; [Walker, Susan] Landcare Res, Dunedin, New Zealand; [Carvalho, Silvia] Univ Lisbon, Dept Anim Biol, Fac Ciencias, P-1749016 Lisbon, Portugal; [Carvalho, Silvia] Univ Porto, Inst Ciencias Agr Vairao, CIBIO, Ctr Invest Biodivers & Recursos Genet, P-4485661 Vairao, Portugal; Univ Nacl Autonoma Mexico, Colecc Nacl Anfibios & Reptiles Inst Biol, Mexico City 04510, DF, Mexico	University of Queensland; Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Landcare Research - New Zealand; Universidade de Lisboa; Universidade do Porto; Universidad Nacional Autonoma de Mexico	McDonald-Madden, E (corresponding author), Univ Queensland, Ctr Appl Environm Decis Anal, Sch Integrat Biol, St Lucia, Qld 4075, Australia.	e.mcdonaldmadden@uq.edu.au	Ponce-Reyes, Rocio/K-1553-2013; Ponce-Reyes, Rocio/V-5178-2019; Carvalho, Silvia B/J-3343-2013; Carvalho, Silvia/AAE-9566-2020; Gordon, Ascelin/I-9184-2012; Bottrill, Madeleine/A-4687-2011; McDonald-Madden, Eve/A-5186-2012; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019	Ponce-Reyes, Rocio/0000-0002-3680-8736; Ponce-Reyes, Rocio/0000-0002-3680-8736; Carvalho, Silvia B/0000-0003-4368-4708; Carvalho, Silvia/0000-0003-4368-4708; Gordon, Ascelin/0000-0002-0648-0346; McDonald-Madden, Eve/0000-0001-7755-2338; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; STEWART, Romola/0000-0002-4280-8951; wintle, brendan/0000-0002-4234-5950				ACCAD A, 2006, REMNANT VEGETATION Q; BALLANCE A, 1999, STATE ENV S AFRICA O; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; *COMM ENV COOP, 2001, N AM MOS STAT ENV RE; *DETR, 2000, CAS STUD BUS BIOD; Economic and Social Commission for Asia and the Pacific, 2005, STAT ENV AS PAC; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; HIGGINS J, 2007, ECOREGIONAL STATUS M; *HJ HEINZ III CTR, 2002, STAT NAT EC MEAS LAN, P1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; POSSINGHAM HP, 2001, TELA, V9, P1; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Salafsky N, 2002, CONSERV BIOL, V16, P1469, DOI 10.1046/j.1523-1739.2002.01232.x; State of the Environment Advisory Council, 1996, AUSTR STAT ENV 1996; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Truscott M, 2006, AUSTR STAT ENV COMM; UNEP, 2007, GLOB ENV OUTL 4 ENV; Walker S, 2008, CONSERV BIOL, V22, P48, DOI 10.1111/j.1523-1739.2007.00844.x	18	30	32	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					43	44		10.1126/science.1164342	http://dx.doi.org/10.1126/science.1164342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119202				2022-12-28	WOS:000262104100026
J	Cohen, J				Cohen, Jon			Students whose behaviour causes concern: Role of universities	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cohen, Jon] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England	University of Brighton; University of Sussex	Cohen, J (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England.	j.cohen@bsms.ac.uk						*GEN MED COUNC, REV TOM DOCT; Levenson R., 2008, UNDERSTANDING DOCTOR; Tooke J, 2007, FINAL REPORT INDEPEN	3	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 29	2008	337								a2884	10.1136/bmj.a2884	http://dx.doi.org/10.1136/bmj.a2884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401MV	19114454	Green Accepted			2022-12-28	WOS:000262945900007
J	Hornung, V; Ablasser, A; Charrel-Dennis, M; Bauernfeind, F; Horvath, G; Caffrey, DR; Latz, E; Fitzgerald, KA				Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Caffrey, Daniel. R.; Latz, Eicke; Fitzgerald, Katherine A.			AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC	NATURE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; INDUCIBLE GENES; HIN-200 FAMILY; DNA; CASPASE-1; EXPRESSION; INFECTION	The innate immune system senses nucleic acids by germline-encoded pattern recognition receptors. RNA is sensed by Toll-like receptor members TLR3, TLR7 and TLR8, or by the RNA helicases RIG-I (also known as DDX58) and MDA-5 (IFIH1)(1). Little is known about sensors for cytoplasmic DNA that trigger antiviral and/or inflammatory responses(2-6). The best characterized of these responses involves activation of the TANK-binding kinase (TBK1)-interferon regulatory factor 3 (IRF3) signalling axis to trigger transcriptional induction of type I interferon genes(2,3). A second, less well-defined pathway leads to the activation of an 'inflammasome' that, via caspase-1, controls the catalytic cleavage of the pro-forms of the cytokines IL1 beta and IL18 (refs 6, 7). Using mouse and human cells, here we identify the PYHIN (pyrin and HIN domain-containing protein)(8) family member absent in melanoma 2 (AIM2) as a receptor for cytosolic DNA, which regulates caspase-1. The HIN200 domain of AIM2 binds to DNA, whereas the pyrin domain (but not that of the other PYHIN family members) associates with the adaptor molecule ASC (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain) to activate both NF-kappa B and caspase-1. Knockdown of Aim2 abrogates caspase-1 activation in response to cytoplasmic double-stranded DNA and the double-stranded DNA vaccinia virus. Collectively, these observations identify AIM2 as a new receptor for cytoplasmic DNA, which forms an inflammasome with the ligand and ASC to activate caspase-1.	[Hornung, Veit; Ablasser, Andrea; Charrel-Dennis, Marie; Bauernfeind, Franz; Horvath, Gabor; Latz, Eicke; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Caffrey, Daniel. R.] Pfizer, Cambridge, MA 02139 USA; [Hornung, Veit; Ablasser, Andrea; Bauernfeind, Franz] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; Pfizer; University of Bonn	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	veit.hornung@uni-bonn.de; kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Bauernfeind, Franz-Georg/ABF-1148-2020; Hornung, Veit/C-3565-2012; Latz, Eicke/H-3951-2014; Horvath, Gabor L/J-3917-2014	Hornung, Veit/0000-0002-4150-194X; Latz, Eicke/0000-0003-1488-5666; Horvath, Gabor L/0000-0003-0309-595X; Fitzgerald, Kate/0000-0003-3175-609X	Deutsche Forschungsgemeinschaft [Ho2783/2-1]; National Institutes of Health [AI-065483, AI-067497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI067497, R56AI067497, R01AI065483, R01AI067497] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank A. Cerny for animal husbandry and genotyping and R. Johnstone for the anti-AIM2 antibody. V. H. is supported by a fellowship from the Deutsche Forschungsgemeinschaft (German Research Foundation; Ho2783/2-1), E. L. and K. A. F. are supported by grants from the National Institutes of Health (AI-065483 (to E. L.) and AI-067497 (to K. A. F.)).	Albrecht M, 2005, BIOCHEM BIOPH RES CO, V327, P679, DOI 10.1016/j.bbrc.2004.12.056; BURRUS GR, 1992, J CELL BIOCHEM, V48, P190, DOI 10.1002/jcb.240480210; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn R., 2003, CURR PROTOC BIOINFOR; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Landolfo S, 1998, BIOCHIMIE, V80, P721, DOI 10.1016/S0300-9084(99)80025-X; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; SCHACHMAN HK, 1960, J BIOL CHEM, V235, P3242; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Szentesi G, 2004, COMPUT METH PROG BIO, V75, P201, DOI 10.1016/j.cmpb.2004.02.004; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TRAPANI JA, 1992, IMMUNOGENETICS, V36, P369; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	29	1686	1766	2	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					514	U6		10.1038/nature07725	http://dx.doi.org/10.1038/nature07725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19158675	Green Accepted, Green Submitted			2022-12-28	WOS:000264532400046
J	Maher, CA; Kumar-Sinha, C; Cao, XH; Kalyana-Sundaram, S; Han, B; Jing, XJ; Sam, L; Barrette, T; Palanisamy, N; Chinnaiyan, AM				Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Transcriptome sequencing to detect gene fusions in cancer	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; LUNG-CANCER; IDENTIFICATION; ABERRATIONS; INHIBITOR; PATTERNS; EFFICACY; IMATINIB; PROTEIN	Recurrent gene fusions, typically associated with haematological malignancies and rare bone and soft-tissue tumours(1), have recently been described in common solid tumours(2-9). Here we use an integrative analysis of high-throughput long- and short-read transcriptome sequencing of cancer cells to discover novel gene fusions. As a proof of concept, we successfully used integrative transcriptome sequencing to 're-discover' the BCR-ABL1 (ref. 10) gene fusion in a chronic myelogenous leukaemia cell line and the TMPRSS2-ERG(2,3) gene fusion in a prostate cancer cell line and tissues. Additionally, we nominated, and experimentally validated, novel gene fusions resulting in chimaeric transcripts in cancer cell lines and tumours. Taken together, this study establishes a robust pipeline for the discovery of novel gene chimaeras using high-throughput sequencing, opening up an important class of cancer-related mutations for comprehensive characterization.	[Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Maher, Christopher A.; Kumar-Sinha, Chandan; Kalyana-Sundaram, Shanker; Han, Bo; Jing, Xiaojun; Sam, Lee; Barrette, Terrence; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Kumar, Chandan/0000-0002-8696-3400; Kalyana-Sundaram, Shanker/0000-0002-7309-3848	National Institutes of Health; Department of Defense; Early Detection Research Network; NCIBI [U54 DA 021519]; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research; Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA132874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Early Detection Research Network; NCIBI; American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research(Amgen); Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Illumina and 454 for technical support, R. Mehra and J. Siddiqui for providing tissue samples, Y. Gong, S. Shankar, X. Wang and A. Menon for technical assistance, J. Yu for help with the Illumina Genome Analyzer, and R. J. Lonigro for discussions. C. A. M. was supported by a National Institutes of Health Ruth L. Kirschstein post-doctoral training grant, and currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship. This work was supported in part by the National Institutes of Health ( to A. M. C.), the Department of Defense ( to A. M. C.), the Early Detection Research Network ( to A. M. C.), and NCIBI (grant number U54 DA 021519).	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gleave M, 2006, PROSTATE, V66, P1674, DOI 10.1002/pros.20499; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Korenchuk S, 2001, IN VIVO, V15, P163; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Takahara T, 2005, MOL CELL, V18, P245, DOI 10.1016/j.molcel.2005.03.018; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	33	623	688	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					97	U9		10.1038/nature07638	http://dx.doi.org/10.1038/nature07638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19136943	Green Accepted			2022-12-28	WOS:000263836000040
J	Ernstorfer, R; Harb, M; Hebeisen, CT; Sciaini, G; Dartigalongue, T; Miller, RJD				Ernstorfer, Ralph; Harb, Maher; Hebeisen, Christoph T.; Sciaini, German; Dartigalongue, Thibault; Miller, R. J. Dwayne			The Formation of Warm Dense Matter: Experimental Evidence for Electronic Bond Hardening in Gold	SCIENCE			English	Article							DIFFRACTION; DYNAMICS; VISUALIZATION	Under strong optical excitation conditions, it is possible to create highly nonequilibrium states of matter. The nuclear response is determined by the rate of energy transfer from the excited electrons to the nuclei and the instantaneous effect of change in electron distribution on the interatomic potential energy landscape. We used femtosecond electron diffraction to follow the structural evolution of strongly excited gold under these transient electronic conditions. Generally, materials become softer with excitation. In contrast, the rate of disordering of the gold lattice is found to be retarded at excitation levels up to 2.85 megajoules per kilogram with respect to the degree of lattice heating, which is indicative of increased lattice stability at high effective electronic temperatures, a predicted effect that illustrates the strong correlation between electronic structure and lattice bonding.	[Ernstorfer, Ralph; Harb, Maher; Hebeisen, Christoph T.; Sciaini, German; Dartigalongue, Thibault; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Ernstorfer, Ralph; Harb, Maher; Hebeisen, Christoph T.; Sciaini, German; Dartigalongue, Thibault; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Ernstorfer, Ralph; Harb, Maher; Hebeisen, Christoph T.; Sciaini, German; Dartigalongue, Thibault; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada	University of Toronto; University of Toronto; University of Toronto	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, 80 St George St, Toronto, ON M5S 3H6, Canada.	dmiller@lphys.chem.utoronto.ca	Ernstorfer, Ralph/D-1590-2009	Ernstorfer, Ralph/0000-0001-6665-3520; Sciaini, German/0000-0002-2120-3996; Harb, Maher/0000-0002-6853-9454	Natural Science and Engineering Research Council; Alexander von Humboldt Foundation	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank A.-A. Dhirani and the Emerging Communications Technology Institute at the University of Toronto for the usage of their deposition chambers and L. Zhigilei, Z. Lin, and S. Mazevet for helpful discussions. We also thank A. Ng for initial discussions that led to this study. Funding was provided by the Natural Science and Engineering Research Council. R. E. thanks the Alexander von Humboldt Foundation for financial support.	Ao T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055001; BISWAS R, 1982, PHYS REV B, V26, P1980, DOI 10.1103/PhysRevB.26.1980; Bottin F, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174114; Dwyer JR, 2006, PHILOS T R SOC A, V364, P741, DOI 10.1098/rsta.2005.1735; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Guo CL, 2000, PHYS REV B, V62, P11921, DOI 10.1103/PhysRevB.62.R11921; Harb M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155504; Hebeisen CT, 2008, OPT EXPRESS, V16, P3334, DOI 10.1364/OE.16.003334; Hohlfeld J, 2000, CHEM PHYS, V251, P237, DOI 10.1016/S0301-0104(99)00330-4; Ivanov DS, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064114; Kandyla M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.214107; Lin Z, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075133; Lin ZB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184113; Lindenberg AM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.135502; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; Mazevet S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.085002; Ping Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255003; Plech A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195423; RADI G, 1970, ACTA CRYSTALL A-CRYS, VA 26, P41, DOI 10.1107/S0567739470000050; Recoules V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055503; Rethfeld B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.092103; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; Ruan CY, 2007, NANO LETT, V7, P1290, DOI 10.1021/nl070269h; Siwick BJ, 2004, CHEM PHYS, V299, P285, DOI 10.1016/j.chemphys.2003.11.040; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Widmann K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125002; Zijlstra ES, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135701	28	256	261	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1033	1037		10.1126/science.1162697	http://dx.doi.org/10.1126/science.1162697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19164708				2022-12-28	WOS:000263478400034
J	Attia, J; Ioannidis, JPA; Thakkinstian, A; McEvoy, M; Scott, RJ; Minelli, C; Thompson, J; Infante-Rivard, C; Guyatt, G				Attia, John; Ioannidis, John P. A.; Thakkinstian, Ammarin; McEvoy, Mark; Scott, Rodney J.; Minelli, Cosetta; Thompson, John; Infante-Rivard, Claire; Guyatt, Gordon			How to Use an Article About Genetic Association C: What Are the Results and Will They Help Me in Caring for My Patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; ALZHEIMERS-DISEASE; VENOUS THROMBOSIS; FACTOR-V; RISK; THROMBOEMBOLISM; SUSCEPTIBILITY; POPULATION; DIAGNOSIS; DEMENTIA	In the first 2 articles of this series, we reviewed the basic genetics concepts necessary to understand genetic association studies, and we enumerated the major issues in judging the validity of these studies. In this third article, we review the issues relating to the applicability of the results in the clinical situation. How large and precise are the associations? Many genetic effects are expected to be smaller in magnitude than traditional risk factors. Does the genetic association improve predictive power beyond easily measured clinical variables? In some cases, the additional genetic information adds only a small increment in the predictive ability of a diagnostic or prognostic test. What are the absolute vs relative effects? Even if the genetic risk is high in relative terms, the baseline risk may be very low in absolute terms. Is the risk- associated allele likely to be present in my patient? A risk allele may have a strong effect but be rare in a particular ethnic group. Is the patient likely better off knowing the genetic information? Given that genes cannot be modified, one must weigh whether the genetic information is likely to be helpful in planning other health interventions or initiating behavior change.	[Attia, John; McEvoy, Mark] Univ Newcastle, Hunter Med Res Inst, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Attia, John] John Hunter Hosp, Dept Gen Med, Newcastle, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr,Dept Med, Boston, MA 02111 USA; [Thakkinstian, Ammarin] Mahidol Univ, Clin Epidemiol Unit, Fac Med, Ramathibodi Hosp, Bangkok 10700, Thailand; [Scott, Rodney J.] John Hunter Hosp, Div Genet, Hunter Area Pathol Serv, New Lambton, Australia; Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Ctr Informat Based Med, Newcastle, NSW 2308, Australia; [Minelli, Cosetta] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Thompson, John] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Infante-Rivard, Claire] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada; [Guyatt, Gordon] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Ioannina; Tufts Medical Center; Tufts University; Mahidol University; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; Imperial College London; University of Leicester; McGill University; McMaster University	Attia, J (corresponding author), Univ Newcastle, Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, Level 3, David Maddison Bldg, Newcastle, NSW 2300, Australia.	john.attia@newcastle.edu.au	Attia, John R/F-5376-2013; Thakkinstian, Ammarin/J-4788-2019; Scott, Rodney J/B-2827-2013; Ioannidis, John P. A./G-9836-2011	Attia, John R/0000-0001-9800-1308; Scott, Rodney J/0000-0001-7724-3404; McEvoy, Mark/0000-0002-5505-5557				*ALL FREQ DAT, GEN FREQ DAT HUM POP; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; BERTRAM L, SYSTEMATIC METAANALY; Cupples LA, 2004, GENET MED, V6, P192, DOI 10.1097/01.GIM.0000132679.92238.58; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Guyatt G., 2015, USERS GUIDES MED LIT; Hamajima N, 2006, J EPIDEMIOL, V16, P45, DOI 10.2188/jea.16.45; HapMap, INT HAPMAP PROJ; Humphries SE, 2004, ARTERIOSCL THROM VAS, V24, P628, DOI 10.1161/01.ATV.0000116216.56511.39; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Lipkus IM, 2004, HEALTH PSYCHOL, V23, P178, DOI 10.1037/0278-6133.23.2.178; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; *NAT COMPR CANC NE, TEST WOM BREAST OV C; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Slooter AJC, 2004, NEUROLOGY, V62, P1196, DOI 10.1212/01.WNL.0000118302.66674.E1; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	31	53	54	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					304	308		10.1001/jama.2008.993	http://dx.doi.org/10.1001/jama.2008.993			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155457				2022-12-28	WOS:000262518700021
J	Ofri, D				Ofri, Danielle			Part-time Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLICIES; FACULTY					dofri@blreview.org		Ofri, Danielle/0000-0001-9865-7104				*AM MED GROUP ASS, AM MED GROUP ASS PHY; GALLAGHER T, 2004, SGIM FORUM, V27, P1; Kahn JA, 2005, ACAD MED, V80, P931, DOI 10.1097/00001888-200510000-00013; Mechaber HF, 2008, J GEN INTERN MED, V23, P300, DOI 10.1007/s11606-008-0514-3; MULVEY H, 2002, ABST ACAD HLTH SERV, V19, P9; Parkerton PH, 2003, J GEN INTERN MED, V18, P717, DOI 10.1046/j.1525-1497.2003.20401.x; Socolar RRS, 2000, ACAD MED, V75, P846, DOI 10.1097/00001888-200008000-00020	7	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					254	255		10.1001/jama.2008.1025	http://dx.doi.org/10.1001/jama.2008.1025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155445				2022-12-28	WOS:000262518700001
J	Wong, CL; Holroyd-Leduc, J; Straus, SE				Wong, Camilla L.; Holroyd-Leduc, Jayna; Straus, Sharon E.			Does This Patient Have a Pleural Effusion?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; COMMUNITY-ACQUIRED PNEUMONIA; AUSCULTATORY PERCUSSION; PARAPNEUMONIC EFFUSIONS; RADIOGRAPHIC FINDINGS; PHYSICAL SIGNS; PERICARDIAL DISEASE; CHEST PERCUSSION; DIAGNOSTIC-VALUE; ULTRASOUND	Context Pleural effusion is a common finding among patients presenting with respiratory symptoms. The value of the bedside examination to detect pleural effusion is unclear. Objective To systematically review the evidence regarding the accuracy of the physical examination in assessing the probability of a pleural effusion. Data Sources We searched MEDLINE ( 1950- October 2008) and EMBASE ( 1980-October 2008) using Ovid to identify English- language studies conducted in a clinical setting. Additional studies were identified by searching the bibliographies of retrieved articles and contacting experts in the field. Study Selection We included prospective studies of diagnostic accuracy that compared at least 1 physical examination maneuver with radiographic confirmation of pleural effusion. Data Extraction Three authors independently appraised study quality and extracted relevant data. Data regarding participant recruitment, reference standard, diagnostic test( s), and test accuracy were extracted. Disagreements were resolved by consensus. Data Synthesis We identified 310 unique citations, but only 5 prospectively conducted studies met inclusion criteria ( N= 934 patients). A random- effects model was used for quantitative synthesis. Of the 8 physical examination maneuvers evaluated in the included studies ( conventional percussion, auscultatory percussion, breath sounds, chest expansion, tactile vocal fremitus, vocal resonance, crackles, and pleural friction rub), dullness to conventional percussion was most accurate for diagnosing pleural effusion ( summary positive likelihood ratio, 8.7; 95% confidence interval, 2.2- 33.8), while the absence of reduced tactile vocal fremitus made pleural effusion less likely ( negative likelihood ratio, 0.21; 95% confidence interval, 0.12- 0.37). Conclusions Based on the limited number of studies, dullness to percussion and tactile fremitus are the most useful findings for pleural effusion. Dull chest percussion makes the probability of a pleural effusion much more likely but requires a chest radiograph to confirm the diagnosis. When the pretest probability of pleural effusion is low, the absence of reduced tactile vocal fremitus makes pleural effusion less likely so that a chest radiograph might not be necessary depending on the overall clinical situation.	[Wong, Camilla L.; Straus, Sharon E.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Wong, Camilla L.] Univ Toronto, Div Geriatr, Toronto, ON, Canada; [Straus, Sharon E.] Univ Toronto, Knowledge Translat Program, Fac Med, Toronto, ON, Canada; [Holroyd-Leduc, Jayna] Univ Calgary, Div Gen Internal Med, Calgary, AB, Canada; [Holroyd-Leduc, Jayna] Univ Calgary, Div Geriatr, Calgary, AB, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Calgary; University of Calgary	Straus, SE (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sharon.straus@utoronto.ca	Wong, Camilla/J-6419-2019	Wong, Camilla/0000-0002-4430-2321	Tier 2 Canada Research Chair; Health Scholar Award; Alberta Heritage Foundation for Medical Research	Tier 2 Canada Research Chair(Canada Research Chairs); Health Scholar Award; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	Dr Straus is supported by a Tier 2 Canada Research Chair and a Health Scholar Award from the Alberta Heritage Foundation for Medical Research.	Azoulay E, 2003, CURR OPIN PULM MED, V9, P291, DOI 10.1097/00063198-200307000-00008; BARTLETT JG, 1974, AM REV RESPIR DIS, V110, P56; Bedford DE, 1941, BRIT HEART J, V3, P93; BERNSTEIN A, 1952, ANN INTERN MED, V37, P733, DOI 10.7326/0003-4819-37-4-733; Blackmore CC, 1996, ACAD RADIOL, V3, P103; BOHADANA AB, 1986, RESPIRATION, V50, P218, DOI 10.1159/000194929; BOURKE S, 1989, IRISH J MED SCI, V158, P82, DOI 10.1007/BF02942111; BOYARS MC, 1997, CONSULTANT, V37, P415; DOCK W, 1973, B NEW YORK ACAD MED, V49, P575; Fartoukh M, 2002, CHEST, V121, P178, DOI 10.1378/chest.121.1.178; FINE NL, 1970, NEW ENGL J MED, V283, P790, DOI 10.1056/NEJM197010082831505; FREIDBERG C, 1966, DIS HEART; Gatt ME, 2003, POSTGRAD MED J, V79, P214, DOI 10.1136/pmj.79.930.214; GUARINO JR, 1974, J KANSAS MED SOC, V75, P193; GUARINO JR, 1994, J GEN INTERN MED, V9, P71, DOI 10.1007/BF02600204; GUARINO JR, 1980, LANCET, V1, P1332, DOI 10.1016/S0140-6736(80)91788-2; Hasley PB, 1996, ARCH INTERN MED, V156, P2206, DOI 10.1001/archinte.156.19.2206; HECKERLING PS, 1986, ARCH INTERN MED, V146, P1321, DOI 10.1001/archinte.146.7.1321; Holleman DR, 1997, J GEN INTERN MED, V12, P165, DOI 10.1007/s11606-006-5024-6; Kalantri S, 2007, RESP MED, V101, P431, DOI 10.1016/j.rmed.2006.07.014; Kataoka H, 2000, AM HEART J, V139, P918, DOI 10.1016/S0002-8703(00)90026-7; Kataoka H, 2000, J AM COLL CARDIOL, V35, P1638, DOI 10.1016/S0735-1097(00)00602-1; Knudsen CW, 2004, AM J MED, V116, P363, DOI 10.1016/j.amjmed.2003.10.028; Lai-Fook SJ, 2004, PHYSIOL REV, V84, P385, DOI 10.1152/physrev.00026.2003; LEUALLEN EC, 1955, NEW ENGL J MED, V252, P79, DOI 10.1056/NEJM195501202520301; Lichtenstein D, 2004, ANESTHESIOLOGY, V100, P9, DOI 10.1097/00000542-200401000-00006; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Light RW, 2001, PLEURAL DIS; Light RW, 2003, TXB PLEURAL DIS; McDermott T D, 1997, J Am Acad Nurse Pract, V9, P483, DOI 10.1111/j.1745-7599.1997.tb01007.x; MCGEE SR, 1995, DM-DIS MON, V41, P645, DOI 10.1016/S0011-5029(95)90098-5; MCPEAK EM, 1946, ANN INTERN MED, V25, P916, DOI 10.7326/0003-4819-25-6-916; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; MOSKOWIT.H, 1973, RADIOLOGY, V109, P33, DOI 10.1148/109.1.33; NEELEY JP, 1982, INVEST RADIOL, V17, P310, DOI 10.1097/00004424-198201730-00022; NELSON RS, 1994, CHEST, V105, P402, DOI 10.1378/chest.105.2.402; PETERMAN TA, 1983, NEW ENGL J MED, V309, P313; Piccoli I, 2005, CHEST, V128, P3413, DOI 10.1378/chest.128.5.3413; Porcel JM, 2006, SOUTH MED J, V99, P98, DOI 10.1097/01.smj.0000199278.81401.2f; RACE GA, 1957, AM J MED, V22, P83, DOI 10.1016/0002-9343(57)90339-X; Rigler LG, 1931, J AMER MED ASSOC, V96, P104, DOI 10.1001/jama.1931.02720280022007; ROTHLIN MA, 1993, J TRAUMA, V34, P488; Rozycki GS, 2001, J TRAUMA, V50, P636, DOI 10.1097/00005373-200104000-00007; Simel DL, 2008, RATIONAL CLIN EXAMIN, P9; SMYLLIE HC, 1965, LANCET, V2, P412; SPITERI MA, 1988, LANCET, V1, P873; TARYLE DA, 1978, CHEST, V74, P170, DOI 10.1378/chest.74.2.170; VARGAS FS, 1992, CHEST, V102, P1333, DOI 10.1378/chest.102.5.1333; WEISS JM, 1983, NEW ENGL J MED, V308, P696, DOI 10.1056/NEJM198303243081205; WEISS JM, 1984, AM J CARDIOL, V53, P951, DOI 10.1016/0002-9149(84)90531-9; WHITE PD, 1947, AM J MED SCI, V214, P243, DOI 10.1097/00000441-194709000-00002; WIENERKRONISH JP, 1985, AM REV RESPIR DIS, V132, P1253; WIENERKRONISH JP, 1993, ANNU REV PHYSIOL, V55, P209, DOI 10.1146/annurev.ph.55.030193.001233; WILLIAMS TJ, 1981, ARCH INTERN MED, V141, P878, DOI 10.1001/archinte.141.7.878; Woodring JH, 2005, SOUTH MED J, V98, P518, DOI 10.1097/01.SMJ.0000152761.02928.88; YERNAULT JC, 1995, EUR RESPIR J, V8, P1756, DOI 10.1183/09031936.95.08101756; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	59	39	39	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 21	2009	301	3					309	317		10.1001/jama.2008.937	http://dx.doi.org/10.1001/jama.2008.937			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395IV	19155458				2022-12-28	WOS:000262518700022
J	Collini, E; Scholes, GD				Collini, Elisabetta; Scholes, Gregory D.			Coherent Intrachain Energy Migration in a Conjugated Polymer at Room Temperature	SCIENCE			English	Article							SITE-SELECTIVE FLUORESCENCE; PHOTOSYNTHETIC SYSTEMS; SPECTROSCOPY; TRANSPORT; OLIGOMERS; DYNAMICS; EXCITONS; MOTION; RANGE; STATE	The intermediate coupling regime for electronic energy transfer is of particular interest because excitation moves in space, as in a classical hopping mechanism, but quantum phase information is conserved. We conducted an ultrafast polarization experiment specifically designed to observe quantum coherent dynamics in this regime. Conjugated polymer samples with different chain conformations were examined as model multichromophoric systems. The data, recorded at room temperature, reveal coherent intrachain (but not interchain) electronic energy transfer. Our results suggest that quantum transport effects occur at room temperature when chemical donor-acceptor bonds help to correlate dephasing perturbations.	[Collini, Elisabetta; Scholes, Gregory D.] Univ Toronto, Dept Chem, Dept Opt Sci, Toronto, ON M5S 3H6, Canada; [Collini, Elisabetta; Scholes, Gregory D.] Univ Toronto, Ctr Quantum Informat & Quantum Control, Toronto, ON M5S 3H6, Canada	University of Toronto; University of Toronto	Scholes, GD (corresponding author), Univ Toronto, Dept Chem, Dept Opt Sci, Toronto, ON M5S 3H6, Canada.	gscholes@chem.utoronto.ca	Collini, Elisabetta/F-1668-2010	Collini, Elisabetta/0000-0002-1019-9100	E. W. R. Steacie Memorial Fellowship; Natural Sciences and Engineering Research Council of Canada	E. W. R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by an E. W. R. Steacie Memorial Fellowship (G. D. S.) and by the Natural Sciences and Engineering Research Council of Canada. We thank Y.-C. Cheng, G. R. Fleming, and R. J. Silbey for their comments on the manuscript.	Akimoto S, 2007, PHOTOCHEM PHOTOBIOL, V83, P163, DOI 10.1562/2006-02-28-IR-825; Bassler H, 1999, ACCOUNTS CHEM RES, V32, P173, DOI 10.1021/ar960228k; Beljonne D, 2002, P NATL ACAD SCI USA, V99, P10982, DOI 10.1073/pnas.172390999; Bredas JL, 2004, CHEM REV, V104, P4971, DOI 10.1021/cr040084k; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Chernyak V, 1996, J CHEM PHYS, V105, P4565, DOI 10.1063/1.472302; Dubin F, 2006, NAT PHYS, V2, P32, DOI 10.1038/nphys196; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; GOCHANOUR CR, 1981, J PHYS CHEM-US, V85, P1989, DOI 10.1021/j150614a008; Goodson T, 2005, ANNU REV PHYS CHEM, V56, P581, DOI 10.1146/annurev.physchem.56.092503.141130; HADZIIOANNOU G, 2007, SEMICONDUCTING POLYM; HAKEN H, 1972, Z PHYS, V249, P253, DOI 10.1007/BF01400230; HEUN S, 1993, J PHYS-CONDENS MAT, V5, P247, DOI 10.1088/0953-8984/5/2/012; KENKRE VM, 1974, PHYS REV B, V9, P5279, DOI 10.1103/PhysRevB.9.5279; Kimura A, 2003, J PHYS CHEM B, V107, P14486, DOI 10.1021/jp027667n; KLAFTER J, 1980, PHYS LETT A, V76, P143, DOI 10.1016/0375-9601(80)90595-2; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Nguyen TQ, 2001, ADV MATER, V13, P609, DOI 10.1002/1521-4095(200104)13:8<609::AID-ADMA609>3.0.CO;2-#; Pisliakov AV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2200705; Prezhdo OV, 1998, PHYS REV LETT, V81, P5294, DOI 10.1103/PhysRevLett.81.5294; RACKOVSKY S, 1973, MOL PHYS, V25, P61, DOI 10.1080/00268977300100081; Rothberg LJ, 1996, SYNTHETIC MET, V80, P41, DOI 10.1016/0379-6779(96)80202-5; Ruseckas A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115214; SARICIFTCI NS, 1997, PRIMARY EXCITATIONS; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; Schwartz BJ, 2003, ANNU REV PHYS CHEM, V54, P141, DOI 10.1146/annurev.physchem.54.011002.103811; Szymanski C, 2005, J PHYS CHEM B, V109, P8543, DOI 10.1021/jp051062k; Yu J, 2000, SCIENCE, V289, P1327, DOI 10.1126/science.289.5483.1327	30	661	672	5	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					369	373		10.1126/science.1164016	http://dx.doi.org/10.1126/science.1164016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150843				2022-12-28	WOS:000262481400035
J	Beaver, K; Tysver-Robinson, D; Campbell, M; Twomey, M; Williamson, S; Hindley, A; Susnerwala, S; Dunn, G; Luker, K				Beaver, Kinta; Tysver-Robinson, Debbie; Campbell, Malcolm; Twomey, Mary; Williamson, Susan; Hindley, Andrew; Susnerwala, Shabbir; Dunn, Graham; Luker, Karen			Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMATION NEEDS; ROUTINE FOLLOW; WOMEN	Objective To compare traditional hospital follow- up with telephone follow- up by specialist nurses after treatment for breast cancer. Design A two centre randomised equivalence trial in which women remained in the study for a mean of 24 months. Setting Outpatient clinics in two NHS hospital trusts in the north west of England. Participants 374 women treated for breast cancer who were at low to moderate risk of recurrence. Interventions Participants were randomised to traditional hospital follow- up ( consultation, clinical examination, and mammography as per hospital policy) or telephone follow- up by specialist nurses ( consultation with structured intervention and mammography according to hospital policy). Main outcome measures Psychological morbidity ( state-trait anxiety inventory, general health questionnaire ( GHQ- 12)), participants' needs for information, participants' satisfaction, clinical investigations ordered, and time to detection of recurrent disease. Results The 95% confidence interval for difference in mean state- trait scores adjusted for treatment received (- 3.33 to 2.07) was within the predefined equivalence region (- 3.5 to 3.5). The women in the telephone group were no more anxious as a result of foregoing clinic examinations and face- to- face consultations and reported higher levels of satisfaction than those attending hospital clinics ( intention to treat P< 0.001). The numbers of clinical investigations ordered did not differ between groups. Recurrences were few ( 4.5%), with no differences between groups for time to detection ( median 60.5 ( range 37- 131) days in hospital group v 39.0 ( 10- 152) days in telephone group; P= 0.228). Conclusions Telephone follow- up was well received by participants, with no physical or psychological disadvantage. It is suitable for women at low to moderate risk of recurrence and those with long travelling distances or mobility problems and decreases the burden on busy hospital clinics. Trial registration National Cancer Research Institute 1477.	[Beaver, Kinta; Campbell, Malcolm; Twomey, Mary; Williamson, Susan; Luker, Karen] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Tysver-Robinson, Debbie] Blackpool Fylde & Wyre Hosp NHS Fdn Trust, Blackpool, Lancs, England; [Hindley, Andrew; Susnerwala, Shabbir] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England; [Dunn, Graham] Univ Manchester, Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England	University of Manchester; Royal Preston Hospital; University of Manchester	Beaver, K (corresponding author), Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England.	kinta.beaver@manchester.ac.uk	Campbell, Malcolm/D-3925-2011; Luker, Karen A/E-8735-2010	Campbell, Malcolm/0000-0002-6125-5731; Luker, Karen A/0000-0002-2437-2904; Beaver, Kinta/0000-0002-6552-2323	Medical Research Council (UK); Rosemere Cancer Foundation (UK)	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosemere Cancer Foundation (UK)	The trial was funded by the Medical Research Council (UK) and a project grant from Rosemere Cancer Foundation (UK). The funding agencies had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, or in the preparation, review or approval of the manuscript	Armitage P, 2001, STAT METHODS MED RES, V4th; Ashkanani F, 2001, AM J SURG, V182, P207, DOI 10.1016/S0002-9610(01)00704-8; Baildam A, 2002, EUR J CANCER, V38, pS136, DOI 10.1016/S0959-8049(02)80448-8; Beaver K, 2005, PSYCHO-ONCOLOGY, V14, P94, DOI 10.1002/pon.824; Beaver K, 2006, EUR J ONCOL NURS, V10, P378, DOI 10.1016/j.ejon.2006.02.004; Boekhorst DST, 2001, EUR J SURG, V167, P490; Churn M, 2001, CLIN ONCOL-UK, V13, P187, DOI 10.1007/s001740170073; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DEWAR JA, 1985, BRIT MED J, V291, P1464, DOI 10.1136/bmj.291.6507.1464; Donnelly J, 2001, INT J CLIN PRACT, V55, P431; Dunn G, 2007, STAT MED, V26, P4719, DOI 10.1002/sim.2891; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Goldberg D, 1978, MANUAL GEN HLTH QUES; Gotay C C, 1998, Eur J Cancer Care (Engl), V7, P225; GRUNFELD E, 1995, FAM PRACT, V12, P60, DOI 10.1093/fampra/12.1.60; Grunfeld E, 1996, BMJ-BRIT MED J, V313, P665; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kitchener HC, 2006, BJOG-INT J OBSTET GY, V113, P1007, DOI 10.1111/j.1471-0528.2006.01035.x; Luker KA, 1996, J ADV NURS, V23, P487, DOI 10.1111/j.1365-2648.1996.tb00010.x; McArdle JMC, 1996, BMJ-BRIT MED J, V312, P813; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; *NAT I HLTH CLIN E, 2002, IMPR OUTC BREAST CAN; NORUSIS MJ, 2007, SPSS 15 ADV STAT PRO; *OFF NAT STAT, HLTH BREAST CANC; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Rojas MP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001768.pub2; Snee M, 1994, Clin Oncol (R Coll Radiol), V6, P154, DOI 10.1016/S0936-6555(94)80053-7; Spielberger C. D., 1983, MIND GARDEN; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa	30	111	112	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2009	338								a3147	10.1136/bmj.a3147	http://dx.doi.org/10.1136/bmj.a3147			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AA	19147478	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000263193100003
J	Contopoulos-Ioannidis, DG; Karvouni, A; Kouri, I; Ioannidis, JPA				Contopoulos-Ioannidis, Despina G.; Karvouni, Anastasia; Kouri, Ioanna; Ioannidis, John P. A.			Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; CLINICAL-TRIALS; STANDARD; GUIDELINES; BIAS	Objective To determine how often health surveys and quality of life evaluations reach different conclusions from those of primary efficacy outcomes and whether discordant results make a difference in the interpretation of trial findings. Design Systematic review. Data sources PubMed, contact with authors for missing information, and author survey for unpublished SF- 36 data. Study selection Randomised trials with SF- 36 outcomes ( the most extensively validated and used health survey instrument for appraising quality of life) that were published in 2005 in 22 journals with a high impact factor. Data extraction Analyses on the two composite and eight subdomain SF- 36 scores that corresponded to the time and mode of analysis of the primary efficacy outcome. Results Of 1057 screened trials, 52 were identified as randomised trials with SF- 36 results ( 66 separate comparisons). Only eight trials reported all 10 SF- 36 scores in the published articles. For 21 of the 66 comparisons, SF- 36 results were discordant for statistical significance compared with the results for primary efficacy outcomes. Of 17 statistically significant SF- 36 scores where primary outcomes were not also statistically significant in the same direction, the magnitude of effect was small in six, moderate in six, large in three, and not reported in two. Authors modified the interpretation of study findings based on SF- 36 results in only two of the 21 discordant cases. Among 100 additional randomly selected trials not reporting any SF- 36 information, at least five had collected SF- 36 data but only one had analysed it. Conclusions SF- 36 measurements sometimes produce different results from those of the primary efficacy outcomes but rarely modify the overall interpretation of randomised trials. Quality of life and health related survey information should be utilised more systematically in randomised trials.	[Karvouni, Anastasia; Kouri, Ioanna; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Contopoulos-Ioannidis, Despina G.] Univ Ioannina, Sch Med, Dept Paediat, GR-45110 Ioannina, Greece; [Contopoulos-Ioannidis, Despina G.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; University of Ioannina; George Washington University; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011					Bottomley A, 2003, EUR J CANCER, V39, P275, DOI 10.1016/S0959-8049(02)00729-3; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; *COMM MED PROD HUM, REFL PAP REG GUID US; Efficace F, 2004, EUR J CANCER, V40, P187, DOI 10.1016/j.ejca.2003.10.012; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Lee CW, 2000, J CLIN EPIDEMIOL, V53, P451, DOI 10.1016/S0895-4356(99)00221-8; Michael M, 1998, CAN MED ASSOC J, V158, P1727; Nieminen Tuomo, 2006, BMC Cardiovasc Disord, V6, P9, DOI 10.1186/1471-2261-6-9; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Osoba D., 2007, J NATL CANC I MONOGR, V37, P5, DOI [DOI 10.1093/JNCIMONOGRAPHS/LGM002, 10.1093/jncimonographs/lgm002]; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Revicki DA, 2007, QUAL LIFE RES, V16, P717, DOI 10.1007/s11136-006-9153-5; Revicki DA, 2007, LANCET, V369, P540, DOI 10.1016/S0140-6736(07)60250-5; Ringash J, 2007, CANCER-AM CANCER SOC, V110, P196, DOI 10.1002/cncr.22799; Sanders C, 1998, BRIT MED J, V317, P1191, DOI 10.1136/bmj.317.7167.1191; Staquet M, 1996, QUAL LIFE RES, V5, P496, DOI 10.1007/BF00540022; *US FDA, 2006, FED REGISTER, V71, P5862; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	28	149	150	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2009	338								a3006	10.1136/bmj.a3006	http://dx.doi.org/10.1136/bmj.a3006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404ZX	19139138	Green Published, hybrid			2022-12-28	WOS:000263192800001
J	Watson, T; Shantsila, E; Lip, GYH				Watson, Timothy; Shantsila, Eduard; Lip, Gregoty Y. H.			Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited	LANCET			English	Review							VON-WILLEBRAND-FACTOR; C-REACTIVE PROTEIN; SOLUBLE P-SELECTIN; SPONTANEOUS ECHO CONTRAST; ENDOTHELIAL GROWTH-FACTOR; CONGESTIVE-HEART-FAILURE; FIBRIN D-DIMER; ANGIOTENSIN-CONVERTING ENZYME; OXIDE SYNTHASE EXPRESSION; DOSE-ADJUSTED WARFARIN	Atrial fibrillation is the most common sustained cardiac arrhythmia, which is associated with a high risk of stroke and thromboembolism. Increasing evidence suggests that the thrombogenic tendency in atrial fibrillation is related to several underlying pathophysiological mechanisms. Abnormal changes in flow are evident by stasis in the left atrium, and seen as spontaneous echocontrast. Abnormal changes in vessel walls-essentially, anatomical and structural defects-include progressive atrial dilatation, endocardial denudation, and oedematous or fibroelastic infiltration of the extracellular matrix. Additionally, abnormal changes in blood constituents are well described, and include haemostatic and platelet activation, as well as inflammation and growth factor changes. These changes result in the fulfilment of Virchow's triad for thrombogenesis, and accord with a prothrombotic or hypercoagulable state in this arrhythmia. In this Review, we present an overview of the established and purported mechanisms for thrombogenesis in atrial fibrillation.	[Watson, Timothy; Lip, Gregoty Y. H.] Univ Birmingham, Dept Med, City Hosp, Birmingham B18 7QH, W Midlands, England; [Shantsila, Eduard] Republican Res & Practical Ctr Cardiol, Minsk, BELARUS	University of Birmingham; Republican Scientific & Practical Center Cardiology	Lip, GYH (corresponding author), Univ Birmingham, Dept Med, City Hosp, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk	Watson, Timothy J/E-5513-2014	Watson, Timothy J/0000-0001-9260-4597; Shantsila, Eduard/0000-0002-2429-6980				Acevedo M, 2006, INT J CARDIOL, V108, P326, DOI 10.1016/j.ijcard.2005.05.017; Amrani D L, 1990, Blood Coagul Fibrinolysis, V1, P443, DOI 10.1097/00001721-199010000-00013; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; Anne W, 2005, CARDIOVASC RES, V67, P655, DOI 10.1016/j.cardiores.2005.04.016; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Arndt M, 2002, CIRCULATION, V105, P720, DOI 10.1161/hc0602.103639; Asinger RW, 1999, J AM SOC ECHOCARDIOG, V12, P1088, DOI 10.1016/S0894-7317(99)70106-9; Atalar E, 2003, PLATELETS, V14, P407, DOI 10.1080/09537100310001638814; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Blackshear JL, 1999, STROKE, V30, P834, DOI 10.1161/01.STR.30.4.834; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Brotman DJ, 2004, SOUTH MED J, V97, P213, DOI 10.1097/01.SMJ.0000105663.01648.25; Bruins P, 1997, CIRCULATION, V96, P3542; Burstein S A, 1996, Stem Cells, V14 Suppl 1, P154; Burstein SA, 1997, PLATELETS, V8, P93, DOI 10.1080/09537109709169324; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Cardin S, 2003, CARDIOVASC RES, V60, P315, DOI 10.1016/j.cardiores.2003.08.014; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chiang CW, 1998, ANN INTERN MED, V128, P885, DOI 10.7326/0003-4819-128-11-199806010-00001; Chirinos JA, 2005, HEART RHYTHM, V2, P525, DOI 10.1016/j.hrthm.2005.01.016; Choudhury A, 2003, PATHOPHYSIOL HAEMO T, V33, P282, DOI 10.1159/000083815; Choudhury A, 2005, EXPERT OPIN PHARMACO, V6, P2193, DOI 10.1517/14656566.6.13.2193; Choudhury A, 2007, THROMB RES, V120, P623, DOI 10.1016/j.thromres.2006.12.008; Choudhury A, 2007, CHEST, V131, P809, DOI 10.1378/chest.06-2039; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Chung NAY, 2002, STROKE, V33, P2187, DOI 10.1161/01.STR.0000023889.84649.3D; Cohen A, 2007, EUR HEART J, V28, P2179, DOI 10.1093/eurheartj/ehm170; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Conway DSG, 2004, AM HEART J, V148, P462, DOI 10.1016/j.ahj.2004.01.026; Conway DSG, 2004, J AM COLL CARDIOL, V43, P2075, DOI 10.1016/j.jacc.2003.11.062; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; Conway DSG, 2003, STROKE, V34, P413, DOI 10.1161/01.STR.0000051728.85133.32; Conway DSG, 2002, CIRCULATION, V106, P1962, DOI 10.1161/01.CIR.0000033220.97592.9A; Das UN, 2005, MED SCI MONITOR, V11, pRA155; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; DEMELLIS J, 2001, ACTA CARDIOL, V56, P375; Dewar RI, 2007, HEART, V93, P25, DOI 10.1136/hrt.2006.099861; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Feinberg WM, 1999, THROMB HAEMOSTASIS, V82, P100, DOI 10.1055/s-0037-1614636; Feinberg WM, 1999, STROKE, V30, P2547, DOI 10.1161/01.STR.30.12.2547; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Freestone B, 2005, ANN MED, V37, P365, DOI 10.1080/07853890510037392; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fukuchi M, 2001, J AM COLL CARDIOL, V37, P1436, DOI 10.1016/S0735-1097(01)01125-1; FURUI H, 1987, JPN HEART J, V28, P177; Gedikli O, 2007, INT J CARDIOL, V120, P193, DOI 10.1016/j.ijcard.2006.09.015; Giansante C, 2000, AM HEART J, V140, P423, DOI 10.1067/mhj.2000.108520; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Goldsmith IRA, 2000, AM J CARDIOL, V85, P1218, DOI 10.1016/S0002-9149(00)00731-1; Granio O, 2007, HUM GENE THER, V18, P1076; Griendling KK, 1997, CIRCULATION, V96, P3264; Habara S, 2007, EUR HEART J, V28, P2217, DOI 10.1093/eurheartj/ehm356; Handke M, 2005, J AM SOC ECHOCARDIOG, V18, P1366, DOI 10.1016/j.echo.2005.05.006; Hatzinikolaou-Kotsakou E, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-2; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Heeringa J, 2006, J THROMB HAEMOST, V4, P1944, DOI 10.1111/j.1538-7836.2006.02115.x; HELGASON CM, 1993, STROKE, V24, P1458, DOI 10.1161/01.STR.24.10.1458; Heppell RM, 1997, HEART, V77, P407, DOI 10.1136/hrt.77.5.407; Madrid AH, 2007, J AM COLL CARDIOL, V49, P1649, DOI 10.1016/j.jacc.2007.02.009; Igarashi Y, 2001, JPN CIRC J, V65, P788, DOI 10.1253/jcj.65.788; Inoue H, 2004, CHEST, V126, P687, DOI 10.1378/chest.126.3.687; Jacob K, 2004, INT J CARDIOL, V95, P83, DOI 10.1016/j.ijcard.2003.05.019; Jue J, 1993, J Am Soc Echocardiogr, V6, P237; Kahn SR, 1997, CAN MED ASSOC J, V157, P673; Kamath S, 2003, HEART, V89, P1093, DOI 10.1136/heart.89.9.1093; Kamath S, 2002, BLOOD COAGUL FIBRIN, V13, P627, DOI 10.1097/00001721-200210000-00008; Kamath S, 2002, EUR HEART J, V23, P1788, DOI 10.1053/euhj.2002.3259; Kamath S, 2002, STROKE, V33, P1237, DOI 10.1161/01.STR.0000013739.82306.7F; Kamath S, 2002, J AM COLL CARDIOL, V40, P484, DOI 10.1016/S0735-1097(02)01984-8; KAPLAN KL, 1978, BRIT J HAEMATOL, V39, P129, DOI 10.1111/j.1365-2141.1978.tb07135.x; KEREN G, 1987, AM HEART J, V114, P1146, DOI 10.1016/0002-8703(87)90190-6; Khan IA, 2003, AM HEART J, V145, P787, DOI 10.1016/S0002-8703(03)00086-3; Kirchhof P, 2007, EUROPACE, V9, P1006, DOI 10.1093/europace/eum191; Koefoed BG, 1997, THROMB HAEMOSTASIS, V77, P845; KUMAGAI K, 1990, J AM COLL CARDIOL, V16, P377, DOI 10.1016/0735-1097(90)90589-H; Kumagai K, 2004, CIRC J, V68, P321, DOI 10.1253/circj.68.321; KUNISHIMA S, 1994, EUR HEART J, V15, P335, DOI 10.1093/oxfordjournals.eurheartj.a060499; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li XP, 2008, MED HYPOTHESES, V70, P317, DOI 10.1016/j.mehy.2007.04.046; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; Li-Saw-Hee FL, 2001, EUR HEART J, V22, P1741, DOI 10.1053/euhj.2000.2531; Lijnen HR, 2000, FIBRINOLYSIS PROTEOL, V14, P175, DOI 10.1054/fipr.2000.0065; Lip GYH, 2007, STROKE, V38, P1229, DOI 10.1161/01.STR.0000260090.90508.3e; Lip GYH, 2006, STROKE, V37, P2294, DOI 10.1161/01.STR.0000236840.00467.84; Lip GYH, 2005, HEART, V91, P759, DOI 10.1136/hrt.2004.036160; Lip GYH, 1996, ANGIOLOGY, V47, P1117, DOI 10.1177/000331979604701201; LIP GYH, 1995, LANCET, V346, P1313, DOI 10.1016/S0140-6736(95)92339-X; LIP GYH, 1995, BRIT HEART J, V73, P527; Lip GYH, 1996, CIRCULATION, V94, P425, DOI 10.1161/01.CIR.94.3.425; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Mahe I, 2002, THROMB RES, V107, P1, DOI 10.1016/S0049-3848(02)00184-6; Marin F, 2003, STROKE, V34, P1181, DOI 10.1161/01.STR.0000065431.76788.D9; Marin V, 2004, HEART, V90, P1162, DOI 10.1136/hrt.2003.024521; Marinkovic S, 1999, SURG NEUROL, V52, P30, DOI 10.1016/S0090-3019(99)00043-9; MASAWA N, 1993, VIRCHOWS ARCH A, V422, P67, DOI 10.1007/BF01605135; MERINO A, 1992, J AM COLL CARDIOL, V20, P1661, DOI 10.1016/0735-1097(92)90463-W; Minamino T, 1999, AM J CARDIOL, V83, P194, DOI 10.1016/S0002-9149(98)00823-6; Minamino T, 1998, CIRCULATION, V98, P1721, DOI 10.1161/01.CIR.98.17.1721; Mitusch R, 1996, THROMB HAEMOSTASIS, V75, P219; Mondillo S, 2000, INT J CARDIOL, V75, P227, DOI 10.1016/S0167-5273(00)00336-3; Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66; Mukherjee R, 2006, AM J CARDIOL, V97, P532, DOI 10.1016/j.amjcard.2005.08.073; Muller I, 2002, PATHOPHYSIOL HAEMO T, V32, P16, DOI 10.1159/000057284; Nakagami H, 1998, AM HEART J, V136, P528, DOI 10.1016/S0002-8703(98)70231-5; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Nakano Y, 2004, J AM COLL CARDIOL, V43, P818, DOI 10.1016/j.jacc.2003.08.060; Neumann FJ, 1997, ARTERIOSCL THROM VAS, V17, P3399, DOI 10.1161/01.ATV.17.12.3399; Nozawa T, 2006, INT J CARDIOL, V109, P59, DOI 10.1016/j.ijcard.2005.05.049; Nozawa T, 2004, CIRC J, V68, P29, DOI 10.1253/circj.68.29; Nozawa T, 2007, INT J CARDIOL, V120, P125, DOI 10.1016/j.ijcard.2006.11.028; OBARSKI TP, 1990, AM HEART J, V120, P988, DOI 10.1016/0002-8703(90)90224-L; Ohara K, 2008, INT J CARDIOL, V126, P316, DOI 10.1016/j.ijcard.2007.06.020; Oltrona L, 1997, CIRCULATION, V95, P2003, DOI 10.1161/01.CIR.95.8.2003; POLLICK C, 1991, CIRCULATION, V84, P223, DOI 10.1161/01.CIR.84.1.223; Pongratz G, 1997, CHEST, V111, P929, DOI 10.1378/chest.111.4.929; Pretorius M, 2007, CIRCULATION, V116, pI1, DOI 10.1161/CIRCULATIONAHA.106.677906; Rastegar R, 2003, J AM COLL CARDIOL, V41, P603, DOI 10.1016/S0735-1097(02)02898-X; Roldan V, 2005, THROMB RES, V116, P321, DOI 10.1016/j.thromres.2005.01.005; Roldan V, 2000, HAEMOSTASIS, V30, P219; Roldan V, 1998, AM HEART J, V136, P956, DOI 10.1016/S0002-8703(98)70149-8; Sackner-Bernstein J D, 2000, Curr Cardiol Rep, V2, P112, DOI 10.1007/s11886-000-0007-4; Sakurai K, 2004, CIRC J, V68, P1041, DOI 10.1253/circj.68.1041; Sakurai K, 2003, CHEST, V124, P1670, DOI 10.1378/chest.124.5.1670; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Schotten U, 2003, J MOL CELL CARDIOL, V35, P437, DOI 10.1016/S0022-2828(03)00012-9; Seko Y, 2000, JPN HEART J, V41, P27, DOI 10.1536/jhj.41.27; Shinohara H, 1998, JPN HEART J, V39, P721; Sohara H, 1997, J AM COLL CARDIOL, V29, P106, DOI 10.1016/S0735-1097(96)00427-5; Somloi M, 2003, AM J CARDIOL, V92, P85, DOI 10.1016/S0002-9149(03)00476-4; Stellbrink C, 2000, EUR HEART J, V21, P795, DOI 10.1053/euhj.1999.2051; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Swiatkowska M, 2000, EUR J BIOCHEM, V267, P1001, DOI 10.1046/j.1432-1327.2000.01086.x; TAKAGISHI T, 1995, BIOCHEM MOL BIOL INT, V35, P265; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tsai LM, 1998, AM J CARDIOL, V81, P1249, DOI 10.1016/S0002-9149(98)00131-3; Tse HF, 2005, J CARDIOVASC ELECTR, V16, P1064, DOI 10.1111/j.1540-8167.2005.50103.x; Turgut N, 2006, CLIN APPL THROMB-HEM, V12, P15, DOI 10.1177/107602960601200104; Tveit A, 2007, AM J CARDIOL, V99, P1544, DOI 10.1016/j.amjcard.2007.01.030; Tveit A, 2008, THROMB RES, V121, P447, DOI 10.1016/j.thromres.2007.06.014; Tziakas DN, 2007, EUROPACE, V9, P589, DOI 10.1093/europace/eum072; Varughese GI, 2007, HEART, V93, P495, DOI 10.1136/hrt.2006.099374; Varughese GI, 2005, J THROMB HAEMOST, V3, P2811, DOI 10.1111/j.1538-7836.2005.01694.x; Vene N, 2003, THROMB HAEMOSTASIS, V90, P1163, DOI 10.1160/TH03-06-0363; Wachtell K, 2005, J AM COLL CARDIOL, V45, P705, DOI 10.1016/j.jacc.2004.06.080; Wang YC, 2005, CHEST, V128, P2551, DOI 10.1378/chest.128.4.2551; Webb NJA, 1998, CLIN SCI, V94, P395, DOI 10.1042/cs0940395; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; YAMAUCHI K, 1986, JPN HEART J, V27, P481; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005; Zeuthen EL, 2004, J THROMB THROMBOLYS, V17, P185, DOI 10.1023/B:THRO.0000040487.25109.ad; Zeuthen EL, 2003, THROMB RES, V109, P241, DOI 10.1016/S0049-3848(03)00240-8	160	645	673	1	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2009	373	9658					155	166		10.1016/S0140-6736(09)60040-4	http://dx.doi.org/10.1016/S0140-6736(09)60040-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	392ZO	19135613				2022-12-28	WOS:000262340900031
J	Ramaraj, R				Ramaraj, Radhakrishnan			An elderly man who suddenly lost consciousness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONVERTING ENZYME-INHIBITORS; AORTIC-VALVE-REPLACEMENT; VALVULAR HEART-DISEASE; STENOSIS; PROGRESSION; GUIDELINES; MANAGEMENT; SURVIVAL; RISK		[Ramaraj, Radhakrishnan] Univ Arizona, Coll Med, Dept Internal Med, Tucson, AZ 85724 USA	University of Arizona	Ramaraj, R (corresponding author), Univ Arizona, Coll Med, Dept Internal Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	drkutty2@gmail.com						American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Bellamy MF, 2002, J AM COLL CARDIOL, V40, P1723, DOI 10.1016/S0735-1097(02)02496-8; Chambers J, 2005, BRIT MED J, V330, P801, DOI 10.1136/bmj.330.7495.801; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Glader CA, 2003, EUR HEART J, V24, P198, DOI 10.1016/S0195-668X(02)00385-8; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jimenez-Candil J, 2005, HEART, V91, P1311, DOI 10.1136/hrt.2004.047233; Khot UN, 2003, NEW ENGL J MED, V348, P1756, DOI 10.1056/NEJMoa022021; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Pereira JJ, 2002, J AM COLL CARDIOL, V39, P1356, DOI 10.1016/S0735-1097(02)01759-X; Ramaraj R, 2008, BMJ-BRIT MED J, V336, P550, DOI 10.1136/bmj.39478.498819.AD; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2009	338								a3009	10.1136/bmj.a3009	http://dx.doi.org/10.1136/bmj.a3009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PO	19129300				2022-12-28	WOS:000263165700002
J	Bao, HM; Fairchild, IJ; Wynn, PM; Spotl, C				Bao, Huiming; Fairchild, Ian J.; Wynn, Peter M.; Spoetl, Christoph			Stretching the Envelope of Past Surface Environments: Neoproterozoic Glacial Lakes from Svalbard	SCIENCE			English	Article							PYRITE OXIDATION; ISOTOPIC-RATIOS; OXYGEN-ISOTOPE; CO2 LEVELS; SULFATE; SULFUR; SPITSBERGEN; REDUCTION	The oxygen isotope composition of terrestrial sulfate is affected measurably by many Earth- surface processes. During the Neoproterozoic, severe " snowball" glaciations would have had an extreme impact on the biosphere and the atmosphere. Here, we report that sulfate extracted from carbonate lenses within a Neoproterozoic glacial diamictite suite from Svalbard, with an age of similar to 635 million years ago, falls well outside the currently known natural range of triple oxygen isotope compositions and indicates that the atmosphere had either an exceptionally high atmospheric carbon dioxide concentration or an utterly unfamiliar oxygen cycle during deposition of the diamictites.	[Bao, Huiming] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Fairchild, Ian J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Wynn, Peter M.] Univ Lancaster, Dept Geog, Lancaster LA1 4YQ, England; [Spoetl, Christoph] Univ Innsbruck, Inst Geol & Palaeontol, A-6020 Innsbruck, Austria	Louisiana State University System; Louisiana State University; University of Birmingham; Lancaster University; University of Innsbruck	Bao, HM (corresponding author), Louisiana State Univ, Dept Geol & Geophys, E235 Howe Russell Complex, Baton Rouge, LA 70803 USA.	bao@lsu.edu	Fairchild, Ian/A-6200-2013; Bao, Huiming/C-1069-2012	Fairchild, Ian/0000-0003-4822-2895; Wynn, Peter Michael/0000-0002-1221-5530	Louisiana State University; NSF; Chinese Academy of Science; Natural Environment Research Council (NERC) [GR3/C511805/1]; Austrian Science Funds; Natural Environment Research Council [NE/C511805/1] Funding Source: researchfish	Louisiana State University; NSF(National Science Foundation (NSF)); Chinese Academy of Science(Chinese Academy of Sciences); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Funds(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	H.B. and I.J.F. designed research and led the writing of the manuscript; H. B. performed CAS extraction and triple oxygen isotope measurements; I.J.F secured samples from field expeditions and conducted sedimentological, petrographic, mineralogical and elemental studies; P.M.W. conducted preliminary CAS extraction and performed delta<SUP>34</SUP>S<INF>CAS</INF> analysis; and C.S. carried out delta<SUP>13</SUP>C and delta<SUP>18</SUP>O analysis of host carbonates. We thank G. Halverson for discussion and Y. Peng for analytical assistance. Financial and facility supports were provided by Louisiana State University, NSF, and Chinese Academy of Science (H.B.), Natural Environment Research Council (NERC) standard grant (GR3/C511805/1) and NERC inductively coupled plasma mass spectrometry facilities (I.J.F.), and Austrian Science Funds (C.S.). The authors declare no competing financial interests.	Angert A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001933; Balci N, 2007, GEOCHIM COSMOCHIM AC, V71, P3796, DOI 10.1016/j.gca.2007.04.017; Bao HM, 2005, CHEM GEOL, V214, P127, DOI 10.1016/j.chemgeo.2004.08.052; Bao HM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016869; Bao HM, 2008, NATURE, V453, P504, DOI 10.1038/nature06959; Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; Crowley TJ, 2001, GEOPHYS RES LETT, V28, P283, DOI 10.1029/2000GL011836; Evans DAD, 2000, AM J SCI, V300, P347, DOI 10.2475/ajs.300.5.347; Fairchild IJ, 2007, J GEOL SOC LONDON, V164, P895, DOI 10.1144/0016-76492006-191; FAIRCHILD IJ, 1989, GEOL MAG, V126, P469, DOI 10.1017/S0016756800022809; FAIRCHILD IJ, 1995, PRECAMBRIAN RES, V73, P217, DOI 10.1016/0301-9268(94)00079-7; FAIRCHILD IJ, 1984, PRECAMBRIAN RES, V26, P111, DOI 10.1016/0301-9268(84)90042-1; Farquhar J, 2008, GEOCHIM COSMOCHIM AC, V72, P2805, DOI 10.1016/j.gca.2008.03.013; Halverson Galen P., 2006, V27, P231; Halverson GP, 2004, BASIN RES, V16, P297, DOI 10.1111/j.1365-2117.2004.00234.x; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; Luz B, 2005, GEOCHIM COSMOCHIM AC, V69, P1099, DOI 10.1016/j.gca.2004.09.001; Moreira NF, 2004, GEOLOGY, V32, P701, DOI 10.1130/G20353.1; MOSES CO, 1991, GEOCHIM COSMOCHIM AC, V55, P471, DOI 10.1016/0016-7037(91)90005-P; Pierrehumbert RT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005162; REEDY BJ, 1994, APPL SPECTROSC, V48, P691, DOI 10.1366/000370294774368893; Socki R. A., 2008, LUN PLAN SCI C NASA, VXXXIX, P1964; TALBOT MR, 1990, CHEM GEOL, V80, P261, DOI 10.1016/0168-9622(90)90009-2	25	76	77	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					119	122		10.1126/science.1165373	http://dx.doi.org/10.1126/science.1165373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119231	Green Submitted, Green Accepted			2022-12-28	WOS:000262104100054
J	Cantlon, JF; Cordes, S; Libertus, ME; Brannon, EM				Cantlon, Jessica F.; Cordes, Sara; Libertus, Melissa E.; Brannon, Elizabeth M.			Comment on "Log or Linear? Distinct Intuitions of the Number Scale in Western and Amazonian Indigene Cultures"	SCIENCE			English	Editorial Material							NUMERICAL ESTIMATION		[Cantlon, Jessica F.; Cordes, Sara; Libertus, Melissa E.; Brannon, Elizabeth M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Cordes, Sara; Libertus, Melissa E.; Brannon, Elizabeth M.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Cantlon, Jessica F.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Duke University; Duke University; Carnegie Mellon University	Cantlon, JF (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	jfc2@duke.edu	Libertus, Melissa/M-6516-2014; Pica, Pierre/N-1342-2019; cantlon, jessica/A-2699-2010	Pica, Pierre/0000-0001-9452-5446; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023103] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD023103] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cordes S, 2007, PERCEPT PSYCHOPHYS, V69, P1185, DOI 10.3758/BF03193955; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; GIBBON J, 1981, J EXP PSYCHOL ANIM B, V7, P87, DOI 10.1037/0097-7403.7.2.87; Krantz D., 1971, FDN MEASUREMENT; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rattermann M.J., 1998, ADV ANALOGY RES INTE, P274; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; Stevens S. S., 1951, HDB EXPT PSYCHOL, P1; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	13	48	49	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910								10.1126/science.1164773	http://dx.doi.org/10.1126/science.1164773			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389OL	19119201	Green Accepted			2022-12-28	WOS:000262104100020
J	Jiricny, J; Menigatti, M				Jiricny, Josef; Menigatti, Mirco			DNA Cytosine Demethylation: Are We Getting Close?	CELL			English	Editorial Material							METHYLATION	Whether 5-methylcytosine (meC) can be enzymatically removed from vertebrate DNA has been the subject of extensive study and also some controversy. Rai et al. (2008) now report that cytosine demethylation can be accomplished in a one-cell zebrafish embryo by the combined action of a cytidine deaminase and a thymine DNA glycosylase.	[Jiricny, Josef] Swiss Fed Inst Technol ETH, Dept Biol, CH-8057 Zurich, Switzerland; [Menigatti, Mirco] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Jiricny, J (corresponding author), Swiss Fed Inst Technol ETH, Dept Biol, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch						Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341	9	28	29	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1167	1169		10.1016/j.cell.2008.12.008	http://dx.doi.org/10.1016/j.cell.2008.12.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109887	Bronze			2022-12-28	WOS:000261989800007
J	Johannes, L; Popoff, V				Johannes, Ludger; Popoff, Vincent			Tracing the Retrograde Route in Protein Trafficking	CELL			English	Review							TRANS-GOLGI NETWORK; MANNOSE 6-PHOSPHATE RECEPTORS; CLATHRIN-COATED VESICLES; TO-TGN TRANSPORT; CLASS-I PATHWAY; SHIGA TOXIN; ENDOPLASMIC-RETICULUM; MAMMALIAN RETROMER; DENDRITIC CELLS; EARLY/RECYCLING ENDOSOMES	Retrograde transport, in which proteins and lipids are shuttled between endosomes and biosynthetic/secretory compartments such as the Golgi apparatus, is crucial for a diverse range of cellular functions. Mechanistic studies that explore the molecular machinery involved in this retrograde trafficking route are shedding light on the functions of transport proteins and are providing fresh insights into possible new therapeutic directions.	[Johannes, Ludger; Popoff, Vincent] CNRS, Ctr Rech, Traff Signaling & Delivery Lab, UMR144, F-75248 Paris 05, France; [Johannes, Ludger; Popoff, Vincent] Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Johannes, L (corresponding author), CNRS, Ctr Rech, Traff Signaling & Delivery Lab, UMR144, F-75248 Paris 05, France.	ludger.johannes@curie.fr	Johannes, Ludger/W-8593-2019; Johannes, Ludger/M-9778-2017	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004	Human Frontier Science Program Organization; 6th European Framework Program CancerImmunotherapy; Curie Institute (PIC Vectorization)	Human Frontier Science Program Organization(Human Frontier Science Program); 6th European Framework Program CancerImmunotherapy(European Commission); Curie Institute (PIC Vectorization)	We thank C. Lamaze for critical reading of the manuscript. L.J. is supported by grants from Human Frontier Science Program Organization, 6th European Framework Program CancerImmunotherapy, and the Curie Institute (PIC Vectorization).	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; AMESSOU M, 2006, CURRENT PROTOCOLS CE; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Arab S, 1999, ONCOL RES, V11, P33; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bantel-Schaal U, 2002, J VIROL, V76, P2340, DOI 10.1128/JVI.76.5.2340-2349.2002; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Birkeli KA, 2003, J BIOL CHEM, V278, P1991, DOI 10.1074/jbc.M209982200; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BONIFACINO JS, 2008, RETROMER CURR OPIN C, V20, P427; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; BURKE B, 1982, EMBO J, V1, P1621, DOI 10.1002/j.1460-2075.1982.tb01364.x; Carlton JG, 2005, J CELL SCI, V118, P4527, DOI 10.1242/jcs.02568; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Chaudhry A, 2008, TRAFFIC, V9, P1925, DOI 10.1111/j.1600-0854.2008.00802.x; Choudhury R, 2005, MOL BIOL CELL, V16, P3467, DOI 10.1091/mbc.E05-02-0120; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crump CM, 2004, J GEN VIROL, V85, P3517, DOI 10.1099/vir.0.80361-0; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gariepy J, 2001, CRIT REV ONCOL HEMAT, V39, P99, DOI 10.1016/S1040-8428(01)00126-3; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hearn AR, 2004, J BIOL CHEM, V279, P51315, DOI 10.1074/jbc.M408279200; Hehnly H, 2006, MOL BIOL CELL, V17, P4379, DOI 10.1091/mbc.E06-04-0310; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Ishitoya S, 2004, J UROLOGY, V171, P1309, DOI 10.1097/01.ju.0000100110.11129.85; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Janssen KP, 2006, CANCER RES, V66, P7230, DOI 10.1158/0008-5472.CAN-06-0631; Johannes L, 2005, GENE THER, V12, P1360, DOI 10.1038/sj.gt.3302557; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lamaze C, 2006, INTRACELLULAR TRAFFI; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medigeshi GR, 2003, TRAFFIC, V4, P802, DOI 10.1034/j.1600-0854.2003.00136.x; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Moron G, 2004, TRENDS IMMUNOL, V25, P92, DOI 10.1016/j.it.2003.11.008; MunierLehmann H, 1996, BIOCHEM SOC T, V24, P133, DOI 10.1042/bst0240133; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Noakes KL, 1999, FEBS LETT, V453, P95, DOI 10.1016/S0014-5793(99)00609-2; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Straley KS, 2000, J CELL BIOL, V151, P107, DOI 10.1083/jcb.151.1.107; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Takenouchi H, 2004, J CELL SCI, V117, P3911, DOI 10.1242/jcs.01246; Tarrago-Trani MT, 2007, ADV DRUG DELIVER REV, V59, P782, DOI 10.1016/j.addr.2007.06.006; Tartour E, 2002, VACCINE, V20, pA32, DOI 10.1016/S0264-410X(02)00385-7; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Torgersen ML, 2005, FEBS J, V272, P4103, DOI 10.1111/j.1742-4658.2005.04835.x; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vingert B, 2006, EUR J IMMUNOL, V36, P1124, DOI 10.1002/eji.200535443; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yamazaki M, 2008, PLANT CELL PHYSIOL, V49, P142, DOI 10.1093/pcp/pcn006; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	104	277	283	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 26	2008	135	7					1175	1187		10.1016/j.cell.2008.12.009	http://dx.doi.org/10.1016/j.cell.2008.12.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109890	Bronze			2022-12-28	WOS:000261989800010
J	Clemente-Blanco, A; Mayan-Santos, M; Schneider, DA; Machin, F; Jarmuz, A; Tschochner, H; Aragon, L				Clemente-Blanco, Andres; Mayan-Santos, Maria; Schneider, David A.; Machin, Felix; Jarmuz, Adam; Tschochner, Herbert; Aragon, Luis			Cdc14 inhibits transcription by RNA polymerase I during anaphase	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME CONDENSATION; NUCLEOLAR SEGREGATION; RIBOSOMAL DNA; MITOTIC EXIT; CELL-CYCLE; RDNA; PHOSPHATASE; MITOSIS	Chromosome condensation and the global repression of gene transcription(1) are features of mitosis inmost eukaryotes. The logic behind this phenomenon is that chromosome condensation prevents the activity of RNA polymerases. In budding yeast, however, transcription was proposed to be continuous during mitosis(2). Here we show that Cdc14, a protein phosphatase required for nucleolar segregation(3) and mitotic exit(4), inhibits transcription of yeast ribosomal genes (rDNA) during anaphase. The phosphatase activity of Cdc14 is required for RNA polymerase I (Pol I) inhibition in vitro and in vivo. Moreover Cdc14-dependent inhibition involves nucleolar exclusion of Pol I subunits. We demonstrate that transcription inhibition is necessary for complete chromosome disjunction, because ribosomal RNA (rRNA) transcripts block condensin binding to rDNA, and show that bypassing the role of Cdc14 in nucleolar segregation requires in vivo degradation of nascent transcripts. Our results show that transcription interferes with chromosome condensation, not the reverse. We conclude that budding yeast, like most eukaryotes, inhibit Pol I transcription before segregation as a prerequisite for chromosome condensation and faithful genome separation.	[Clemente-Blanco, Andres; Mayan-Santos, Maria; Machin, Felix; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, London W12 0NN, England; [Schneider, David A.] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Tschochner, Herbert] Univ Regensburg, Inst Biochem Mikrobiol & Genet, Munich, Germany	Imperial College London; University of Alabama System; University of Alabama Birmingham; University of Regensburg	Aragon, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Cell Cycle Grp, Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Mayán, María D./AAR-9227-2021; Blanco, Andrés Clemente/D-4255-2014; Machín, Félix/K-6569-2017; Mayan, Maria D./C-8813-2012	Mayán, María D./0000-0002-5809-9440; Blanco, Andrés Clemente/0000-0002-3674-0671; Machín, Félix/0000-0003-4559-7798; Mayan, Maria D./0000-0002-5809-9440; Schneider, David/0000-0003-0635-5091	Medical Research Council of the UK; UAB HSF-GEF; La Junta de Extremadura; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UAB HSF-GEF; La Junta de Extremadura; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Amon, D. Morgan, K. Kitamoto and J. Van Etten for providing reagents, and M. Nomura for advice. We thank members of the Aragon laboratory for discussions. Weacknowledge grant support from UAB HSF-GEF to D. A. S. and from 'La Junta de Extremadura' to A. C.-B. The Aragon laboratory is supported by the Medical Research Council of the UK.	Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; D'Amours D, 2004, CELL, V117, P455, DOI 10.1016/S0092-8674(04)00413-1; ELLIOTT SG, 1979, MOL GEN GENET, V169, P237, DOI 10.1007/BF00382269; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; FUJII T, 1995, BIOSCI BIOTECH BIOCH, V59, P1869, DOI 10.1271/bbb.59.1869; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; GRANOT D, 1991, CELL MOTIL CYTOSKEL, V20, P47, DOI 10.1002/cm.970200106; Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Machin F, 2005, J CELL BIOL, V168, P209, DOI 10.1083/jcb.200408087; Machin F, 2006, J CELL BIOL, V173, P893, DOI 10.1083/jcb.200511129; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tomson BN, 2006, MOL CELL BIOL, V26, P6239, DOI 10.1128/MCB.00693-06; Torres-Rosell J, 2004, CELL CYCLE, V3, P496; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wang BD, 2004, CELL CYCLE, V3, P960; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292	30	94	95	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					219	U8		10.1038/nature07652	http://dx.doi.org/10.1038/nature07652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19158678	Green Accepted			2022-12-28	WOS:000264059700047
J	Leidel, S; Pedrioli, PGA; Bucher, T; Brost, R; Costanzo, M; Schmidt, A; Aebersold, R; Boone, C; Hofmann, K; Peter, M				Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Brost, Renee; Costanzo, Michael; Schmidt, Alexander; Aebersold, Ruedi; Boone, Charles; Hofmann, Kay; Peter, Matthias			Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA	NATURE			English	Article							PROTEIN CONJUGATION; STATISTICAL-MODEL; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BIOSYNTHESIS; YEAST; IDENTIFICATION; THIAMIN; TANDEM; GENES	Ubiquitin-like proteins (UBLs) can change protein function, localization or turnover by covalent attachment to lysine residues(1). Although UBLs achieve this conjugation through an intricate enzymatic cascade, their bacterial counterparts MoaD and ThiS function as sulphur carrier proteins(2,3). Here we show that Urm1p, the most ancient UBL3, acts as a sulphur carrier in the process of eukaryotic transfer RNA ( tRNA) modification, providing a possible evolutionary link between UBL and sulphur transfer. Moreover, we identify Uba4p, Ncs2p, Ncs6p and Yor251cp as components of this conserved pathway. Using in vitro assays, we show that Ncs6p binds to tRNA, whereas Uba4p first adenylates and then directly transfers sulphur onto Urm1p. Finally, functional analysis reveals that the thiolation function of Urm1p is critical to regulate cellular responses to nutrient starvation and oxidative stress conditions, most likely by increasing translation fidelity.	[Leidel, Sebastian; Pedrioli, Patrick G. A.; Bucher, Tamara; Peter, Matthias] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Brost, Renee; Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Schmidt, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Schmidt, Alexander; Aebersold, Ruedi; Peter, Matthias] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University of Toronto; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Institute for Systems Biology (ISB); Miltenyi Biotec	Peter, M (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	kay.hofmann@miltenyibiotec.de; matthias.peter@bc.biol.ethz.ch	Bucher, Tamara/AAR-9797-2020; Hofmann, Kay/D-6714-2011; Schmidt, Alexander/D-6426-2011; Leidel, Sebastian/K-9507-2019	Bucher, Tamara/0000-0003-3244-5867; Hofmann, Kay/0000-0002-2289-9083; Schmidt, Alexander/0000-0002-3149-2381; Leidel, Sebastian/0000-0002-0523-6325; Peter, Matthias/0000-0002-2160-6824	EuroDyna; Roche Research Foundation; ETHZ; SNF; Canadian Institutes of Health Research; Genome Canada through the Ontario Genomics Institute	EuroDyna; Roche Research Foundation; ETHZ(ETH Zurich); SNF; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	We thank C. Rupp for technical support, M. Sohrmann for yeast strains, G. Rabut for the gift of the pGR51 plasmid, G. L. Igloi and K.-H. Altmann for providing APM, S. Mitani for tut-1(tm1297), B. Casado-Fernandez and D. Hilvert for discussion and technical advice, and T. Kurz and J. D. Alfonzo for reading the manuscript. This work was supported by grants from EuroDyna ( to S. L.), the Roche Research Foundation ( to P. G. A. P.), ETHZ ( to S. L. and M. P.), the SNF ( to M. P.), the Canadian Institutes of Health Research ( to C. B.) and Genome Canada through the Ontario Genomics Institute ( to C. B.).	Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; BRENNER S, 1974, GENETICS, V77, P71; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mueller EG, 1999, PROTEIN SCI, V8, P2424; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tong A. H. Y., 2007, METHD MICROBIOL, V36, p[369, 706]; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Xu JJ, 2006, P NATL ACAD SCI USA, V103, P11625, DOI 10.1073/pnas.0604876103	49	197	212	4	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					228	U9		10.1038/nature07643	http://dx.doi.org/10.1038/nature07643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19145231				2022-12-28	WOS:000264059700049
J	Rothman, JS; Cathala, L; Steuber, V; Silver, RA				Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus			Synaptic depression enables neuronal gain control	NATURE			English	Article							SHUNTING INHIBITION; PYRAMIDAL NEURONS; NMDA RECEPTORS; SINGLE; NOISE; TRANSMISSION; INVARIANCE; SYNAPSES; CELLS; MODEL	To act as computational devices, neurons must perform mathematical operations as they transform synaptic and modulatory input into output firing rate(1). Experiments and theory indicate that neuronal firing typically represents the sum of synaptic inputs(1-3), an additive operation, but multiplication of inputs is essential for many computations(1). Multiplication by a constant produces a change in the slope, or gain, of the input - output relationship, amplifying or scaling down the sensitivity of the neuron to changes in its input. Such gain modulation occurs in vivo, during contrast invariance of orientation tuning(4), attentional scaling(5), translation- invariant object recognition(6), auditory processing(7) and coordinate transformations(8,9). Moreover, theoretical studies highlight the necessity of gain modulation in several of these tasks(9-11). Although potential cellular mechanisms for gain modulation have been identified, they often rely on membrane noise and require restrictive conditions to work(3,12-18). Because nonlinear components are used to scale signals in electronics, we examined whether synaptic nonlinearities are involved in neuronal gain modulation. We used synaptic stimulation and the dynamic- clamp technique to investigate gain modulation in granule cells in acute slices of rat cerebellum. Here we show that when excitation is mediated by synapses with short- term depression ( STD), neuronal gain is controlled by an inhibitory conductance in a noise-independent manner, allowing driving and modulatory inputs to be multiplied together. The nonlinearity introduced by STD transforms inhibition- mediated additive shifts in the input - output relationship into multiplicative gain changes. When granule cells were driven with bursts of high- frequency mossy fibre input, as observed in vivo(19,20), larger inhibition- mediated gain changes were observed, as expected with greater STD. Simulations of synaptic integration in more complex neocortical neurons suggest that STD- based gain modulation can also operate in neurons with large dendritic trees. Our results establish that neurons receiving depressing excitatory inputs can act as powerful multiplicative devices even when integration of postsynaptic conductances is linear.	[Rothman, Jason S.; Cathala, Laurence; Steuber, Volker; Silver, R. Angus] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Steuber, Volker/0000-0003-0186-3580; Silver, Robin/0000-0002-5480-6638; Rothman, Jason/0000-0003-3036-2291	Wellcome Trust; MRC [G0400598]; EU EUSynapse [LSHM-CT-2005-019055]; Wellcome Senior Research Fellowship; BBSRC [BB/F005369/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005369/1] Funding Source: researchfish; Medical Research Council [G0400598] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EUSynapse; Wellcome Senior Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This was supported by the Wellcome Trust, MRC (G0400598) and EU (EUSynapse, LSHM-CT-2005-019055). R.A.S. is in receipt of a Wellcome Senior Research Fellowship. We thank P. Gleeson for help with neuroConstruct, D. Ward and R. Kanichay for their experimental support, D. Digregorio and P. Kirkby for discussions, and A. Arenz, D. Attwell, G. Billings, E. Chaigneau, D. DiGregorio, M. Farrant, F. Minneci and K. Vervaeke for their comments on the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Berends M, 2005, NEURAL COMPUT, V17, P2531, DOI 10.1162/089976605774320520; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Cathala L, 2003, J NEUROSCI, V23, P6074, DOI 10.1523/JNEUROSCI.23-14-06074.2003; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gleeson P, 2007, NEURON, V54, P219, DOI 10.1016/j.neuron.2007.03.025; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Koch Christof, 1999, P1; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Murphy BK, 2003, J NEUROSCI, V23, P10040; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SALINAS E, 1995, J NEUROSCI, V15, P6461; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tiesinga PHE, 2000, PHYS REV E, V62, P8413, DOI 10.1103/PhysRevE.62.8413; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P5495; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varela JA, 1997, J NEUROSCI, V17, P7926; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003	44	157	157	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1015	U6		10.1038/nature07604	http://dx.doi.org/10.1038/nature07604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19145233	Green Accepted			2022-12-28	WOS:000263425400043
J	Panickar, J; Lakhanpaul, M; Lambert, PC; Kenia, P; Stephenson, T; Smyth, A; Grigg, J				Panickar, Jayachandran; Lakhanpaul, Monica; Lambert, Paul C.; Kenia, Priti; Stephenson, Terence; Smyth, Alan; Grigg, Jonathan			Oral Prednisolone for Preschool Children with Acute Virus-Induced Wheezing.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY ASSESSMENT MEASURE; ACUTE ASTHMA; YOUNG; RHINOVIRUS; INFECTION; CHILDHOOD; TODDLERS; EFFICACY; INDEX	Background: Attacks of wheezing induced by upper respiratory viral infections are common in preschool children between the ages of 10 months and 6 years. A short course of oral prednisolone is widely used to treat preschool children with wheezing who present to a hospital, but there is conflicting evidence regarding its efficacy in this age group. Methods: We conducted a randomized, double-blind, placebo-controlled trial comparing a 5-day course of oral prednisolone (10 mg once a day for children 10 to 24 months of age and 20 mg once a day for older children) with placebo in 700 children between the ages of 10 months and 60 months. The children presented to three hospitals in England with an attack of wheezing associated with a viral infection; 687 children were included in the intention-to-treat analysis (343 in the prednisolone group and 344 in the placebo group). The primary outcome was the duration of hospitalization. Secondary outcomes were the score on the Preschool Respiratory Assessment Measure, albuterol use, and a 7-day symptom score. Results: There was no significant difference in the duration of hospitalization between the placebo group and the prednisolone group (13.9 hours vs. 11.0 hours; ratio of geometric means, 0.90; 95% confidence interval, 0.77 to 1.05) or in the interval between hospital admission and signoff for discharge by a physician. In addition, there was no significant difference between the two study groups for any of the secondary outcomes or for the number of adverse events. Conclusions: In preschool children presenting to a hospital with mild-to-moderate wheezing associated with a viral infection, oral prednisolone was not superior to placebo.	[Grigg, Jonathan] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, Ctr Pediat, London E1 2AT, England; [Panickar, Jayachandran; Lakhanpaul, Monica; Kenia, Priti] Univ Leicester, Div Child Hlth, Leicester, Leics, England; [Lambert, Paul C.] Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Leicester, Leics, England; [Stephenson, Terence; Smyth, Alan] Univ Nottingham, Univ Hosp Queens Med Ctr, Nottingham NG7 2RD, England	University of London; Queen Mary University London; University of Leicester; University of Leicester; University of Nottingham	Grigg, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, Ctr Pediat, 4 Newark St, London E1 2AT, England.	j.grigg@qmul.ac.uk		Smyth, Alan/0000-0001-5494-5438; Grigg, Jonathan/0000-0003-3109-6028; Lambert, Paul/0000-0002-5337-663X; Lakhanpaul, Monica/0000-0002-9855-2043; Stephenson, Terence/0000-0001-8871-7847	Asthma UK [04/039]; AstraZeneca UK; Novartis; Profile Pharma; Boehringer; Roche; Forest Laboratories; Boots Healthcare and Forest Laboratories; GlaxoSmithKline	Asthma UK; AstraZeneca UK(AstraZeneca); Novartis(Novartis); Profile Pharma; Boehringer(Boehringer Ingelheim); Roche(Roche Holding); Forest Laboratories; Boots Healthcare and Forest Laboratories; GlaxoSmithKline(GlaxoSmithKline)	Supported by a grant (04/039) from Asthma UK. Dr. Lakhanpaul reports receiving travel support from AstraZeneca UK to attend a scientific meeting; Dr. Smyth, receiving consulting fees from Novartis, Profile Pharma, and Boehringer, lecture fees from Roche and Forest Laboratories, and research grants from Boots Healthcare and Forest Laboratories; and Dr. Grigg, receiving a lecture fee from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported. We thank Dr. Jane Clarke, who was chair of the data and safety monitoring committee, and Natasha Lafond for her support during the trial.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Chalut DS, 2000, J PEDIATR-US, V137, P762, DOI 10.1067/mpd.2000.110121; Csonka P, 2003, J PEDIATR-US, V143, P725, DOI 10.1067/S0022-3476(03)00498-0; Ducharme FM, 2008, J PEDIATR-US, V152, P476, DOI 10.1016/j.jpeds.2007.08.034; Efron B., 1994, INTRO BOOTSTRAP; Grigg J, 2006, EUR RESPIR MONOGR, P153, DOI 10.1183/1025448x.00037011; Jartti T, 2007, PEDIATR PULM, V42, P1125, DOI 10.1002/ppul.20706; Jartti T, 2006, PEDIATR INFECT DIS J, V25, P482, DOI 10.1097/01.inf.0000215226.69696.0c; Kuehni C, 2001, LANCET, V358, P846; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; Maclennan C, 2006, PEDIATR PULM, V41, P577, DOI 10.1002/ppul.20415; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matricardi PM, 2008, EUR RESPIR J, V32, P585, DOI 10.1183/09031936.00066307; National Heart Lung and Blood Institute. National Asthma Education and Prevention Program, 2007, 3 NAT HEART LUNG BLO; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Rowe BH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002178; Rowe BH, 2001, COCHRANE DB SYST REV, V1; Saglani S, 2007, SEMIN RESP CRIT CARE, V28, P272, DOI 10.1055/s-2007-981648; Smith M., 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD002886; Stafler P, 2007, NEW ENGL J MED, V357, P1659; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; TAL A, 1990, PEDIATRICS, V86, P350; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; Weinberger M, 2007, J ALLERGY CLIN IMMUN, V119, P567, DOI 10.1016/j.jaci.2006.12.641; 2007, GLOBAL STRATEGY ASTH	27	224	230	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					329	338		10.1056/NEJMoa0804897	http://dx.doi.org/10.1056/NEJMoa0804897			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19164186	Green Submitted, Green Published			2022-12-28	WOS:000262519900005
J	Paynter, NP; Chasman, DI; Buring, JE; Shiffman, D; Cook, NR; Ridker, PM				Paynter, Nina P.; Chasman, Daniel I.; Buring, Julie E.; Shiffman, Dov; Cook, Nancy R.; Ridker, Paul M.			Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; POLYMORPHISMS; REPLICATION; VALIDATION; MODELS	Background: Although genetic variation at chromosome 9p21.3 is associated with incident cardiovascular disease, it is unclear whether screening for this polymorphism improves risk prediction. Objective: To determine whether knowledge of variation at chromosome 9p21.3 provides predictive information beyond that from other readily available risk factors. Design: Prospective cohort study. Setting: United States. Patients: 22 129 female white health professionals participating in the Women's Genome Health Study, initially without any major chronic disease, who were prospectively followed over a median of 10.2 years for incident cardiovascular disease. Measurements: Polymorphism at rs10757274 in chromosome 9p21.3 and additional cardiovascular disease risk factors (blood pressure, smoking status, diabetes, blood levels of cholesterol, highsensitivity C-reactive protein, and family history of premature myocardial infarction). Results: Polymorphism at rs10757274 was associated with an adjusted hazard ratio for incident cardiovascular disease of 1.25 (95% CI, 1.04 to 1.51) for the AG genotype and 1.32 (CI, 1.07 to 1.63) for the GG genotype. However, the addition of the genotype to a prediction model based on traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction had no effect on model discrimination as measured by the c-index (0.807 to 0.809) and did not improve the Net Reclassification Improvement score (-0.2%; P = 0.59) or the Integrated Discrimination Improvement score (0.0; P = 0.18). Limitation: Study participants were all white women. Conclusion: In this large prospective cohort of white women, genetic variation in chromosome 9p21.3 was associated with incident cardiovascular disease but did not improve on the discrimination or classification of predicted risk achieved with traditional risk factors, high-sensitivity C-reactive protein, and family history of premature myocardial infarction.	[Paynter, Nina P.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Celera, Alameda, CA USA	Harvard University; Brigham & Women's Hospital	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	npaynter@partners.org			National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; Amgen; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; Leducq Foundation; Celera(Leducq Foundation); Roche Diagnostics; Amgen(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute and National Cancer Institute; Donald W. Reynolds Foundation; Leducq Foundation; Celera; Roche Diagnostics; and Amgen.	Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	22	195	199	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					65	U16		10.7326/0003-4819-150-2-200901200-00003	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153409	Green Accepted			2022-12-28	WOS:000262655200001
J	Lichtenstein, P; Yip, BH; Bjork, C; Pawitan, Y; Cannon, TD; Sullivan, PF; Hultman, CM				Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Cannon, Tyrone D.; Sullivan, Patrick F.; Hultman, Christina M.			Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study	LANCET			English	Article							GENOME SCAN METAANALYSIS; CANDIDATE GENES; BINARY TRAITS; RISK-FACTORS; I DISORDER; TWIN; SUSCEPTIBILITY; PSYCHOSIS; RELATIVES; REGISTER	Background Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete or shared causative processes is much debated in psychiatry. We aimed to assess genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and their comorbidity. Methods We linked the multi-generation register, which contains information about all children and their parents in Sweden, and the hospital discharge register, which includes all public psychiatric inpatient admissions in Sweden. We identified 9 009 202 unique individuals in more than 2 million nuclear families between 1973 and 2004. Risks for schizophrenia, bipolar disorder, and their comorbidity were assessed for biological and adoptive parents, offspring, full-siblings and half-siblings of probands with one of the diseases. We used a multivariate generalised linear mixed model for analysis of genetic and environmental contributions to liability for schizophrenia, bipolar disorder, and comorbidity. Findings First-degree relatives of probands with either schizophrenia (n=35 985) or bipolar disorder (n=40 487) were at increased risk of these disorders. Half-siblings had a significantly increased risk (schizophrenia: relative risk [RR] 3.6, 95% CI 2.3-5.5 for maternal half-siblings, and 2.7, 1. 9-3 . 8 for paternal half-siblings; bipolar disorder: 4.5, 2.7-7.4 for maternal half-siblings, and 2.4, 1.4-4-1 for paternal half-siblings), but substantially lower than that of the full-siblings (schizophrenia: 9.0, 8.5-11 .6; bipolar disorder: 7.9, 7.1-8.8). When relatives of probands with bipolar disorder were analysed, increased risks for schizophrenia existed for all relationships, including adopted children to biological parents with bipolar disorder. Heritability for schizophrenia and bipolar disorder was 64% and 59%, respectively. Shared environmental effects were small but substantial (schizophrenia: 4.5%, 4.4%-7.4%; bipolar disorder: 3.4%, 2.3%-6.2%) for both disorders. The comorbidity between disorders was mainly (63%) due to additive genetic effects common to both disorders. Interpretation Similar to molecular genetic studies, we showed evidence that schizophrenia and bipolar disorder partly share a common genetic cause. These results challenge the current nosological dichotomy between schizophrenia and bipolar disorder, and are consistent with a reappraisal of these disorders as distinct diagnostic entities. Funding Swedish Council for Working Life and Social Research, and the Swedish Research Council.	[Lichtenstein, Paul; Yip, Benjamin H.; Bjork, Camilla; Pawitan, Yudi; Sullivan, Patrick F.; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hultman, Christina M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Biobehav Sci, Los Angeles, CA 90024 USA	Karolinska Institutet; Uppsala University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lichtenstein, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	paul.lichtenstein@ki.se	Yip, Benjamin/AAC-7845-2019; YIP, Benjamin HK/I-2336-2013	Yip, Benjamin/0000-0002-4749-7611; lichtenstein, paul/0000-0003-3037-5287	NIMH NIH HHS [R01 MH077139] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1992, INT CLASS DIS; Arvidsson H, 2005, NORD J PSYCHIAT, V59, P186, DOI 10.1080/08039480510023061; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Carter CJ, 2007, SCHIZOPHRENIA BULL, V33, P1343, DOI 10.1093/schbul/sbm007; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; GENTZ A, 1992, J COMPUTATIONAL GRAP, V1, P141; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P952; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2006, PSYCHOL MED, V36, P1417, DOI 10.1017/S0033291706008385; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; McIntosh AM, 2005, BIOL PSYCHIAT, V58, P254, DOI 10.1016/j.biopsych.2005.03.044; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Pawitan Y., 2001, ALL LIKELIHOOD STAT; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; SAS Institute Inc, 2004, SAS STAT SOFTW VERS; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; *STAT SWED, 2006, MULT REG 2005 DESCR; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tsuang MT, 2004, J PSYCHIATR RES, V38, P3, DOI 10.1016/S0022-3956(03)00096-7; *WHO, 1978, INT CLASS DIS; World Health Organization, 1967, INT CLASS DIS; Yip BH, 2008, STAT MED, V27, P1086, DOI 10.1002/sim.2996	33	1398	1422	2	250	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					234	239		10.1016/S0140-6736(09)60072-6	http://dx.doi.org/10.1016/S0140-6736(09)60072-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150704	Green Accepted			2022-12-28	WOS:000262537500026
J	Rottingen, JA; Buss, PM; Davies, S; Toure, O				Rottingen, John-Arne; Buss, Paulo Marchiori; Davies, Sally; Toure, Oumar			Global-health research architecture-time for mergers?	LANCET			English	Editorial Material									[Rottingen, John-Arne] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Buss, Paulo Marchiori] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil; [Davies, Sally] Dept Hlth, London SE1 6TE, England; [Toure, Oumar] Minist Hlth, Bamako, Mali	Norwegian Knowledge Centre for Health Services; Fundacao Oswaldo Cruz	Rottingen, JA (corresponding author), Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway.	John-Arne.Rottingen@kunnskapssenteret.no						ANDREANO R, 2001, INT HLTH POLICY PROG; [Anonymous], 2004, MEXICO STATEMENT HLT; [Anonymous], 2008, BAMAKO CALL ACTION R; *COUNC HLTH RES DE, 2007, SUPP NAT HLTH RES SY; *GLOB FOR HLTH RES, 2008, BEC HLTH EQ IS PRIOR; *IN VACC RES, 2006, STRAT PLAN 2006 2009; *TDR WHO, 2007, 10 YEAR VIS STRAT; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; *WHO, 2008, WHO STRAT R IN PRESS; *WHO, 2008, GLOB STRAT PLAN ACT; *WHO, PROV FDN SEX REPR HL; *WHO ALL HLTH POL, 2006, KNOWL BETT HLTH SYST; World Health Organization, 1996, INV HLTH RES DEV REP	13	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 17	2009	373	9659					193	195		10.1016/S0140-6736(09)60054-4	http://dx.doi.org/10.1016/S0140-6736(09)60054-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150692	Green Accepted			2022-12-28	WOS:000262537500008
J	Kelly, JD; Fawcett, DP; Goldberg, LC				Kelly, John D.; Fawcett, Derek P.; Goldberg, Lawrence C.			Assessment and management of non-visible haematuria in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ASYMPTOMATIC MICROHEMATURIA; PREVALENCE; DISEASE; HYPERTENSION; MICROSCOPY; INFECTION		[Kelly, John D.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England; [Fawcett, Derek P.] Royal Berkshire Hosp, Harold Hopkins Dept Urol, Reading RG1 5AN, Berks, England; [Goldberg, Lawrence C.] Royal Sussex Cty Hosp, Sussex Kidney Unit, Brighton & Sussex Univ Hosp NHS Trust, Brighton BN2 5BE, E Sussex, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Berkshire Hospital; Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Kelly, JD (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England.	jk334@cam.ac.uk						Bellinghieri G, 2008, J RENAL NUTR, V18, P158, DOI 10.1053/j.jrn.2007.10.031; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DOWELL AC, 1990, BRIT J GEN PRACT, V40, P67; Edwards TJ, 2006, BJU INT, V97, P301, DOI 10.1111/j.1464-410X.2006.05976.x; FRENI SC, 1977, J CLIN PATHOL, V30, P336, DOI 10.1136/jcp.30.4.336; Friedman G D, 1995, J Med Screen, V2, P219; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; GONZALEZ CA, 1991, EUR J CANCER, V27, P498, DOI 10.1016/0277-5379(91)90395-T; Grossfeld GD, 2001, UROLOGY, V57, P599, DOI 10.1016/S0090-4295(01)00919-0; HIATT RA, 1994, CANCER EPIDEM BIOMAR, V3, P439; Hurlen M, 2006, THROMB RES, V118, P433, DOI 10.1016/j.thromres.2005.07.023; KANTOR AF, 1984, AM J EPIDEMIOL, V119, P510, DOI 10.1093/oxfordjournals.aje.a113768; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; KOHLER H, 1991, KIDNEY INT, V40, P115, DOI 10.1038/ki.1991.188; Kouri T, 2008, CLIN CHEM LAB MED, V46, P703, DOI 10.1515/CCLM.2008.122; Mishriki SF, 2008, UROLOGY, V71, P13, DOI 10.1016/j.urology.2007.08.031; MOHR DN, 1986, JAMA-J AM MED ASSOC, V256, P224, DOI 10.1001/jama.256.2.224; *NAT I HLTH CLIN E, 2008, CHRON KIDN DIS GUID; RAMAN GV, 1986, NEPHRON, V44, P304; Rodgers M, 2006, HEALTH TECHNOL ASSES, V10, pIII; *ROYAL COLL PHYS J, 2006, CHRON KIDN DIS AD UK; *SCOTT INT GUID NE, 1997, INV AS MICR HAEM AD; SINERT R, 1994, ANN EMERG MED, V23, P1301, DOI 10.1016/S0196-0644(94)70356-6; SUTTON JM, 1990, JAMA-J AM MED ASSOC, V263, P2475, DOI 10.1001/jama.263.18.2475; TIEBOSCH ATMG, 1987, KIDNEY INT, V32, P112, DOI 10.1038/ki.1987.179; Tsai JJ, 2005, AM J KIDNEY DIS, V46, P820, DOI 10.1053/j.ajkd.2005.07.039; VANSAVAGE JG, 1995, J UROLOGY, V153, P1594, DOI 10.1016/S0022-5347(01)67469-X; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214	31	27	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2009	338								a3021	10.1136/bmj.a3021	http://dx.doi.org/10.1136/bmj.a3021			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151065				2022-12-28	WOS:000263193500002
J	Schumacher, MA; Piro, KM; Xu, W; Hansen, S; Lewis, K; Brennan, RG				Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Hansen, Sonja; Lewis, Kim; Brennan, Richard G.			Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ELONGATION-FACTOR-TU; PERSISTER CELLS; AFFECTS LETHALITY; AFFECTS FREQUENCY; MUREIN SYNTHESIS; DNA-SYNTHESIS; INHIBITION; PEPTIDOGLYCAN; COMPLEX	Bacterial multidrug tolerance is largely responsible for the inability of antibiotics to eradicate infections and is caused by a small population of dormant bacteria called persisters. HipA is a critical Escherichia coli persistence factor that is normally neutralized by HipB, a transcription repressor, which also regulates hipBA expression. Here, we report multiple structures of HipA and a HipA-HipB-DNA complex. HipA has a eukaryotic serine/threonine kinase-like fold and can phosphorylate the translation factor EF-Tu, suggesting a persistence mechanism via cell stasis. The HipA-HipB-DNA structure reveals the HipB-operator binding mechanism, similar to 70 degrees DNA bending, and unexpected HipA-DNA contacts. Dimeric HipB interacts with two HipA molecules to inhibit its kinase activity through sequestration and conformational inactivation. Combined, these studies suggest mechanisms for HipA-mediated persistence and its neutralization by HipB.	[Schumacher, Maria A.; Piro, Kevin M.; Xu, Weijun; Brennan, Richard G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Hansen, Sonja; Lewis, Kim] Northeastern Univ, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Northeastern University; Northeastern University	Schumacher, MA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org; rgbrenna@mdanderson.org		Brennan, Richard/0000-0001-7647-485X	Burroughs Wellcome [992863]; NIH [GM074815, GM061162, AI048593]; Robert A. Welch Foundation [G0040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815, R01GM061162] Funding Source: NIH RePORTER	Burroughs Wellcome(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. R. Knudsen for her generous gift of the GST-EF-Tu expression construct. Coordinates and structure factor amplitudes for the apoHipA, HipA-ATP, HipA-HipB-DNA, and HipA(ATP)-HipB-DNA complexes have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (www.rcsb.org/) under accession codes 3DNU, 3DNT, 3DNV, and 3DNW, respectively. We acknowledge support from Burroughs Wellcome Career Development Award 992863 and NIH grant GM074815 (to M. A. S.), NIH grant GM061162 (to K. L.), and the Robert A. Welch Foundation (grant G0040) and NIH grant AI048593 (to R. G. B.).	ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; DeLano W.L, PYMOL MOL GRAPHICS S; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nyborg J, 1998, FEBS LETT, V430, P95, DOI 10.1016/S0014-5793(98)00624-3; Papapanagiotou I, 2007, NUCLEIC ACIDS RES, V35, P2643, DOI 10.1093/nar/gkm129; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; SHAH D, 2006, BMC MICROBIOL, V12, P6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	30	242	252	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					396	401		10.1126/science.1163806	http://dx.doi.org/10.1126/science.1163806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150849	Green Accepted			2022-12-28	WOS:000262481400043
J	Willis, JH				Willis, John H.			GENETICS Origin of Species in Overdrive	SCIENCE			English	Editorial Material							HYBRID STERILITY; EXPLANATION		[Willis, John H.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Willis, JH (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jwillis@duke.edu						Coyne J.A., 2004, SPECIATION; Darwin C., 1877, ORIGIN SPECIES; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HURST LD, 1991, GENETICS, V128, P841; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Orr HA, 2001, GENETICS, V158, P1089; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Trachtulec Z, 2008, GENETICS, V178, P1777, DOI 10.1534/genetics.107.082404	12	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2009	323	5912					350	351		10.1126/science.1169442	http://dx.doi.org/10.1126/science.1169442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394VP	19150836				2022-12-28	WOS:000262481400028
J	Detry, O; De Roover, A				Detry, Olivier; De Roover, Arnaud			Spider Angiomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Detry, Olivier; De Roover, Arnaud] Univ Liege, B-4000 Liege, Belgium	University of Liege	Detry, O (corresponding author), Univ Liege, B-4000 Liege, Belgium.	oli.detry@chu.ulg.ac.be	Detry, Olivier/I-9333-2019	Detry, Olivier/0000-0002-9436-6673					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2009	360	3					280	280		10.1056/NEJMicm0706361	http://dx.doi.org/10.1056/NEJMicm0706361			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	394GR	19144943				2022-12-28	WOS:000262434500010
J	Landefeld, CS; Steinman, MA				Landefeld, C. Seth; Steinman, Michael A.			The Neurontin legacy - Marketing through Misinformation and Manipulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Landefeld, C. Seth; Steinman, Michael A.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Landefeld, C. Seth; Steinman, Michael A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Landefeld, CS (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.							DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Dickersin K., 2008, REPORTING OTHER BIAS; Landefeld CS, 2004, AM J MED, V117, P876, DOI 10.1016/j.amjmed.2004.10.001; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008	4	81	82	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2009	360	2					103	106		10.1056/NEJMp0808659	http://dx.doi.org/10.1056/NEJMp0808659			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	391UG	19129523				2022-12-28	WOS:000262258300002
J	Munday, JN; Capasso, F; Parsegian, VA				Munday, J. N.; Capasso, Federico; Parsegian, V. Adrian			Measured long-range repulsive Casimir-Lifshitz forces	NATURE			English	Article							DER-WAALS FORCES; MU-M; ATTRACTION; PHYSICS; SOLIDS; SILICA	Quantum fluctuations create intermolecular forces that pervade macroscopic bodies(1-3). At molecular separations of a few nanometres or less, these interactions are the familiar van der Waals forces(4). However, as recognized in the theories of Casimir, Polder and Lifshitz(5-7), at larger distances and between macroscopic condensed media they reveal retardation effects associated with the finite speed of light. Although these long- range forces exist within all matter, only attractive interactions have so far been measured between material bodies(8-11). Here we show experimentally that, in accord with theoretical prediction(12), the sign of the force can be changed from attractive to repulsive by suitable choice of interacting materials immersed in a fluid. The measured repulsive interaction is found to be weaker than the attractive. However, in both cases the magnitude of the force increases with decreasing surface separation. Repulsive Casimir - Lifshitz forces could allow quantum levitation of objects in a fluid and lead to a new class of switchable nanoscale devices with ultra-low static friction(13-15).	[Capasso, Federico] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munday, J. N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Parsegian, V. Adrian] NIH, Bethesda, MD 20892 USA	Harvard University; Harvard University; National Institutes of Health (NIH) - USA	Capasso, F (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu	Munday, Jeremy N/E-6512-2016	Munday, Jeremy N/0000-0002-0881-9876	Center for Nanoscale Systems at Harvard University; Intramural Research Program of the NIH; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NSF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000241] Funding Source: NIH RePORTER	Center for Nanoscale Systems at Harvard University; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank D. Iannuzzi, R. Podgornik, J. Zimmerberg, S. M. Bezrukov and M. B. Romanowsky for discussions. This project was partially supported by the Center for Nanoscale Systems at Harvard University, and by the Intramural Research Program of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development. J.N.M. acknowledges support from the NSF.	[Anonymous], 1992, INTERMOLECULAR SURFA; Ball P, 2007, NATURE, V447, P772, DOI 10.1038/447772a; Bressi G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.041804; Bschorr O, 1999, J ACOUST SOC AM, V106, P3730, DOI 10.1121/1.428224; Capasso F, 2007, IEEE J SEL TOP QUANT, V13, P400, DOI 10.1109/JSTQE.2007.893082; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; CASIMIR HBG, 1948, PHYS REV, V73, P360, DOI 10.1103/PhysRev.73.360; Chan HB, 2001, SCIENCE, V291, P1941, DOI 10.1126/science.1057984; DERJAGUIN BV, 1956, Q REV CHEM SOC, V10, P295, DOI 10.1039/qr9561000295; DZYALOSHINSKII IE, 1961, ADV PHYS, V10, P165, DOI 10.1080/00018736100101281; Feiler AA, 2008, LANGMUIR, V24, P2274, DOI 10.1021/la7036907; Graham N, 2004, NUCL PHYS B, V677, P379, DOI 10.1016/j.nuclphysb.2003.11.001; Hamaker HC, 1937, PHYSICA, V4, P1058, DOI 10.1016/S0031-8914(37)80203-7; Hertlein C, 2008, NATURE, V451, P172, DOI 10.1038/nature06443; IANNUZZI D, 2005, Patent No. 20070066494; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Lee S, 2001, J COLLOID INTERF SCI, V243, P365, DOI 10.1006/jcis.2001.7901; Lee SW, 2002, COLLOID SURFACE A, V204, P43, DOI 10.1016/S0927-7757(01)01118-9; Leonhardt U, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/254; LIFSHITZ EM, 1956, SOV PHYS JETP-USSR, V2, P73; London F., 1937, T FARADAY SOC, V33, p8b, DOI DOI 10.1039/TF937330008B; Meurk A, 1997, LANGMUIR, V13, P3896, DOI 10.1021/la9610967; Milling A, 1996, J COLLOID INTERF SCI, V180, P460, DOI 10.1006/jcis.1996.0326; Milonni P. W., 1993, QUANTUM VACUUM INTRO; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; Munday JN, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.060102; Munday JN, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.032109; Parsegian V. A., 2006, VANDERWAALS FORCES H; SABISKY ES, 1973, PHYS REV A, V7, P790, DOI 10.1103/PhysRevA.7.790; VANBLOKLAND PHGM, 1978, J CHEM SOC FARAD T 1, V74, P2637, DOI 10.1039/f19787402637	30	466	480	4	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2009	457	7226					170	173		10.1038/nature07610	http://dx.doi.org/10.1038/nature07610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393GS	19129843	Green Accepted			2022-12-28	WOS:000262360200027
J	Bradley, TD; Floras, JS				Bradley, T. Douglas; Floras, John S.			Obstructive sleep apnoea and its cardiovascular consequences	LANCET			English	Review							POSITIVE AIRWAY PRESSURE; HEART-FAILURE PATIENTS; CORONARY-ARTERY-DISEASE; SYMPATHETIC-NERVE ACTIVITY; LEFT-VENTRICULAR FUNCTION; C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIAC-ARRHYTHMIAS; INSULIN-RESISTANCE; CONTROLLED-TRIAL	Obstructive sleep apnoea (OSA) is a common disorder in which repetitive apnoeas expose the cardiovascular system to cycles of hypoxia, exaggerated negative intrathoracic pressure, and arousals. These noxious stimuli can, in turn, depress myocardial contractility activate the sympathetic nervous system, raise blood pressure, heart rate, and myocardial wall stress, depress parasympathetic activity, provoke oxidative stress and systemic inflammation, activate platelets, and impair vascular endothelial function. Epidemiological studies have shown significant independent associations between OSA and hypertension, coronary artery disease, arrhythmias, heart failure, and stroke. In randomised trials, treating OSA with continuous positive airway pressure lowered blood pressure, attenuated signs of early atherosclerosis, and, in patients with heart failure, improved cardiac function. Current data therefore suggest that OSA increases the risk of developing cardiovascular diseases, and that its treatment has the potential to diminish such risk. However, large-scale randomised trials are needed to determine, definitively, whether treating OSA improves cardiovascular outcomes.	[Bradley, T. Douglas; Floras, John S.] Toronto Gen Hosp, Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Bradley, T. Douglas; Floras, John S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Bradley, T. Douglas; Floras, John S.] Toronto Gen Hosp, Ctr Sleep Med & Circadian Biol, Toronto, ON M5G 2C4, Canada; [Bradley, T. Douglas] Toronto Rehabil Inst, Sleep Res Lab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Bradley, TD (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada.	douglas.bradley@utoronto.ca	Floras, John S./D-4042-2015		Canadian Institutes of Health Research [MOP-82731]; Canada Research Chair in Integrative Cardiovascular Biology; Career Investigator Award; Heart and Stroke Foundation of Ontario, Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Integrative Cardiovascular Biology(Canada Research Chairs); Career Investigator Award; Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario)	This paper is supported by a grant from the Canadian Institutes of Health Research (MOP-82731). JSF is supported by a Canada Research Chair in Integrative Cardiovascular Biology and a Career Investigator Award from the Heart and Stroke Foundation of Ontario, Canada.	Alajmi M, 2007, LUNG, V185, P67, DOI 10.1007/s00408-006-0117-x; Amin RS, 2002, AM J RESP CRIT CARE, V165, P1395, DOI 10.1164/rccm.2105118; Arabi Y, 1999, J APPL PHYSIOL, V87, P689, DOI 10.1152/jappl.1999.87.2.689; Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Arzt M, 2006, AM J RESP CRIT CARE, V173, P1300, DOI 10.1164/rccm.200511-1745PP; Arzt M, 2006, ARCH INTERN MED, V166, P1716, DOI 10.1001/archinte.166.16.1716; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barnes M, 2004, AM J RESP CRIT CARE, V170, P656, DOI 10.1164/rccm.200311-1571OC; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; BEDWELL S, 1989, BIOCHEM J, V262, P707, DOI 10.1042/bj2620707; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; BOKINSKY G, 1995, CHEST, V108, P625, DOI 10.1378/chest.108.3.625; Bonsignore MR, 1997, SLEEP, V20, P1167; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Bradley TD, 2001, CHEST, V119, P1827, DOI 10.1378/chest.119.6.1827; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Buxbaum SG, 2002, GENET EPIDEMIOL, V22, P243, DOI 10.1002/gepi.0170; Campos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459; CARGILL RI, 1995, CLIN SCI, V89, P165, DOI 10.1042/cs0890165; Carlson JT, 1996, J HYPERTENS, V14, P577, DOI 10.1097/00004872-199605000-00006; Chan J, 1997, CHEST, V111, P1488, DOI 10.1378/chest.111.6.1488; Chin K, 1996, AM J RESP CRIT CARE, V153, P1972, DOI 10.1164/ajrccm.153.6.8665063; Chiu KL, 2006, AM J RESP CRIT CARE, V174, P1378, DOI 10.1164/rccm.200607-927OC; Dimsdale JE, 2000, HYPERTENSION, V35, P144, DOI 10.1161/01.HYP.35.1.144; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Egea CJ, 2008, SLEEP MED, V9, P660, DOI 10.1016/j.sleep.2007.06.018; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Ferguson KA, 1996, CHEST, V109, P1269, DOI 10.1378/chest.109.5.1269; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; FLEMONS WW, 1993, AM REV RESPIR DIS, V148, P618, DOI 10.1164/ajrccm/148.3.618; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLETCHER EC, 1985, ANN INTERN MED, V103, P190, DOI 10.7326/0003-4819-103-2-190; Fletcher EC, 1999, AM J RESP CRIT CARE, V160, P1688, DOI 10.1164/ajrccm.160.5.9810003; Floras JS, 2007, HYPERTENSION, V50, P289, DOI 10.1161/HYPERTENSIONAHA.107.092106; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gami AS, 2005, NEW ENGL J MED, V352, P1206, DOI 10.1056/NEJMoa041832; Garrigue S, 2002, NEW ENGL J MED, V346, P404, DOI 10.1056/NEJMoa011919; Gilman MR, 2008, CLIN SCI, V114, P243, DOI 10.1042/CS20070172; GONZALEZROTHI RJ, 1988, CHEST, V94, P531, DOI 10.1378/chest.94.3.531; Good DC, 1996, STROKE, V27, P252, DOI 10.1161/01.STR.27.2.252; Gotsopoulos H, 2004, SLEEP, V27, P934, DOI 10.1093/sleep/27.5.934; Grimm W, 1996, AM J CARDIOL, V77, P1310, DOI 10.1016/S0002-9149(96)00197-X; Guilleminault C, 1980, Adv Intern Med, V26, P347; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; HORNER RL, 1995, J APPL PHYSIOL, V79, P151, DOI 10.1152/jappl.1995.79.1.151; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; Hsu CY, 2006, J NEUROL NEUROSUR PS, V77, P1143, DOI 10.1136/jnnp.2005.086686; Imadojemu VA, 2002, AM J RESP CRIT CARE, V165, P950, DOI 10.1164/ajrccm.165.7.2102003; Ip MSM, 2001, CHEST, V119, P62, DOI 10.1378/chest.119.1.62; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P2166, DOI 10.1164/ajrccm.162.6.2002126; Javaheri S, 2006, INT J CARDIOL, V106, P21, DOI 10.1016/j.ijcard.2004.12.068; Kanagala R, 2003, CIRCULATION, V107, P2589, DOI 10.1161/01.CIR.0000068337.25994.21; Kaneko Y, 2003, SLEEP, V26, P293, DOI 10.1093/sleep/26.3.293; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; KATO H, 1988, CIRCULATION, V77, P407, DOI 10.1161/01.CIR.77.2.407; Kato M, 2000, CIRCULATION, V102, P2607; KLINGELHOFER J, 1992, STROKE, V23, P1427, DOI 10.1161/01.STR.23.10.1427; Krahn AD, 2006, J AM COLL CARDIOL, V47, P379, DOI 10.1016/j.jacc.2005.09.026; KUSUOKA H, 1986, CIRC RES, V59, P270, DOI 10.1161/01.RES.59.3.270; Leung RST, 2005, SLEEP, V28, P1543, DOI 10.1093/sleep/28.12.1543; Li KK, 2000, LARYNGOSCOPE, V110, P1689, DOI 10.1097/00005537-200010000-00022; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Luthje L, 2005, AM J RESP CRIT CARE, V172, P118, DOI 10.1164/rccm.200409-1258OC; MANCIA G, 1993, NEW ENGL J MED, V328, P347, DOI 10.1056/NEJM199302043280511; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marney AM, 2007, CLIN SCI, V113, P267, DOI 10.1042/CS20070123; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Milleron O, 2004, EUR HEART J, V25, P728, DOI 10.1016/j.ehj.2004.02.008; Minoguchi K, 2005, AM J RESP CRIT CARE, V172, P625, DOI 10.1164/rccm.200412-1652OC; Minoguchi K, 2007, AM J RESP CRIT CARE, V175, P612, DOI 10.1164/rccm.200608-1141OC; Mooe T, 1996, CHEST, V109, P659, DOI 10.1378/chest.109.3.659; Mooe T, 1996, AM J MED, V101, P251, DOI 10.1016/S0002-9343(96)00122-2; Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nakashima H, 2006, EUR HEART J, V27, P2317, DOI 10.1093/eurheartj/ehl219; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Niroumand M, 2001, AM J RESP CRIT CARE, V163, P1632, DOI 10.1164/ajrccm.163.7.2007014; NODA A, 1995, CHEST, V107, P1538, DOI 10.1378/chest.107.6.1538; Norman D, 2006, HYPERTENSION, V47, P840, DOI 10.1161/01.HYP.0000217128.41284.78; Oliven A, 2003, J APPL PHYSIOL, V95, P2023, DOI 10.1152/japplphysiol.00203.2003; Oltmanns KM, 2004, AM J RESP CRIT CARE, V169, P1231, DOI 10.1164/rccm.200308-1200OC; Parker JD, 1999, AM J RESP CRIT CARE, V160, P1888, DOI 10.1164/ajrccm.160.6.9807074; Peker Y, 1999, EUR RESPIR J, V14, P179, DOI 10.1034/j.1399-3003.1999.14a30.x; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Pepin JL, 2005, EUR RESPIR J, V25, P343, DOI 10.1183/09031936.05.00132703; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; RANGEMARK C, 1995, SLEEP, V18, P188, DOI 10.1093/sleep/18.3.188; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Roche F, 2003, PACE, V26, P669, DOI 10.1046/j.1460-9592.2003.00116.x; Ruttanaumpawan P, 2008, J HYPERTENS, V26, P1163, DOI 10.1097/HJH.0b013e3282fb81ed; Ryan CM, 2005, THORAX, V60, P781, DOI 10.1136/thx.2005.040972; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2006, AM J RESP CRIT CARE, V174, P824, DOI 10.1164/rccm.200601-066OC; Sampol G, 2003, AM J RESP CRIT CARE, V168, P1528, DOI 10.1164/rccm.200304-566OC; Sandberg O, 2001, EUR RESPIR J, V18, P630, DOI 10.1183/09031936.01.00070301; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; SCHARF SM, 1992, AM REV RESPIR DIS, V146, P321, DOI 10.1164/ajrccm/146.2.321; SCHARF SM, 1981, CIRCULATION, V63, P871, DOI 10.1161/01.CIR.63.4.871; Schulz R, 2000, AM J RESP CRIT CARE, V162, P566, DOI 10.1164/ajrccm.162.2.9908091; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Sher AE, 2002, SLEEP MED REV, V6, P195, DOI 10.1053/smrv.2002.0242; Shiota S, 2007, THORAX, V62, P868, DOI 10.1136/thx.2006.071183; Simantirakis EN, 2004, EUR HEART J, V25, P1070, DOI 10.1016/j.ehj.2004.04.017; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Sin DD, 2003, CHEST, V123, P1536, DOI 10.1378/chest.123.5.1536; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Spaak J, 2005, HYPERTENSION, V46, P1327, DOI 10.1161/01.HYP.0000193497.45200.66; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Steiner S, 2005, CARDIOLOGY, V104, P92, DOI 10.1159/000086729; STOOHS R, 1992, J APPL PHYSIOL, V72, P583, DOI 10.1152/jappl.1992.72.2.583; SULLIVAN CE, 1981, LANCET, V1, P862; TILKIAN AG, 1977, AM J MED, V63, P348, DOI 10.1016/0002-9343(77)90272-8; Tkacova R, 1998, CIRCULATION, V98, P2269, DOI 10.1161/01.CIR.98.21.2269; Usui K, 2005, J AM COLL CARDIOL, V45, P2008, DOI 10.1016/j.jacc.2004.12.080; Usui K, 2006, AM J RESP CRIT CARE, V173, P1170, DOI 10.1164/rccm.200503-320OC; Vongpatanasin W, 2007, CIRCULATION, V115, P1020, DOI 10.1161/CIRCULATIONAHA.106.664854; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; West SD, 2007, THORAX, V62, P969, DOI 10.1136/thx.2006.074351; WHITE DP, 1985, J APPL PHYSIOL, V59, P384, DOI 10.1152/jappl.1985.59.2.384; Wright J, 1997, BRIT MED J, V314, P851; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Yoshinaga K, 2007, J AM COLL CARDIOL, V49, P450, DOI 10.1016/j.jacc.2006.08.059; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Yumino Dai, 2008, Proc Am Thorac Soc, V5, P226, DOI 10.1513/pats.200708-129MG; Yumino D, 2007, AM J CARDIOL, V99, P26, DOI 10.1016/j.amjcard.2006.07.055; ZWILLICH C, 1982, J CLIN INVEST, V69, P1286, DOI 10.1172/JCI110568	161	904	932	6	150	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2009	373	9657					82	93		10.1016/S0140-6736(08)61622-0	http://dx.doi.org/10.1016/S0140-6736(08)61622-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SK	19101028				2022-12-28	WOS:000262183800034
J	Kimmelman, J; Weijer, C; Meslin, EM				Kimmelman, Jonathan; Weijer, Charles; Meslin, Eric M.			Helsinki discords: FDA, ethics, and international drug trials	LANCET			English	Editorial Material									[Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada; [Kimmelman, Jonathan] McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON, Canada; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46204 USA	McGill University; McGill University; Western University (University of Western Ontario); Western University (University of Western Ontario); Indiana University System; Indiana University-Purdue University Indianapolis	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074	FOGARTY INTERNATIONAL CENTER [R25TW006070] Funding Source: NIH RePORTER; FIC NIH HHS [R25TW006070] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ASCHCROFT RE, 2007, OXFORD TXB CLIN RES; *FOOD DRUG ADM, 2008, FED REG         0428, P22800; *FOOD DRUG ADM, 2001, GUID IND ACC FOR STU; Friedmann T, 2008, MOL THER, V16, P1643, DOI 10.1038/mt.2008.193; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES, VI; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; World Medical Association, 2008, DECL HELS	9	35	36	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 3	2009	373	9657					13	14		10.1016/S0140-6736(08)61936-4	http://dx.doi.org/10.1016/S0140-6736(08)61936-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	390SK	19121708				2022-12-28	WOS:000262183800010
J	Safdar, N; Abad, CL; Narayan, S; Kaul, DR; Saint, S				Safdar, Nasia; Abad, Cybele L.; Narayan, Shoba; Kaul, Daniel R.; Saint, Sanjay			Keeping an Open Mind	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRYPTOCOCCAL MENINGITIS; AGGLUTINATION; RECIPIENTS; NEOFORMANS; ANTIGEN		[Safdar, Nasia; Abad, Cybele L.; Narayan, Shoba] Univ Wisconsin, Ctr Clin Sci, Div Infect Dis, Sch Med,Dept Med, Madison, WI 53792 USA; [Kaul, Daniel R.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Dept Vet Affairs Hlth Serv Res & Dev Ctr Excellen, Ann Arbor, MI USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Safdar, N (corresponding author), Univ Wisconsin, Ctr Clin Sci, Div Infect Dis, Sch Med,Dept Med, H4-572 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	ns2@medicine.wisc.edu	Saint, Sanjay/AAF-5126-2019		National Institutes of Health to the University of Wisconsin School of Medicine and Public Health [5 K12 AG019247-05]; Society of Critical Care Medicine; Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs; NATIONAL INSTITUTE ON AGING [K12AG019247] Funding Source: NIH RePORTER	National Institutes of Health to the University of Wisconsin School of Medicine and Public Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Critical Care Medicine; Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a K12 institutional training grant (5 K12 AG019247-05) from the National Institutes of Health to the University of Wisconsin School of Medicine and Public Health and a grant from the Society of Critical Care Medicine (to Dr. Safdar), and an Advanced Career Development Award from the Health Services Research and Development Program of the Department of Veterans Affairs (to Dr. Saint).; No potential conflict of interest relevant to this article was reported.; We thank Dr. Christina Hull and Joanne Ekena for performing serotyping PCR on the cryptococcus isolate.	BLOOMFIELD N, 1963, P SOC EXP BIOL MED, V114, P64, DOI 10.3181/00379727-114-28586; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cohen Bruce A, 2005, Curr Neurol Neurosci Rep, V5, P429, DOI 10.1007/s11910-005-0030-3; CURRIE BP, 1993, J CLIN MICROBIOL, V31, P2519, DOI 10.1128/JCM.31.9.2519-2522.1993; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; Gendelman HE, 2005, LANCET NEUROL, V4, P12, DOI 10.1016/S1474-4422(04)00951-2; Hajjeh RA, 1999, J INFECT DIS, V179, P449, DOI 10.1086/314606; JOHN GT, 1994, TRANSPLANTATION, V58, P855, DOI 10.1097/00007890-199410150-00020; LEVITZ SM, 1991, REV INFECT DIS, V13, P1163; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Redelmeier DA, 2005, ANN INTERN MED, V142, P115, DOI 10.7326/0003-4819-142-2-200501180-00010; STAMM AM, 1980, JAMA-J AM MED ASSOC, V244, P1359, DOI 10.1001/jama.244.12.1359; Vilchez RA, 2002, AM J TRANSPLANT, V2, P575, DOI 10.1034/j.1600-6143.2002.20701.x; Wu G, 2002, Transpl Infect Dis, V4, P183, DOI 10.1034/j.1399-3062.2002.t01-1-02005.x	15	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2009	360	1					72	76		10.1056/NEJMcps0803420	http://dx.doi.org/10.1056/NEJMcps0803420			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389MI	19118307				2022-12-28	WOS:000262096800011
J	Liu, D; Vader, G; Vromans, MJM; Lampson, MA; Lens, SMA				Liu, Dan; Vader, Gerben; Vromans, Martijn J. M.; Lampson, Michael A.; Lens, Susanne M. A.			Sensing Chromosome Bi-Orientation by Spatial Separation of Aurora B Kinase from Kinetochore Substrates	SCIENCE			English	Article							MICROTUBULE ATTACHMENT; CLEAVAGE FURROW; CELL-DIVISION; SPINDLE; ANAPHASE; COMPLEX; LOCALIZATION; CYTOKINESIS; MECHANISMS; CHECKPOINT	Successful cell division requires that chromosomes attach to opposite poles of the mitotic spindle (bi-orientation). Aurora B kinase regulates chromosome-spindle attachments by phosphorylating kinetochore substrates that bind microtubules. Centromere tension stabilizes bi-oriented attachments, but how physical forces are translated into signaling at individual centromeres is unknown. Using fluorescence resonance energy transfer-based biosensors to measure localized phosphorylation dynamics in living cells, we found that phosphorylation of an Aurora B substrate at the kinetochore depended on its distance from the kinase at the inner centromere. Furthermore, repositioning Aurora B closer to the kinetochore prevented stabilization of bi-oriented attachments and activated the spindle checkpoint. Thus, centromere tension can be sensed by increased spatial separation of Aurora B from kinetochore substrates, which reduces phosphorylation and stabilizes kinetochore microtubules.	[Liu, Dan; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Vader, Gerben; Vromans, Martijn J. M.; Lens, Susanne M. A.] Univ Med Ctr, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands	University of Pennsylvania; Utrecht University; Utrecht University Medical Center	Lampson, MA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	lampson@sas.upenn.edu	Liu, Dan/G-9006-2018	Liu, Dan/0000-0003-4017-3136; Vader, Gerben/0000-0001-5729-0991	American Cancer Society [IRG-78-002-30]; National Institutes of Health [GM083988]; Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research [Vidi 917.66.332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Penn Genome Frontiers Institute; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Kapoor (Rockefeller University) and R. H. Medema (University Medical Center, Utrecht) for their support during the initiation of these studies. We also thank B. E. Black, G. Kops, and R. H. Medema for critical reading of the manuscript and helpful comments and K. V. Le and T. Chiang for assistance with preparing reagents. This work was supported by grants from the American Cancer Society (IRG-78-002-30, M.A.L.), the National Institutes of Health (GM083988, M.A.L.), the Searle Scholars Program (M.A.L.), the Penn Genome Frontiers Institute (M.A.L.), and the Netherlands Organization for Scientific Research (Vidi 917.66.332, S.M.A.L.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	21	408	412	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1350	1353		10.1126/science.1167000	http://dx.doi.org/10.1126/science.1167000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19150808	Green Accepted			2022-12-28	WOS:000263876700044
J	Naldi, L; Rebora, A				Naldi, Luigi; Rebora, Alfredo			Seborrheic Dermatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PIMECROLIMUS CREAM 1-PERCENT; LITHIUM SUCCINATE OINTMENT; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; KETOCONAZOLE 2-PERCENT; COMPARATIVE EFFICACY; SEVERE DANDRUFF; SKIN CONDITIONS; CLINICAL-TRIAL; HIV-INFECTION		[Naldi, Luigi; Rebora, Alfredo] Osped Riuniti Bergamo, Ctr Studi GISED, I-24128 Bergamo, Italy; [Naldi, Luigi] Osped Riuniti Bergamo, Dept Dermatol, I-24128 Bergamo, Italy; [Rebora, Alfredo] Univ Genoa, Dermatol Sect, Dept Endocrinol & Med Sci, Genoa, Italy	Ospedali Riuniti di Bergamo; Ospedali Riuniti di Bergamo; University of Genoa	Naldi, L (corresponding author), Osped Riuniti Bergamo, Ctr Studi GISED, Largo Barozzi 1, I-24128 Bergamo, Italy.	luigi.naldi@gised.it	Naldi, Luigi/AFM-8982-2022; Misery, Laurent/I-1186-2019; Naldi, Luigi/K-6343-2016	Naldi, Luigi/0000-0002-3160-2835; Naldi, Luigi/0000-0002-3160-2835; rebora, alfredo/0000-0001-6233-9980	Boehringer Ingelheim; Research Institute for Fragrance Materials; Italian Medication Agency	Boehringer Ingelheim(Boehringer Ingelheim); Research Institute for Fragrance Materials; Italian Medication Agency	We thank Dr. Olivier Chosidow for his helpful comments.	BERG M, 1989, PHOTODERMATOLOGY, V6, P80; BINDER RL, 1983, ARCH DERMATOL, V119, P473, DOI 10.1001/archderm.119.6.473; CARR MM, 1987, BRIT J DERMATOL, V116, P213, DOI 10.1111/j.1365-2133.1987.tb05814.x; Chosidow O, 2003, DERMATOLOGY, V206, P233, DOI 10.1159/000068904; Comert A, 2007, AM J CLIN DERMATOL, V8, P235; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; DANBY FW, 1993, J AM ACAD DERMATOL, V29, P1008, DOI 10.1016/0190-9622(93)70282-X; Davies DB, 1999, J DERMATOL TREAT, V10, P177, DOI 10.3109/09546639909056025; de Padua CAM, 2008, ALLERGY, V63, P946, DOI 10.1111/j.1398-9995.2008.01728.x; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; Department of Health Education and Welfare (DHEW) National Commission for the Protection of human subjects' of Biomedical and Behavioral Research, 1978, DHEW PUBL; Dreno B, 2003, BRIT J DERMATOL, V148, P1230, DOI 10.1046/j.1365-2133.2003.05328.x; Dreno B, 2002, EUR J DERMATOL, V12, P549; Dunic I, 2004, HIV MED, V5, P50, DOI 10.1111/j.1468-1293.2004.00185.x; Elewski Boni, 2006, J Drugs Dermatol, V5, P646; Elewski Boni E, 2007, J Drugs Dermatol, V6, P1001; Ercis M, 1996, CLIN GENET, V50, P317; FAERGEMANN J, 1986, BRIT J DERMATOL, V114, P695, DOI 10.1111/j.1365-2133.1986.tb04878.x; Firooz A, 2006, ARCH DERMATOL, V142, P1066, DOI 10.1001/archderm.142.8.1066; Foley P, 2003, ARCH DERMATOL, V139, P318, DOI 10.1001/archderm.139.3.318; Freeman Susanne, 2002, Australas J Dermatol, V43, P186, DOI 10.1046/j.1440-0960.2002.00592.x; Gambichler T, 2005, J AM ACAD DERMATOL, V52, P660, DOI 10.1016/j.jaad.2004.08.047; GOULD DJ, 1992, J AM ACAD DERMATOL, V26, P452, DOI 10.1016/0190-9622(92)70071-M; Gupta AK, 2004, J CLIN MICROBIOL, V42, P4253, DOI 10.1128/JCM.42.9.4253-4260.2004; Hay RJ, 1997, CLIN EXP DERMATOL, V22, P3, DOI 10.1046/j.1365-2230.1997.d01-231.x; HIRT M, 1969, J ABNORM PSYCHOL, V74, P486, DOI 10.1037/h0027787; Koca R, 2003, INT J DERMATOL, V42, P632, DOI 10.1046/j.1365-4362.2003.01981.x; Langtry JAA, 1997, CLIN EXP DERMATOL, V22, P216, DOI 10.1046/j.1365-2230.1997.2570678.x; Mahe A, 1996, J AM ACAD DERMATOL, V34, P1084, DOI 10.1016/S0190-9622(96)90295-9; Mallal SA, 1998, J ACQ IMMUN DEF SYND, V17, pS23, DOI 10.1097/00042560-199801001-00008; Moehrle M, 2000, DERMATOLOGY, V201, P146, DOI 10.1159/000018458; PETER RU, 1995, BRIT J DERMATOL, V132, P441, DOI 10.1111/j.1365-2133.1995.tb08680.x; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2002, SKIN PHARMACOL APPL, V15, P434, DOI 10.1159/000066452; Rigopoulos D, 2004, BRIT J DERMATOL, V151, P1071, DOI 10.1111/j.1365-2133.2004.06208.x; Rocha N, 2005, J EUR ACAD DERMATOL, V19, P605, DOI 10.1111/j.1468-3083.2005.01222.x; SEGAL R, 1992, ACTA DERM-VENEREOL, V72, P454; Shuster S, 2005, ARCH DERMATOL, V141, P47, DOI 10.1001/archderm.141.1.47; STRATIGOS JD, 1988, J AM ACAD DERMATOL, V19, P850, DOI 10.1016/S0190-9622(88)70244-3; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017; TEGNER E, 1983, ACTA DERM-VENEREOL, V63, P335; THOMAS DS, 2008, FEMS IMMUNOL ME 0821; Unholzer A, 2002, INFECTION, V30, P373, DOI 10.1007/s15010-002-2196-9; Vena GA, 2005, INT J IMMUNOPATH PH, V18, P745, DOI 10.1177/039463200501800418; Warshaw EM, 2007, J AM ACAD DERMATOL, V57, P257, DOI 10.1016/j.jaad.2006.11.007; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; ZIENICKE H, 1993, MYCOSES, V36, P325, DOI 10.1111/j.1439-0507.1993.tb00776.x	48	77	81	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					387	396		10.1056/NEJMcp0806464	http://dx.doi.org/10.1056/NEJMcp0806464			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19164189				2022-12-28	WOS:000262519900010
J	Battisti, DS; Naylor, RL				Battisti, David. S.; Naylor, Rosamond L.			Historical Warnings of Future Food Insecurity with Unprecedented Seasonal Heat	SCIENCE			English	Article							YIELDS	Higher growing season temperatures can have dramatic impacts on agricultural productivity, farm incomes, and food security. We used observational data and output from 23 global climate models to show a high probability (> 90%) that growing season temperatures in the tropics and subtropics by the end of the 21st century will exceed the most extreme seasonal temperatures recorded from 1900 to 2006. In temperate regions, the hottest seasons on record will represent the future norm in many locations. We used historical examples to illustrate the magnitude of damage to food systems caused by extreme seasonal heat and show that these short- run events could become long-term trends without sufficient investments in adaptation.	[Battisti, David. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Naylor, Rosamond L.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; Stanford University	Battisti, DS (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	battisti@washington.edu; roz@stanford.edu	Battisti, David S/A-3340-2013	Battisti, David S/0000-0003-4871-1293	NSF [SES 0433679]; Tamaki Foundation	NSF(National Science Foundation (NSF)); Tamaki Foundation	This work was made possible by grants from the NSF (grant SES 0433679) and the Tamaki Foundation. We thank M. Baker, M. Burke, W. Falcon, D. Kennedy, S.-H. Kim, D. Lobell, R. Nicholas, K. Niemer Johnson, K. Rennert, and D. Vimont for comments and/or assistance on the draft.	Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; DEBONO A, 2004, ENV ALERT B IMPACTS; Dronin Nikolai M., 2005, CLIMATE DEPENDENCE F; EASTERLING W, 2007, CLIMATE CHANGE 2007, P976; HATHAWAY DE, 1974, BROOKINGS PAPERS EC, V1, P63; *INT FIN STAT DAT, 2008, US GULF PORTS WHEAT; IPCC, 2007, 4 ASS REP SYNTH; JAYNE T, 2008, TRANSFORMATION AGRIF; KANDJI ST, 2006, CLIMATE CHANGE VARIA; LARSEN J, 2006, EARTH POLICY I; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; NAYLOR R, 2008, BOSTON REV, V33, P13; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; PIRARD A, 2005, EUROSURVEILLANCE, V10, P554; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; *WORLD BANK, 2007, WORLD DEV REP 2008 A; World Bank, 2007, AFR DEV IND 2007	19	947	984	14	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					240	244		10.1126/science.1164363	http://dx.doi.org/10.1126/science.1164363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131626				2022-12-28	WOS:000262290600035
J	Mayor, S				Mayor, Susan			Unravelling the secrets of ageing	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEUKOCYTE TELOMERE LENGTH; DISEASE; CANCER					susanmayor@mac.com						ABRAHAM A, 2004, SCI AGING KNOW ENV, V51, P43; ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Guralnih JM, 2008, ARCH INTERN MED, V168, P131, DOI 10.1001/archinternmed.2007.11; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Poonepalli A, 2008, GENE CHROMOSOME CANC, V47, P1098, DOI 10.1002/gcc.20608; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	9	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2009	338								a3024	10.1136/bmj.a3024	http://dx.doi.org/10.1136/bmj.a3024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404PQ	19131385				2022-12-28	WOS:000263165900006
J	Smith, MK; Wood, WB; Adams, WK; Wieman, C; Knight, JK; Guild, N; Su, TT				Smith, M. K.; Wood, W. B.; Adams, W. K.; Wieman, C.; Knight, J. K.; Guild, N.; Su, T. T.			Why Peer Discussion Improves Student Performance on In-Class Concept Questions	SCIENCE			English	Article							EXPLANATIONS	When students answer an in-class conceptual question individually using clickers, discuss it with their neighbors, and then revote on the same question, the percentage of correct answers typically increases. This outcome could result from gains in understanding during discussion, or simply from peer influence of knowledgeable students on their neighbors. To distinguish between these alternatives in an undergraduate genetics course, we followed the above exercise with a second, similar ( isomorphic) question on the same concept that students answered individually. Our results indicate that peer discussion enhances understanding, even when none of the students in a discussion group originally knows the correct answer.	[Smith, M. K.; Wood, W. B.; Knight, J. K.; Guild, N.; Su, T. T.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Adams, W. K.; Wieman, C.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wieman, C.] Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z3, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of British Columbia	Smith, MK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	michelle.k.smith@colorado.edu	Adams, Wendy K/I-7523-2012	KNIGHT, JENNY/0000-0002-0041-5500	University of Colorado Science Education Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087276] Funding Source: NIH RePORTER	University of Colorado Science Education Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.K.S., W.K.A. and J.K.K. were supported by the University of Colorado Science Education Initiative.	CHI MTH, 1994, COGNITIVE SCI, V18, P439, DOI 10.1207/s15516709cog1803_3; COHEN PA, 1982, AM EDUC RES J, V19, P237, DOI 10.2307/1162567; Coleman EB, 1997, J LEARN SCI, V6, P347, DOI 10.1207/s15327809jls0604_1; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; DUNCAN DOUGLAS, 2006, CLICKERS ASTRONOMY C; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; KOTOVSKY K, 1985, COGNITIVE PSYCHOL, V17, P248, DOI 10.1016/0010-0285(85)90009-X; Mazur E., 1997, PEER INSTRUCTION USE; Palinscar A.S., 1984, COGNITION INSTRUCT, V1, P117, DOI [10.1207/s1532690xci0102_1, DOI 10.1207/S1532690XCI0102_1]; Reay NW, 2008, AM J PHYS, V76, P171, DOI 10.1119/1.2820392; SIMON HA, 1976, COGNITIVE PSYCHOL, V8, P165, DOI 10.1016/0010-0285(76)90022-0	12	470	484	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2009	323	5910					122	124		10.1126/science.1165919	http://dx.doi.org/10.1126/science.1165919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119232				2022-12-28	WOS:000262104100055
J	Kremer, JR; Muller, CP				Kremer, Jacques R.; Muller, Claude P.			Measles in Europe-there is room for improvement	LANCET			English	Editorial Material							EPIDEMIC		[Kremer, Jacques R.; Muller, Claude P.] CRP Sante, Inst Immunol, WHO Reg Reference Lab Measles & Rubella, Lab Natl Sante, L-1950 Luxembourg, Luxembourg	Luxembourg Institute of Health	Kremer, JR (corresponding author), CRP Sante, Inst Immunol, WHO Reg Reference Lab Measles & Rubella, Lab Natl Sante, L-1950 Luxembourg, Luxembourg.	Jacques.Kremer@lns.etat.lu						de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; *EUVACNET, 2008, MEASL SURV 1 Q REP 2; *EUVACNET, 2008, MEASL SURV 2 Q REP 2; Friederichs V, 2006, ARCH DIS CHILD, V91, P465, DOI 10.1136/adc.2005.085944; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Kremer JR, 2008, EMERG INFECT DIS, V14, P107, DOI 10.3201/eid1401.070778; Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015; Muscat M, 2009, LANCET, V373, P383, DOI 10.1016/S0140-6736(08)61849-8; van den Hof S, 2002, J INFECT DIS, V186, P1483, DOI 10.1086/344894; Velicko I, 2008, VACCINE, V26, P6980, DOI 10.1016/j.vaccine.2008.09.012; *WHO, 2008, WHO UNICEF CDC REGR; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X	12	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2009	373	9661					356	358		10.1016/S0140-6736(08)61850-4	http://dx.doi.org/10.1016/S0140-6736(08)61850-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	401BC	19131098				2022-12-28	WOS:000262912100005
J	Sun, S; Kondabagil, K; Draper, B; Alam, TI; Bowman, VD; Zhang, Z; Hegde, S; Fokine, A; Rossmann, MG; Rao, VB				Sun, Siyang; Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Bowman, Valorie D.; Zhang, Zhihong; Hegde, Shylaja; Fokine, Andrei; Rossmann, Michael G.; Rao, Venigalla B.			The Structure of the Phage T4 DNA Packaging Motor Suggests a Mechanism Dependent on Electrostatic Forces	CELL			English	Article							ATPASE ACTIVITY; PORTAL PROTEIN; REVEALS; RECONSTRUCTION; VISUALIZATION; ORGANIZATION; GENERATION; MICROSCOPY; RESOLUTION; EVOLUTION	Viral genomes are packaged into "procapsids'' by powerful molecular motors. We report the crystal structure of the DNA packaging motor protein, gene product 17 (gp17), in bacteriophage T4. The structure consists of an N-terminal ATPase domain, which provides energy for compacting DNA, and a C-terminal nuclease domain, which terminates packaging. We show that another function of the C-terminal domain is to translocate the genome into the procapsid. The two domains are in close contact in the crystal structure, representing a "tensed state.'' A cryo-electron microscopy reconstruction of the T4 procapsid complexed with gp17 shows that the packaging motor is a pentamer and that the domains within each monomer are spatially separated, representing a "relaxed state.'' These structures suggest a mechanism, supported by mutational and other data, in which electrostatic forces drive the DNA packaging by alternating between tensed and relaxed states. Similar mechanisms may occur in other molecular motors.	[Sun, Siyang; Bowman, Valorie D.; Fokine, Andrei; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kondabagil, Kiran; Draper, Bonnie; Alam, Tanfis I.; Zhang, Zhihong; Hegde, Shylaja; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Catholic University of America	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu; rao@cua.edu	Fokine, Andrei/A-1330-2013	Rao, Venigalla/0000-0002-0777-6587	U. S. Department of Energy; National Institutes of Health; National Science Foundation [MCB-443899, MCB-423528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	U. S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Petr Leiman, Ping Zhang, Ye Xiang, Paul Chipman, and especially Victor Kostyuchenko for helpful advice on cryo-EM reconstruction. We also thank Anastasia Aksyuk, Petr Leiman, and William Cramer for discussions on the mechanisms of ATP-driven motors. We are grateful to David Stuart, Marc Morais, Petr Leiman, and Bentley Fane for reading and commenting on the manuscript. We thank Sheryl Kelly and Cheryl Towell for help in the preparation of the manuscript. We also thank the staff of the Advanced Photon Source, The General Medicine and Cancer Institutes sector for their help in X-ray diffraction data collection, whose facilities are supported by the U. S. Department of Energy and the National Institutes of Health. This work was supported by National Science Foundation grants to M. G. R (MCB-443899) and V. B. R (MCB-423528).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kanamaru S, 2004, J BIOL CHEM, V279, P40795, DOI 10.1074/jbc.M403647200; Kondabagil KR, 2006, J MOL BIOL, V363, P786, DOI 10.1016/j.jmb.2006.08.054; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RAO VB, 1985, J MOL BIOL, V185, P565, DOI 10.1016/0022-2836(85)90072-5; Rao VB, 2001, J MOL BIOL, V314, P401, DOI 10.1006/jmbi.2001.5169; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rao Venigalla B., 2005, P40; Rentas FJ, 2003, J MOL BIOL, V334, P37, DOI 10.1016/j.jmb.2003.09.028; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; STREISIN.G, 1967, P NATL ACAD SCI USA, V57, P292, DOI 10.1073/pnas.57.2.292; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510	52	181	188	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1251	1262		10.1016/j.cell.2008.11.015	http://dx.doi.org/10.1016/j.cell.2008.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109896	Bronze			2022-12-28	WOS:000261989800016
J	Trivedi, AN; Swaminathan, S; Mor, V				Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent			Insurance Parity and the Use of Outpatient Mental Health Care Following a Psychiatric Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; FEDERAL-EMPLOYEES; SUBSTANCE-ABUSE; SERVICES; QUALITY; LEGISLATION; COVERAGE; BENEFITS; TRENDS; READMISSION	Context Mental health services are typically subject to higher cost sharing than other health services. In 2008, the US Congress enacted legislation requiring parity in insurance coverage for mental health services in group health plans and Medicare Part B. Objective To determine the relationship between mental health insurance parity and the use of timely follow- up care after a psychiatric hospitalization. Design, Setting, and Population We reviewed cost- sharing requirements for outpatient mental health and general medical services for 302 Medicare health plans from 2001 to 2006. Among 43 892 enrollees in 173 health plans who were hospitalized for a mental illness, we determined the relation between parity in cost sharing and receipt of timely outpatient mental health care after discharge using cross- sectional analyses of all Medicare plans and longitudinal analyses of 10 plans that discontinued parity compared with 10 matched control plans that maintained parity. Main Outcome Measures Outpatient mental health visits within 7 and 30 days following a discharge for a psychiatric hospitalization. Results More than three- quarters of Medicare plans, representing 79% of Medicare enrollees, required greater cost sharing for mental health care compared with primary or specialty care. The adjusted rate of follow- up within 30 days after a psychiatric hospitalization was 10.9 percentage points greater ( 95% confidence interval [CI], 4.6- 17.3; P <. 001) in plans with equivalent cost sharing for mental health and primary care compared with plans with mental health cost sharing greater than primary and specialty care cost sharing. The association of parity with follow- up care was increased for enrollees from areas of low income and less education. Rates of follow- up visits within 30 days decreased by 7.7 percentage points ( 95% CI, - 12.9 to - 2.4; P=. 004) in plans that discontinued parity and increased by 7.5 percentage points ( 95% CI, 2.012.9; P=. 008) among control plans that maintained parity ( adjusted difference in difference, 14.2 percentage points; 95% CI, 4.5- 23.9; P=. 007). Conclusion Medicare enrollees in health plans with insurance parity for mental health and primary care have markedly higher use of clinically appropriate mental health services following a psychiatric hospitalization.	[Trivedi, Amal N.; Swaminathan, Shailender; Mor, Vincent] Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence VA Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Dept Community Hlth, Warren Alpert Med Sch, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			Health Policy Scholars Award; Agency for Healthcare Research and Quality [T32 HS000011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER	Health Policy Scholars Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by a Health Policy Scholars Award to Dr Trivedi from the Pfizer Foundation. Dr Swaminathan was supported by a postdoctoral training grant (T32 HS000011) from the Agency for Healthcare Research and Quality, of which Dr Mor is principal investigator.	*AG HEALTHC RES QU, 2004, 2004 NAT HEALTHC QUA; [Anonymous], 2001, INTERSTUDY COMPETITI; Bao YH, 2004, HEALTH SERV RES, V39, P1361, DOI 10.1111/j.1475-6773.2004.00294.x; Barry CL, 2003, HEALTH AFFAIR, V22, P127, DOI 10.1377/hlthaff.22.5.127; Buchmueller TC, 2007, HEALTH AFFAIR, V26, pW483, DOI 10.1377/hlthaff.26.4.w483; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; DORWART RA, 1994, AM J PUBLIC HEALTH, V84, P1229, DOI 10.2105/AJPH.84.8.1229; Druss BG, 2002, AM J PSYCHIAT, V159, P860, DOI 10.1176/appi.ajp.159.5.860; FRANK R, 1999, 7052 NAT BUR EC RES; Frank RG, 2001, NEW ENGL J MED, V345, P1701, DOI 10.1056/NEJM200112063452311; Glied SA, 2006, BETTER BUT NOT WELL; Glied SA, 2008, NEW ENGL J MED, V359, P113, DOI 10.1056/NEJMp0804447; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Harman JS, 2003, J BEHAV HEALTH SER R, V30, P332, DOI 10.1007/BF02287321; Harris KM, 2006, MED CARE, V44, P499, DOI 10.1097/01.mlr.0000215813.16211.00; *HLTH CAR FIN ADM, 301998 HEDIS HLTH CA; Hodgkin D, 2003, MED CARE RES REV, V60, P101, DOI 10.1177/1077558702250248; KEELER E B, 1985, Journal of the American Medical Association, V254, P1926, DOI 10.1001/jama.254.14.1926; KEELER EB, 1988, J HEALTH ECON, V7, P369, DOI 10.1016/0167-6296(88)90021-5; Kerry SM, 1998, BRIT MED J, V316, P549, DOI 10.1136/bmj.316.7130.549; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Klinkenberg WD, 1996, PSYCHIATR SERV, V47, P487; LURIE N, 1989, AM J PUBLIC HEALTH, V79, P640, DOI 10.2105/AJPH.79.5.640; MANNING WG, 1986, J HUM RESOUR, V21, P293, DOI 10.2307/145965; MECHANIC D, 1993, MILBANK Q, V71, P349, DOI 10.2307/3350406; Mechanic D, 2003, PSYCHIAT SERV, V54, P1227, DOI 10.1176/appi.ps.54.9.1227; MECHANIC D, 1995, MILBANK Q, V73, P19, DOI 10.2307/3350312; Nelson EA, 2000, PSYCHIAT SERV, V51, P885, DOI 10.1176/appi.ps.51.7.885; Pacula RL, 2000, HEALTH SERV RES, V35, P263; Patel KK, 2006, HEALTH AFFAIR, V25, P681, DOI 10.1377/hlthaff.25.3.681; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; Regier DA, 2008, HEALTH AFFAIR, V27, pW70, DOI 10.1377/hlthaff.27.1.w70; ROSENFIELD S, 1986, J APPL BEHAV SCI, V22, P411, DOI 10.1177/002188638602200405; Sakauye K, 2005, PSYCHIAT SERV, V56, P795; SCHOENBAUM SC, 1995, PSYCHIATR SERV, V46, P943; SOLOMON P, 1986, HOSP COMMUNITY PSYCH, V37, P708; Sturm R, 1997, JAMA-J AM MED ASSOC, V278, P1533, DOI 10.1001/jama.278.18.1533; Sturm R, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.5.182; Sturm Roland, 2000, J Ment Health Policy Econ, V3, P209; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; WINSTON A, 1977, HOSP COMMUNITY PSYCH, V28, P118; Zuvekas Samuel H., 1998, J Ment Health Policy Econ, V1, P135, DOI 10.1002/(SICI)1099-176X(1998100)1:3<135::AID-MHP17>3.0.CO;2-S	43	31	31	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2008	300	24					2879	2885						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	386ZG	19109116	Green Accepted, Bronze			2022-12-28	WOS:000261920900021
J	McManus, RJ; Glasziou, P; Hayen, A; Mant, J; Padfield, P; Potter, J; Bray, EP; Mant, D				McManus, Richard J.; Glasziou, Paul; Hayen, Andrew; Mant, Jonathan; Padfield, Paul; Potter, John; Bray, Emma P.; Mant, David			Blood pressure self monitoring: questions and answers from a national conference	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; HOME; OHASAMA; RISK; METAANALYSIS; AMLODIPINE; PREDICTION; GUIDELINES		[McManus, Richard J.; Bray, Emma P.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Glasziou, Paul; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Hayen, Andrew] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Padfield, Paul] Univ Edinburgh, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland; [Potter, John] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; University of Oxford; University of Sydney; University of Cambridge; University of Edinburgh; University of East Anglia	McManus, RJ (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	r.j.mcmanus@bham.ac.uk	Mant, David CA/C-7763-2009; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Mant, Jonathan/0000-0002-9531-0268; Bray, Emma/0000-0001-9882-3539; Hayen, Andrew/0000-0003-4046-8030	The National Institute for Health Research Health Technology Assessment; National Institute for Health Research [RP-PG-0606-1153] Funding Source: researchfish	The National Institute for Health Research Health Technology Assessment(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The National Institute for Health Research Health Technology Assessment funded the July conference.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Brown GE, 1930, ANN INTERN MED, V3, P1177, DOI 10.7326/0003-4819-3-12-1177; Brueren MM, 1997, FAM PRACT, V14, P130, DOI 10.1093/fampra/14.2.130; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Fahey T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Imai Y, 1999, HYPERTENS RES-CLIN E, V22, P261, DOI 10.1291/hypres.22.261; Imai Y, 1999, J HYPERTENS, V17, P889, DOI 10.1097/00004872-199917070-00004; Jani B, 2006, J HUM HYPERTENS, V20, P543, DOI 10.1038/sj.jhh.1002016; Johnson KA, 1999, ARCH INTERN MED, V159, P2689, DOI 10.1001/archinte.159.22.2689; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; McAlister FA, 2001, BMJ-BRIT MED J, V322, P908, DOI 10.1136/bmj.322.7291.908; McManus RJ, 2007, J HUM HYPERTENS, V21, P741, DOI 10.1038/sj.jhh.1002217; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; *MED HEALTHC PROD, 2008, MAN MED DEV; Ogedegbe Gbenga, 2006, J Clin Hypertens (Greenwich), V8, P174, DOI 10.1111/j.1524-6175.2006.04872.x; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/00004872-200406000-00009; Ohkubo T, 2004, BLOOD PRESS MONIT, V9, P315, DOI 10.1097/00126097-200412000-00009; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Rogers MAM, 2001, ANN INTERN MED, V134, P1024, DOI 10.7326/0003-4819-134-11-200106050-00008; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Stergiou G, 2004, BMJ-BRIT MED J, V329, P870, DOI 10.1136/bmj.329.7471.870; Thijs L, 1998, ARCH INTERN MED, V158, P481, DOI 10.1001/archinte.158.5.481; Turnbull F, 2003, LANCET, V362, P1527; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	33	26	26	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2008	337								a2732	10.1136/bmj.a2732	http://dx.doi.org/10.1136/bmj.a2732			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394EI	19103628				2022-12-28	WOS:000262428100002
J	Parker, C				Parker, Charles			Eculizumab for paroxysmal nocturnal haemoglobinuria	LANCET			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; TERMINAL COMPLEMENT; NATURAL-HISTORY; COMPONENT; ANTIBODY; MENINGITIS; DEFICIENCY; DIAGNOSIS; DRUGS	The complement system plays a central part in both innate and acquired immunity, but the contribution of complement activation to pathobiology is largely ancillary. An exception to the non-dominant role of complement in disease is the haemolytic anaemia of paroxysmal nocturnal haemoglobinuria (PNH). The intravascular haemolysis that is the clinical hallmark of PNH is a consequence of deficiency of the complement inhibitory proteins decay accelerating factor (DAF, CD55) and membrane inhibitor of reactive lysis (MIRL, CD59). Eculizumab is a humanised monoclonal antibody that binds and prevents activation of complement C5 and the subsequent formation of the cytolytic membrane attack complex of complement. Eculizumab inhibits the intravascular haemolysis of PNH, reduces transfusion requirements, stabilises haemoglobin concentration, and improves quality of life. Although chronic treatment with eculizumab increases the risk of infections with Neisseria meningitides, the drug is generally safe and well tolerated. But as is the case with other drugs developed for treatment of ultra-orphan diseases, eculizumab is expensive, and treatment must continue indefinitely because C5 inhibition does not affect the process (ie, clonal proliferation of haemopoietic stem cells with a mutant phosphatidylinositol glycan complementation class A [PIGA] gene) that underlies PNH. Moreover, due to the heterogeneous nature of the disease, treatment with eculizumab is not appropriate for all patients with PNH.	Univ Utah, Sch Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Parker, C (corresponding author), Univ Utah, Sch Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	Charles.Parker@hsc.utah.edu						Bao L, 2007, SEMIN NEPHROL, V27, P69, DOI 10.1016/j.semnephrol.2006.09.009; Brodsky RA, 2008, ANN INTERN MED, V148, P587, DOI 10.7326/0003-4819-148-8-200804150-00003; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; DACIE J V, 1972, Series Haematologica, V5, P3; de Latour RP, 2008, BLOOD, V112, P3099, DOI 10.1182/blood-2008-01-133918; Ferreira VP, 2007, BLOOD, V110, P2190, DOI 10.1182/blood-2007-04-083170; HAENEY MR, 1980, CLIN EXP IMMUNOL, V40, P16; Hall C, 2003, BLOOD, V102, P3587, DOI 10.1182/blood-2003-01-0009; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; HARRIMAN GR, 1981, J IMMUNOL, V127, P2386; Hill A, 2005, BLOOD, V106, P2559, DOI 10.1182/blood-2005-02-0564; Hill Anita, 2008, Clin Adv Hematol Oncol, V6, P499; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Hillmen P, 2007, BLOOD, V110, P4123, DOI 10.1182/blood-2007-06-095646; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Luzzatto L, 2006, INT J HEMATOL, V84, P104, DOI 10.1532/IJH97.06117; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; Nishimura JI, 2004, MEDICINE, V83, P193, DOI 10.1097/01.md.0000126763.68170.46; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Parker CJ, 2007, NAT REV DRUG DISCOV, V6, P515, DOI 10.1038/nrd2369; Parker CJ, 2007, EXP HEMATOL, V35, P523, DOI 10.1016/j.exphem.2007.01.046; Parker CJ, 2003, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RELATED DISORDERS, P11; PETER G, 1981, PEDIATRICS, V67, P882; Platonov AE, 2003, VACCINE, V21, P4437, DOI 10.1016/S0264-410X(03)00440-7; Richards SJ, 2000, CYTOMETRY, V42, P223, DOI 10.1002/1097-0320(20000815)42:4<223::AID-CYTO2>3.0.CO;2-D; Rother RP, 2004, LUPUS, V13, P328, DOI 10.1191/0961203303lu1021oa; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Ruggenenti P, 2007, EXPERT OPIN PHARMACO, V8, P3159, DOI 10.1517/14656566.8.18.3159; Socie G, 1996, LANCET, V348, P573, DOI 10.1016/S0140-6736(95)12360-1; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Wang Y, 1996, P NATL ACAD SCI USA, V93, P8563, DOI 10.1073/pnas.93.16.8563; YONEMURA Y, 1990, BRIT J HAEMATOL, V74, P108, DOI 10.1111/j.1365-2141.1990.tb02546.x	39	118	122	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					759	767		10.1016/S0140-6736(09)60001-5	http://dx.doi.org/10.1016/S0140-6736(09)60001-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19144399				2022-12-28	WOS:000263725400035
J	Karakis, I; Kosmas, C				Karakis, Ioannis; Kosmas, Christos			Medical Mystery: A Medical Mystery -- Constipation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Karakis, Ioannis] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kosmas, Christos] Georgetown Univ, Sch Med, Washington, DC 20057 USA	Boston University; Georgetown University	Karakis, I (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.			Karakis, Ioannis/0000-0001-5122-7211					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2009	360	4					397	397		10.1056/NEJMicm070665	http://dx.doi.org/10.1056/NEJMicm070665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395JH	19164190				2022-12-28	WOS:000262519900011
J	Vetter, ML; Cardillo, S; Rickels, MR; Iqbal, N				Vetter, Marion L.; Cardillo, Serena; Rickels, Michael R.; Iqbal, Nayyar			Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Review							GASTRIC BYPASS-SURGERY; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; WEIGHT-LOSS; PLASMA GHRELIN; INHIBITORY POLYPEPTIDE; GUT HORMONE; BILIOPANCREATIC DIVERSION; INSULIN SENSITIVITY; GLUCOSE-METABOLISM	Bariatric surgery leads to substantial and durable weight reduction. Nearly 30% of patients who undergo bariatric surgery have type 2 diabetes, and for many of them, diabetes resolves after surgery (84% to 98% for bypass procedures and 48% to 68% for restrictive procedures). Glycemic control improves in part because of caloric restriction but also because gut peptide secretion changes. Gut peptides, which mediate the enteroinsular axis, include the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic peptide, as well as ghrelin and peptide YY. Bariatric surgery (particularly bypass procedures) alters secretion of these gut hormones, which results in enhanced insulin secretion and sensitivity. This review discusses the various bariatric procedures and how they alter the enteroinsular axis. Familiarity with these effects can help physicians decide among the different surgical procedures and avoid postoperative hypoglycemia.	[Vetter, Marion L.] Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Vetter, ML (corresponding author), Hosp Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, 1 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	marion.vetter@uphs.upenn.edu	Rickels, Michael/D-1380-2009	Rickels, Michael/0000-0002-9253-838X				Ballantyne GH, 2006, OBES SURG, V16, P651, DOI 10.1381/096089206776944959; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145; Clements RH, 2004, AM SURGEON, V70, P1; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Colquitt J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub2; Creutzfeldt W, 2005, REGUL PEPTIDES, V128, P87, DOI 10.1016/j.regpep.2004.08.004; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; CROCKETT SE, 1976, DIABETES, V25, P931, DOI 10.2337/diabetes.25.10.931; Cummings DE, 2007, SURG OBES RELAT DIS, V3, P109, DOI 10.1016/j.soard.2007.02.003; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2003, J CLIN ENDOCR METAB, V88, P2999, DOI 10.1210/jc.2003-030705; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Dixon JB, 2003, DIABETIC MED, V20, P127, DOI 10.1046/j.1464-5491.2003.00889.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dunn JP., 2007, CLIN DIABETES, V25, P112, DOI [10.2337/diaclin.25.3.112, DOI 10.2337/DIACLIN.25.3.112]; Faraj M, 2003, J CLIN ENDOCR METAB, V88, P1594, DOI 10.1210/jc.2002-021309; Ferchak CV, 2004, DIABETES-METAB RES, V20, P438, DOI 10.1002/dmrr.507; Fetner R, 2005, SURG OBES RELAT DIS, V1, P597; Fetner Rachel, 2005, Surg Obes Relat Dis, V1, P589, DOI 10.1016/j.soard.2005.09.001; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Folli F, 2007, MED CLIN N AM, V91, P393, DOI 10.1016/j.mcna.2007.01.005; Fruhbeck G, 2004, OBES SURG, V14, P606, DOI 10.1381/096089204323093363; Geloneze B, 2003, OBES SURG, V13, P17, DOI 10.1381/096089203321136539; Goldfine AB, 2007, J CLIN ENDOCR METAB, V92, P4678, DOI 10.1210/jc.2007-0918; Gould J, 2005, J GASTROINTEST SURG, V9, P1117; GREY N, 1971, NEW ENGL J MED, V285, P827, DOI 10.1056/NEJM197110072851504; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holdstock C, 2003, J CLIN ENDOCR METAB, V88, P3177, DOI 10.1210/jc.2002-021734; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; HOROWITZ M, 1984, BRIT J SURG, V71, P435, DOI 10.1002/bjs.1800710610; Kageyama H, 2005, REGUL PEPTIDES, V126, P67, DOI 10.1016/j.regpep.2004.08.031; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KELLEY DE, 1993, J CLIN ENDOCR METAB, V77, P1287, DOI 10.1210/jc.77.5.1287; Korner J, 2005, J CLIN ENDOCR METAB, V90, P359, DOI 10.1210/jc.2004-1076; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Korner J, 2006, OBESITY, V14, P1553, DOI 10.1038/oby.2006.179; LAFERRERE B, 2007, OBESITY, V15, P7; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Levy P, 2007, OBES SURG, V17, P1248, DOI 10.1007/BF02802098; Luque MA, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730465; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Marceau P, 1998, WORLD J SURG, V22, P947, DOI 10.1007/s002689900498; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Morinigo R, 2008, ANN SURG, V247, P270, DOI 10.1097/SLA.0b013e31815f6e77; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Naslund E, 1998, DIGEST DIS SCI, V43, P945, DOI 10.1023/A:1018806129102; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nijhuis J, 2004, OBES SURG, V14, P783, DOI 10.1381/0960892041590980; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Patriti A, 2007, SURGERY, V142, P74, DOI 10.1016/j.surg.2007.03.001; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685; Ponce J, 2004, OBES SURG, V14, P1335, DOI 10.1381/0960892042583932; Pontiroli AE, 2002, J CLIN ENDOCR METAB, V87, P3555, DOI 10.1210/jc.87.8.3555; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; ROSS SA, 1977, DIABETES, V26, P525, DOI 10.2337/diabetes.26.6.525; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schneider BE, 2005, DIABETES CARE, V28, P475, DOI 10.2337/diacare.28.2.475; Scopinaro N, 2005, DIABETES CARE, V28, P2406, DOI 10.2337/diacare.28.10.2406; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Shak JR, 2008, OBES SURG, V18, P1089, DOI 10.1007/s11695-008-9454-6; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sugerman HJ, 2003, ANN SURG, V237, P751, DOI 10.1097/00000658-200306000-00002; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tseng CC, 1996, AM J PHYSIOL-ENDOC M, V270, pE661, DOI 10.1152/ajpendo.1996.270.4.E661; UNGER RH, 1969, ARCH INTERN MED, V123, P261, DOI 10.1001/archinte.123.3.261; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	89	127	140	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2009	150	2					94	U54		10.7326/0003-4819-150-2-200901200-00007	http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397ID	19153412				2022-12-28	WOS:000262655200004
J	Gubb, J				Gubb, James			Have targets done more harm than good in the English NHS? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCIDENT		[Gubb, James] Civitas, London SW1P 2EZ, England		Gubb, J (corresponding author), Civitas, London SW1P 2EZ, England.	james.gubb@civitas.org.uk						Barber M., 2007, INSTRUCTION DELIVER; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; *BMA, 2005, SURV ACC EM WAIT TIM; *CAN HLTH SERV RES, 2008, EUROHEALTH, V14, P37; *DEP HLTH, 2008, HOSP ACT STAT; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; GUBB J, 2008, WHY ARE WE WAITING A, P10; GUBB J, 2008, CHECKING UP DOCTORS; Halligan A., 2007, BR J HLTH MANAG, V13, P288; HALLIGAN A, 2007, BR J HLTH MANAG, V13, P421; Halligan A, 2008, J ROY SOC MED, V101, P480, DOI 10.1258/jrsm.08k019; Jones Daniel., 2006, LEAN THINKING NHS RE; Le Grand J., 2006, MOTIVATION AGENCY PU; Liker J. K., 2004, TOYOTA WAY 14 MANAGE; Mayhew L, 2008, HEALTH CARE MANAG SC, V11, P11, DOI 10.1007/s10729-007-9033-8; NEAVE R, 1990, DEMING DIMENSION; Orendi J, 2008, LANCET, V371, P1401, DOI 10.1016/S0140-6736(08)60610-8; Propper C, 2008, BE J ECON ANAL POLI, V8, DOI 10.2202/1935-1682.1863; Seddon J., 2008, SYSTEM THINKING PUBL, P162; Sheldon T A, 2001, J Health Serv Res Policy, V6, P3, DOI 10.1258/1355819011927125; Walley P, 2003, EMERG MED J, V20, P126, DOI 10.1136/emj.20.2.126; Womack J, 1998, LEAN THINKING BANISH; Young TP, 2008, QUAL SAF HEALTH CARE, V17, P382, DOI 10.1136/qshc.2006.020131; Youngson R., 2008, COMPASSION HEALTHCAR	25	36	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2009	338								a3130	10.1136/bmj.a3130	http://dx.doi.org/10.1136/bmj.a3130			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AE	19151062				2022-12-28	WOS:000263193500004
J	Pinnock, H				Pinnock, Hilary			A woman attending for routine review of her chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FLUTICASONE PROPIONATE; SYMPTOMS; DYSPNEA; RISK; TERM		[Pinnock, Hilary] Univ Edinburgh, Allergy & Resp Res Grp, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Pinnock, H (corresponding author), Univ Edinburgh, Allergy & Resp Res Grp, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk			Chief Scientist Office [PCRCA/08/01] Funding Source: Medline	Chief Scientist Office		Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Brocklebank D, 2001, Health Technol Assess, V5, P1; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; *GEN PRACT AIRW GR, 2006, DIAGN MAN CHRON OBST; Global Initiative for Chronic Obstructive Lung Disease, 2008, GLOB STRAT DIAGN MAN; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; *MAN TOB US WORK G, 2004, VA DOD CLIN PRACT GU; Nannini LJ, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006826, 10.1002/14651858.CD006826.pub2]; National Institute for Clinical Excellence, 2004, THORAX S1, V59, pS1; Nonoyama ML, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005372.pub2; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Schermer T R J, 2004, Prim Care Respir J, V13, P48, DOI 10.1016/j.pcrj.2003.11.005; Scott S, 2006, THORAX, V61, P440, DOI 10.1136/thx.2005.041848; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van Grunsven P, 2003, RESP MED, V97, P1303, DOI 10.1016/j.rmed.2003.08.001; van Manen JG, 2002, THORAX, V57, P412, DOI 10.1136/thorax.57.5.412; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; *WHO, 2001, EV BAS REC TREATM TO; WOLKOVE N, 1989, CHEST, V96, P1247, DOI 10.1378/chest.96.6.1247; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3	26	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2009	338								b70	10.1136/bmj.b70	http://dx.doi.org/10.1136/bmj.b70			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405AA	19147483				2022-12-28	WOS:000263193100002
J	Dede, C				Dede, Chris			Immersive Interfaces for Engagement and Learning	SCIENCE			English	Editorial Material									[Dede, Chris] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University	Dede, C (corresponding author), Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA.	chris_dede@harvard.edu						Baker E, 2007, ASSESSMENT PROBLEM S, P37; Barab Sasha A., 2006, J SCI ED TECHNOLOGY, V16, P59, DOI [10.1007/s10956-006-9033-3, DOI 10.1007/S10956-006-9033-3, 10.1007/S10956-006-9033-3]; Bransford JD., 2000, PEOPLE LEARN; Clarke J., 2006, Educational Technology, V46, P27; CLARKE J, 2007, 2007 COMP SUPP COLL, P141; Dede C., 2000, INNOVATIONS SCI MATH, P361; Dunleavy M, 2009, J SCI EDUC TECHNOL, V18, P7, DOI 10.1007/s10956-008-9119-1; Gee J. P., 2008, ECOLOGY GAMES CONNEC, P21; Klopfer E, 2008, AUGMENTED REALITY RE; Lessiter J, 2001, PRESENCE-TELEOP VIRT, V10, P282, DOI 10.1162/105474601300343612; Mestre J., 2002, TRANSFER LEARNING IS; Nelson B., 2007, J SCI EDUC TECHNOL, V16, P83, DOI [DOI 10.1007/S10956-006-9039-X, 10.1007/s10956-006-9039-x]; Neulight Nina, 2007, J Sci Educ Technol, V16, P47, DOI 10.1007/s10956-006-9029-z; O'Shea P, 2009, INT J GAMING COMPUT-, V1, P1, DOI 10.4018/jgcms.2009010101; Oblinger J. Oblinger, 2005, ED NET GENERATION; Salzman M. C., 1999, P SIGCHI C HUM FACT, P489, DOI [DOI 10.1145/302979.303141, 10.1145/302979.303141]; Schank RC, 2005, LESSONS LEARNING E L; Schwartz DL., 2005, TRANSFER LEARNING MO, P1; Stanney K. M., 2002, HDB VIRTUAL ENV; Steinkuehler C, 2008, J SCI EDUC TECHNOL, V17, P530, DOI 10.1007/s10956-008-9120-8; Zyda M, 2005, COMPUTER, V38, P25, DOI 10.1109/MC.2005.297	21	623	637	12	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2009	323	5910					66	69		10.1126/science.1167311	http://dx.doi.org/10.1126/science.1167311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389OL	19119219				2022-12-28	WOS:000262104100039
J	Galluzzi, L; Kroemer, G				Galluzzi, Lorenzo; Kroemer, Guido			Necroptosis: A Specialized Pathway of Programmed Necrosis	CELL			English	Editorial Material							CELL-DEATH	Necrosis is often viewed as an accidental and unregulated cellular event. However, accumulating evidence suggests that necrosis, like apoptosis, can be executed by regulated mechanisms. Hitomi et al. (2008) now describe an extensive network of genes that mediate a form of programmed necrosis called necroptosis.	[Galluzzi, Lorenzo; Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Galluzzi, Lorenzo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris 11, F-94270 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Kroemer, G (corresponding author), INSERM, U848, F-94805 Villejuif, France.	kroemer@igr.fr	Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6294-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/K-2709-2012; KROEMER, Guido/B-4263-2013	Galluzzi, Lorenzo/0000-0003-2257-8500; KROEMER, Guido/0000-0002-9334-4405				Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	9	390	431	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1161	1163		10.1016/j.cell.2008.12.004	http://dx.doi.org/10.1016/j.cell.2008.12.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109884	Bronze			2022-12-28	WOS:000261989800004
J	Zhao, R; Follows, GA; Beer, PA; Scott, LM; Huntly, BJP; Green, AR; Alexander, DR				Zhao, Rui; Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.; Alexander, Denis R.			Inhibition of the Bcl-x(L) Deamidation Pathway in Myeloproliferative Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; X-L DEAMIDATION; TYROSINE KINASE JAK2; BCL-X; POLYCYTHEMIA-VERA; V617F MUTATION; DNA-DAMAGE; STEM-CELLS; RESISTANCE; APOPTOSIS	Background: The myeloproliferative disorders are clonal disorders with frequent somatic gain-of-function alterations affecting tyrosine kinases. In these diseases, there is an increase in DNA damage and a risk of progression to acute leukemia. The molecular mechanisms in myeloproliferative disorders that prevent apoptosis induced by damaged DNA are obscure. Methods: We searched for abnormalities of the proapoptotic Bcl-x(L) deamidation pathway in primary cells from patients with chronic myeloid leukemia (CML) or polycythemia vera, myeloproliferative disorders associated with the BCR-ABL fusion kinase and the Janus tyrosine kinase 2 (JAK2) V617F mutation, respectively. Results: The Bcl-x(L) deamidation pathway was inhibited in myeloid cells, but not T cells, in patients with CML or polycythemia vera. DNA damage did not increase levels of the amiloride-sensitive sodium-hydrogen exchanger isoform 1 (NHE-1), intracellular pH, Bcl-x(L) deamidation, and apoptosis. Inhibition of the pathway was reversed by enforced alkalinization or overexpression of NHE-1, leading to a restoration of apoptosis. In patients with CML, the pathway was blocked in CD34+ progenitor cells and mature myeloid cells. Imatinib or JAK2 inhibitors reversed inhibition of the pathway in cells from patients with CML and polycythemia vera, respectively, but not in cells from a patient with resistance to imatinib because of a mutation in the BCR-ABL kinase domain. Conclusions: BCR-ABL and mutant JAK2 inhibit the Bcl-x(L) deamidation pathway and the apoptotic response to DNA damage in primary cells from patients with CML or polycythemia vera.	[Zhao, Rui; Alexander, Denis R.] Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England; [Follows, George A.; Beer, Philip A.; Scott, Linda M.; Huntly, Brian J. P.; Green, Anthony R.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zhao, R (corresponding author), Univ Cambridge, Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England.	rui.zhao@bbsrc.ac.uk; arg1000@cam.ac.uk	Scott, Linda/D-9777-2012; huntly, brian JP/E-6725-2014	Scott, Linda/0000-0003-0334-1479; huntly, brian JP/0000-0003-0312-161X; Beer, Philip/0000-0003-3056-5419; Green, Anthony/0000-0002-9795-0218	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council; U.K. Leukaemia Research Fund; Wellcome Trust; U.K. Medical Research Council; Cancer Research UK; National Institute for Health Research Cambridge Biomedical Research Center; U.S. Leukemia and Lymphoma Society; MRC [G116/187] Funding Source: UKRI; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G116/187, G0300723B] Funding Source: researchfish	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Leukaemia Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); U.S. Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Association for International Cancer Research, the Biotechnology and Biological Sciences Research Council, the U.K. Leukaemia Research Fund, the Wellcome Trust, the U.K. Medical Research Council, Cancer Research UK, the National Institute for Health Research Cambridge Biomedical Research Center, and the U.S. Leukemia and Lymphoma Society.	Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Amarante-Mendes GP, 1998, BLOOD, V91, P1700, DOI 10.1182/blood.V91.5.1700.1700_1700_1705; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Amundson SA, 2000, CANCER RES, V60, P6101; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chang CY, 2006, ONCOGENE, V25, P2656, DOI 10.1038/sj.onc.1209294; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fang GF, 2000, BLOOD, V96, P2246, DOI 10.1182/blood.V96.6.2246.h8002246_2246_2253; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kano Y, 2001, BLOOD, V97, P1999, DOI 10.1182/blood.V97.7.1999; Koschmieder S, 2005, BLOOD, V105, P324, DOI 10.1182/blood-2003-12-4369; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kuroda J, 2007, CELL DEATH DIFFER, V14, P1667, DOI 10.1038/sj.cdd.4402168; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Nishii K, 1996, ONCOGENE, V13, P2225; Oetzel C, 2000, CLIN CANCER RES, V6, P1958; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Robinson N. E., 2004, MOL CLOCKS DEAMIDATI; Schiffer CA, 2007, NEW ENGL J MED, V357, P258, DOI 10.1056/NEJMct071828; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Skorski T, 2002, ONCOGENE, V21, P8591, DOI 10.1038/sj.onc.1206087; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Topaly J, 2001, LEUKEMIA, V15, P342, DOI 10.1038/sj.leu.2402041; Zhao R, 2004, CANCER CELL, V5, P37, DOI 10.1016/S1535-6108(03)00333-7; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001	44	71	74	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2008	359	26					2778	2789		10.1056/NEJMoa0804953	http://dx.doi.org/10.1056/NEJMoa0804953			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387KJ	19109573	Bronze			2022-12-28	WOS:000261950800005
J	Wegrzyn, J; Potla, R; Chwae, YJ; Sepuri, NBV; Zhang, QF; Koeck, T; Derecka, M; Szczepanek, K; Szelag, M; Gornicka, A; Moh, A; Moghaddas, S; Chen, Q; Bobbili, S; Cichy, J; Dulak, J; Baker, DP; Wolfman, A; Stuehr, D; Hassan, MO; Fu, XY; Avadhani, N; Drake, JI; Fawcett, P; Lesnefsky, EJ; Larner, AC				Wegrzyn, Joanna; Potla, Ramesh; Chwae, Yong-Joon; Sepuri, Naresh B. V.; Zhang, Qifang; Koeck, Thomas; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Moh, Akira; Moghaddas, Shadi; Chen, Qun; Bobbili, Santha; Cichy, Joanna; Dulak, Jozef; Baker, Darren P.; Wolfman, Alan; Stuehr, Dennis; Hassan, Medhat O.; Fu, Xin-Yuan; Avadhani, Narayan; Drake, Jennifer I.; Fawcett, Paul; Lesnefsky, Edward J.; Larner, Andrew C.			Function of Mitochondrial Stat3 in Cellular Respiration	SCIENCE			English	Article							REGULATORY GENE-PRODUCT; INTERFERON-BETA; COMPLEX-I; GRIM-19; SUBUNIT; PROTEIN; DOMAIN; NADH	Cytokines such as interleukin- 6 induce tyrosine and serine phosphorylation of Stat3 that results in activation of Stat3- responsive genes. We provide evidence that Stat3 is present in the mitochondria of cultured cells and primary tissues, including the liver and heart. In Stat3(-/-) cells, the activities of complexes I and II of the electron transport chain ( ETC) were significantly decreased. We identified Stat3 mutants that selectively restored the protein's function as a transcription factor or its functions within the ETC. In mice that do not express Stat3 in the heart, there were also selective defects in the activities of complexes I and II of the ETC. These data indicate that Stat3 is required for optimal function of the ETC, which may allow it to orchestrate responses to cellular homeostasis.	[Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Chwae, Yong-Joon; Zhang, Qifang; Derecka, Marta; Szczepanek, Karol; Szelag, Magdalena; Gornicka, Agnieszka; Bobbili, Santha; Fawcett, Paul] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Wegrzyn, Joanna; Szelag, Magdalena; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Potla, Ramesh; Stuehr, Dennis] Cleveland State Univ, Dept Biol, Cleveland, OH 44114 USA; [Sepuri, Naresh B. V.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Koeck, Thomas; Stuehr, Dennis] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Derecka, Marta; Szczepanek, Karol; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Gornicka, Agnieszka] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moh, Akira; Fu, Xin-Yuan] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Moghaddas, Shadi; Chen, Qun; Lesnefsky, Edward J.] Case Western Reserve Univ, Div Cardiol, Dept Med, Cleveland, OH 44106 USA; [Baker, Darren P.] Biogenldec, Cambridge, MA 02142 USA; [Wolfman, Alan] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Hassan, Medhat O.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Pathol & Lab Med Serv, Cleveland, OH 44106 USA; [Avadhani, Narayan] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Drake, Jennifer I.; Fawcett, Paul] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Med Serv, Cleveland, OH 44106 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University; University System of Ohio; Cleveland State University; University of Hyderabad; Cleveland Clinic Foundation; Jagiellonian University; Jagiellonian University; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Pennsylvania; Virginia Commonwealth University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu	zhang, qifang/H-5691-2013; Sepuri, Naresh/AAF-2704-2020; Chen, Qun/HGD-0868-2022; zhang, qifang/F-9857-2013	Derecka, Marta/0000-0001-6265-9781; Cichy, Joanna/0000-0002-0552-8344	NIH [CA098924, PO1AG15885]; Office of Research and Development; Medical Research Service Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA098924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development; Medical Research Service Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants CA098924 (A.C.L.) and PO1AG15885 and the Office of Research and Development, Medical Research Service Department of Veterans Affairs (E.J.L.). We thank I. Scheffler for his many suggestions. DHQ was a kind gift from C. Hoppel. This manuscript is dedicated to Joseph Larner in honor of 60 years of scientific achievement and enthusiasm.	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gamero AM, 2006, J BIOL CHEM, V281, P16238, DOI 10.1074/jbc.M509516200; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	14	686	706	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2009	323	5915					793	797		10.1126/science.1164551	http://dx.doi.org/10.1126/science.1164551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	403EV	19131594	Green Accepted, Green Submitted			2022-12-28	WOS:000263066800050
J	Sirotin, YB; Das, A				Sirotin, Yevgeniy B.; Das, Aniruddha			Anticipatory haemodynamic signals in sensory cortex not predicted by local neuronal activity	NATURE			English	Article							INTRINSIC SIGNAL; BOLD FMRI; SPECTROSCOPY; STIMULATION; SPIKES; MAPS; V1	Haemodynamic signals underlying functional brain imaging ( for example, functional magnetic resonance imaging ( fMRI)) are assumed to reflect metabolic demand generated by local neuronal activity, with equal increases in haemodynamic signal implying equal increases in the underlying neuronal activity(1-6). Few studies have compared neuronal and haemodynamic signals in alert animals(7,8) to test for this assumed correspondence. Here we present evidence that brings this assumption into question. Using a dual-wavelength optical imaging technique(9) that independently measures cerebral blood volume and oxygenation, continuously, in alert behaving monkeys, we find two distinct components to the haemodynamic signal in the alert animals' primary visual cortex (V1). One component is reliably predictable from neuronal responses generated by visual input. The other component - of almost comparable strength - is a hither to unknown signal that entrains to task structure independently of visual input or of standard neural predictors of haemodynamics. This latter component shows predictive timing, with increases of cerebral blood volume in anticipation of trial onsets even in darkness. This trial- locked haemodynamic signal could be due to an accompanying V1 arterial pumping mechanism, closely matched in time, with peaks of arterial dilation entrained to predicted trial onsets. These findings ( tested in two animals) challenge the current understanding of the link between brain haemodynamics and local neuronal activity. They also suggest the existence of a novel preparatory mechanism in the brain that brings additional arterial blood to cortex in anticipation of expected tasks.	[Sirotin, Yevgeniy B.; Das, Aniruddha] Columbia Univ, Dept Neurosci, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, WM Keck Ctr Brain Plastic & Cognit, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Mahoney Ctr Brain & Behav, New York, NY 10027 USA; [Das, Aniruddha] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Das, Aniruddha] New York State Psychiat Inst & Hosp, Unit 87, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Das, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	ad2069@columbia.edu		Sirotin, Yevgeniy/0000-0001-7058-0424	Keck foundation; National Institutes of Health; Klingenstein Foundation; Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award; NATIONAL EYE INSTITUTE [R01EY013759] Funding Source: NIH RePORTER	Keck foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Gatsby Initiative in Brain Circuitry; Dana Foundation; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank: K. Korinek for designing and fabricating much of the dual- wavelength optical imaging hardware; P. P. Mitra for the suggestion of making continuous recordings and the use of the Chronux analysis software; E. M. C. Hillman for insights into brain haemodynamic mechanisms; C. Ma, G. Cantone, J. Ordinario, E. Glushenkova, W. Zhang, and M. Bucklin for help with recordings; E. Seidemann and R. Siegel for technical help during our initial setup; C. D. Gilbert and members of the Mahoney Center and the Center for Theoretical Neuroscience at Columbia University for comments on the manuscript. The work was supported by the Keck foundation, grants from the National Institutes of Health, the Klingenstein Foundation, the Gatsby Initiative in Brain Circuitry and the Dana Foundation to A. D. and a National Research Service Award to Y. B. S.	Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lucas B.D., 1981, P 7 INT JOINT C ARTI, P674, DOI DOI 10.5555/1623264.1623280; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; MATSUDA K, 2000, SOC NEUR ABSTR, V26; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PRAHL S, 2007, TABULATED MOLAR EXTI; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; VANDERMOLEN MW, 1989, PSYCHOPHYSIOLOGY, V26, P70; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555	30	296	296	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2009	457	7228					475	U6		10.1038/nature07664	http://dx.doi.org/10.1038/nature07664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395JA	19158795	Green Accepted			2022-12-28	WOS:000262519200046
J	Owen, MJ; Craddock, N				Owen, Michael J.; Craddock, Nick			Diagnosis of functional psychoses: time to face the future	LANCET			English	Editorial Material									[Owen, Michael J.; Craddock, Nick] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, Wales	Cardiff University	Owen, MJ (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, Wales.	owenmj@cardiff.ac.uk						Bramon E, 2001, Curr Psychiatry Rep, V3, P332; BROCKINGTON IF, 1983, PSYCHIAT DEV, V1, P317; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; KENDELL RE, 1987, BRIT MED BULL, V43, P499, DOI 10.1093/oxfordjournals.bmb.a072198; KRAEPELIN E, 1899, PSYCHIAT LEHREBUCH S; Kraepelin E., 1919, MANIC DEPRESSIVE INS; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MARNEROS A, 2006, OVERLAP AFFECTIVE SC; Owen MJ, 2007, SCHIZOPHRENIA BULL, V33, P905, DOI 10.1093/schbul/sbm053	12	29	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					190	191		10.1016/S0140-6736(09)60053-2	http://dx.doi.org/10.1016/S0140-6736(09)60053-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QB	19150691				2022-12-28	WOS:000262537500006
J	van Marrewijk, CJ; Mujakovic, S; Fransen, GAJ; Numans, ME; de Wit, NJ; Muris, JWM; van Oijen, MGH; Jansen, JBMJ; Grobbee, DE; Knottnerus, JA; Laheij, RJF				van Marrewijk, Corine J.; Mujakovic, Suhreta; Fransen, Gerdine A. J.; Numans, Mattijs E.; de Wit, Niek J.; Muris, Jean W. M.; van Oijen, Martijn G. H.; Jansen, Jan B. M. J.; Grobbee, Diederik E.; Knottnerus, J. Andre; Laheij, Robert J. F.			Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H-2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial	LANCET			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; UNINVESTIGATED DYSPEPSIA; GENERAL-PRACTICE; MANAGEMENT; OMEPRAZOLE; ENDOSCOPY; HEARTBURN; THERAPY; MULTICENTER; RANITIDINE	Background Substantial physician workload and high costs are associated with the treatment of dyspepsia in primary health care. Despite the availability of consensus statements and guidelines, the most cost-effective empirical strategy for initial management of the condition remains to be determined. We compared step-up and step-down treatment strategies for initial management of patients with new onset dyspepsia in primary care. Methods Patients aged 18 years and older who consulted with their family doctor for new onset dyspepsia in the Netherlands were eligible for enrolment in this double-blind, randomised controlled trial. Between October, 2003, and January, 2006, 664 patients were randomly assigned to receive stepwise treatment with antacid, H-2-receptor antagonist, and proton pump inhibitor (step-up; n=341), or these drugs in the reverse order (step-down; n=323), by use of a computer-generated sequence with blocks of six. Each step lasted 4 weeks and treatment only continued with the next step if symptoms persisted or relapsed within 4 weeks. Primary outcomes were symptom relief and cost-effectiveness of initial management at 6 months. Analysis was by intention to treat (ITT); the ITT population consisted of all patients with data for the primary outcome at 6 months. This trial is registered with ClinicalTrials.gov, number NCT00247715. Findings 332 patients in the step-up, and 313 in the step-down group reached an endpoint with sufficient data for evaluation; the main reason for dropout was loss to follow-up. Treatment success after 6 months was achieved in 238 (72%) patients in the step-up group and 219 (70%) patients in the step-down group (odds ratio 0.92, 95% CI 0.7-1.3). The average medical costs were lower for patients in the step-up group than for those in the step-down group ((euro)228 vs (euro)245; p=0 . 0008), which was mainly because of costs of medication. One or more adverse drug events were reported by 94 (28%) patients in the step-up and 93 (29%) patients in the step-down group. All were minor events, including (other) dyspeptic symptoms, diarrhoea, constipation, and bad/dry taste. Interpretation Although treatment success with either step-up or step-down treatment is similar, the step-up strategy is more cost effective at 6 months for initial treatment of patients with new onset dyspeptic symptoms in primary care. Funding The Netherlands Organisation for Health Research and Development.	[van Marrewijk, Corine J.; van Oijen, Martijn G. H.; Jansen, Jan B. M. J.; Laheij, Robert J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands; [Mujakovic, Suhreta; Numans, Mattijs E.; de Wit, Niek J.; Grobbee, Diederik E.] Univ Utrecht, Med Ctr, Julius Ctr Primary Care & Hlth Sci, Utrecht, Netherlands; [Fransen, Gerdine A. J.; Muris, Jean W. M.; Knottnerus, J. Andre] Maastricht Univ, Dept Gen Practice, Caphri, Maastricht, Netherlands	Radboud University Nijmegen; Utrecht University; Maastricht University	van Marrewijk, CJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	c.vanmarrewijk@antrg.umcn.nl	van Marrewijk, Corine/D-2053-2016; Grobbee, Diederick/C-7651-2014; Fransen, Gerdine/A-2860-2016; Knottnerus, Johannes A/A-3829-2009; Knottnerus, Andre/F-4866-2013	van Marrewijk, Corine/0000-0002-9547-908X; Grobbee, Diederick/0000-0003-4472-4468; Muris, Jean/0000-0002-8780-476X	DIAMOND [945-03-052]	DIAMOND	We thank the general Practitioners for including patients in our trial and collecting the medical data. We are also grateful to the Dutch College of General Practitioners (NHG) and the Dutch Institute for Healthcare Improvement (CBO) for their support of our trial, to Leo van Rossum for his advice and support in data-management, to Annie van Schaik for her work and support in the laboratory, and to all the patients who participated. The Netherlands Organisation for Health Research and Development (ZonMw) financially supported the DIAMOND project (grant number 945-03-052).	Armstrong D, 2005, ALIMENT PHARM THER, V21, P1189, DOI 10.1111/j.1365-2036.2005.02466.x; Beck IT, 2002, AM J GASTROENTEROL, V97, P503; Bovenschen HJ, 2006, DIGEST DIS SCI, V51, P1509, DOI 10.1007/s10620-006-9120-6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chey WD, 2004, ALIMENT PHARM THER, V19, P1, DOI 10.1111/j.0953-0673.2004.01829.x; COLINJONES DG, 1988, LANCET, V1, P576; *CVZ, 2006, MED COSTS; *CVZ, 2006, PHARM PREC; Delamothe T, 2008, BRIT MED J, V336, P54, DOI 10.1136/bmj.39455.401817.80; Delaney B, 2005, COCHRANE DB SYST REV, V4; DROSSMAN DA, 2000, ROME, V2; Festen HPM, 1999, AM J GASTROENTEROL, V94, P931; Fransen GAJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-16; Goves J, 1998, ALIMENT PHARM THERAP, V12, P147; *GR, 2000, 200026 HLTH COUNC NE; GRAINGER SL, 1994, POSTGRAD MED J, V70, P154, DOI 10.1136/pgmj.70.821.154; Heading RC, 1999, SCAND J GASTROENTERO, V34, P3, DOI 10.1080/003655299750025200; HEADING RC, 1991, SCAND J GASTROENTERO, V26, P1, DOI 10.3109/00365529109109529; HOLDSTOCK G, 1981, GUT, V22, P673, DOI 10.1136/gut.22.8.673; Howden CW, 2001, AM J GASTROENTEROL, V96, P1704, DOI 10.1111/j.1572-0241.2001.03861.x; Inadomi JM, 2003, AM J GASTROENTEROL, V98, P1940, DOI 10.1016/S0002-9270(03)00628-2; Jones R, 2001, ALIMENT PHARM THER, V15, P765, DOI 10.1046/j.1365-2036.2001.00985.x; Laheij RJF, 2004, J CLIN GASTROENTEROL, V38, P490, DOI 10.1097/01.mcg.0000123164.86324.24; Laheij RJF, 1997, GASTROENTEROLOGY, V113, P2023; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Makris N, 2003, INT J TECHNOL ASSESS, V19, P446; Mason I, 1998, ALIMENT PHARM THERAP, V12, P263; Meineche-Schmidt V, 2000, AM J GASTROENTEROL, V95, P2777, DOI 10.1016/S0002-9270(00)01098-4; *NHG CBO, 2004, MULT GUID DYSP ALPH; NICE, 2004, DYSP MAN DYSP AD PRI; OOSTENBRINK JB, 2004, GUIDELINES EC RES ME; Panter SJ, 2004, ALIMENT PHARM THERAP, V19, P981, DOI 10.1111/j.1365-2036.2004.01924.x; *SCOTT INT GUID NE, 2003, 68 SCOTT INT GUID NE; Straus WL, 2002, AM J GASTROENTEROL, V97, P1951; Talley Nicholas J, 2005, Gastroenterology, V129, P1753; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; Talley NJ, 1998, ALIMENT PHARM THER, V12, P1055; van Zanten SJOV, 2005, CAN J GASTROENTEROL, V19, P285, DOI 10.1155/2005/674607; van Zanten SJOV, 2005, AM J GASTROENTEROL, V100, P1477, DOI 10.1111/j.1572-0241.2005.40280.x; Westbrook JI, 2000, SCAND J GASTROENTERO, V35, P227	40	40	41	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 17	2009	373	9659					215	225		10.1016/S0140-6736(09)60070-2	http://dx.doi.org/10.1016/S0140-6736(09)60070-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QB	19150702				2022-12-28	WOS:000262537500024
J	Kamerow, D				Kamerow, Douglas			What should the US surgeon general do?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 13	2009	338								b122	10.1136/bmj.b122	http://dx.doi.org/10.1136/bmj.b122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404ZY	19141498				2022-12-28	WOS:000263192900003
J	Perepichka, DF; Rosei, F				Perepichka, Dmitrii F.; Rosei, Federico			CHEMISTRY Extending Polymer Conjugation into the Second Dimension	SCIENCE			English	Editorial Material							SURFACE; SCIENCE		[Perepichka, Dmitrii F.] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Perepichka, Dmitrii F.; Rosei, Federico] Univ Quebec, Ctr Self Assembled Chem Struct, Varennes, PQ J3X 1S2, Canada; [Rosei, Federico] Univ Quebec, Inst Natl Rech Sci Energie Mat & Telecommun, Varennes, PQ J3X 1S2, Canada	McGill University; University of Quebec; University of Quebec; Institut national de la recherche scientifique (INRS)	Perepichka, DF (corresponding author), McGill Univ, Dept Chem, 801 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	dmitrii.perepichka@mcgill.ca; rosei@emt.inrs.ca	Perepichka, Dmitrii/K-2850-2012; Rosei, Federico/AAH-1159-2021	Perepichka, Dmitrii/0000-0003-2233-416X; 				ABRAHAM FF, 1990, SCIENCE, V249, P393, DOI 10.1126/science.249.4967.393; BAUGHMAN RH, 1987, J CHEM PHYS, V87, P6687, DOI 10.1063/1.453405; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180; Matena M, 2008, ANGEW CHEM INT EDIT, V47, P2414, DOI 10.1002/anie.200704072; Michl J, 2002, P NATL ACAD SCI USA, V99, P4788, DOI 10.1073/pnas.052016299; Miura A, 2003, LANGMUIR, V19, P6474, DOI 10.1021/la027051p; Mullen K, 2008, ACCOUNTS CHEM RES, V41, P511, DOI 10.1021/ar7001446; Okawa Y, 2001, NATURE, V409, P683, DOI 10.1038/35055625; Sakaguchi H, 2005, SCIENCE, V310, P1002, DOI 10.1126/science.1117990; Sakaguchi H, 2004, NAT MATER, V3, P551, DOI 10.1038/nmat1176; Tanaka K, 1998, SYNTHETIC MET, V92, P253, DOI 10.1016/S0379-6779(98)80093-3; TIEKE B, 1976, ANGEW CHEM INT EDIT, V15, P764, DOI 10.1002/anie.197607641; Veld MI, 2008, CHEM COMMUN, P1536, DOI 10.1039/b718865j; Weigelt S, 2008, ANGEW CHEM INT EDIT, V47, P4406, DOI 10.1002/anie.200705079; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f	17	263	263	1	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2009	323	5911					216	217		10.1126/science.1165429	http://dx.doi.org/10.1126/science.1165429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392GG	19131618				2022-12-28	WOS:000262290600024
J	Woo, JS; Lim, JH; Shin, HC; Suh, MK; Ku, B; Lee, KH; Joo, K; Robinson, H; Lee, J; Park, SY; Ha, NC; Oh, BH				Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Joo, Keehyoung; Robinson, Howard; Lee, Jooyoung; Park, Sam-Yong; Ha, Nam-Chul; Oh, Byung-Ha			Structural Studies of a Bacterial Condensin Complex Reveal ATP-Dependent Disruption of Intersubunit Interactions	CELL			English	Article							ESCHERICHIA-COLI; CHROMOSOME CONDENSATION; BACILLUS-SUBTILIS; SMC PROTEINS; CELL-CYCLE; MITOTIC CHROMOSOME; MUKB; DNA; LOCALIZATION; SEGREGATION	Condensins are key mediators of chromosome condensation across organisms. Like other condensins, the bacterial MukBEF condensin complex consists of an SMC family protein dimer containing two ATPase head domains, MukB, and two interacting subunits, MukE and MukF. We report complete structural views of the intersubunit interactions of this condensin along with ensuing studies that reveal a role for the ATPase activity of MukB. MukE and MukF together form an elongated dimeric frame, and MukF's C-terminal winged-helix domains (C-WHDs) bind MukB heads to constitute closed ring-like structures. Surprisingly, one of the two bound C-WHDs is forced to detach upon ATP-mediated engagement of MukB heads. This detachment reaction depends on the linker segment preceding the C-WHD, and mutations on the linker restrict cell growth. Thus ATP-dependent transient disruption of the MukB-MukF interaction, which creates openings in condensin ring structures, is likely to be a critical feature of the functional mechanism of condensins.	[Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea; [Woo, Jae-Sung; Lim, Jae-Hong; Shin, Ho-Chul; Suh, Min-Kang; Ku, Bonsu; Lee, Kwang-Hoon; Oh, Byung-Ha] Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, South Korea; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Institute for Advanced Study (KIAS); United States Department of Energy (DOE); Brookhaven National Laboratory; Yokohama City University; Pusan National University	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Ctr Biomol Recognit, Pohang 790784, South Korea.	bhoh@postech.ac.kr	Woo, Jae-Sung/T-2343-2019; Oh, Byung-Ha/C-2061-2011; Woo, Jae-Sung/J-4531-2017	Woo, Jae-Sung/0000-0001-9163-3433; Woo, Jae-Sung/0000-0001-9163-3433; Shin, Ho-chul/0000-0001-5500-3901; Ku, Bonsu/0000-0003-1784-8975	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF; Core Research Program of POSTECH; Brain Korea 21 Project; NIH institute; National Center for Research Resources	Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF(Korea Science and Engineering Foundation); Core Research Program of POSTECH; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NIH institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Creative Research Initiatives (Center for Biomolecular Interaction) of MOST/KOSEF and partly by Core Research Program of POSTECH. J.-H.L., M.-K.S., H.-C.S., B.K. and K.-H.L. were supported by the Brain Korea 21 Project. This study made use of the beamline 4A at the Pohang Accelerator Laboratory in Korea, the beamline BL-5A at Photon Factory in Japan and the Brookhaven National Laboratory/Biology beamline X29 at the National Synchrotron Light Source in USA. The BNL Biology/PX Mail-in program is supported by the NIH institute, National Center for Research Resources.	Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fennell-Fezzie R, 2005, EMBO J, V24, P1921, DOI 10.1038/sj.emboj.7600680; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Strunnikov AV, 2006, PLASMID, V55, P135, DOI 10.1016/j.plasmid.2005.08.004; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	29	119	121	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 9	2009	136	1					85	96		10.1016/j.cell.2008.10.050	http://dx.doi.org/10.1016/j.cell.2008.10.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	392QX	19135891	Green Submitted, Bronze			2022-12-28	WOS:000262318400017
J	Thomas, VL; Gostin, LO				Thomas, Victoria L.; Gostin, Lawrence O.			The Americans With Disabilities Act Shattered Aspirations and New Hope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Thomas, Victoria L.] Amer Diabet Assoc, Alexandria, VA USA	Georgetown University; American Diabetes Association	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.							Federico SG, 2007, PEDIATRICS, V120, pe1009, DOI 10.1542/peds.2006-3094; *KAIS FAM FDN, 2008, UN PRIM; Long A. B., 2008, NW U LAW REV COLLOQU, V103, P217	3	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 7	2009	301	1					95	97		10.1001/jama.2008.912	http://dx.doi.org/10.1001/jama.2008.912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391FY	19126814				2022-12-28	WOS:000262220400025
J	Ayalon, G; Davis, JQ; Scotland, PB; Bennett, V				Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann			An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan	CELL			English	Article							BRONCHIAL EPITHELIAL-CELLS; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; NEUROMUSCULAR SYNAPSE; BETA-DYSTROGLYCAN; LATERAL MEMBRANE; SPECTRIN; SARCOLEMMA; DYNACTIN	beta-dystroglycan (DG) and the dystrophin- glycoprotein complex (DGC) are localized at costameres and neuromuscular junctions in the sarcolemma of skeletal muscle. We present evidence for an ankyrin-based mechanism for sarcolemmal localization of dystrophin and beta-DG. Dystrophin binds ankyrin-B and ankyrin-G, while beta-DG binds ankyrin-G. Dystrophin and beta-DG require ankyrin- G for retention at costameres but not delivery to the sarcolemma. Dystrophin and beta-DG remain intracellular in ankyrin- B-depleted muscle, where beta-DG accumulates in a juxta-TGN compartment. The neuromuscular junction requires ankyrin- B for localization of dystrophin/utrophin and beta-DG and for maintenance of its postnatal morphology. A Becker muscular dystrophy mutation reduces ankyrin binding and impairs sarcolemmal localization of dystrophin-Dp71. Ankyrin-B also binds to dynactin-4, a dynactin subunit. Dynactin-4 and a subset of microtubules disappear from sarcolemmal sites in ankyrin-B-depleted muscle. Ankyrin-B thus is an adaptor required for sarcolemmal localization of dystrophin, as well as dynactin-4.	[Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ayalon, Gai; Davis, Jonathan Q.; Scotland, Paula B.; Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	v.bennett@cellbio.duke.edu			Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank K. Kizhatil for the plasmid-siRNA constructs, K. P. Campbell for his gift of beta-DG antibody, and L. Davis, J. Hostettler, and J. Hoffman for technical assistance. We also acknowledge P. Mohler and K. Abdi for performing the yeast two-hybrid screen that revealed ankB binding by dyn4/p62. This study was funded in part by the Muscular Dystrophy Association. Author contributions: G.A.: Figures 1-7, Figures S1-S5; J.Q.D.: Figures 5 and 6, Figure S3; P.B.S.: Figure 5; G.A. and V.B. wrote the paper.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Bloch RJ, 2004, J MUSCLE RES CELL M, V25, P590; BOUDRIAU S, 1993, J HISTOCHEM CYTOCHEM, V41, P1013, DOI 10.1177/41.7.8515044; Brancaccio A, 2005, NEUROMUSCULAR DISORD, V15, P825, DOI 10.1016/j.nmd.2005.08.003; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; JOE V, 2003, BIOESSAYS, V25, P25; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; Kordeli E, 1998, J CELL SCI, V111, P2197; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; NELSON WJ, 1984, P NATL ACAD SCI-BIOL, V81, P3292, DOI 10.1073/pnas.81.11.3292; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Roma J, 2004, ACTA NEUROPATHOL, V108, P443, DOI 10.1007/s00401-004-0908-1; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SCHROER TA, 2004, J CELL BIOL, V143, P1305; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; VYBIRAL T, 1992, CELL MOTIL CYTOSKEL, V21, P293, DOI 10.1002/cm.970210405; Williams MW, 2001, J CELL SCI, V114, P751; WINDHOLZ M, 1983, MERCK INDEX, P206	52	102	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 26	2008	135	7					1189	1200		10.1016/j.cell.2008.10.018	http://dx.doi.org/10.1016/j.cell.2008.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	387ZJ	19109891	Bronze			2022-12-28	WOS:000261989800011
J	Watts, G				Watts, Geoff			Profile Werner Hacke: a pioneer in stroke care	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk							0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2008	372	9656					2103	2103		10.1016/S0140-6736(08)61909-1	http://dx.doi.org/10.1016/S0140-6736(08)61909-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386PB	19101372				2022-12-28	WOS:000261894000013
J	Couzin, J				Couzin, Jennifer			Friendship as a Health Factor	SCIENCE			English	News Item																			0	17	17	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2009	323	5913					454	457		10.1126/science.323.5913.454	http://dx.doi.org/10.1126/science.323.5913.454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396JL	19164722				2022-12-28	WOS:000262587900013
